List of Medications
Transcription
List of Medications
List of Medications Last Updated on 19 April 2013 Produced by: Service des relations avec la clientèle Legal deposit — Bibliothèque et Archives nationales du Québec, 2013 ISSN 1913-2794 ISBN 978-2-550-67245-6 Quebec, 17 April 2013 Schedule 1 List of Medications 19 April 2013 Table of Contents 1. 2. 3. 4. 5. 6. Establishing the Prices Indicated on the List of Medications.................................................................................2 Establishing the Price Payable..............................................................................................................................2 Extemporaneous Preparations..............................................................................................................................4 Exceptional Medications .......................................................................................................................................4 Supplies ................................................................................................................................................................5 Conditions, Cases and Circumstances on or in Which the Cost of Any Other Medication is Covered by the Basic Plan, Except the Medications or Classes of Medications Specified Below..................................................6 APPENDIX I: Manufacturers That Have Submitted Different Guaranteed Selling Prices for Wholesalers and Pharmacists APPENDIX II: Drug Wholesalers Accredited by the Minister and Each Wholesaler’s Mark-Up APPENDIX III: Products for Which the Wholesaler’s Mark-Up Is Limited to a Maximum Amount APPENDIX IV: List of Exceptional Medications With Recognized Indications for Payment Sections and Therapeutic Classes 4:00 8:00 10:00 12:00 20:00 24:00 28:00 36:00 40:00 48:00 52:00 56:00 60:00 64:00 68:00 84:00 86:00 88:00 92:00 Antihistamine Drugs Anti-infective Agents Antineoplastic Agents Autonomic Drugs Blood Formation and Coagulation Cardiovascular Drugs Central Nervous System Agents Diagnostic Agents Electrolytic, Caloric and Water Balance Antitussives, Expectorants and Mucolytic Agents EENT Preparations Gastrointestinal Drugs Gold Compounds Heavy Metal Antagonists Hormones and Synthetic Substitutes Skin and Mucous Membrane Agents Smooth Muscle Relaxants Vitamins Unclassified Therapeutic Agents Exceptional Medications Supplies Products for Extemporaneous Preparations Vehicles, Solvents or Adjuvants 1 1. ESTABLISHING THE PRICES INDICATED ON THE LIST OF MEDICATIONS The prices indicated on the List of Medications are established according to the "guaranteed selling price” concept, in keeping with the manufacturer’s commitment and in accordance with the methods of establishing drug prices provided for in section 60 of the Act respecting prescription drug insurance. However, for certain drugs no price is indicated on the list, in which case the price payable is the pharmacist’s cost price. Such drugs may include: – drugs produced by non-accredited manufacturers but considered unique and essential (identified by the symbol “UE” in the “unit price” column); – products for extemporaneous preparations; – solvents, vehicles and adjuvants; – supplies; – drugs listed by generic name only, with no brand name or manufacturer’s name indicated. For drugs that have been withdrawn from the market by the manufacturer, the symbol “W” appears in the “unit price” column. These drugs remain payable during the period of validity of this edition, so that existing stocks can be sold. 1.1 Guaranteed selling price The manufacturer’s commitment stipulates that the manufacturer must submit a guaranteed selling price, per package size, for any drug it wishes to have included on the List of Medications. The number of package sizes is limited to two, and the price submitted must reflect prices for quantities that are multiples of these package sizes. Where the therapeutic use of more than two package sizes has been established, as in the case of certain drugs such as antibiotics in oral suspensions, ophthalmic solutions, and topical creams and ointments, the manufacturer may submit a guaranteed selling price for each package size. The guaranteed selling price must remain in effect during the period for which the List of Medications is valid. The guaranteed selling price may differ for sales to pharmacists and sales to wholesalers, in which case the difference between the pharmacist’s price and the wholesaler’s price must not exceed 6.50% for any package size but may be different for each product in question. For a given product, the difference must be the same for all package sizes. A manufacturer’s guaranteed selling price for sales to wholesalers must be the same for all wholesalers. It should be noted that the guaranteed selling price indicated on the list is the guaranteed selling price for sales to pharmacists. Manufacturers that have submitted different guaranteed selling prices for sales to pharmacists and sales to wholesalers are listed in Appendix I. 2. ESTABLISHING THE PRICE PAYABLE The price paid by the Régie de l’assurance maladie du Québec is the price at which the drug is sold by an accredited manufacturer or wholesaler. This price is established according to the method described below or, in certain cases, is the maximum price indicated on the list. 2.1 Actual purchase price The method used to establish the price payable by the Régie is the actual purchase price method. Under this method, the price paid by the Régie to a pharmacist is the price indicated on the edition of the list that is valid at the time the prescription is filled, taking into account the source of supply and the package size. Where the manufacturer’s name does not appear on the list, the price payable by the Régie is the pharmacist’s cost price. This is the case, for example, with products considered unique and essential, products for which no brand name or manufacturer’s name is indicated, and certain products appearing in the sections entitled Products for Extemporaneous Preparations, Vehicles, Solvents or Adjuvants and Supplies. 2.2 The lowest price For certain drugs (generic names) that have appeared on the List of Medications and that are produced by two or more manufacturers, the lowest price method is used to establish the price payable. The lowest price method is based on the lowest guaranteed selling price for sales to pharmacists that is submitted by a manufacturer for a given package size. 2.2.1 The lowest price method The lowest price method works as follows: – For a given drug (generic name, dosage form, strength), all products for which the manufacturer has submitted a guaranteed selling price are considered insured and therefore appear on the List of Medications. – The price payable is the lowest price, which is the price of the manufacturer that submitted the lowest guaranteed selling price. 2 – Where it exceeds the lowest price, the guaranteed selling price submitted by the manufacturer is payable only where, for particular reasons, the prescriber who issued the prescription wrote on it, in his own handwriting, that no substitutions are allowed. – Where an insured person refuses a substitution and insists on receiving the more expensive product prescribed, the pharmacist may charge that person the difference between the price of the product prescribed and the lowest price (the price reimbursed by the Régie). 2.2.2 Grouping of dosage forms and strengths For the purpose of applying the lowest price method, certain dosage forms or strengths in active ingredients may be grouped together under the same generic name. Thus, under a given generic name, slow-release products are grouped with regular-release products. The price payable is then established on the basis of the price of the least expensive product, taking into account the corresponding dosages. Dosage forms and strengths are not grouped together where, for therapeutic or other reasons, this is not considered desirable. 2.2.3 Exception to the basic principle The lowest price method does not apply to a drug (generic name) that, for therapeutic or other reasons, is not considered desirable even if the drug is produced by two or more manufacturers. 2.3 Maximum amount The Minister may establish a maximum amount payable for a drug, in which case the price payable may not exceed the maximum amount indicated on the list. 2.4 Accredited drug wholesaler’s mark-up The drug wholesaler’s mark-up is payable only if the drug was actually purchased through an accredited wholesaler. For certain expensive drugs, the mark-up may be limited to a maximum amount, under the terms and conditions described below. Accredited drug wholesalers and their mark-ups for the period of validity of the List of Medications are listed in Appendix II. 2.4.1 Maximum mark-up Under the regulatory provisions, the mark-up on certain expensive drugs may be limited to a maximum amount. For these drugs, the wholesaler’s mark-up is limited to a maximum of $39. The products to which this measure applies are those whose guaranteed selling price for sales to wholesalers, for the smallest package size or its indivisible multiple, is $600 or more. The price appearing on the list is the guaranteed selling price for sales to pharmacists and does not include the wholesaler’s mark-up. Products for which the wholesaler’s mark-up is limited to $39 are listed in Appendix III. 2.4.2 Two guaranteed selling prices Where a manufacturer has submitted different guaranteed selling prices for sales to wholesalers and sales to pharmacists, the price payable is established as follows: If the difference between the guaranteed selling prices for sales to wholesalers and sales to pharmacists is equal to or greater than 5%, this difference constitutes the wholesaler’s mark-up. The price payable is then the guaranteed selling price for sales to pharmacists, except in the case of expensive products, for which the mark-up is limited to $39. If the difference between the guaranteed selling prices for sales to wholesalers and sales to pharmacists is less than 5%, the price payable is the guaranteed selling price for sales to wholesalers, increased by the wholesaler’s mark-up. 2.5 Conditions of supply The only products for which pharmacists may bill the Régie are those appearing on the list and purchased through a recognized manufacturer or wholesaler. When obtaining drug supplies, pharmacists must apply sound management practices and make rational purchases based on the quantity of a drug dispensed over a period of at least 30 days. Under this provision, the wholesaler must, in keeping with its commitment, declare the percentage mark-up that it must add exclusively to the manufacturer’s guaranteed selling price for drugs appearing on the list during the period for which it is valid, except drugs for which different selling prices for sales to wholesalers and sales to pharmacists are submitted. 3 2.6 Price institutions payable for drugs supplied – A preparation for topical use composed of a mixture of a drug listed in Class 84:00 Skin and Mucous Membrane Agents of the List of Medications and of one or more of the following products for extemporaneous preparations: salicylic acid, sulfur and tar in association, where applicable, with one or more vehicles, solvents or adjuvants. by Under section 37 of the Pharmacy Act (R.S.Q., c. P10), institutions are authorized to supply drugs to persons other than persons admitted or registered with them. In addition to the responsibilities entrusted to them under the Regulation respecting the application of the Hospital Insurance Act, these institutions may bill the basic prescription drug insurance plan for drugs appearing on the List of Medications drawn up by the Minister pursuant to section 60 of the Act respecting prescription drug insurance, where these drugs are supplied to persons insured under the basic plan. – A preparation for topical use composed of one or more of the following products: salicylic acid, erythromycin, sulfur, tar and hydrocortisone in a cream, ethanol, ointment, oil or lotion base, but not a preparation that is only hydrocortisone-based that has a concentration of less than 1%. In such cases, the price payable to institutions is the lesser of the actual purchase price and the price established according to the method described in the list. 3. – An ophthalmic preparation containing: • amikacin, amphotericine B, cefazolin, ceftazidime, fluconazole, mitomycin, penicillin G, vancomycin or EXTEMPORANEOUS PREPARATIONS 3.1 • gentamicin or tobramycin in concentrations of more than 3 mg/mL or Definition An extemporaneous preparation is any drug prepared by a pharmacist from a prescription, as opposed to an officinal preparation, which is pre-prepared. 3.2 • cyclosporine at a concentration of 1% or 2%. – A solution or oral suspension of folic acid, dexamethasone, methadone, phytonadione or vancomycin. Extemporaneous preparations whose cost is covered by the basic prescription drug insurance plan – One of the following preparations: The cost of an extemporaneous preparation is covered by the basic plan if the preparation is an extemporaneous mixture of products appearing on the List of Medications, is not equivalent to a drug already manufactured, and consists of: – A systemic-effect preparation manufactured from oral forms of drugs already appearing on the List of Medications and consisting of a single active substance. – A mouthwash preparation resulting from the mixture • of two or more of the following drugs in noninjectable form: diphenhydramine hydrochloride, erythromycin, hydroxyzine, ketoconazole, lidocaine, magnesium hydroxide / aluminum hydroxide, nystatin, sucralfate, tetracycline and a corticosteroid, in association, where applicable, with one or more vehicles, solvents or adjuvants or • of an oral form of tranexamic acid with one or more vehicles, solvents or adjuvants. • a topical preparation of nitrogen (mechlorethamine hydrochloride); mustard • a sucralfate-based preparation for rectal use; • a topical preparation containing trinitrate, nifedipine or diltiazem. glyceryl Products for extemporaneous preparations, as well as vehicles, solvents or adjuvants whose price is payable by the Régie are listed in two special sections of the List of Medications. 3.3 Price payable The method applicable for establishing the price payable by the Régie for products for extemporaneous preparations is the price indicated on the list. Where no price is indicated, the price payable is the pharmacist’s cost price. 4. 4.1 EXCEPTIONAL MEDICATIONS Objectives The Measure regarding exceptional medications aim to achieve the following objectives: 4 (a) to ensure that the cost of a drug classified as an exceptional medication is covered by the basic plan only when used for the therapeutic indications recognized by the Institut national d’excellence en santé et en services sociaux. (b) to permit, on an exceptional basis, payment for a drug classified as an exceptional medication where the drug: – is considered effective for limited indications, since neither its effectiveness nor the cost of treatment warrants its regular and continuous use for other indications; – offers no therapeutic advantages to warrant a higher cost than the cost of using products that have the same pharmacotherapeutic properties and that appear on the list, but where these products are not tolerated, are contraindicated, or have been rendered ineffective by the patient’s clinical condition. 4.2 Classification of exceptional medications Drugs corresponding to the definition of exceptional medications are classified separately, in the section entitled Exceptional Medications. 4.3 Authorization for payment and duration of authorization The exceptional medications listed in Appendix IV are insured under the basic plan where the following conditions are fulfilled: (1) in the case of persons whose basic plan coverage is provided by the Régie de l’assurance maladie du Québec, a prior request for authorization, duly completed in accordance with the form prescribed to that effect in the Regulation respecting forms and statements of fees under the Health Insurance Act (R.R.Q., 1981, c. A-29, r. 2) was sent to the Régie; (2) in the case of persons whose basic plan coverage is provided by insurers transacting group insurance or by administrators of private-sector employee benefit plans, a prior request for authorization, if required under the applicable group insurance contract or employee benefit plan, was sent to the insurer or to the administrator of the employee benefit plan, according to the terms and conditions provided for in that contract or plan. Notwithstanding the foregoing, these drugs are covered only for the duration authorized, as the case may be, by the Régie, by the insurer, or by the administrator of the employee benefit plan concerned, if they are prescribed for the therapeutic indications stipulated for each of them. 5. SUPPLIES The List of Medications may include certain supplies considered by the Minister to be essential for the administration of prescription drugs. Supplies whose cost is covered by the basic plan appear on the list in the sections entitled Supplies and Vehicles, Solvents or Adjuvants. 5.1 Price payable The method used to establish the price payable by the Régie for supplies is the method described in the List of Medications. Where no price is indicated, the price payable for supplies is the pharmacist’s cost price. 6. CONDITIONS, CASES AND CIRCUMSTANCES ON OR IN WHICH THE COST OF ANY OTHER MEDICATION IS COVERED BY THE BASIC PLAN, EXCEPT THE MEDICATIONS OR CLASSES OF MEDICATIONS SPECIFIED BELOW 6.1 Objective The purpose of this measure is to provide for the payment, in exceptional circumstances, of a medication that is not on the list or an exceptional medication prescribed for a therapeutic indication not specified on the list for that medication, on or in the conditions, cases and circumstances described below, and to provide for coverage under the basic prescription drug insurance plan of the cost of the medication and the cost of the pharmaceutical services provided by a pharmacist to an eligible person. 6.2 Conditions, cases and circumstances 6.2.1 Conditions A medication not appearing on the list or an exceptional medication that is prescribed for a therapeutic indication not specified on the list for that medication is covered by the basic prescription drug insurance plan on an exceptional basis when no other pharmacological treatment specified on the list or no other medical treatment whose cost is covered under the Health Insurance Act (R.S.Q. chapter A-29) can be considered because the treatment is contraindicated, there is significant intolerance to the treatment, or the treatment has been rendered ineffective due to the clinical condition of the eligible person. That medication must: (1) be manufactured and marketed in Canada and, subject to the fourth paragraph of this section, have been assigned a DIN by Health Canada; or 5 (2) be manufactured and marketed in Canada and have an NPN assigned by Health Canada, on condition that the medication already had been assigned a DIN by the same authority or (3) be an extemporaneous preparation consisting of ingredients marketed in Canada, on condition that there are no medications marketed in Canada of the same form and strength, containing the same ingredients; or (4) be a sterile preparation made by a pharmacist from sterile pharmaceutical products marketed in Canada, at least one of which is not specified on the list for parenteral administration or ophthalmic use, on condition that there are no preparations marketed in Canada of the same form and strength, containing the same ingredients. If, however, the consequences of the severe medical condition are significant functional psychological injury, the injury must be immediate and as a consequence already severely restrict the eligible person's activities or quality of life. The medication is covered by the basic plan if it satisfies every condition specified for both of the following criteria: (3) notwithstanding the degree of severity criteria in section 6.2.1.1, to provide for the administration of a medication required for final phase ambulatory palliative care in the case of a terminal illness. (1) severity of the medical condition; and (2) chronicity, treatment of an acute infection, and palliative care. An exceptional medication referred to in Appendix IV may be covered by the basic plan even if it has not been assigned a DIN by Health Canada, insofar as its coverage is not subject to any exclusion set out in the list. 6.2.1.1 Severity of the medical condition The medication is to be used to treat a severe medical condition of an eligible person for whom there is a specific necessity of an exceptional nature to use the medication, recorded in the person's medical file. "Severe medical condition" means a symptom, illness or severe complication arising from the illness with consequences that pose a serious health threat, such as significant physical or psychological injury, with a high probability that the person will require the use of a number of services in the health network such as frequent medical services or hospitalization if the medication is not administered, and whose severity is, as the case may be: (1) immediate, in that it already severely restricts the afflicted person's activities or quality of life or would, according to the current state of scientific knowledge, lead to significant functional injury or the person's death; or (2) foreseeable in the short term, in that its evolution or complications could affect the eligible person's morbidity or mortality risk. 6.2.1.2 Chronicity, treatment of an acute severe infection, and palliative care The medication is to be used, as the case may be: (1) to treat a chronic medical condition or a complication or manifestation arising from the chronic medical condition provided its degree of severity satisfies subparagraph 1 or 2 of the second paragraph of section 6.2.1.1; (2) to treat an acute severe infection; 6.3 Exclusions Despite the conditions being satisfied for coverage by the basic plan under section 6.2.1 as a medication not on the List or as an exceptional medication prescribed for a therapeutic indication not specified on the list for that medication, a request for payment authorization must be denied for the following medications: (1) (Deleted) (2) medications prescribed for aesthetic or cosmetic purposes; (3) medications baldness; prescribed to treat alopecia or (4) medications prescribed to treat erectile dysfunction; (5) medications prescribed to treat obesity; (6) medications prescribed stimulate appetite; and for cachexia and to (7) oxygen. 6.4 Price payable by the Régie de l’assurance maladie du Québec The price of a medication to which section 6 applies, and for which the Régie de l'assurance maladie du Québec assumes payment for persons whose basic plan coverage is provided by the Régie, is the actual purchase price paid for the medication by the pharmacist. 6 6.5 Payment authorization authorization and duration of The prescriber must send: (1) to the Régie de l’assurance maladie du Québec, in the case of persons whose basic plan coverage is provided by the Régie, a request for prior authorization on the duly completed form provided by the Régie; (2) to the insurer or administrator of the employee benefit plan, in the case of persons whose basic plan coverage is provided by insurers transacting group insurance or by administrators of privatesector employee benefit plans, if it is required by the applicable group insurance contract or benefit plan, a prior request for authorization duly completed in accordance with the terms and conditions of the contract or plan, as the case may be. If the request is accepted, the medication for which payment authorization is sought is covered only for the period authorized by the Régie, by the insurer or by the administrator of the employee benefit plan, as the case may be. 7 APPENDIX I MANUFACTURERS THAT HAVE SUBMITTED DIFFERENT GUARANTEED SELLING PRICES FOR WHOLESALERS AND PHARMACISTS Difference between pharmacist's GSP and wholesaler's GSP Manufacturer * Accord Atlas * Biomed Bionime Del * Erfa * GMP * GSK Health-ULC Lalco * MedFutures Medisure Medline * Nipro Diag * Purdue Red Leaf * Septa * Serono Sterigen * Tyco * Valeo Vida Nutra Accord Healthcare Inc. Laboratoire Atlas Inc. Biomed 2002 Inc. Bionime Corporation Del Pharmaceuticals Inc. Erfa Canada 2012 Inc. Generic Medical Partners Inc. GlaxoSmithKline Inc. Healthpoint Canada ULC Laboratoire Lalco Enr. Medical Futures Inc. Medi + Sure Medline Canada Corporation Nipro Diagnostics Inc. Purdue Pharma Red Leaf Medical Inc. Septa Pharmaceuticals EMD Serono Canada Inc. Sterigen Groupe Tyco Médical Canada Inc. Valeo Pharma Inc. Vida Nutra Pharma Inc. 5% 5,71%, 5,66%, 5,65%, 5,7% 5% 5,66% 5,56% 5% 5% 5% 6,25% 6% 6% 6,5% 2% 6% 5% 6% 5% 5% 4% 6% 5%, 6% 6% * The difference applies only to certain of this manufacturer's products. 2013-04 APPENDIX I - 1 APPENDIX II DRUG WHOLESALERS ACCREDITED BY THE MINISTER AND EACH WHOLESALER'S MARK-UP FAMILIPRIX INC. LE GROUPE JEAN COUTU (PJC) INC. Head office: Head office: FAMILIPRIX INC. 6000, rue Armand-Viau Québec (Québec) G2C 2C5 Mark-up .................................................................... 6.5% LE GROUPE JEAN COUTU (PJC) INC. 530, rue Bériault Longueuil (Québec) J4G 1S8 Mark-up .................................................................... 6.5% Supply source code A Supply source code D MCMAHON DISTRIBUTEUR PHARMACEUTIQUE INC. MCKESSON SERVICES PHARMACEUTIQUES Head office: Head office: MCMAHON DISTRIBUTEUR PHARMACEUTIQUE INC. 12225, boul. Industriel, suite 100 Montréal (P.A.T.) Québec H1B 5M7 Mark-up .................................................................... 6.5% MCKESSON SERVICES PHARMACEUTIQUES 8290, boul. Pie IX Montréal (Québec) H1Z 4E8 Mark-up .................................................................... Supply source code F Supply source code G AMERISOURCE BERGEN CANADA KOHL & FRISCH LIMITED Head office: Head office: AMERISOURCE BERGEN CANADA 10600, boul. du Golf Anjou (Québec) H1J 2Y7 Mark-up .................................................................... 6.5% KOHL & FRISCH LIMITED 7622, Keele Street Concord (Ontario) L4K 2R5 Mark-up .................................................................... Supply source code H Supply source code I SHOPPERS DRUG MART LIMITED DISTRIBUTIONS PHARMAPLUS INC. Head office: Head office: SHOPPERS DRUG MART LIMITED 243, Consumers Road North York (Ontario) M2J 4W8 Mark-up .................................................................... 6.5% Supply source code M INNOMAR STRATEGIES INC. GMD DISTRIBUTION INC. Head office: Head office: 6.5% Supply source code N 6.5% DISTRIBUTIONS PHARMAPLUS INC. 2797, avenue Turbide Beauport (Québec) G1E 3R1 Mark-up .................................................................... Supply source code J INNOMAR STRATEGIES INC. 3450, Harvester Road Burlington (Ontario) L7N 3M7 Mark-up .................................................................... 6.5% GMD DISTRIBUTION INC. 1215, North Service Rd. W. Oakville (Ontario) L6M 2W2 Mark-up .................................................................... 6.5% 6.5% Supply source code O PharmaTrust MedServices Inc. Head office: PharmaTrust MedServices Inc. 2880 Brighton Road, Unit 2 Oakville (Ontario) L6H 5S3 Mark-up .................................................................... 6.5% Supply source code P 2013-04 APPENDIX II - 1 APPENDIX III PRODUCTS FOR WHICH THE WHOLESALER'S MARK-UP IS LIMITED TO A MAXIMUM AMOUNT Manufacturer Brand name Novartis Roche S. & N. Aclasta I.V. Perf. Sol. 5 mg/ 100 mL Actemra I.V. Perf. Sol. 400 mg/20 ml Acticoat Flex 3 (40 cm x 40 cm - 1 600 cm²) Dressing More than 500 cm² (active surface) Adcirca Tab. 20 mg Advagraf L.A. Caps. 5 mg Afinitor Tab. 10 mg Apo-Lamivudine Tab. 300 mg Apo-Olanzapine Tab. Oral Disint. or Tab. 20 mg Aptivus Caps. 250 mg Aranesp Syringe 60 mcg/0.3 mL Aranesp Syringe 80 mcg/0.4 mL Aranesp Syringe 100 mcg/0.5 mL Aranesp Syringe 130 mcg/0.65 mL Aranesp Syringe 150 mcg/0.3 mL Aranesp Syringe 300 mcg/0.6 mL Aranesp Syringe 500 mcg/1.0 mL Atripla Tab. 600 mg - 200 mg - 300 mg Avonex Pen I.M. Inj. Sol. 30 mcg (6 MUI) Avonex PS I.M. Inj. Sol. 30 mcg (6 MUI) Baraclude Tab. 0.5 mg Betaseron Inj. Pd. 0.3 mg Betaseron Inj. Pd. 0.3 mg Betaseron - Initiation pack Kit 0.3 mg Botox I.M. Inj. Pd. 200 UI Celsentri Tab. 150 mg Celsentri Tab. 300 mg Co Bosentan Tab. 62.5 mg Co Bosentan Tab. 125 mg Co Olanzapine Tab. Oral Disint. or Tab. 20 mg Co Temozolomide Caps. 140 mg Co Temozolomide Caps. 140 mg Co Temozolomide Caps. 250 mg Co Temozolomide Caps. 250 mg Complera Tab. 200 mg - 25 mg - 300 mg Copaxone S.C. Inj.Sol (syr) 20 mg/mL Cystadane Oral Pd. 1 g/1.7 mL Lilly Astellas Novartis Apotex Apotex Bo. Ing. Amgen Amgen Amgen Amgen Amgen Amgen Amgen B.M.S.-Gil Biogen Biogen B.M.S. Bayer Bayer Bayer Allergan ViiV ViiV Cobalt Cobalt Cobalt Cobalt Cobalt Cobalt Cobalt Gilead Teva Innov RDT 2013-04 Packaging 1 1 6 56 50 30 100 100 120 4 4 4 4 4 1 1 30 4 4 30 15 45 1 1 60 60 60 60 100 5 20 5 20 30 30 180 g APPENDIX III - 1 Manufacturer Brand name SanofiAven SanofiAven SanofiAven Amgen Amgen Amgen Janss. Inc Janss. Inc Novartis Ferring Lilly Roche Novartis Novartis Serono Serono Gilead Lilly AbbVie Abbott Vertex Pfizer Pfizer Janss. Inc Janss. Inc Merck Eligard Kit 22.5 mg Eligard Kit 30 mg Eligard Kit 45 mg Enbrel S.C. Inj. Pd. 25 mg Enbrel S.C. Inj.Sol (syr) 50 mg/mL Enbrel SureClick S.C. Inj.Sol (syr) 50 mg/mL Eprex Syringe 8 000 UI/0.8 mL Eprex Syringe 10 000 UI/1.0 mL Extavia Inj. Pd. 0.3 mg Firmagon Kit 120 mg Forteo S.C. Inj. Sol. 250 mcg/mL (2.4 mL or 3 mL) Fuzeon S.C. Inj. Pd. 108 mg Gleevec Tab. 100 mg Gleevec Tab. 400 mg Gonal-f Inj. Pd. 1050 UI Gonal-f Sty 900 UI Hepsera Tab. 10 mg Humatrope Cartridge 24 mg Humira S.C. Inj.Sol (syr) 40 mg Humira (pen) S.C. Inj.Sol (syr) 40 mg Incivek Tab. 375 mg Inlyta Tab. 1 mg Inlyta Tab. 5 mg Intelence Tab. 100 mg Intelence Tab. 200 mg Intron A (sans albumine) S.C. Inj.Sol (syr) 60 M UI/ 1.2 mL Invega Sustenna I.M. Inj. Susp. 150 mg/1.5 mL Iressa Tab. 250 mg Isentress Tab. 400 mg Jakavi Tab. 5 mg Jakavi Tab. 15 mg Jakavi Tab. 20 mg Kaletra Tab. 200 mg -50 mg Kivexa Tab. 600 mg - 300 mg Kuvan Tab. 100 mg Lioresal Intrathecal Inj. Sol. 2 mg/mL (5 mL) Lucentis Inj. Sol. 10 mg/mL (0,23ml) Lupron Depot Kit 11.25 mg Lupron Depot Kit 22.5 mg Janss. Inc AZC Merck Novartis Novartis Novartis AbbVie ViiV Biomarin Novartis Novartis AbbVie AbbVie APPENDIX III - 2 Packaging 1 1 1 4 4 4 6 6 15 1 1 60 120 30 1 1 30 1 2 2 168 60 60 120 60 1 1 30 60 60 60 60 120 30 120 5 1 1 1 2013-04 Manufacturer Brand name AbbVie Pfizer Mylan Mylan Mylan Genzyme Amgen Amgen Bayer Valeant Allergan Merck Merck Merck Merck Merck Merck Merck Merck Merck Phmscience Phmscience Merck Janss. Inc Janss. Inc Janss. Inc Merck Astellas Roche Merck Pfizer Ratiopharm Serono Serono Janss. Inc U.T.C. U.T.C. U.T.C. U.T.C. Pfizer Lupron Depot Kit 30 mg Macugen Syringe 0.3 mg Mylan-Bosentan Tab. 62.5 mg Mylan-Bosentan Tab. 125 mg Mylan-Olanzapine Tab. Oral Disint. or Tab. 20 mg Myozyme I.V. Perf. Pd. 50 mg Neupogen Inj. Sol. 300 mcg/mL (1.0 mL) Neupogen Inj. Sol. 300 mcg/mL (1.6mL) Nimotop Tab. 30 mg Nitoman Tab. 25 mg Ozurdex Implant intravitreal 0.7 mg Pegetron Kit 200 mg-50 mcg/0.5 mL Pegetron Kit 200 mg-80 mcg/0.5 mL Pegetron Kit 200 mg-100 mcg/0.5 mL Pegetron Kit 200 mg-120 mcg/0.5 mL Pegetron Kit 200 mg-150 mcg/0.5 mL Pegetron Redipen Kit 200 mg-80 mcg/0.5 mL Pegetron Redipen Kit 200 mg-100 mcg/0.5 mL Pegetron Redipen Kit 200 mg-120 mcg/0.5 mL Pegetron Redipen Kit 200 mg-150 mcg/0.5 mL pms-Bosentan Tab. 62.5 mg pms-Bosentan Tab. 125 mg Posanol Oral Susp. 40 mg/mL Prezista Tab. 75 mg Prezista Tab. 150 mg Prezista Tab. 600 mg Primaxin I.V. Inj. Pd. 500 mg -500 mg Prograf Caps. 5 mg Pulmozyme Sol. Inh. 1 mg/mL (2.5 mL) Puregon Cartridge 900 UI Rapamune Tab. 1 mg ratio-Sildenafil R Tab. 20 mg Rebif S.C. Inj. Sol. 22 mcg/0.5 mL (1,5 mL) Rebif S.C. Inj. Sol. 44 mcg/0.5 mL (1,5 mL) Remicade I.V. Perf. Pd. 100 mg Remodulin Inj. Sol. 1 mg/mL Remodulin Inj. Sol. 2.5 mg/mL Remodulin Inj. Sol. 5 mg/mL Remodulin Inj. Sol. 10 mg/mL Revatio Tab. 20 mg 2013-04 Packaging 1 1 56 56 100 1 10 10 100 112 1 1 1 1 1 1 1 1 1 1 60 60 1 480 240 60 25 100 30 1 100 100 4 4 1 20 ml 20 ml 20 ml 20 ml 90 APPENDIX III - 3 Manufacturer Brand name Celgene Celgene Celgene Celgene GSK GSK GSK GSK B.M.S. B.M.S. B.M.S. Serono Novartis Novartis Novartis Sandoz Sandoz Amgen Janss. Inc Janss. Inc Tercica Tercica Tercica B.M.S. B.M.S. B.M.S. B.M.S. Janss. Inc PPC SanofiAven SanofiAven Pfizer Pfizer Pfizer Roche Roche Novartis Novartis Merck Merck Revlimid Caps. 5 mg Revlimid Caps. 10 mg Revlimid Caps. 15 mg Revlimid Caps. 25 mg Revolade Tab. 25 mg Revolade Tab. 25 mg Revolade Tab. 50 mg Revolade Tab. 50 mg Reyataz Caps. 150 mg Reyataz Caps. 200 mg Reyataz Caps. 300 mg Saizen Cartridge 20 mg Sandostatin LAR I.M. Inj. Susp. 10 mg Sandostatin LAR I.M. Inj. Susp. 20 mg Sandostatin LAR I.M. Inj. Susp. 30 mg Sandoz Bosentan Tab. 62.5 mg Sandoz Bosentan Tab. 125 mg Sensipar Tab. 90 mg Simponi S.C. Inj.Sol (App.) 50 mg/0.5 mL Simponi S.C. Inj.Sol (syr) 50 mg/0.5 mL Somatuline Autogel S.C. Inj.Sol (syr) 60 mg/0.3 mL Somatuline Autogel S.C. Inj.Sol (syr) 90 mg/0.3 mL Somatuline Autogel S.C. Inj.Sol (syr) 120 mg/0.5 mL Sprycel Tab. 20 mg Sprycel Tab. 50 mg Sprycel Tab. 70 mg Sprycel Tab. 100 mg Stelara Syringe 45 mg/0.5 mL Sterile Vancomycin Hydrochloride I.V. Perf. Pd. 500 mg Suprefact Depot Implant 6.3 mg Suprefact Depot 3 mois Implant 9.45 mg Sutent Caps. 12.5 mg Sutent Caps. 25 mg Sutent Caps. 50 mg Tarceva Tab. 100 mg Tarceva Tab. 150 mg Tasigna Caps. 150 mg Tasigna Caps. 200 mg Temodal Caps. 100 mg Temodal Caps. 140 mg APPENDIX III - 4 Packaging 28 28 21 21 14 28 14 28 60 60 30 1 1 1 1 60 60 30 1 1 1 1 1 60 60 60 30 1 25 1 1 28 28 28 30 30 112 112 5 5 2013-04 Manufacturer Brand name Merck Merck Teva Can Celgene Celgene Celgene Novartis Novartis Actelion Actelion Paladin ViiV Gilead Pfizer GSK Biogen Merck Merck Merck Merck Roche B.M.S. Roche Pfizer Merck Merck Merck Merck Merck Temodal Caps. 140 mg Temodal Caps. 250 mg Teva-Olanzapine Tab. Oral Disint. or Tab. 20 mg Thalomid Caps. 50 mg Thalomid Caps. 100 mg Thalomid Caps. 200 mg Tobi Sol. Inh. 300 mg/5 mL Tobi Podhaler Inh. Pd. 28 mg Tracleer Tab. 62.5 mg Tracleer Tab. 125 mg Trelstar LA Kit 11.25 mg Trizivir Tab. 300 mg - 150 mg - 300 mg Truvada Tab. 200mg- 300mg Tygacil I.V. Perf. Pd. 50 mg Tykerb Tab. 250 mg Tysabri I.V. Inj. Sol. 300mg/15ml Unitron-Peg S.C. Inj. Pd. 50 mcg/0.5 mL Unitron-Peg S.C. Inj. Pd. 80 mcg/0.5 mL Unitron-Peg S.C. Inj. Pd. 120 mcg/0.5 mL Unitron-Peg S.C. Inj. Pd. 150 mcg/0.5 mL Valcyte Tab. 450 mg Vepesid Caps. 50 mg Vesanoid Caps. 10 mg Vfend Tab. 200 mg Victrelis Caps. 200 mg Victrelis Triple Kit 200 mg - 200 mg - 80 mcg/0.5 mL Victrelis Triple Kit 200 mg - 200 mg - 100 mcg/0.5 mL Victrelis Triple Kit 200 mg - 200 mg - 120 mcg/0.5 mL Victrelis Triple (84) Kit 200 mg - 200 mg - 150 mcg/0.5 mL Victrelis Triple (98) Kit 200 mg - 200 mg - 150 mcg/0.5 mL Visudyne I.V. Inj. Pd. 15 mg Volibris Tab. 5 mg Volibris Tab. 10 mg Votrient Tab. 200 mg Xeloda Tab. 500 mg Zelboraf Tab. 240 mg Zoladex LA Implant 10.8 mg Zytiga Tab. 250 mg Zyvoxam Tab. 600 mg Merck Novartis GSK GSK GSK Roche Roche AZC Janss. Inc Pfizer 2013-04 Packaging 20 5 100 28 28 28 56 224 56 56 1 60 30 10 70 1 2 2 2 2 60 20 100 30 168 1 1 1 1 1 1 30 30 120 120 56 1 120 20 APPENDIX III - 5 APPENDIX IV LIST OF EXCEPTIONAL MEDICATIONS WITH RECOGNIZED INDICATIONS FOR PAYMENT ABATACEPT: ♦ for treatment of moderate or severe rheumatoid arthritis; Upon initiation of treatment or if the person has been receiving the drug for less than five months: • • the person must, prior to the beginning of treatment, have eight or more joints with active synovitis and one of the following five elements must be present: - a positive rheumatoid factor; - radiologically measured erosions; - a score of more than 1 on the Health Assessment Questionnaire (HAQ); - an elevated C-reactive protein level; - an elevated sedimentation rate, and the disease must still be active despite treatment with two disease-modifying anti-rheumatic drugs, used either concomitantly or not, for at least three months each. Unless there is serious intolerance or a serious contraindication, one of the two drugs must be methotrexate at a dose of 20 mg or more per week. The initial request is authorized for a maximum of five months. When requesting continuation of treatment, the physician must provide information making it possible to establish the treatment's beneficial effects, specifically: • a decrease of at least 20% in the number of joints with active synovitis and one of the following four elements: - a decrease of 20% or more in the C-reactive protein level; - a decrease of 20% or more in the sedimentation rate; - a decrease of 0.20 in the HAQ score; a return to work. Requests for continuation of treatment are authorized for a period of 12 months. Authorizations for abatacept are given for three doses of 10 mg/kg every two weeks, then for 10 mg/kg every four weeks; ♦ for treatment of moderate or severe juvenile idiopathic arthritis (juvenile rheumatoid arthritis and juvenile chronic arthritis) of the polyarticular or systemic type; Upon initiation of treatment or if the person has been receiving the drug for less than five months: • • the person must, prior to the beginning of treatment, have five or more joints with active synovitis and one of the following two elements must be present: - an elevated C-reactive protein level; - an elevated sedimentation rate, and 2 the disease must still be active despite treatment with methotrexate at a dose of 15 mg/M or more (maximum dose of 20 mg) per week for at least three months, unless there is intolerance or a contraindication. APPENDIX IV - 1 The initial request is authorized for a maximum of five months. When requesting continuation of treatment, the physician must provide information making it possible to establish the treatment's beneficial effects, specifically: • a decrease of at least 20% in the number of joints with active synovitis and one of the following six elements: - a decrease of 20% or more in the C-reactive protein level; - a decrease of 20% or more in the sedimentation rate; - an decrease of 0.13 in the Childhood Health Assessment Questionnaire (CHAQ) score or a return to school; - an improvement of at least 20% in the physician's overall assessment (visual analogue scale); - an improvement of at least 20% in the person's or parent's overall assessment (visual analogue scale); - a decrease of 20% or more in the number of affected joints with limited movement. Requests for continuation of treatment are authorized for a maximum of 12 months. Authorizations for abatacept are given for 10 mg/kg every two weeks for three doses, then for 10 mg/kg every four weeks; ABIRATERONE: ♦ for treatment of metastatic castration-resistant prostrate cancer in men: • who have progressed during or following docetaxel-based chemotherapy, unless there is a serious contraindication or intolerance; • whose ECOG performance status is ≤ 2. The maximum duration of each authorization is four months. Upon subsequent requests, the physician must provide evidence of a beneficial clinical effect (absence of disease progression). The ECOG performance status must remain at ≤ 2. ACAMPROSATE: ♦ to maintain abstinence in persons suffering from alcohol dependency who have abstained from alcohol for at least 5 days and who are taking part in a full alcohol management program centred on alcohol abstinence; The maximum duration of each authorization is three months. When requesting continuation of treatment, the physician must provide evidence of a beneficial clinical effect defined by maintained alcohol abstinence. The total maximum duration of treatment is 12 months; ADALIMUMAB: ♦ for treatment of moderate or severe rheumatoid arthritis or of moderate or severe psoriasic arthritis of the rheumatoid type; Upon initiation of treatment or if the person has been receiving the drug for less than five months: • the person must, prior to the beginning of treatment, have eight or more joints with active synovitis and one of the following five elements must be present: - a positive rheumatoid factor for rheumatoid arthritis only; - radiologically measured erosions; APPENDIX IV - 2 • - a score of more than 1 on the Health Assessment Questionnaire (HAQ); - an elevated C-reactive protein level; - an elevated sedimentation rate, and the disease must still be active despite treatment with two disease-modifying anti-rheumatic drugs, used either concomitantly or not, for at least three months each. Unless there is serious intolerance or a serious contraindication, one of the two drugs must be: for rheumatoid arthritis: - methotrexate at a dose of 20 mg or more per week; for psoriasic arthritis of the rheumatoid type: - methotrexate at a dose of 20 mg or more per week, or - sulfasalazine at a dose of 2 000 mg per day. The initial request is authorized for a maximum of five months. When requesting continuation of treatment, the physician must provide information making it possible to establish the treatment's beneficial effects, specifically: • a decrease of at least 20% in the number of joints with active synovitis and one of the following four elements: - a decrease of 20% or more in the C-reactive protein level; - a decrease of 20% or more in the sedimentation rate; - a decrease of 0.20 in the HAQ score; a return to work. Requests for continuation of treatment are authorized for a maximum period of 12 months. For rheumatoid arthritis, authorizations for adalimumab are given for a dose of 40 mg every two weeks. However, after 12 weeks of treatment with adalimumab as monotherapy, an authorization may be given for 40 mg per week. For psoriasic arthritis of the rheumatoid type, authorizations for adalimumab are given for a dose of 40 mg every two weeks; ♦ for treatment of moderate or severe psoriasic arthritis of a type other than rheumatoid; Upon initiation of treatment or if the person has been receiving the drug for less than five months: • • the person must, prior to the beginning of treatment, have at least three joints with active synovitis and a score of more than 1 on the Health Assessment Questionnaire (HAQ), and the disease must still be active despite treatment with two disease-modifying anti-rheumatic drugs, used either concomitantly or not, for at least three months each. Unless there is serious intolerance or a serious contraindication, one of the two drugs must be: - methotrexate at a dose of 20 mg or more per week, or - sulfasalazine at a dose of 2 000 mg per day. The initial request is authorized for a maximum of five months. When requesting continuation of treatment, the physician must provide information making it possible to establish the treatment's beneficial effects, specifically: APPENDIX IV - 3 • a decrease of at least 20% in the number of joints with active synovitis and one of the following four elements: - a decrease of 20% or more in the C-reactive protein level; - a decrease of 20% or more in the sedimentation rate; - a decrease of 0.20 in the HAQ score; a return to work. Requests for continuation of treatment are authorized for a maximum period of 12 months. Authorizations for adalimumab are given for a dose of 40 mg every two weeks; ♦ for treatment of persons suffering from moderate or severe ankylosing spondylitis whose BASDAI score is ≥ 4 on a scale of 0 to 10 and in whom the sequential use of two non-steroidal antiinflammatories at the optimal dose for a period of three months each did not adequately control the disease, unless there is a contraindication; • Upon the initial request, the physician must provide the following information: - the BASDAI score; - the degree of functional injury, according to the BASFI (scale of 0 to 10); The initial request will be authorized for a maximum of five months. • When requesting continuation of treatment, the physician must provide information making it possible to establish the treatment's beneficial effects, specifically: - a decrease of 2.2 points or 50% on the BASDAI scale, compared with the pre-treatment score, or - a decrease of 1.5 points or 43% on the BASFI scale, or a return to work. Requests for continuation of treatment will be authorized for maximum periods of 12 months. Authorizations for adalimumab are given for a maximum of 40 mg every two weeks; ♦ for treatment of moderate or severe intestinal Crohn's disease that is still active despite treatment with corticosteroids and immunosuppressors, unless there is a contraindication or major intolerance to corticosteroids. An immunosuppressor must have been tried for at least eight weeks; Upon the initial request, the physician must indicate the immunosuppressor used as well as the duration of treatment. The initial request is authorized for a maximum of three months, which includes induction treatment at the rate of 160 mg initially and 80 mg on the second week, followed by maintenance treatment with a dosage of 40 mg every two weeks. Upon subsequent requests, the physician must provide evidence of a beneficial clinical effect. Requests for continuation of treatment will be authorized for a maximum period of 12 months. However, if the medical condition justifies increasing the dosage to 40 mg per week as of the 12th week of treatment, authorization will be given for a maximum period of three months. After which, for subsequent authorizations renewals, lasting a maximum of 12 months, the physician will have to demonstrate the clinical benefits obtained with this dosage; APPENDIX IV - 4 ♦ for treatment of moderate or severe intestinal Crohn's disease that is still active despite treatment with corticosteroids, unless there is a contraindication or major intolerance to corticosteroids, where immunosuppressors are contraindicated or not tolerated, or where they have been ineffective in the past during a similar episode after treatment combined with corticosteroids; Upon the initial request, the physician must indicate the nature of the contraindication or the intolerance as well as the immunosuppressor used. The initial request is authorized for a maximum of three months, which includes induction treatment at the rate of 160 mg initially and 80 mg on the second week, followed by maintenance treatment with a dosage of 40 mg every two weeks. Upon subsequent requests, the physician must provide evidence of a beneficial clinical effect. Requests for continuation of treatment will be authorized for a maximum period of 12 months. However, if the medical condition justifies increasing the dosage to 40 mg per week as of the 12th week of treatment, authorization will be given for a maximum period of three months. After which, for subsequent authorizations renewals, lasting a maximum of 12 months, the physician will have to demonstrate the clinical benefits obtained with this dosage; ♦ for treatment of persons suffering from a severe form of chronic plaque psoriasis: • • • • in the presence of a score greater than or equal to 15 on the Psoriasis Area and Severity Index (PASI) or of large plaques on the face, palms or soles or in the genital area; and in the presence of a score greater than or equal to 15 on the Dermatology Quality of Life Index (DQLI) questionnaire; and where a phototherapy treatment of 30 sessions or more for three months has not made it possible to optimally control the disease, unless the treatment is contraindicated, not tolerated or not accessible or unless a treatment of 12 sessions or more for one month has not provided significant improvement in the lesions; and where a treatment with two systemic agents, used concomitantly or not, for at least three months each, has not made it possible to optimally control the disease. Except in the case of serious intolerance or a serious contraindication, these two agents must be: - methotrexate at a dose of 15 mg or more per week; or - cyclosporine at a dose of 3 mg/kg or more per day; or - acitretin at a dose of 25 mg or more per day. The initial request is authorized for a maximum four months. When requesting continuation of treatment, the physician must provide information making it possible to establish the treatment's beneficial effects, specifically: • • • an improvement of at least 75% in the PASI score; or an improvement of at least 50% in the PASI score and a decrease of at least five points on the DQLI questionnaire; or a significant improvement in lesions on the face, palms or soles or in the genital area and a decrease of at least five points on the DQLI questionnaire. Requests for continuation of treatment are authorized for a maximum of six months. APPENDIX IV - 5 Authorizations for adalimumab are given for an induction dose of 80 mg, followed by a maintenance treatment beginning the second week at a dose of 40 mg every two weeks; ADEFOVIR DIPIVOXIL: ♦ for treatment of chronic hepatitis B in persons: • having a resistance to lamivudine as defined by one of the following: − a 1-log increase in HBV-DNA under treatment with lamivudine, confirmed by a second test one month later; − a laboratory trial showing resistance to lamivudine; − a 1-log increase in HBV-DNA under treatment with lamivudine, with viremia greater than 20 000 IU/m; • • • • with cirrhosis that is decompensated or at risk of decompensation, with a Child-Pugh score of > 6; after a liver transplant or where the graft is infected with the hepatitis B virus; infected with HIV but not being treated with antiretrovirals for that condition; not having a resistance to lamivudine and whose viral load is greater than 20 000 IU/mL (HBeAg-positive) or 2 000 IU/mL (HBeAg-negative) prior to the beginning of treatment; ALGLUCOSIDASE ALFA: ♦ for treatment of an infantile-onset (or a rapidly progressive form) of Pompe’s disease, in children whose symptoms appeared before the age of 12 months; When requesting continuation of treatment, the physician must provide evidence of a beneficial clinical effect by the absence of extensive deterioration. Extensive deterioration occurs when the following two criteria are met: • the presence of invasive ventilation; and • an increase of two points or more in the ventricular mass index Z-score in comparison to the previous value. The maximum duration of each authorization is six months. ALISKIREN: ♦ for treatment of arterial hypertension, in association with at least one antihypertensive agent, if there is a therapeutic failure of, intolerance to, or a contraindication for: • a thiazide diuretic; and • an angiotensin converting enzyme inhibitor (ACEI); and • an angiotensin II receptor antagonist (ARA); However, following therapeutic failure of an ACEI, a trial of an ARA is not required and vice versa. ALISKIREN / HYDROCHLOROTHIAZIDE: ♦ for treatment of arterial hypertension if there is a therapeutic failure of a thiazide diuretic and if there is a therapeutic failure of intolerance to, or a contraindication for: • an angiotensin converting enzyme inhibitor (ACEI); and • an angiotensin II receptor antagonist (ARA); APPENDIX IV - 6 However, following therapeutic failure of an ACEI, a trial of an ARA is not required and vice versa. AMBRISENTAN: ♦ for treatment of pulmonary arterial hypertension of WHO functional class III that is either idiopathic or associated with connectivitis and that is symptomatic despite the optimal conventional treatment. Persons must be evaluated and followed up on by physicians working at designated centres specializing in the treatment of pulmonary arterial hypertension; AMLODIPINE BESYLATE / ATORVASTATIN CALCIUM: ♦ for persons who have been receiving a stable-dose treatment with amlodipine and atorvastatin for at least three months; AMPHETAMINE MIXED SALTS: ♦ for treatment of persons suffering from attention deficit disorder and in whom the use of short-acting methylphenidate or of dexamphetamine has not properly controlled the symptoms of the disease. Before it can be concluded that these treatments are ineffective, the stimulant must have been titrated optimally, unless there is proper justification; ANETHOLTRITHION: for treatment of severe xerostomia; + APREPITANT: ♦ As first-line antiemetic therapy for nausea and vomiting during a highly emetic chemotherapy treatment, in association with dexamethasone and a 5-HT3 receptor antagonist. However, the latter medication must be administered during only the first day of the chemotherapy treatment. Authorizations are given for a maximum of three doses of aprepitant per chemotherapy treatment; ATOMOXETINE HYDROCHLORIDE: ♦ for treatment of children and adolescents suffering from attention deficit disorder in whom it has not been possible to properly control the symptoms of the disease with methylphenidate and an amphetamine or for whom these drugs are contraindicated. Before it can be concluded that these drugs are ineffective, they must have been titrated at optimal doses and, in addition, a 12-hour controlled-release form of methylphenidate or a form of amphetamine mixed salts or lisdexamfetamine must have been tried, unless there is proper justification for not complying with these requirements; AXITINIB: ♦ for second-line treatment of a metastatic renal adenocarcinoma characterized by the presence of clear cells after treatment with a tyrosine kinase inhibitor has failed, unless there is a serious contraindication or intolerance, in persons whose ECOG performance status is 0 or 1. The initial authorization is for a maximum duration of four months. APPENDIX IV - 7 Upon subsequent requests, the physician must provide evidence of a complete or partial response or of disease stabilization, confirmed by imaging during the six weeks before the end of the current authorization. In addition, the ECOG performance status must remain at 0 or 1. Subsequent authorizations will also be for maximum durations of four months. AZELAIC ACID: ♦ for treatment of rosacea where a topical preparation of metronidazole is ineffective, contraindicated or poorly tolerated; BETAHISTINE DIHYDROCHLORIDE: ♦ to reduce the severity of vertigo of peripheral origin; BISACODYL: ♦ for treatment of constipation related to a medical condition BOCEPREVIR: ♦ for treatment of persons suffering from chronic hepatitis C genotype 1 who are not HIV-1 infected, in the absence of cirrhosis, and who have never received an anti-HCV treatment, when used concomitantly with a combination of ribavirin / pegylated interferon alfa. Before beginning treatment with boceprevir, the persons must first have received 4 weeks of preliminary treatment with the combination of ribavirin / pegylated interferon alfa. The authorization is granted for a maximum period of 24 weeks. The total duration of treatment, including preliminary treatment, will be 28 weeks if the HCV-RNA viral load is undetectable on treatment week 24. It will be 48 weeks, including preliminary treatment and following the combination of ribavirin / pegylated interferon alfa, if the viral load is detectable on week 8, less than 100 UI/ml on week 12 and undetectable on week 24. ♦ for treatment of persons suffering from chronic hepatitis C genotype 1 who are not HIV-1 infected, in the absence of cirrhosis, and who have experienced a partial response or relapse following treatment combining ribavirin and an interferon, when used concomitantly with a combination of ribavirin / pegylated interferon alfa. Before beginning treatment with boceprevir, the persons must first have received 4 weeks of preliminary treatment with the combination of ribavirin / pegylated interferon alfa. Partial response means a lowering of the viral load (HCV-RNA) of at least 1.8 log10 on week 12, but without having obtained a sustained virological response, while relapse is defined by a viral load (HCV-RNA) that is undetectable at the end of treatment, but detectable thereafter. The initial authorization is granted for a period of 26 weeks. The authorization will be renewed for 6 weeks if the viral load (HCV-RNA) is less than 100 UI/ml on treatment week 12 and undetectable on treatment week 24. In that case, the total duration of treatment, including preliminary treatment, will be 36 weeks. It will be 48 weeks, including preliminary treatment and following the combination of ribavirin / pegylated interferon alfa, if the viral load (HCVRNA) is detectable on week 8, but undetectable on week 24. APPENDIX IV - 8 ♦ for treatment of persons suffering from chronic hepatitis C genotype 1 who are not HIV-1 infected, in the presence of serious hepatic fibrosis or cirrhosis, when used concomitantly with a combination of ribavirin / pegylated interferon alfa. Before beginning treatment with boceprevir, the persons must first have received 4 weeks of preliminary treatment with the combination of ribavirin / pegylated interferon alfa. The initial authorization is granted for a period of 26 weeks. The authorization will be renewed for 18 weeks if the viral load (HCV-RNA) is less than 100 UI/ml on treatment week 12 and undetectable on treatment week 24. In that case, the total duration of treatment, including preliminary treatment, will be 48 weeks. BOCEPREVIR / RIBAVIRIN / PEGYLATED INTERFERON ALFA-2B: ♦ for treatment of persons suffering from chronic hepatitis C genotype 1 who are not HIV-1 infected, in the absence of cirrhosis, and who have never received an anti-HCV treatment, when used concomitantly with a combination of ribavirin / pegylated interferon alfa. Before beginning treatment with boceprevir, the persons must first have received 4 weeks of preliminary treatment with the combination of ribavirin / pegylated interferon alfa-2b. The authorization is granted for a maximum period of 24 weeks. The total duration of treatment, including preliminary treatment, will be 28 weeks if the HCV-RNA viral load is undetectable on treatment week 24. It will be 48 weeks, including preliminary treatment and following the combination of ribavirin / pegylated interferon alfa, if the viral load is detectable on week 8, less than 100 UI/ml on week 12 and undetectable on week 24. ♦ for treatment of persons suffering from chronic hepatitis C genotype 1 who are not HIV-1 infected, in the absence of cirrhosis, and who have experienced a partial response or relapse following treatment combining ribavirin and an interferon, when used concomitantly with a combination of ribavirin / pegylated interferon alfa. Before beginning treatment with boceprevir, the persons must first have received 4 weeks of preliminary treatment with the combination of ribavirin / pegylated interferon alfa-2b. Partial response means a lowering of the viral load (HCV-RNA) of at least 1.8 log10 on week 12, but without having obtained a sustained virological response, while relapse is defined by a viral load (HCV-RNA) that is undetectable at the end of treatment, but detectable thereafter. The initial authorization is granted for a period of 26 weeks. The authorization will be renewed for 6 weeks if the viral load (HCV-RNA) is less than 100 UI/ml on treatment week 12 and undetectable on treatment week 24. In that case, the total duration of treatment, including preliminary treatment, will be 36 weeks. It will be 48 weeks, including preliminary treatment and following the combination of ribavirin / pegylated interferon alfa, if the viral load (HCVRNA) is detectable on week 8, but undetectable on week 24. APPENDIX IV - 9 ♦ for treatment of persons suffering from chronic hepatitis C genotype 1 who are not HIV-1 infected, in the presence of serious hepatic fibrosis or cirrhosis, when used concomitantly with a combination of ribavirin / pegylated interferon alfa. Before beginning treatment with boceprevir, the persons must have first received 4 weeks of preliminary treatment with the combination of ribavirin / pegylated interferon alfa-2b. The initial authorization is granted for a period of 26 weeks. The authorization will be renewed for 18 weeks if the viral load (HCV-RNA) is less than 100 UI/ml on treatment week 12 and undetectable on treatment week 24. In that case, the total duration of treatment, including preliminary treatment, will be 48 weeks. BOSENTAN: ♦ for treatment of pulmonary arterial hypertension of WHO functional class III that is either idiopathic or associated with connectivitis and that is symptomatic despite the optimal conventional treatment; Persons must be evaluated and followed up on by physicians working at designated centres specializing in the treatment of pulmonary arterial hypertension; BOTULINUM TOXIN TYPE A: ♦ for treatment of cervical dystonia, blepharospasm, strabismus and other severe spasticity conditions; ♦ for treatment of adults suffering from severe axillary hyperhidrosis causing significant effects on the functional and psychosocial levels, where an aluminum chloride preparation of at least 20% used for one month or more according to the recommendations to maximize its effect and tolerance has proven ineffective. In the initial request for authorization, the physician must document the above-mentioned effects. Authorization will then be granted for four months for a dose of 100 units of this drug. Upon subsequent requests, the physician must show evidence of a beneficial effect in the form of a decrease in sudation and an observed improvement on the functional and psychosocial levels; BOTULINUM TOXIN TYPE A WITHOUT COMPLEXING PROTEINS: ♦ for treatment of cervical dystonia, blepharospasm and other severe spasticity conditions; BUPRENORPHINE / NALOXONE: ♦ for replacement treatment of opioid dependency: • where methadone has failed, is not tolerated or is contraindicated; or • where a methadone maintenance program is not available or not accessible; CABERGOLINE: ♦ for treatment of hyperprolactinemia in persons for whom bromocriptine or quinagolide is ineffective, contraindicated or not tolerated; Notwithstanding the payment indication set out above, cabergoline remains covered by the basic prescription drug insurance plan for insured persons who used this drug during the 12-month period preceding 1 October 2007 and if its cost was already covered under that plan as part of the recognized indications provided in the appendix hereto. APPENDIX IV - 10 CALCIPOTRIOL / BETAMETHASONE DIPROPIONATE: ♦ for treatment of psoriasis where a vitamin D analogue is ineffective of poorly tolerated; CALCIUM GLUCONATE / CALCIUM LACTATE: ♦ for persons unable to take tablets; CALCIUM GLUCONATE / CALCIUM LACTATE / VITAMIN D: ♦ for persons unable to take tablets; CAPECITABINE: ♦ for treatment of advanced or metastatic breast cancer that has not responded to first-line chemotherapy administered during the advanced or metastatic phase, unless such chemotherapy is contraindicated; ♦ for treatment of colorectal cancer of stage III (stage C according to the Dukes classification) or IV (stage D according to the Dukes classification or metastatic); CARBOXYMETHYLCELLULOSE SODIUM: ♦ for treatment of keratoconjunctivitis sicca or other severe conditions accompanied by markedly reduced tear production; CARBOXYMETHYLCELLULOSE SODIUM / PURITE: ♦ for treatment of keratoconjunctivitis sicca or other severe conditions accompanied by markedly reduced tear production; + CASPOFUNGIN ACETATE: ♦ for treatment of invasive aspergillosis in persons for whom first-line treatment has failed or is contraindicated, or who are intolerant to such a treatment; ♦ for treatment of invasive candidosis in persons for whom treatment with fluconazole has failed or is contraindicated, or who are intolerant to such a treatment; ♦ for treatment of esophageal candidosis in persons for whom treatment with itraconazole or with fluconazole and an amphotericin B formulation has failed or is contraindicated or who are intolerant to such a treatment; CETRORELIX: ♦ for women, as part of an assisted procreation activity; CHORIOGONADOTROPIN ALFA: ♦ for women, as part of an assisted procreation activity; APPENDIX IV - 11 CHORIONIC GONADOTROPIN: ♦ for women, as part of an assisted procreation activity; ♦ for men suffering from hypogonadotropic hypogonadism, as part of an assisted procreation activity. The maximum duration of the initial authorization is 12 months. • for men with spermatogenesis induced by this treatment, continuation of treatment will be granted for a maximum duration of 14 months; • for men without spermatogenesis who have been treated for at least six months, continuation of treatment, in association with a gonadotropin, will be granted for a maximum duration of 24 months. CINACALCET HYDROCHLORIDE: ♦ for treatment of dialysized persons having severe secondary hyperparathyroiditis with an intact parathormone level greater than 88 pmol/L measured twice within a three-month period, despite an optimal phosphate binder and vitamin D based treatment, unless there is significant intolerance to these agents or they are contraindicated, and having: • a corrected calcemia ≥ 2.54 mmol/L or; • a phosphoremia ≥ 1.78 mmol/L or; • a phosphocalcic product ≥ 4.5 mmol2/L2 or; • symptomatic osteoarticular manifestations. The optimal vitamin D based treatment is defined as follows: one minimum weekly dose of 3 mcg of calcitriol or alfacalcidol. + CIPROFLOXACIN HYDROCHLORIDE, I.V. Perf. Sol.: ♦ for treatment of infections where oral ciprofloxacin cannot be used; CLINDAMYCIN PHOSPHATE, Vag. Cr.: ♦ for treatment of bacterial vaginosis during the first trimester of pregnancy; ♦ where intravaginal metronidazole is ineffective, contraindicated or poorly tolerated; CLINDAMYCIN PHOSPHATE, Vag. Cr. (single dose): ♦ where intravaginal metronidazole is ineffective, contraindicated or poorly tolerated; + CLOPIDOGREL BISULFATE, Tab. 75 mg: ♦ for secondary prevention of ischemic vascular manifestations in persons for whom a platelet inhibitor is indicated but for whom acetylsalicylic acid is ineffective, contraindicated or poorly tolerated; ♦ for prevention of ischemic vascular manifestations, in association with acetylsalicylic acid, in persons for whom an angioplasty, with or without the installation of a coronary artery stent, has been performed. The duration of the authorization will be 12 months; APPENDIX IV - 12 ♦ for treatment of acute coronary syndrome in persons: • who are already being treated with acetylsalicylic acid; • who were not previously taking acetylsalicylic acid. The maximum duration of the authorization is 12 months; + CODEINE PHOSPHATE, Syr.: ♦ for treatment of pain in persons unable to take tablets; COLESEVELAM HYDROCHLORIDE: ♦ for treatment of hypercholesterolemia, in persons at high risk of cardiovascular disease: • in association with an HMG-CoA reductase inhibitor (statin) at the optimal dose or at a lower dose in case of intolerance to that dose; • where an HMG-CoA reductase inhibitor (statin) is contraindicated; • where intolerance has led to a cessation of treatment of at least two HMG-CoA reductase inhibitors (statin). COLLAGENASE: ♦ for wound debridement in the presence of devitalized tissue. Authorization is given for a maximal period of 60 days; CYANOCOBALAMINE L.A. Tab. and Oral Sol.: ♦ for persons suffering from a vitamin B12 deficiency; DABIGATRAN ETEXILATE: ♦ in persons with non-valvular atrial fibrillation requiring anticoagulant therapy: • for whom anticoagulation with warfarine or nicoumalone is not within the targeted therapeutic range; or • for whom anticoagulation monitoring with warfarin or nicoumalone is not possible or is not available; DARBEPOETIN ALFA: ♦ for treatment of anemia related to severe chronic renal failure (creatinine clearance less than or equal to 35 mL/min); ♦ for treatment of chronic and symptomatic non-hemolytic anemia not caused by an iron, folic acid or vitamin B12 deficiency; • in persons having a non-myeloid tumour treated with chemotherapy and whose hemoglobin rate is less than 100 g/L. The maximum duration of the initial authorization is three months. When requesting continuation of treatment, the physician must provide evidence of a beneficial effect defined by an increase in the reticulocyte count of at least 40x109/L or an increase in the hemoglobin measurement of at least 10 g/L. A hemoglobin rate under 120 g/L should be targeted. APPENDIX IV - 13 However, for persons suffering from cancer other than those previously specified, darbepeotin alfa remains covered by the basic prescription drug insurance plan until 31 January 2008 insofar as the treatment is already underway on 1 October 2007 and that its cost was already covered under that plan as part of the recognized indications provided in the appendix hereto and that the physician provides evidence of a beneficial effect defined by an increase in the reticulocyte count of at least 40x109/L or an increase in the hemoglobin measurement of at least 10 g/L. DARUNAVIR Tab. 600 mg: ♦ for treatment, in association with other antiretrovirals, of HIV-infected persons: • who have tried, since the beginning of their antiretroviral therapy, at least one therapy that included another protease inhibitor and that resulted: − in a documented virological failure, after at least three months of treatment with an association of several antiretroviral agents; or − in serious intolerance to at least three protease inhibitors, to the point of calling into question the continuation of the antiretroviral treatment; ♦ for first-line treatment, in association with other antiretrovirals, of HIV-infected persons for whom a laboratory test showed an absence of sensitivity to other protease inhibitors, coupled with a resistance to one or the other class of nucleoside reverse transcriptase inhibitors and non-nucleoside reverse transcriptase inhibitors, or to both, and: • whose current viral load and another dating back at least one month are greater than or equal to 500 copies/mL; and • whose current CD4 lymphocyte count and another dating back at least one month are less than or equal to 350/µL; and • for whom the use of darunavir is necessary to establish an effective therapeutic regimen; DASATINIB: ♦ for treatment of chronic myeloid leukemia in the chronic phase in adults: • for whom imatinib or nilotinib has failed or produced a sub-optimal response; or • who have serious intolerance to imatinib or nilotinib; Authorizations will be given for a maximum daily dose of 140 mg for a maximum duration of six months. For continuation of treatment, the physician must provide evidence of a hematologic response. ♦ for treatment of chronic myeloid leukemia in the accelerated phase in adults: • for whom imatinib has failed or produced a sub-optimal response; or • who have serious intolerance to imatinib; Authorizations will be given for a maximum daily dose of 180 mg for a maximum duration of six months. For continuation of treatment, the physician must provide evidence of a hematologic response. APPENDIX IV - 14 ♦ for first-line treatment of chronic myeloid leukemia in the chronic phase in adults having a serious contraindication to imatinib and nilotinib; Authorizations will be given for a maximum daily dose of 100 mg for a maximum duration of six months. For continuation of treatment, the physician must provide evidence of a hematologic response. DENOSUMAB S.C. Inj. Sol. (syr) 60 mg/mL: ♦ for treatment of postmenopausal osteoporosis in women who cannot receive an oral bisphosphonate because of serious intolerance or a contraindication; DENOSUMAB, Inj. Sol. 120 mg/1.7mL ♦ for prevention of bone events in persons suffering from castration-resistant prostate cancer with at least one bone metastasis; ♦ for prevention of bone events in persons suffering from breast cancer with at least one bone metastasis, where pamidronate is not tolerated; DEXAMETHASONE, Intravitreal implant: ♦ for treatment of macula edema secondary to central retinal vein occlusion. The authorization is granted for treatment lasting a maximum of one year, with a maximum of two implants per injured eye. DICLOFENAC SODIUM, Oph. Sol.: ♦ for treatment of ocular inflammation in persons for whom ophthalmic corticosteroids are not indicated; DIPHENHYDRAMINE HYDROCHLORIDE: ♦ for adjuvant treatment of certain psychiatric disorders and of Parkinson’s disease; DIPYRIDAMOLE / ACETYLSALICYLIC ACID: ♦ for secondary prevention of strokes in persons who have already had a stroke or a transient ischemic attack; DOCUSATE CALCIUM: ♦ for treatment of constipation related to a medical condition; DOCUSATE SODIUM: ♦ for treatment of constipation related to a medical condition; APPENDIX IV - 15 + DOLASETRON MESYLATE: ♦ during the first day of: • a moderately or highly emetic chemotherapy treatment, or • a highly emetic radiotherapy treatment; ♦ during: • a chemotherapy treatment undergone by persons for whom the conventional antiemetic therapy is ineffective, contraindicated or poorly tolerated and who are not receiving aprepitant or fosaprepitant, or • a radiotherapy treatment undergone by persons for whom the conventional antiemetic therapy is ineffective, contraindicated or poorly tolerated; DONEPEZIL HYDROCHLORIDE: ♦ as monotherapy for persons suffering from Alzheimer's disease at the mild or moderate stage. Upon the initial request, the following elements must be present: • • an MMSE score of 10 to 26, or as high as 27 or 28 if there is proper justification; medical confirmation of the degree to which the person is affected (intact domain, mildly, moderately or severely affected) in the following five domains: intellectual function, including memory; - mood; - behaviour; - autonomy in activities of daily living (ADL) and in instrumental activities of daily living (IADL); - social interaction, including the ability to carry on a conversation. The duration of the initial authorization for a treatment with donepezil is six months from the beginning of treatment. However, where the cholinesterase inhibitor is used following treatment with memantine, the concomitant use of both medications is authorized for one month. Upon subsequent requests, the physician must provide evidence of a beneficial effect confirmed by each of the following elements: • • • an MMSE score of 10 or more, unless there is proper justification; a maximum decrease of 3 points in the MMSE score per six-month period compared with the previous evaluation, or a greater decrease accompanied by proper justification; stabilization or improvement of symptoms in one or more of the following domains: intellectual function, including memory; - mood; - behaviour; - autonomy in activities of daily living (ADL) and in instrumental activities of daily living (IADL); - social interaction, including the ability to carry on a conversation. The maximum duration of authorization is 12 months; APPENDIX IV - 16 DORNASE ALFA: ♦ during initial treatment in persons over 5 years of age suffering from cystic fibrosis and whose forced vital capacity is more than 40 percent of the predicted value. The maximum duration of the initial authorization is three months; ♦ during maintenance treatment in persons for whom the physician provides evidence of a beneficial clinical effect. The maximum duration of authorization is one year; DRESSING, ABSORPTIVE – GELLING FIBRE: ♦ ♦ ♦ ♦ ♦ for treatment of persons suffering from severe burns; for treatment of persons suffering from a pressure sore of stage 2 or greater; for treatment of persons suffering from a severe wound (affecting the subcutaneous tissue) caused by a chronic disease or by cancer; for treatment of persons suffering from a severe cutaneous ulcer (affecting the subcutaneous tissue) related to arterial or venous insufficiency; for treatment of persons suffering from a severe chronic wound (affecting the subcutaneous tissue) where the scarring process is compromised. In this case, a chronic wound is a wound that has lasted for more than 45 days; DRESSING, ABSORPTIVE – HYDROPHILIC FOAM ALONE OR IN ASSOCIATION: ♦ ♦ ♦ ♦ ♦ for treatment of persons suffering from severe burns; for treatment of persons suffering from a pressure sore of stage 2 or greater; for treatment of persons suffering from a severe wound (affecting the subcutaneous tissue) caused by a chronic disease or by cancer; for treatment of persons suffering from a severe cutaneous ulcer (affecting the subcutaneous tissue) related to arterial or venous insufficiency; for treatment of persons suffering from a severe chronic wound (affecting the subcutaneous tissue) where the scarring process is compromised. In this case, a chronic wound is a wound that has lasted for more than 45 days; DRESSING, ABSORPTIVE – SODIUM CHLORIDE: ♦ ♦ ♦ ♦ ♦ for treatment of persons suffering from severe burns; for treatment of persons suffering from a pressure sore of stage 2 or greater; for treatment of persons suffering from a severe wound (affecting the subcutaneous tissue) caused by a chronic disease or by cancer; for treatment of persons suffering from a severe cutaneous ulcer (affecting the subcutaneous tissue) related to arterial or venous insufficiency; for treatment of persons suffering from a severe chronic wound (affecting the subcutaneous tissue) where the scarring process is compromised. In this case, a chronic wound is a wound that has lasted for more than 45 days; DRESSING, ANTIMICROBIAL – IODINE: ♦ for treatment of persons suffering from severe burns or severe chronic wounds (affecting the subcutaneous tissue) with critical colonization by at least one pathogen, documented by a bacterial culture from the debrided wound base. The request is authorized for a maximum of 12 weeks. APPENDIX IV - 17 Critical colonization is defined by the presence of at least one pathogen, documented by a culture, in a severe wound, showing the following clinical signs: increased exudate, friable granulation tissue, stagnation in the scarring process, accentuated odour, accentuated pain and inflammation less than two cm from the edge. Critical colonization of a chronic wound, if it persists, may lead to infection of the chronic wound with systemic signs or symptoms; DRESSING, ANTIMICROBIAL – SILVER: ♦ for treatment of persons suffering from severe burns or severe chronic wounds (affecting the subcutaneous tissue) with critical colonization by at least one pathogen, documented by a bacterial culture from the debrided wound base. The request is authorized for a maximum of 12 weeks. Critical colonization is defined by the presence of at least one pathogen, documented by a culture, in a severe wound, showing the following clinical signs: increased exudate, friable granulation tissue, stagnation in the scarring process, accentuated odour, accentuated pain and inflammation less than two cm from the edge. Critical colonization of a chronic wound, if it persists, may lead to infection of the chronic wound with systemic signs or symptoms; DRESSING, BORDERED ABSORPTIVE– GELLING FIBRE ♦ ♦ ♦ ♦ ♦ for treatment of persons suffering from severe burns; for treatment of persons suffering from a pressure sore of stage 2 or greater; for treatment of persons suffering from a severe wound (affecting the subcutaneous tissue) caused by a chronic disease or by cancer; for treatment of persons suffering from a severe cutaneous ulcer (affecting the subcutaneous tissue) related to arterial or venous insufficiency; for treatment of persons suffering from a severe chronic wound (affecting the subcutaneous tissue) where the scarring process is compromised. In this case, a chronic wound is a wound that has lasted for more than 45 days; DRESSING, BORDERED ABSORPTIVE – HYDROPHILIC FOAM ALONE OR IN ASSOCIATION: ♦ ♦ ♦ ♦ ♦ for treatment of persons suffering from severe burns; for treatment of persons suffering from a pressure sore of stage 2 or greater; for treatment of persons suffering from a severe wound (affecting the subcutaneous tissue) caused by a chronic disease or by cancer; for treatment of persons suffering from a severe cutaneous ulcer (affecting the subcutaneous tissue) related to arterial or venous insufficiency; for treatment of persons suffering from a severe chronic wound (affecting the subcutaneous tissue) where the scarring process is compromised. In this case, a chronic wound is a wound that has lasted for more than 45 days; DRESSING, BORDERED ABSORPTIVE– POLYESTER AND RAYON FIBRE ♦ ♦ ♦ ♦ ♦ for treatment of persons suffering from severe burns; for treatment of persons suffering from a pressure sore of stage 2 or greater; for treatment of persons suffering from a severe wound (affecting the subcutaneous tissue) caused by a chronic disease or by cancer; for treatment of persons suffering from a severe cutaneous ulcer (affecting the subcutaneous tissue) related to arterial or venous insufficiency; for treatment of persons suffering from a severe chronic wound (affecting the subcutaneous tissue) where the scarring process is compromised. In this case, a chronic wound is a wound that has lasted for more than 45 days; APPENDIX IV - 18 DRESSING, BORDERED ANTIMICROBIAL – SILVER: ♦ for treatment of persons suffering from severe burns or severe chronic wounds (affecting the subcutaneous tissue) with critical colonization by at least one pathogen, documented by a bacterial culture from the debrided wound base. The request is authorized for a maximum of 12 weeks. Critical colonization is defined by the presence of at least one pathogen, documented by a culture, in a severe wound, showing the following clinical signs: increased exudate, friable granulation tissue, stagnation in the scarring process, accentuated odour, accentuated pain and inflammation less than two cm from the edge. Critical colonization of a chronic wound, if it persists, may lead to infection of the chronic wound with systemic signs or symptoms; DRESSING, BORDERED MOISTURE-RETENTIVE– HYDROCOLLOID OR POLYURETHANE: ♦ ♦ ♦ ♦ ♦ for treatment of persons suffering from severe burns; for treatment of persons suffering from a pressure sore of stage 2 or greater; for treatment of persons suffering from a severe wound (affecting the subcutaneous tissue) caused by a chronic disease or by cancer; for treatment of persons suffering from a severe cutaneous ulcer (affecting the subcutaneous tissue) related to arterial or venous insufficiency; for treatment of persons suffering from a severe chronic wound (affecting the subcutaneous tissue) where the scarring process is compromised. In this case, a chronic wound is a wound that has lasted for more than 45 days; DRESSING, INTERFACE – POLYAMIDE OR SILICONE: ♦ to facilitate the treatment of persons suffering from very painful severe burns; DRESSING, MOISTURE RETENTIVE – HYDROCOLLOID OR POLYURETHANE: ♦ ♦ ♦ ♦ ♦ for treatment of persons suffering from severe burns; for treatment of persons suffering from a pressure sore of stage 2 or greater; for treatment of persons suffering from a severe wound (affecting the subcutaneous tissue) caused by a chronic disease or by cancer; for treatment of persons suffering from a severe cutaneous ulcer (affecting the subcutaneous tissue) related to arterial or venous insufficiency; for treatment of persons suffering from a severe chronic wound (affecting the subcutaneous tissue) where the scarring process is compromised. In this case, a chronic wound is a wound that has lasted for more than 45 days; DRESSING, ODOUR-CONTROL – ACTIVATED CHARCOAL: ♦ ♦ ♦ ♦ for treatment of persons suffering from a foul-smelling pressure sore of stage 2 or greater; for treatment of persons suffering from a severe foul-smelling wound (affecting the subcutaneous tissue) caused by a chronic disease or by cancer; for treatment of persons suffering from a severe foul-smelling cutaneous ulcer (affecting the subcutaneous tissue) related to arterial or venous insufficiency; for treatment of persons suffering from a severe foul-smelling chronic wound (affecting the subcutaneous tissue) where the scarring process is compromised. In this case, a chronic wound is a wound that has lasted for more than 45 days; DULOXETINE: ♦ for treatment of pain related to a diabetic peripheral neuropathy; APPENDIX IV - 19 ♦ for relief of chronic pain associated with fibromyalgia, where amitriptyline is not tolerated or is contraindicated, or where it provides insufficient benefits in the course of treatment lasting at least 12 weeks. The maximum duration of the initial authorization is four months. When requesting continuation of treatment, the physician must provide information making it possible to establish clinical benefits, such as improvement of at least 30% on a pain scale, improvement of the functional level or attainment of other clinical objectives (such as a reduction in analgesics). The maximum duration of the authorization will then be 12 months. Authorizations are granted for a maximum dose of 60 mg per day. ♦ for treatment of moderate or severe low back pain, without a neuropathic component, where acetaminophen and non-steroidal anti-inflammatories are not tolerated or are contraindicated, or where they provide insufficient benefits in the course of a treatment lasting at least 12 weeks. The initial request is authorized for a maximum four months. When requesting continuation of treatment, the physician must provide information that demonstrates clinical benefits in comparison to the pre-treatment assessment: improvement of at least 30% on a pain scale or improvement of the functional level. The maximum duration of authorizations will then be 12 months. The maximum dose authorized is 60 mg per day. ♦ for management of moderate or severe chronic pain associated with knee osteoarthritis, where acetaminophen and non-steroidal anti-inflammatories are not tolerated or are contraindicated, or where they provide insufficient benefits in the course of a treatment lasting at least 12 weeks. The initial request is authorized for a maximum four months. When requesting continuation of treatment, the physician must provide information that demonstrates clinical benefits in comparison to the pre-treatment assessment: improvement of at least 30% on a pain scale or improvement of the functional level. The maximum duration of authorizations will then be 12 months. The maximum dose authorized is 60 mg per day. ELTROMBOPAG: ♦ for treatment of chronic idiopathic thrombocytopenic purpura in: • splenectomized or non-splenectomized persons, where surgery is contraindicated and; • who are refractory to corticotherapy or for whom corticotherapy is contraindicated and; • who have been undergoing maintenance treatment with intravenous immunoglobulin for at least six months, unless there is a contraindication and; • whose platelet count was less than 30 x 109/l before intravenous immunoglobulin treatment was initiated or whose platelet count is less than 30 x 109/l where intravenous immunoglobulin is contraindicated. The initial authorization is for a maximum duration of four months. APPENDIX IV - 20 Upon subsequent requests, the physician will have to provide evidence of a treatment response 9 defined by a platelet count greater than 50 x 10 /l without having to resort to administering intravenous immunoglobulin as part of rescue therapy. Subsequent authorizations will be granted for a maximum duration of six months. ENFUVIRTIDE: ♦ for treatment, in association with other antiretrovirals, of HIV-infected persons for whom a laboratory test showed sensitivity to only one antiretroviral or to none and for whom enfuvirtide has never led to a virological failure; The initial authorization, lasting a maximum of 5 months, will be given if the viral load is greater than or equal to 5 000 copies/mL. In the case of a first-line treatment, the CD4 lymphocyte count and another dating back at least one month must be less than or equal to 350/µL. Upon subsequent requests, the physician must provide evidence of a beneficial effect: • on a recent viral load measurement, showing a reduction of at least 0.5 log compared with the viral load measurement obtained before the enfuvirtide treatment began, or • on a recent CD4 count, showing an increase of at least 30% compared with the CD4 count obtained before the enfuvirtide treatment began; Authorizations will then have a maximum duration of 12 months. ♦ for treatment, in association with other antiretrovirals, of HIV-infected persons who are not concerned by the first paragraph of the previous statement: • whose current viral load and another dating back at least one month are greater than or equal to 500 copies/mL, while having been treated with an association of three or more antiretrovirals for at least three months and during the interval between the two viral load measurements, and • who previously received at least one other antiretroviral treatment that resulted in a documented virological failure after at least three months of treatment, and • who have tried, since the beginning of their antiretroviral therapy, at least one non-nucleoside reverse transcriptase inhibitor (except in the presence of a resistance to that class), one nucleoside reverse transcriptase inhibitor and one protease inhibitor; The maximum duration of the initial authorization is five months. Upon subsequent requests, the physician must provide evidence of a beneficial effect: • • on a recent viral load measurement, showing a reduction of at least 0.5 log compared with the viral load measurement obtained before the enfuvirtide treatment began, or on a recent CD4 count, showing an increase of at least 30% compared with the CD4 count obtained before the enfuvirtide treatment began; Authorizations will then have a maximum duration of 12 months; ENTECAVIR: ♦ for treatment of chronic hepatitis B, at a dose of 0.5 mg per day, in persons not having a resistance to lamivudine and whose viral load is greater than 20 000 IU/mL (HBeAg-positive) or 2 000 IU/mL (HBeAg-negative) prior to the beginning of treatment; APPENDIX IV - 21 ♦ for treatment of chronic hepatitis B in persons: • having a resistance to lamivudine as defined by one of the following: − a 1-log increase in HBV-DNA under treatment with lamivudine, confirmed by a second test one month later; − a laboratory trial showing resistance to lamivudine; − a 1-log increase in HBV-DNA under treatment with lamivudine, with viremia greater than 20 000 IU/mL; and • for whom adefovir or tenofovir has failed, is contraindicated or is not tolerated; + EPLERENONE: ♦ for persons showing signs of heart failure and left ventricular systolic dysfunction (with ejection fraction ≤ 40 %) after an acute myocardial infarction, when initiation of eplerenone starts in the days following the infarction as a complement to standard therapy. EPOETIN ALFA: ♦ for treatment of anemia related to severe chronic renal failure (creatinine clearance less than or equal to 35 mL/min); ♦ for treatment of chronic and symptomatic non-hemolytic anemia not caused by an iron, folic acid or vitamin B12 deficiency: • in persons having a non-myeloid tumour treated with chemotherapy and whose hemoglobin rate less than 100 g/L; • in non cancerous persons whose hemoglobin rate is less than 100 g/L; The maximum duration of the initial authorization is three months. When requesting continuation of treatment, the physician must provide evidence of a beneficial effect defined by an increase in the reticulocyte count of at least 40x109/L or an increase in the hemoglobin measurement of at least 10 g/L. A hemoglobin rate of less than 120g/L should be targeted. However, for persons suffering from cancer other than those previously specified, epoetin alfa remains covered by the basic prescription drug insurance plan until 31 January 2008 insofar as the treatment is already underway on 1 October 2007 and that its cost was already covered under that plan as part of the recognized indications provided in the appendix hereto and that the physician provides evidence of a beneficial effect defined by an increase in the reticulocyte count of at least 40x109/L or an increase in the hemoglobin measurement of at least 10 g/L. EPOPROSTENOL SODIUM: ♦ for treatment of pulmonary arterial hypertension of WHO functional class III or IV that is either idiopathic or associated with connectivitis and that is symptomatic despite the optimal conventional treatment; Persons must be evaluated and followed up on by physicians working at designated centres specializing in the treatment of pulmonary arterial hypertension; ERLOTINIB HYDROCHLORIDE: ♦ for treatment of locally advanced or metastatic non-small-cell lung cancer in persons: • for whom a first-line therapy has failed and who are not eligible for other chemotherapy, or for whom a second-line therapy has failed and; APPENDIX IV - 22 • who do not have symptomatic cerebral metastases and; • whose ECOG performance status is ≤ 3. The maximum duration of each authorization is three months. Upon subsequent requests, the physician must provide evidence of a beneficial clinical effect (absence of disease progression); ESTRADIOL-17B: ♦ in persons unable to take estrogens orally because of intolerance or where medical factors favour the transdermal route; ESTRADIOL-17B / LEVONORGESTREL: ♦ in persons unable to take estrogens or progestogens orally because of intolerance or where medical factors favour the transdermal route; ESTRADIOL-17B / NORETHINDRONE ACETATE: ♦ in persons unable to take estrogens or progestogens orally because of intolerance or where medical factors favour the transdermal route; ETANERCEPT: ♦ for treatment of moderate or severe rheumatoid arthritis and moderate or severe psoriasic arthritis of the rheumatoid type; Upon initiation of treatment or if the person has been receiving the drug for less than five months: • • the person must, prior to the beginning of treatment, have eight or more joints with active synovitis and one of the following five elements must be present: - a positive rheumatoid factor for rheumatoid arthritis only; - radiologically measured erosions; - a score of more than 1 on the Health Assessment Questionnaire (HAQ); - an elevated C-reactive protein level; - an elevated sedimentation rate, and the disease must still be active despite treatment with two disease-modifying anti-rheumatic drugs, used either concomitantly or not, for at least three months each. Unless there is serious intolerance or a serious contraindication, one of the two drugs must be: for rheumatoid arthritis: - methotrexate at a dose of 20 mg or more per week; for psoriasic arthritis of the rheumatoid type: - methotrexate at a dose of 20 mg or more per week, or - sulfasalazine at a dose of 2 000 mg per day. The initial request is authorized for a maximum of five months. When requesting continuation of treatment, the physician must provide information making it possible to establish the treatment's beneficial effects, specifically: • a decrease of at least 20% in the number of joints with active synovitis and one of the following four elements: - a decrease of 20% or more in the C-reactive protein level; - a decrease of 20% or more in the sedimentation rate; APPENDIX IV - 23 - a decrease of 0.20 in the HAQ score; a return to work. Requests for continuation of treatment are authorized for a maximum period of 12 months. Authorizations for etanercept are given for a dose of 50 mg per week; ♦ for treatment of moderate or severe juvenile idiopathic arthritis (juvenile rheumatoid arthritis and juvenile chronic arthritis) of the polyarticular or systemic type; Upon initiation of treatment or if the person has been receiving the drug for less than five months: • • the person must, prior to the beginning of treatment, have five or more joints with active synovitis and one of the following two elements must be present: - an elevated C-reactive protein level; - an elevated sedimentation rate, and the disease must still be active despite treatment with methotrexate at a dose of 15 mg/M2 or more (maximum dose of 20 mg) per week for at least three months, unless there is intolerance or a contraindication. The initial request is authorized for a maximum of five months. When requesting continuation of treatment, the physician must provide information making it possible to establish the treatment's beneficial effects, specifically: • a decrease of 20% or more in the number of joints with active synovitis and one of the following six elements: - a decrease of 20% or more in the C-reactive protein level; - a decrease of 20% or more in the sedimentation rate; - an decrease of 0.13 in the Childhood Health Assessment Questionnaire (CHAQ) score or a return to school; - an improvement of at least 20% in the physician's overall assessment (visual analogue scale); - an improvement of at least 20% in the person's or parent's overall assessment (visual analogue scale); - a decrease of 20% or more in the number of affected joints with limited movement. Requests for continuation of treatment are authorized for a maximum of 12 months. Authorizations for etanercept are given for 0.8 mg/kg (maximum dose of 50 mg) per week; ♦ for treatment of moderate or severe psoriasic arthritis of a type other than rheumatoid; Upon initiation of treatment or if the person has been receiving the drug for less than five months: • • the person must, prior to the beginning of treatment, have at least three joints with active synovitis and a score of more than 1 on the Health Assessment Questionnaire (HAQ), and the disease must still be active despite treatment with two disease-modifying anti-rheumatic drugs, used either concomitantly or not, for at least three months each. Unless there is serious intolerance or a serious contraindication, one of the two drugs must be: - methotrexate at a dose of 20 mg or more per week, or - sulfasalazine at a dose of 2 000 mg per day. APPENDIX IV - 24 The initial request is authorized for a maximum of five months. When requesting continuation of treatment, the physician must provide information making it possible to establish the treatment's beneficial effects, specifically: • a decrease of at least 20% in the number of joints with active synovitis and one of the following four elements: - a decrease of 20% or more in the C-reactive protein level; - a decrease of 20% or more in the sedimentation rate; - a decrease of 0.20 in the HAQ score; a return to work. Requests for continuation of treatment are authorized for a maximum of 12 months. Authorizations for etanercept are given for a dose of 50 mg per week; ♦ for treatment of persons suffering from moderate or severe ankylosing spondylitis whose BASDAI score is ≥ 4 on a scale of 0 to 10 and in whom the sequential use of two non-steroidal antiinflammatories at the optimal dose for a period of three months each did not adequately control the disease, unless there is a contraindication; • Upon the initial request, the physician must provide the following information: - the BASDAI score; - the degree of functional injury, according to the BASFI (scale of 0 to 10); The initial request will be authorized for a maximum of five months. When requesting continuation of treatment, the physician must provide information making it possible to establish the treatment's beneficial effects, specifically: - a decrease of 2.2 points or 50% on the BASDAI scale, compared with the pre-treatment score, or - a decrease of 1.5 points or 43% on the BASFI scale, or a return to work. Requests for continuation of treatment will be authorized for maximum periods of 12 months. • Authorizations for etanercept are given for a maximum of 50 mg per week; ♦ for treatment of persons suffering from a severe form of chronic plaque psoriasis: • • • • in the presence of a score greater than or equal to 15 on the Psoriasis Area and Severity Index (PASI) or of large plaques on the face, palms or soles or in the genital area; and in the presence of a score greater than or equal to 15 on the Dermatology Quality of Life Index (DQLI) questionnaire; and where a phototherapy treatment of 30 sessions or more for three months has not made it possible to optimally control the disease, unless the treatment is contraindicated, not tolerated or not accessible or unless a treatment of 12 sessions or more for one month has not provided significant improvement in the lesions; and where a treatment with two systemic agents, used concomitantly or not, for at least three months each, has not made it possible to optimally control the disease. Except in the case of serious intolerance or a serious contraindication, these two agents must be: APPENDIX IV - 25 - methotrexate at a dose of 15 mg or more per week; or cyclosporine at a dose of 3 mg/kg or more per day; or acitretin at a dose of 25 mg or more per day. The initial request is authorized for a maximum four months. When requesting continuation of treatment, the physician must provide information making it possible to establish the treatment's beneficial effects, specifically: • • • an improvement of at least 75% in the PASI score; or an improvement of at least 50% in the PASI score and a decrease of at least five points on the DQLI questionnaire; or significant improvement in lesions on the face, palms or soles or in the genital area and a decrease of at least five points on the DQLI questionnaire. Requests for continuation of treatment are authorized for a maximum of six months. Authorizations for etanercept are given for a maximum of 50 mg, twice per week; ETRAVIRINE: ♦ for treatment, in association with other antiretrovirals, of HIV-infected persons: • who have tried, since the beginning of their antiretroviral therapy, at least one therapy that included delavirdine, efavirenz or nevirapine, unless there is a primary resistance to one of those drugs, and that resulted: − in a documented virological failure, after at least three months of treatment with an association of several antiretroviral agents; or − in serious intolerance to one of those agents, to the point of calling into question the continuation of the antiretroviral treatment; and • who have tried, since the beginning of their antiretroviral therapy, at least one therapy that included a protease inhibitor and that resulted: − in a documented virological failure, after at least three months of treatment with an association of several antiretroviral agents; or − in serious intolerance to at least three protease inhibitors, to the point of calling into question the continuation of the antiretroviral treatment. Where a therapy including another non-nucleoside reverse transcriptase inhibitor cannot be used because of a primary resistance to delavirdine, efavirenz or nevirapine, a trial of at least two therapies, each including a protease inhibitor, is necessary and must have resulted in the same conditions as those listed above. ♦ for first-line treatment, in association with other antiretrovirals, of HIV-infected persons for whom a laboratory test showed a resistance to at least one nucleoside reverse transcriptase inhibitor, one non-nucleoside reverse transcriptase inhibitor and one protease inhibitor, and • whose current viral load and another dating back at least one month are greater than or equal to 500 copies/mL; and APPENDIX IV - 26 • • whose current CD4 lymphocyte count and another dating back at least one month are less than or equal to 350/µL; and for whom the use of etravirine is necessary to establish an effective therapeutic regimen; EVEROLIMUS: ♦ for second-line treatment of a metastatic renal adenocarcinoma characterized by the presence of clear cells after treatment with a tyrosine kinase inhibitor has failed, unless there is a serious contraindication or intolerance, in persons whose ECOG performance status is ≤ 2. The initial authorization is for a maximum duration of four months. Upon subsequent requests, the physician must provide evidence of a complete or partial response or of disease stabilization, confirmed by imaging during the six weeks before the end of the current authorization. In addition, the ECOG performance status must remain at ≤ 2. Subsequent authorizations will also be for maximum durations of four months. ♦ for treatment of unresectable and evolutive, well- or moderately-differentiated pancreatic neuroendocrine tumours, at an advanced or metastatic stage, in persons whose ECOG performance status is ≤ 2; The initial authorization is for a maximum duration of four months. Upon subsequent requests, the physician must provide evidence of a beneficial clinical effect (absence of disease progression) confirmed by imaging. The ECOG performance status must remain at ≤ 2. Subsequent authorizations will be for durations of six months. Authorizations are given for a maximum daily dose of 10 mg. It must be noted that everolimus will not be authorized in association with sunitinib, nor will it be following failure with sunitinib if the latter was administered to treat this condition. EZETIMIBE: ♦ where ezetimibe is not used in association with an HMG-CoA reductase inhibitor (statin): • where at least two hypolipemiants are contraindicated, ineffective or not tolerated; ♦ where ezetimibe is used in association with an HMG-CoA reductase inhibitor (statin): • if the statin treatment, at the optimal dose or at a lower dose in case of intolerance to that dose, did not make it possible to adequately control the cholesterolemia; FEBUXOSTAT: ♦ for treatment of persons with complications stemming from chronic hyperucemia, such as urate deposits revealed by tophus or arthritic gout, when there is a serious contraindication or serious intolerance to allopurinol; FESOTERODINE FUMARATE ♦ for treatment of vesical hyperactivity in persons for whom oxybutynine is poorly tolerated, contraindicated or ineffective; APPENDIX IV - 27 + FILGRASTIM: ♦ for treatment of persons undergoing cycles of moderately or highly myelosuppressive chemotherapy (≥ 40 percent risk of febrile neutropenia); ♦ for treatment of persons at risk of developing severe neutropenia during chemotherapy; ♦ in subsequent cycles of chemotherapy, for treatment of persons having suffered from severe 9 neutropenia (neutrophil count below 0.5 x 10 /L) during the first cycles of chemotherapy and for whom a reduction in the antineoplastic dose is inappropriate; ♦ in subsequent cycles of curative chemotherapy, for treatment of persons having suffered from neutropenia (neutrophil count below 1.5 x 109/L) during the first cycles of chemotherapy and for whom a reduction in the dose or a delay in the chemotherapy administration plan is unacceptable; ♦ during chemotherapy undergone by children suffering from solid tumours; ♦ 9 for treatment of persons suffering from severe medullary aplasia (neutrophil count below 0.5 x 10 /L) and awaiting curative treatment by means of a bone marrow transplant or with antithymocyte serum; ♦ for treatment of persons suffering from congenital, hereditary, idiopathic or cyclic chronic neutropenia 9 whose neutrophil count is below 0.5 x 10 /L; ♦ for treatment of HIV-infected persons suffering from severe neutropenia (neutrophil count below 0.5 x 109/L); ♦ to stimulate bone marrow in the recipient in the case of an autograft; ♦ as an adjunctive treatment for acute myeloid leukemia; FLUCONAZOLE, Oral Susp.: ♦ for treatment of esophageal candidiasis; ♦ for treatment of oropharyngeal candidiasis or other mycoses in persons for whom the conventional therapy is ineffective or poorly tolerated and who are unable to take fluconazole tablets; FLUDARABINE PHOSPHATE: ♦ for treatment of persons suffering from chronic lymphoid leukemia who have not responded to or do not tolerate first-line chemotherapy; ♦ for treatment of persons suffering from non-Hodgkin's lymphoma of low-malignancy or from Waldenstrom's macroglobulinemia where second-line chemotherapy, specifically CAP (cyclophosphamide, doxorubicin and prednisone), CHOP (cyclophosphamide, doxorubicin, vincristine and prednisone) and CVP (cyclophosphamide, vincristine and prednisone), has failed, is not tolerated or is contraindicated; FOLLITROPIN ALPHA: ♦ for women, as part of an assisted procreation activity; APPENDIX IV - 28 FOLLITROPIN BETA: ♦ for women, as part of an assisted procreation activity; FORMOTEROL FUMARATE DIHYDRATE / BUDESONIDE: ♦ for treatment of asthma and other reversible obstructive diseases of the respiratory tract in persons whose control of the disease is insufficient despite the use of an inhaled corticosteroid; ♦ for treatment of persons suffering from moderate or severe chronic obstructive pulmonary disease (COPD) whose symptoms are not under control despite the use of an inhaled short-acting ß2 agonist, an inhaled long-acting ß2 agonist and an inhaled anticholinergic agent. ♦ for treatment of persons suffering from moderate to severe chronic obstructive pulmonary disease (COPD), who have shown at least one exacerbation of the symptoms of the disease in the last year, despite regular use through inhalation of at least one long-acting bronchodilator; Exacerbation, is understood as a sustained and repeated aggravation of the symptoms requiring intensified pharmacological treatment, for instance, the addition of oral corticosteroids, or a precipitated medical visit or a hospitalization; In the case of the medical conditions set out in the preceding paragraphs, persons insured by the RAMQ who obtained a reimbursement for an association of formoterol fumarate dihydrate / budesonide or of salmeterol xinafoate / fluticasone propionate within 365 days preceding 1 October 2003 are eligible for a continuation of their treatment. GALANTAMINE HYDROBROMIDE: ♦ as monotherapy for persons suffering from Alzheimer's disease at the mild or moderate stage. Upon the initial request, the following elements must be present: • • an MMSE score of 10 to 26, or as high as 27 or 28 if there is proper justification; medical confirmation of the degree to which the person is affected (intact domain, mildly, moderately or severely affected) in the following five domains: intellectual function, including memory; - mood; - behaviour; - autonomy in activities of daily living (ADL) and in instrumental activities of daily living (IADL); - social interaction, including the ability to carry on a conversation. The duration of the initial authorization for a treatment with galantamine is six months from the beginning of treatment. However, where the cholinesterase inhibitor is used following treatment with memantine, the concomitant use of both medications is authorized for one month. Upon subsequent requests, the physician must provide evidence of a beneficial effect confirmed by each of the following elements: • • • an MMSE score of 10 or more, unless there is proper justification; a maximum decrease of 3 points in the MMSE score per six-month period compared with the previous evaluation, or a greater decrease accompanied by proper justification; stabilization or improvement of symptoms in one or more of the following domains: APPENDIX IV - 29 - intellectual function, including memory; mood; behaviour; autonomy in activities of daily living (ADL) and in instrumental activities of daily living (IADL); social interaction, including the ability to carry on a conversation. The maximum duration of authorization is 12 months. GANIRELIX: ♦ for women, as part of an assisted procreation activity; GEFITINIB: ♦ for first-line treatment of persons suffering from a locally advanced or metastatic non-small-cell lung cancer, having an activating mutation of the EGFR tyrosine kinase and whose ECOG performance status is ≤ 2. The initial authorization is for a maximum duration of four months. Upon subsequent requests, the physician must provide evidence of a beneficial clinical effect (absence of disease progression). Subsequent authorizations will also be for maximum durations of four months. GLATIRAMER ACETATE: ♦ for treatment of persons who have had a documented first acute clinical episode of demyelinization; The physician must provide, at the beginning of treatment, the results of an MRI showing: • the presence of four or more lesions of the white substance, including a lesion located in the cerebellum, the corpus callosum or the periventricular region, and • one such lesion having a diameter of 6 mm or more. The maximum duration of the initial authorization is 12 months. When submitting subsequent requests, the physician must provide evidence of a beneficial effect (absence of new clinical episodes). ♦ for treatment of persons suffering from remitting multiple sclerosis who have had two or more episodes of the disease within the last two years and whose EDSS scale result is less than 7. The physician must provide, at the beginning of treatment and with each subsequent request, the following information: number of attacks per year and EDSS scale result. The maximum duration of the initial authorization is six months. When submitting subsequent requests, the physician must provide evidence of a beneficial effect (absence of deterioration). For persons who previously received an interferon beta for treatment of the first acute clinical episode with documented demyelinization, the interval between the two episodes may exceed two years; APPENDIX IV - 30 GLICLAZIDE: ♦ where another sulfonylurea is not tolerated or is ineffective; ♦ for treatment of non-insulindependent diabetic persons suffering from renal failure; GLIMEPIRIDE: ♦ where another sulfonylurea is not tolerated or is ineffective; GLYCERIN, Supp.: ♦ for treatment of constipation related to a medical condition; GOLIMUMAB: ♦ for treatment of moderate or severe rheumatoid arthritis and moderate or severe psoriasic arthritis of rheumatoid type. In the case of rheumatoid arthritis, methotrexate must be use concomitantly; Upon initiation of treatment or if the person has been receiving the drug for less than five months: • • the person must, prior to the beginning of treatment, have eight or more joints with active synovitis and one of the following five elements must be present: - a positive rheumatoid factor; - radiologically measured erosions; - a score of more than 1 on the Health Assessment Questionnaire (HAQ); - an elevated C-reactive protein level; - an elevated sedimentation rate, and the disease must still be active despite treatment with two disease-modifying anti-rheumatic drugs, used either concomitantly or not, for at least three months each. In the case of rheumatoid arthritis, one of the two drugs must be methotrexate, at a dose of 20 mg or more per week, unless there is serious intolerance or a serious contraindication to this dose. In the case of moderate or severe psoriasic arthritis of rheumatoid type, unless there is serious intolerance or a serious contraindication, one of the two drugs must be: - methotrexate at a dose of 20 mg or more per week, or sulfasalazine at a dose of 2 000 mg per day. The initial request is authorized for a maximum of five months. When requesting continuation of treatment, the physician must provide information making it possible to establish the treatment's beneficial effects, specifically: • a decrease of at least 20% in the number of joints with active synovitis and one of the following four elements: - a decrease of 20% or more in the C-reactive protein level; - a decrease of 20% or more in the sedimentation rate; - a decrease of 0.20 in the HAQ score; a return to work. APPENDIX IV - 31 Requests for continuation of treatment are authorized for a maximum period of 12 months. Authorizations for golimumab are given for 50 mg per month. ♦ for treatment of moderate or severe psoriasic arthritis of a type other than rheumatoid; Upon initiation of treatment or if the person has been receiving the drug for less than five months: • • the person must, prior to the beginning of treatment, have at least three joints with active synovitis and a score of more than 1 on the Health Assessment Questionnaire (HAQ), and the disease must still be active despite treatment with two disease-modifying anti-rheumatic drugs, used either concomitantly or not, for at least three months each. Unless there is serious intolerance or a serious contraindication, one of the two drugs must be: - methotrexate at a dose of 20 mg or more per week, or - sulfasalazine at a dose of 2 000 mg per day. The initial request is authorized for a maximum of five months. When requesting continuation of treatment, the physician must provide information making it possible to establish the treatment's beneficial effects, specifically: • a decrease of at least 20% in the number of joints with active synovitis and one of the following four elements: - a decrease of 20% or more in the C-reactive protein level; - a decrease of 20% or more in the sedimentation rate; - a decrease of 0.20 in the HAQ score; a return to work. Requests for continuation of treatment are authorized for a maximum of 12 months. Authorizations for golimumab are given for 50 mg per month; ♦ for treatment of persons suffering from moderate or severe ankylosing spondylitis whose BASDAI score is ≥ 4 on a scale of 0 to 10 and in whom the sequential use of two non-steroidal antiinflammatories at the optimal dose for a period of three months each did not adequately control the disease, unless there is a contraindication; • Upon the initial request, the physician must provide the following information: - the BASDAI score; - the degree of functional injury, according to the BASFI (scale of 0 to 10); The initial request will be authorized for a maximum of five months. • When requesting continuation of treatment, the physician must provide information making it possible to establish the treatment's beneficial effects, specifically: - a decrease of 2.2 points or 50% on the BASDAI scale, compared with the pre-treatment score, or - a decrease of 1.5 points or 43% on the BASFI scale, or a return to work. APPENDIX IV - 32 Requests for continuation of treatment will be authorized for maximum periods of 12 months. Authorizations for golimumab are given for 50 mg per month. GONADORELIN: ♦ for women suffering from hypogonadotropic hypogonadism; GONADOTROPINS: ♦ for women, as part of an assisted procreation activity; ♦ for men suffering from hypogonadotropic hypogonadism, in association with a chorionic gonadotropin, as part of an assisted procreation activity; The men must previously have been treated with a chorionic gonadotropin, as monotherapy, for at least six months. The maximum duration of the authorization is 24 months. + GRANISETRON HYDROCHLORIDE: ♦ during the first day of: • a moderately or highly emetic chemotherapy treatment, or • a highly emetic radiotherapy treatment; ♦ in children during emetic chemotherapy or radiotherapy; ♦ during: • a chemotherapy treatment undergone by persons for whom the conventional antiemetic therapy is ineffective, contraindicated or poorly tolerated and who are not receiving aprepitant or fosaprepitant, or • a radiotherapy treatment undergone by persons for whom the conventional antiemetic therapy is ineffective, contraindicated or poorly tolerated; GRASS POLLEN ALLERGENIC EXTRACT ♦ for treatment of the symptoms of moderate or severe seasonal allergic rhinitis associated with grass pollen. The maximum duration of the authorization will be for three consecutive pollen seasons. It must be noted that Oralair™ is not authorized in association with subcutaneous immunotherapy. HYDROXYPROPYLMETHYLCELLULOSE: ♦ for treatment of keratoconjunctivitis sicca or other severe conditions accompanied by markedly reduced tear production; HYDROXYPROPYLMETHYLCELLULOSE / DEXTRAN 70: ♦ for treatment of keratoconjunctivitis sicca or other severe conditions accompanied by markedly reduced tear production; APPENDIX IV - 33 IMATINIB MESYLATE: ♦ for treatment of chronic myeloid leukemia in the chronic phase; ♦ for treatment of chronic myeloid leukemia in the blastic or accelerated phase; ♦ for adjuvant treatment of a gastrointestinal stromal tumour with presence of the c-kit receptor (CD117) that, following a complete resection, poses a high risk of recurrence according to the classification published in 2006 by Miettinen; The authorization is for a daily dose of 400 mg for a 12 months period. ♦ for treatment of an inoperable, recidivant or metastatic gastrointestinal stromal tumour with presence of the c-kit receptor (CD117); The initial authorization is for a daily dose of 400 mg for a duration of six months. For persons whose recurrence appeared during adjuvant treatment with imatinib, the initial authorization may be for a daily dose of up to 800 mg. An authorization for a daily dose of up to 800 mg may be obtained with evidence of disease progression, confirmed by imaging, after at least three months of treatment at a daily dose of 400 mg. When making subsequent requests, the physician must provide evidence of a complete or partial response or of disease stabilization, confirmed by imaging. Authorizations will be for six-month periods. ♦ in adults suffering from refractory or recidivant acute lymphoblastic leukemia with a positive Philadelphia chromosome and for whom a stem cell transplant is foreseeable. The maximum duration of each authorization is three months. Upon subsequent requests, the physician must provide evidence of a beneficial clinical effect (absence of disease progression); ♦ for treatment of acute lymphoblastic leukemia newly diagnosed in an adult, with a positive Philadelphia chromosome, after parenteral chemotherapy, specifically, during the maintenance phase. Authorizations are granted for a maximum dose of 600 mg per day. The maximum duration of the initial authorization is six months. Upon subsequent requests, the physician must provide evidence of a beneficial clinical effect, specifically, the absence of disease progression; IMIQUIMOD: ♦ for treatment of external genital and peri-anal condylomas, as well as condyloma acuminata, upon failure of physical destructive therapy or of chemical destructive therapy of a minimum duration of four weeks, unless there is a contraindication. The maximum duration of the initial authorization is 16 weeks. When requesting continuation of treatment, the physician must provide evidence of a beneficial effect defined by a reduction in the extent of the lesions. The request may then be authorized for a maximum period of 16 weeks; APPENDIX IV - 34 INFLIXIMAB: ♦ for treatment of moderate or severe intestinal Crohn's disease that is still active despite treatment with corticosteroids and immunosuppressors, unless there is a contraindication or a major intolerance to corticosteroids. An immunosuppressor must have been tried for at least eight weeks. The initial authorization is for a maximum of three 5 mg/kg doses. Upon the initial request, the physician must indicate the nature of the contraindication or intolerance, as well as the immunosuppressor used. Upon subsequent requests, the physician must provide evidence of a beneficial clinical effect, in which case the request will be authorized for a period of 12 months. ♦ for treatment of moderate or severe intestinal Crohn's disease that is still active despite treatment with corticosteroids, unless there is a contraindication or a major intolerance to corticosteroids, where immunosuppressors are contraindicated, are not tolerated or have been ineffective in treating a similar episode after a combined treatment with corticosteroids. The initial authorization is for a maximum of three 5 mg/kg doses. Upon the initial request, the physician must indicate the immunosuppressor used and the duration of the treatment. Upon subsequent requests, the physician must provide evidence of a beneficial clinical effect, in which case the request will be authorized for a period of 12 months. ♦ for treatment of moderate or severe rheumatoid arthritis; Upon initiation of treatment or if the person has been receiving the drug for less than five months: • • the person must, prior to the beginning of treatment, have eight or more joints with active synovitis and one of the following five elements must be present: - a positive rheumatoid factor; - radiologically measured erosions; - a score of more than 1 on the Health Assessment Questionnaire (HAQ); - an elevated C-reactive protein level; - an elevated sedimentation rate, and the disease must still be active despite treatment with two disease-modifying anti-rheumatic drugs, used either concomitantly or not, for at least three months each. Unless there is serious intolerance or a serious contraindication, one of the two drugs must be: - methotrexate at a dose of 20 mg or more per week. The initial request is authorized for a maximum of five months. When requesting continuation of treatment, the physician must provide information making it possible to establish the treatment's beneficial effects, specifically: • a decrease of at least 20% in the number of joints with active synovitis and one of the following four elements: - a decrease of 20% or more in the C-reactive protein level; - a decrease of 20% or more in the sedimentation rate; - a decrease of 0.20 in the HAQ score; a return to work. Requests for continuation of treatment are authorized for a period of 12 months. APPENDIX IV - 35 Authorizations for infliximab are given for three doses of 3 mg/kg, with the possibility of increasing the dose to 5 mg/kg after three doses or in the 14th week; ♦ for treatment of moderate or severe juvenile idiopathic arthritis (juvenile rheumatoid arthritis and juvenile chronic arthritis) of the polyarticular or systemic type; Upon initiation of treatment or if the person has been receiving the drug for less than five months: • • the person must, prior to the beginning of treatment, have five or more joints with active synovitis and one of the following two elements must be present: - an elevated C-reactive protein level; - an elevated sedimentation rate, and the disease must still be active despite treatment with methotrexate at a dose of 15 mg/M2 or more (maximum 20 mg per dose) per week for at least three months, unless there is intolerance or a contraindication. The initial request is authorized for a maximum of five months. When requesting continuation of treatment, the physician must provide information making it possible to establish the treatment's beneficial effects: • a decrease of at least 20% in the number of joints with active synovitis and one of the following six elements: - a decrease of 20% or more in the C-reactive protein level; - a decrease of 20% or more in the sedimentation rate; - an improvement of 0.13 in the Childhood Health Assessment Questionnaire (CHAQ) score or a return to school; - an improvement of at least 20% in the physician's overall assessment (visual analogue scale); - an improvement of at least 20% in the person's or parent's overall assessment (visual analogue scale); - a decrease of 20% or more in the number of affected joints with limited movement. Requests for continuation of treatment are authorized for a maximum of 12 months. Authorizations for infliximab are given for three doses of 3 mg/kg, with the possibility of increasing the dose to 5 mg/kg after three doses or in the 14th week; ♦ for treatment of persons suffering from moderate or severe ankylosing spondylitis whose BASDAI score is ≥ 4 on a scale of 0 to 10 and in whom the sequential use of two non-steroidal antiinflammatories at the optimal dose for a period of three months each did not adequately control the disease, unless there is a contraindication; • Upon the initial request, the physician must provide the following information: - the BASDAI score; - the degree of functional injury, according to the BASFI (scale of 0 to 10); The initial request will be authorized for a maximum of five months. • When requesting continuation of treatment, the physician must provide information making it possible to establish the treatment's beneficial effects, specifically: APPENDIX IV - 36 - a decrease of 2.2 points or 50% on the BASDAI scale, compared with the pre-treatment score, or - a decrease of 1.5 points or 43% on the BASFI scale, or a return to work. Requests for continuation of treatment will be authorized for maximum periods of 12 months. Authorizations for infliximab are given for a maximum of 5 mg/kg in weeks 0, 2 and 6 and then every six to eight weeks; ♦ for treatment of moderate or severe psoriasic arthritis of the rheumatoid type; • where a treatment with an anti-TNF appearing in this appendix for treatment of that disease did not make it possible to optimally control the disease or was not tolerated. The anti-TNF must have been used in respect of the indications for which it is recognized in this appendix for that pathology. The initial request for is authorized for a maximum of 5 months. When requesting continuation of treatment, the physician must provide information making it possible to establish the treatment's beneficial effects, specifically: • a decrease of at least 20% in the number of joints with active synovitis and one of the following four elements: - a decrease of 20% or more in the C-reactive protein level; - a decrease of 20% or more in the sedimentation rate; - a decrease of 0.20 in the HAQ score; a return to work. Requests for continuation of treatment are authorized for a maximum period of 12 months. For psoriasic arthritis of the rheumatoid type, authorizations for infliximab are given for a maximum of 5 mg/kg in weeks 0, 2 and 6 and then every six to eight weeks. ♦ for treatment of moderate or severe psoriasic arthritis of a type other than rhumatoid; • where a treatment with an anti-TNF appearing in this appendix for treatment of that disease did not make it possible to optimally control the disease or was not tolerated. The anti-TNF must have been used in respect of the indications for which it is recognized in this appendix for that pathology. The initial request for is authorized for a maximum of 5 months. When requesting continuation of treatment, the physician must provide information making it possible to establish the treatment's beneficial effects, specifically: • a decrease of at least 20% in the number of joints with active synovitis and one of the following four elements: - a decrease of 20% or more in the C-reactive protein level; - a decrease of 20% or more in the sedimentation rate; - a decrease of 0.20 in the HAQ score; a return to work. APPENDIX IV - 37 Requests for continuation of treatment are authorized for a maximum period of 12 months. Authorizations for infliximab are given for a maximum of 5 mg/kg in weeks 0, 2 and 6 and then every six to eight weeks. ♦ for treatment of persons suffering from a severe form of chronic plaque psoriasis: • • • • in the presence of a score greater than or equal to 15 on the Psoriasis Area and Severity Index (PASI) or in the presence of large plaques on the face, palms or soles or in the genital area; and in the presence of a score greater than or equal to 15 on the Dermatology Quality of Life Index (DQLI) questionnaire; and where a phototherapy treatment of 30 sessions or more for three months has not made it possible to optimally control the disease, unless the treatment is contraindicated, not tolerated or not accessible or unless a treatment of 12 sessions or more for one month has not provided significant improvement in the lesions; and where a treatment with two systemic agents, used concomitantly or not, for at least three months each, has not made it possible to optimally control the disease. Except in the case of serious intolerance or a serious contraindication, these two agents must be: - methotrexate at a dose of 15 mg or more per week; or - cyclosporine at a dose of 3 mg/kg or more per day; or - acitretin at a dose of 25 mg or more per day. The initial request is authorized for a maximum of four months. When requesting continuation of treatment, the physician must provide information making it possible to establish the treatment's beneficial effects, specifically: • • • an improvement of at least 75% in the PASI score; or an improvement of at least 50% in the PASI score and a decrease of at least five points on the DLQI questionnaire; or a significant improvement in lesions on the face, palms or soles or in the genital area and a decrease of at least five points on the DLQI questionnaire. Requests for continuation of treatment are authorized for a maximum of six months. Authorizations for infliximab are given for a maximum of 5 mg/kg in weeks 0, 2 and 6 and then every eight weeks. INSULIN ASPART / INSULIN ASPART PROTAMINE: ♦ for treatment of diabetes, where a trial of a premixture of 30/70 insuline did not adequately control the glycemic profile without causing episodes of hypoglycemia; INSULIN DETEMIR: ♦ for treatment of diabetes, where a prior trial of intermediate-acting insulin did not adequately control the glycemic profile without causing an episode of severe hypoglycemia or frequent episodes of hypoglycemia; APPENDIX IV - 38 INSULIN GLARGINE: ♦ for treatment of diabetes, where a prior trial of intermediate-acting insulin did not adequately control the glycemic profile without causing an episode of severe hypoglycemia or frequent episodes of hypoglycemia; INSULIN LISPRO / INSULIN LISPRO PROTAMINE: ♦ for treatment of diabetes, where a trial of a premixture of 30/70 insulin did not adequately control the glycemic profile without causing episodes of hypoglycemia; INTERFERON ALFA-2B (PEGYLATED): ♦ for treatment of persons suffering from chronic hepatitis C for whom ribavirin is contraindicated: • in the presence of hereditary hemolytic anemia (thalassemia and others); or • in the presence of severe renal failure (creatinine clearance less than or equal to 35 mL/min). The initial request is authorized for a maximum of 20 weeks. The authorization will be renewed if the decrease in the HCV-RNA is greater than or equal to 1.8 log after 12 weeks of treatment. The authorization will then be given for a maximum of 12 weeks. The request will be renewed if the HCVRNA is negative after 24 weeks of treatment. The total duration of treatment will be 48 weeks; ♦ for treatment of persons suffering from chronic hepatitis C for whom ribavirin is not tolerated: • in persons who have developed severe anemia while taking ribavirin, despite a decrease in the dosage to 600 mg per day (Hb < 80 g/L or < 100 g/L if co-morbidity of the atherosclerotic heart disease type); or • in persons who have developed a severe intolerance to ribavirin: appearance of an allergy, of an incapacitating skin rash or of incapacitating dyspnea with effort; The initial request is authorized for a maximum of 20 weeks. The authorization will be renewed if the decrease in the HCV-RNA is greater than or equal to 1.8 log after 12 weeks of treatment. The authorization will then be given for a maximum of 12 weeks. The request will be renewed if the HCVRNA is negative after 24 weeks of treatment. The total duration of treatment will be 48 weeks. INTERFERON BETA-1A, I.M. Inj. Sol.: ♦ for treatment of persons who have had a documented first acute clinical episode of demyelinization. The physician must provide, at the beginning of treatment, the results of an MRI showing: • the presence of four or more lesions of the white substance, including a lesion located in the cerebellum, the corpus callosum or the periventricular region; and • one such lesion having a diameter of 6 mm or more. Authorizations are given for 30 mcg once per week. The maximum duration of the initial authorization is 12 months. When submitting subsequent requests, the physician must provide evidence of a beneficial effect (absence of new clinical episodes); ♦ for treatment of persons suffering from remitting multiple sclerosis who have had two or more episodes of the disease within the last two years and whose EDSS scale result is less than 7. The physician must provide, at the beginning of treatment and with each subsequent request, the following information: number of attacks per year and EDSS scale result. APPENDIX IV - 39 The maximum duration of the initial authorization is six months. When submitting subsequent requests, the physician must provide evidence of a beneficial effect (absence of deterioration); For persons who previously received an interferon beta for treatment of the first acute clinical episode with documented demyelinization, the interval between the two episodes may exceed two years; ♦ for treatment of persons suffering from secondary progressive multiple sclerosis who have had clinical episodes of the disease and whose EDSS scale result is less than 7. The physician must provide, at the beginning of treatment and with each subsequent request, the following information: number of attacks per year and EDSS scale result. The maximum duration of the initial authorization is 12 months. When submitting subsequent requests, the physician must provide evidence of a beneficial effect (absence of deterioration). Authorizations are given for 30 mcg once per week; INTERFERON BETA-1A, S.C. Inj. Sol. and S.C. Inj. Sol. (Syr.): ♦ for treatment of persons who have had a documented first acute clinical episode of demyelinization. The physician must provide, at the beginning of treatment, the results of an MRI showing: • • the presence of four or more lesions of the white substance, including a lesion located in the cerebellum, the corpus callosum or the periventricular region, and one such lesion having a diameter of 6 mm or more. The maximum duration of the initial authorization is 12 months. When submitting subsequent requests, the physician must provide evidence of a beneficial effect (absence of new clinical episodes). Authorizations are given for 22 mcg once per week; ♦ for treatment of persons suffering from remitting multiple sclerosis who have had two or more episodes of the disease within the last two years and whose EDSS scale result is less than 7. The physician must provide, at the beginning of treatment and with each subsequent request, the following information: number of attacks per year and EDSS scale result. The maximum duration of the initial authorization is six months. When submitting subsequent requests, the physician must provide evidence of a beneficial effect (absence of deterioration). For persons who previously received an interferon beta for treatment of the first acute clinical episode with documented demyelinization, the interval between the two episodes may exceed two years; ♦ for treatment of persons suffering from secondary progressive multiple sclerosis, whether or not they have had clinical episodes, and whose EDSS scale result is less than 7. The physician must provide, at the beginning of treatment and with each subsequent request, the following information: number of attacks per year, where applicable, and EDSS scale result. The maximum duration of the initial authorization is 12 months. When submitting subsequent requests, the physician must provide evidence of a beneficial effect (absence of deterioration). APPENDIX IV - 40 Authorizations are given for 22 mcg three times per week; INTERFERON BETA-1B: ♦ for treatment of persons who have had a documented first acute clinical episode of demyelinization. The physician must provide, at the beginning of treatment, the results of an MRI showing: • • the presence of four or more lesions of the white substance, including a lesion located in the cerebellum, the corpus callosum or the periventricular region, and one such lesion having a diameter of 6 mm or more. The maximum duration of the initial authorization is 12 months. When submitting subsequent requests, the physician must provide evidence of a beneficial effect (absence of new clinical episodes). Authorizations will be given for a dose of 8 MIU every two days; ♦ for treatment of persons suffering from remitting multiple sclerosis who have had two or more episodes of the disease within the last two years and whose EDSS scale result is less than 7. The physician must provide, at the beginning of treatment and with each subsequent request, the following information: number of attacks per year and EDSS scale result. The maximum duration of the initial authorization is six months. When submitting subsequent requests, the physician must provide evidence of a beneficial effect (absence of deterioration). For persons who previously received an interferon beta for treatment of the first acute clinical episode with documented demyelinization, the interval between the two episodes may exceed two years; ♦ for treatment of persons suffering from secondary progressive multiple sclerosis, whether or not they have had clinical episodes, and whose EDSS scale result is less than 7. The physician must provide, at the beginning of treatment and with each subsequent request, the following information: number of attacks per year, where applicable, and EDSS scale result. The maximum duration of the initial authorization is 12 months. When submitting subsequent requests, the physician must provide evidence of a beneficial effect (absence of deterioration); KETOROLAC TROMETHAMINE: ♦ for treatment of ocular inflammation in persons for whom ophthalmic corticosteroids are not indicated; LACOSAMIDE: ♦ for adjuvant treatment of persons suffering from refractory partial epilepsy, that is, who have not responded adequately to at least two antiepileptic drugs; LACTULOSE: ♦ for prevention and treatment of hepatic encephalopathy; APPENDIX IV - 41 ♦ for treatment of constipation related to a medical condition; LANTHANUM HYDRATE: ♦ as a phosphate binder in persons suffering from severe renal failure, where a calcium salt is contraindicated, is not tolerated, or does not make it possible to optimally control the hyperphosphoremia; It must be noted that lanthanum hydrate will not be authorized concomitantly with sevelamer. LAPATINIB: ♦ in association with an aromatase inhibitor for first-line treatment in menopausal women suffering from a hormone receptor positive metastatic breast cancer with HER-2 overexpression: • whose ECOG performance status is ≤ 2; and • who are unable to receive trastuzumab due to lower left ventricular ejection fraction of less than or equal to 55% or due to serious intolerance; The maximum duration of each authorization is four months. Upon subsequent requests, the physician must provide evidence of a beneficial clinical effect (absence of disease progression). The ECOG performance status must remain ≤ 2. ♦ for treatment of advanced or metastatic breast cancer where the tumour over-expresses the HER2 receptor, in association with capecitabine, in women whose breast cancer has progressed despite administration of a taxane, anthracycline and trastusumab, unless one of those drugs is contraindicated. The ECOG performance status must be 0 or 1. The maximum duration of each authorization is four months. Upon subsequent requests, the physician must provide evidence of a beneficial clinical effect (absence of disease progression). The ECOG performance status must remain at 0 or 1. LATANOPROST / TIMOLOL MALEATE: ♦ for control of intra-ocular pressure where the use of an antiglaucoma agent as monotherapy is insufficient; LEFLUNOMIDE: ♦ for treatment of rheumatoid arthritis in persons for whom methotrexate is ineffective, contraindicated or not tolerated; LENALIDOMIDE: ♦ for treatment of anemia caused by a myelodysplastic syndrome (MDS) of low-risk or intermediate-1risk, according to the IPSS (International Prognostic Scoring System for MDS), accompanied by a deletion 5q cytogenetic abnormality. Anemia in this case is characterized by a hemoglobin rate of less than 90 g/L or by transfusion dependence. Upon each request, the physician must provide a recent hemoglobin rate result for the person concerned and a history of the person’s blood transfusions over the past six months. Upon requests for continuation of treatment: APPENDIX IV - 42 • in the case of a person with transfusion dependence before the beginning of the treatment, the physician must provide evidence of a beneficial effect defined by: - a reduction of at least 50% in blood transfusions, in comparison to the beginning of the treatment; • in the case of a person who did not have a blood transfusion during the six months preceding the beginning of the treatment, the physician must provide evidence of a beneficial effect defined by: - an increase of at least 15 g/L in the hemoglobin rate, in comparison to the rate observed before the beginning of the treatment; and - the maintenance of transfusion independence. The duration of each authorization is six months. The maximum dose authorized is 10 mg per day. ♦ in association with dexamethasone, for treatment of refractory or recidivant multiple myeloma in persons: • who have received at least two therapies for treatment of multiple myeloma; and • whose ECOG performance status is ≤ 2. The maximum duration of the initial authorization is four 28-day cycles. Upon subsequent requests, the physician must provide evidence of a beneficial clinical effect (absence of disease progression) documented by each of the following three elements: The disease is progressing as soon as one of the elements is met. Disease progression is defined for each of them in the following manner: • an increase of ≥ 25% (in comparison to the lowest result (nadir)) of: - serum monoclonal protein (the absolute increase must be ≥ 5 g/L); - urinary monclonal protein (the absolute increase must be ≥ 200 mg per 24 hours); - the difference between free light chains (the absolute increase must be ≥ 100 mg/L); - medullary plasmocytes (the absolute increase must be ≥ 10 %); Among the four above dosages, the physician must provide the test result he or she deems the most appropriate for the person being treated. • an increase in bone lesions or plasmacytomas; • the appearance of hypercalcemia defined by corrected calcemia > 2.8 mmol/L without any other apparent cause. The maximum duration of subsequent authorizations is six 28-day cycles. It must be noted that lenalidomide will not be authorized in association with bortezomib. ♦ in association with dexamethasone, for second-line treatment of refractory or recidivant multiple myeloma in persons for whom bortezomib is not a treatment option and whose ECOG performance status is ≤ 2: The maximum duration of the initial authorization is four 28-day cycles. Upon subsequent requests, the physician must provide evidence of a beneficial clinical effect (absence of disease progression) documented by each of the following three elements: APPENDIX IV - 43 The disease is progressing as soon as one of the elements is met. Disease progression is defined for each of them in the following manner: • an increase of ≥ 25% (in comparison to the lowest result (nadir) of: - serum monoclonal protein (the absolute increase must be ≥ 5 g/L); - urinary monclonal protein (the absolute increase must be ≥ 200 mg per 24 hours); - the difference between free light chains (the absolute increase must be ≥ 100 mg/L); - medullary plasmocytes (the absolute increase must be ≥ 10 %); Among the four above dosages, the physician must provide the test result he or she deems the most appropriate for the person being treated. • an increase in bone lesions or plasmacytomas; • the appearance of hypercalcemia defined by corrected calcemia > 2.8 mmol/L without any other apparent cause. The maximum duration of subsequent authorizations is six 28-day cycles. + LEVOFLOXACIN, I.V. Perf. Sol.: ♦ for treatment of infections where oral levofloxacin cannot be used; LINAGLIPTIN: ♦ for treatment of type-2 diabetic persons: • as monotherapy when metformin and a sulfonylurea are contraindicated or poorly tolerated; or • in association with metformin where a sulfonylurea is contraindicated, not tolerated or ineffective; + LINEZOLID, I.V. Perf. Sol.: ♦ for treatment of proven or presumed methicillin-resistant staphylococci infections, where vancomycin is ineffective, contraindicated or not tolerated and where linezolid cannot be used orally; ♦ for treatment of vancomycin-resistant proven enterococci infections, where linezolide cannot be used orally; + LINEZOLID, Tab.: ♦ for treatment of proven or presumed methicillin-resistant staphylococci infections, where vancomycin is ineffective, contraindicated or not tolerated; ♦ for treatment of vancomycin-resistant proven enterococci infections; ♦ for continuation of treatment of proven or presumed methicillin-resistant staphylococci infections initiated intravenously in a hospital; LISDEXAMFÉTAMINE DIMESYLATE: ♦ for treatment of persons suffering from attention deficit disorder and in whom the use of short-acting methylphenidate or of dexamphetamine has not properly controlled the symptoms of the disease; Before it can be concluded that these treatments are ineffective, the stimulant must have been titrated optimally, unless there is proper justification. APPENDIX IV - 44 MAGNESIUM HYDROXIDE: ♦ for treatment of constipation related to a medical condition; MAGNESIUM HYDROXYDE / ALUMINUM HYDROXYDE: ♦ as a phosphate binder in persons suffering from severe renal failure; MARAVIROC ♦ for treatment, in association with other antiretrovirals, of HIV-infected persons for whom the tropism test carried out during the past three months showed the presence of a CCR5 tropic virus exclusively and: • who have tried, since the beginning of their antiretroviral therapy, at least one therapy that included delavirdine, efavirenz or nevirapine, unless there is a primary resistance to one of those drugs, and that resulted: - in a documented virological failure, after at least three months of treatment with an association of several antiretroviral agents; or - in serious intolerance to one of those agents, to the point of calling into question the continuation of the antiretroviral treatment; and • who have tried, since the beginning of their antiretroviral therapy, at least one therapy that included a protease inhibitor and that resulted: - in a documented virological failure, after at least three months of treatment with an association of several antiretroviral agents; or - in serious intolerance to at least three protease inhibitors, to the point of calling into question the continuation of the antiretroviral treatment. Where a therapy including a non-nucleoside reverse transcriptase inhibitor cannot be used because of a primary resistance to delavirdine, efavirenz or nevirapine, a trial of at least two therapies, each including a protease inhibitor, is necessary and must have resulted in the same conditions as those listed above. The maximum duration of the initial authorization is six months. Upon the first request for continuation of treatment, the physician must provide evidence of a beneficial effect, specifically, a recent viral load measurement of which the result is less than 400 copies/mL. That second authorization will have a maximum duration of six months. Upon subsequent requests for continuation of treatment, the physician must provide evidence of a beneficial effect, specifically, a recent viral load measurement of which the result is less than 50 copies/mL. The authorizations will then have a maximum duration of 12 months. ♦ for first-line treatment, in association with other antiretrovirals, of HIV-infected persons for whom the tropism test carried out during the past three months showed the presence of a CCR5 tropic virus exclusively and for whom a laboratory test showed a resistance to at least one nucleoside reverse transcriptase inhibitor, one non-nucleoside reverse transcriptase inhibitor and one protease inhibitor, and: • whose current viral load and another dating back at least one month are greater than or equal to 500 copies/mL; and • whose current CD4 lymphocyte count and another dating back at least one month are less than or equal to 350/µL; and APPENDIX IV - 45 • for whom the use of maraviroc is necessary for constituting an effective therapeutic regimen. The maximum duration of the initial authorization is six months. Upon the first request for continuation of treatment, the physician must provide evidence of a beneficial effect, specifically, a recent viral load measurement of which the result is less than 400 copies/mL. That second authorization will have a maximum duration of six months. Upon subsequent requests for continuation of treatment, the physician must provide evidence of a beneficial effect, specifically, a recent viral load measurement of which the result is less than 50 copies/mL. The authorizations will then have a maximum duration of 12 months. MEGESTROL ACETATE: ♦ for hormone therapy in the treatment of breast, endometrium and prostate cancer; ♦ for hormone replacement therapy where oral progestogens are ineffective or contraindicated or not tolerated; MEMANTINE HYDROCHLORIDE: ♦ as monotherapy for person suffering from Alzheimer's disease at the moderate or severe stage who are living at home, specifically, who do not live in a residential and long-term care centre that is either a public institution or a private institution under agreement; Upon the initial request, the following elements must be present: • • an MMSE score of 3 to 14; medical confirmation of the degree to which the person is affected (intact domain, mildly, moderately or severely affected) in the following five domains: intellectual function, including memory; - mood; - behaviour; - autonomy in activities of daily living (ADL) and in instrumental activities of daily living (IADL); - social interaction, including the ability to carry on a conversation. The duration of the initial authorization for a treatment with memantine is six months from the beginning of treatment. However, where memantine is used following treatment with a cholinesterase inhibitor, the concomitant use of both medications is authorized for one month. Upon subsequent requests, the physician must provide evidence of a beneficial effect confirmed by stabilization or improvement of symptoms in at least three of the following domains: intellectual function, including memory; mood; behaviour; autonomy in activities of daily living (ADL) and in instrumental activities of daily living (IADL); social interaction, including the ability to carry on a conversation. The maximum duration of the authorization is six months; APPENDIX IV - 46 METHYL AMINOLEVULINATE: ♦ for treatment of superficial basal cell carcinoma where surgery is contraindicated and another physical or chemical destruction treatment is poorly tolerated or contraindicated; METHYLPHENIDATE HYDROCHLORIDE, L.A. Caps.: ♦ for treatment of children and adolescents suffering from attention deficit disorder and in whom the use of short-acting methylphenidate or of dexamphetamine has not properly controlled the symptoms of the disease. Before it can be concluded that these treatments are ineffective, the stimulant must have been titrated optimally, unless there is proper justification; METHYLPHENIDATE HYDROCHLORIDE, L.A. Tab. (12 h): ♦ for treatment of persons suffering from attention deficit disorder and in whom the use of short-acting methylphenidate or of dexamphetamine has not properly controlled the symptoms of the disease. Before it can be concluded that these treatments are ineffective, the stimulant must have been titrated optimally, unless there is proper justification; METRONIDAZOLE, Vag. Gel: ♦ for treatment of bacterial vaginosis during the second and third trimesters of pregnancy; ♦ for treatment of bacterial vaginosis where metronidazole administered orally is not tolerated; + MICAFUNGIN SODIUM: ♦ for prevention of fungal infections in persons who will undergo a hematopoietic stem cell transplant; ♦ for treatment of invasive candidosis in persons for whom treatment with fluconazole has failed or is contraindicated, or who are intolerant to such a treatment; MICRONIZED PROGESTERONE, Caps.: ♦ for persons unable to take medroxyprogesterone acetate because of major intolerance; MINERAL OIL: ♦ for treatment of constipation related to a medical condition; MODAFINIL: ♦ ♦ for symptomatic treatment of diurnal hypersomnolence accompanying narcolepsy or idiopathic or post-traumatic hypersomnia, where dexamphetamine sulfate or methylphenidate is ineffective, contraindicated or not tolerated; for adjunctive treatment of diurnal hypersomnolence secondary to sleep apnea or hypopnea syndrome that persists despite the use of a nasal continuous positive airway pressure device; MOMETASONE FUROATE / FORMOTEROL FUMARATE DIHYDRATE ♦ for treatment of asthma and other reversible obstructive diseases of the respiratory tract, in persons whose control of the disease is insufficient despite the use of an inhaled corticosteroid; APPENDIX IV - 47 + MOXIFLOXACIN HYDROCHLORIDE, I.V. Perf. Sol.: ♦ for treatment of infections, where oral moxifloxacin cannot be used; MULTIVITAMINS: ♦ for persons suffering from cystic fibrosis; NAPROXEN / ESOMEPRAZOLE: ♦ for treatment of medical conditions requiring chronic use of a non-steroidal anti-inflammatory drug in persons with at least one of the following gastrointestinal complication risk factors: • person age 65 or over; • history of uncomplicated ulcer of the upper digestive tract; • comorbidity, i.e. a serious medical condition predisposing a person to an exacerbation of his/her clinical condition following the taking of a non-steroidal anti-inflammatory drug; • concomitant drugs predisposing a person to an exacerbated risk of gastrointestinal complications; • use of more than one non-steroidal anti-inflammatory drug. NATALIZUMAB: ♦ for monotherapy treatment of persons suffering from remitting multiple sclerosis whose EDSS scale score is ≤ 5 before the treatment and in whom there has been a rapid evolution of the disease, defined as: • the occurrence of two or more incapacitating clinical episodes with partial recovery during the past year; or • the occurrence of two or more incapacitating clinical episodes with full recovery during the past year and: - the presence of at least one gadolinium-enhanced lesion on magnetic resonance imaging (MRI); or - an increase of two or more T2 hyperintense lesions in comparison with a previous MRI. The maximum duration of the authorizations is one year. For continuation of treatment, the physician must provide evidence of a beneficial effect in comparison with the evaluation carried out before the treatment began, specifically: • a reduction in the annual frequency of incapacitating episodes during the past year; and • a stabilization of the EDSS scale score or an increase of less than 2 points without the score exceeding 5. An incapacitating episode means an episode during which a neurological examination confirms optical neuritis, posterior fossa syndrome (cerebral trunk and cervelet) or symptoms revealing that the spinal cord is affected (myelitis). NILOTINIB: ♦ for treatment of chronic myeloid leukemia (CML) in the chronic or accelerated phase in adults: • for whom imatinib has failed or produced a sub-optimal response; or • who have serious intolerance to imatinib; Authorizations will be given for a maximum daily dose of 1 200 mg for a maximum duration of six months. APPENDIX IV - 48 For continuation of treatment, the physician must provide evidence of a hematologic response. ♦ for first-line treatment of chronic myeloid leukemia in the chronic phase; Authorizations will be given for a maximum daily dose of 600 mg for a maximum duration of six months. For continuation of treatment, the physician must provide evidence of a hematologic response. NUTRITIONAL FORMULAS – CASEIN-BASED (INFANTS AND CHILDREN): ♦ for infants and children who are allergic to complete milk proteins. In such cases, the maximum duration of the initial authorization is up to the age of 12 months. The results of an allergen skin test or of re-exposure to milk must be provided in order for utilization to continue; ♦ for infants and children suffering from galactomsemia and requiring a lactose-free diet; ♦ for infants and children suffering from persistent diarrhea or other severe gastrointestinal problems. The results of re-exposure to milk must be provided in order for utilization to continue; NUTRITIONAL FORMULAS – FAT EMULSION (INFANTS AND CHILDREN): ♦ to increase the caloric content of the diet or of other nutritional formulas in the presence of cardiac or metabolic disorders in children under age 4, and for whom the polymerized glucose nutritional formulas are not sufficient or not tolerated; NUTRITIONAL FORMULAS – FOLLOW-UP PREPARATIONS FOR PREMATURE INFANTS: ♦ for infants whose birth weight is less than or equal to 1 800 g or who are born after 34 weeks of pregnancy or less. In this case, the maximum duration of the authorization will be until one year corrected age, in other words, until one year after the expected date of birth; NUTRITIONAL FORMULAS – FRACTIONATED COCONUT OIL: ♦ for persons unable to effectively digest or absorb long-chain fatty foods; NUTRITIONAL FORMULAS – MONOMERIC: ♦ for enteral feeding; ♦ for oral feeding of persons requiring monomeric nutritional formulas or semi-elemental nutritional formulas as their source of nutrition in the presence of severe maldigestion or malabsorption disorders and for whom polymeric formulas are not recommended or not tolerated; ♦ for children suffering from malnutrition, malabsorption or growth failure related to a medical condition; ♦ for persons suffering from cystic fibrosis; APPENDIX IV - 49 NUTRITIONAL FORMULAS – MONOMERIC WITH IRON (INFANTS OR CHILDREN): ♦ for infants or children who are allergic to complete milk proteins, soy proteins or multiple dietary proteins and in whom the utilization of a casein hydrolysate formula has not succeeded in eliminating the symptoms. In such cases, the maximum duration of the initial authorization is one year. The results of an allergen skin test or of re-exposure to a casein hydrolysate formula or milk must be provided in order for utilization to continue; ♦ for infants or children who are suffering from persistent diarrhea or other severe gastrointestinal problems and in whom the utilization of a casein hydrolysate formula has not succeeded in eliminating the symptoms. In such cases, the maximum duration of the initial authorization is one year. The results of reexposure to a casein hydrolysate formula or milk must be provided in order for utilization to continue; ♦ for infants or children whose condition requires hospitalization and who have severe gastrointestinal problems of which the confirmed cause is a bovine protein allergy. In such cases, the maximum duration of the initial authorization is one year. The results of an allergen skin test or of re-exposure to a casein hydrolysate formula or milk must be provided in order for the authorization to continue; NUTRITIONAL FORMULAS – POLYMERIC LOW-RESIDUE: ♦ for enteral feeding; ♦ for total oral feeding of persons requiring nutritional formulas as their source of nutrition in presence of esophageal dysfunction or dysphagia, maldigestion or malabsorption; ♦ for children suffering from malnutrition, malabsorption or growth failure related to a medical condition; ♦ for persons suffering from cystic fibrosis; NUTRITIONAL FORMULAS – POLYMERIC LOW-RESIDUE – SPECIFIC USE: ♦ for total feeding, whether enteral or oral, of children suffering from Crohn's disease; NUTRITIONAL FORMULAS – POLYMERIC WITH RESIDUE: ♦ for enteral feeding; ♦ for total oral feeding of persons requiring nutritional formulas as their source of nutrition in presence of esophageal dysfunction or dysphagia, maldigestion or malabsorption; ♦ for children suffering from malnutrition, malabsorption or growth failure related to a medical condition; ♦ for persons suffering from cystic fibrosis; NUTRITIONAL FORMULAS – POLYMERIZED GLUCOSE: ♦ to increase the caloric content of the diet or of other nutritional formulas; APPENDIX IV - 50 NUTRITIONAL FORMULAS – PROTEINS: ♦ to increase the protein content of other nutritional formulas; NUTRITIONAL FORMULAS – SEMI-EMEMENTAL: ♦ for enteral feeding; ♦ for oral feeding in persons requiring monometric nutritional formulas or semi-elemental nutritional formulas as their source of nutrition in the presence of severe maldigestion or malabsorption disorders and for whom polymeric formulas are not recommended or not tolerated; ♦ for children suffering from malnutrition, malabsorption or growth failure related to a medical condition; ♦ for persons suffering from cystic fibrosis; NUTRITIONAL FORMULAS – SKIM MILK / COCONUT OIL: ♦ for persons unable to effectively digest or absorb long-chain fatty foods; + ONDANSETRON: ♦ during the first day of: • a moderately or highly emetic chemotherapy treatment, or • a highly emetic radiotherapy treatment; ♦ in children during emetic chemotherapy or radiotherapy; ♦ during: • a chemotherapy treatment undergone by persons for whom the conventional antiemetic therapy is ineffective, contraindicated or poorly tolerated and who are not receiving aprepitant or fosaprepitant, or • a radiotherapy treatment undergone by persons for whom the conventional antiemetic therapy is ineffective, contraindicated or poorly tolerated; + OSELTAMIVIR PHOSPHATE: ♦ for treatment of type A or B influenza (seasonal flu): • in persons living in a homecare centre; • in persons suffering from a chronic disease requiring regular medical follow-up or hospital care (according to the MSSS definition); • in pregnant women at their 2nd or 3rd trimester of pregnancy (13 weeks or more); ♦ for type A or B influenza (seasonal flu) prophylaxis: • in persons living in a homecare centre in close contact with an infected person (index case); The request is authorized when the following conditions are fulfilled: • the existing surveillance data demonstrate the presence and sensitivity of type A or B influenza viruses, according to notices issued by regional and provincial public health directorates, where applicable; • the treatment administration time frame with the antiviral is met (48 hours); APPENDIX IV - 51 Chronic diseases are defined as follows: • cardiac or pulmonary disorders (including bronchopulmonary dysplasia, cystic fibrosis, chronic obstructive pulmonary disease (COPD), emphysema and asthma) serious enough to warrant regular medical follow-up or hospital care; • diabetes or other chronic metabolic disorders, hepatic disorders (including cirrhosis), renal disorders, hematologic disorders (including hemoglobinopathy), cancer, immunodeficiency (including HIV) or immunosuppression (radiotherapy, chemotherapy, anti-rejection drugs); • medical conditions that may compromise the handling of respiratory secretions and increase the risk of aspiration (e.g. cognitive impairments, spinal cord injuries, convulsive disorders, neuromuscular disorders, morbid obesity). OXCARBAZEPINE: ♦ for treatment of epilepsy; ♦ for persons for whom carbamazepine is not tolerated or is contraindicated, or for whom treatment with carbamazepine has failed; OXYBUTYNINE, Patch: ♦ for treatment of vesical hyperactivity in persons for whom immediate-release oxybutynine is poorly tolerated; OXYBUTYNINE CHLORIDE, L.A. Tab.: ♦ for treatment of vesical hyperactivity in persons for whom immediate-release oxybutynine is poorly tolerated; OXYCODONE, L.A. Tab.: ♦ when two other opiates are not tolerated, contraindicated or ineffective. Long-acting oxycodone is covered under the basic prescription drug insurance plan for insured persons having used that medication from 1 March 2012 to 15 July 2012. PALIPERIDONE palmitate: ♦ for persons who have an observance problem with an oral antipsychotic agent or for whom a prolonged-acting injectable conventional antipsychotic agent is ineffective or poorly tolerated; PARAFFIN / MINERAL OIL: ♦ for treatment of keratoconjunctivitis sicca or other severe conditions accompanied by markedly reduced tear production; PAZOPANIB HYDROCHLORIDE: ♦ for first-line treatment of a metastatic renal adenocarcinoma characterized by the presence of clear cells, in persons whose ECOG performance status is 0 or 1; The initial authorization is for a maximum duration of 18 weeks. APPENDIX IV - 52 Upon subsequent requests, the physician must provide evidence of a complete or partial response or of disease stabilization, confirmed by imaging during the six weeks before the end of the current authorization. In addition, the ECOG performance status must remain at 0 or 1. Subsequent authorizations will also be for maximum durations of 18 weeks. Authorizations are given for a daily dose of 800 mg. PEGAPTANIB SODIUM: ♦ for treatment of age-related macular degeneration • in the presence of minimally classic choroidal neovascularization where less than 50% of the lesions are of the classic type, or of the occult type without lesions of the classic type; • in the presence of predominantly classic choroidal neovascularization where 50% or more of the lesions are of the classic type, following failure of a therapy consisting of four treatments with verteporfin, unless that drug is not tolerated or is contraindicated. The initial request is authorized for a maximum of six months and the request for continuation of treatment will be authorized for another six months, for a total authorization period of 12 months. However, in the latter case, a beneficial clinical effect, consisting in a stabilization or improvement of the medical condition shown by a retinal angiography or by optical coherence tomography, must be proven. Pegaptanib will not be authorized concomitantly with verteporfin for treatment of the same eye; PEGINTERFERON ALFA-2A: ♦ for treatment of persons suffering from chronic hepatitis C for whom ribavirin is contraindicated: • in the presence of hereditary hemolytic anemia (thalassemia and others); or • in the presence of severe renal failure (creatinine clearance less than or equal to 35 mL/min). The initial request is authorized for a maximum of 20 weeks. The authorization will be renewed if the decrease in the HCV-RNA is greater than or equal to 1.8 log after 12 weeks of treatment. The authorization will then be given for a maximum of 12 weeks. The request will be renewed if the HCVRNA is negative after 24 weeks of treatment. The total duration of treatment will be 48 weeks; ♦ for treatment of persons suffering from chronic hepatitis C for whom ribavirin is not tolerated: • in persons who have developed severe anemia while taking ribavirin, despite a decrease in the dosage to 600 mg per day (Hb < 80 g/L or < 100 g/L if co-morbidity of the atherosclerotic heart disease type); or • in persons who have developed a severe intolerance to ribavirin: appearance of an allergy, of an incapacitating skin rash or of incapacitating dyspnea with effort; The initial request is authorized for a maximum of 20 weeks. The authorization will be renewed if the decrease in the HCV-RNA is greater than or equal to 1.8 log after 12 weeks of treatment. The authorization will then be given for a maximum of 12 weeks. The request will be renewed if the HCVRNA is negative after 24 weeks of treatment. The total duration of treatment will be 48 weeks; ♦ for treatment of HBeAg-negative chronic hepatitis B. The request is authorized for a maximum of 48 weeks; PENTOXIFYLLINE: ♦ for treatment of persons suffering from serious and chronic peripheral vascular ailments, specifically: • in the case of venous insufficiency with cutaneous ulcer (or antecedents); • in the case of arterial insufficiency with cutaneous ulcer (or antecedents), gangrene, antecedents of amputation or pain at rest; APPENDIX IV - 53 PILOCARPINE HYDROCHLORIDE, Tab.: ♦ for treatment of severe xerostomia; PIMECROLIMUS: ♦ for treatment of atopical dermatitis in children, where a topical corticosteroid treatment has failed; PIOGLITAZONE HYDROCHLORIDE: ♦ for treatment of type-2 diabetic persons: • in association with metformin where a sulfonylurea is contraindicated, not tolerated or ineffective; • in association with a sulfonylurea where metformin is contraindicated, not tolerated or ineffective; • where metformin and a sulfonylurea cannot be used because of a contraindication or an intolerance to those drugs; • in association with metformin and a sulfonylurea where going to insulin therapy is indicated but the person is not in a position to receive it; • who are suffering from renal failure. However, pioglitazone remains covered by the basic prescription drug insurance plan for those insured persons having used this drug in the three months before 1 October 2009 and if its cost was already covered under that plan as part of the indications provided in the appendix hereto. For information purposes, the association of pioglitazone and insulin and the association of rosiglitazone and insulin increase the risk of congestive heart failure. POLYETHYLENE GLYCOL: ♦ for treatment of constipation related to a medical condition; POLYETHYLENE GLYCOL / SODIUM (sulfate) / SODIUM (bicarbonate) / SODIUM (chloride) / POTASSIUM (chloride): ♦ for treatment of constipation related to a medical condition; POLYVINYL ALCOHOL: ♦ for treatment of keratoconjunctivitis sicca or other severe conditions accompanied by markedly reduced tear production; POLYVINYL ALCOHOL / POVIDONE: ♦ for treatment of keratoconjunctivitis sicca or other severe conditions accompanied by markedly reduced tear production; + POSACONAZOLE: ♦ for prevention of invasive fungal infections in persons having developed neutropenia following chemotherapy to treat acute myeloid leucemia or myelodysplastic syndrome; ♦ for treatment of invasive aspergillosis in persons for whom first-line treatment has failed or is contraindicated, or who are intolerant to such a treatment; APPENDIX IV - 54 + PRASUGREL: ♦ where acute coronary syndrome occurs, for prevention of ischemic vascular manifestations, in association with acetylsalicylic acid, in persons for whom percutaneous coronary angioplasty has been performed. The duration of the authorization will be 12 months; PROGESTERONE, Vag. Gel (App.): ♦ for women, as part of an assisted procreation activity; PROGESTERONE, Vag. Tab. (eff.): ♦ for women, as part of an assisted procreation activity. PSYLLIUM MUCILLOID: ♦ for treatment of constipation related to a medical condition; ♦ for treatment of chronic diarrhea; QUANTITATIVE PROTHROMBIN-TIME BLOOD TEST: ♦ to measure the international normalized ratio (INR) in persons who require life-long anticoagulation, whose unstable coagulation condition necessitates close monitoring (INR one or more times per week), and whose access to a sample-taking site is particularly difficult. RANIBIZUMAB: ♦ for treatment of age-related macular degeneration in the presence of choroidal neovascularization. The eye to be treated must meet the following four criteria: • optimal visual acuity after correction between 6/12 and 6/96; • linear dimension of the lesion less than or equal to 12 disc areas; • absence of significant permanent structural damage to the centre of the macula. The structural damage is defined by fibrosis, atrophy or a chronic disciform scar such that, according to the treating physician, it precludes a functional benefit; • progression of the disease in the last three months, confirmed by retinal angiography, optical coherence tomography or recent changes in visual acuity. The initial request is authorized for a maximum of four months. Upon subsequent requests, the physician must provide information making it possible to establish a beneficial clinical effect, consisting in a stabilization or improvement of the medical condition shown by a retinal angiography or by optical coherence tomography. Authorizations will then be given for a maximum of 12 months. Authorizations are given for one dose per month and per eye. Ranibizumab will not be authorized concomitantly with verteporfin for treatment of the same eye. However, ranibizumab remains covered by the basic prescription drug insurance plan for those insured persons having used this drug in the 12 months before 1 February 2010 and if its cost was already covered under that plan as part of the indications provided in the appendix hereto. ♦ for treatment of visual deficiency caused by diabetic macular edema. The eye to be treated must meet the following two criteria: • optimal visual acuity after correction between 6/9 and 6/96; • thickness of the central retina ≥ 250 µm. APPENDIX IV - 55 The initial request is authorized for a maximum of four months. When requesting continuation of treatment, the physician must provide information making it possible to establish a beneficial clinical effect, consisting in a stabilization or improvement of visual acuity measured on the Snellen scale and improvement of the macular edema confirmed by optical coherence tomography. The request for continuation of treatment will be authorized for a maximum of 20 months. Authorizations are given for a maximum of one dose per month and per eye. The maximum total duration of treatment will be 24 months. ♦ for treatment of visual deficiency due to macular edema secondary to central retinal vein occlusion. The eye to be treated must meet the following three criteria: • optimal visual acuity after correction between 6/12 and 6/96; • thickness of the central retina ≥ 250 µm. • absence of afferent pupillary defect. The initial request is authorized for a maximum of four months. When requesting continuation of treatment, the physician must provide information making it possible to establish a beneficial clinical effect, consisting in a stabilization or improvement of visual acuity measured on the Snellen scale and stabilization or improvement of the macular edema confirmed by optical coherence tomography. The request for continuation of treatment will be authorized for a maximum of 20 months. Authorizations are given for a maximum of one dose per month and per eye. The maximum total duration of treatment will be 24 months. RASAGILINE MESYLATE: ♦ for persons suffering from Parkinson's disease with motor fluctuations, despite levodopa therapy. REPAGLINIDE: ♦ where a sulfonylurea is contraindicated, not tolerated or ineffective; ♦ for treatment of non-insulindependent diabetic persons suffering from renal failure; RIBAVIRIN / PEGYLATED INTERFERON ALFA-2B: ♦ for treatment of persons suffering from chronic hepatitis C of genotype 2 or 3. The maximum duration of the authorization will be 24 weeks. However, persons who, during a previous treatment with an association of ribavirin / pegylated interferon alfa-2b: did not obtain a negativation of their viremia after 24 weeks of treatment, or did not obtain a sustained virological response 24 weeks after the end of the treatment, except in the case of rapid responders (negativation) at four weeks who relapsed after a shortened 12week to 16-week treatment; are not eligible for a second treatment; ♦ for treatment of persons suffering from chronic hepatitis C of a genotype other than 2 or 3, and for treatment of chronic hepatitis C of any genotype in persons infected with HIV. APPENDIX IV - 56 The total duration of the authorization is a maximum of 48 weeks. For persons suffering from chronic hepatitis C of genotype 2 or 3 and who are coinfected with HIV, the initial request is authorized for a maximum of 32 weeks. Thereafter, an authorization will be granted for a maximum of 16 weeks for treatment termination purposes, only if the qualitative HCVRNA result 24 weeks from the beginning of the treatment is negative. For other persons, authorizations will be granted under different conditions based on the type of test conducted for the purpose of evaluating response to the treatment after the first 12 weeks of treatment. The initial request is authorized for a maximum of 20 weeks. A quantitative or qualitative HCV-RNA screening test 12 weeks from the beginning of the treatment is necessary to determine response to the treatment. • • In the case of a qualitative test, another authorization, for a maximum of 28 weeks, will be granted for treatment termination purposes, only if the test result is negative. In the case of a quantitative test, another authorization, for an additional maximum of 12 weeks, will be granted only if the test result shows a decrease in viremia greater than or equal to 1.8 log compared with pre-treatment viremia. Thereafter, an authorization will be granted for a maximum of 16 weeks for treatment termination purposes, only if the qualitative HCV-RNA result is negative after 24 weeks of treatment. However, persons who, during a previous treatment with an association of ribavirin / pegylated interferon alfa-2b: did not obtain a 1.8-log decrease in viremia after 12 weeks compared to the pre-treatment value; did not obtain a negativation of their viremia after a minimum of 24 weeks of treatment; did not obtain a sustained virological response 24 weeks after the end of the treatment, except in the case of rapid responders (negativation) at four weeks who relapsed after a shortened 24week treatment; are not eligible for a second treatment; ♦ for treatment of chronic hepatitis C in persons having received a transplant. The maximum duration of the authorization will be 48 weeks. However, persons who, during a previous treatment with an association of ribavirin / pegylated interferon alfa-2b, did not obtain a negativation of their viremia after 48 weeks of treatment or a sustained virological response 24 weeks after the end of the treatment are not eligible for a second treatment; ♦ for treatment of persons suffering from chronic hepatitis genotype 1 who are not HIV-1 infected, in the absence of cirrhosis, when used concomitantly with an antiviral NS3/4A protease inhibitor (boceprevir or telaprevir) and who have never received an anti-HCV treatment. The total duration of treatment, including the 4 weeks of preliminary treatment when boceprevir is the agent used, will be a maximum of 24, 28 or 48 weeks depending on the results of the viral load (HCV-RNA) tests for the weeks set out in the recognized indications for the chosen antiviral NS3/4A protease inhibitor. When the viral load (HCV-RNA) is detectable on week 24, the combination treatment (tritherapy) must be terminated. APPENDIX IV - 57 ♦ for treatment of persons suffering from chronic hepatitis C genotype 1 who are not HIV-1 infected, in the presence of serious hepatic fibrosis or cirrhosis, when used concomitantly with an antiviral NS3/4A protease inhibitor (boceprevir or telaprevir) or who have experienced therapeutic failure with an interferon and with ribavirin. Previous therapeutic failure means the occurrence of a partial response defined by a lowering of the viral load (HCV-RNA) of at least 1.8 log10 on week 12 but without having obtained a sustained virological response, or the occurrence of relapse defined by a viral load (HCV-RNA) that is undetectable at the end of treatment, but detectable thereafter. Regarding telaprevir, this also includes the persons for whom that treatment has failed, i.e. the persons not showing a lowering of their viral load of 1.8 log10 UI/ml on week 12. The total duration of treatment, including the 4 weeks of preliminary treatment when boceprevir is the agent used, will be a maximum of 36 weeks or 48 weeks, depending on the results of the viral load (HCV-RNA) tests for the weeks set out in the recognized indications for the chosen antiviral NS3/4A protease inhibitor. When the viral load (HCV-RNA) is detectable on week 24, the combination treatment (tritherapy) must be terminated. RIBAVIRIN / PEGINTERFERON ALFA-2A: ♦ for treatment of persons suffering from chronic hepatitis C of genotype 2 or 3. The maximum duration of the authorization will be 24 weeks. However, persons who, during a previous treatment with an association of ribavirin / peginterferon alfa-2a: did not obtain a negativation of their viremia after 24 weeks of treatment, or did not obtain a sustained virological response 24 weeks after the end of the treatment, except in the case of rapid responders (negativation) at four weeks who relapsed after a shortened 12week to 16-week treatment; are not eligible for a second treatment; ♦ for treatment of persons suffering from chronic hepatitis C of a genotype other than 2 or 3, and for treatment of chronic hepatitis C of any genotype in persons infected with HIV. The total duration of the authorization is a maximum of 48 weeks. For persons suffering from chronic hepatitis C of genotype 2 or 3 and who are coinfected with HIV, the initial request is authorized for a maximum of 32 weeks. Thereafter, an authorization will be granted for a maximum of 16 weeks for treatment termination purposes, only if the qualitative HCVRNA result 24 weeks from the beginning of the treatment is negative. For other persons, authorizations will be granted under different conditions based on the type of test conducted for the purpose of evaluating response to the treatment after the first 12 weeks of treatment. The initial request is authorized for a maximum of 20 weeks. A quantitative or qualitative HCV-RNA screening test 12 weeks from the beginning of the treatment is necessary to determine response to the treatment. APPENDIX IV - 58 • In the case of a qualitative test, another authorization, for a maximum of 28 weeks, will be granted for treatment termination purposes, only if the test result is negative. • In the case of a quantitative test, another authorization, for an additional maximum of 12 weeks, will be granted only if the test result shows a decrease in viremia greater than or equal to 1.8 log compared with pre-treatment viremia. Thereafter, an authorization will be granted for a maximum of 16 weeks for treatment termination purposes, only if the qualitative HCV-RNA result 24 weeks from the beginning of the treatment is negative. However, persons who, during a previous treatment with an association of ribavirin / peginterferon alfa-2a: did not obtain a 1.8-log decrease in viremia in the 12th week compared to the pre-treatment value; did not obtain a negativation of their viremia after a minimum of 24 weeks of treatment; did not obtain a sustained virological response 24 weeks after the end of the treatment, except in the case of rapid responders (negativation) at four weeks who relapsed after a shortened 24week treatment; are not eligible for a second treatment; ♦ for treatment of chronic hepatitis C in persons having received a transplant. The maximum duration of the authorization will be 48 weeks. However, persons who, during a previous treatment with an association of ribavirin / peginterferon alfa-2a, did not obtain a negativation of their viremia after 48 weeks of treatment or a sustained virological response 24 weeks after the end of the treatment are not eligible for a second treatment; ♦ for treatment of persons suffering from chronic hepatitis genotype 1 who are not HIV-1 infected, in the absence of cirrhosis, when used concomitantly with an antiviral NS3/4A protease inhibitor (boceprevir or telaprevir) and who have never received an anti-HCV treatment. The total duration of treatment, including the 4 weeks of preliminary treatment when boceprevir is the agent used, will be a maximum of 24, 28 or 48 weeks depending on the results of the viral load (HCVRNA) tests for the weeks set out in the recognized indications for the chosen antiviral NS3/4A protease inhibitor. When the viral load (HCV-RNA) is detectable on week 24, the combination treatment (tritherapy) must be terminated. ♦ for treatment of persons suffering from chronic hepatitis C genotype 1 who are not HIV-1 infected, in the presence of serious hepatic fibrosis or cirrhosis, when used concomitantly with an antiviral NS3/4A protease inhibitor (boceprevir or telaprevir) or who have experienced therapeutic failure with an interferon and with ribavirin Previous therapeutic failure means the occurrence of a partial response defined by a lowering of the viral load (HCV-RNA) of at least 1.8 log10 on week 12 but without having obtained a sustained virological response, or the occurrence of relapse defined by a viral load (HCV-RNA) that is undetectable at the end of treatment, but detectable thereafter. Regarding telaprevir, this also includes the persons for whom that treatment has failed, i.e. the persons not showing a lowering of their viral load of 1.8 log10 UI/ml on week 12. The total duration of treatment, including the 4 weeks of preliminary treatment when boceprevir is the agent used, will be a maximum of 36 weeks or 48 weeks, depending on the results of the viral load (HCV-RNA) tests for the weeks set out in the recognized indications for the chosen antiviral NS3/4A protease inhibitor. APPENDIX IV - 59 When the viral load (HCV-RNA) is detectable on week 24, the combination treatment (tritherapy) must be terminated. RILUZOLE: ♦ for treatment of amiotrophic lateral sclerosis in patients who have had symptoms of the disease for less than 5 years, whose vital capacity is more than 60% of the predicted value and who have not undergone a tracheotomy. Upon the initial request (new case), the physician must indicate the date on which symptoms of the disease began and the patient's vital capacity measurement, and must confirm that the patient has not undergone a tracheotomy. The maximum duration of the initial authorization is six months. Upon subsequent requests, and for patients already being treated, the physician must confirm that the patient has not undergone a tracheotomy. The maximum duration of authorization is six months. No renewal will be authorized in the presence of a tracheotomy. RISPERIDONE, I.M. Inj. Pd.: ♦ for persons who have an observance problem with an oral antipsychotic agent or for whom a prolonged-acting injectable conventional antipsychotic agent is ineffective or poorly tolerated; RITUXIMAB: ♦ for treatment of moderate or severe rheumatoid arthritis, in association with methotrexate, or with leflunomide in the case of intolerance or contraindication to methotrexate; Upon the initial request: • • the person must, prior to the beginning of treatment, have eight or more joints with active synovitis and one of the following five elements must be present: - a positive rheumatoid factor; - radiologically measured erosions; - a score of more than 1 on the Health Assessment Questionnaire (HAQ); - an elevated C-reactive protein level; - an elevated sedimentation rate, and the disease must still be active despite treatment of sufficient duration with a tumour necrosis factor alpha inhibitor (anti-TNFα) included on the lists of medications as first-line biological treatment of rheumatoid arthritis, or with a biological agent having a different mechanism of action, included for the same purposes, unless there is a serious intolerance or contraindication to anti-TNFα. The initial authorization is given for a maximum period of six months. When requesting continuation of treatment, the physician must provide information making it possible to establish a treatment response observed during the first six months after the last perfusion. A treatment response is defined by: APPENDIX IV - 60 • a decrease of at least 20% in the number of joints with active synovitis and one of the following four elements: - a decrease of 20% or more in the C-reactive protein level; - a decrease of 20% or more in the sedimentation rate; - a decrease of 0.20 in the HAQ score; a return to work. Administering a subsequent treatment is possible if the disease is still not in remission or if, following attainment of a remission, the disease is reactivated. Requests for continuation of treatment are authorized for a minimum period of 12 months and a maximum of 2 treatments. A treatment comprises 2 perfusions of rituximab of 1 000 mg each. + RIVAROXABAN, 10 mg: ♦ for prevention of venous thromboembolism following a knee arthroplasty; The maximum duration of the authorization is 14 days. ♦ for prevention of venous thromboembolism following a hip arthroplasty; The maximum duration of the authorization is 35 days. + RIVAROXABAN, 15 mg and 20 mg: ♦ for treatment of persons suffering from deep vein thrombosis who are unable to receive therapy comprising a heparine followed by vitamin K antagonist treatment; Treatment of deep vein thrombosis with rivaroxaban must include a dose of 15 mg twice a day during the first three weeks of treatment followed by a daily dose of 20 mg. The maximum duration of the authorization is six months. ♦ in persons with non-valvular atrial fibrillation requiring anticoagulant therapy: • for whom anticoagulation with warfarine or nicoumalone is not within the targeted therapeutic range; or • for whom anticoagulation monitoring with warfarin or nicoumalone is not possible or is not available; RIVASTIGMINE: ♦ as monotherapy for persons suffering from Alzheimer's disease at the mild or moderate stage. Upon the initial request, the following elements must be present: • an MMSE score of 10 to 26, or as high as 27 or 28 if there is proper justification; • medical confirmation of the degree to which the person is affected (intact domain, mildly, moderately or severely affected) in the following five domains: intellectual function, including memory; - mood; - behaviour; - autonomy in activities of daily living (ADL) and in instrumental activities of daily living (IADL); - social interaction, including the ability to carry on a conversation. APPENDIX IV - 61 The duration of the initial authorization for a treatment with rivastigmine is six months from the beginning of treatment. However, where the cholinesterase inhibitor is used following treatment with memantine, the concomitant use of both medications is authorized for one month. Upon subsequent requests, the physician must provide evidence of a beneficial effect confirmed by each of the following elements: • • • an MMSE score of 10 or more, unless there is proper justification; a maximum decrease of 3 points in the MMSE score per six-month period compared with the previous evaluation, or a greater decrease accompanied by proper justification; stabilization or improvement of symptoms in one or more of the following domains: intellectual function, including memory; - mood; - behaviour; - autonomy in activities of daily living (ADL) and in instrumental activities of daily living (IADL); - social interaction, including the ability to carry on a conversation. The maximum duration of authorization is 12 months. ROSIGLITAZONE MALEATE: ♦ for treatment of type-2 diabetic persons: • in association with metformin where a sulfonylurea is contraindicated, not tolerated or ineffective; • in association with a sulfonylurea where metformin is contraindicated, not tolerated or ineffective; • where metformin and a sulfonylurea cannot be used because of a contraindication or an intolerance to those drugs; • in association with metformin and a sulfonylurea where going to insulin therapy is indicated but the person is not in a position to receive it; • who are suffering from renal failure; However, rosiglitazone remains covered by the basic prescription drug insurance plan for those insured persons having used this drug in the three months before 1 October 2009 and if its cost was already covered under that plan as part of the indications provided in the appendix hereto. For information purposes, the association of pioglitazone and insulin and the association of rosiglitazone and insulin increase the risk of congestive heart failure. ROSIGLITAZONE MALEATE / METFORMIN HYDROCHLORIDE: ♦ for treatment of type-2 diabetic persons under treatment with metformin and a thiazolidinedione and whose daily doses have been stable for at least three months. These persons must also fulfill the requirements of the recognized payment indication for thiazolidinediones. However, the rosiglitazone / metformin association remains covered by the basic prescription drug insurance plan for those insured persons having used this drug in the three months before 1 October 2009 and if its cost was already covered under that plan as part of the indications provided in the appendix hereto. APPENDIX IV - 62 RUFINAMIDE: ♦ for persons suffering from Lennox-Gastaut syndrome where at least three antiepileptics are contraindicated, not tolerated or ineffective; The initial request is authorized for a maximum of three months. Upon subsequent requests, the physician must provide information making it possible to establish a treatment response, i.e. a decrease in the number or intensity of convulsive seizures or quicker recovery after a postictal phase. Authorizations for subsequent requests will be granted for a period of 12 months. RUXOLITINIB PHOSPHATE: ♦ for treatment of splenomegaly associated with primary myelofibrosis, myelofibrosis secondary to polycythemia vera or essential thrombocythemia in persons with: • a palpable spleen at 5 cm or more under the left costal margin, accompanied by basic imaging; • an intermediate-2 or high-risk disease according to the IPSS (International Prognostic Scoring System); • an ECOG performance status ≤ 3. The initial authorization is for a maximum duration of six months. Upon subsequent requests, the physician must provide evidence of a beneficial clinical effect by a significant reduction of the splenomegaly confirmed by imaging and by improvement of the symptomatology in patients who were initially symptomatic. Subsequent authorizations will be for durations of six months. Authorizations are given for a maximum daily dose of 50 mg. SALBUTAMOL SULFATE, Pd for Inh.: ♦ ™ for treatment of persons having difficulty using an inhalation device other than the Diskus device or who are already receiving another drug through this device; SALMETEROL XINAFOATE / FLUTICASONE PROPIONATE: ♦ for treatment of asthma and other reversible obstructive diseases of the respiratory tract in persons whose control of the disease is insufficient despite the use of an inhaled corticosteroid; ♦ for treatment of persons suffering from moderate or severe chronic obstructive pulmonary disease (COPD) whose symptoms are not under control despite the use of an inhaled short-acting ß2 agonist, an inhaled long-acting ß2 agonist and an inhaled anticholinergic agent. ♦ for treatment of persons suffering from moderate to severe chronic obstructive pulmonary disease (COPD), who have shown at least one exacerbation of the symptoms of the disease in the last year, despite regular use through inhalation of at least one long-acting bronchodilator; Exacerbation, is understood as a sustained and repeated aggravation of the symptoms requiring intensified pharmacological treatment, for instance, the addition of oral corticosteroids, or a precipitated medical visit or a hospitalization; In the case of the medical conditions set out in the preceding paragraphs, persons insured by the Régie de l'assurance maladie du Québec who obtained a reimbursement for an association of formoterol fumarate dihydrate / budesonide or of salmeterol xinafoate / fluticasone propionate within 365 days preceding 1 October 2003 are eligible for a continuation of their treatment. APPENDIX IV - 63 SAPROPTERIN DIHYDROCHLORIDE: ♦ for women suffering from phenylketonuria who wish to procreate, a two-month trial period is authorized to determine those responding to sapropterine; Thereafter, the physician will have to provide the following proof: • a response to sapropterine defined by an average decrease of serum phenylalanine concentration of at least 30%; and • a serum phenylalanine concentration greater than 360 µmol/l despite a low phenylalanine diet; Authorization will be granted for the period during which the women actively attempt to procreate, up to the end of their pregnancy. SAXAGLIPTIN: ♦ for treatment of type-2 diabetic persons: • in association with metformin where a sulfonylurea is contraindicated, not tolerated or ineffective; or • in association with a sulfonylurea where metformin is contraindicated, not tolerated or ineffective; SENNOSIDES A & B: ♦ for treatment of constipation related to a medical condition; SEVELAMER carbonate: ♦ as a phosphate binder in persons suffering from severe renal failure, where a calcium salt is contraindicated, is not tolerated, or does not make it possible to optimally control the hyperphosphoremia; It must be noted that sevelamer will not be authorized concomitantly with lanthanum hydrate. SEVELAMER HYDROCHLORIDE: ♦ as a phosphate binder in persons suffering from severe renal failure, where a calcium salt is contraindicated, is not tolerated, or does not make it possible to optimally control the hyperphosphoremia. It must be noted that sevelamer will not be authorized concomitantly with lanthanum hydrate. SILDENAFIL CITRATE: ♦ for treatment of pulmonary arterial hypertension (WHO functional class III) that is either idiopathic or related to connectivitis and that is symptomatic despite the optimal conventional treatment. The person must be evaluated and followed up on by physicians working at designated centres specializing in the treatment of pulmonary arterial hypertension. Authorizations will be given for 20 mg three times per day. SITAGLIPTIN: ♦ for treatment of type-2 diabetic persons: APPENDIX IV - 64 • as monotherapy where metformin and a sulfonylurea are contraindicated or not tolerated; or • in association with metformin, where a sulfonylurea is contraindicated, not tolerated or ineffective; SITAGLIPTIN / METFORMIN: ♦ for treatment of type-2 diabetic persons: • • where a sulfonylurea is contraindicated, not tolerated or ineffective; and where the daily doses of metformin have been stable for at least three months; SODIUM CITRATE / SODIUM LAURYLSULFOACETATE / SORBITOL: ♦ for treatment of constipation related to a medical condition; SODIUM PHOSPHATE MONOBASIC / SODIUM PHOSPHATE DIBASIC: ♦ for treatment of constipation related to a medical condition; SOLIFENACIN SUCCINATE: ♦ for treatment of vesical hyperactivity in persons for whom oxybutynine is poorly tolerated, contraindicated or ineffective; SOMATOTROPHIN: ♦ for treatment of children and adolescents suffering from delayed growth due to insufficient secretion of endogenous growth hormone, where they meet the following criteria: • unterminated growth, a growth rate for their bone age below the 25th percentile (calculated over at least a 12-month period), and a somatotrophin serum or plasma level below 8 μg/L in two pharmacological stimulation tests or between 8 and 10 μg/L if the tests are repeated twice at a 6-month interval. • • • ♦ The 12-month observation period does not apply to children suffering from hypoglycemia secondary to growth hormone deficiency; excluded are children and adolescents suffering from achondroplasia or delayed growth of a genetic or familial type; excluded are children and adolescents whose bone age has reached 15 years for girls and 16 years for boys; excluded are children and adolescents whose growth rate during treatment falls below 2 cm per year when evaluated on two consecutive visits (at a 3-month interval); for treatment of children and adolescents suffering from delayed growth related to chronic renal failure until they undergo a kidney transplant, where they meet the following criteria: • unterminated growth, a glomerular filtration rate ≤ 1.25 mL/s./1.73m² (75 mL/min./ 1.73m²), and a Z score (HSDS) ≤ a standard deviation of -2 (HSDS = height compared to the average of normal values for their age and sex) or a Δ Z score (HSDS) < a standard deviation of 0 where their height is below the 10th percentile (based on observation periods of at least six months for children over the age of one and at least three months for children under the age of one); • excluded are children and adolescents in whom, during treatment, no response (no increase in Δ of Z score (HSDS) in the first 12 months of treatment) is observed; • excluded are children and adolescents in whom, during treatment, an ossification of the conjugative cartilages is observed or who have reached their final predicted height; APPENDIX IV - 65 • ♦ excluded are children and adolescents whose growth rate, evaluated on two consecutive visits (at a 3-month interval), falls below 2 cm per year; for treatment of growth hormone deficiency in persons whose bone growth has terminated and who meet the following criteria: • somatotrophin serum or plasma level between 0 and 3 μg/mL in a pharmacological test; In persons who have a multiple hypophyseal hormone deficiency, and to confirm a deficiency acquired during childhood or adolescence, only one pharmacological stimulation test is necessary. In the case of an isolated growth hormone deficiency, two tests are required. The insulin hypoglycemia test is recommended. If this test is contraindicated, the arginine test alone, or combined with the GHRH, may be substituted for it. Where the arginine test is combined with the GHRH, the value must be ≤ 9 μg/L; • ♦ in the case of adult onset, the deficiency must be secondary to hypophyseal or hypothalamic disease, surgery, radiotherapy or trauma; for treatment of Turner’s syndrome: • the syndrome must have been demonstrated by a karyotype compatible with this diagnosis (complete absence or structural anomaly of one of the X chromosomes). This karyotype may be homogeneous or may be a mosaic; • excluded are girls whose bone age has reached 14 years; • excluded are girls whose growth rate, during treatment, falls below 2 cm per year when evaluated on two consecutive visits (at a 3-month interval); SOMATROPIN: ♦ for treatment of children and adolescents suffering from delayed growth due to insufficient secretion of endogenous growth hormone, where they meet the following criteria: • unterminated growth, a growth rate for their bone age below the 25th percentile (calculated over at least a 12-month period), and a somatotrophin serum or plasma level below 8 μg/L in two pharmacological stimulation tests or between 8 and 10 μg/L if the tests are repeated twice at a 6-month interval. The 12-month observation period does not apply to children suffering from hypoglycemia secondary to growth hormone deficiency; • • • excluded are children and adolescents suffering from achondroplasia or delayed growth of a genetic or familial type; excluded are children and adolescents whose bone age has reached 15 years for girls and 16 years for boys; excluded are children and adolescents whose growth rate during treatment falls below 2 cm per year when evaluated on two consecutive visits (at a 3-month interval); SUNITINIB MALATE: ♦ for treatment of an inoperable, recidivant or metastatic gastrointestinal stromal tumour, in persons whose ECOG performance status is ≤ 2 and: • who have not responded to an imatinib treatment (primary resistance); • whose cancer has evolved after initially responding to imatinib (secondary resistance); • who have an intolerance to imatinib. The initial authorization is for a maximum duration of six months. APPENDIX IV - 66 Upon subsequent requests, the physician must provide evidence of a complete or partial response or of disease stabilization, confirmed by imaging. In addition, the ECOG performance status must remain ≤ 2. Subsequent authorizations will also be for maximum durations of six months. ♦ Authorizations are given for a daily dose of 50 mg for four weeks every six weeks. for first-line treatment of a metastatic renal adenocarcinoma characterized by the presence of clear cells, in persons whose ECOG performance status is 0 or 1; The initial authorization is for a maximum duration of three cycles (18 weeks). Upon subsequent requests, the physician must provide evidence of a complete or partial response or of disease stabilization, confirmed by imaging during the six weeks before the end of the current authorization. In addition, the ECOG performance status must remain at 0 or 1. Subsequent authorizations will also be for maximum durations of three cycles (18 weeks). Authorizations are given for one daily dose of 50 mg for four weeks every six weeks. ♦ for treatment of unresectable and evolutive, well-differentiated pancreatic neuroendocrine tumours at an advanced or metastatic stage in persons whose ECOG performance status is 0 or 1; The initial authorization is for a maximum duration of four months. Upon subsequent requests, the physician must provide evidence of a beneficial clinical effect (absence of disease progression) confirmed by imaging. The ECOG performance status must remain at 0 or 1. Subsequent authorizations will be for maximum durations of six months. Authorizations are given for a maximum daily dose of 37.5 mg. It must be noted that sunitinib will not be authorized in association with everolimus, nor will it be following failure with everolimus if the latter was administered to treat this condition. TACROLIMUS, Top. Oint.: ♦ for treatment of atopic dermatitis in children, following failure of a treatment with a topical corticosteroid; ♦ for treatment of atopical dermatitis in adults, following failure of at least two treatments with a different topical corticosteroid of intermediate strength or greater, or following failure of at least two treatments on the face with a different low-strength topical corticosteroid; TADALAFIL: ♦ for treatment of pulmonary arterial hypertension (WHO functional class III) that is either idiopathic or related to connectivitis and that is symptomatic despite the optimal conventional treatment. The persons must be evaluated and followed up on by physicians working at designated centres specializing in the treatment of pulmonary arterial hypertension. Authorizations will be given for 40 mg once per day. TELAPREVIR: ♦ for treatment of persons suffering from chronic hepatitis C genotype 1 who are not HIV-1 infected, in the absence of cirrhosis, and who have never received an anti-HCV treatment, when used concomitantly with a combination of ribavirin / pegylated interferon alfa. APPENDIX IV - 67 The authorization is granted for a period of 12 weeks. The total duration of treatment, including the concomitant and subsequent taking of the combination of ribavirin / pegylated interferon alfa will be 24 weeks if the viral load (HCV-RNA) is undetectable on treatment weeks 4 and 12. It will be 48 weeks, if the viral load is detectable, but less than 1 000 UI/ml on treatment weeks 4 and 12 and undetectable on week 24. ♦ for treatment of persons suffering from chronic hepatitis C genotype 1 who are not HIV-1 infected, in the presence of serious hepatic fibrosis or cirrhosis, or who have experienced therapeutic failure with an interferon and with ribavirin. The authorization is granted for a period of 12 weeks. The total duration of treatment, including the concomitant and subsequent taking of the combination of ribavirin / pegylated interferon alfa will be 48 weeks if the viral load (HCV-RNA) is undetectable on treatment week 24. TEMOZOLOMIDE: ♦ for treatment of persons suffering from anaplastic astrocytoma or glioblastoma multiforme and in whom a recurrence or progression of the disease is observed after administration of a first-line treatment; ♦ for first-line treatment, in association with radiotherapy, of persons suffering from glioblastoma multiforme; TERIPARATIDE: ♦ for treatment of severe osteoporosis in menopausal women: • whose osteoporotic fractures are documented by a T-score of less than or equal to – 3.0; and • who have shown an inadequate response to continued taking of a bisphosphonate (or raloxifene, if a bisphosphonate is contraindicated), that is, who have shown the following characteristics: - a new fragility fracture following continued taking of the antiresorptive therapy for at least 12 months; or - significant decrease in mineral bone density, less than the T-score observed during pretreatment, despite continued taking of the antiresorptive therapy for at least 24 months. The total duration of the authorization is 18 months. THALIDOMIDE: ♦ in association with melphalan and prednisone, for first-line treatment of multiple myeloma, in persons who are not candidates for stem cell transplant. The initial request is authorized for a maximum six months. Upon subsequent requests, the physician must provide evidence of a beneficial clinical effect (absence of disease progression) documented by each of the following three elements: The disease progresses as soon as one of the elements is met. Disease progression is defined for each of the elements in the following manner: APPENDIX IV - 68 The disease is progressing as soon as one of the elements is met. Disease progression is defined for each of them in the following manner: • an increase of ≥ 25% (in comparison to the result observed at the beginning of the treatment) of: - serum monoclonal protein (the absolute increase must be ≥ 5 g/L); - urinary monoclonal protein (the absolute increase must be ≥ 200 mg per 24 hours); - the difference between free light chains (the absolute increase must be ≥ 100 mg/L); - medullary plasmocytes (the absolute increase must be ≥ 10 %); Among the four above dosages, the physician must provide the test result he or she deems the most appropriate for the person being treated. • an increase in bone lesions or plasmacytomas; • the appearance of hypercalcemia defined by corrected calcemia > 2.8 mmol/L without any other apparent cause. The maximum duration of subsequent authorizations is six months. It must be noted that thalidomide will not be authorized in association with bortezomib. + TICAGRELOR: ♦ where acute coronary syndrome occurs, for prevention of ischemic vascular manifestations, in association with acetylsalicylic acid; The maximum duration of the authorization is 12 months. + TIGECYCLINE: ♦ for treatment of proven or presumed methicillin-resistant staphylococcus aureus (MRSA) polymicrobial complicated skin infections: • necessitating antibiotherapy targeting simultaneously the MRSA and Gram-negative bacteria, and • where vancomycin in combination with another antibiotic is ineffective, contraindicated or not tolerated; ♦ for treatment of complicated intra-abdominal infections where first-line treatment has failed, is contraindicated or is not tolerated; TIPRANAVIR: ♦ for treatment, in association with other antiretrovirals, of HIV-infected persons: • who have tried, since the beginning of their antiretroviral therapy, at least one therapy that included delavirdine, efavirenz or nevirapine, unless there is a primary resistance to one of those drugs, and that resulted: − in a documented virological failure, after at least three months of treatment with an association of several antiretroviral agents; or − in serious intolerance to one of those agents, to the point of calling into question the continuation of the antiretroviral treatment; and • who have tried, since the beginning of their antiretroviral therapy, at least one therapy that included another protease inhibitor and that resulted: APPENDIX IV - 69 − − in a documented virological failure, after at least three months of treatment with an association of several antiretroviral agents; or in serious intolerance to at least three protease inhibitors, to the point of calling into question the continuation of the antiretroviral treatment. Where a therapy including a non-nucleoside reverse transcriptase inhibitor cannot be used because of a primary resistance to delavirdine, efavirenz or nevirapine, a trial of at least two therapies, each including a protease inhibitor, is necessary and must have resulted in the same conditions as those listed above. ♦ for first line treatment, in association with other antiretrovirals, of HIV infected persons for whom a laboratory test showed an absence of sensitivity to other protease inhibitors, coupled with a resistance to one or the other class of nucleoside reverse transcriptase inhibitors and nonnucleoside reverse transcriptase inhibitors, or to both, and: • whose current viral load and another dating back at least one month are greater than or equal to 500 copies/mL; and • whose current CD4 lymphocyte count and another dating back at least one month are less than or equal to 350/µL; and • for whom darunavir or tipranavir is necessary to establish an effective therapeutic regimen; TIZANIDINE HYDROCHLORIDE: ♦ for treatment of spasticity where baclofen is ineffective, contraindicated or not tolerated; TOBRAMYCIN SULFATE, Inh. Sol. and Inh. Pd.: ♦ for treatment of chronic Pseudomonas aeruginosa infections in persons suffering from cystic fibrosis, where deterioration of the person's clinical condition is observed despite the conventional treatment or where the person is allergic to preservatives; TOCILIZUMAB: ♦ for treatment of moderate or severe rheumatoid arthritis; Upon initiation of treatment or if the person has been receiving the drug for less than five months: • • the person must, prior to the beginning of treatment, have eight or more joints with active synovitis and one of the following five elements must be present: - a positive rheumatoid factor; - radiologically measured erosions; - a score of more than 1 on the Health Assessment Questionnaire (HAQ); - an elevated C-reactive protein level; - an elevated sedimentation rate, and the disease must still be active despite treatment with two disease-modifying anti-rheumatic drugs, used either concomitantly or not, for at least three months each. Unless there is serious intolerance or a serious contraindication, one of the two drugs must be methotrexate at a dose of 20 mg or more per week. The initial request is authorized for a maximum of five months. APPENDIX IV - 70 When requesting continuation of treatment, the physician must provide information making it possible to establish the treatment's beneficial effects, specifically: a decrease of at least 20% in the number of joints with active synovitis and one of the following four elements: - a decrease of 20% or more in the C-reactive protein level; - a decrease of 20% or more in the sedimentation rate; - a decrease of 0.20 in the HAQ score; a return to work. Requests for continuation of treatment are authorized for a period of 12 months. • Authorizations for tocilizumab are given for a maximum dose of 8 mg/kg every four weeks. ♦ for treatment of moderate or severe systemic juvenile idiopathic arthritis, with predominant articular manifestations; Upon initiation of treatment or if the person has been receiving the drug for less than five months: • • • the person must, prior to the beginning of treatment, have five or more joints with active synovitis and one of the following two elements: - an elevated C-reactive protein level; - an elevated sedimentation rate, and the disease must still be active despite treatment with methotrexate at a dose of 15 mg/m2 or more (maximum 20 mg per dose) per week for at least three months, unless there is intolerance or a contraindication. and the disease must still be active despite treatment with a biological response modulating agent titrated optimally during at least five months, unless there is intolerance or a contraindication. The initial request is authorized for a maximum of five months. When requesting continuation of treatment, the physician must provide information making it possible to establish the treatment's beneficial effects, specifically: • a decrease of at least 20% in the number of joints with active synovitis and one of the following six elements: - a decrease of 20% or more in the C-reactive protein level; - a decrease of 20% or more in the sedimentation rate; - an decrease of 0.13 in the Childhood Health Assessment Questionnaire (CHAQ) score or a return to school; - an improvement of at least 20% in the physician's overall assessment (visual analogue scale); - an improvement of at least 20% in the person's or parent's overall assessment (visual analogue scale); - a decrease of 20% or more in the number of affected joints with limited movement. Requests for continuation of treatment are authorized for a period of 12 months. Authorizations for tocilizumab are given for doses of 12 mg/kg every two weeks for children weighing less than 30 kg and 8 mg/kg every two weeks for children weighing 30 kg or more. ♦ for treatment of moderate or severe systemic juvenile idiopathic arthritis, with predominant systemic manifestations; APPENDIX IV - 71 Upon initiation of treatment or if the person has been receiving the drug for less than five months: • the person must, prior to the beginning of treatment, have had one or more joints with active synovitis and one of the following three elements: - an elevated C-reactive protein level; - an elevated sedimentation rate; - another sign of chronic inflammation, such as anemia, thrombocytosis, leukocytosis, and • at least one systemic illness among the following: persistence of fever episodes (≥ 38°C); typical skin eruption; adenomegaly, hepatomegaly or splenomegaly; serositis The initial request is authorized for a maximum of five months. When requesting continuation of treatment, the physician must provide information making it possible to establish the treatment's beneficial effects, specifically: • two of the following elements or a decrease of at least 20% in the number of joints with active synovitis and one of the following six elements: - a decrease of 20% or more in the C-reactive protein level; - a decrease of 20% or more in the sedimentation rate; - a decrease of 0.13 in the Childhood Health Assessment Questionnaire (CHAQ) score or a return to school; - an improvement of at least 20% in the physician's overall assessment (visual analogue scale); - an improvement of at least 20% in the person's or parent's overall assessment (visual analogue scale); - a decrease of 20% or more in the number of affected joints with limited movement. and • disappearance of fever episodes. Requests for continuation of treatment are authorized for a maximum of 12 months. Authorizations for tocilizumab are given for doses of 12 mg/kg every two weeks for children weighing less than 30 kg and 8 mg/kg every two weeks for children weighing 30 kg or more. TOCOPHERYL ACETATE (DL-ALPHA): ♦ for prevention and treatment of neurological manifestations associated with malabsorption of vitamin E; TOLTERODINE L-TARTRATE: ♦ for treatment of vesical hyperactivity in persons for whom oxybutynin is poorly tolerated, contraindicated or ineffective; TRANDOLAPRIL / VERAPAMIL (HYDROCHLORIDE): ♦ for persons already being treated with an angiotensin converting enzyme inhibitor and verapamil taken separately; APPENDIX IV - 72 TRAVOPROST / TIMOLOL MALEATE: ♦ for control of intra-ocular pressure where the use of an antiglaucoma agent as monotherapy is insufficient; TREPROSTINIL SODIUM: ♦ for treatment of pulmonary arterial hypertension of WHO functional class III or IV that is either idiopathic or associated with connectivitis and that is symptomatic despite the optimal conventional treatment; Persons must be evaluated and followed up on by physicians working at designated centres specializing in the treatment of pulmonary arterial hypertension; TRETINOIN, Top. Cr. and Top. Gel: ♦ for treatment of acne or other skin diseases necessitating a keratolytic treatment; TROSPIUM CHLORIDE: ♦ for treatment of vesical hyperactivity in persons for whom oxybutynine is poorly tolerated, contraindicated or ineffective; UROFOLLITROPIN: ♦ for women, as part of an assisted procreation activity; USTEKINUMAB: ♦ for treatment of persons suffering from a severe form of chronic plaque psoriasis: • in the presence of a score greater than or equal to 15 on the Psoriasis Area and Severity Index (PASI) or of large plaques on the face, palms or soles or in the genital area; and • in the presence of a score greater than or equal to 15 on the Dermatology Quality of Life Index (DQLI) questionnaire; and • • where a phototherapy treatment of 30 sessions or more for three months has not made it possible to optimally control the disease, unless the treatment is contraindicated, not tolerated or not accessible or unless a treatment of 12 sessions or more for one month has not provided significant improvement in the lesions; and where a treatment with two systemic agents, used concomitantly or not, for at least three months each, has not made it possible to optimally control the disease. Except in the case of serious intolerance or a serious contraindication, these two agents must be: - methotrexate at a dose of 15 mg or more per week; or - cyclosporine at a dose of 3 mg/kg or more per day; or - acitretin at a dose of 25 mg or more per day. The initial request is authorized for a maximum five months. APPENDIX IV - 73 When requesting continuation of treatment, the physician must provide information making it possible to establish the treatment's beneficial effects, specifically: • • • an improvement of at least 75% in the PASI score; or an improvement of at least 50% in the PASI score and a decrease of at least five points on the DQLI questionnaire; or a significant improvement in lesions on the face, palms or soles or in the genital area and a decrease of at least five points on the DQLI questionnaire. Requests for continuation of treatment are authorized for a maximum of six months. Authorizations for ustekinumab are given for a dose of 45 mg in weeks 0 and 4, then every 12 weeks. A dose of 90 mg may be authorized for persons whose body weight is greater than 100 kg. + VALGANCICLOVIR HYDROCHLORIDE: ♦ for treatment of cytomegalovirus (CMV) retinitis in immunocompromised persons; ♦ for CMV-infection prophylaxis in D+R- persons having had a solid organ transplant and in D+R+ and D-R+ persons having had a lung transplant. The maximum duration of the authorization is 100 days; ♦ for CMV-infection prophylaxis in D+R-, D+R+ and D-R+ persons having had a solid organ transplant when receiving antilymphocyte antibodies. The maximum duration of each authorization is 100 days; ♦ for pre-emptive treatment (in the presence of documented CMV viral replication) of CMV infection in D+R-, D+R+ and D-R+ persons who have had a solid organ transplant. The maximum duration of the authorization is 100 days per episode; VEMURAFENIB: ♦ as monotherapy for first-line treatment of unresectable or metastatic melanoma with a BRAF V600 mutation, in persons whose ECOG performance status is 0 or 1. The initial authorization is for a maximum four months. Upon subsequent requests, the physician must provide evidence of a beneficial clinical effect (absence of disease progression) confirmed by imaging or based on a physical examination. The ECOG performance status must remain at 0 or 1. Subsequent authorizations will be for durations of four months. Authorizations are given for a maximum daily dose of 1 920 mg. VERTEPORFIN: ♦ for treatment of age-related macular degeneration with neovascularization in persons where 50% or more of the macular area is affected; ♦ for treatment of pathological myopia with neovascularization; ♦ for treatment of presumed ocular histoplasmosis syndrome with neovascularisation; APPENDIX IV - 74 + VORICONAZOLE, I.V. Perf. Pd.: ♦ for treatment of invasive aspergillosis; ♦ for treatment of candidemia in non-neutropenic persons for whom fluconazole and an amphotericin B formulation have failed, are not tolerated or are contraindicated; + VORICONAZOLE, Tab.: ♦ for treatment of invasive aspergillosis. The initial authorization is for a maximum duration of three months. Upon submission of a subsequent request, the authorization may be renewed if relevant justification is provided; ♦ for treatment of candidemia in non-neutropenic persons for whom fluconazole and an amphotericin B formulation have failed, are not tolerated or are contraindicated; + ZANAMIVIR : ♦ for treatment of type A or B influenza (seasonal flu): • in persons living in a homecare centre; • in persons suffering from a chronic disease requiring regular medical follow-up or hospital care (according to the MSSS definition); nd rd • in pregnant women at their 2 or 3 trimester of pregnancy (13 weeks or more); ♦ for type A or B influenza (seasonal flu) prophylaxis: • in persons living in a homecare centre in close contact with an infected person (index case); The request is authorized when the following conditions are fulfilled: • the existing surveillance data demonstrate the presence and sensitivity of type A or B influenza viruses, according to notices issued by regional and provincial public health directorates, where applicable; • the treatment administration time frame with the antiviral is met (48 hours); Chronic diseases are defined as follows: • cardiac or pulmonary disorders (including bronchopulmonary dysplasia, cystic fibrosis, chronic obstructive pulmonary disease (COPD), emphysema and asthma) serious enough to warrant regular medical follow-up or hospital care; • diabetes or other chronic metabolic disorders, hepatic disorders (including cirrhosis), renal disorders, hematologic disorders (including hemoglobinopathy), cancer, immunodeficiency (including HIV) or immunosuppression (radiotherapy, chemotherapy, anti-rejection drugs); • medical conditions that may compromise the handling of respiratory secretions and increase the risk of aspiration (e.g. cognitive impairments, spinal cord injuries, convulsive disorders, neuromuscular disorders, morbid obesity). ZOLEDRONIC ACID, , I.V. Perf. Sol. 4 mg/5 mL: ♦ for treatment of hypercalcemia of tumoral origin, where pamidronate is ineffective or not tolerated; ♦ for prevention of bone events in persons suffering from breast cancer with bone metastases, where pamidronate is not tolerated; APPENDIX IV - 75 ♦ for prevention of bone events in persons suffering from multiple myeloma with bone lesions, where pamidronate is not tolerated. Notwithstanding the payment indications set out above, zoledronic acid is covered by the basic prescription drug insurance plan for insured persons who used this drug during the 12-month period preceding 28 April 2004. Persons referred to in the preceding paragraph who are insured by the Régie de l’assurance maladie du Québec are not required to submit the form entitled "Demande d’autorisation – médicament d’exception". The Régie de l’assurance maladie du Québec will cover the cost of this drug without other formalities, if it had already done so during the above-mentioned period. ZOLEDRONIC ACID, I.V. Perf. Sol. 5 mg/100 mL: ♦ for treatment of Paget's disease; for treatment of postmenopausal osteoporosis in women who cannot receive an oral bisphosphonate because of serious intolerance or a contraindication APPENDIX IV - 76 Legend ♦ Symbols used in this list Z Drug subject to the Narcotic Control Regulations (C.R.C., ch. 1041). X Drug listed in Schedule F to the Food and Drugs Regulations (C.R.C., c. 870). Y Controlled drug listed in Schedule G to the Food and Drugs Regulations (C.R.C., c. 870). V Drug subject to the Benzodiazepines and Other Targeted Substances Regulations (SOR/2000-217). * Drug about which the information has been changed since the previous edition. + Drug added since the previous edition was published. suppl. The service cost for this product is the service cost applicable to nutritional formulas. UE Drug considered unique and essential from an unrecognized manufacturer. W Product withdrawn from the market by the manufacturer but covered by the Régie during the period for which this edition is valid. LPM The lowest price method applies to drugs having this generic name, dosage form and strength. Identifies the price payable in conformity with the lowest price method. Identifies the maximum price payable. 1 4:00 ANTIHISTAMINE DRUGS 4:04 4:04.04 4:04.16 first generation antihistamines ethanolamine derivatives piperazine derivatives CODE BRAND NAME MANUFACTURER COST OF PKG. SIZE SIZE UNIT PRICE 4:00 ANTIHISTAMINE DRUGS KETOTIFENE FUMARATE X Syr. 1 mg/5 mL 02176084 Novo-Ketotifen Novopharm 00577308 Zaditen Teva Can 250 ml Tab. 33.25 0.1330 1 mg 100 38.00 0.3800 4:04.04 ETHANOLAMINE DERIVATIVES DIPHENHYDRAMINE HYDROCHLORIDE Inj. Sol. 00596612 Diphenhydramine (chlorhydrate de) 00878200 pms-Diphenhydramine 50 mg/mL PPB Sandoz 1 ml 4.04 Phmscience 10 ml 11.50 1.1500 4:04.16 PIPERAZINE DERIVATIVES FLUNARIZINE HYDROCHLORIDE X Caps. 02246082 Flunarizine 2013-04 5 mg AA Pharma 60 100 43.22 72.04 0.5522 0.5520 Page 3 8:00 ANTI-INFECTIVE AGENTS 8:08 8:12 8:12.02 8:12.06 8:12.07 8:12.08 8:12.12 8:12.16 8:12.18 8:12.20 8:12.24 8:12.28 8:14 8:14.04 8:14.08 8:14.28 8:16 8:16.04 8:16.92 8:18 8:18.04 8:18.08 8:18.20 8:18.32 8:30 8:30.04 8:30.08 8:30.92 8:36 anthelmintics antibiotique aminoglycosides cephalosporins miscellaneous b‑lactam antibiotics chloramphenicol macrolides penicillins quinolones sulfonamides tetracyclines miscellaneous antibiotics antifungals allylamines azoles polyenes antimycobacterials agents antituberculosis agents miscellaneous antimycobacterials antivirals adamantanes antiretroviral agents interferons nucleosides and nucleotides antiprotozoals amebicides antimalarials miscellaneous antiprotozoals urinary anti‑infectives CODE BRAND NAME MANUFACTURER COST OF PKG. SIZE SIZE UNIT PRICE 8:08 ANTHELMINTICS MEBENDAZOLE X Tab. 00556734 Vermox 100 mg Janss. Inc 6 Bayer 6 19.27 PRAZIQUANTEL X Tab. 02230897 Biltricide 3.2117 600 mg 34.68 5.7800 8:12.02 AMINOGLYCOSIDES AMIKACINE SULFATE X Inj. Sol. 02242971 Amikacine (Sulfate d') 250 mg/mL Sandoz 2 ml 35.15 Sandoz 2 ml 5.93 Sterimax 1 44.15 GENTAMICIN SULFATE X Inj. Sol. 02242652 Gentamicine 40 mg/mL STREPTOMYCIN SULFATE X Inj. Pd. 02243660 Streptomycin 1g TOBRAMYCIN SULFATE X Inj. Sol. 40 mg/mL PPB 02382814 Tobramycin Jamp 02230640 Tobramycin PPC 99005069 Tobramycine (sans preservatif) 02241210 Tobramycine (sulfate de) Sandoz Sandoz 2 ml 30 ml 2 ml 30 ml 2 ml 4.45 69.75 4.45 69.75 5.45 2 ml 30 ml 4.45 69.75 8:12.06 CEPHALOSPORINS CEFACLOR X Caps. 02230263 Apo-Cefaclor 00465186 Ceclor 2013-04 250 mg PPB Apotex Pendopharm 100 100 96.97 102.07 0.9697 0.9874 Page 7 CODE BRAND NAME MANUFACTURER SIZE Caps. UNIT PRICE 500 mg PPB 02230264 Apo-Cefaclor 00465194 Ceclor Apotex Pendopharm 100 100 Oral Susp. Pendopharm 100 ml 150 ml Pendopharm 100 ml 150 ml Pendopharm 70 ml 100 ml Oral Susp. Oral Susp. CEFADROXIL MONOHYDRATE X Caps. 02240774 Apo-Cefadroxil 02235134 Novo-Cefadroxil 02311062 Pro-Cefadroxil-500 0.1056 0.1056 19.93 29.90 0.1930 0.1930 Cefazoline Cefazoline for injection Cefazoline for injection Cefazoline for injection 20.10 28.72 0.2047 0.2047 500 mg PPB Apotex Novopharm Pro Doc 100 100 100 CEFAZOLIN (SODIUM) X Inj. Pd. 84.21 84.21 84.21 0.8421 0.8421 0.8421 1 g PPB Novopharm Apotex PPC Sandoz 10 10 25 10 Inj. Pd. 37.50 37.50 93.75 37.50 3.7500 3.7500 3.7500 3.7500 10 g PPB Cefazolin Cefazoline for injection Cefazoline for injection Cefazoline for injection Teva Can Apotex PPC Sandoz 1 10 10 1 Novopharm PPC Sandoz 10 25 10 25.00 62.50 25.00 B.M.S. 1 15.99 Inj. Pd. 02108119 Cefazoline 02237137 Cefazoline for injection 02308932 Cefazoline for injection 02163632 Maxipime 35.00 350.00 350.00 35.00 35.0000 35.0000 500 mg PPB CEFEPIME HYDROCHLORIDE X Inj. Pd. 8 10.89 16.34 375 mg/5 mL 00832804 Ceclor 02108135 02297213 02237140 02308967 1.9300 1.9652 250 mg/5 mL 00465216 Ceclor 02108127 02297205 02237138 02308959 193.00 200.40 125 mg/5 mL 00465208 Ceclor Page COST OF PKG. SIZE 2.5000 2.5000 2.5000 1g 2013-04 CODE BRAND NAME MANUFACTURER SIZE Inj. Pd. 02319039 Cefepime for injection 02163640 Maxipime UNIT PRICE 2 g PPB Apotex B.M.S. 10 1 CEFIXIME X Oral Susp. 00868965 Suprax COST OF PKG. SIZE 224.26 31.97 19.1820 100 mg/5 mL SanofiAven 50 ml Tab. 18.32 0.3664 400 mg 00868981 Suprax SanofiAven 7 10 SanofiAven 1 CEFOTAXIME (SODIUM) X Inj. Pd. 02225093 Claforan SanofiAven 1 SanofiAven 1 19.18 500 mg CEFPROZIL X Oral Susp. 6.09 125 mg/5 mL PPB 02293943 Apo-Cefprozil Apotex 02347261 Auro-Cefprozil Aurobindo 02163675 Cefzil B.M.S. 02329204 Ran-Cefprozil Ranbaxy 02303426 Sandoz Cefprozil Sandoz 2013-04 9.58 2g Inj. Pd. 02225085 Claforan 3.2629 3.2630 1g Inj. Pd. 02225107 Claforan 22.84 32.63 75 ml 100 ml 75 ml 100 ml 75 ml 100 ml 75 ml 100 ml 75 ml 100 ml 4.45 5.93 4.45 5.93 12.38 16.50 4.45 5.93 4.45 5.93 0.0593 0.0593 0.0593 0.0593 0.1651 0.1650 0.0593 0.0593 0.0593 0.0593 Page 9 CODE BRAND NAME MANUFACTURER Oral Susp. SIZE UNIT PRICE 250 mg/5 mL PPB 02293951 Apo-Cefprozil Apotex 75 ml 100 ml 75 ml 100 ml 75 ml 100 ml 75 ml 100 ml 75 ml 100 ml 02347288 Auro-Cefprozil Aurobindo 02163683 Cefzil B.M.S. 02293579 Ran-Cefprozil Ranbaxy 02303434 Sandoz Cefprozil Sandoz 02292998 02347245 02163659 02293528 02302179 Apo-Cefprozil Auro-Cefprozil Cefzil Ran-Cefprozil Sandoz Cefprozil Apotex Aurobindo B.M.S. Ranbaxy Sandoz 100 100 100 100 100 02293005 02347253 02324180 02163667 02293536 02302187 Apo-Cefprozil Auro-Cefprozil Cefprozil Cefzil Ran-Cefprozil Sandoz Cefprozil Apotex Aurobindo Pro Doc B.M.S. Ranbaxy Sandoz 100 100 100 100 100 100 Tab. 8.89 11.85 8.89 11.85 24.76 33.01 8.89 11.85 8.89 11.85 0.1185 0.1185 0.1185 0.1185 0.3301 0.3301 0.1185 0.1185 0.1185 0.1185 250 mg PPB Tab. 43.32 43.32 168.94 43.32 43.32 0.4332 0.4332 1.6894 0.4332 0.4332 500 mg PPB CEFTAZIDIME PENTAHYDRATE X Inj. Pd. 00886971 Ceftazidime pour injection 02212218 Fortaz 00886955 Ceftazidime pour injection 02212226 Fortaz PPC GSK 1 1 PPC GSK 1 1 PPC GSK 1 1 10 18.85 21.35 37.10 42.00 6 g PPB CEFTIZOXIME SODIUM X Inj. Pd. 01919490 Cefizox 0.8494 0.8494 0.8494 3.3123 0.8494 0.8494 2 g PPB Inj. Pd. 00886963 Ceftazidime pour injection 02212234 Fortaz 84.94 84.94 84.94 331.23 84.94 84.94 1 g PPB Inj. Pd. Page COST OF PKG. SIZE 111.29 125.99 1g GSK 1 10.00 10.0000 2013-04 CODE BRAND NAME MANUFACTURER SIZE Inj. Pd. GSK 1 Sterimax Apotex Sandoz Hospira 10 10 10 10 124.95 124.95 124.95 124.95 Novopharm 1 12.50 CEFTRIAXONE SODIUM X Inj. Pd. 02325616 02292874 02292270 02250292 Ceftriaxone Ceftriaxone for injection Ceftriaxone for injection Ceftriaxone sodium for injection 02287633 Ceftriaxone sodium for injection 20.00 20.0000 1 g PPB Inj. Pd. 12.4950 12.4950 12.4950 12.4950 2 g PPB Ceftriaxone Ceftriaxone for injection Ceftriaxone for injection Ceftriaxone sodium for injection Sterimax Apotex Sandoz Hospira 10 10 10 10 Inj. Pd. 02325632 Ceftriaxone 02292904 Ceftriaxone for injection 02292815 Ceftriaxone sodium for injection 02287668 Ceftriaxone sodium for injection 02292866 Ceftriaxone for injection 02250276 Ceftriaxone sodium for injection Sterimax Apotex Hospira 1 1 1 183.60 183.60 183.60 Novopharm 1 183.60 Apotex Hospira 10 10 PPC 1 PPC 1 3.9510 3.9510 28.04 7.5 g Inj. Pd. 02241638 Cefuroxime for injection 39.51 39.51 1.5 g Inj. Pd. 02241640 Cefuroxime for injection 24.1400 24.1400 24.1400 24.1400 250 mg PPB CEFUROXIME (SODIUM) X Inj. Pd. 02241639 Cefuroxime for injection 241.40 241.40 241.40 241.40 10 g PPB Inj. Pd. 2013-04 UNIT PRICE 2g 01919504 Cefizox 02325624 02292882 02292289 02250306 COST OF PKG. SIZE 105.14 750 mg PPC 1 14.01 Page 11 CODE BRAND NAME MANUFACTURER SIZE CEFUROXIME AXETIL X Oral Susp. UNIT PRICE 125 mg/5 mL 02212307 Ceftin GSK 70 ml 100 ml 02244393 02344823 02212277 02242656 Apo-Cefuroxime Auro-Cefuroxime Ceftin ratio-Cefuroxime Apotex Aurobindo GSK Ratiopharm 100 60 60 60 02244394 02344831 02212285 02311453 02242657 Apo-Cefuroxime Auro-Cefuroxime Ceftin Pro-Cefuroxime ratio-Cefuroxime Apotex Aurobindo GSK Pro Doc Ratiopharm 100 60 60 100 60 Tab. 11.57 16.52 0.1653 0.1652 250 mg PPB Tab. 72.37 43.42 93.72 43.42 0.7237 0.7237 1.5620 0.7237 500 mg PPB CEPHALEXIN MONOHYDRATE X Caps. or Tab. 00768723 Apo-Cephalex Apotex 00342084 Novo-Lexin 00583413 Novo-Lexin (Co.) Novopharm Novopharm Apotex 00828866 Cephalexin-500 Pro Doc 00342114 Novo-Lexin Novopharm 00583421 Novo-Lexin (Co.) Novopharm 100 1000 100 100 1000 100 500 100 500 100 500 100 500 Oral Susp. 12 22.50 225.00 22.50 22.50 225.00 0.2250 0.2250 0.2250 0.2250 0.2250 45.00 225.00 45.00 225.00 45.00 225.00 45.00 225.00 0.4500 0.4500 0.4500 0.4500 0.4500 0.4500 0.4500 0.4500 125 mg/5 mL Novopharm 100 ml 150 ml Oral Susp. 00342092 Novo-Lexin 250 1.4337 1.4337 3.0945 1.4337 1.4337 500 mg PPB 00768715 Apo-Cephalex 00342106 Novo-Lexin 125 143.37 86.02 185.67 143.37 86.02 250 mg PPB Caps. or Tab. Page COST OF PKG. SIZE 4.57 6.86 0.0457 0.0457 250 mg/5 mL Novopharm 100 ml 150 ml 9.48 14.22 0.0948 0.0948 2013-04 CODE BRAND NAME MANUFACTURER SIZE COST OF PKG. SIZE UNIT PRICE 8:12.07 MISCELLANEOUS B-LACTAM ANTIBIOTICS CEFOXITIN SODIUM X Inj. Pd. 02128187 Cefoxitine 02291711 Cefoxitine for injection 1 g PPB Novopharm Apotex 1 10 Inj. Pd. 02128195 Cefoxitine 02291738 Cefoxitine for injection Novopharm Apotex 1 10 Janss. Inc 1 Merck 10 Merck 25 Merck 25 49.9500 326.00 13.0400 609.50 24.3800 1 g PPB Sandoz AZC 10 1 Inj. Pd. 02378787 Meropenem 02218488 Merrem 499.50 500 mg -500 mg MEROPENEM X Inj. Pd. 02378795 Meropenem 02218496 Merrem 32.46 250 mg -250 mg I.V. Inj. Pd. 00717282 Primaxin 21.2500 1g IMIPENEM/ CILASTATIN X I.V. Inj. Pd. 00717274 Primaxin 21.25 212.50 500 mg ERTAPENEM SODIUM X Inj. Pd. 02247437 Invanz 10.6000 2 g PPB DORIPENEM X I.V. Perf. Pd. 02332906 Doribax 10.60 106.00 297.10 50.52 29.7100 50.5200 500 mg PPB Sandoz AZC 10 1 148.60 25.26 14.8600 25.2600 8:12.08 CHLORAMPHENICOL CHLORAMPHENICOL SODIUM SUCCINATE X Inj. Pd. 00312363 Chloromycetin 2013-04 Erfa 1g 1 4.90 Page 13 CODE BRAND NAME MANUFACTURER SIZE COST OF PKG. SIZE UNIT PRICE 8:12.12 MACROLIDES AZITHROMYCIN X I.V. Perf. Pd. 02297566 Azithromycin for Injection 02239952 Zithromax I.V. 500 mg PPB Teva Can Pfizer Oral Susp. 02315157 02274388 02332388 02223716 1 10 12.3900 20.6440 100 mg/5 mL PPB Novo-Azithromycin Pediatric pms-Azithromycin Sandoz Azithromycin Zithromax Novopharm Phmscience Sandoz Pfizer Oral Susp. 15 ml 15 ml 15 ml 15 ml 5.94 5.94 5.94 16.17 0.3960 0.3960 0.3960 1.0780 200 mg/5 mL PPB 02315165 Novo-Azithromycin Pediatric Novopharm 02274396 pms-Azithromycin Phmscience 02332396 Sandoz Azithromycin Sandoz 02223724 Zithromax Pfizer 15 ml 22.5 ml 15 ml 22.5 ml 15 ml 37.5 ml 15 ml 22.5 ml Tab. Page 14.56 206.44 8.41 12.61 8.41 12.61 8.41 21.02 22.92 34.37 0.5607 0.5604 0.5607 0.5604 0.5607 0.5604 1.5280 1.5276 250 mg PPB 02247423 Apo-Azithromycin Apotex 02330881 Azithromycin Sanis 02255340 Co Azithromycin Cobalt 02278359 Mylan-Azithromycin Mylan 02267845 Novo-Azithromycin Novopharm 02278588 phl-Azithromycin Pharmel 02261634 pms-Azithromycin Phmscience 02310600 Pro-Azithromycine 02275287 ratio-Azithromycin Pro Doc Ratiopharm 02275309 Riva-Azithromycin Riva 02265826 Sandoz Azithromycin Sandoz 02212021 Zithromax Pfizer 14 6 100 6 30 6 100 6 30 6 30 6 100 6 100 6 6 100 6 100 6 100 30 7.85 130.71 7.85 39.21 7.85 130.71 7.85 39.21 7.85 39.21 7.85 130.71 7.85 130.71 7.85 7.85 130.71 7.85 130.71 7.85 130.71 146.41 1.3083 1.3071 1.3083 1.3071 1.3083 1.3071 1.3083 1.3071 1.3083 1.3071 1.3083 1.3071 1.3083 1.3071 1.3083 1.3083 1.3071 1.3083 1.3071 1.3083 1.3071 4.8803 2013-04 CODE BRAND NAME MANUFACTURER SIZE Tab. COST OF PKG. SIZE UNIT PRICE 600 mg PPB 02330911 02256088 02261642 02275317 02231143 Azithromycin Co Azithromycin pms-Azithromycin Riva-Azithromycin Zithromax Sanis Cobalt Phmscience Riva Pfizer CLARITHROMYCINE X Co. or Co. L.A. 02274744 01984853 02244756 02324482 02248856 Apo-Clarithromycin Biaxin Bid Biaxin XL Clarithromycin Mylan-Clarithromycin Apotex Abbott Abbott Pro Doc Mylan Phmscience 02361426 Ran-Clarithromycin Ranbaxy 02247818 ratio-Clarithromycin Ratiopharm 02346524 Riva-Clarithromycine Riva 02266539 Sandoz Clarithromycin Sandoz 02248804 Teva Clarithromycin Teva Can Oral Susp. 6.0000 6.0000 6.0000 6.0000 11.7127 100 100 60 100 100 500 100 250 100 500 100 500 100 250 100 250 100 41.22 161.27 150.86 41.22 41.22 206.09 41.22 103.05 41.22 206.09 41.22 206.09 41.22 103.05 41.22 103.05 41.22 0.4122 1.6127 2.5143 0.4122 0.4122 0.4122 0.4122 0.4122 0.4122 0.4122 0.4122 0.4122 0.4122 0.4122 0.4122 0.4122 0.4122 125 mg/5 mL PPB 02390442 Accel-Clarithromycin Accel 02146908 Biaxin Abbott Oral Susp. 2013-04 36.00 36.00 180.00 36.00 351.38 250 mg / 500 mg L.A. PPB 02247573 pms-Clarithromycin 02390450 Accel-Clarithromycin 02244641 Biaxin 6 6 30 6 30 55 ml 105 ml 55 ml 105 ml 11.26 21.49 15.77 30.09 0.1722 0.1720 0.2867 0.2866 250 mg/5 mL PPB Accel Abbott 105 ml 105 ml 41.98 57.89 0.3309 0.5513 Page 15 CODE BRAND NAME MANUFACTURER SIZE Tab. UNIT PRICE 500 mg PPB 02274752 02126710 02324490 02248857 02247574 Apo-Clarithromycin Biaxin Bid Clarithromycin Mylan-Clarithromycin pms-Clarithromycin Apotex Abbott Pro Doc Mylan Phmscience 02361434 Ran-Clarithromycin Ranbaxy 02247819 ratio-Clarithromycin Ratiopharm 02346532 Riva-Clarithromycine Riva 02266547 Sandoz Clarithromycin Sandoz 02248805 Teva Clarithromycin Teva Can 100 100 100 100 100 250 100 500 100 500 100 250 100 250 100 ERYTHROMYCIN X Ent. Caps. 00726672 Apo-Erythro E-C 00607142 Eryc 01925938 Apo-Erythro E-C 100 100 500 AA Pharma 100 AA Pharma 100 1000 Abbott 250 16 43.32 0.4332 18.28 182.80 0.1828 0.1828 208.43 0.8337 250 mg/5 mL Novopharm 100 ml 500 ml Novopharm 100 ml 150 ml ERYTHROMYCIN ETHYLSUCCINATE X Oral Susp. 00605859 Novo-Rythro Ethylsuccinate 0.3900 0.2211 0.2211 500 mg ERYTHROMYCIN ESTOLATE X Oral Susp. 00262595 Novo-Rythro Estolate 39.00 22.11 110.55 250 mg Ent. Tab. 00893862 Erybid 1.6297 3.2662 1.6297 1.6297 1.6297 1.6297 1.6297 1.6297 1.6297 1.6297 1.6297 1.6297 1.6297 1.6297 1.6297 333 mg PPB Ent. Tab. 00682020 Erythro-Base 162.97 326.62 162.97 162.97 162.97 407.43 162.97 814.85 162.97 814.85 162.97 407.43 162.97 407.43 162.97 250 mg PPB AA Pharma Pfizer Ent. Caps. Page COST OF PKG. SIZE 7.13 35.65 0.0713 0.0713 200 mg/5 mL 6.69 10.03 0.0669 0.0669 2013-04 CODE BRAND NAME MANUFACTURER SIZE Oral Susp. COST OF PKG. SIZE UNIT PRICE 400 mg/5 mL 00652318 Novo-Rythro Ethylsuccinate Novopharm 100 ml 150 ml 00637416 Erythro-ES AA Pharma 100 Tab. 10.13 15.20 0.1013 0.1013 600 mg ERYTHROMYCIN STEARATE X Tab. 33.63 0.3363 250 mg 00545678 Apo-Erythro-S AA Pharma 100 00688568 Apo-Erythro-S AA Pharma 100 Odan 50 Tab. 21.18 0.2118 500 mg SPIRAMYCIN X Caps. 01927825 Rovamycine 54.25 0.5425 250 mg Caps. 62.35 1.2470 500 mg 01927817 Rovamycine Odan 50 02352710 Amoxicillin Sanis 00628115 Apo-Amoxi Apotex 02388073 Auro-Amoxicillin Aurobindo 02238171 Mylan-Amoxicillin 00406724 Novamoxin Mylan Novopharm 02345501 NTP-Amoxicillin NT Pharma 02262851 phl-Amoxicillin Pharmel 02230243 pms-Amoxicillin Phmscience 100 1000 100 1000 100 500 1000 100 1000 100 1000 500 1000 500 124.70 2.4940 8:12.16 PENICILLINS AMOXICILLIN X Caps. 2013-04 250 mg PPB 17.50 175.00 17.50 175.00 17.50 87.50 175.00 17.50 175.00 17.50 175.00 87.50 175.00 87.50 0.1750 0.1750 0.1750 0.1750 0.1750 0.1750 0.1750 0.1750 0.1750 0.1750 0.1750 0.1750 0.1750 0.1750 Page 17 CODE BRAND NAME MANUFACTURER SIZE Caps. UNIT PRICE 500 mg PPB 02352729 Amoxicillin Sanis 00628123 Apo-Amoxi Apotex 02388081 Auro-Amoxicillin Aurobindo 02238172 Mylan-Amoxicillin Mylan 00406716 Novamoxin Novopharm 02345528 NTP-Amoxicillin NT Pharma 02262878 phl-Amoxicillin Pharmel 02230244 pms-Amoxicillin 00644315 Pro-Amox-500 Phmscience Pro Doc 100 500 100 500 100 500 100 500 100 500 100 500 250 500 500 500 Chew. Tab. 02036347 Novamoxin 02036355 Novamoxin Novopharm 100 Novopharm 100 0.3417 0.3417 0.3417 0.3417 0.3417 0.3417 0.3417 0.3417 0.3417 0.3417 0.3417 0.3417 0.3417 0.3417 0.3417 0.3417 41.67 0.4167 250 mg Oral Susp. 61.38 0.6138 125 mg/5 mL PPB 00628131 Apo-Amoxi Apotex 99002582 Apo-Amoxi sans sucrose Apotex 01934171 Novamoxin Novopharm 00452149 Novamoxin 125 Novopharm 02262886 phl-Amoxicillin Pharmel 02230245 pms-Amoxicillin Phmscience 18 34.17 170.85 34.17 170.85 34.17 170.85 34.17 170.85 34.17 170.85 34.17 170.85 85.42 170.85 170.85 170.85 125 mg Chew. Tab. Page COST OF PKG. SIZE 100 ml 150 ml 100 ml 150 ml 75 ml 100 ml 150 ml 75 ml 100 ml 150 ml 100 ml 150 ml 100 ml 150 ml 3.53 5.30 3.53 5.30 2.65 3.53 5.30 2.65 3.53 5.30 3.53 5.30 3.53 5.30 0.0353 0.0353 0.0353 0.0353 0.0353 0.0353 0.0353 0.0353 0.0353 0.0353 0.0353 0.0353 0.0353 0.0353 2013-04 CODE BRAND NAME MANUFACTURER Oral Susp. UNIT PRICE 250 mg/5 mL PPB 02352753 Amoxicillin Sanis 00628158 Apo-Amoxi Apotex 99002590 Apo-Amoxi sans sucrose Apotex 00452130 Novamoxin 250 Novopharm 01934163 Novamoxin Hypoglucidique Novopharm 02345552 NTP-Amoxicillin NT Pharma 02262894 phl-Amoxicillin Pharmel 02230246 pms-Amoxicillin Phmscience 00644331 Pro-Amox-250 Pro Doc AMOXICILLIN/ POTASSIUM CLAVULANATE X Oral Susp. 02243986 Apo-Amoxi Clav Apotex 01916882 Clavulin-125 F 02244646 ratio-Aclavulanate 125F GSK Ratiopharm Oral Susp. 02238831 Clavulin-200 COST OF PKG. SIZE SIZE 75 ml 100 ml 150 ml 100 ml 150 ml 100 ml 150 ml 75 ml 100 ml 150 ml 75 ml 100 ml 150 ml 75 ml 100 ml 150 ml 100 ml 150 ml 100 ml 150 ml 100 ml 150 ml 4.05 5.40 8.10 5.40 8.10 5.40 8.10 4.05 5.40 8.10 4.05 5.40 8.10 4.05 5.40 8.10 5.40 8.10 5.40 8.10 5.40 8.10 0.0540 0.0540 0.0540 0.0540 0.0540 0.0540 0.0540 0.0540 0.0540 0.0540 0.0540 0.0540 0.0540 0.0540 0.0540 0.0540 0.0540 0.0540 0.0540 0.0540 0.0540 0.0540 125 mg -31.25 mg/5 mL PPB 100 ml 150 ml 100 ml 100 ml 5.17 7.76 10.88 5.17 0.0517 0.0517 0.1088 0.0517 200 mg -28.5 mg/5 mL GSK Oral Susp. 70 ml 9.39 0.1341 250 mg -62.5 mg/5 mL PPB 02243987 Apo-Amoxi Clav Apotex 01916874 Clavulin-250 F 02244647 ratio-Aclavulanate 250F GSK Ratiopharm Oral Susp. 100 ml 150 ml 100 ml 100 ml 8.69 13.04 18.72 8.69 0.0869 0.0869 0.1872 0.0869 400 mg - 57 mg/5mL PPB 02288559 Apo-Amoxi Clav 02238830 Clavulin-400 Apotex GSK 70 ml 70 ml 02243350 Apo-Amoxi Clav Apotex 100 Tab. 13.78 17.95 0.1539 0.2564 250 mg -125 mg 2013-04 93.75 0.4449 Page 19 CODE BRAND NAME MANUFACTURER Tab. SIZE UNIT PRICE 500 mg -125 mg PPB 02326515 02243351 01916858 02243771 Amoxi-Clav Apo-Amoxi Clav Clavulin-500 F ratio-Aclavulanate Pro Doc Apotex GSK Ratiopharm Tab. 100 100 100 100 66.73 66.73 137.82 66.73 0.6673 0.6673 1.3782 0.6673 875 mg -125 mg PPB 02326523 02245623 02238829 02248138 02247021 Amoxi-Clav Apo-Amoxi Clav Clavulin-875 Novo-Clavamoxin 875 ratio-Aclavulanate Pro Doc Apotex GSK Novopharm Ratiopharm 100 100 60 20 60 Novopharm 100 AMPICILLIN X Caps. 00020877 Novo-Ampicillin 55.50 55.50 124.03 11.10 33.30 0.5550 0.5550 2.0672 0.5550 0.5550 250 mg Caps. 30.71 0.3071 500 mg 00020885 Novo-Ampicillin Novopharm 100 AMPICILLIN (SODIUM) X Inj. Pd. 01933345 Ampicilline Sodique 02226995 Ampicillin for Injection 01933353 Ampicilline Sodique Novopharm 1 PPC Novopharm 1 1 Novopharm 1 3.60 7.20 7.20 250 mg Inj. Pd. 00872652 Ampicilline Sodique 0.5955 2 g PPB Inj. Pd. 00872644 Ampicilline Sodique 59.55 1g Inj. Pd. 2.05 500 mg Novopharm 1 CLOXACILLIN (SODIUM) X Caps. 2.15 250 mg 00337765 Novo-Cloxin Novopharm 100 02069679 Cloxacilline-500 00337773 Novo-Cloxin Pro Doc Novopharm 100 100 Caps. Page COST OF PKG. SIZE 18.50 0.1850 500 mg PPB 20 34.98 34.98 0.3498 0.3498 2013-04 CODE BRAND NAME MANUFACTURER SIZE Inj. Pd. 02367424 Cloxacillin 01912410 Cloxacilline Sodique Sterimax Novopharm 10 1 Sterimax Novopharm 10 1 Novopharm 100 ml 200 ml Pfizer 10 Bioniche Novopharm PPC 1 1 1 Bioniche Novopharm PPC 1 1 1 4.50 9.00 0.0450 0.0450 406.96 40.6960 2.40 2.40 2.40 5 000 000 U PPB Inj. Pd. 02060108 Crystapen 01930680 Penicilline G 02220296 Penicilline G sodium for injection 4.5600 1 000 000 U PPB Inj. Pd. 02060094 Crystapen 00883751 Penicilline G 02220288 Penicilline G sodium for injection 45.60 4.56 1 2000 000 UI / 2 mL PENICILLIN G (SODIUM) X Inj. Pd. 02060086 Crystapen 01930672 Penicilline G 02220261 Penicilline G sodium for injection 7.3200 125 mg/5 mL PENICILLIN G (BENZATHINE) X I.M. Inj. Susp. 02291924 Bicillin L-A 73.20 7.32 500 mg PPB Oral Susp. 00337757 Novo-Cloxin UNIT PRICE 2 g PPB Inj. Pd. 02367408 Cloxacillin 01912429 Cloxacilline Sodique COST OF PKG. SIZE 5.10 5.10 5.10 10 000 000 U PPB Bioniche Novopharm PPC 1 1 1 8.90 8.90 8.90 PHENOXYMETHYLPENICILLIN (BASE OR POTASSIUM SALT) X Tab. 250 mg to 300 mg PPB 00642215 Apo-Pen-VK Apotex 00468029 Penicilline V Pro Doc 2013-04 100 1000 1000 7.10 71.00 71.00 0.0710 0.0710 0.0710 Page 21 CODE BRAND NAME MANUFACTURER COST OF PKG. SIZE SIZE PHENOXYMETHYLPENICILLIN (POTASSIUM) X Oral Susp. 00642223 Apo-Pen-VK Apotex Oral Susp. 00642231 Apo-Pen-VK 125 mg/5 mL 100 ml 100 ml 4.72 Hospira 1 13.31 2 g -0.25 g PPB Agila-Jamp Sterimax Apotex 10 10 1 60.60 60.60 6.06 Sandoz 1 6.06 Teva Can Pfizer 10 1 60.60 11.21 Agila-Jamp Sterimax Apotex 10 10 1 90.80 90.80 9.08 Sandoz 1 9.08 Teva Can Pfizer 10 1 90.80 16.81 Page 22 6.0600 9.0800 9.0800 9.0800 4 g -0.5 g PPB Agila-Jamp Sterimax Apotex 10 10 1 121.10 121.10 12.11 Sandoz 1 12.11 Teva Can Pfizer 10 1 121.10 22.41 TICARCILLINE DISODIUM/ CLAVULANATE POTASSIUM X I.V. Inj. Pd. 01916939 Timentin 6.0600 6.0600 3 g -0.375 g PPB I.V. Perf. Pd. 02391546 AJ-Pip/Taz 02362635 Piperacilline et Tazobactam 02308460 Piperacilline et Tazobactam for injection 02299658 Piperacilline sodique/ Tazobactam sodique 02370174 Piperacilline/Tazobactam 02170809 Tazocin 0.0472 3g I.V. Perf. Pd. 02391538 AJ-Pip/Taz 02362627 Piperacilline et Tazobactam 02308452 Piperacilline et Tazobactam for injection 02299631 Piperacilline sodique/ Tazobactam sodique 02370166 Piperacilline/Tazobactam 02170795 Tazocin 0.0535 250 mg to 300 mg/5 mL PIPERACILLIN SODIUM/ TABACTAM SODIUM X I.V. Perf. Pd. 02391511 AJ-Pip/Taz 02362619 Piperacilline et Tazobactam 02308444 Piperacilline et Tazobactam for injection 02299623 Piperacilline sodique/ Tazobactam sodique 02370158 Piperacilline/Tazobactam 02170817 Tazocin 5.35 Apotex PIPERACILLIN (SODIUM) X Inj. Pd. 02246641 Piperacilline UNIT PRICE GSK 12.1100 12.1100 12.1100 3 g -0,1 g 1 10.16 2013-04 CODE BRAND NAME MANUFACTURER SIZE COST OF PKG. SIZE UNIT PRICE 8:12.18 QUINOLONES CIPROFLOXACIN HYDROCHLORIDE X L.A. Tab. 02247916 Cipro XL 500 mg Bayer 50 Bayer 50 L.A. Tab. 144.81 2.8962 1000 mg 02251787 Cipro XL Oral Susp. 144.81 2.8962 500 mg/5 mL 02237514 Cipro Bayer 02229521 Apo-Ciproflox 02381907 Auro-Ciprofloxacin Apotex Aurobindo 02155958 02353318 02386119 02247339 02380358 02379686 02317427 02245647 02161737 02251310 02248437 02317796 02303728 02246825 02251221 02248756 02379627 02266962 Bayer Sanis Sivem Cobalt Jamp Marcan Mint Mylan Novopharm Pharmel Phmscience Pro Doc Ranbaxy Ratiopharm Riva Sandoz Septa Taro 100 ml Tab. 53.23 0.5323 250 mg PPB 2013-04 Cipro Ciprofloxacin Ciprofloxacin Co Ciprofloxacin Jamp-Ciprofloxacin Mar-Ciprofloxacin Mint-Ciprofloxacine Mylan-Ciprofloxacin Novo-Ciprofloxacin phl-Ciprofloxacin pms-Ciprofloxacin Pro-Ciprofloxacin Ran-Ciproflox ratio-Ciprofloxacin Riva-Ciprofloxacin Sandoz Ciprofloxacin Septa-Ciprofloxacin Taro-Ciprofloxacin 100 100 500 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 61.86 61.86 309.30 229.35 61.86 61.86 61.86 61.86 61.86 61.86 61.86 61.86 61.86 61.86 61.86 61.86 61.86 61.86 61.86 61.86 111.05 0.6186 0.6186 0.6186 2.2935 0.6186 0.6186 0.6186 0.6186 0.6186 0.6186 0.6186 0.6186 0.6186 0.6186 0.6186 0.6186 0.6186 0.6186 0.6186 0.6186 1.1105 Page 23 CODE BRAND NAME MANUFACTURER SIZE Tab. UNIT PRICE 500 mg PPB 02229522 Apo-Ciproflox Apotex 02381923 Auro-Ciprofloxacin Aurobindo 02155966 02353326 02386127 02247340 02380366 Bayer Sanis Sivem Cobalt Jamp Cipro Ciprofloxacin Ciprofloxacin Co Ciprofloxacin Jamp-Ciprofloxacin 02379694 Mar-Ciprofloxacin 02317435 Mint-Ciprofloxacine 02245648 Mylan-Ciprofloxacin Marcan Mint Mylan 02161745 Novo-Ciprofloxacin Novopharm 02251329 phl-Ciprofloxacin Pharmel 02248438 pms-Ciprofloxacin Phmscience 02317818 Pro-Ciprofloxacin Pro Doc 02303736 Ran-Ciproflox 02246826 ratio-Ciprofloxacin 02251248 Riva-Ciprofloxacin Ranbaxy Ratiopharm Riva 02248757 Sandoz Ciprofloxacin 02379635 Septa-Ciprofloxacin 02266970 Taro-Ciprofloxacin Sandoz Septa Taro 02229523 Apo-Ciproflox 02381931 Auro-Ciprofloxacin Apotex Aurobindo 02155974 Cipro Bayer 02353334 02247341 02380374 02379708 02317443 02245649 02161753 Ciprofloxacin Co Ciprofloxacin Jamp-Ciprofloxacin Mar-Ciprofloxacin Mint-Ciprofloxacine Mylan-Ciprofloxacin Novo-Ciprofloxacin Sanis Cobalt Jamp Marcan Mint Mylan Novopharm 02251337 02248439 02303744 02246827 02251256 02248758 02379643 phl-Ciprofloxacin pms-Ciprofloxacin Ran-Ciproflox ratio-Ciprofloxacin Riva-Ciprofloxacin Sandoz Ciprofloxacin Septa-Ciprofloxacin Pharmel Phmscience Ranbaxy Ratiopharm Riva Sandoz Septa 100 500 100 500 100 100 100 100 100 500 100 100 100 500 100 500 100 500 100 500 100 500 100 100 100 500 100 100 100 Tab. Page COST OF PKG. SIZE 69.79 348.94 69.79 348.94 258.76 69.79 69.79 69.79 69.79 348.94 69.79 69.79 69.79 348.94 69.79 348.94 69.79 348.94 69.79 348.94 69.79 348.94 69.79 69.79 69.79 348.94 69.79 69.79 125.29 0.6979 0.6979 0.6979 0.6979 2.5876 0.6979 0.6979 0.6979 0.6979 0.6979 0.6979 0.6979 0.6979 0.6979 0.6979 0.6979 0.6979 0.6979 0.6979 0.6979 0.6979 0.6979 0.6979 0.6979 0.6979 0.6979 0.6979 0.6979 1.2529 750 mg PPB 24 100 50 100 50 100 50 50 50 50 100 100 50 100 100 100 100 50 100 50 50 127.80 63.90 127.80 241.13 482.21 63.90 63.90 63.90 63.90 127.80 127.80 63.90 127.80 127.80 127.80 127.80 63.90 127.80 63.90 63.90 1.2780 1.2780 1.2780 4.8226 4.8221 1.2780 1.2780 1.2780 1.2780 1.2780 1.2780 1.2780 1.2780 1.2780 1.2780 1.2780 1.2780 1.2780 1.2780 1.2780 2013-04 CODE BRAND NAME MANUFACTURER SIZE LEVOFLOXACIN X Tab. COST OF PKG. SIZE UNIT PRICE 250 mg PPB 02284707 02315424 02236841 02313979 02248262 02284677 02298635 Apo-Levofloxacin Co Levofloxacin Levaquin Mylan-Levofloxacin Novo-Levofloxacin pms-Levofloxacin Sandoz Levofloxacin Apotex Cobalt Janss. Inc Mylan Novopharm Phmscience Sandoz 100 50 50 100 100 100 50 02284715 02315432 02236842 02313987 02248263 02284685 02298643 Apo-Levofloxacin Co Levofloxacin Levaquin Mylan-Levofloxacin Novo-Levofloxacin pms-Levofloxacin Sandoz Levofloxacin Apotex Cobalt Janss. Inc Mylan Novopharm Phmscience Sandoz 100 100 50 100 100 100 100 02325942 02315440 02246804 02285649 02305585 02298651 Apo-Levofloxacin Co Levofloxacin Levaquin Novo-Levofloxacin pms-Levofloxacin Sandoz Levofloxacin Apotex Cobalt Janss. Inc Novopharm Phmscience Sandoz 100 50 50 100 100 50 Tab. 120.38 60.19 239.45 120.38 120.38 120.38 60.19 1.2038 1.2038 4.7890 1.2038 1.2038 1.2038 1.2038 500 mg PPB Tab. 137.18 137.18 266.99 137.18 137.18 137.18 137.18 1.3718 1.3718 5.3398 1.3718 1.3718 1.3718 1.3718 750 mg PPB MOXIFLOXACIN HYDROCHLORIDE X Tab. 02242965 Avelox Apo-Norflox Co Norfloxacin Novo-Norfloxacin pms-Norfloxacin Riva-Norfloxacin Bayer 30 165.04 5.5013 400 mg PPB Apotex Cobalt Novopharm Phmscience Riva 100 100 100 100 100 AA Pharma 100 OFLOXACINE X Tab. 02231529 Apo-Oflox 4.8479 4.8479 9.8246 4.8479 4.8479 4.8479 400 mg NORFLOXACIN X Tab. 02229524 02269627 02237682 02246596 02301504 484.79 242.40 491.23 484.79 484.79 242.40 54.49 54.49 54.49 54.49 54.49 0.5449 0.5449 0.5449 0.5449 0.5449 200 mg Tab. 130.41 1.3041 300 mg 02231531 Ofloxacin 2013-04 AA Pharma 100 153.23 1.2647 Page 25 CODE BRAND NAME MANUFACTURER SIZE Tab. COST OF PKG. SIZE UNIT PRICE 400 mg 02231532 Ofloxacin AA Pharma 100 00598488 pms-Sulfasalazine-E.C. Phmscience 02064472 Salazopyrin EN-Tabs Pfizer 100 500 100 300 00598461 pms-Sulfasalazine Phmscience 02064480 Salazopyrin Pfizer 153.23 1.2647 8:12.20 SULFONAMIDES SULFASALAZINE X Ent. Tab. 500 mg PPB Tab. 0.1580 0.1580 0.2632 0.2634 500 mg PPB TRIMETHOPRIM/ SULFAMETHOXAZOLE X I.V. Perf. Sol. 00550086 Septra 100 500 100 300 12.80 64.00 16.86 50.57 0.1012 0.1012 0.1686 0.1686 16 mg -80 mg/mL Triton Oral Susp. 5 ml 6.32 40 mg -200 mg/5 mL 00726540 Novo-Trimel Novopharm 00445266 Apo-Sulfatrim-PED Apotex 100 ml 400 ml Tab. 1.98 7.92 0.0198 0.0198 20 mg -100 mg Tab. 100 9.11 0.0911 80 mg -400 mg PPB 00445274 Apo-Sulfatrim Apotex 00510637 Novo-Trimel Novopharm 00445282 Apo-Sulfatrim-DS Apotex 00510645 Novo-Trimel D.S. Novopharm 00512524 Protrin DF Pro Doc Tab. Page 20.00 100.00 26.32 79.02 100 1000 100 1000 4.82 48.20 4.82 48.20 0.0482 0.0482 0.0482 0.0482 160 mg -800 mg PPB 26 100 500 100 500 100 12.21 61.05 12.21 61.05 12.21 0.1221 0.1221 0.1221 0.1221 0.1221 2013-04 CODE BRAND NAME MANUFACTURER SIZE COST OF PKG. SIZE UNIT PRICE 8:12.24 TETRACYCLINES DOXYCYCLINE HYCLATE X Caps. or Tab. 100 mg PPB 00740713 Apo-Doxy Apotex 00874256 Apo-Doxy-Tabs Apotex 00817120 Doxycin Riva 00860751 Doxycin (co.) Riva 02351234 Doxycycline (Caps.) Sanis 02351242 Doxycycline (Co.) 00887064 Doxytab 00725250 Novo-Doxilin Sanis Pro Doc Novopharm 02158574 Novo-Doxylin (Co.) 02347687 NTP-Doxycycline (Caps.) Novopharm NT Pharma 02347679 NTP-Doxycycline (Co.) 00024368 Vibramycine NT Pharma Pfizer 100 250 100 250 100 300 100 300 100 200 100 100 100 200 100 100 200 100 50 MINOCYCLINE HYDROCHLORIDE X Caps. 0.5860 0.5860 0.5860 0.5860 0.5860 0.5860 0.5860 0.5860 0.5860 0.5860 0.5860 0.5860 0.5860 0.5860 0.5860 0.5860 0.5860 0.5860 1.6474 50 mg PPB 02084090 Apo-Minocycline Apotex 02173514 Minocin 02287226 Minocycline 02153394 Minocycline-50 GSK Sanis Pro Doc 02230735 Mylan-Minocycline Mylan 02108143 Novo-Minocycline 02294133 phl-Minocycline 02239238 pms-Minocycline Novopharm Pharmel Phmscience 02294419 pms-Minocycline 01914138 ratio-Minocycline 02242080 Riva-Minocycline Phmscience Ratiopharm Riva 02237313 Sandoz Minocycline Sandoz 2013-04 58.60 146.50 58.60 146.50 58.60 175.80 58.60 175.80 58.60 117.20 58.60 58.60 58.60 117.20 58.60 58.60 117.20 58.60 82.37 100 250 100 100 100 250 100 250 100 100 100 250 100 100 100 250 100 32.13 80.33 61.19 32.13 32.13 80.33 32.13 80.33 32.13 32.13 32.13 80.33 32.13 32.13 32.13 80.33 32.13 0.3213 0.3213 0.6119 0.3213 0.3213 0.3213 0.3213 0.3213 0.3213 0.3213 0.3213 0.3213 0.3213 0.3213 0.3213 0.3213 0.3213 Page 27 CODE BRAND NAME MANUFACTURER SIZE Caps. COST OF PKG. SIZE UNIT PRICE 100 mg PPB 02084104 Apo-Minocycline Apotex 02287234 Minocycline 02154366 Minocycline-100 Sanis Pro Doc 02230736 Mylan-Minocycline Mylan 02108151 Novo-Minocycline 02294141 phl-Minocycline 02239239 pms-Minocycline Novopharm Pharmel Phmscience 02294427 pms-Minocycline 01914146 ratio-Minocycline 02242081 Riva-Minocycline Phmscience Ratiopharm Riva 02237314 Sandoz Minocycline Sandoz 100 250 100 100 250 100 250 100 100 100 250 100 100 100 250 100 TETRACYCLINE HYDROCHLORIDE X Caps. 00580929 Tetracycline 61.99 154.98 61.99 61.99 154.98 61.99 154.98 61.99 61.99 61.99 154.98 61.99 61.99 61.99 154.98 61.99 0.6199 0.6199 0.6199 0.6199 0.6199 0.6199 0.6199 0.6199 0.6199 0.6199 0.6199 0.6199 0.6199 0.6199 0.6199 0.6199 250 mg AA Pharma 100 1000 Pfizer 50 ml 6.57 65.70 0.0657 0.0657 8:12.28 MISCELLANEOUS ANTIBIOTICS BACITRACIN Inj./Top. Pd. 50 000 U 00030708 Bacitracine CLINDAMYCIN HYDROCHLORIDE X Caps. 150 mg PPB 02245232 02248525 00030570 02258331 02293382 02241709 Apo-Clindamycine Clindamycine-150 Dalacin C Mylan-Clindamycin Riva-Clindamycin Teva-Clindamycin Apotex Pro Doc Pfizer Mylan Riva Teva Can 100 100 100 100 100 100 02245233 02248526 02182866 02258358 02241710 02293390 Apo-Clindamycine Clindamycine-300 Dalacin C Mylan-Clindamycin Novo-Clindamycin Riva-Clindamycin Apotex Pro Doc Pfizer Mylan Novopharm Riva 100 100 100 100 100 100 Caps. Page 9.10 22.17 22.17 85.97 22.17 22.17 22.17 0.2217 0.2217 0.8597 0.2217 0.2217 0.2217 300 mg PPB 28 44.34 44.34 172.71 44.34 44.34 44.34 0.4434 0.4434 1.7271 0.4434 0.4434 0.4434 2013-04 CODE BRAND NAME MANUFACTURER SIZE CLINDAMYCIN PALMITATE HYDROCHLORIDE X Oral Susp. 00225851 Dalacin C Pfizer 100 ml Sandoz 02230540 Clindamycine Sandoz 02230535 Clindamycine (format pharmacie) 00260436 Dalacin C Sandoz Pfizer 2 ml 4 ml 6 ml 2 ml 4 ml 6 ml 60 ml 4.57 9.15 13.73 4.57 9.15 13.73 149.50 2 ml 4 ml 6 ml 6.88 13.76 18.75 COLISTIMETHATE (SODIUM) X Inj. Pd. 0.1162 1.8600 1.8600 1.6883 1.8600 1.8600 1.6883 1.8577 150 mg PPB Sterimax Erfa ERYTROMYCIN ETHYLSUCCINATE/ SULFISOXAZOLE ACETYL X Oral Susp. 1 1 31.62 30.80 200 mg -600 mg/5 mL Abbott 105 ml 150 ml Pfizer 2 ml LINCOMYCIN HYDROCHLORIDE X Inj. Sol. 00030732 Lincocin 11.62 150 mg/mL PPB 02385716 Clindamycin SDZ 00583405 Pediazole UNIT PRICE 75 mg/5 mL CLINDAMYCIN PHOSPHATE X Inj. Sol. 02244849 Colistimethate 00476420 Coly-Mycin M Parenteral COST OF PKG. SIZE 11.35 16.21 0.1081 0.1081 300 mg/mL VANCOMYCIN HYDROCHLORIDE X Caps. 5.32 125 mg PPB 00800430 Vancocin 02377470 Vancomycine (hydrochloride) Merus Labs PPC 20 20 00788716 Vancocin 02377489 Vancomycine (hydrochloride) Merus Labs PPC 20 20 Caps. 103.60 103.60 5.1800 5.1800 250 mg PPB 2013-04 207.20 207.20 10.3600 10.3600 Page 29 CODE BRAND NAME MANUFACTURER SIZE I.V. Perf. Pd. 02241821 pms-Vancomycin 02139383 Sterile Vancomycin Hydrochloride 02342863 Val-Vanco 02230192 Vancomycine (hydrochloride) Phmscience PPC 10 10 589.90 589.90 58.9900 58.9900 Valeo Hospira 10 10 589.90 589.90 58.9900 58.9900 5g PPC 1 I.V. Perf. Pd. 02241807 Sterile Vancomycin Hydrochloride Page 30 294.95 10 g PPC 1 Phmscience PPC 10 25 310.50 776.25 31.0500 31.0500 Valeo Hospira 10 10 310.50 310.50 31.0500 31.0500 I.V. Perf. Pd. 02241820 pms-Vancomycin 02139375 Sterile Vancomycin Hydrochloride 02342855 Val-Vanco 02230191 Vancomycine (hydrochloride) UNIT PRICE 1 g PPB I.V. Perf. Pd. 02139243 Sterile Vancomycin Hydrochloride COST OF PKG. SIZE 589.90 500 mg PPB 2013-04 CODE BRAND NAME MANUFACTURER SIZE COST OF PKG. SIZE UNIT PRICE 8:14.04 ALLYLAMINES TERBINAFIN HYDROCHLORIDE X Tab. 250 mg PPB 02239893 Apo-Terbinafine Apotex 02320134 Auro-Terbinafine Aurobindo 02254727 Co Terbinafine Cobalt 02357070 Jamp-Terbinafine Jamp 02031116 Lamisil 02242503 Mylan-Terbinafine Novartis Mylan 02240346 Novo-Terbinafine Novopharm 02297973 phl-Terbinafine 02294273 pms-Terbinafine Pharmel Phmscience 02262924 Riva-Terbinafine Riva 02262177 Sandoz Terbinafine Sandoz 02353121 Terbinafine Sanis 02385279 Terbinafine Sivem 02242735 Terbinafine-250 Pro Doc 30 100 28 100 30 100 30 100 28 28 100 28 100 100 30 100 30 100 28 100 30 100 30 100 30 100 55.63 185.43 51.92 185.43 55.63 185.43 55.63 185.43 102.27 51.92 185.43 51.92 185.43 185.43 55.63 185.43 55.63 185.43 51.92 185.43 55.63 185.43 55.63 185.43 55.63 185.43 1.8543 1.8543 1.8543 1.8543 1.8543 1.8543 1.8543 1.8543 3.6525 1.8543 1.8543 1.8543 1.8543 1.8543 1.8543 1.8543 1.8543 1.8543 1.8543 1.8543 1.8543 1.8543 1.8543 1.8543 1.8543 1.8543 8:14.08 AZOLES FLUCONAZOLE Caps. 02241895 02141442 02301954 02294044 02282348 02310694 02255510 150 mg PPB Apo-Fluconazole-150 Diflucan-150 Fluconazole phl-Fluconazole pms-Fluconazole Pro-Fluconazole Riva-Fluconazole Apotex Pfizer Sorres Pharmel Phmscience Pro Doc Riva 1 1 1 1 1 1 1 FLUCONAZOLE X I.V. Perf. Sol. 00891835 02388448 02247922 02248443 02247749 2013-04 Diflucan Fluconazole Fluconazole Injectable Fluconazole Injection Fluconazole Omega 3.95 14.23 3.95 3.95 3.95 3.95 3.95 2 mg/mL PPB Pfizer Sandoz Novopharm Sandoz Oméga 100 ml 100 ml 100 ml 100 ml 100 ml 37.56 26.87 26.87 26.87 26.87 Page 31 CODE BRAND NAME MANUFACTURER SIZE Tab. COST OF PKG. SIZE UNIT PRICE 50 mg PPB 02237370 02281260 02301938 02245292 02236978 02245643 Apo-Fluconazole Co Fluconazole Fluconazole Mylan-Fluconazole Novo-Fluconazole pms-Fluconazole Apotex Cobalt Sorres Mylan Novopharm Phmscience 50 50 50 50 100 50 02237371 02281279 02301946 02245293 02236979 02245644 02310686 02271516 Apo-Fluconazole Co Fluconazole Fluconazole Mylan-Fluconazole Novo-Fluconazole pms-Fluconazole Pro-Fluconazole Riva-Fluconazole Apotex Cobalt Sorres Mylan Novopharm Phmscience Pro Doc Riva 50 50 50 50 50 50 50 50 Janss. Inc 28 30 Tab. 64.52 64.52 64.52 64.52 129.04 64.52 1.2904 1.2904 1.2904 1.2904 1.2904 1.2904 100 mg PPB ITRACONAZOLE X Caps. 02047454 Sporanox 106.21 113.80 3.7932 3.7933 10 mg/mL Janss. Inc 150 ml KETOCONAZOLE X Tab. 02237235 Apo-Ketoconazole 02231061 Novo-Ketoconazole 2.2892 2.2892 2.2892 2.2892 2.2892 2.2892 2.2892 2.2892 100 mg Oral Sol. 02231347 Sporanox 114.46 114.46 114.46 114.46 114.46 114.46 114.46 114.46 115.28 0.7685 200 mg PPB Apotex Novopharm 100 100 00792667 pms-Nystatin Phmscience 02194201 ratio-Nystatin Ratiopharm 48 ml 100 ml 24 ml 48 ml 100 ml 93.93 93.93 0.9393 0.9393 8:14.28 POLYENES NYSTATIN X Oral Susp. 100 000 U/mL PPB Tab. 0.0521 0.0520 0.0521 0.0521 0.0520 500 000 U 02194198 ratio-Nystatin Page 2.50 5.20 1.25 2.50 5.20 32 Ratiopharm 100 16.80 0.1680 2013-04 CODE BRAND NAME MANUFACTURER SIZE COST OF PKG. SIZE UNIT PRICE 8:16.04 ANTITUBERCULOSIS AGENTS ETHAMBUTOL HYDROCHLORIDE X Tab. 100 mg 00247960 Etibi Valeant 100 00247979 Etibi Valeant 100 Tab. 9.73 0.0973 400 mg ISONIAZID X Syr. 27.11 0.2711 50 mg/5 mL 00577812 pms-Isoniazid Phmscience 500 ml 00577790 pms-Isoniazid Phmscience 100 Tab. 98.77 0.1975 100 mg Tab. 63.40 0.6340 300 mg 00577804 pms-Isoniazid Phmscience 100 PYRAZINAMIDE X Tab. 00618810 pms-Pyrazinamide 0.6340 500 mg Phmscience 100 Pfizer 100 RIFABUTIN X Caps. 02063786 Mycobutin 63.40 103.96 1.0396 150 mg 394.95 3.9495 RIFAMPIN X Caps. 150 mg PPB 02091887 Rifadin 00393444 Rofact 150 SanofiAven Valeant 100 100 02092808 Rifadin 00343617 Rofact 300 SanofiAven Valeant 100 100 Caps. 66.69 60.38 0.6669 0.6038 300 mg PPB RIFAMPINE/ ISONIAZIDE/ PYRAZINAMIDE X Tab. 02148625 Rifater 2013-04 SanofiAven 104.95 95.03 1.0495 0.9503 120 mg- 50 mg- 300 mg 60 21.38 0.3563 Page 33 CODE BRAND NAME MANUFACTURER SIZE COST OF PKG. SIZE UNIT PRICE 8:16.92 MISCELLANEOUS ANTIMYCOBACTERIALS DAPSONE X Tab. 02041510 Dapsone 100 mg Jacobus 100 UE 02139200 Mylan-Amantadine 01990403 pms-Amantadine Mylan Phmscience 100 100 02022826 pms-Amantadine Phmscience 500 ml 8:18.04 ADAMANTANES AMANTADINE HYDROCHLORIDE X Caps. 100 mg PPB 51.79 51.79 Syr. 0.5179 0.5179 50 mg/5 mL 40.50 0.0810 8:18.08 ANTIRETROVIRAL AGENTS ABACAVIR (SULFATE) / LAMIVUDINE / ZIDOVUDINE X Tab. 02244757 Trizivir 300 mg - 150 mg - 300 mg ViiV 60 998.88 ViiV 240 ml ABACAVIR SULFATE X Oral Sol. 02240358 Ziagen 20 mg/mL Tab. 103.26 0.4303 300 mg 02240357 Ziagen ViiV 60 ABACAVIR/LAMIVUDINE X Tab. 02269341 Kivexa 02248610 Reyataz 396.38 6.6063 600 mg - 300 mg ViiV 30 B.M.S. 60 ATAZANAVIR SULFATE X Caps. 661.99 22.0663 150 mg Caps. 648.00 10.8000 200 mg 02248611 Reyataz Page 16.6480 34 B.M.S. 60 651.87 10.8645 2013-04 CODE BRAND NAME MANUFACTURER SIZE Caps. COST OF PKG. SIZE UNIT PRICE 300 mg 02294176 Reyataz B.M.S. 30 Janss. Inc 480 DARUNAVIR X Tab. 02338432 Prezista 648.01 21.6003 75 mg Tab. 854.88 1.7810 150 mg 02369753 Prezista Janss. Inc 240 Tab. 854.88 3.5620 400 mg 10 02324016 Prezista Janss. Inc 60 DELAVIRDINE MESYLATE X Tab. 02238348 Rescriptor ViiV 360 B.M.S. 30 B.M.S. 30 B.M.S. 30 3.4230 164.30 5.4767 205.37 6.8457 400 mg B.M.S. 30 B.M.S. 30 EFAVIRENZ X Caps. 02239886 Sustiva 102.69 250 mg Ent. Caps. 02244599 Videx EC 0.7178 200 mg Ent. Caps. 02244598 Videx EC 258.40 125 mg Ent. Caps. 02244597 Videx EC 9.7692 100 mg DIDANOSIN X Ent. Caps. 02244596 Videx EC 586.15 329.25 10.9750 50 mg Caps. 35.41 1.1803 200 mg 02239888 Sustiva B.M.S. 90 424.92 4.7213 10 Reimbursement of 400 mg-strength darunavir tablets is limited to two tablets per day. 2013-04 Page 35 CODE BRAND NAME MANUFACTURER SIZE Tab. COST OF PKG. SIZE UNIT PRICE 600 mg 02246045 Sustiva B.M.S. 30 424.92 14.1640 EFAVIRENZ/ EMTRICITABINE/ TENOFOVIR DISOPROXIL FUMARATE X Tab. 600 mg - 200 mg - 300 mg 02300699 Atripla B.M.S.-Gil 30 1165.41 38.8470 EMTRICITABINE/ RILPIVIRINE / TENOFOVIR DISOPROXIL (FUMARATE DE ) X Tab. 200 mg - 25 mg - 300 mg 02374129 Complera Gilead 30 EMTRICITABINE/ TENOFOVIR DISOPROXIL FUMARATE X Tab. 02274906 Truvada Gilead 30 783.06 26.1020 50 mg/mL ViiV 225 ml Tab. 129.27 0.5745 700 mg 02261545 Telzir ViiV 60 INDINAVIR (SULFATE) X Caps. 471.52 7.8587 200 mg 02229161 Crixivan Merck 360 02229196 Crixivan Merck 180 Caps. 484.80 1.3467 400 mg LAMIVUDINE X Oral Sol. 484.80 2.6933 10 mg/mL 02192691 3TC ViiV 02393239 Apo-Lamivudine HBV 02239193 Heptovir Apotex GSK 240 ml Tab. Page 39.2227 200mg- 300mg FOSAMPRENAVIR CALCIUM X Oral Susp. 02261553 Telzir 1176.68 72.93 0.3039 100 mg PPB 36 100 60 353.16 273.50 2.7350 4.5583 2013-04 CODE BRAND NAME MANUFACTURER SIZE Tab. COST OF PKG. SIZE UNIT PRICE 150 mg PPB 02192683 3TC 02369052 Apo-Lamivudine ViiV Apotex 60 100 02247825 3TC 02369060 Apo-Lamivudine ViiV Apotex 30 100 Tab. 279.05 362.69 4.6508 2.7905 300 mg PPB LAMIVUDINE/ ZIDOVUDIN X Tab. 279.05 725.38 9.3017 5.5811 150 mg -300mg PPB 02375540 Apo-Lamivudine-Zidovudine Apotex 02239213 Combivir ViiV 02387247 Teva Lamivudine/ Teva Can Zidovudine LOPINAVIR/ RITONAVIR X Oral Sol. 100 60 60 261.03 156.62 156.62 2.6103 2.6103 2.6103 80 mg - 20 mg/mL 02243644 Kaletra AbbVie 160 ml 02312301 Kaletra AbbVie 60 Tab. 345.28 2.1580 100 mg -25 mg Tab. 157.34 2.6223 200 mg -50 mg 02285533 Kaletra AbbVie 120 Pfizer 300 NELFINAVIR MESYLATE X Tab. 02238617 Viracept 644.19 5.3683 250 mg Tab. 546.00 1.8200 625 mg 02248761 Viracept Pfizer 120 NEVIRAPINE X L.A. Tab. 02367289 Viramune XR 2013-04 546.00 4.5500 400 mg Bo. Ing. 30 74.08 2.4693 Page 37 CODE BRAND NAME MANUFACTURER SIZE Tab. UNIT PRICE 200 mg PPB 02318601 Auro-Nevirapine 02387727 Mylan-Nevirapine Aurobindo Mylan 02352893 Teva-Nevirapine 02238748 Viramune Teva Can Bo. Ing. 60 60 100 60 60 RALTEGRAVIR X Tab. 02301881 Isentress 02370603 Edurant Merck 60 Janss. Inc 30 690.00 11.5000 413.91 13.7970 100 mg AbbVie 120 AbbVie 240 ml Oral Sol. 02229145 Norvir 1.2347 1.2347 1.2346 1.2347 4.9150 25 mg RITONAVIR X Caps. 02241480 Norvir Sec 74.08 74.08 123.46 74.08 294.90 400 mg RILPIVIRINE X Tab. 174.74 1.4562 80 mg/mL Tab. 279.51 1.1646 100 mg 02357593 Norvir AbbVie 30 SAQUINAVIR MESYLATE X Caps. 43.68 1.4560 200 mg 02216965 Invirase Roche 270 02279320 Invirase Roche 120 Tab. 501.23 1.8564 500 mg STAVUDINE X Caps. 514.08 4.2840 15 mg 02216086 Zerit B.M.S. 60 02216094 Zerit B.M.S. 60 Caps. Page COST OF PKG. SIZE 250.40 4.1733 20 mg 38 260.35 4.3392 2013-04 CODE BRAND NAME MANUFACTURER SIZE Caps. COST OF PKG. SIZE UNIT PRICE 30 mg 02216108 Zerit B.M.S. 60 02216116 Zerit B.M.S. 60 271.61 Caps. 4.5268 40 mg 281.54 TENOFOVIR DISOPROXIL FUMARATE X Tab. 02247128 Viread 300 mg Gilead 30 518.67 ZIDOVUDIN X Caps. 01946323 Apo-Zidovudine 01902660 Retrovir 4.6923 17.2890 100 mg PPB Apotex ViiV 100 100 Inj. Sol. 127.50 175.55 1.0533 1.7555 10 mg/mL 01902644 Retrovir ViiV 20 ml 01902652 Retrovir ViiV 240 ml Syr. 16.70 10 mg/mL 44.94 0.1873 8:18.20 INTERFERONS INTERFERON ALFA-2B X S.C. Inj. Pd. 02223406 Intron A 10 millions UI Merck 1 ml Merck 1 ml S.C. Inj. Pd. 02231651 Intron A 18 millions UI INTERFERON ALFA-2B (HUMAN ALBUMIN FREE) X Inj. Sol. 02238674 Intron A (sans albumine) Merck 2013-04 214.47 10 millions UI/mL Merck S.C. Inj.Sol (syr) 02240693 Intron A (sans albumine) 222.04 6 M UI/mL 3 ml Inj. Sol. 02238675 Intron A (sans albumine) 123.35 2.5 ml 297.87 18 millions UI/1.2 mL Merck 1 214.47 Page 39 CODE BRAND NAME MANUFACTURER COST OF PKG. SIZE SIZE S.C. Inj.Sol (syr) UNIT PRICE 30 M UI / 1.2 mL 02240694 Intron A (sans albumine) Merck 1 Merck 1 S.C. Inj.Sol (syr) 357.42 60 M UI/ 1.2 mL 02240695 Intron A (sans albumine) 714.89 8:18.32 NUCLEOSIDES AND NUCLEOTIDES ACYCLOVIR X Oral Susp. 200 mg/5 mL 00886157 Zovirax GSK 475 ml 02286556 Acyclovir 02207621 Apo-Acyclovir Sanis Apotex 02242784 Mylan-Acyclovir Mylan 02285959 Novo-Acyclovir 02078627 ratio-Acyclovir Novopharm Ratiopharm 00634506 Zovirax GSK 100 100 500 100 250 100 100 500 100 02286564 02207648 02242463 02285967 02078635 01911627 Acyclovir Apo-Acyclovir Mylan-Acyclovir Novo-Acyclovir ratio-Acyclovir Zovirax Sanis Apotex Mylan Novopharm Ratiopharm GSK 100 100 100 100 100 100 02286572 02207656 02242464 02285975 02078651 01911635 Acyclovir Apo-Acyclovir Mylan-Acyclovir Novo-Acyclovir ratio-Acyclovir Zovirax Sanis Apotex Mylan Novopharm Ratiopharm GSK 100 100 100 100 100 50 Tab. 0.2475 200 mg PPB Tab. 64.52 64.52 322.60 64.52 161.30 64.52 64.52 322.60 123.46 0.6452 0.6452 0.6452 0.6452 0.6452 0.6452 0.6452 0.6452 1.2346 400 mg PPB Tab. 127.00 127.00 127.00 127.00 127.00 248.76 1.2700 1.2700 1.2700 1.2700 1.2700 2.4876 800 mg PPB ACYCLOVIR SODIUM X I.V. Perf. Sol. 02236916 Acyclovir 02236926 Acyclovir Sodique 40 126.73 126.73 126.73 126.73 126.73 239.56 1.2673 1.2673 1.2673 1.2673 1.2673 4.7912 25 mg/mL Hospira 20 ml I.V. Perf. Sol. Page 117.56 58.41 50 mg/mL PPC 10 ml 20 ml 85.78 171.57 2013-04 CODE BRAND NAME MANUFACTURER SIZE FAMCICLOVIR X Tab. COST OF PKG. SIZE UNIT PRICE 125 mg PPB 02292025 02305682 02324865 02229110 02278081 02278634 Apo-Famciclovir Co Famciclovir Famciclovir Famvir pms-Famciclovir Sandoz Famciclovir Apotex Cobalt Pro Doc Novartis Phmscience Sandoz 30 10 10 10 10 10 02292041 02305690 02324873 02229129 02278103 Apo-Famciclovir Co Famciclovir Famciclovir Famvir pms-Famciclovir Apotex Cobalt Pro Doc Novartis Phmscience 30 30 30 30 30 100 30 100 Tab. 41.82 13.94 13.94 27.15 13.94 13.94 1.3940 1.3940 1.3940 2.7150 1.3940 1.3940 250 mg PPB 02278642 Sandoz Famciclovir Sandoz 02292068 Apo-Famciclovir 02305704 Co Famciclovir Apotex Cobalt 02324881 Famciclovir 02177102 Famvir 02278111 pms-Famciclovir Pro Doc Novartis Phmscience 02278650 Sandoz Famciclovir Sandoz Tab. 56.20 56.20 56.20 112.10 56.20 187.33 56.20 187.33 1.8733 1.8733 1.8733 3.7367 1.8733 1.8733 1.8733 1.8733 500 mg PPB 30 21 100 21 21 21 100 21 100 GANCICLOVIR SODIUM X I.V. Perf. Pd. 02162695 Cytovene 5 210.19 42.0380 500 mg PPB 02295822 Apo-Valacyclovir Apotex 02331748 Co Valacyclovir 02351579 Mylan-Valacyclovir Cobalt Mylan 02357534 02298457 02315173 02316447 02219492 Teva Can Phmscience Pro Doc Riva GSK 2013-04 1.6907 1.6907 1.6906 1.6907 6.6371 1.6907 1.6906 1.6907 1.6906 500 mg Roche VALACYCLOVIR (HYDROCHLORIDE) X Tab. Novo-Valacyclovir pms-Valacyclovir Pro-Valacyclovir Riva-Valacyclovir Valtrex 50.72 35.50 169.06 35.50 139.38 35.50 169.06 35.50 169.06 8 100 100 8 100 42 100 100 100 30 6.78 84.81 84.75 6.78 84.81 35.60 84.81 84.75 84.75 93.56 0.8475 0.8481 0.8475 0.8475 0.8481 0.8475 0.8481 0.8475 0.8475 3.1187 Page 41 CODE BRAND NAME MANUFACTURER SIZE COST OF PKG. SIZE UNIT PRICE 8:30.04 AMEBICIDES IODOQUINOL X Tab. 210 mg 01997769 Diodoquin Glenwood 100 01997750 Diodoquin Glenwood 100 Tab. 58.48 0.5848 650 mg PAROMOMYCINE SULFATE X Caps. 02078759 Humatin 72.56 0.7256 250 mg Erfa 100 221.25 2.2125 8:30.08 ANTIMALARIALS ATOVAQUONE/ PROGUANIL (HYDROCHLORIDE) X Tab. 02264935 Malarone pediatrique GSK Tab. 62.5 mg - 25 mg 12 1.4808 250 mg - 100 mg PPB 02238151 Malarone 02380927 Teva Atovaquone Proguanil GSK Teva Can 12 12 Novopharm 100 CHLOROQUINE PHOSPHATE X Tab. 00021261 Novo-Chloroquine Apotex 02252600 Mylan-Hydroxychloroquine 02017709 Plaquenil 02311011 Pro-Hydroxyquine-200 Mylan SanofiAven Pro Doc 100 500 100 100 100 500 MEFLOQUINE HYDROCHLORIDE X Tab. 42 4.3175 2.5367 32.08 0.3208 200 mg PPB 02246691 Apo-Hydroxyquine 02244366 Mefloquine 51.81 30.44 250 mg HYDROXYCHLOROQUIN SULFATE X Tab. Page 17.77 26.20 131.00 26.20 56.62 26.20 131.00 0.2620 0.2620 0.2620 0.5662 0.2620 0.2620 250 mg AA Pharma 8 29.56 3.6950 2013-04 CODE BRAND NAME MANUFACTURER SIZE PRIMAQUINE PHOSPHATE X Tab. 02017776 Primaquine UNIT PRICE 26.3 mg SanofiAven 100 PYRIMETHAMINE X Tab. 00004774 Daraprim COST OF PKG. SIZE 36.44 0.3644 25 mg Tribute 50 02254514 Apo-Quinine 00021008 Novo-Quinine Apotex Novopharm 02311216 Pro-Quinine-200 00695440 Quinine-Odan (Caps.) Pro Doc Odan 100 100 500 100 100 500 QUININE SULFATE Caps. 66.91 1.3382 200 mg PPB Caps. or Tab. 23.90 23.90 119.50 23.90 23.90 119.50 0.2390 0.2390 0.2390 0.2390 0.2390 0.2390 300 mg PPB 02254522 Apo-Quinine (Caps.) 00021016 Novo-Quinine (Caps.) Apotex Novopharm 02311224 Pro-Quinine-300 (Caps.) 00695459 Quinine-Odan (Caps.) Pro Doc Odan 00695432 Quinine-Odan (Co.) Odan 100 100 500 100 100 500 100 37.50 37.50 187.50 37.50 37.50 187.50 37.50 0.3750 0.3750 0.3750 0.3750 0.3750 0.3750 0.3750 8:30.92 MISCELLANEOUS ANTIPROTOZOALS ATOVAQUONE X Oral Susp. 02217422 Mepron 150 mg/mL GSK 210 ml Hospira 100 ml METRONIDAZOLE X I.V. Perf. Sol. 00649074 Metronidazole 504.15 2.4007 5 mg/mL Tab. 14.58 250 mg 00545066 Metronidazole 2013-04 AA Pharma 500 29.75 0.0595 Page 43 CODE BRAND NAME MANUFACTURER SIZE COST OF PKG. SIZE UNIT PRICE 8:36 URINARY ANTI-INFECTIVES NITROFURANTIN MONOHYDRATE (MACROCRYSTALS) X Caps. 02063662 MacroBid 100 mg Warner 100 AA Pharma 100 NITROFURANTOIN X Tab. 00319511 Nitrofurantoin 0.6817 50 mg Tab. 16.70 0.1670 100 mg 00312738 Nitrofurantoin AA Pharma 100 NITROFURANTOIN (MACROCRYSTALS) X Caps. 22.27 0.2227 50 mg 02231015 Novo-Furantoin Novopharm 100 02231016 Novo-Furantoin Novopharm 100 Caps. 31.87 0.3187 100 mg TRIMETHOPRIM X Tab. 61.10 0.6110 100 mg 02243116 Trimethoprim AA Pharma 100 02243117 Trimethoprim AA Pharma 100 Tab. Page 68.17 25.66 0.2566 200 mg 44 52.73 0.5273 2013-04 10:00 ANTINEOPLASTIC AGENTS CODE BRAND NAME MANUFACTURER SIZE COST OF PKG. SIZE UNIT PRICE 10:00 ANTINEOPLASTIC AGENTS ANASTROZOLE X Tab. 1 mg PPB 02351218 Anastrozole 02395649 Anastrozole 02374420 Apo-Anastrozole Accord Pro Doc Apotex 02224135 Arimidex AZC Biomed + 02392488 Bio-Anastrozole 02394898 Co Anastrozole 02339080 Jamp-Anastrozole Cobalt Jamp 02379562 Mar-Anastrozole Marcan 02379104 02393573 02361418 02320738 02328690 02392259 02338467 02365650 02313049 GMP Mint Mylan Phmscience Ranbaxy Riva Sandoz Taro Teva Can Med-Anastrozole Mint-Anastrozole Mylan-Anastrozole pms-Anastrozole Ran-Anastrozole Riva-Anastrozole Sandoz Anastrozole Taro-Anastrozole Teva Anastrozole 30 30 30 100 30 30 100 30 30 100 30 100 30 30 30 30 100 30 30 30 30 100 BICALUTAMIDE X Tab. 1.2729 1.2729 1.2729 1.2729 5.0917 1.2729 1.2729 1.2729 1.2729 1.2729 1.2729 1.2729 1.2729 1.2729 1.2729 1.2729 1.2729 1.2729 1.2729 1.2730 1.2729 1.2729 50 mg PPB 02296063 Apo-Bicalutamide 02325985 Bicalutamide Apotex Accord 02382423 Bicalutamide Sivem 02325233 Bicalutamide 02184478 Casodex 02274337 Co Bicalutamide Sorres AZC Cobalt 02357216 Jamp-Bicalutamide 02302403 Mylan-Bicalutamide Jamp Mylan 02270226 Novo-Bicalutamide Novopharm 02281163 phl-Bicalutamide Pharmel 02275589 pms-Bicalutamide Phmscience 02311038 Pro-Bicalutamide-50 02371324 Ran-Bicalutamide Pro Doc Ranbaxy 02277700 ratio-Bicalutamide 02276089 Sandoz Bicalutamide Ratiopharm Sandoz 2013-04 38.19 38.19 38.19 127.29 152.75 38.19 127.29 38.19 38.19 127.29 38.19 127.29 38.19 38.19 38.19 38.19 127.29 38.19 38.19 38.19 38.19 127.29 30 30 100 30 100 100 30 30 100 30 30 100 30 100 30 100 30 100 30 30 100 30 30 48.30 48.30 161.00 48.30 161.00 161.00 200.70 48.30 161.00 48.30 48.30 161.00 48.30 161.00 48.30 161.00 48.30 161.00 48.30 48.30 161.00 48.30 48.30 1.6100 1.6100 1.6100 1.6100 1.6100 1.6100 6.6900 1.6100 1.6100 1.6100 1.6100 1.6100 1.6100 1.6100 1.6100 1.6100 1.6100 1.6100 1.6100 1.6100 1.6100 1.6100 1.6100 Page 47 CODE BRAND NAME MANUFACTURER SIZE BUSERELIN ACETATE X Implant 02228955 Suprefact Depot SanofiAven 1 SanofiAven 1 SanofiAven 10 ml SanofiAven 5.5 ml 25 Triton 25 Baxter 200 1.4128 33.30 1.3320 25 mg Tab. 70.40 0.3520 50 mg 02241796 Procytox Baxter 100 ESTRAMUSTINE DISODIUM PHOSPHATE X Caps. 02063794 Emcyt 00616192 Vepesid 48 47.40 0.4740 140 mg Pfizer 100 B.M.S. 20 ETOPOSIDE X Caps. Page 35.32 2 mg CYCLOPHOSPHAMIDE X Tab. 02241795 Procytox 51.76 2 mg Triton CHLORAMBUCIL X Tab. 00004626 Leukeran 69.35 1 mg/mL BUSULFAN X Tab. 00004618 Myleran 1083.76 10 mL S.C. Inj. Sol. 02225166 Suprefact 733.47 9.45 mg Nas. spray 02225158 Suprefact UNIT PRICE 6.3 mg Implant 02240749 Suprefact Depot 3 mois COST OF PKG. SIZE 306.44 3.0644 50 mg 656.42 32.8210 2013-04 CODE BRAND NAME MANUFACTURER SIZE EXEMESTANE X Tab. 02242705 Aromasin 02390183 Co Exemestane Pfizer Cobalt 30 30 155.35 90.79 Apotex Merck Novopharm Phmscience 100 100 100 100 5.1783 3.0263 250 mg PPB Apo-Flutamide Euflex Novo-Flutamide pms-Flutamide GOSERELINE ACETATE X Implant 02049325 Zoladex 02225905 Zoladex LA 1 10.8 mg AZC 1 1113.00 500 mg PPB B.M.S. Sanis Mylan 100 100 100 INTERFERON ALFA-2B X S.C. Inj. Pd. 02223406 Intron A Merck 1 ml Merck 1 ml 123.35 222.04 6 M UI/mL Merck 3 ml Merck 2.5 ml Inj. Sol. 02238675 Intron A (sans albumine) 1.0203 1.0203 1.0203 18 millions UI INTERFERON ALFA-2B (HUMAN ALBUMIN FREE) X Inj. Sol. 02238674 Intron A (sans albumine) 102.03 102.03 102.03 10 millions UI S.C. Inj. Pd. 02231651 Intron A 1.3530 1.3890 1.3530 1.3530 390.50 HYDROXYUREA X Caps. 00465283 Hydrea 02343096 Hydroxyurea 02242920 Mylan-Hydroxyurea 135.30 138.90 135.30 135.30 3.6 mg AZC Implant 2013-04 UNIT PRICE 25 mg PPB FLUTAMIDE X Tab. 02238560 00637726 02230089 02230104 COST OF PKG. SIZE 214.47 10 millions UI/mL 297.87 Page 49 CODE BRAND NAME MANUFACTURER S.C. Inj.Sol (syr) SIZE UNIT PRICE 18 millions UI/1.2 mL 02240693 Intron A (sans albumine) Merck 1 Merck 1 S.C. Inj.Sol (syr) 214.47 30 M UI / 1.2 mL 02240694 Intron A (sans albumine) S.C. Inj.Sol (syr) 357.42 60 M UI/ 1.2 mL 02240695 Intron A (sans albumine) Merck 1 LETROZOLE X Tab. 714.89 2.5 mg PPB 02358514 Apo-Letrozole 02231384 Femara 02373009 Jamp-Letrozole Apotex Novartis Jamp 02338459 02348969 02348896 02347997 02373424 02322315 02372169 02309114 02372282 Accord Cobalt MeliaPharm Teva Can Marcan GMP Mylan Phmscience Ranbaxy Letrozole Letrozole Letrozole Letrozole Mar-Letrozole Med-Letrozole Myl-Letrozole pms-Letrozole Ran-Letrozole 02344815 Sandoz Letrozole Sandoz 30 30 30 100 30 30 30 30 30 30 30 30 30 100 30 AbbVie 1 LEUPORIDE ACETATE X Kit 00884502 Lupron Depot 41.34 163.96 41.34 137.80 41.34 41.34 41.34 41.34 41.34 41.34 41.34 41.34 41.34 137.80 41.34 1.3780 5.4653 1.3780 1.3780 1.3780 1.3780 1.3780 1.3780 1.3780 1.3780 1.3780 1.3780 1.3780 1.3780 1.3780 3.75 mg Kit 336.23 5 mg/mL 00727695 Lupron AbbVie 14 02248239 Eligard 00836273 Lupron Depot SanofiAven AbbVie 1 1 Kit 189.41 7.5 mg Kit 310.72 387.97 11.25 mg 02239834 Lupron Depot AbbVie 1 02248240 Eligard 02230248 Lupron Depot SanofiAven AbbVie 1 1 Kit Page COST OF PKG. SIZE 1008.68 22.5 mg 50 891.00 1071.00 2013-04 CODE BRAND NAME MANUFACTURER SIZE Kit COST OF PKG. SIZE UNIT PRICE 30 mg 02248999 Eligard 02239833 Lupron Depot SanofiAven AbbVie 1 1 02268892 Eligard SanofiAven 1 Kit 1285.20 1428.00 45 mg MELPHALAN X Tab. 00004715 Alkeran 2 mg Triton 50 MERCAPTOPURINE X Tab. 00004723 Purinethol 1450.00 74.18 1.4836 50 mg Novopharm 25 METHOTREXATE X Inj. Sol. 119.21 4.7684 25 mg/mL 02182777 Methotrexate Sodium Hospira 02182955 Methotrexate Sodium sans preservatif Hospira 02182963 Apo-Methotrexate 02244798 ratio-Methotrexate Hospira Ratiopharm 2 ml 20 ml 2 ml Tab. 11.75 117.50 11.54 2.5 mg PPB 100 100 Tab. 63.25 63.25 0.6325 0.6325 10 mg 02182750 Methotrexate Hospira 100 SanofiAven 90 NILUMAMID X Tab. 02221861 Anandron 2013-04 2.1455 50 mg PROCARBAZINE HYDROCHLORIDE X Caps. 00012750 Matulane 214.55 165.31 1.8368 50 mg Sigma-Tau 100 UE Page 51 CODE BRAND NAME MANUFACTURER SIZE TAMOXIFEN CITRATE X Tab. COST OF PKG. SIZE UNIT PRICE 10 mg PPB 00812404 Apo-Tamox 02088428 Mylan-Tamoxifen Apotex Mylan 00851965 Novo-Tamoxifen Novopharm 100 60 250 100 Tab. 17.50 10.50 43.75 17.50 0.1750 0.1750 0.1750 0.1750 20 mg PPB 00812390 Apo-Tamox Apotex 02089858 Mylan-Tamoxifen Mylan 02048485 Nolvadex-D 00851973 Novo-Tamoxifen AZC Novopharm 100 250 30 250 30 30 100 THIOGUANINE X Tab. 00282081 Lanvis 35.00 87.50 10.50 87.50 11.05 10.50 35.00 0.3500 0.3500 0.3500 0.3500 0.3683 0.3500 0.3500 40 mg Triton 25 102.93 4.1172 TRETINOIN X Caps. 10 mg 02145839 Vesanoid Roche 100 Paladin 1 TRIPTORELIN (AS PAMOATE) X Kit 02240000 Trelstar 13.1090 3.75 mg Kit 304.43 11.25 mg 02243856 Trelstar LA Page 1310.90 52 Paladin 1 932.12 2013-04 12:00 AUTONOMIC DRUGS 12:04 12:08 12:08.08 12:12 12:12.04 12:12.08 12:12.12 12:16 12:16.04 12:20 12:20.04 12:20.08 12:20.12 12:20.92 12:92 parasympathomimetic agents anticholinergic agents antimuscarinics / antispasmodics sympathomimetic agents alpha‑adrenergic agonists beta adrenergic agonists alpha and beta adrenergic agonists sympatholytic agents alpha‑adrenergic blocking agents skeletal muscle relaxants centrally acting skeletal muscle relaxants direct‑acting skeletal muscle relaxants GABA‑derivative skeletal muscle relaxants skeletal muscle relaxants, miscellaneous Miscellaneous autonomic drugs CODE BRAND NAME MANUFACTURER SIZE COST OF PKG. SIZE UNIT PRICE 12:04 PARASYMPATHOMIMETIC AGENTS BETHANECHOL CHLORIDE X Tab. 10 mg 01947958 Duvoid Paladin 100 01947931 Duvoid Paladin 100 Tab. 25.98 0.2598 25 mg Tab. 42.07 0.4207 50 mg 01947923 Duvoid Paladin 100 Valeant 100 Valeant 30 NEOSTIGMINE BROMIDE X Tab. 00869945 Prostigmin 0.5526 15 mg PYRIDOSTIGMINE BROMIDE X L.A. Tab. 00869953 Mestinon Supraspan 55.26 43.70 0.4370 180 mg Tab. 28.19 0.9397 60 mg 00869961 Mestinon Valeant 100 42.95 0.4295 12:08.08 ANTIMUSCARINICS / ANTISPASMODICS GLYCOPYRROLATE Inj. Sol. 02039508 Glycopyrrolate injection 0.2 mg/mL Sandoz 1 ml 2 ml HYOSCINE BUTYLBROMIDE Inj. Sol. 02229868 Butylbromure d'hyoscine 3.70 7.40 20 mg/mL Sandoz 1 ml 4.52 4.1300 IPRATROPIUM (BROMIDE) / SALBUTAMOL (SULFATE) X Sol. Inh. 0.2 mg -1 mg/mL (2.5 mL) PPB 02231675 Combivent UDV 02272695 Mylan-Combo Sterinebs 02243789 ratio-Ipra Sal UDV 2013-04 Bo. Ing. Mylan Ratiopharm 20 20 20 30.15 14.68 14.68 1.5075 0.7340 0.7340 Page 55 CODE BRAND NAME MANUFACTURER IPRATROPIUM BROMIDE X Oral aerosol 02247686 Atrovent HFA UNIT PRICE 0.02 mg/dose Bo. Ing. Sol. Inh. 200 dose(s) 18.92 0.125 mg/mL (2 mL) PPB 02231135 pms-Ipratropium Polynebs 02097176 ratio-Ipratropium UDV Phmscience Ratiopharm 20 20 Sol. Inh. 02126222 02239131 02210479 02231136 COST OF PKG. SIZE SIZE 13.18 13.18 0.6590 0.6590 0.25 mg/mL PPB Apo-Ipravent Mylan-Ipratropium Novo-Ipramide pms-Ipratropium Apotex Mylan Novopharm Phmscience Sol. Inh. 20 ml 20 ml 20 ml 20 ml 6.32 6.32 6.32 6.32 0.25 mg/mL (1 mL) PPB 02216221 Mylan-Ipratropium sterinebs Mylan 02231244 pms-Ipratropium Polynebs Phmscience 99001446 ratio-Ipratropium UDV Ratiopharm Sol. Inh. 20 20 20 13.18 13.18 13.18 0.6590 0.6590 0.6590 0.25 mg/mL (2 mL) PPB 99002795 Mylan-Ipratropium sterinebs Mylan 02231245 pms-Ipratropium Polynebs Phmscience 02097168 ratio-Ipratropium UDV Ratiopharm 10 10 10 13.18 13.18 13.18 1.3180 1.3180 1.3180 SCOPOLAMINE HYDROBROMIDE Inj. Sol. 02242810 Scopolamine Hydrobromide Injection 0.4 mg/mL Oméga 1 Inj. Sol. 02242811 Scopolamine Hydrobromide Injection 0.6 mg/mL Oméga 1 TIOTROPIUM MONOHYDRATED BROMIDE X Inh. Pd. (App.) 02246793 Spiriva 4.50 Bo. Ing. 5.00 18 mcg 30 63.00 12:12.04 ALPHA-ADRENERGIC AGONISTS MIDODRINE HYDROCHLORIDE X Tab. 02278677 Midodrine Page 56 2.5 mg AA Pharma 100 33.78 0.3378 2013-04 CODE BRAND NAME MANUFACTURER COST OF PKG. SIZE SIZE Tab. UNIT PRICE 5 mg 02278685 Midodrine AA Pharma 100 56.30 0.5630 12:12.08 BETA ADRENERGIC AGONISTS FORMOTEROL FUMARATE DIHYDRATE X Inh. Pd. 02237225 Oxeze Turbuhaler 6 mcg /dose AZC 33.24 60 dose(s) Inh. Pd. 12 mcg/dose 02237224 Oxeze Turbuhaler AZC 60 dose(s) FORMOTEROL (FUMARATE) X Inh. Pd. 02230898 Foradil & Aerolizer 44.28 12 mcg/caps. Novartis 60 Novartis 30 Apotex 250 ml INDACATEROL (MALEATE) X Inh. Pd. (App.) * 02376938 Onbrez Breezhaler 46.48 0.7747 75 mcg 46.50 ORCIPRENALINE SULFATE X Syr. 10 mg/5 mL 02236783 Apo-Orciprenaline SALBUTAMOL X Oral aerosol 02232570 02245669 02326450 02241497 Airomir Apo-Salvent sans CFC Novo-Salbutamol HFA Ventolin HFA 2013-04 0.0308 100 mcg/dose PPB Med Pharma Apotex Novopharm GSK SALBUTAMOL SULFATE X Sol. Inh. 02208245 pms-Salbutamol Polynebs 02239365 ratio-Salbutamol 02213400 Ventolin Nebules P.F. 14.35 200 dose(s) 200 dose(s) 200 dose(s) 200 dose(s) 5.00 5.00 5.00 6.00 0.5 mg/mL (2.5mL) PPB Phmscience Ratiopharm GSK 20 20 20 5.37 5.37 9.95 0.2685 0.2685 0.4975 Page 57 CODE BRAND NAME MANUFACTURER Sol. Inh. 01926934 02208229 01986864 02213419 Mylan-Salbutamol Sterinebs pms-Salbutamol Polynebs ratio-Salbutamol Ventolin Nebules P.F. Mylan Phmscience Ratiopharm GSK 20 20 20 20 7.24 7.24 7.24 20.00 Mylan-Salbutamol Sterinebs pms-Salbutamol Polynebs ratio-Salbutamol Salmol Ventolin Nebules P.F. Mylan Phmscience Ratiopharm Riva GSK 20 20 20 20 20 13.75 13.75 13.75 13.75 38.01 pms-Salbutamol ratio-Salbutamol Sandoz Salbutamol Ventolin Phmscience Ratiopharm Sandoz GSK 10 ml 10 ml 10 ml 10 ml 0.6875 0.6875 0.6875 0.6875 1.9005 5 mg/mL PPB 3.52 3.52 3.52 9.71 Tab. 2 mg 02146843 Apo-Salvent Apotex 100 12.74 Tab. 0.1274 4 mg 02146851 Apo-Salvent Apotex 100 SALMETEROL XINAFOATE X Inh. Pd. 02231129 Serevent Diskus 02214261 Serevent 60 dose(s) GSK 15 58 52.64 52.64 GSK 15 AZC 100 dose(s) 3.5093 50 mcg/coque (4) TERBUTALIN SULFATE X Inh. Pd. 00786616 Bricanyl Turbuhaler 0.2134 50 mcg/coque (4) Inh. Pd. (App.) 99000091 Serevent & Diskhaler 21.34 50 mcg/coque GSK Inh. Pd. Page 0.3620 0.3620 0.3620 1.0000 2 mg/mL (2.5 mL) PPB Sol. Inh. 02069571 00860808 02154412 02213486 UNIT PRICE 1 mg/mL (2.5 mL) PPB Sol. Inh. 02173360 02208237 02239366 02228297 02213427 COST OF PKG. SIZE SIZE 55.91 0.5 mg/dose 7.64 2013-04 CODE BRAND NAME MANUFACTURER SIZE COST OF PKG. SIZE UNIT PRICE 12:12.12 ALPHA AND BETA ADRENERGIC AGONISTS EPINEPHRINE Inj. Sol. (App.) 0,15 mg/dose PPB 00578657 EpiPen Jr. 02268205 Twinject Pfizer Paladin Inj. Sol. (App.) 1 1 2 81.00 81.00 152.00 0,3 mg/dose PPB 00509558 EpiPen 02247310 Twinject Pfizer Paladin 1 1 2 81.00 81.00 152.00 12:16.04 ALPHA-ADRENERGIC BLOCKING AGENTS ALFUZOSINE HYDROCHLORIDE X L.A. Tab. 02315866 02314282 02304678 02245565 Apo-Alfuzosin Novo-Alfuzosin PR Sandoz Alfuzosin Xatral 10 mg PPB Apotex Teva Can Sandoz SanofiAven 100 100 100 100 DIHYDROERGOTAMINE MESYLATE X Inj. Sol. 00027243 Dihydroergotamine 02241163 Mesylate de dihydroergotamine 0.4966 0.4966 0.4966 1.0130 1 mg/mL PPB Sterimax Sandoz 1 ml 1 ml Nas. spray 02228947 Migranal 49.66 49.66 49.66 101.30 4.22 3.72 3.2300 4 mg/mL Sterimax 3 SILODOSINE X Caps. 28.22 9.4067 4 mg 02361663 Rapaflo Watson 30 02361671 Rapaflo Watson 30 90 Caps. 13.15 0.4383 8 mg 2013-04 13.15 39.45 0.4383 0.4383 Page 59 CODE BRAND NAME MANUFACTURER SIZE TAMSULOSIN HYDROCHLORIDE X LA Tab or LA Caps Apotex 02270102 02352419 02298570 02281392 02294885 02294265 02295121 02340208 Bo. Ing. Jamp Mylan Novopharm Ranbaxy Ratiopharm Sandoz Sandoz + 02368242 Teva-Tamsulosin CR UNIT PRICE 0.4 mg PPB 02362406 Apo-Tamsulosin CR Flomax CR Jamp-Tamsulosin Mylan-Tamsulosin Novo-Tamsulosin Ran-Tamsulosin ratio-Tamsulosin Sandoz Tamsulosin Sandoz Tamsulosin CR COST OF PKG. SIZE Teva Can 100 500 30 100 100 100 100 100 100 100 500 30 15.00 75.00 18.00 15.00 15.00 15.00 15.00 15.00 15.00 15.00 75.00 4.50 0.1500 0.1500 0.6000 0.1500 0.1500 0.1500 0.1500 0.1500 0.1500 0.1500 0.1500 0.1500 12:20.04 CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS CYCLOBENZAPRINE HYDROCHLORIDE X Tab. 10 mg PPB 02177145 Apo-Cyclobenzaprine Apotex 02348853 Auro-Cyclobenzaprine Aurobindo 02287064 Cyclobenzaprine 02325195 Cyclobenzaprine 02220644 Cyclobenzaprine-10 Sanis Sorres Pro Doc 02357127 Jamp-Cyclobenzaprine Jamp 02231353 Mylan-Cyclobenzaprine Mylan 02080052 Novo-Cycloprine Novopharm 02249359 phl-Cyclobenzaprine Pharmel 02212048 pms-Cyclobenzaprine Phmscience 02236506 ratio-Cyclobenzaprine Ratiopharm 02242079 Riva-Cycloprine Riva 100 500 100 500 100 100 100 500 100 500 100 500 100 500 100 500 100 500 100 500 100 500 37.27 186.35 37.27 186.35 37.27 37.27 37.27 186.35 37.27 186.35 37.27 186.35 37.27 186.35 37.27 186.35 37.27 186.35 37.27 186.35 37.27 186.35 0.3727 0.3727 0.3727 0.3727 0.3727 0.3727 0.3727 0.3727 0.3727 0.3727 0.3727 0.3727 0.3727 0.3727 0.3727 0.3727 0.3727 0.3727 0.3727 0.3727 0.3727 0.3727 12:20.08 DIRECT-ACTING SKELETAL MUSCLE RELAXANTS DANTROLENE (SODIUM) X Caps. 01997602 Dantrium 25 mg JHP 100 Caps. 0.3780 100 mg 01997653 Dantrium Page 37.80 60 JHP 100 75.68 0.7568 2013-04 CODE BRAND NAME MANUFACTURER SIZE COST OF PKG. SIZE UNIT PRICE 12:20.12 GABA-DERIVATIVE SKELETAL MUSCLE RELAXANTS BACLOFEN X Inj. Sol. 0.05 mg/mL (1 mL) 02131048 Lioresal Intrathecal Novartis 5 Novartis 1 Inj. Sol. 50.23 10.0460 0.5 mg/mL (20 mL) 02131056 Lioresal Intrathecal Inj. Sol. 150.54 2 mg/mL (5 mL) 02131064 Lioresal Intrathecal Novartis 5 02139332 Apo-Baclofen Apotex 02287021 Baclofen 02152584 Baclofen-10 Sanis Pro Doc 00455881 Lioresal 02088398 Mylan-Baclofen Novartis Mylan 02236963 phl-Baclofen Pharmel 02063735 pms-Baclofen Phmscience 02236507 ratio-Baclofen Ratiopharm 02242150 Riva-Baclofen Riva 100 500 100 100 500 100 100 500 100 500 100 500 100 500 100 500 Tab. 752.79 150.5580 10 mg PPB Tab. 15.95 79.74 15.95 15.95 79.74 51.02 15.95 79.74 15.95 79.74 15.95 79.74 15.95 79.74 15.95 79.74 0.1595 0.1595 0.1595 0.1595 0.1595 0.5102 0.1595 0.1595 0.1595 0.1595 0.1595 0.1595 0.1595 0.1595 0.1595 0.1595 20 mg PPB 02139391 02287048 02152592 00636576 02088401 02236964 02063743 02236508 02242151 Apo-Baclofen Baclofen Baclofen-20 Lioresal D.S. Mylan-Baclofen phl-Baclofen pms-Baclofen ratio-Baclofen Riva-Baclofen Apotex Sanis Pro Doc Novartis Mylan Pharmel Phmscience Ratiopharm Riva 100 100 100 100 100 100 100 100 100 500 31.04 31.04 31.04 99.32 31.04 31.04 31.04 31.04 31.04 224.90 0.3104 0.3104 0.3104 0.9932 0.3104 0.3104 0.3104 0.3104 0.3104 0.4498 12:20.92 SKELETAL MUSCLE RELAXANTS, MISCELLANEOUS ORPHENADRINE CITRATE L.A. Tab. 01966154 Norflex 02243559 Sandoz Orphenadrine 2013-04 100 mg PPB Med Pharma Sandoz 100 100 63.70 50.95 0.6370 0.3822 Page 61 CODE BRAND NAME MANUFACTURER SIZE Tab. COST OF PKG. SIZE UNIT PRICE 100 mg 02047535 Orfenace Sterimax 100 35.35 0.3535 12:92 MISCELLANEOUS AUTONOMIC DRUGS NICOTINE 1 Chewing gum 2 mg PPB 02091933 Nicorette McNeil Co 80000396 Thrive N.C.H.C. 100 105 36 108 Chewing gum McNeil Co 80000402 Thrive N.C.H.C. 100 105 36 108 Past. Or. N.C.H.C. 36 108 N.C.H.C. 36 108 9.15 21.77 0.2542 0.2016 10.40 28.47 0.2889 0.2636 7 mg/24 h PPB 01943057 Habitrol 02093111 Nicoderm N.C.H.C. McNeil Co 7 7 Patch 18.75 18.75 2.6786 2.6786 14 mg/24 h PPB 01943065 Habitrol 02093138 Nicoderm N.C.H.C. McNeil Co 7 7 Patch 18.75 18.75 2.6786 2.6786 21 mg/24 h PPB 01943073 Habitrol 02093146 Nicoderm Page 0.2965 0.2965 0.2889 0.2636 2 mg Patch 1 29.65 31.13 10.40 28.47 1 mg Past. Or. 80007464 Thrive 0.2579 0.2579 0.2542 0.2016 4 mg PPB 02091941 Nicorette 80007461 Thrive 25.79 27.08 9.15 21.77 N.C.H.C. McNeil Co 7 7 14 18.75 18.75 47.32 2.6786 2.6786 3.3800 The duration of reimbursements for stop-smoking treatments with various nicotine preparations is limited to 12 consecutive weeks per 12-month period. In addition, the total quantity of chewing gum or lozenges for which the cost is reimbursable during the 12 weeks is limited to 840 units, all forms combined. 62 2013-04 CODE BRAND NAME MANUFACTURER SIZE VARENICLINE TARTRATE 7 X Tab. 02291177 Champix COST OF PKG. SIZE UNIT PRICE 0.5 mg Pfizer Tab. 56 96.15 1.7170 0.5 mg (11 tab.) and 1 mg (14 tab.) 02298309 Champix (Starter pack) Pfizer 25 02291185 Champix Pfizer 28 Tab. 42.93 1 mg 7 2013-04 48.08 1.7171 The duration of reimbursements for varenicline stop-smoking treatments is initially limited to a total of 12 consecutive weeks per 12-month period. A 12-week extension will be authorized for persons having stopped smoking on the 12th week. The duration of reimbursements is then limited to a total of 24 consecutive weeks per 12 month period. Page 63 20:00 BLOOD FORMATION AND COAGULATION 20:04 20:04.04 20:12 20:12.04 20:12.14 20:12.18 20:28 20:28.16 antianémique iron preparations antithrombotic agents anticoagulants Platelet‑reducing Agents platelet‑aggregation inhibitors antihemorrhagic agents hemostatics CODE BRAND NAME MANUFACTURER COST OF PKG. SIZE SIZE UNIT PRICE 20:04.04 IRON PREPARATIONS FERROUS SULFATE Ped. Oral Sol. 00762954 02237385 80008309 02232202 02222574 Fer-in-Sol Ferodan Jamp-Ferrous Sulfate Pediafer pms-Ferrous Sulfate 75 mg/mL(Fe-15mg/mL) PPB M.J. Odan Jamp Euro-Pharm Phmscience Syr. or Oral Sol. 50 ml 50 ml 50 ml 50 ml 50 ml 9.27 9.27 9.70 9.27 9.27 150 mg/5 mL(Fe-30 mg/5 mL) PPB 00017884 Fer-in-Sol 00758469 Ferodan M.J. Odan 80008295 Jamp-Ferrous Sulfate 02242863 Pediafer Sirop 00792675 pms-Ferrous Sulfate Jamp Euro-Pharm Phmscience 01912518 02246733 02248699 00031100 00586323 Apotex Euro-Pharm Odan Jamp Phmscience Tab. 250 ml 250 ml 500 ml 250 ml 250 ml 250 ml 500 ml 12.61 6.80 13.60 6.80 6.80 6.80 13.60 0.0504 0.0272 0.0272 0.0272 0.0272 0.0272 0.0272 300 mg to 325 mg (Fe-60 mg to 65 mg) PPB Apo-Ferrous Sulfate Euro-Ferrous Sulfate Ferodan Jamp-Ferrous Sulfate pms-Ferrous Sulfate 1000 1000 1000 1000 100 1000 FERUMOXYTOL X I.V. Inj. Sol. 02377217 Feraheme Takeda Janss. Inc 1 10 2013-04 241.33 24.1330 50 mg/mL PPB Mylan Sandoz IRON SUCROSE I.V. Inj. Sol. 02243716 Venofer 187.50 12.5 mg (Ir)/mL (5 mL) IRON DEXTRAN Inj. Sol. 02205963 Dexiron 02221780 Infufer 0.0163 0.0157 0.0157 0.0157 0.0207 0.0157 30 mg/mL IRON (FERRIC GLUCONATE/ SUCROSE COMPLEX) X I.V. Inj. Sol. 02243333 Ferrlecit 33.39 15.71 15.71 15.71 2.07 15.71 2 ml 2 ml 27.50 27.50 20 mg (Fe)/mL (5 mL) Mylan 10 375.00 37.5000 Page 67 CODE BRAND NAME MANUFACTURER SIZE COST OF PKG. SIZE UNIT PRICE 20:12.04 ANTICOAGULANTS DALTEPARINE SODIC X Inj. Sol. 02377454 Fragmin 2 500 UI/mL (4 mL) Pfizer 10 159.29 Pfizer 3.8 ml Inj. Sol. 02231171 Fragmin 25 000 U/mL S.C. Inj. Sol. 02132664 Fragmin Pfizer 1 ml Pfizer 1 5.04 5 000 UI/0.2 mL Pfizer 1 Pfizer 1 10.09 S.C. Inj.Sol (syr) 02352648 Fragmin 7 500 UI/0.3 ml S.C. Inj.Sol (syr) 02352656 Fragmin Pfizer 1 Pfizer 1 25.22 15 000 UI/0.6 mL Pfizer 1 Pfizer 1 S.C. Inj.Sol (syr) 02352680 Fragmin 20.18 12 500 UI/0.5 mL S.C. Inj.Sol (syr) 02352672 Fragmin 15.13 10 000 UI/0.4 mL S.C. Inj.Sol (syr) 02352664 Fragmin Page 68 36.32 100 mg/mL SanofiAven 3 ml S.C. Inj.Sol (syr) 02012472 Lovenox 30.26 18 000 UI/0.72 mL ENOXAPARIN X S.C. Inj. Sol. 02236564 Lovenox 15.93 2 500 UI/0.2 mL S.C. Inj.Sol (syr) 02132648 Fragmin 151.32 10 000 UI/mL S.C. Inj.Sol (syr) 02132621 Fragmin 15.9290 62.51 30 mg/ 0.3 mL SanofiAven 1 6.29 2013-04 CODE BRAND NAME MANUFACTURER SIZE S.C. Inj.Sol (syr) 02236883 Lovenox SanofiAven 1 SanofiAven 1 SanofiAven 1 SanofiAven 1 SanofiAven 1 SanofiAven 1 GSK 1 GSK 1 Leo 10 ml Leo 10 ml Leo 5 ml 2013-04 5.01 10 000 UI/mL Inj. Sol. 00453781 Heparine 4.26 1 000 U/mL Inj. Sol. 00579718 Heparine Leo 25.00 100 U/mL Inj. Sol. 00453811 Heparine 14.82 7.5 mg/0.6 mL HEPARIN (SODIUM) Inj. Sol. 00727520 Heparine Leo 31.24 2.5 mg/0.5 mL S.C. Inj.Sol (syr) 02258056 Arixtra 24.99 150 mg/1.0 mL FONDAPARINUX X S.C. Inj.Sol (syr) 02245531 Arixtra 20.83 120 mg/0.8 mL S.C. Inj.Sol (syr) 02378469 Lovenox HP 16.66 100 mg/1.0 mL S.C. Inj.Sol (syr) 99004941 Lovenox HP 12.50 80 mg/0.8 mL S.C. Inj.Sol (syr) 02378442 Lovenox 8.33 60 mg/0.6 mL S.C. Inj.Sol (syr) 02378434 Lovenox UNIT PRICE 40 mg/0.4 mL S.C. Inj.Sol (syr) 02378426 Lovenox COST OF PKG. SIZE 12.47 25 000 U/mL Leo 2 ml 15.57 Page 69 CODE BRAND NAME MANUFACTURER SIZE NADROPARINE CALCIUM X S.C. Inj.Sol (syr) 99002698 Fraxiparine GSK 1 GSK 1 GSK 1 GSK 1 GSK 1 GSK 1 GSK 1 GSK 1 18.12 1 mg Paladin 100 Tab. 27.33 0.2733 4 mg 00010391 Sintrom Paladin 100 Merck 10 SODIUM DANAPAROID X Inj. Sol. 02129043 Orgaran 02167840 Innohep 70 85.91 0.8591 750 U/0.6 mL TINZAPARIN SODIUM X S.C. Inj. Sol. Page 18.12 19 000 U/1.0 mL NICOUMALONE X Tab. 00010383 Sintrom 18.12 15 200 U/0.8 mL S.C. Inj.Sol (syr) 02240114 Fraxiparine Forte 9.06 11 400 U/0.6 mL S.C. Inj.Sol (syr) 99003317 Fraxiparine Forte 9.06 9 500 U/1.0 mL S.C. Inj.Sol (syr) 99003309 Fraxiparine Forte 9.06 7 600 U/0.8 mL S.C. Inj.Sol (syr) 99002736 Fraxiparine 9.06 5 700 U/0.6 mL S.C. Inj.Sol (syr) 99002728 Fraxiparine 9.06 3 800 U/0.4 mL S.C. Inj.Sol (syr) 99002744 Fraxiparine UNIT PRICE 2 850 U/0.3 mL S.C. Inj.Sol (syr) 99002701 Fraxiparine COST OF PKG. SIZE 190.81 19.0810 10 000 UI/mL Leo 2 ml 33.43 2013-04 CODE BRAND NAME MANUFACTURER SIZE S.C. Inj. Sol. 02229515 Innohep Leo 2 ml Leo 2 10 Leo 2 10 Leo 2 10 Leo 2 10 Leo 2 10 15.16 75.80 Leo 2 10 33.54 167.70 48.20 241.00 7.5800 7.5800 16.7700 16.7700 24.1000 24.1000 18 000 UI/0.9 mL WARFARIN (SODIUM) X Tab. 61.97 309.85 30.9850 30.9850 1 mg PPB 02242924 Apo-Warfarin Apotex 01918311 Coumadin B.M.S. 02244462 Mylan-Warfarin Mylan 02265273 Novo-Warfarin Novopharm 02242680 Taro-Warfarin Taro 02344025 Warfarin Sanis 2013-04 5.9000 5.9000 14 000 UI/ 0.7 mL S.C. Inj.Sol (syr) 02358182 Innohep 11.80 59.00 10 000 UI/ 0.5 mL S.C. Inj.Sol (syr) 02358174 Innohep 4.2150 4.2150 4 500 UI/0.45 mL S.C. Inj.Sol (syr) 02231478 Innohep 8.43 42.15 3 500 UI/0.35 mL S.C. Inj.Sol (syr) 02358166 Innohep 67.90 2 500 UI/0.25 mL S.C. Inj.Sol (syr) 02358158 Innohep UNIT PRICE 20 000 UI/mL S.C. Inj.Sol (syr) 02229755 Innohep COST OF PKG. SIZE 100 500 100 1000 100 1000 100 250 100 250 100 7.96 39.78 7.96 79.55 7.96 79.55 7.96 19.89 7.96 19.89 7.96 0.0796 0.0796 0.0796 0.0796 0.0796 0.0796 0.0796 0.0796 0.0796 0.0796 0.0796 Page 71 CODE BRAND NAME MANUFACTURER SIZE Tab. UNIT PRICE 2 mg PPB 02242925 Apo-Warfarin Apotex 01918338 Coumadin B.M.S. 02244463 Mylan-Warfarin Mylan 02242681 Taro-Warfarin Taro 02344033 Warfarin Sanis 02242926 Apo-Warfarin Apotex 01918346 Coumadin B.M.S. 02244464 Mylan-Warfarin Mylan 02242682 Taro-Warfarin Taro 02344041 Warfarin Sanis 02245618 Apo-Warfarin 02240205 Coumadin Apotex B.M.S. 02287498 Mylan-Warfarin 02242683 Taro-Warfarin 02344068 Warfarin Mylan Taro Sanis 02242927 Apo-Warfarin Apotex 02007959 Coumadin B.M.S. 02244465 Mylan-Warfarin 02242684 Taro-Warfarin Mylan Taro 02344076 Warfarin Sanis 100 500 100 250 100 1000 100 250 100 Tab. 8.41 42.05 8.41 21.03 8.41 84.10 8.41 21.03 8.41 0.0841 0.0841 0.0841 0.0841 0.0841 0.0841 0.0841 0.0841 0.0841 2.5 mg PPB 100 500 100 250 100 1000 100 250 100 Tab. 6.74 33.68 6.74 16.84 6.74 67.35 6.74 16.84 6.74 0.0674 0.0674 0.0674 0.0674 0.0674 0.0674 0.0674 0.0674 0.0674 3 mg PPB 100 100 250 100 100 100 Tab. Page COST OF PKG. SIZE 10.43 10.43 31.15 10.43 10.43 10.43 0.1043 0.1043 0.1246 0.1043 0.1043 0.1043 4 mg PPB 72 100 500 100 250 100 100 250 100 10.43 52.15 10.43 26.08 10.43 10.43 26.08 10.43 0.1043 0.1043 0.1043 0.1043 0.1043 0.1043 0.1043 0.1043 2013-04 CODE BRAND NAME MANUFACTURER SIZE Tab. COST OF PKG. SIZE UNIT PRICE 5 mg PPB 02242928 Apo-Warfarin Apotex 01918354 Coumadin B.M.S. 02244466 Mylan-Warfarin Mylan 02265346 Novo-Warfarin Novopharm 02242685 Taro-Warfarin Taro 02344084 Warfarin Sanis 100 500 100 250 100 1000 100 250 100 250 100 Tab. 6.75 33.74 6.75 16.87 6.75 67.48 6.75 16.87 6.75 16.87 6.75 0.0675 0.0675 0.0675 0.0675 0.0675 0.0675 0.0675 0.0675 0.0675 0.0675 0.0675 6 mg PPB 02240206 02287501 02242686 02344092 Coumadin Mylan-Warfarin Taro-Warfarin Warfarin B.M.S. Mylan Taro Sanis 100 100 100 100 Tab. 22.25 22.25 22.25 22.25 0.2225 0.2225 0.2225 0.2225 7.5 mg PPB 02287528 Mylan-Warfarin 02242697 Taro-Warfarin 02344106 Warfarin Mylan Taro Sanis 100 100 100 Tab. 30.14 30.14 30.14 0.3014 0.3014 0.3014 10 mg PPB 02242929 01918362 02244467 02242687 02344114 Apo-Warfarin Coumadin Mylan-Warfarin Taro-Warfarin Warfarin Apotex B.M.S. Mylan Taro Sanis 100 100 100 100 100 Shire Mylan Phmscience Sandoz 100 100 100 100 12.11 12.11 12.11 12.11 12.11 0.1211 0.1211 0.1211 0.1211 0.1211 20:12.14 PLATELET-REDUCING AGENTS ANAGRELIDE HYDROCHLORIDE X Caps. 02236859 02253054 02274949 02260107 2013-04 Agrylin Mylan-Anagrelide pms-Anagrelide Sandoz Anagrelide 0.5 mg PPB 528.30 263.61 263.61 263.61 5.2830 2.6361 2.6361 2.6361 Page 73 CODE BRAND NAME MANUFACTURER SIZE COST OF PKG. SIZE UNIT PRICE 20:12.18 PLATELET-AGGREGATION INHIBITORS TICLOPIDIN HYDROCHLORIDE X Tab. 250 mg PPB 02237701 Apo-Ticlopidine 02239744 Mylan-Ticlopidine 02236848 Novo-Ticlopidine Apotex Mylan Novopharm 02243587 Sandoz Ticlopidine 02343045 Ticlopidine Sandoz Sanis 100 100 28 100 100 100 31.41 31.41 8.80 31.41 31.41 31.43 0.3141 0.3141 0.3143 0.3141 0.3141 0.3143 20:28.16 HEMOSTATICS TRANEXAMIC ACID X Tab. 02064405 Cyklokapron Page 74 500 mg Pfizer 100 102.48 1.0248 2013-04 24:00 CARDIAC DRUGS 24:04 24:04.04 24:04.08 24:06 24:06.04 24:06.06 24:06.08 24:06.92 24:08 24:08.16 24:08.20 24:12 24:12.08 24:12.92 24:20 24:24 24:28 24:28.08 24:28.92 24:32 24:32.04 24:32.08 24:32.20 cardiac drugs Antiarrhythmic Agents cardiotonic agents antilipemic agents bile acid sequestrants fibric acid derivatives HMG‑CoA reductase inhibitors miscellaneous antilipemic agents hypotensive agents central alpha‑agonists direct vasodilators vasodilating agents nitrates and nitrites miscellaneous vasodilating agents alpha‑adrenergics blocking agents bêta‑adrenergics blocking agents calcium‑channel blocking agents dihydropyridines miscellaneous calcium‑channel blocking agents renin‑angiotensin system inhibitors angiotensin‑converting enzyme inhibitors (ACEI) angiotensin II receptor antagonists aldosterone receptor antagonists CODE BRAND NAME MANUFACTURER SIZE COST OF PKG. SIZE UNIT PRICE 24:04.04 ANTIARRHYTHMIC AGENTS AMIODARONE HYDROCHLORIDE X Tab. 100 mg 02292173 pms-Amiodarone Phmscience 100 02364336 02385465 02300893 02246194 02036282 02240604 02245781 02242472 02309661 02240071 02247217 02243836 02239835 Sanis Sivem Sorres Apotex Pfizer Mylan Pharmel Phmscience Pro Doc Ratiopharm Riva Sandoz Teva Can 100 100 100 100 100 100 100 100 100 100 100 100 100 SanofiAven 84 Tab. 67.76 0.6776 200 mg PPB Amiodarone Amiodarone Amiodarone Apo-Amiodarone Cordarone Mylan-Amiodarone phl-Amiodarone pms-Amiodarone Pro-Amiodarone-200 ratio-Amiodarone Riva-Amiodarone Sandoz Amiodarone Teva-Amiodarone DISOPYRAMIDE X Caps. 02224801 Rythmodan 51.47 51.47 51.47 51.47 205.89 51.47 51.47 51.47 51.47 51.47 51.47 51.47 51.47 0.5147 0.5147 0.5147 0.5147 2.0589 0.5147 0.5147 0.5147 0.5147 0.5147 0.5147 0.5147 0.5147 100 mg Caps. 18.93 0.2254 150 mg 02224828 Rythmodan SanofiAven 84 AA Pharma Med Pharma 100 100 FLECAINIDE ACETATE X Tab. 02275538 Flecainide 01966197 Tambocor 27.47 0.3270 50 mg PPB Tab. 39.56 51.68 0.3101 0.5168 100 mg PPB 02275546 Flecainide 01966200 Tambocor AA Pharma Med Pharma 100 100 Novopharm 100 MEXILETINE HYDROCHLORIDE X Caps. 02230359 Novo-Mexiletine 79.12 103.37 0.6203 1.0337 100 mg Caps. 81.62 0.8162 200 mg 02230360 Novo-Mexiletine 2013-04 Novopharm 100 109.30 1.0930 Page 77 CODE BRAND NAME MANUFACTURER SIZE PROCAINAMIDE HYDROCHLORIDE X L.A. Tab. 00638692 Procan SR COST OF PKG. SIZE UNIT PRICE 250 mg Erfa 100 Erfa 100 L.A. Tab. 15.80 0.1580 500 mg 00638676 Procan SR L.A. Tab. 31.60 0.3160 750 mg 00638684 Procan SR Erfa 100 PROPAFENONE HYDROCHLORIDE X Tab. 47.40 0.4740 150 mg PPB 02243324 02245372 02294559 02343053 02243783 00603708 Apo-Propafenone Mylan-Propafenone pms-Propafenone Propafenone Propafenone-150 Rythmol Apotex Mylan Phmscience Sanis Pro Doc Abbott 100 100 100 100 100 100 02243325 02245373 02294575 02343061 02243784 00603716 Apo-Propafenone Mylan-Propafenone pms-Propafenone Propafenone Propafenone-300 Rythmol Apotex Mylan Phmscience Sanis Pro Doc Abbott 100 100 100 100 100 100 Pendopharm 115 ml Tab. 29.66 29.66 29.66 29.66 29.66 94.10 0.2966 0.2966 0.2966 0.2966 0.2966 0.9410 300 mg PPB 52.28 52.28 52.28 52.28 52.28 165.86 0.5228 0.5228 0.5228 0.5228 0.5228 1.6586 24:04.08 CARDIOTONIC AGENTS DIGOXIN X Oral Sol. 02242320 Toloxin 0.05 mg/mL Tab. 0.3419 0.0625 mg 02335700 Toloxin Pendopharm 250 02335719 Toloxin Pendopharm 250 Tab. 51.61 0.2064 0.125 mg Tab. 51.61 0.2064 0.25 mg 02335727 Toloxin Page 39.32 78 Pendopharm 250 51.61 0.2064 2013-04 CODE BRAND NAME MANUFACTURER SIZE MILRINONE LACTATE X I.V. Inj. Sol. 02244622 Milrinone Lactate Injection COST OF PKG. SIZE UNIT PRICE 1 mg/mL PPC 10 ml 20 ml 46.80 93.60 24:06.04 BILE ACID SEQUESTRANTS CHOLESTYRAMIN RESIN X Oral Pd. 02210320 Olestyr 00890960 Olestyr sugar free 4 g/sac. Pendopharm Pendopharm 30 30 COLESTIPOL HYDROCHLORIDE X Oral Pd. 39.50 39.50 1.3167 1.3167 5 g/sac. 00642975 Colestid 02132699 Colestid Orange Pfizer Pfizer 30 30 25.85 25.85 02132680 Colestid Pfizer 120 29.49 Tab. 0.8617 0.8617 1g 0.2458 24:06.06 FIBRIC ACID DERIVATIVES BEZAFIBRATE X L.A. Tab. 02083523 Bezalip S.R. 2013-04 400 mg Tribute 30 53.20 1.6583 Page 79 CODE BRAND NAME MANUFACTURER SIZE COST OF PKG. SIZE UNIT PRICE FENOFIBRATE (NANOCRYSTALIZED OR MICROCOATED OR MICRONIZED) X Caps. or Tab. 145 mg or 160 mg or 200 mg PPB 02239864 Apo-Feno-Micro (200 mg) Apotex Sandoz 30 100 30 100 100 30 100 30 30 30 30 100 30 100 30 100 30 100 30 100 100 30 100 30 100 90 02246860 Apo-Feno-Super (160 mg) Apotex 02286092 Fenofibrate Micro (200 mg) 02240360 Feno-Micro-200 Sanis Pro Doc 02269082 02146959 02241602 02240210 Lipidil EZ (145 mg) Lipidil Micro (200 mg) Lipidil Supra (160 mg) Mylan-Fenofibrate Micro (200 mg) 02243552 Novo-Fenofibrate Micronise (200 mg) 02289091 Novo-Fenofibrate-S (160 mg) 02352389 NTP-Fenofibrate-S (160 mg) Fournier Fournier Fournier Mylan 02273551 pms-Fenofibrate Micro (200 mg) 02310236 Pro-Feno-Super-160 02250039 ratio-Fenofibrate MC (200 mg) 02247306 Riva-Fenofibrate Micro (200 mg) 02288052 Sandoz Fenofibrate S (160 mg) Phmscience Fournier 30 Novopharm Novopharm NT Pharma Pro Doc Ratiopharm Riva FENOFIBRATE (NANOCRYSTALLIZED) X Tab. 02269074 Lipidil EZ 12.56 0.4187 300 mg PPB 01979574 Apo-Gemfibrozil Apotex 02185407 Mylan-Gemfibrozil 02241704 Novo-Gemfibrozil 02239951 pms-Gemfibrozil Mylan Novopharm Phmscience 80 0.2723 0.2723 0.2723 0.2723 0.2723 0.2723 0.2723 1.0720 1.0890 1.2423 0.2723 0.2723 0.2723 0.2723 0.2723 0.2723 0.2723 0.2723 0.2723 0.2723 0.2723 0.2723 0.2723 0.2723 0.2723 0.2723 48 mg GEMFIBROZIL X Caps. Page 8.17 27.23 8.17 27.23 27.23 8.17 27.23 32.16 32.67 37.27 8.17 27.23 8.17 27.23 8.17 27.23 8.17 27.23 8.17 27.23 27.23 8.17 27.23 8.17 27.23 24.51 100 500 100 100 100 13.40 66.98 13.40 13.40 13.40 0.1340 0.1340 0.1340 0.1340 0.1340 2013-04 CODE BRAND NAME MANUFACTURER SIZE Tab. COST OF PKG. SIZE UNIT PRICE 600 mg PPB 01979582 Apo-Gemfibrozil Apotex 02136058 02230476 02142074 02230183 02242126 Pro Doc Mylan Novopharm Phmscience Riva Gemfibrozil-600 Mylan-Gemfibrozil Novo-Gemfibrozil pms-Gemfibrozil Riva-Gemfibrozil 100 500 100 100 100 100 100 250 MICROCOATED FENOFIBRATE X Tab. Apotex 02241601 02289083 02352370 02310228 02288044 Fournier Novopharm NT Pharma Pro Doc Sandoz 30 100 30 30 30 100 90 Apotex Novopharm 100 100 MICRONIZED FENOFIBRATE X Caps. 02243180 Apo-Feno-Micro 02243551 Novo-Fenofibrate Micronise 2013-04 0.5355 0.5352 0.5355 0.5355 0.5355 0.5355 0.5355 0.5352 100 mg PPB 02246859 Apo-Feno-Super Lipidil Supra Novo-Fenofibrate-S NTP-Fenofibrate-S Pro-Feno-Super-100 Sandoz Fenofibrate S 53.55 267.60 53.55 53.55 53.55 53.55 53.55 133.80 17.01 56.70 32.34 17.01 17.01 56.70 51.03 0.5670 0.5670 1.0780 0.5670 0.5670 0.5670 0.5670 67 mg PPB 43.25 43.25 0.4325 0.4325 Page 81 CODE BRAND NAME MANUFACTURER SIZE COST OF PKG. SIZE UNIT PRICE 24:06.08 HMG-COA REDUCTASE INHIBITORS ATORVASTATINE CALCIUM X Tab. 10 mg PPB 02295261 Apo-Atorvastatin Apotex 02346486 Atorvastatin Pro Doc 02348705 Atorvastatin 02387891 Atorvastatin Sanis Sivem 02310899 Co Atorvastatin Cobalt 02391058 Jamp-Atorvastatin Jamp 02230711 Lipitor 02373203 Mylan-Atorvastatin Pfizer Mylan 02302675 Novo-Atorvastatin Teva Can 02313448 pms-Atorvastatin Phmscience 02313707 Ran-Atorvastatin Ranbaxy 02350297 ratio-Atorvastatin Ratiopharm 02324946 Sandoz Atorvastatin Sandoz 02295288 Apo-Atorvastatin Apotex 02346494 Atorvastatin Pro Doc 02348713 Atorvastatin 02387905 Atorvastatin Sanis Sivem 02310902 Co Atorvastatin Cobalt 02391066 Jamp-Atorvastatin Jamp 02230713 Lipitor 02373211 Mylan-Atorvastatin Pfizer Mylan 02302683 Novo-Atorvastatin Teva Can 02313456 pms-Atorvastatin Phmscience 02313715 Ran-Atorvastatin Ranbaxy 02350319 ratio-Atorvastatin Ratiopharm 02324954 Sandoz Atorvastatin Sandoz 90 500 100 500 500 30 500 90 500 90 500 90 90 500 30 500 90 500 90 500 30 500 30 500 Tab. Page 37.44 208.00 41.60 208.00 208.00 12.48 208.00 37.44 208.00 37.44 208.00 155.69 37.44 208.00 12.48 208.00 37.44 208.00 37.44 208.00 12.48 208.00 12.48 208.00 0.4160 0.4160 0.4160 0.4160 0.4160 0.4160 0.4160 0.4160 0.4160 0.4160 0.4160 1.7299 0.4160 0.4160 0.4160 0.4160 0.4160 0.4160 0.4160 0.4160 0.4160 0.4160 0.4160 0.4160 20 mg PPB 82 90 500 100 500 500 30 500 90 500 90 500 90 90 500 30 500 90 500 90 500 30 500 30 500 46.80 260.00 52.00 260.00 260.00 15.60 260.00 46.80 260.00 46.80 260.00 194.62 46.80 260.00 15.60 260.00 46.80 260.00 46.80 260.00 15.60 260.00 15.60 260.00 0.5200 0.5200 0.5200 0.5200 0.5200 0.5200 0.5200 0.5200 0.5200 0.5200 0.5200 2.1624 0.5200 0.5200 0.5200 0.5200 0.5200 0.5200 0.5200 0.5200 0.5200 0.5200 0.5200 0.5200 2013-04 CODE BRAND NAME MANUFACTURER SIZE Tab. COST OF PKG. SIZE UNIT PRICE 40 mg PPB 02295296 Apo-Atorvastatin Apotex 02346508 Atorvastatin Pro Doc 02348721 Atorvastatin 02387913 Atorvastatin Sanis Sivem 02310910 Co Atorvastatin Cobalt 02391074 Jamp-Atorvastatin Jamp 02230714 Lipitor 02373238 Mylan-Atorvastatin Pfizer Mylan 02302691 Novo-Atorvastatin Teva Can 02313464 pms-Atorvastatin Phmscience 02313723 Ran-Atorvastatin Ranbaxy 02350327 ratio-Atorvastatin Ratiopharm 02324962 Sandoz Atorvastatin Sandoz 02295318 Apo-Atorvastatin Apotex 02346516 Atorvastatin Pro Doc 02348748 Atorvastatin Sanis 02387921 Atorvastatin Sivem 02310929 Co Atorvastatin 02391082 Jamp-Atorvastatin Cobalt Jamp 02243097 Lipitor 02373246 Mylan-Atorvastatin 02302713 Novo-Atorvastatin Pfizer Mylan Teva Can 02313472 pms-Atorvastatin Phmscience 02313758 Ran-Atorvastatin Ranbaxy 02350335 ratio-Atorvastatin Ratiopharm 02324970 Sandoz Atorvastatin Sandoz 90 500 100 500 500 30 500 90 500 90 500 90 90 500 30 500 90 500 90 500 30 500 30 500 Tab. 50.31 279.50 55.90 279.50 279.50 16.77 279.50 50.31 279.50 50.31 279.50 209.22 50.31 279.50 16.77 279.50 50.31 279.50 50.31 279.50 16.77 279.50 16.77 279.50 0.5590 0.5590 0.5590 0.5590 0.5590 0.5590 0.5590 0.5590 0.5590 0.5590 0.5590 2.3247 0.5590 0.5590 0.5590 0.5590 0.5590 0.5590 0.5590 0.5590 0.5590 0.5590 0.5590 0.5590 80 mg PPB 2013-04 90 500 30 100 90 500 30 100 90 90 500 30 90 30 500 90 500 90 500 30 100 30 100 50.31 279.50 16.77 55.90 50.31 279.50 16.77 55.90 50.31 50.31 279.50 69.74 50.31 16.77 279.50 50.31 279.50 50.31 279.50 16.77 55.90 16.77 55.90 0.5590 0.5590 0.5590 0.5590 0.5590 0.5590 0.5590 0.5590 0.5590 0.5590 0.5590 2.3247 0.5590 0.5590 0.5590 0.5590 0.5590 0.5590 0.5590 0.5590 0.5590 0.5590 0.5590 Page 83 CODE BRAND NAME MANUFACTURER SIZE FLUVASTATINE SODIUM X Caps. * 02061562 Lescol + 02299224 Teva Fluvastatin UNIT PRICE 20 mg PPB Novartis Teva Can 100 100 Caps. 84.47 50.68 0.8447 0.5068 40 mg PPB * 02061570 Lescol + 02299232 Teva Fluvastatin Novartis Teva Can 100 100 L.A. Tab. 02250527 Lescol XL Novartis 28 02220172 Apo-Lovastatin Apotex 02248572 Co Lovastatin Cobalt 02353229 Lovastatin Sanis 00795860 Mevacor 02243127 Mylan-Lovastatin Merck Mylan 02246542 Novo-Lovastatin Novopharm 02246989 phl-Lovastatin Pharmel 02246013 pms-Lovastatine Phmscience 02312670 Pro-Lovastatin Pro Doc 02245822 ratio-Lovastatin Ratiopharm 02272288 Riva-Lovastatin 02247056 Sandoz Lovastatin Riva Sandoz 100 500 30 500 100 500 30 100 500 100 500 100 500 30 100 30 100 100 500 100 100 84 118.25 70.95 1.1825 0.7095 80 mg LOVASTATINE X Tab. Page COST OF PKG. SIZE 40.01 1.4289 20 mg PPB 49.19 245.94 14.76 245.94 49.19 245.94 57.33 49.19 245.94 49.19 245.94 49.19 245.94 14.76 49.19 14.76 49.19 49.19 245.94 49.19 49.19 0.4919 0.4919 0.4919 0.4919 0.4919 0.4919 1.9110 0.4919 0.4919 0.4919 0.4919 0.4919 0.4919 0.4919 0.4919 0.4919 0.4919 0.4919 0.4919 0.4919 0.4919 2013-04 CODE BRAND NAME MANUFACTURER SIZE Tab. COST OF PKG. SIZE UNIT PRICE 40 mg PPB 02220180 Apo-Lovastatin 02248573 Co Lovastatin Apotex Cobalt 02353237 00795852 02243129 02246543 02246990 Lovastatin Mevacor Mylan-Lovastatin Novo-Lovastatin phl-Lovastatin Sanis Merck Mylan Novopharm Pharmel 02246014 pms-Lovastatine Phmscience 02312689 Pro-Lovastatin Pro Doc 02245823 ratio-Lovastatin 02272296 Riva-Lovastatin 02247057 Sandoz Lovastatin Ratiopharm Riva Sandoz 100 30 100 100 30 100 100 30 100 30 100 30 100 100 100 100 PRAVASTATINE SODIUM X Tab. 0.8985 0.8987 0.8985 0.8985 3.5253 0.8985 0.8985 0.8987 0.8985 0.8987 0.8985 0.8987 0.8985 0.8985 0.8985 0.8985 10 mg PPB 02243506 Apo-Pravastatin Apotex 02248182 Co Pravastatin Cobalt 02330954 Jamp-Pravastatin Jamp 02317451 Mint-Pravastatin Mint 02257092 Mylan-Pravastatin Mylan 02247008 Novo-Pravastatin Novopharm 02247655 pms-Pravastatin Phmscience 00893749 Pravachol 02249766 Pravastatin B.M.S. MeliaPharm 02356546 Pravastatin Sanis 02389703 Pravastatin Sivem 02301792 Pravastatin 02243824 Pravastatin-10 Sorres Pro Doc 02284421 Ran-Pravastatin Ranbaxy 02270234 Riva-Pravastatin Riva 02247856 Sandoz Pravastatin Sandoz 2013-04 89.85 26.96 89.85 89.85 105.76 89.85 89.85 26.96 89.85 26.96 89.85 26.96 89.85 89.85 89.85 89.85 30 100 30 100 30 100 30 100 30 100 30 100 30 100 90 30 100 30 100 30 100 100 30 100 30 100 30 100 30 100 12.15 40.50 12.15 40.50 12.15 40.50 12.15 40.50 12.15 40.50 12.15 40.50 12.15 40.50 36.45 12.15 40.50 12.15 40.50 12.15 40.50 40.50 12.15 40.50 12.15 40.50 12.15 40.50 12.15 40.50 0.4050 0.4050 0.4050 0.4050 0.4050 0.4050 0.4050 0.4050 0.4050 0.4050 0.4050 0.4050 0.4050 0.4050 W 0.4050 0.4050 0.4050 0.4050 0.4050 0.4050 0.4050 0.4050 0.4050 0.4050 0.4050 0.4050 0.4050 0.4050 0.4050 Page 85 CODE BRAND NAME MANUFACTURER SIZE Tab. Page COST OF PKG. SIZE UNIT PRICE 20 mg PPB 02243507 Apo-Pravastatin Apotex 02248183 Co Pravastatin Cobalt 02330962 Jamp-Pravastatin Jamp 02317478 Mint-Pravastatin Mint 02257106 Mylan-Pravastatin Mylan 02247009 Novo-Pravastatin Novopharm 02247656 pms-Pravastatin Phmscience 00893757 Pravachol 02249774 Pravastatin 02356554 Pravastatin B.M.S. MeliaPharm Sanis 02389738 Pravastatin Sivem 02301806 Pravastatin 02243825 Pravastatin-20 Sorres Pro Doc 02284448 Ran-Pravastatin Ranbaxy 02270242 Riva-Pravastatin Riva 02247857 Sandoz Pravastatin Sandoz 86 30 500 30 100 30 100 30 100 30 500 30 100 30 100 90 30 30 100 30 100 100 30 100 30 100 30 100 30 100 14.33 238.85 14.33 47.77 14.33 47.77 14.33 47.77 14.33 238.85 14.33 47.77 14.33 47.77 42.99 14.33 14.33 47.77 14.33 47.77 47.77 14.33 47.77 14.33 47.77 14.33 47.77 14.33 47.77 0.4777 0.4777 0.4777 0.4777 0.4777 0.4777 0.4777 0.4777 0.4777 0.4777 0.4777 0.4777 0.4777 0.4777 0.4777 0.4777 0.4777 0.4777 0.4777 0.4777 0.4777 0.4777 0.4777 0.4777 0.4777 0.4777 0.4777 0.4777 0.4777 2013-04 CODE BRAND NAME MANUFACTURER SIZE Tab. COST OF PKG. SIZE UNIT PRICE 40 mg PPB 02243508 Apo-Pravastatin Apotex 02248184 Co Pravastatin Cobalt 02330970 Jamp-Pravastatin Jamp 02317486 Mint-Pravastatin Mint 02257114 Mylan-Pravastatin Mylan 02247010 Novo-Pravastatin Novopharm 02247657 pms-Pravastatin Phmscience 02222051 Pravachol 02249782 Pravastatin B.M.S. MeliaPharm 02356562 Pravastatin Sanis 02389746 Pravastatin Sivem 02301814 Pravastatin 02243826 Pravastatin-40 Sorres Pro Doc 02284456 Ran-Pravastatin Ranbaxy 02270250 Riva-Pravastatin Riva 02247858 Sandoz Pravastatin Sandoz 2013-04 30 100 30 100 30 100 30 100 30 100 30 100 30 100 90 30 100 30 100 30 100 100 30 100 30 100 30 100 30 100 17.27 57.55 17.27 57.55 17.27 57.55 17.27 57.55 17.27 57.55 17.27 57.55 17.27 57.55 51.80 17.27 57.55 17.27 57.55 17.27 57.55 57.55 17.27 57.55 17.27 57.55 17.27 57.55 17.27 57.55 0.5755 0.5755 0.5755 0.5755 0.5755 0.5755 0.5755 0.5755 0.5755 0.5755 0.5755 0.5755 0.5755 0.5755 0.5755 0.5755 0.5755 0.5755 0.5755 0.5755 0.5755 0.5755 0.5755 0.5755 0.5755 0.5755 0.5755 0.5755 0.5755 0.5755 Page 87 CODE BRAND NAME MANUFACTURER SIZE ROSUVASTATIN CALCIUM X Tab. UNIT PRICE 5 mg PPB 02337975 Apo-Rosuvastatin Apotex 02339765 Co Rosuvastatin Cobalt 02265540 Crestor 02391252 Jamp-Rosuvastatin AZC Jamp 02381265 Mylan-Rosuvastatin Mylan 02378523 pms-Rosuvastatin Phmscience 02382644 Ran-Rosuvastatin Ranbaxy 02380013 Riva-Rosuvastatin Riva 02381176 Rosuvastatin Pro Doc 02389037 Rosuvastatin Sivem 02338726 Sandoz Rosuvastatin Sandoz 02354608 Teva Rosuvastatin Teva Can 30 500 30 500 30 100 500 30 500 30 500 100 500 30 500 30 500 30 100 30 500 30 500 Tab. Page COST OF PKG. SIZE 9.68 161.25 9.68 161.25 38.70 32.25 161.25 9.68 161.25 9.68 161.25 32.25 161.25 9.68 161.25 9.68 161.25 9.68 32.25 9.68 161.25 9.68 161.25 0.3225 0.3225 0.3225 0.3225 1.2900 0.3225 0.3225 0.3225 0.3225 0.3225 0.3225 0.3225 0.3225 0.3225 0.3225 0.3225 0.3225 0.3225 0.3225 0.3225 0.3225 0.3225 0.3225 10 mg PPB 02337983 Apo-Rosuvastatin Apotex 02339773 Co Rosuvastatin Cobalt 02247162 Crestor 02391260 Jamp-Rosuvastatin AZC Jamp 02381273 Mylan-Rosuvastatin Mylan 02378531 pms-Rosuvastatin Phmscience 02382652 Ran-Rosuvastatin Ranbaxy 02380056 Riva-Rosuvastatin Riva 02381184 Rosuvastatin Pro Doc 02389045 Rosuvastatin Sivem 02338734 Sandoz Rosuvastatin Sandoz 02354616 Teva Rosuvastatin Teva Can 88 30 500 30 500 30 100 500 30 500 30 500 100 500 30 500 30 500 30 100 30 500 30 500 10.20 170.00 10.20 170.00 40.80 34.00 170.00 10.20 170.00 10.20 170.00 34.00 170.00 10.20 170.00 10.20 170.00 10.20 34.00 10.20 170.00 10.20 170.00 0.3400 0.3400 0.3400 0.3400 1.3600 0.3400 0.3400 0.3400 0.3400 0.3400 0.3400 0.3400 0.3400 0.3400 0.3400 0.3400 0.3400 0.3400 0.3400 0.3400 0.3400 0.3400 0.3400 2013-04 CODE BRAND NAME MANUFACTURER SIZE Tab. COST OF PKG. SIZE UNIT PRICE 20 mg PPB 02337991 Apo-Rosuvastatin Apotex 02339781 Co Rosuvastatin Cobalt 02247163 Crestor 02391279 Jamp-Rosuvastatin AZC Jamp 02381281 Mylan-Rosuvastatin Mylan 02378558 pms-Rosuvastatin Phmscience 02382660 Ran-Rosuvastatin Ranbaxy 02380064 Riva-Rosuvastatin Riva 02381192 Rosuvastatin Pro Doc 02389053 Rosuvastatin Sivem 02338742 Sandoz Rosuvastatin Sandoz 02354624 Teva Rosuvastatin Teva Can 02338009 Apo-Rosuvastatin Apotex 02339803 Co Rosuvastatin Cobalt 02247164 Crestor 02391287 Jamp-Rosuvastatin AZC Jamp 02381303 Mylan-Rosuvastatin Mylan 02378566 pms-Rosuvastatin Phmscience 02382679 Ran-Rosuvastatin Ranbaxy 02380102 Riva-Rosuvastatin Riva 02381206 Rosuvastatin Pro Doc 02389061 Rosuvastatin Sivem 02338750 Sandoz Rosuvastatin Sandoz 02354632 Teva Rosuvastatin Teva Can 30 500 30 500 30 100 500 30 500 30 500 100 500 30 500 30 500 30 100 30 500 30 500 Tab. 12.75 212.50 12.75 212.50 51.00 42.50 212.50 12.75 212.50 12.75 212.50 42.50 212.50 12.75 212.50 12.75 212.50 12.75 42.50 12.75 212.50 12.75 212.50 0.4250 0.4250 0.4250 0.4250 1.7000 0.4250 0.4250 0.4250 0.4250 0.4250 0.4250 0.4250 0.4250 0.4250 0.4250 0.4250 0.4250 0.4250 0.4250 0.4250 0.4250 0.4250 0.4250 40 mg PPB 2013-04 30 500 30 500 30 100 500 30 100 30 500 100 500 30 500 30 500 30 100 30 100 30 500 14.93 248.75 14.93 248.75 59.70 49.75 248.75 14.93 49.75 14.93 248.75 49.75 248.75 14.93 248.75 14.93 248.75 14.93 49.75 14.93 49.75 14.93 248.75 0.4975 0.4975 0.4975 0.4975 1.9900 0.4975 0.4975 0.4975 0.4975 0.4975 0.4975 0.4975 0.4975 0.4975 0.4975 0.4975 0.4975 0.4975 0.4975 0.4975 0.4975 0.4975 0.4975 Page 89 CODE BRAND NAME MANUFACTURER SIZE SIMVASTATIN X Tab. 02247011 02248103 02331020 02375591 02375036 02372932 02246582 02281546 Page Apo-Simvastatin Co Simvastatin Jamp-Simvastatin Jamp-Simvastatin Mar-Simvastatin Mint-Simvastatin Mylan-Simvastatin phl-Simvastatin Apotex Cobalt Jamp Jamp Marcan Mint Mylan Pharmel Phmscience 02329131 Ran-Simvastatin 02247297 Riva-Simvastatin Ranbaxy Riva 02343142 02284723 02386291 02378884 MeliaPharm Sanis Sivem Odan 02250144 Teva-Simvastatin Teva Can 00884324 Zocor 02300907 Zym-Simvastatin Merck Zymcan 90 UNIT PRICE 5 mg PPB 02269252 pms-Simvastatin Simvastatin Simvastatin Simvastatin Simvastatin-Odan COST OF PKG. SIZE 100 100 100 100 100 100 100 30 100 30 100 100 30 100 100 100 100 30 100 30 100 28 100 25.57 25.57 25.57 25.57 25.57 25.57 25.57 7.67 25.57 7.67 25.57 25.57 7.67 25.57 25.57 25.57 25.57 7.67 25.57 7.67 25.57 27.81 25.57 0.2557 0.2557 0.2557 0.2557 0.2557 0.2557 0.2557 0.2557 0.2557 0.2557 0.2557 0.2557 0.2557 0.2557 0.2557 0.2557 0.2557 0.2557 0.2557 0.2557 0.2557 0.9932 0.2557 2013-04 CODE BRAND NAME MANUFACTURER SIZE Tab. COST OF PKG. SIZE UNIT PRICE 10 mg PPB 02247012 Apo-Simvastatin Apotex 02248104 Co Simvastatin Cobalt 02331039 Jamp-Simvastatin 02375605 Jamp-Simvastatin Jamp Jamp 02375044 Mar-Simvastatin Marcan 02372940 Mint-Simvastatin 02246583 Mylan-Simvastatin Mint Mylan 02250152 Novo-Simvastatin Novopharm 02281554 phl-Simvastatin Pharmel 02269260 pms-Simvastatin Phmscience 02329158 Ran-Simvastatin Ranbaxy 02247298 Riva-Simvastatin Riva 02247828 Sandoz Simvastatin Sandoz 02343150 Simvastatin 02284731 Simvastatin 02386305 Simvastatin MeliaPharm Sanis Sivem 02247221 Simvastatin-10 Pro Doc 02378892 Simvastatin-Odan Odan 02265885 Taro-Simvastatin 00884332 Zocor 02300915 Zym-Simvastatin Taro Merck Zymcan 2013-04 30 500 30 500 100 30 100 100 500 100 30 100 30 500 30 100 30 100 100 500 30 500 30 100 100 100 30 100 30 500 30 500 100 28 100 15.17 252.85 15.17 252.85 50.57 15.17 50.57 50.57 252.85 50.57 15.17 50.57 15.17 252.85 15.17 50.57 15.17 50.57 50.57 252.85 15.17 252.85 15.17 50.57 50.57 50.57 15.17 50.57 15.17 252.85 15.17 252.85 50.57 54.41 50.57 0.5057 0.5057 0.5057 0.5057 0.5057 0.5057 0.5057 0.5057 0.5057 0.5057 0.5057 0.5057 0.5057 0.5057 0.5057 0.5057 0.5057 0.5057 0.5057 0.5057 0.5057 0.5057 0.5057 0.5057 0.5057 0.5057 0.5057 0.5057 0.5057 0.5057 0.5057 0.5057 0.5057 1.9432 0.5057 Page 91 CODE BRAND NAME MANUFACTURER SIZE Tab. Page COST OF PKG. SIZE UNIT PRICE 20 mg PPB 02247013 Apo-Simvastatin Apotex 02248105 Co Simvastatin Cobalt 02331047 Jamp-Simvastatin 02375613 Jamp-Simvastatin Jamp Jamp 02375052 Mar-Simvastatin Marcan 02372959 Mint-Simvastatin 02246737 Mylan-Simvastatin Mint Mylan 02250160 Novo-Simvastatin Novopharm 02281562 phl-Simvastatin Pharmel 02269279 pms-Simvastatin Phmscience 02329166 Ran-Simvastatin Ranbaxy 02247299 Riva-Simvastatin Riva 02247830 Sandoz Simvastatin Sandoz 02343169 Simvastatin 02284758 Simvastatin MeliaPharm Sanis 02386313 Simvastatin Sivem 02247222 Simvastatin-20 Pro Doc 02378906 Simvastatin-Odan Odan 02265893 Taro-Simvastatin 00884340 Zocor 02300923 Zym-Simvastatin Taro Merck Zymcan 92 30 500 30 500 100 30 100 100 500 100 30 100 30 100 30 100 30 100 100 500 30 500 30 100 100 100 500 30 100 30 500 30 500 100 28 100 18.75 312.50 18.75 312.50 62.50 18.75 62.50 62.50 312.50 62.50 18.75 62.50 18.75 62.50 18.75 62.50 18.75 62.50 62.50 312.50 18.75 312.50 18.75 62.50 62.50 62.50 312.50 18.75 62.50 18.75 312.50 18.75 312.50 62.50 67.71 62.50 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 2.4182 0.6250 2013-04 CODE BRAND NAME MANUFACTURER SIZE Tab. COST OF PKG. SIZE UNIT PRICE 40 mg PPB 02247014 Apo-Simvastatin Apotex 02248106 Co Simvastatin Cobalt 02331055 Jamp-Simvastatin 02375621 Jamp-Simvastatin Jamp Jamp 02375060 Mar-Simvastatin 02372967 Mint-Simvastatin 02246584 Mylan-Simvastatin Marcan Mint Mylan 02281570 phl-Simvastatin Pharmel 02269287 pms-Simvastatin Phmscience 02329174 Ran-Simvastatin Ranbaxy 02247300 Riva-Simvastatin Riva 02247831 Sandoz Simvastatin Sandoz 02343177 Simvastatin 02284766 Simvastatin 02386321 Simvastatin MeliaPharm Sanis Sivem 02247223 Simvastatin-40 Pro Doc 02378914 Simvastatin-Odan Odan 02265907 Taro-Simvastatin 02250179 Teva-Simvastatin Taro Teva Can 00884359 Zocor 02300931 Zym-Simvastatin Merck Zymcan 2013-04 30 100 30 500 100 30 100 100 100 30 100 30 100 30 100 100 500 30 100 30 100 100 100 30 100 30 100 30 100 100 30 100 28 100 18.75 62.50 18.75 312.50 62.50 18.75 62.50 62.50 62.50 18.75 62.50 18.75 62.50 18.75 62.50 62.50 312.50 18.75 62.50 18.75 62.50 62.50 62.50 18.75 62.50 18.75 62.50 18.75 62.50 62.50 18.75 62.50 67.71 62.50 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 2.4182 0.6250 Page 93 CODE BRAND NAME MANUFACTURER SIZE Tab. COST OF PKG. SIZE UNIT PRICE 80 mg PPB 02247015 Apo-Simvastatin Apotex 02248107 Co Simvastatin Cobalt 02331063 02375648 02375079 02372975 02246585 02281589 Jamp Jamp Marcan Mint Mylan Pharmel Jamp-Simvastatin Jamp-Simvastatin Mar-Simvastatin Mint-Simvastatin Mylan-Simvastatin phl-Simvastatin 02269295 pms-Simvastatin Phmscience 02329182 Ran-Simvastatin 02247301 Riva-Simvastatin Ranbaxy Riva 02247833 Sandoz Simvastatin Sandoz 02343185 Simvastatin 02247224 Simvastatin MeliaPharm Pro Doc 02284774 Simvastatin 02386348 Simvastatin Sanis Sivem 02378922 Simvastatin-Odan Odan 02250187 Teva-Simvastatin Teva Can 02240332 Zocor 02300974 Zym-Simvastatin Merck Zymcan 30 100 30 100 100 100 100 100 100 30 100 30 100 100 30 100 30 100 100 30 100 100 30 100 30 100 30 100 28 100 18.75 62.50 18.75 62.50 62.50 62.50 62.50 62.50 62.50 18.75 62.50 18.75 62.50 62.50 18.75 62.50 18.75 62.50 62.50 18.75 62.50 62.50 18.75 62.50 18.75 62.50 18.75 62.50 67.71 62.50 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 0.6250 2.4182 0.6250 24:06.92 MISCELLANEOUS ANTILIPEMIC AGENTS NIACIN X L.A. Tab. 02309254 Niaspan FCT 500 mg Sunovion 90 Sunovion 90 L.A. Tab. 02309262 Niaspan FCT 1.1000 750 mg L.A. Tab. 02309289 Niaspan FCT 99.00 99.00 1.1000 1000 mg Sunovion 90 99.00 1.1000 NIACIN Tab. 100 mg 00268585 Niacine-ICN Page 94 Valeant 500 12.00 0.0240 2013-04 CODE BRAND NAME MANUFACTURER SIZE Tab. COST OF PKG. SIZE UNIT PRICE 500 mg PPB 00557412 Jamp-Niacin 01939130 Niacine 00294950 Niacine-ICN Jamp Odan Valeant 100 100 500 4.62 7.95 22.78 0.0462 0.0459 0.0456 24:08.16 CENTRAL ALPHA-AGONISTS CLONIDINE HYDROCHLORIDE X Tab. 0.1 mg PPB 00259527 Catapres 01910396 Clonidine 0.1 Bo. Ing. Pro Doc 02046121 Novo-Clonidine Novopharm 100 100 500 100 Tab. 18.53 13.58 67.90 13.58 0.1853 0.1358 0.1358 0.1358 0.2 mg PPB 00868957 00291889 01908162 02046148 Apo-Clonidine Catapres Clonidine 0.2 Novo-Clonidine Apotex Bo. Ing. Pro Doc Novopharm 100 100 100 100 METHYLDOPA X Tab. 24.24 33.06 24.24 24.24 0.2424 0.3306 0.2424 0.2424 125 mg 00360252 Methyldopa AA Pharma 100 00360260 Methyldopa AA Pharma 100 1000 00426830 Methyldopa AA Pharma 100 Tab. 9.89 0.0989 250 mg Tab. 14.33 143.30 0.1433 0.1433 500 mg 25.38 0.2538 24:08.20 DIRECT VASODILATORS DIAZOXIDE X Caps. 00503347 Proglycem 100 mg Merck 100 HYDRALAZINE HYDROCHLORIDE X Tab. 161.41 1.6141 10 mg 00441619 Apo-Hydralazine AA Pharma 100 00441627 Apo-Hydralazine AA Pharma 100 Tab. 13.47 0.1347 25 mg 2013-04 23.14 0.2314 Page 95 CODE BRAND NAME MANUFACTURER COST OF PKG. SIZE SIZE MINOXIDIL X Tab. UNIT PRICE 2.5 mg 00514497 Loniten Pfizer 100 00514500 Loniten Pfizer 100 33.30 Tab. 0.3330 10 mg 73.42 0.7342 24:12.08 NITRATES AND NITRITES GLYCERYL TRINITRATE Patch 0.2 mg/h PPB 02162806 01911910 00584223 02230732 Minitran Nitro-Dur Transderm-Nitro Trinipatch Med Pharma Key Novartis Paladin 30 30 30 30 Patch 17.00 17.00 18.77 17.00 0.4 mg/h PPB 02163527 01911902 00852384 02230733 Minitran Nitro-Dur Transderm-Nitro Trinipatch Med Pharma Key Novartis Paladin 30 30 30 30 Patch 19.20 19.20 21.20 19.20 0.6400 0.6400 0.7067 0.6400 0.6 mg/h PPB 02163535 01911929 02046156 02230734 Minitran Nitro-Dur Transderm-Nitro Trinipatch Med Pharma Key Novartis Paladin 30 30 30 30 Key 30 19.20 19.20 21.20 19.20 Patch 0.6400 0.6400 0.7067 0.6400 0.8 mg/h 02011271 Nitro-Dur S.-Ling. Spray 02393433 02243588 02231441 02238998 Apo-Nitroglycerin Mylan-Nitro SL Spray Nitrolingual Pompe Rho-Nitro 01926454 Nitrol 96 33.30 1.1100 0.4 mg PPB Apotex Mylan SanofiAven Sandoz 200 dose(s) 200 dose(s) 200 dose(s) 200 dose(s) Top. Oint. Page 0.5667 0.5667 0.6257 0.5667 8.46 8.46 13.37 8.46 0.0361 0.0361 0.0361 2% Paladin 30 g 60 g 7.93 17.19 2013-04 CODE BRAND NAME MANUFACTURER SIZE GLYCERYL TRINITRATE (STABILIZED) S-Ling. Tab. 00037613 Nitrostat Pfizer 100 Pfizer 100 AA Pharma 100 2.81 0.6 mg ISOSORBIDE DINITRATE S-Ling. Tab. 00670944 Apo-Isdn UNIT PRICE 0.3 mg S-Ling. Tab. 00037621 Nitrostat COST OF PKG. SIZE 2.93 5 mg Tab. 6.21 0.0621 10 mg 00441686 Apo-Isdn AA Pharma 100 1000 00441694 Isdn AA Pharma 100 Tab. 3.65 36.50 0.0365 0.0365 30 mg ISOSORBIDE-5-MONONITRATE X L.A. Tab. 8.57 0.0857 60 mg PPB 02272830 Apo-ISMN 02126559 Imdur Apotex AZC 02301288 pms-ISMN Phmscience 02311321 Pro-ISMN-60 Pro Doc 100 30 100 30 100 100 35.23 20.55 68.50 10.57 35.23 35.23 0.3523 0.6850 0.6850 0.3523 0.3523 0.3523 24:12.92 MISCELLANEOUS VASODILATING AGENTS DIPYRIDAMOLE X Tab. 00895644 Apo-Dipyridamole-FC 25 mg Apotex 100 Tab. 26.33 0.1466 50 mg PPB 00895652 Apo-Dipyridamole-FC 00067393 Persantine Apotex Bo. Ing. 100 100 Tab. 29.32 38.79 0.2328 0.3879 75 mg PPB 00895660 Apo-Dipyridamole-FC 00452092 Persantine 2013-04 Apotex Bo. Ing. 100 100 43.98 52.24 0.3135 0.5224 Page 97 CODE BRAND NAME MANUFACTURER SIZE COST OF PKG. SIZE UNIT PRICE 24:20 ALPHA-ADRENERGICS BLOCKING AGENTS DOXAZOSIN MESYLATE X Tab. 1 mg PPB 02240588 01958100 02240498 02242728 02244527 Apo-Doxazosin Cardura-1 Mylan-Doxazosin Novo-Doxazosin pms-Doxazosin Apotex Pfizer Mylan Novopharm Phmscience 100 100 100 100 100 02240589 01958097 02240499 02242729 02244528 Apo-Doxazosin Cardura-2 Mylan-Doxazosin Novo-Doxazosin pms-Doxazosin Apotex Pfizer Mylan Novopharm Phmscience 100 100 100 100 100 Tab. 0.1417 0.5737 0.1417 0.1417 0.1417 2 mg PPB Tab. 16.99 68.81 16.99 16.99 16.99 0.1699 0.6881 0.1699 0.1699 0.1699 4 mg PPB 02240590 01958119 02240500 02242730 02244529 Apo-Doxazosin Cardura-4 Mylan-Doxazosin Novo-Doxazosin pms-Doxazosin Apotex Pfizer Mylan Novopharm Phmscience 100 100 100 100 100 PRAZOSIN HYDROCHLORIDE X Tab. 00882801 Apo-Prazo 01934198 Novo-Prazin 22.09 89.47 22.09 22.09 22.09 0.2209 0.8947 0.2209 0.2209 0.2209 1 mg PPB Apotex Novopharm 100 100 Tab. 13.71 13.71 0.1371 0.1371 2 mg PPB 00882828 Apo-Prazo 01934201 Novo-Prazin Apotex Novopharm 100 100 00882836 Apo-Prazo 01934228 Novo-Prazin Apotex Novopharm 100 100 Tab. 18.62 18.62 0.1862 0.1862 5 mg PPB TERAZOSIN HYDROCHLORIDE X Kit 02187876 Hytrin Page 14.17 57.37 14.17 14.17 14.17 98 25.60 25.60 0.2560 0.2560 1 mg, 2 mg, 5 mg Abbott 1 22.20 2013-04 CODE BRAND NAME MANUFACTURER SIZE Tab. COST OF PKG. SIZE UNIT PRICE 1 mg PPB 02234502 Apo-Terazosin Apotex 00818658 02396289 02246544 02243518 02218941 02350475 02230805 Abbott Mylan Pharmel Phmscience Ratiopharm Sanis Teva Can Hytrin Mylan-Terazosin phl-Terazosin pms-Terazosin ratio-Terazosin Terazosin Teva-Terazosin 100 500 100 100 100 100 100 100 100 Tab. 18.36 91.77 61.18 18.36 18.36 18.36 18.36 18.36 18.36 0.1836 0.1835 0.6118 0.1836 0.1836 0.1836 0.1836 0.1836 0.1836 2 mg PPB 02234503 Apo-Terazosin Apotex 00818682 02396297 02246545 02243519 02218968 02350483 02237477 02230806 Abbott Mylan Pharmel Phmscience Ratiopharm Sanis Pro Doc Teva Can Hytrin Mylan-Terazosin phl-Terazosin pms-Terazosin ratio-Terazosin Terazosin Terazosin-2 Teva-Terazosin 100 500 100 100 100 100 100 100 100 100 Tab. 23.33 116.64 77.76 23.33 23.33 23.33 23.33 23.33 23.33 23.33 0.2333 0.2333 0.7776 0.2333 0.2333 0.2333 0.2333 0.2333 0.2333 0.2333 5 mg PPB 02234504 Apo-Terazosin Apotex 00818666 02396300 02246546 02243520 02218976 02350491 02237478 02230807 Abbott Mylan Pharmel Phmscience Ratiopharm Sanis Pro Doc Teva Can Hytrin Mylan-Terazosin phl-Terazosin pms-Terazosin ratio-Terazosin Terazosin Terazosin-5 Teva-Terazosin 100 500 100 100 100 100 100 100 100 100 Tab. 31.68 158.40 105.61 31.68 31.68 31.68 31.68 31.68 31.68 31.68 0.3168 0.3168 1.0561 0.3168 0.3168 0.3168 0.3168 0.3168 0.3168 0.3168 10 mg PPB 02234505 00818674 02396319 02246547 02243521 02218984 02350505 02230808 2013-04 Apo-Terazosin Hytrin Mylan-Terazosin phl-Terazosin pms-Terazosin ratio-Terazosin Terazosin Teva-Terazosin Apotex Abbott Mylan Pharmel Phmscience Ratiopharm Sanis Teva Can 100 100 100 100 100 100 100 100 46.38 154.60 46.38 46.38 46.38 46.38 46.38 46.38 0.4638 1.5460 0.4638 0.4638 0.4638 0.4638 0.4638 0.4638 Page 99 CODE BRAND NAME MANUFACTURER SIZE COST OF PKG. SIZE UNIT PRICE 24:24 BÊTA-ADRENERGICS BLOCKING AGENTS ACEBUTOL HYDROCHLORIDE X Tab. 100 mg PPB 02286246 Acebutolol 02164396 Acebutolol-100 Sanis Pro Doc 02147602 Apo-Acebutolol Apotex 02237721 Mylan-Acebutolol Mylan 02237885 Mylan-Acebutolol S Mylan 02204517 Novo-Acebutolol 01910140 Rhotral Novopharm SanofiAven 01926543 Sectral SanofiAven 100 100 500 100 500 100 500 100 500 100 100 500 100 Tab. 0.0787 0.0787 0.0787 0.0787 0.0787 0.0787 0.0787 0.0787 0.0787 0.0787 0.0787 0.0787 0.3002 200 mg PPB 02286254 Acebutolol 02164418 Acebutolol-200 Sanis Pro Doc 02147610 Apo-Acebutolol Apotex 02237722 Mylan-Acebutolol Mylan 02237886 Mylan-Acebutolol S Mylan 02204525 Novo-Acebutolol 01910159 Rhotral Novopharm SanofiAven 01926551 Sectral SanofiAven 02286262 Acebutolol 02164426 Acebutolol-400 Sanis Pro Doc 02147629 Apo-Acebutolol Apotex 02237723 02237887 02204533 01910167 Mylan Mylan Novopharm SanofiAven 100 100 500 100 500 100 500 100 500 100 100 500 100 Tab. 11.77 11.77 58.85 11.77 58.85 11.77 58.85 11.77 58.85 11.77 11.77 58.85 45.02 0.1177 0.1177 0.1177 0.1177 0.1177 0.1177 0.1177 0.1177 0.1177 0.1177 0.1177 0.1177 0.4502 400 mg PPB Mylan-Acebutolol Mylan-Acebutolol S Novo-Acebutolol Rhotral 01926578 Sectral Page 7.87 7.87 39.33 7.87 39.33 7.87 39.33 7.87 39.33 7.87 7.87 39.33 30.02 100 SanofiAven 100 100 500 100 500 100 100 100 100 500 100 24.66 24.66 123.28 24.66 123.28 24.66 24.66 24.66 24.66 123.28 89.61 0.2466 0.2466 0.2466 0.2466 0.2466 0.2466 0.2466 0.2466 0.2466 0.2466 0.8961 2013-04 CODE BRAND NAME MANUFACTURER SIZE ATENOLOL X Tab. COST OF PKG. SIZE UNIT PRICE 25 mg PPB 02351331 Atenolol 02326701 Atenolol MeliaPharm Pro Doc 02247182 02367556 02371979 02368013 02303647 Sivem Jamp Marcan Mint Mylan Atenolol Jamp-Atenolol Mar-Atenolol Mint-Atenol Mylan-Atenolol 02246581 pms-Atenolol Phmscience 02373963 Ran-Atenolol 02277379 Riva-Atenolol Ranbaxy Riva 02368633 Septa-Atenolol 02266660 Teva-Atenol Septa Teva Can 100 100 500 100 100 100 100 30 100 100 500 100 100 500 100 100 Tab. 9.46 9.46 54.05 9.46 9.46 9.46 9.46 2.84 10.81 9.46 54.05 9.46 9.46 54.05 9.46 9.46 0.0946 0.0946 0.1081 0.0946 0.0946 0.0946 0.0946 0.0946 0.1081 0.0946 0.1081 0.0946 0.0946 0.1081 0.0946 0.0946 50 mg PPB 00773689 Apo-Atenol Apotex 02351358 Atenolol MeliaPharm 02238316 Atenolol Sivem 00828807 Atenolol-50 Pro Doc 02255545 Co Atenolol Cobalt 02367564 Jamp-Atenolol Jamp 02371987 Mar-Atenolol Marcan 02368021 Mint-Atenol Mint 02146894 Mylan-Atenolol Mylan 02237600 pms-Atenolol Phmscience 02267985 Ran-Atenolol Ranbaxy 02171791 ratio-Atenolol Ratiopharm 02242094 Riva-Atenolol Riva 02231731 Sandoz Atenolol Sandoz 02368641 Septa-Atenolol Septa 02039532 Tenormin 01912062 Teva-Atenol AZC Teva Can 2013-04 100 500 30 500 30 500 100 500 30 500 30 100 30 500 30 500 30 500 30 500 30 500 30 500 30 500 30 500 30 500 30 30 500 14.37 71.83 4.31 71.83 4.31 71.83 14.37 71.83 4.31 71.83 4.31 14.37 4.31 71.83 4.31 71.83 4.31 71.83 4.31 71.83 4.31 71.83 4.31 71.83 4.31 71.83 4.31 71.83 4.31 71.83 17.91 4.31 71.83 0.1437 0.1437 0.1437 0.1437 0.1437 0.1437 0.1437 0.1437 0.1437 0.1437 0.1437 0.1437 0.1437 0.1437 0.1437 0.1437 0.1437 0.1437 0.1437 0.1437 0.1437 0.1437 0.1437 0.1437 0.1437 0.1437 0.1437 0.1437 0.1437 0.1437 0.5970 0.1437 0.1437 Page 101 CODE BRAND NAME MANUFACTURER SIZE Tab. UNIT PRICE 100 mg PPB 00773697 Apo-Atenol Apotex 02351366 Atenolol MeliaPharm 02238318 Atenolol Sivem 00828793 Atenolol-100 Pro Doc 02255553 Co Atenolol Cobalt 02367572 Jamp-Atenolol Jamp 02371995 Mar-Atenolol Marcan 02368048 Mint-Atenol Mint 02147432 Mylan-Atenolol Mylan 02237601 pms-Atenolol Phmscience 02267993 Ran-Atenolol Ranbaxy 02171805 ratio-Atenolol Ratiopharm 02242093 Riva-Atenolol Riva 02231733 Sandoz Atenolol Sandoz 02368668 Septa-Atenolol Septa 02039540 Tenormin 01912054 Teva-Atenol AZC Teva Can 100 500 30 500 30 100 100 500 30 500 30 100 30 500 30 100 30 500 30 500 30 500 30 500 30 500 30 500 30 500 30 30 500 BISOPROLOL FUMARATE X Tab. 02256134 02391589 02383055 02321556 02384418 02267470 02308339 02302632 02306999 02247439 Page COST OF PKG. SIZE 102 Apo-Bisoprolol Bisoprolol Bisoprolol Bisoprolol Mylan-Bisoprolol Novo-Bisoprolol phl-Bisoprolol pms-Bisoprolol Pro-Bisoprolol-5 Sandoz Bisoprolol 23.62 118.08 7.09 118.08 7.09 23.62 23.62 118.08 7.09 118.08 7.09 23.62 7.09 118.08 7.09 23.62 7.09 118.08 7.09 118.08 7.09 118.08 7.09 118.08 7.09 118.08 7.09 118.08 7.09 118.08 29.44 7.09 118.08 0.2362 0.2362 0.2362 0.2362 0.2362 0.2362 0.2362 0.2362 0.2362 0.2362 0.2362 0.2362 0.2362 0.2362 0.2362 0.2362 0.2362 0.2362 0.2362 0.2362 0.2362 0.2362 0.2362 0.2362 0.2362 0.2362 0.2362 0.2362 0.2362 0.2362 0.9813 0.2362 0.2362 5 mg PPB Apotex Sanis Sivem Sorres Mylan Novopharm Pharmel Phmscience Pro Doc Sandoz 100 100 100 100 100 100 100 100 100 100 9.94 9.94 9.94 9.94 9.94 9.94 9.94 9.94 9.94 9.94 0.0994 0.0994 0.0994 0.0994 0.0994 0.0994 0.0994 0.0994 0.0994 0.0994 2013-04 CODE BRAND NAME MANUFACTURER SIZE Tab. COST OF PKG. SIZE UNIT PRICE 10 mg PPB 02256177 02391597 02383063 02321572 02384426 02267489 02308347 02302640 02307006 02247440 Apo-Bisoprolol Bisoprolol Bisoprolol Bisoprolol Mylan-Bisoprolol Novo-Bisoprolol phl-Bisoprolol pms-Bisoprolol Pro-Bisoprolol-10 Sandoz Bisoprolol Apotex Sanis Sivem Sorres Mylan Novopharm Pharmel Phmscience Pro Doc Sandoz 100 100 100 100 100 100 100 100 100 100 Apotex MeliaPharm Pro Doc Sanis Sivem Jamp Mylan Phmscience Ranbaxy Ratiopharm Zymcan 100 100 100 100 100 100 100 100 100 100 100 CARVEDILOL X Tab. 02247933 02344637 02324504 02364913 02248752 02368897 02347512 02245914 02268027 02252309 02338068 Apo-Carvedilol Carvedilol Carvedilol Carvedilol Carvedilol Jamp-Carvedilol Mylan-Carvedilol pms-Carvedilol Ran-Carvedilol ratio-Carvedilol Zym-Carvedilol 14.50 14.50 14.50 14.50 14.50 14.50 14.50 14.50 14.50 14.50 0.1450 0.1450 0.1450 0.1450 0.1450 0.1450 0.1450 0.1450 0.1450 0.1450 3.125 mg PPB Tab. 33.77 33.77 33.77 33.77 33.77 33.77 33.77 33.77 33.77 33.77 33.77 0.3377 0.3377 0.3377 0.3377 0.3377 0.3377 0.3377 0.3377 0.3377 0.3377 0.3377 6.25 mg PPB 02247934 02344645 02324512 02364921 02248753 02368900 02347520 02245915 02268035 02252317 02338092 Apo-Carvedilol Carvedilol Carvedilol Carvedilol Carvedilol Jamp-Carvedilol Mylan-Carvedilol pms-Carvedilol Ran-Carvedilol ratio-Carvedilol Zym-Carvedilol Apotex MeliaPharm Pro Doc Sanis Sivem Jamp Mylan Phmscience Ranbaxy Ratiopharm Zymcan 100 100 100 100 100 100 100 100 100 100 100 Tab. 33.77 33.77 33.77 33.77 33.77 33.77 33.77 33.77 33.77 33.77 33.77 0.3377 0.3377 0.3377 0.3377 0.3377 0.3377 0.3377 0.3377 0.3377 0.3377 0.3377 12.5 mg PPB 02247935 02344653 02324520 02364948 02248754 02368919 02347555 02245916 02268043 02252325 02338106 2013-04 Apo-Carvedilol Carvedilol Carvedilol Carvedilol Carvedilol Jamp-Carvedilol Mylan-Carvedilol pms-Carvedilol Ran-Carvedilol ratio-Carvedilol Zym-Carvedilol Apotex MeliaPharm Pro Doc Sanis Sivem Jamp Mylan Phmscience Ranbaxy Ratiopharm Zymcan 100 100 100 100 100 100 100 100 100 100 100 33.77 33.77 33.77 33.77 33.77 33.77 33.77 33.77 33.77 33.77 33.77 0.3377 0.3377 0.3377 0.3377 0.3377 0.3377 0.3377 0.3377 0.3377 0.3377 0.3377 Page 103 CODE BRAND NAME MANUFACTURER SIZE Tab. UNIT PRICE 25 mg PPB 02247936 02344661 02324539 02364956 02248755 02368927 02347571 02245917 02268051 02252333 02338114 Apo-Carvedilol Carvedilol Carvedilol Carvedilol Carvedilol Jamp-Carvedilol Mylan-Carvedilol pms-Carvedilol Ran-Carvedilol ratio-Carvedilol Zym-Carvedilol Apotex MeliaPharm Pro Doc Sanis Sivem Jamp Mylan Phmscience Ranbaxy Ratiopharm Zymcan 100 100 100 100 100 100 100 100 100 100 100 Paladin 100 LABETALOL (HYDROCHLORIDE) X Tab. 02106272 Trandate 33.77 33.77 33.77 33.77 33.77 33.77 33.77 33.77 33.77 33.77 33.77 0.3377 0.3377 0.3377 0.3377 0.3377 0.3377 0.3377 0.3377 0.3377 0.3377 0.3377 100 mg Tab. 26.00 0.2600 200 mg 02106280 Trandate Page COST OF PKG. SIZE 104 Paladin 100 45.95 0.4595 2013-04 CODE BRAND NAME MANUFACTURER METOPROLOL TARTRATE X Co. or Co. L.A. COST OF PKG. SIZE UNIT PRICE 50 mg /100 mg L.A. PPB 00618632 Apo-Metoprolol 50 mg Apotex 00749354 Apo-Metoprolol L 50 mg Apotex 02285169 Apo-Metoprolol SR 02356821 Jamp-Metoprolol-L Apotex Jamp 00397423 Lopresor 50 mg Novartis 00658855 Lopresor SR 100 mg Novartis 02350394 Metoprolol 50 mg Sanis 02351404 Metoprolol SR 00648019 Metoprolol-50 Pro Doc Pro Doc 02253518 Metoprolol-L MeliaPharm 02315114 Metoprolol-L 02174545 Mylan-Metoprolol (Type L) Sorres Mylan 02347024 NTP-Metoprolol 50 mg NT Pharma 02230803 pms-Metoprolol-L Phmscience 02315319 Riva-Metoprolol-L Riva 02354187 Sandoz Metoprolol L 50 Sandoz 02303396 Sandoz Metoprolol SR 100 00648035 Teva-Metoprolol Sandoz Teva Can 00842648 Teva-Metoprolol Teva Can 2013-04 SIZE 100 1000 100 1000 100 100 500 100 500 100 250 100 500 100 100 1000 100 1000 100 100 1000 100 500 100 500 100 1000 100 500 100 100 500 100 500 6.24 62.38 6.24 62.38 12.48 6.24 31.19 22.71 106.82 26.52 66.28 6.24 31.19 12.48 6.24 62.38 6.24 62.38 6.24 6.24 62.38 6.24 31.19 6.24 31.19 6.24 62.38 6.24 31.19 12.48 6.24 31.19 6.24 31.19 0.0624 0.0624 0.0624 0.0624 0.1248 0.0624 0.0624 0.2271 0.2136 0.2652 0.2651 0.0624 0.0624 0.1248 0.0624 0.0624 0.0624 0.0624 0.0624 0.0624 0.0624 0.0624 0.0624 0.0624 0.0624 0.0624 0.0624 0.0624 0.0624 0.1248 0.0624 0.0624 0.0624 0.0624 Page 105 CODE BRAND NAME MANUFACTURER Co. or Co. L.A. SIZE UNIT PRICE 100 mg / 200 mg L.A. PPB 00618640 Apo-Metoprolol 100 mg Apotex 00751170 Apo-Metoprolol L 100 mg Apotex 02285177 Apo-Metoprolol SR 02356848 Jamp-Metoprolol-L Apotex Jamp 00397431 Lopresor 100 mg 00534560 Lopresor SR 200 mg Novartis Novartis 02350408 Metoprolol 100 mg Sanis 02351412 Metoprolol SR 00648027 Metoprolol-100 Pro Doc Pro Doc 02253526 Metoprolol-L MeliaPharm 02315122 Metoprolol-L 02174553 Mylan-Metoprolol (Type L) Sorres Mylan 00842656 Novo-Metoprol B 100 mg Novopharm 02347032 NTP-Metoprolol 100 mg NT Pharma 02230804 pms-Metoprolol-L Phmscience 02315327 Riva-Metoprolol-L Riva 02354195 Sandoz Metoprolol L 100 Sandoz 02303418 Sandoz Metoprolol SR 200 00648043 Teva-Metoprolol Sandoz Teva Can 02246010 Apo-Metoprolol Apotex 02356813 Jamp-Metoprolol-L Jamp 02296713 Metoprolol-25 Pro Doc 02253496 02315106 02302055 02261898 02248855 MeliaPharm Sorres Mylan Novopharm Phmscience 100 1000 100 1000 100 100 500 100 100 250 100 500 100 100 1000 100 1000 100 100 1000 100 500 100 500 100 500 100 1000 100 500 100 100 500 Tab. 12.50 136.05 12.50 136.05 24.99 12.50 68.03 46.60 48.12 120.28 12.50 68.03 24.99 12.50 136.05 12.50 136.05 12.50 12.50 136.05 12.50 68.03 12.50 68.03 12.50 68.03 12.50 136.05 12.50 68.03 24.99 12.50 68.03 0.1250 0.1361 0.1250 0.1361 0.2499 0.1250 0.1361 0.4660 0.4812 0.4811 0.1250 0.1361 0.2499 0.1250 0.1361 0.1250 0.1361 0.1250 0.1250 0.1361 0.1250 0.1361 0.1250 0.1361 0.1250 0.1361 0.1250 0.1361 0.1250 0.1361 0.2499 0.1250 0.1361 25 mg PPB Metoprolol-L Metoprolol-L Mylan-Metoprolol (Type L) Novo-Metoprol pms-Metoprolol 25 mg 02315300 Riva-Metoprolol-L Page COST OF PKG. SIZE 106 Riva 100 1000 100 500 100 1000 100 100 100 100 100 500 100 500 6.43 64.30 6.43 32.15 6.43 64.30 6.43 6.43 6.43 6.43 6.43 32.15 6.43 32.15 0.0643 0.0643 0.0643 0.0643 0.0643 0.0643 0.0643 0.0643 0.0643 0.0643 0.0643 0.0643 0.0643 0.0643 2013-04 CODE BRAND NAME MANUFACTURER SIZE NADOLOL X Tab. COST OF PKG. SIZE UNIT PRICE 40 mg PPB 00782505 Apo-Nadol Apotex 00828815 Nadolol-40 02126753 Novo-Nadolol Pro Doc Novopharm 100 500 100 100 Tab. 24.65 123.25 24.65 24.65 0.2465 0.2465 0.2465 0.2465 80 mg PPB 00782467 Apo-Nadol 00818704 Nadolol-80 02126761 Novo-Nadolol Apotex Pro Doc Novopharm 100 100 100 PINDOLOL X Tab. 35.15 35.15 35.15 0.3515 0.3515 0.3515 5 mg PPB 00755877 Apo-Pindol 02057808 Mylan-Pindolol 00869007 Novo-Pindol Apotex Mylan Novopharm 00828416 02231536 02261782 00417270 Pro Doc Phmscience Sandoz Novartis Pindolol-5 pms-Pindolol Sandoz Pindolol Visken 100 100 100 500 100 100 100 100 13.61 13.61 13.61 68.03 13.61 13.61 13.61 45.71 0.1361 W 0.1361 0.1361 0.1361 0.1361 0.1361 0.4571 10 mg PPB Tab. 00755885 Apo-Pindol Apotex 02057816 Mylan-Pindolol 00869015 Novo-Pindol Mylan Novopharm 00828424 02231537 02261790 00443174 Pro Doc Phmscience Sandoz Novartis Pindolol-10 pms-Pindolol Sandoz Pindolol Visken 100 500 100 100 500 100 100 100 100 Tab. 23.24 116.17 23.24 23.24 116.17 23.24 23.24 23.24 78.06 0.2324 0.2323 W 0.2324 0.2323 0.2324 0.2324 0.2324 0.7806 15 mg PPB 00755893 00869023 02231539 02261804 00417289 Apo-Pindol Novo-Pindol pms-Pindolol Sandoz Pindolol Visken Apotex Novopharm Phmscience Sandoz Novartis 100 100 100 100 100 PINDOLOL / HYDROCHLOROTHIAZIDE X Tab. 00568627 Viskazide 10/25 2013-04 33.71 33.71 33.71 33.71 113.23 0.3371 0.3371 0.3371 0.3371 1.1323 10 mg -25 mg Novartis 105 80.28 0.7646 Page 107 CODE BRAND NAME MANUFACTURER PROPRANOLOL HYDROCHLORIDE X L.A. Caps or Tab. Apotex 02042231 Inderal L.A. 60 mg 00740675 Novo-Pranol 20 mg Pfizer Novopharm L.A. Caps or Tab. UNIT PRICE 100 1000 100 100 500 2.77 27.68 44.93 2.77 13.84 0.0277 0.0277 0.4493 0.0277 0.0277 40 mg / 80 mg / 120 mg L.A. PPB 00402753 Apo-Propranolol 40 mg Apotex 02042266 Inderal L.A. 120 mg 02042258 Inderal L.A. 80 mg 00496499 Novo-Pranol 40 mg Pfizer Pfizer Novopharm L.A. Caps or Tab. 100 1000 100 100 100 1000 3.07 30.63 78.02 50.56 3.07 30.63 0.0307 0.0306 0.7802 0.5056 0.0307 0.0306 80 mg / 160 mg L.A. PPB Apotex Pfizer Novopharm 100 100 100 500 Tab. 5.09 92.27 5.09 25.43 0.0509 0.9227 0.0509 0.0509 10 mg PPB 00402788 Apo-Propranolol Apotex 00496480 Novo-Pranol Novopharm 100 1000 100 1000 Tab. 1.73 17.23 1.73 17.23 0.0173 0.0172 0.0173 0.0172 120 mg 00504335 Apo-Propranolol Page COST OF PKG. SIZE 20 mg /60 mg L.A. PPB 00663719 Apo-Propranolol 20 mg 00402761 Apo-Propranolol 80 mg 02042274 Inderal L.A. 160 mg 00496502 Novo-Pranol 80 mg SIZE 108 Apotex 100 30.91 0.1097 2013-04 CODE BRAND NAME MANUFACTURER SIZE SOTALOL HYDROCHLORIDE X Tab. UNIT PRICE 80 mg PPB 02210428 Apo-Sotalol Apotex 02270625 Co Sotalol 02368617 Jamp-Sotalol Cobalt Jamp 02229778 Mylan-Sotalol 02231181 Novo-Sotalol Mylan Novopharm 02238768 phl-Sotalol 02238326 pms-Sotatol Pharmel Phmscience 02316528 Pro-Sotalol Pro Doc 02084228 02272164 02257831 02385988 02325209 Ratiopharm Riva Sandoz Sivem Sorres ratio-Sotalol Riva-Sotalol Sandoz Sotalol Sotalol Sotalol COST OF PKG. SIZE 100 500 100 100 500 100 100 500 100 100 500 100 500 100 100 100 100 100 Tab. 59.32 296.60 59.32 59.32 296.60 59.32 59.32 296.60 59.32 59.32 296.60 59.32 296.60 59.32 59.32 59.32 59.32 59.32 0.5932 0.5932 0.5932 0.5932 0.5932 0.5932 0.5932 0.5932 0.5932 0.5932 0.5932 0.5932 0.5932 0.5932 0.5932 0.5932 0.5932 0.5932 160 mg PPB 02167794 Apo-Sotalol Apotex 02270633 Co Sotalol 02368625 Jamp-Sotalol Cobalt Jamp 02229779 Mylan-Sotalol 02231182 Novo-Sotalol Mylan Novopharm 02238769 02238327 02316536 02084236 02242157 02257858 02385996 02325217 Pharmel Phmscience Pro Doc Ratiopharm Riva Sandoz Sivem Sorres phl-Sotalol pms-Sotatol Pro-Sotalol ratio-Sotalol Riva-Sotalol Sandoz Sotalol Sotalol Sotalol 100 500 100 100 500 100 100 500 100 100 100 100 100 100 100 100 TIMOLOL MALEATE X Tab. 00755842 Apo-Timol 01947796 Novo-Timol 16.23 81.15 16.23 16.23 81.15 16.23 16.23 81.15 16.23 16.23 16.23 16.23 16.23 16.23 16.23 16.23 0.1623 0.1623 0.1623 0.1623 0.1623 0.1623 0.1623 0.1623 0.1623 0.1623 0.1623 0.1623 0.1623 0.1623 0.1623 0.1623 5 mg PPB Apotex Novopharm 100 100 Tab. 16.49 16.49 0.1649 0.1649 10 mg PPB 00755850 Apo-Timol 01947818 Novo-Timol 2013-04 Apotex Novopharm 100 100 25.72 25.72 0.2572 0.2572 Page 109 CODE BRAND NAME MANUFACTURER SIZE Tab. COST OF PKG. SIZE UNIT PRICE 20 mg PPB 00755869 Apo-Timol 01947826 Novo-Timol Apotex Novopharm 100 100 50.05 50.05 0.5005 0.5005 24:28.08 DIHYDROPYRIDINES AMLODIPINE (BESYLATE) X Tab. 02343193 02326795 02385783 02378744 Amlodipine Amlodipine Amlodipine Amlodipine Odan + 02392127 Bio-Amlodipine Page 2.5 mg PPB MeliaPharm Pro Doc Sivem Odan 02297477 Co Amlodipine 02357186 Jamp-Amlodipine Biomed Cobalt Jamp 02371707 Mar-Amlodipine Marcan 02326760 02295148 02331489 02330474 02357704 Pharmel Phmscience Riva Sandoz Septa 110 phl-Amlodipine pms-Amlodipine Riva-Amlodipine Sandoz Amlodipine Septa-Amlodipine 100 100 100 100 500 100 100 30 100 100 500 100 100 100 100 100 500 32.82 32.82 32.82 32.82 164.10 32.82 32.82 9.85 32.82 32.82 164.10 32.82 32.82 32.82 32.82 32.82 164.10 0.3282 0.3282 0.3282 0.3282 0.3282 0.3282 0.3282 0.3282 0.3282 0.3282 0.3282 0.3282 0.3282 0.3282 0.3282 0.3282 0.3282 2013-04 CODE BRAND NAME MANUFACTURER SIZE Tab. COST OF PKG. SIZE UNIT PRICE 5 mg PPB 02343207 Amlodipine MeliaPharm 02326809 Amlodipine Pro Doc 02331284 Amlodipine Sanis 02385791 Amlodipine Sivem 02378760 Amlodipine Odan Odan 02273373 Apo-Amlodipine Apotex + 02392135 Bio-Amlodipine Biomed 02297485 Co Amlodipine Cobalt 02357194 Jamp-Amlodipine Jamp 02371715 Mar-Amlodipine Marcan 02362651 Mint-Amlodipine Mint 02272113 Mylan-Amlodipine Mylan 00878928 Norvasc Pfizer 02326779 phl-Amlodipine Pharmel 02284065 pms-Amlodipine Phmscience 02321858 Ran-Amlodipine Ranbaxy 02259605 ratio-Amlodipine Ratiopharm 02331497 Riva-Amlodipine Riva 02284383 Sandoz Amlodipine Sandoz 02357712 Septa-Amlodipine Septa 02250497 Teva-Amlodipine Teva Can 02342790 Zym-Amlodipine Zymcan 2013-04 100 500 100 500 100 500 100 500 100 500 100 500 100 500 100 500 100 500 100 500 100 250 100 500 100 250 100 500 100 500 100 500 100 500 100 500 100 500 100 500 100 500 100 33.91 169.55 33.91 169.55 33.91 169.55 33.91 169.55 33.91 169.55 33.91 169.55 33.91 169.55 33.91 169.55 33.91 169.55 33.91 169.55 33.91 84.78 33.91 169.55 129.99 324.97 33.91 169.55 33.91 169.55 33.91 169.55 33.91 169.55 33.91 169.55 33.91 169.55 33.91 169.55 33.91 169.55 33.91 0.3391 0.3391 0.3391 0.3391 0.3391 0.3391 0.3391 0.3391 0.3391 0.3391 0.3391 0.3391 0.3391 0.3391 0.3391 0.3391 0.3391 0.3391 0.3391 0.3391 0.3391 0.3391 0.3391 0.3391 1.2999 1.2999 0.3391 0.3391 0.3391 0.3391 0.3391 0.3391 0.3391 0.3391 0.3391 0.3391 0.3391 0.3391 0.3391 0.3391 0.3391 0.3391 0.3391 Page 111 CODE BRAND NAME MANUFACTURER SIZE Tab. UNIT PRICE 10 mg PPB 02343215 Amlodipine MeliaPharm 02297493 Co Amlodipine Cobalt 02357208 Jamp-Amlodipine Jamp 02371723 Mar-Amlodipine Marcan 02362678 Mint-Amlodipine Mint 02272121 Mylan-Amlodipine Mylan 00878936 Norvasc Pfizer 02326787 phl-Amlodipine Pharmel 02284073 pms-Amlodipine Phmscience 02321866 Ran-Amlodipine Ranbaxy 02259613 ratio-Amlodipine Ratiopharm 02331500 Riva-Amlodipine Riva 02284391 Sandoz Amlodipine Sandoz 02357720 Septa-Amlodipine Septa 02250500 Teva-Amlodipine Teva Can 02342804 Zym-Amlodipine Zymcan 100 500 100 500 100 500 100 500 100 500 100 500 100 500 100 500 100 500 100 500 100 250 100 500 100 250 100 500 100 500 100 500 100 500 100 500 100 500 100 500 100 250 100 02326817 Amlodipine Pro Doc 02331292 Amlodipine Sanis 02385805 Amlodipine Sivem 02378779 Amlodipine Odan Odan 02273381 Apo-Amlodipine Apotex AZC SanofiAven 30 30 + 02392143 Bio-Amlodipine Biomed FELODIPIN X L.A. Tab. 02057778 Plendil 02221985 Renedil Page COST OF PKG. SIZE 112 50.31 251.55 50.31 251.55 50.31 251.55 50.31 251.55 50.31 251.55 50.31 251.55 50.31 251.55 50.31 251.55 50.31 251.55 50.31 251.55 50.31 125.78 50.31 251.55 192.96 482.39 50.31 251.55 50.31 251.55 50.31 251.55 50.31 251.55 50.31 251.55 50.31 251.55 50.31 251.55 50.31 125.78 50.31 0.5031 0.5031 0.5031 0.5031 0.5031 0.5031 0.5031 0.5031 0.5031 0.5031 0.5031 0.5031 0.5031 0.5031 0.5031 0.5031 0.5031 0.5031 0.5031 0.5031 0.5031 0.5031 0.5031 0.5031 1.9296 1.9296 0.5031 0.5031 0.5031 0.5031 0.5031 0.5031 0.5031 0.5031 0.5031 0.5031 0.5031 0.5031 0.5031 0.5031 0.5031 0.5031 0.5031 2.5 mg PPB 15.27 9.51 0.5090 0.3170 2013-04 CODE BRAND NAME MANUFACTURER SIZE L.A. Tab. 00851779 Plendil 02221993 Renedil 02280264 Sandoz Felodipine AZC SanofiAven Sandoz 30 30 30 100 AZC SanofiAven Sandoz 30 30 30 100 0.6800 0.4633 0.3673 0.3672 30.62 20.20 20.20 69.25 1.0207 0.6733 0.6253 0.6252 5 mg AA Pharma 100 Bayer 28 98 L.A. Tab. (24 h) 02237618 Adalat XL 20.40 13.90 13.86 46.20 10 mg PPB NIFEDIPINE X Caps. 00725110 Nifedipine UNIT PRICE 5 mg PPB L.A. Tab. 00851787 Plendil 02222000 Renedil 02280272 Sandoz Felodipine COST OF PKG. SIZE 36.79 0.3679 20 mg L.A. Tab. (24 h) 25.99 90.94 0.9282 0.9280 30 mg PPB 02155907 Adalat XL Bayer 02349167 Mylan-Nifedipine Extented Release Mylan 28 98 100 L.A. Tab. (24 h) 17.28 60.48 61.71 0.6171 0.6171 0.6171 60 mg PPB 02155990 Adalat XL Bayer 02321149 Mylan-Nifedipine Extented Release Mylan 28 98 100 26.25 91.87 93.74 0.9374 0.9374 0.9374 NIFEDIPINE/ACETYLSALICYLIC (ACIDE) X L.A. Tab. (24 h) 20 mg - 81 mg (28 L.A. Tab.(24h) - 28 Ent. Tab.) 02313766 Adalat XL PLUS L.A. Tab. (24 h) 02313774 Adalat XL PLUS L.A. Tab. (24 h) 02313782 Adalat XL PLUS 2013-04 Bayer 56 25.27 0.4513 30 mg - 81 mg (28 L.A. Tab.(24h) - 28 Ent. Tab.) Bayer 56 29.52 0.5271 60 mg - 81 mg (28 L.A. Tab.(24h) - 28 Ent. Tab.) Bayer 56 47.79 0.8534 Page 113 CODE BRAND NAME MANUFACTURER SIZE NIMODIPINE X Tab. COST OF PKG. SIZE UNIT PRICE 30 mg 02325926 Nimotop Bayer 100 988.00 9.8800 24:28.92 MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS DILTIAZEM HYDROCHLORIDE X L.A. Caps. 02291037 02370441 02325306 02271605 02245918 02231150 Apo-Diltiaz TZ Co Diltiazem T Diltiazem TZ Novo-Diltiazem HCl ER Sandoz Diltiazem T Tiazac 120 mg PPB Apotex Cobalt Pro Doc Novopharm Sandoz Valeant 100 100 100 100 100 100 L.A. Caps. 02291045 02370492 02325314 02271613 02245919 Apo-Diltiaz TZ Co Diltiazem T Diltiazem TZ Novo-Diltiazem HCl ER Sandoz Diltiazem T Apotex Cobalt Pro Doc Novopharm Sandoz Valeant 100 100 100 100 100 500 100 Apo-Diltiaz TZ Co Diltiazem T Diltiazem TZ Novo-Diltiazem HCl ER Sandoz Diltiazem T Tiazac Apotex Cobalt Pro Doc Novopharm Sandoz Valeant 100 100 100 100 100 100 Apo-Diltiaz TZ Co Diltiazem T Diltiazem TZ Novo-Diltiazem HCl ER Sandoz Diltiazem T Apotex Cobalt Pro Doc Novopharm Sandoz 100 100 100 100 100 500 100 L.A. Caps. Valeant L.A. Caps. Page 114 0.2889 0.2889 0.2889 0.2889 0.2889 0.2889 1.1248 38.32 38.32 38.32 38.32 38.32 149.20 0.3832 0.3832 0.3832 0.3832 0.3832 1.4920 300 mg PPB 02231154 Tiazac 02291088 02370522 02325349 02271656 02245922 02231155 28.89 28.89 28.89 28.89 28.89 144.45 112.48 240 mg PPB L.A. Caps. 02291061 02370514 02325330 02271648 02245921 0.2134 0.2134 0.2134 0.2134 0.2134 0.8349 180 mg PPB 02231151 Tiazac 02291053 02370506 02325322 02271621 02245920 02231152 21.34 21.34 21.34 21.34 21.34 83.49 47.20 47.20 47.20 47.20 47.20 235.98 183.75 0.4720 0.4720 0.4720 0.4720 0.4720 0.4720 1.8375 360 mg PPB Apo-Diltiaz TZ Co Diltiazem T Diltiazem TZ Novo-Diltiazem HCl ER Sandoz Diltiazem T Tiazac Apotex Cobalt Pro Doc Novopharm Sandoz Valeant 100 100 100 100 100 100 57.78 57.78 57.78 57.78 57.78 224.97 0.5778 0.5778 0.5778 0.5778 0.5778 2.2497 2013-04 CODE BRAND NAME MANUFACTURER SIZE L.A. Caps. (24 h) UNIT PRICE 120 mg PPB 02230997 Apo-Diltiaz CD Apotex 02097249 Cardizem CD 02370611 Co Diltiazem CD Valeant Cobalt 02231472 Diltiazem-CD Pro Doc 02242538 Novo-Diltiazem CD Novopharm 02355752 pms-Diltiazem CD Phmscience 02229781 ratio-Diltiazem CD Ratiopharm 02243338 Sandoz Diltiazem CD Sandoz 100 500 100 100 500 100 500 100 500 100 500 100 500 100 500 L.A. Caps. (24 h) 36.35 181.72 129.79 36.35 181.72 36.35 181.72 36.35 181.72 36.35 181.72 36.35 181.72 36.35 181.72 0.3635 0.3634 1.2979 0.3635 0.3634 0.3635 0.3634 0.3635 0.3634 0.3635 0.3634 0.3635 0.3634 0.3635 0.3634 180 mg PPB 02230998 Apo-Diltiaz CD Apotex 02097257 Cardizem CD 02370638 Co Diltiazem CD Valeant Cobalt 02231474 Diltiazem-CD Pro Doc 02242539 Novo-Diltiazem CD Novopharm 02355760 pms-Diltiazem CD Phmscience 02229782 ratio-Diltiazem CD Ratiopharm 02243339 Sandoz Diltiazem CD Sandoz 100 500 100 100 500 100 500 100 500 100 500 100 500 100 500 L.A. Caps. (24 h) 48.25 241.22 172.28 48.25 241.22 48.25 241.22 48.25 241.22 48.25 241.22 48.25 241.22 48.25 241.22 0.4825 0.4824 1.7228 0.4825 0.4824 0.4825 0.4824 0.4825 0.4824 0.4825 0.4824 0.4825 0.4824 0.4825 0.4824 240 mg PPB 02230999 Apo-Diltiaz CD Apotex 02097265 Cardizem CD 02370646 Co Diltiazem CD Valeant Cobalt 02231475 Diltiazem-CD Pro Doc 02242540 Novo-Diltiazem CD Novopharm 02355779 pms-Diltiazem CD Phmscience 02229783 ratio-Diltiazem CD Ratiopharm 02243340 Sandoz Diltiazem CD Sandoz 2013-04 COST OF PKG. SIZE 100 500 100 100 500 100 500 100 500 100 500 100 500 100 500 63.99 319.95 228.51 63.99 319.95 63.99 319.95 63.99 319.95 63.99 319.95 63.99 319.95 63.99 319.95 0.6399 0.6399 2.2851 0.6399 0.6399 0.6399 0.6399 0.6399 0.6399 0.6399 0.6399 0.6399 0.6399 0.6399 0.6399 Page 115 CODE BRAND NAME MANUFACTURER SIZE L.A. Caps. (24 h) UNIT PRICE 300 mg PPB 02229526 Apo-Diltiaz CD Apotex 02355787 pms-Diltiazem CD 02229784 ratio-Diltiazem CD Phmscience Ratiopharm 02243341 Sandoz Diltiazem CD Sandoz 100 500 100 100 100 100 500 100 100 500 100 02097273 02370654 02231057 02242541 Valeant Cobalt Pro Doc Novopharm Valeant 90 Cardizem CD Co Diltiazem CD Diltiazem-CD Novo-Diltiazem CD L.A. Tab. 79.99 399.94 285.65 79.99 79.99 79.99 399.94 79.99 79.99 399.94 79.99 0.7999 0.7999 2.8565 0.7999 0.7999 0.7999 0.7999 0.7999 0.7999 0.7999 0.7999 120 mg 02256738 Tiazac XC L.A. Tab. 71.39 0.7932 180 mg 02256746 Tiazac XC Valeant 90 Valeant 90 L.A. Tab. 94.85 1.0539 240 mg 02256754 Tiazac XC L.A. Tab. 126.07 1.4008 300 mg 02256762 Tiazac XC Valeant 90 Valeant 90 L.A. Tab. 125.82 1.3980 360 mg 02256770 Tiazac XC Tab. 126.07 1.4008 30 mg PPB 00771376 Apo-Diltiaz Apotex 00862924 Novo-Diltazem Novopharm 100 500 100 Tab. 18.66 93.30 18.66 0.1866 0.1866 0.1866 60 mg PPB 00771384 Apo-Diltiaz 00828777 Diltiazem-60 Apotex Pro Doc 00862932 Novo-Diltazem Novopharm 100 100 500 100 VERAPAMIL HYDROCHLORIDE X L.A. Tab. 02246893 01907123 02210347 02324156 Page COST OF PKG. SIZE 116 Apo-Verap SR Isoptin SR Mylan-Verapamil SR Pro-Verapamil SR 32.73 32.73 163.65 32.73 0.3273 0.3273 0.3273 0.3273 120 mg PPB Apotex Abbott Mylan Pro Doc 100 100 100 100 50.78 101.78 50.78 50.78 0.5078 1.0178 0.5078 0.5078 2013-04 CODE BRAND NAME MANUFACTURER SIZE L.A. Tab. 02246894 01934317 02210355 02324164 COST OF PKG. SIZE UNIT PRICE 180 mg PPB Apo-Verap SR Isoptin SR Mylan-Verapamil SR Pro-Verapamil SR Apotex Abbott Mylan Pro Doc 100 100 100 100 L.A. Tab. 52.04 114.94 52.04 52.04 0.5204 1.1494 0.5204 0.5204 240 mg PPB 02246895 Apo-Verap SR Apotex 00742554 Isoptin SR 02210363 Mylan-Verapamil SR Abbott Mylan 02211920 Novo-Veramil SR Novopharm 02238276 phl-Verapamil SR 02237791 pms-Verapamil SR 02312697 Pro-Verapamil SR Pharmel Phmscience Pro Doc 02248082 Riva-Verapamil SR 02303558 Verapamil SR Riva Sorres 100 500 100 100 500 100 500 100 100 100 500 100 100 Tab. 50.75 253.75 153.25 50.75 253.75 50.75 253.75 50.75 50.75 50.75 253.75 50.75 50.75 0.5075 0.5075 1.5325 0.5075 0.5075 0.5075 0.5075 0.5075 0.5075 0.5075 0.5075 0.5075 0.5075 80 mg PPB 00782483 Apo-Verap Apotex 00554316 Isoptin 02237921 Mylan-Verapamil Abbott Mylan 100 500 250 100 00782491 Apo-Verap 00554324 Isoptin 02237922 Mylan-Verapamil Apotex Abbott Mylan 100 250 100 Tab. 27.35 136.74 68.37 27.35 0.2735 0.2735 0.2735 0.2735 120 mg PPB 42.50 106.25 42.50 0.4250 0.4250 0.4250 24:32.04 ANGIOTENSIN-CONVERTING ENZYME INHIBITORS (ACEI) BENAZEPRIL X Tab. 5 mg PPB 02290332 Apo-Benazepril 00885835 Lotensin AA Pharma Novartis 100 28 02290340 Apo-Benazepril AA Pharma 100 Tab. 55.77 17.78 0.3810 0.6350 10 mg Tab. 65.95 0.6595 20 mg PPB 02273918 Apo-Benazepril 00885851 Lotensin 2013-04 AA Pharma Novartis 100 28 75.67 24.10 0.5165 0.8607 Page 117 CODE BRAND NAME MANUFACTURER SIZE CAPTOPRIL X Tab. UNIT PRICE 6.25 mg 01999559 Apo-Capto Apotex 100 00893595 02238555 02163551 01942964 Apo-Capto Captopril Mylan-Captopril Novo-Captoril Apotex Pharmel Mylan Novopharm 100 500 100 100 00893609 02238556 02163578 01942972 Apo-Capto Captopril Mylan-Captopril Novo-Captoril Apotex Pharmel Mylan Novopharm 100 1000 100 100 1000 Tab. 12.37 0.1237 12.5 mg PPB Tab. 21.20 106.00 21.20 21.20 0.2120 0.2120 0.2120 0.2120 25 mg PPB Tab. 30.00 300.00 30.00 30.00 300.00 0.3000 0.3000 0.3000 0.3000 0.3000 50 mg PPB 00893617 02238557 02163586 01942980 Apo-Capto Captopril Mylan-Captopril Novo-Captoril Apotex Pharmel Mylan Novopharm 100 500 100 100 500 00893625 02238558 02163594 01942999 02230206 Apo-Capto Captopril Mylan-Captopril Novo-Captoril pms-Captopril Apotex Pharmel Mylan Novopharm Phmscience 100 100 100 100 100 Tab. 55.90 279.50 55.90 55.90 279.50 0.5590 0.5590 0.5590 0.5590 0.5590 100 mg PPB CILAZAPRIL X Tab. 02291134 02350963 02283778 02266350 02309378 02280442 Page COST OF PKG. SIZE 118 103.95 103.95 103.95 103.95 103.95 1.0395 1.0395 1.0395 1.0395 1.0395 1 mg PPB Apo-Cilazapril Cilazapril Mylan-Cilazapril Novo-Cilazapril phl-Cilazapril pms-Cilazapril Apotex Sanis Mylan Novopharm Pharmel Phmscience 100 100 100 100 100 100 15.57 15.57 15.57 15.57 15.57 15.57 0.1557 0.1557 0.1557 0.1557 0.1557 0.1557 2013-04 CODE BRAND NAME MANUFACTURER SIZE Tab. COST OF PKG. SIZE UNIT PRICE 2.5 mg PPB 02291142 02350971 02285215 01911473 02283786 02266369 Apo-Cilazapril Cilazapril Co Cilazapril Inhibace Mylan-Cilazapril Novo-Cilazapril 02309386 phl-Cilazapril 02280450 pms-Cilazapril Apotex Sanis Cobalt Roche Mylan Novopharm Pharmel Phmscience 100 100 100 100 100 100 500 100 100 Tab. 17.95 17.95 17.95 73.23 17.95 17.95 89.74 17.95 17.95 0.1795 0.1795 0.1795 0.7323 0.1795 0.1795 0.1795 0.1795 0.1795 5 mg PPB 02291150 02350998 02285223 01911481 02283794 02266377 Apo-Cilazapril Cilazapril Co Cilazapril Inhibace Mylan-Cilazapril Novo-Cilazapril Apotex Sanis Cobalt Roche Mylan Novopharm 02309394 phl-Cilazapril Pharmel 02280469 pms-Cilazapril Phmscience CILAZAPRIL/ HYDROCHLOROTHIAZIDE X Tab. 02284987 Apo-Cilazapril - HCTZ 02181479 Inhibace Plus 02313731 Novo-Cilazapril/HCTZ 100 100 100 100 100 100 500 100 500 100 500 0.2085 0.2085 0.2085 0.8508 0.2085 0.2085 0.2085 0.2085 0.2085 0.2085 0.2085 5 mg -12.5 mg PPB Apotex Roche Novopharm 100 28 100 02020025 Apo-Enalapril 02291878 Co Enalapril Apotex Cobalt 02300036 Mylan-Enalapril Mylan 02300680 Novo-Enalapril Novopharm 02300079 pms-Enalapril Phmscience 02311402 Pro-Enalapril-2.5 02352230 Ran-Enalapril 02300796 Riva-Enalapril Pro Doc Ranbaxy Riva 02299933 Sandoz Enalapril Sandoz 00851795 Vasotec Merck 100 100 500 30 500 30 100 30 500 100 100 100 500 30 500 28 100 ENALAPRIL MALEATE X Tab. 2013-04 20.85 20.85 20.85 85.08 20.85 20.85 104.27 20.85 104.27 20.85 104.27 41.70 23.82 41.70 0.4170 0.8507 0.4170 2.5 mg PPB 18.63 18.63 93.15 5.59 93.15 5.59 18.63 5.59 93.15 18.63 18.63 18.63 93.15 5.59 93.15 10.58 37.78 0.1863 0.1863 0.1863 0.1863 0.1863 0.1863 0.1863 0.1863 0.1863 0.1863 0.1863 0.1863 0.1863 0.1863 0.1863 0.3779 0.3778 Page 119 CODE BRAND NAME MANUFACTURER SIZE Tab. UNIT PRICE 5 mg PPB 02019884 Apo-Enalapril Apotex 02291886 Co Enalapril Cobalt 02300044 Mylan-Enalapril Mylan 02233005 Novo-Enalapril Novopharm 02300087 pms-Enalapril Phmscience 02311410 Pro-Enalapril-5 Pro Doc 02352249 Ran-Enalapril 02300818 Riva-Enalapril Ranbaxy Riva 02299941 Sandoz Enalapril Sandoz 00708879 Vasotec Merck 100 500 30 500 30 500 30 500 30 500 100 500 100 30 500 30 500 28 Tab. Page COST OF PKG. SIZE 22.03 110.15 6.61 110.15 6.61 110.15 6.61 110.15 6.61 110.15 22.03 110.15 22.03 6.61 110.15 6.61 110.15 12.52 0.2203 0.2203 0.2203 0.2203 0.2203 0.2203 0.2203 0.2203 0.2203 0.2203 0.2203 0.2203 0.2203 0.2203 0.2203 0.2203 0.2203 0.4471 10 mg PPB 02019892 Apo-Enalapril Apotex 02291894 Co Enalapril Cobalt 02300052 Mylan-Enalapril Mylan 02233006 Novo-Enalapril Novopharm 02300095 pms-Enalapril Phmscience 02311429 Pro-Enalapril-10 Pro Doc 02352257 Ran-Enalapril 02300826 Riva-Enalapril Ranbaxy Riva 02299968 Sandoz Enalapril Sandoz 00670901 Vasotec Merck 120 100 500 30 500 30 500 30 500 30 500 100 500 100 30 500 30 500 28 26.47 132.35 7.94 132.35 7.94 132.35 7.94 132.35 7.94 132.35 26.47 132.35 26.47 7.94 132.35 7.94 132.35 15.04 0.2647 0.2647 0.2647 0.2647 0.2647 0.2647 0.2647 0.2647 0.2647 0.2647 0.2647 0.2647 0.2647 0.2647 0.2647 0.2647 0.2647 0.5371 2013-04 CODE BRAND NAME MANUFACTURER SIZE Tab. COST OF PKG. SIZE UNIT PRICE 20 mg PPB 02019906 Apo-Enalapril Apotex 02291908 Co Enalapril Cobalt 02300060 Mylan-Enalapril Mylan 02233007 Novo-Enalapril Novopharm 02300109 pms-Enalapril Phmscience 02311437 Pro-Enalapril-20 Pro Doc 02352265 Ran-Enalapril 02300834 Riva-Enalapril Ranbaxy Riva 02299976 Sandoz Enalapril Sandoz 00670928 Vasotec Merck ENALAPRIL MALEATE/ HYDROCHLOROTHIAZIDE X Tab. 02352923 Apo-Enalapril Maleate/ HCTZ 02300222 Novo-Enalapril/HCTZ 100 500 100 500 30 500 30 500 30 500 100 500 100 30 500 30 500 28 100 31.95 159.75 31.95 159.75 9.59 159.75 9.59 159.75 9.59 159.75 31.95 159.75 31.95 9.59 159.75 9.59 159.75 18.14 64.79 0.3195 0.3195 0.3195 0.3195 0.3195 0.3195 0.3195 0.3195 0.3195 0.3195 0.3195 0.3195 0.3195 0.3195 0.3195 0.3195 0.3195 0.6479 0.6479 5 mg -12.5 mg PPB Apotex 100 49.27 0.4927 Novopharm 30 14.78 0.4927 Tab. 10 mg -25 mg PPB 02352931 Apo-Enalapril Maleate/ HCTZ 02300230 Novo-Enalapril/HCTZ Apotex 100 54.79 0.5479 Novopharm 00657298 Vaseretic Merck 30 100 28 16.44 59.20 29.67 0.5479 0.5920 1.0596 2013-04 Page 121 CODE BRAND NAME MANUFACTURER SIZE LISINOPRIL X Tab. Page UNIT PRICE 5 mg PPB 02217481 Apo-Lisinopril Apotex 02271443 Co Lisinopril Cobalt 02361531 02294583 02386232 02321580 02274833 Jamp MeliaPharm Sivem Sorres Mylan Jamp-Lisinopril Lisinopril Lisinopril Lisinopril Mylan-Lisinopril 02285061 Novo-Lisinopril (Type P) Novopharm 02285118 Novo-Lisinopril (Type Z) Novopharm 02292203 pms-Lisinopril Phmscience 00839388 Prinivil Merck 02310961 Pro-Lisinopril-5 Pro Doc 02294230 Ran-Lisinopril Ranbaxy 02256797 ratio-Lisinopril P Ratiopharm 02299879 ratio-Lisinopril Z Ratiopharm 02300958 Riva-Lisinopril Riva 02289199 Sandoz Lisinopril Sandoz 02049333 Zestril AZC 122 COST OF PKG. SIZE 100 500 100 500 100 100 100 100 100 500 30 100 30 100 30 100 28 100 100 500 100 500 100 500 100 500 100 500 30 500 100 13.47 67.35 13.47 67.35 13.47 13.47 13.47 13.47 13.47 67.35 4.04 13.47 4.04 13.47 4.04 13.47 16.32 58.30 13.47 67.35 13.47 67.35 13.47 67.35 13.47 67.35 13.47 67.35 4.04 67.35 55.94 0.1347 0.1347 0.1347 0.1347 0.1347 0.1347 0.1347 0.1347 0.1347 0.1347 0.1347 0.1347 0.1347 0.1347 0.1347 0.1347 0.5829 0.5830 0.1347 0.1347 0.1347 0.1347 0.1347 0.1347 0.1347 0.1347 0.1347 0.1347 0.1347 0.1347 0.5594 2013-04 CODE BRAND NAME MANUFACTURER SIZE Tab. COST OF PKG. SIZE UNIT PRICE 10 mg PPB 02217503 Apo-Lisinopril Apotex 02271451 Co Lisinopril Cobalt 02361558 Jamp-Lisinopril Jamp 02294591 Lisinopril MeliaPharm 02386240 Lisinopril 02321610 Lisinopril 02274841 Mylan-Lisinopril Sivem Sorres Mylan 02285126 Novo-Lisinopril (Type Z) Novopharm 02292211 pms-Lisinopril Phmscience 00839396 Prinivil 02310988 Pro-Lisinopril-10 Merck Pro Doc 02294249 Ran-Lisinopril Ranbaxy 02256800 ratio-Lisinopril P Ratiopharm 02299887 ratio-Lisinopril Z Ratiopharm 02300982 Riva-Lisinopril Riva 02289202 Sandoz Lisinopril Sandoz 02285088 Teva-Lisinopril (Type P) Teva Can 02049376 Zestril AZC 2013-04 100 500 100 500 100 500 100 500 100 100 100 500 30 100 100 500 28 100 500 100 500 100 500 100 500 100 500 30 500 30 100 100 16.19 80.93 16.19 80.93 16.19 80.93 16.19 80.93 16.19 16.19 16.19 80.93 4.86 16.19 16.19 80.93 19.61 16.19 80.93 16.19 80.93 16.19 80.93 16.19 80.93 16.19 80.93 4.86 80.93 4.86 16.19 67.23 0.1619 0.1619 0.1619 0.1619 0.1619 0.1619 0.1619 0.1619 0.1619 0.1619 0.1619 0.1619 0.1619 0.1619 0.1619 0.1619 0.7004 0.1619 0.1619 0.1619 0.1619 0.1619 0.1619 0.1619 0.1619 0.1619 0.1619 0.1619 0.1619 0.1619 0.1619 0.6723 Page 123 CODE BRAND NAME MANUFACTURER SIZE Tab. UNIT PRICE 20 mg PPB 02217511 Apo-Lisinopril Apotex 02271478 Co Lisinopril Cobalt 02361566 Jamp-Lisinopril Jamp 02294605 Lisinopril MeliaPharm 02386259 Lisinopril Sivem 02321629 Lisinopril 02274868 Mylan-Lisinopril Sorres Mylan 02285134 Novo-Lisinopril (Type Z) Novopharm 02292238 pms-Lisinopril Phmscience 00839418 Prinivil Merck 02310996 Pro-Lisinopril-20 Pro Doc 02294257 Ran-Lisinopril Ranbaxy 02256819 ratio-Lisinopril P Ratiopharm 02299895 ratio-Lisinopril Z Ratiopharm 02300990 Riva-Lisinopril Riva 02289229 Sandoz Lisinopril Sandoz 02285096 Teva-Lisinopril (Type P) Teva Can 02049384 Zestril AZC LISINOPRIL HYDROCHLOROTHIAZIDE X Tab. Apotex Sanis 02297736 Mylan-Lisinopril HCTZ Mylan 02103729 Zestoretic 124 100 500 100 500 100 500 100 500 100 500 100 100 500 30 500 30 500 28 100 100 500 100 500 100 500 100 500 100 500 30 500 30 500 100 19.45 97.24 19.45 97.24 19.45 97.24 19.45 97.24 19.45 97.24 19.45 19.45 97.24 5.84 97.24 5.84 97.24 23.56 84.14 19.45 97.24 19.45 97.24 19.45 97.24 19.45 97.24 19.45 97.24 5.84 97.24 5.84 97.24 80.78 0.1945 0.1945 0.1945 0.1945 0.1945 0.1945 0.1945 0.1945 0.1945 0.1945 0.1945 0.1945 0.1945 0.1945 0.1945 0.1945 0.1945 0.8414 0.8414 0.1945 0.1945 0.1945 0.1945 0.1945 0.1945 0.1945 0.1945 0.1945 0.1945 0.1945 0.1945 0.1945 0.1945 0.8078 10 mg -12.5 mg PPB 02261979 Apo-Lisinopril/HCTZ 02362945 Lisinopril/HCTZ (Type Z) 02302136 Novo-Lisinopril/HCTZ (Type Novopharm P) 02301768 Novo-Lisinopril/HCTZ (Type Novopharm Z) 02302365 Sandoz Lisinopril HCT Sandoz Page COST OF PKG. SIZE AZC 100 30 100 30 100 30 100 30 100 30 100 100 20.84 6.26 20.84 6.26 20.84 6.26 20.84 6.26 20.84 6.26 20.84 86.54 0.2084 0.2087 0.2084 0.2087 0.2084 0.2087 0.2084 0.2087 0.2084 0.2087 0.2084 0.8654 2013-04 CODE BRAND NAME MANUFACTURER Tab. SIZE COST OF PKG. SIZE UNIT PRICE 20 mg -12.5 mg PPB 02261987 Apo-Lisinopril/HCTZ 02362953 Lisinopril/HCTZ (Type Z) 02297744 Mylan-Lisinopril HCTZ Apotex Sanis Mylan 02302144 Novo-Lisinopril/HCTZ (Type Novopharm P) 00884413 Prinzide Merck 02302373 Sandoz Lisinopril HCT Sandoz 02301776 Teva-Lisinopril/HCTZ (Type Z) 02045737 Zestoretic Teva Can 02261995 Apo-Lisinopril/HCTZ 02362961 Lisinopril/HCTZ (Type Z) Apotex Sanis 02297752 Mylan-Lisinopril HCTZ Mylan AZC Tab. 100 100 30 100 100 25.04 25.03 7.51 25.04 25.04 0.2504 0.2503 0.2503 0.2504 0.2504 100 30 100 30 100 100 85.90 7.51 25.04 7.51 25.04 104.00 0.8590 0.2503 0.2504 0.2503 0.2504 1.0400 20 mg -25 mg PPB 02302152 Novo-Lisinopril/HCTZ (Type Novopharm P) 02301784 Novo-Lisinopril/HCTZ (Type Novopharm Z) 02302381 Sandoz Lisinopril HCT Sandoz 02045729 Zestoretic AZC 100 30 100 30 100 100 42.86 12.86 42.86 12.86 42.86 42.86 0.4286 0.4287 0.4286 0.4287 0.4286 0.4286 30 100 30 100 100 12.86 42.86 12.86 42.86 104.00 0.4287 0.4286 0.4287 0.4286 1.0400 PERINDOPRIL ERBUMIN X Tab. 2 mg 02123274 Coversyl Servier 30 02123282 Coversyl Servier 30 Tab. 18.88 0.6293 4 mg Tab. 23.60 0.7867 8 mg 02246624 Coversyl Servier 30 Servier 30 PERINDOPRIL ERBUMIN/INDAPAMIDE X Tab. 02246569 Coversyl Plus 33.05 1.1017 4 mg -1.25 mg Tab. 29.29 0.9763 8 mg - 2.5 mg 02321653 Coversyl Plus HD 2013-04 Servier 30 32.76 1.0920 Page 125 CODE BRAND NAME MANUFACTURER SIZE QUINAPRIL HYDROCHLORIDE X Tab. UNIT PRICE 5 mg 01947664 Accupril Pfizer 90 01947672 Accupril Pfizer 90 Tab. 79.94 0.8882 10 mg Tab. 79.94 0.8882 20 mg 01947680 Accupril Pfizer 90 Tab. 79.94 0.8882 40 mg 01947699 Accupril Pfizer 90 QUINAPRIL HYDROCHLORIDE / HYDROCHLOROTHIAZIDE X Tab. 02237367 Accuretic Pfizer 79.94 0.8882 10 mg -12.5 mg 28 Tab. 24.86 0.8879 20 mg -12.5 mg 02237368 Accuretic Pfizer 28 02237369 Accuretic Pfizer 28 Tab. 24.86 0.8879 20 mg -25 mg RAMIPRIL X Caps. Page COST OF PKG. SIZE 0.8611 1.25 mg PPB 02221829 Altace 02251515 Apo-Ramipril SanofiAven Apotex 02387387 Auro-Ramipril Aurobindo 02295482 02331101 02301148 02295369 Cobalt Jamp Mylan Phmscience Co Ramipril Jamp-Ramipril Mylan-Ramipril pms-Ramipril 02310023 Pro-Ramipril Pro Doc 02299372 Ramipril Riva 02308363 Ramipril 02310503 Ran-Ramipril Sivem Ranbaxy 126 24.11 30 30 100 30 500 100 100 100 30 100 30 100 30 100 100 100 500 20.97 5.20 17.33 5.20 86.65 17.33 17.33 17.33 5.20 17.33 5.20 17.33 5.20 17.33 17.33 17.33 86.65 0.6990 0.1733 0.1733 0.1733 0.1733 0.1733 0.1733 0.1733 0.1733 0.1733 0.1733 0.1733 0.1733 0.1733 0.1733 0.1733 0.1733 2013-04 CODE BRAND NAME MANUFACTURER SIZE Caps. COST OF PKG. SIZE UNIT PRICE 2.5 mg PPB 02221837 Altace SanofiAven 02251531 Apo-Ramipril Apotex 02387395 Auro-Ramipril Aurobindo 02295490 Co Ramipril Cobalt 02331128 Jamp-Ramipril 02301156 Mylan-Ramipril Jamp Mylan 02247917 pms-Ramipril Phmscience 02310066 Pro-Ramipril Pro Doc 02255316 Ramipril Riva 02374846 Ramipril Sanis 02287927 Ramipril Sivem 02310511 Ran-Ramipril Ranbaxy 02247945 Teva-Ramipril Teva Can 02221845 Altace SanofiAven 02251574 Apo-Ramipril Apotex 02387409 Auro-Ramipril Aurobindo 02295504 Co Ramipril Cobalt 02331136 Jamp-Ramipril 02301164 Mylan-Ramipril Jamp Mylan 02247918 pms-Ramipril Phmscience 02310074 Pro-Ramipril Pro Doc 02255324 Ramipril Riva 02374854 Ramipril Sanis 02287935 Ramipril Sivem 02310538 Ran-Ramipril Ranbaxy 02247946 Teva-Ramipril Teva Can 30 100 30 500 30 500 30 500 100 100 500 30 500 30 500 30 500 100 500 30 500 100 500 30 500 Caps. 24.20 80.66 6.00 99.99 6.00 99.99 6.00 99.99 20.00 20.00 99.99 6.00 99.99 6.00 99.99 6.00 99.99 20.00 99.99 6.00 99.99 20.00 99.99 6.00 99.99 0.8067 0.8066 0.2000 0.2000 0.2000 0.2000 0.2000 0.2000 0.2000 0.2000 0.2000 0.2000 0.2000 0.2000 0.2000 0.2000 0.2000 0.2000 0.2000 0.2000 0.2000 0.2000 0.2000 0.2000 0.2000 5 mg PPB 2013-04 30 100 30 500 30 500 30 500 100 30 500 30 500 30 500 30 500 100 500 30 500 100 500 30 500 24.20 80.66 6.00 99.99 6.00 99.99 6.00 99.99 20.00 6.00 99.99 6.00 99.99 6.00 99.99 6.00 99.99 20.00 99.99 6.00 99.99 20.00 99.99 6.00 99.99 0.8067 0.8066 0.2000 0.2000 0.2000 0.2000 0.2000 0.2000 0.2000 0.2000 0.2000 0.2000 0.2000 0.2000 0.2000 0.2000 0.2000 0.2000 0.2000 0.2000 0.2000 0.2000 0.2000 0.2000 0.2000 Page 127 CODE BRAND NAME MANUFACTURER SIZE Caps. UNIT PRICE 10 mg PPB 02221853 Altace SanofiAven 02251582 Apo-Ramipril Apotex 02387417 Auro-Ramipril Aurobindo 02295512 Co Ramipril Cobalt 02331144 Jamp-Ramipril 02301172 Mylan-Ramipril Jamp Mylan 02247919 pms-Ramipril Phmscience 02310104 Pro-Ramipril Pro Doc 02255332 Ramipril Riva 02374862 Ramipril Sanis 02287943 Ramipril Sivem 02310546 Ran-Ramipril Ranbaxy 02247947 Teva-Ramipril Teva Can 02281112 Altace SanofiAven 02325381 Apo-Ramipril Apotex 02311194 ratio-Ramipril Ratiopharm 30 100 30 500 30 500 30 500 100 100 500 30 500 30 100 30 500 100 500 30 500 100 500 30 500 Caps. 30.65 102.16 7.60 126.65 7.60 126.65 7.60 126.65 25.33 25.33 126.65 7.60 126.65 7.60 25.33 7.60 126.65 25.33 126.65 7.60 126.65 25.33 126.65 7.60 126.65 1.0217 1.0216 0.2533 0.2533 0.2533 0.2533 0.2533 0.2533 0.2533 0.2533 0.2533 0.2533 0.2533 0.2533 0.2533 0.2533 0.2533 0.2533 0.2533 0.2533 0.2533 0.2533 0.2533 0.2533 0.2533 15 mg PPB RAMIPRIL/ HYDROCHLOROTHIAZIDE X Tab. 02283131 Altace HCT 02342138 pms-Ramipril-HCTZ + 02388332 Teva Ramipril/HCTZ 30 100 30 100 30 100 33.68 112.27 17.57 58.55 17.57 58.55 1.1227 1.1227 0.5857 0.5855 0.5857 0.5855 2.5 mg - 12.5 mg PPB SanofiAven Phmscience Teva Can Tab. 28 100 30 8.37 22.50 4.84 0.2989 0.2250 0.1613 5 mg -12.5 mg PPB * 02342146 pms-Ramipril-HCTZ 02283158 Altace HCT SanofiAven Phmscience + 02388340 Teva Ramipril/HCTZ Teva Can Page COST OF PKG. SIZE 128 28 30 100 30 10.72 6.20 22.63 6.20 0.3829 0.2067 0.2263 0.2067 2013-04 CODE BRAND NAME MANUFACTURER Tab. COST OF PKG. SIZE UNIT PRICE 5 mg - 25 mg PPB 02283174 Altace HCT 02342162 pms-Ramipril-HCTZ + 02388367 Teva Ramipril/HCTZ SanofiAven Phmscience Teva Can Tab. 28 100 30 10.72 22.63 6.20 0.3829 0.2263 0.2067 10 mg -12.5 mg PPB * 02342154 pms-Ramipril-HCTZ 02283166 Altace HCT SanofiAven Phmscience + 02388359 Teva Ramipril/HCTZ Teva Can Tab. * SIZE 28 30 100 30 13.65 7.90 28.65 7.90 0.4875 0.2633 0.2865 0.2633 10 mg -25 mg PPB 02283182 Altace HCT 02342170 pms-Ramipril-HCTZ + 02388375 Teva Ramipril/HCTZ SanofiAven Phmscience Teva Can 28 30 100 30 SODIUM FOSINOPRIL X Tab. 02266008 02303000 02331004 01907107 02262401 02294524 02265923 02247802 Apo-Fosinopril Fosinopril-10 Jamp-Fosinopril Monopril Mylan-Fosinopril Ran-Fosinopril Riva-Fosinopril Teva-Fosinopril 13.65 7.90 28.65 7.90 0.4875 0.2633 0.2865 0.2633 10 mg PPB Apotex Pro Doc Jamp B.M.S. Mylan Ranbaxy Riva Teva Can 100 100 100 30 100 100 100 30 100 Tab. 21.78 21.78 21.78 6.53 21.78 21.78 21.78 6.53 21.78 0.2178 0.2178 0.2178 0.2178 0.2178 0.2178 0.2178 0.2178 0.2178 20 mg PPB 02266016 02303019 02331012 01907115 02262428 02294532 02265931 02247803 Apo-Fosinopril Fosinopril-20 Jamp-Fosinopril Monopril Mylan-Fosinopril Ran-Fosinopril Riva-Fosinopril Teva-Fosinopril Apotex Pro Doc Jamp B.M.S. Mylan Ranbaxy Riva Teva Can 100 100 100 30 100 100 100 30 100 TRANDOLAPRIL X Caps. 26.19 26.19 26.19 7.86 26.19 26.19 26.19 7.86 26.19 0.2619 0.2619 0.2619 0.2619 0.2619 0.2619 0.2619 0.2619 0.2619 0.5 mg 02231457 Mavik Abbott 100 02231459 Mavik Abbott 100 Caps. 27.33 0.2733 1 mg 2013-04 67.00 0.6700 Page 129 CODE BRAND NAME MANUFACTURER SIZE Caps. COST OF PKG. SIZE UNIT PRICE 2 mg 02231460 Mavik Abbott 100 02239267 Mavik Abbott 100 Caps. 77.00 0.7700 4 mg 95.00 0.9500 24:32.08 ANGIOTENSIN II RECEPTOR ANTAGONISTS CANDESARTAN CILEXETIL X Tab. 02365359 Apo-Candesartan Apotex 02239091 Atacand 02377934 Candesartan AZC Pro Doc 02388928 Candesartan Sanis 02388707 Candesartan Sivem 02379279 Candesartan cilexetil Accord 02376539 02386518 02379139 02391198 Cobalt Jamp Mylan Phmscience Co Candesartan Jamp-Candesartan Mylan-Candesartan pms-Candesartan + 02380692 Ran-Candesartan Page 8 mg PPB 02326965 Sandoz Candesartan Ranbaxy Sandoz 02366312 Teva Candesartan Teva Can 130 100 500 30 30 100 100 500 30 100 30 100 100 100 100 30 100 100 30 500 30 100 28.50 142.50 35.52 8.55 28.50 28.50 142.50 8.55 28.50 8.55 28.50 28.50 28.50 28.50 8.55 28.50 28.50 8.55 142.50 8.55 28.50 0.2850 0.2850 1.1840 0.2850 0.2850 0.2850 0.2850 0.2850 0.2850 0.2850 0.2850 0.2850 0.2850 0.2850 0.2850 0.2850 0.2850 0.2850 0.2850 0.2850 0.2850 2013-04 CODE BRAND NAME MANUFACTURER SIZE Tab. COST OF PKG. SIZE UNIT PRICE 16 mg PPB 02365367 Apo-Candesartan Apotex 02239092 Atacand 02377942 Candesartan AZC Pro Doc 02388936 Candesartan Sanis 02388715 Candesartan Sivem 02379287 Candesartan cilexetil Accord 02376547 02386526 02379147 02391201 Cobalt Jamp Mylan Phmscience Co Candesartan Jamp-Candesartan Mylan-Candesartan pms-Candesartan + 02380706 Ran-Candesartan 02326973 Sandoz Candesartan Ranbaxy Sandoz 02366320 Teva Candesartan Teva Can 100 500 30 30 100 100 500 30 100 30 100 100 100 100 30 100 100 30 500 30 100 Tab. 28.50 142.50 35.52 8.55 28.50 28.50 142.50 8.55 28.50 8.55 28.50 28.50 28.50 28.50 8.55 28.50 28.50 8.55 142.50 8.55 28.50 0.2850 0.2850 1.1840 0.2850 0.2850 0.2850 0.2850 0.2850 0.2850 0.2850 0.2850 0.2850 0.2850 0.2850 0.2850 0.2850 0.2850 0.2850 0.2850 0.2850 0.2850 32 mg PPB 02311658 Atacand 02379295 Candesartan cilexetil AZC Accord 02376555 02386534 02379155 02391228 Cobalt Jamp Mylan Phmscience Co Candesartan Jamp-Candesartan Mylan-Candesartan pms-Candesartan + 02380714 Ran-Candesartan 02392267 Sandoz Candesartan Ranbaxy Sandoz 02366339 Teva Candesartan Teva Can 2013-04 30 30 100 100 100 100 30 100 30 30 100 30 35.52 8.55 28.50 28.50 28.50 28.50 8.55 28.50 8.55 8.55 28.50 8.55 1.1840 0.2850 0.2850 0.2850 0.2850 0.2850 0.2850 0.2850 0.2850 0.2850 0.2850 0.2850 Page 131 CODE BRAND NAME MANUFACTURER CANDESARTAN CILEXETIL/ HYDROCHLOROTHIAZIDE X Tab. 02367866 Apo-Candesartan/ HCTZ Apotex 02244021 Atacand Plus 02392275 Candesartan - HCTZ AZC Pro Doc 02394812 Candesartan HCT Sivem 02394804 Candesartan/ HCTZ 02388650 Co Candesartan/ HCT Sanis Cobalt 02374897 Mylan-Candesartan HCTZ 02391295 pms-Candesartan-HCTZ 02327902 Sandoz Candesartan Plus Mylan Phmscience Sandoz 02395541 Teva Candesartan/ HCTZ Teva Can 02395126 Apo-Candesartan/ HCTZ 02332922 Atacand Plus 02395568 Teva Candesartan/ HCTZ Apotex AZC Teva Can 02395134 Apo-Candesartan/ HCTZ 02332957 Atacand Plus 02395576 Teva Candesartan/ HCTZ Apotex AZC Teva Can Tab. SIZE UNIT PRICE 16 mg -12.5 mg PPB 100 500 30 30 100 30 100 100 30 100 100 30 30 500 30 29.93 149.75 35.10 8.98 29.95 8.98 29.95 29.93 8.98 29.95 29.93 8.98 8.98 149.75 8.98 0.2993 0.2995 1.1700 0.2993 0.2995 0.2993 0.2995 0.2993 0.2993 0.2995 0.2993 0.2993 0.2993 0.2995 0.2993 32 mg - 12.5 mg PPB Tab. 30 30 30 18.95 35.10 18.95 0.6317 1.1700 0.6317 32 mg - 25 mg PPB 30 30 30 EPROSARTAN (MESYLATE D')/ HYDROCHLOROTHIAZIDE X Tab. 02253631 Teveten Plus 02240432 Teveten 18.95 35.10 18.95 0.6317 1.1700 0.6317 600 mg - 12.5 mg Abbott 28 Abbott 28 EPROSARTAN MESYLATE X Tab. 30.34 1.0836 400 mg Tab. 19.81 0.7075 600 mg 02243942 Teveten Page COST OF PKG. SIZE 132 Abbott 28 30.34 1.0836 2013-04 CODE BRAND NAME MANUFACTURER SIZE IRBESARTAN X Tab. 02386968 02237923 02328070 02365197 02372347 02385287 02347296 02317060 02316390 02328461 02315971 Apo-Irbesartan Avapro Co Irbesartan Irbesartan Irbesartan Irbesartan Mylan-Irbesartan pms-Irbesartan ratio-Irbesartan Sandoz Irbesartan Teva Irbesartan COST OF PKG. SIZE UNIT PRICE 75 mg PPB Apotex SanofiAven Cobalt Pro Doc Sanis Sivem Mylan Phmscience Teva Can Sandoz Teva Can 100 90 100 100 100 100 90 100 100 100 100 02386976 Apo-Irbesartan Apotex 02237924 Avapro 02328089 Co Irbesartan SanofiAven Cobalt 02365200 Irbesartan Pro Doc 02372371 02385295 02347318 02317079 Sanis Sivem Mylan Phmscience 100 500 90 100 500 100 500 100 100 90 100 500 100 100 500 100 Tab. 30.25 107.33 30.25 30.25 30.25 30.25 27.23 30.25 30.25 30.25 30.25 0.3025 1.1926 0.3025 0.3025 0.3025 0.3025 0.3025 0.3025 0.3025 0.3025 0.3025 150 mg PPB Irbesartan Irbesartan Mylan-Irbesartan pms-Irbesartan 02316404 ratio-Irbesartan 02328488 Sandoz Irbesartan Teva Can Sandoz 02315998 Teva Irbesartan Teva Can 02386984 Apo-Irbesartan Apotex 02237925 Avapro 02328100 Co Irbesartan SanofiAven Cobalt 02365219 Irbesartan Pro Doc 02372398 02385309 02347326 02317087 Sanis Sivem Mylan Phmscience Tab. 30.25 151.25 107.33 30.25 151.25 30.25 151.25 30.25 30.25 27.23 30.25 151.25 30.25 30.25 151.25 30.25 0.3025 0.3025 1.1926 0.3025 0.3025 0.3025 0.3025 0.3025 0.3025 0.3025 0.3025 0.3025 0.3025 0.3025 0.3025 0.3025 300 mg PPB Irbesartan Irbesartan Mylan-Irbesartan pms-Irbesartan 02316412 ratio-Irbesartan 02328496 Sandoz Irbesartan Teva Can Sandoz 02316005 Teva Irbesartan Teva Can 2013-04 100 500 90 100 250 100 500 100 100 90 100 500 100 100 500 100 30.25 151.25 107.33 30.25 75.63 30.25 151.25 30.25 30.25 27.23 30.25 151.25 30.25 30.25 151.25 30.25 0.3025 0.3025 1.1926 0.3025 0.3025 0.3025 0.3025 0.3025 0.3025 0.3025 0.3025 0.3025 0.3025 0.3025 0.3025 0.3025 Page 133 CODE BRAND NAME MANUFACTURER IRBESARTAN/ HYDROCHLOROTHIAZIDE X Tab. Apotex 02241818 02357399 02385317 02372886 02365162 02392992 02328518 02363208 02330512 02337428 SanofiAven Cobalt Sivem Sanis Pro Doc Mint Phmscience Ranbaxy Teva Can Sandoz 02316013 Teva Irbesartan / HCTZ Teva Can Tab. UNIT PRICE 100 500 90 100 100 100 100 100 100 100 100 100 500 100 30.24 151.20 107.33 30.24 30.24 30.24 30.24 30.24 30.24 30.24 30.24 30.24 151.20 30.24 0.3024 0.3024 1.1926 0.3024 0.3024 0.3024 0.3024 0.3024 0.3024 0.3024 0.3024 0.3024 0.3024 0.3024 300 mg- 12.5 mg PPB 02387654 Apo-Irbesartan/HCTZ Apotex 02241819 02357402 02385325 02372894 02365170 02393018 02328526 02363216 02330520 02337436 SanofiAven Cobalt Sivem Sanis Pro Doc Mint Phmscience Ranbaxy Teva Can Sandoz Avalide Co Irbesartan/HCT Irbesartan HCT Irbesartan HCTZ Irbesartan-HCTZ Mint-Irbesartan/ HCTZ pms-Irbesartan-HCTZ Ran-Irbesartan HCTZ ratio-Irbesartan HCTZ Sandoz Irbesartan HCT 02316021 Teva Irbesartan / HCTZ Teva Can 02387662 Apo-Irbesartan/HCTZ Apotex 02357410 02385333 02372908 02365189 02393026 02328534 02363224 02330539 02337444 Cobalt Sivem Sanis Pro Doc Mint Phmscience Ranbaxy Teva Can Sandoz Tab. 100 500 90 100 100 100 100 100 100 100 100 100 500 100 30.24 151.20 107.33 30.24 30.24 30.24 30.24 30.24 30.24 30.24 30.24 30.24 151.20 30.24 0.3024 0.3024 1.1926 0.3024 0.3024 0.3024 0.3024 0.3024 0.3024 0.3024 0.3024 0.3024 0.3024 0.3024 300 mg - 25 mg PPB Co Irbesartan/HCT Irbesartan HCT Irbesartan HCTZ Irbesartan-HCTZ Mint-Irbesartan/ HCTZ pms-Irbesartan-HCTZ Ran-Irbesartan HCTZ ratio-Irbesartan HCTZ Sandoz Irbesartan HCT 02316048 Teva Irbesartan / HCTZ Page COST OF PKG. SIZE 150 mg- 12.5 mg PPB 02387646 Apo-Irbesartan/HCTZ Avalide Co Irbesartan/HCT Irbesartan HCT Irbesartan HCTZ Irbesartan-HCTZ Mint-Irbesartan/ HCTZ pms-Irbesartan-HCTZ Ran-Irbesartan HCTZ ratio-Irbesartan HCTZ Sandoz Irbesartan HCT SIZE 134 Teva Can 100 500 100 100 100 100 100 100 100 100 100 500 100 30.04 150.20 30.04 30.04 30.04 30.04 30.04 30.04 30.04 30.04 30.04 150.20 30.04 0.3004 0.3004 0.3004 0.3004 0.3004 0.3004 0.3004 0.3004 0.3004 0.3004 0.3004 0.3004 0.3004 2013-04 CODE BRAND NAME MANUFACTURER SIZE LOSARTAN POTASSIUM X Tab. COST OF PKG. SIZE UNIT PRICE 25 mg PPB 02379058 Apo-Losartan Apotex 02354829 Co Losartan Cobalt 02182815 Cozaar 02394367 Losartan Merck Pro Doc 02388863 Losartan 02388790 Losartan 02368277 Mylan-Losartan Sanis Sivem Mylan 02309750 pms-Losartan 02313332 Sandoz Losartan Phmscience Sandoz 02380838 Teva Losartan Teva Can 02353504 Apo-Losartan Apotex 02354837 Co Losartan Cobalt 02182874 Cozaar Merck 02394375 Losartan Pro Doc 02388871 Losartan 02388804 Losartan Sanis Sivem 02368285 Mylan-Losartan Mylan 02309769 pms-Losartan Phmscience 02313340 Sandoz Losartan Sandoz 02357968 Teva Losartan Teva Can 30 100 30 100 100 30 100 100 100 30 100 100 30 100 30 100 Tab. 9.44 31.47 9.44 31.47 117.07 9.44 31.47 31.47 31.47 9.44 31.47 31.47 9.44 31.47 9.44 31.47 0.3147 0.3147 0.3147 0.3147 1.1707 0.3147 0.3147 0.3147 0.3147 0.3147 0.3147 0.3147 0.3147 0.3147 0.3147 0.3147 50 mg PPB 2013-04 30 100 30 100 30 100 30 100 100 30 100 30 100 30 100 30 100 30 100 9.44 31.47 9.44 31.47 35.12 117.07 9.44 31.47 31.47 9.44 31.47 9.44 31.47 9.44 31.47 9.44 31.47 9.44 31.47 0.3147 0.3147 0.3147 0.3147 1.1707 1.1707 0.3147 0.3147 0.3147 0.3147 0.3147 0.3147 0.3147 0.3147 0.3147 0.3147 0.3147 0.3147 0.3147 Page 135 CODE BRAND NAME MANUFACTURER SIZE Tab. UNIT PRICE 100 mg PPB 02353512 Apo-Losartan Apotex 02354845 Co Losartan Cobalt 02182882 Cozaar Merck 02394383 Losartan Pro Doc 02388898 Losartan 02388812 Losartan Sanis Sivem 02368293 Mylan-Losartan Mylan 02309777 pms-Losartan Phmscience 02313359 Sandoz Losartan Sandoz 02357976 Teva Losartan Teva Can LOSARTAN POTASSIUM/ HYDROCHLOROTHIAZIDE X Tab. Page COST OF PKG. SIZE 02371235 Apo-Losartan/HCTZ Apotex 02388251 Co Losartan/HCT Cobalt 02230047 Hyzaar Merck 02394391 Losartan - HCTZ Pro Doc 02388960 Losartan/HCT Sivem 02378078 Mylan-Losartan HCTZ Mylan 02392224 pms-Losartan-HCTZ Phmscience 02313375 Sandoz Losartan HCT Sandoz 02358263 Teva Losartan/HCTZ Teva Can 136 30 100 30 100 30 100 30 100 100 30 100 30 100 30 100 30 100 30 100 9.44 31.47 9.44 31.47 35.12 117.07 9.44 31.47 31.47 9.44 31.47 9.44 31.47 9.44 31.47 9.44 31.47 9.44 31.47 0.3147 0.3147 0.3147 0.3147 1.1707 1.1707 0.3147 0.3147 0.3147 0.3147 0.3147 0.3147 0.3147 0.3147 0.3147 0.3147 0.3147 0.3147 0.3147 50 mg -12.5 mg PPB 30 100 30 100 30 100 30 100 30 100 30 100 30 100 30 100 30 9.44 31.47 9.44 31.47 35.12 117.07 9.44 31.47 9.44 31.47 9.44 31.47 9.44 31.47 9.44 31.47 9.44 0.3147 0.3147 0.3147 0.3147 1.1707 1.1707 0.3147 0.3147 0.3147 0.3147 0.3147 0.3147 0.3147 0.3147 0.3147 0.3147 0.3147 2013-04 CODE BRAND NAME MANUFACTURER Tab. SIZE COST OF PKG. SIZE UNIT PRICE 100 mg - 12.5 mg PPB 02371243 Apo-Losartan/HCTZ Apotex 02388278 Co Losartan/HCT Cobalt 02297841 Hyzaar Merck 02394405 Losartan - HCTZ Pro Doc 02388979 Losartan/HCT Sivem 02378086 Mylan-Losartan HCTZ Mylan 02392232 pms-Losartan-HCTZ Phmscience 02362449 Sandoz Losartan HCT Sandoz 02377144 Teva Losartan/HCTZ Teva Can Tab. 30 100 30 100 30 100 30 100 30 100 30 100 30 100 30 100 30 9.25 30.82 9.25 30.82 35.02 116.73 9.25 30.82 9.25 30.82 9.25 30.82 9.25 30.82 9.25 30.82 9.25 0.3083 0.3082 0.3083 0.3082 1.1673 1.1673 0.3083 0.3082 0.3083 0.3082 0.3083 0.3082 0.3083 0.3082 0.3083 0.3082 0.3083 100 mg -25 mg PPB 02371251 Apo-Losartan/HCTZ Apotex 02388286 Co Losartan/HCT Cobalt 02241007 Hyzaar DS Merck 02394413 Losartan - HCTZ Pro Doc 02388987 Losartan/HCT Sivem 02378094 Mylan-Losartan HCTZ Mylan 02392240 pms-Losartan-HCTZ Phmscience 02313383 Sandoz Losartan HCT DS Sandoz 02377152 Teva Losartan/HCTZ Teva Can 30 100 30 100 30 100 30 100 30 100 30 100 30 100 30 100 30 OLMESARTAN MEDOXOMIL X Tab. 02318660 Olmetec 9.44 31.47 9.44 31.47 35.12 117.07 9.44 31.47 9.44 31.47 9.44 31.47 9.44 31.47 9.44 31.47 9.44 0.3147 0.3147 0.3147 0.3147 1.1707 1.1707 0.3147 0.3147 0.3147 0.3147 0.3147 0.3147 0.3147 0.3147 0.3147 0.3147 0.3147 20 mg Merck 28 30 Tab. 28.46 30.49 1.0164 1.0163 40 mg 02318679 Olmetec 2013-04 Merck 28 30 28.46 30.49 1.0164 1.0163 Page 137 CODE BRAND NAME MANUFACTURER SIZE OLMESARTAN MEDOXOMIL/HYDROCHLOROTHIAZIDE X Tab. UNIT PRICE 20 mg -12.5 mg 02319616 Olmetec Plus Merck 28 30 02319624 Olmetec Plus Merck 28 30 Tab. 28.46 30.49 1.0164 1.0163 40 mg - 12.5 mg Tab. 28.46 30.49 1.0164 1.0163 40 mg - 25 mg 02319632 Olmetec Plus Merck 28 30 02393247 Co Telmisartan Cobalt 02240769 Micardis 02376717 Mylan-Telmisartan Bo. Ing. Mylan 02391236 pms-Telmisartan 02375958 Sandoz Telmisartan Phmscience Sandoz 02395223 Telmisartan Pro Doc 02388944 Telmisartan 02390345 Telmisartan Sanis Sivem 02320177 Teva Telmisartan Teva Can 30 100 28 28 100 100 30 100 30 100 100 30 100 30 100 TELMISARTAN X Tab. 28.46 30.49 1.0164 1.0163 40 mg PPB Tab. Page COST OF PKG. SIZE 8.46 28.24 31.63 7.90 28.24 28.21 8.46 28.24 8.46 28.24 28.24 8.46 28.24 8.46 28.24 0.2821 0.2824 1.1296 0.2821 0.2824 0.2821 0.2821 0.2824 0.2821 0.2824 0.2824 0.2821 0.2824 0.2821 0.2824 80 mg PPB 02393255 Co Telmisartan Cobalt 02240770 Micardis 02376725 Mylan-Telmisartan Bo. Ing. Mylan 02391244 pms-Telmisartan 02375966 Sandoz Telmisartan Phmscience Sandoz 02395231 Telmisartan Pro Doc 02388952 Telmisartan Sanis 02390353 Telmisartan Sivem 02320185 Teva Telmisartan Teva Can 138 30 100 28 28 100 100 30 100 30 100 100 500 30 100 30 100 8.46 28.24 31.63 7.90 28.24 28.21 8.46 28.24 8.46 28.24 28.21 141.20 8.46 28.24 8.46 28.24 0.2821 0.2824 1.1296 0.2821 0.2824 0.2821 0.2821 0.2824 0.2821 0.2824 0.2821 0.2824 0.2821 0.2824 0.2821 0.2824 2013-04 CODE BRAND NAME MANUFACTURER TELMISARTAN/ HYDROCHLOROTHIAZIDE X Tab. 02393263 Co Telmisartan/HCT Cobalt 02244344 Micardis Plus 02373564 Mylan-Telmisartan HCTZ Bo. Ing. Mylan 02393557 Sandoz Telmisartan HCT Sandoz 02395525 Telmisartan - HCTZ Pro Doc 02390302 Telmisartan HCTZ Sivem 02395355 Telmisartan/ HCTZ 02330288 Teva Telmisartan HCTZ Sanis Teva Can Tab. SIZE COST OF PKG. SIZE UNIT PRICE 80 mg - 12.5 mg PPB 30 100 28 28 100 30 100 30 100 30 100 100 30 500 8.47 28.24 31.63 7.91 28.24 8.47 28.24 8.47 28.24 8.47 28.24 28.23 8.47 141.20 0.2823 0.2824 1.1296 0.2823 0.2824 0.2823 0.2824 0.2823 0.2824 0.2823 0.2824 0.2823 0.2823 0.2824 80 mg - 25 mg PPB 02393271 Co Telmisartan/HCT Cobalt 02318709 Micardis Plus 02373572 Mylan-Telmisartan HCTZ Bo. Ing. Mylan 02393565 Sandoz Telmisartan HCT Sandoz 02395533 Telmisartan - HCTZ Pro Doc 02390310 Telmisartan HCTZ Sivem 02395363 Telmisartan/ HCTZ 02379252 Teva Telmisartan HCTZ Sanis Teva Can 30 100 28 28 100 30 100 30 100 30 100 100 30 100 TELMISARTAN/AMLODIPINE X Tab. 02371022 Twynsta 8.47 28.24 31.63 7.91 28.24 8.47 28.24 8.47 28.24 8.47 28.24 28.23 8.47 28.24 0.2823 0.2824 1.1296 0.2823 0.2824 0.2823 0.2824 0.2823 0.2824 0.2823 0.2824 0.2823 0.2823 0.2824 40 mg - 5 mg Bo. Ing. 28 Tab. 19.09 0.6818 40 mg - 10 mg 02371030 Twynsta Bo. Ing. 28 02371049 Twynsta Bo. Ing. 28 Tab. 19.09 0.6818 80 mg -5 mg Tab. 19.09 0.6818 80 mg - 10 mg 02371057 Twynsta 2013-04 Bo. Ing. 28 19.09 0.6818 Page 139 CODE BRAND NAME MANUFACTURER SIZE VALSARTAN X Tab. 02371510 02337487 02270528 02383527 02312999 02363062 02356740 UNIT PRICE 40 mg PPB Apo-Valsartan Co Valsartan Diovan Mylan-Valsartan pms-Valsartan Ran-Valsartan Sandoz Valsartan Apotex Cobalt Novartis Mylan Phmscience Ranbaxy Sandoz 02356643 Teva Valsartan 02367726 Valsartan Teva Can Pro Doc 02366940 Valsartan 02384523 Valsartan Sanis Sivem 30 100 28 100 30 100 30 100 30 30 100 100 30 100 Tab. Page COST OF PKG. SIZE 12.24 40.80 31.27 40.80 12.24 40.80 12.24 40.80 12.24 12.24 40.80 40.80 12.24 40.80 0.4080 0.4080 1.1168 0.4080 0.4080 0.4080 0.4080 0.4080 0.4080 0.4080 0.4080 0.4080 0.4080 0.4080 80 mg PPB 02371529 Apo-Valsartan Apotex 02337495 02244781 02383535 02313006 Cobalt Novartis Mylan Phmscience Co Valsartan Diovan Mylan-Valsartan pms-Valsartan 02363100 Ran-Valsartan Ranbaxy 02356759 Sandoz Valsartan Sandoz 02356651 Teva Valsartan Teva Can 02367734 Valsartan Pro Doc 02366959 Valsartan Sanis 02384531 Valsartan Sivem 140 30 500 100 28 100 30 100 100 500 30 500 30 100 30 500 100 500 30 100 8.87 147.85 29.57 31.47 29.57 8.87 29.57 29.57 147.85 8.87 147.85 8.87 29.57 8.87 147.85 29.57 147.85 8.87 29.57 0.2957 0.2957 0.2957 1.1239 0.2957 0.2957 0.2957 0.2957 0.2957 0.2957 0.2957 0.2957 0.2957 0.2957 0.2957 0.2957 0.2957 0.2957 0.2957 2013-04 CODE BRAND NAME MANUFACTURER SIZE Tab. COST OF PKG. SIZE UNIT PRICE 160 mg PPB 02371537 Apo-Valsartan Apotex 02337509 02244782 02383543 02313014 Cobalt Novartis Mylan Phmscience Co Valsartan Diovan Mylan-Valsartan pms-Valsartan 02363119 Ran-Valsartan Ranbaxy 02356767 Sandoz Valsartan Sandoz 02356678 Teva Valsartan Teva Can 02367742 Valsartan Pro Doc 02366967 Valsartan Sanis 02384558 Valsartan Sivem 02371545 02337517 02289504 02383551 02344564 Apotex Cobalt Novartis Mylan Phmscience 30 500 100 28 100 30 100 100 500 30 500 30 100 30 500 100 500 30 100 Tab. 8.87 147.85 29.57 31.47 29.57 8.87 29.57 29.57 147.85 8.87 147.85 8.87 29.57 8.87 147.85 29.57 147.85 8.87 29.57 0.2957 0.2957 0.2957 1.1239 0.2957 0.2957 0.2957 0.2957 0.2957 0.2957 0.2957 0.2957 0.2957 0.2957 0.2957 0.2957 0.2957 0.2957 0.2957 320 mg PPB Apo-Valsartan Co Valsartan Diovan Mylan-Valsartan pms-Valsartan 02356775 Sandoz Valsartan Sandoz 02356686 Teva Valsartan 02367750 Valsartan Teva Can Pro Doc 02366975 Valsartan 02384566 Valsartan Sanis Sivem VALSARTAN/HYDROCHLOROTHIAZIDE X Tab. 8.53 28.43 31.47 28.43 8.53 28.43 8.53 28.43 8.53 8.53 28.43 28.43 8.53 28.43 0.2843 0.2843 1.1239 0.2843 0.2843 0.2843 0.2843 0.2843 0.2843 0.2843 0.2843 0.2843 0.2843 0.2843 80 mg - 12.5 mg PPB 02382547 Apo-Valsartan/HCTZ Apotex 02241900 Diovan-HCT 02373734 Mylan-Valsartan-HCTZ 02356694 Sandoz Valsartan HCT Novartis Mylan Sandoz 02356996 Teva Valsartan/HCTZ Teva Can 02367009 Valsartan HCT 02384736 Valsartan HCT Sanis Sivem 02367769 Valsartan-HCTZ Pro Doc 2013-04 30 100 28 100 30 100 30 100 30 30 100 100 30 100 30 100 28 100 30 100 30 50 100 30 100 30 100 8.87 29.58 32.16 29.57 8.87 29.58 8.87 14.79 29.57 8.87 29.58 8.87 29.58 0.2957 0.2958 1.1486 0.2957 0.2957 0.2958 0.2957 0.2958 0.2957 0.2957 0.2958 0.2957 0.2958 Page 141 CODE BRAND NAME MANUFACTURER Tab. COST OF PKG. SIZE UNIT PRICE 160 mg -12.5 mg PPB 02382555 Apo-Valsartan/HCTZ Apotex 02241901 Diovan-HCT 02373742 Mylan-Valsartan-HCTZ 02356708 Sandoz Valsartan HCT Novartis Mylan Sandoz 02357003 Teva Valsartan/HCTZ Teva Can 02367017 Valsartan HCT Sanis 02384744 Valsartan HCT Sivem 02367777 Valsartan-HCTZ Pro Doc 02382563 Apo-Valsartan/HCTZ Apotex 02246955 Diovan-HCT 02373750 Mylan-Valsartan-HCTZ 02356716 Sandoz Valsartan HCT Novartis Mylan Sandoz 02357011 Teva Valsartan/HCTZ Teva Can 02367025 Valsartan HCT Sanis 02384752 Valsartan HCT Sivem 02367785 Valsartan-HCTZ Pro Doc 02382571 02308908 02373769 02356724 Apotex Novartis Mylan Sandoz Tab. 30 500 28 100 30 500 30 50 100 500 30 100 30 500 8.87 147.90 32.10 29.57 8.87 147.90 8.87 14.79 29.57 147.90 8.87 29.58 8.87 147.90 0.2957 0.2958 1.1464 0.2957 0.2957 0.2958 0.2957 0.2958 0.2957 0.2958 0.2957 0.2958 0.2957 0.2958 160 mg - 25 mg PPB Tab. 30 500 28 100 30 500 30 50 100 500 30 100 30 500 8.87 147.90 31.99 29.57 8.87 147.90 8.87 14.79 29.57 147.90 8.87 29.58 8.87 147.90 0.2957 0.2958 1.1425 0.2957 0.2957 0.2958 0.2957 0.2958 0.2957 0.2958 0.2957 0.2958 0.2957 0.2958 320 mg - 12.5 mg PPB Apo-Valsartan/HCTZ Diovan-HCT Mylan-Valsartan-HCTZ Sandoz Valsartan HCT 02357038 Teva Valsartan/HCTZ 02367033 Valsartan HCT 02384760 Valsartan HCT Teva Can Sanis Sivem 02382598 02308916 02373777 02356732 Apotex Novartis Mylan Sandoz Tab. 30 28 100 30 100 30 30 30 8.74 31.49 29.13 8.74 29.12 8.74 8.74 8.74 0.2913 1.1246 0.2913 0.2913 0.2912 0.2913 0.2913 0.2913 320 mg - 25 mg PPB Apo-Valsartan/HCTZ Diovan-HCT Mylan-Valsartan-HCTZ Sandoz Valsartan HCT 02357046 Teva Valsartan/HCTZ 02367041 Valsartan HCT 02384779 Valsartan HCT Page SIZE 142 Teva Can Sanis Sivem 30 28 100 30 100 30 100 30 8.74 31.49 29.13 8.74 29.12 8.74 29.13 8.74 0.2913 1.1246 0.2913 0.2913 0.2912 0.2913 0.2913 0.2913 2013-04 CODE BRAND NAME MANUFACTURER SIZE COST OF PKG. SIZE UNIT PRICE 24:32.20 ALDOSTERONE RECEPTOR ANTAGONISTS SPIRONOLACTONE X Tab. 00028606 Aldactone 00613215 Novo-Spiroton 25 mg PPB Pfizer Novopharm 100 500 Tab. 7.47 34.60 0.0747 0.0448 100 mg PPB 00285455 Aldactone 00613223 Novo-Spiroton 2013-04 Pfizer Novopharm 100 100 22.93 21.20 0.2293 0.1376 Page 143 28:00 CENTRAL NERVOUS SYSTEM AGENTS 28:08 28:08.04 28:08.08 28:08.12 28:08.92 28:10 28:12 28:12.04 28:12.08 28:12.12 28:12.20 28:12.92 28:16 28:16.04 28:16.08 28:20 28:20.04 28:20.92 28:24 28:24.08 28:24.92 28:28 28:32 28:32.28 28:32.92 28:36 28:36.04 28:36.08 28:36.12 28:36.16 28:36.20 28:36.32 28:36.92 28:92 analgesics and antipyretics nonsteroidal anti‑ inflammatory agents opiate agonists opiate partial agonists miscellaneous analgesics and antipyretics opiate antagonists anticonvulsants barbiturates benzodiazepines hydantoins succinimides miscellaneous anticonvulsants psychotropics antidepressants antipsychotic agents cns stimulants amphetamines cns stimulants, miscellaneous anxiolytics, sedatives and hypnotics benzodiazepines miscellaneous anxiolytics, sedatives, hypnotics antimanic agents antimigraine agents selective serotonin agonists antimigraine agents, miscellaneous Antiparkinsonian Agents Adamantanes Anticholinergic Agents Catechol‑O‑Methyltransferase Inhibitors Dopamine Precursors Dopamine Receptor Agonists Monoamine Oxydase B Inhibitors Antiparkinsonian Agents, Miscellaneous miscellaneous Central Nervous System Agents CODE BRAND NAME MANUFACTURER SIZE COST OF PKG. SIZE UNIT PRICE 28:08.04 NONSTEROIDAL ANTI- INFLAMMATORY AGENTS ACETYLSALICYLIC ACID Ent. Tab. 325 mg PPB 02352427 Asatab EC 325 mg 02010526 Jamp-AAS EC 02284529 pms-ASA EC Odan Jamp Phmscience 1000 500 1000 Ent. Tab. 28.00 14.00 28.00 0.0280 0.0280 0.0280 650 mg PPB 02352435 Asatab EC 650 mg 00794244 Enteric coated ASA Odan Jamp Supp. 500 500 27.50 27.50 0.0550 0.0550 640 mg to 650 mg 00582867 pms-ASA Phmscience 10 02321750 ASA 80 02321769 ASA EC 80 02009013 Asaphen Sorres Sorres Phmscience 02238545 Asaphen E.C. Phmscience 02280167 02150352 02250675 02269139 02283905 02296004 Odan Bayer Euro-Pharm Jamp Jamp Euro-Pharm 100 500 100 500 500 1000 500 300 500 500 1000 30 500 30 500 100 500 120 500 500 1000 100 500 100 500 100 1000 Tab or EntTab or ChewTab Asatab Aspirin (Chew Tab) Euro-ASA Jamp-A.A.S. (Chew. Tab.) Jamp-A.A.S. (Ent. Tab.) Lowprin (chew. tab.) Euro-Pharm 02247318 phl-Asa Pharmel 02247355 phl-Asa E.C. Pharmel 02311496 Pro-AAS EC-80 Pro Doc 02311518 Pro-AAS-80 (chewable) Pro Doc 02202352 Rivasa (Co. Croq.) Riva 02202360 Rivasa FC (Co.) Riva CELECOXIB X Caps. 2013-04 1.1000 80 mg PPB 02295563 Lowprin (tab.) 02239941 Celebrex 11.00 5.60 28.00 5.60 28.00 28.00 56.00 28.00 16.80 28.00 28.00 56.00 1.68 28.00 1.68 28.00 5.60 28.00 6.72 28.00 28.00 56.00 5.60 28.00 5.60 28.00 5.60 56.00 0.0560 0.0560 0.0560 0.0560 0.0560 0.0560 0.0560 0.0560 0.0560 0.0560 0.0560 0.0560 0.0560 0.0560 0.0560 0.0560 0.0560 0.0560 0.0560 0.0560 0.0560 0.0560 0.0560 0.0560 0.0560 0.0560 0.0560 100 mg Pfizer 100 500 67.58 337.88 0.6758 0.6758 Page 147 CODE BRAND NAME MANUFACTURER SIZE Caps. UNIT PRICE 200 mg 02239942 Celebrex Pfizer DICLOFENAC POTASSIUM OR SODIUM X Tab - Ent.Tab or LA Tab 100 500 135.15 675.77 1.3515 1.3515 50 mg /50 mg L.A. /100 mg L.A. PPB 00839183 Apo-Diclo 50 mg Apotex 02048698 Novo-Difenac SR 100 mg 02347849 NTP-Diclofenac 50 mg 02302624 pms-Diclofenac 50 mg Novopharm NT Pharma Phmscience 02239753 pms-Diclofenac-K 50 mg Phmscience 02231505 pms-Diclofenac-SR 100 mg Phmscience 02311461 Pro-Diclo Fast-50 02261960 Sandoz Diclofenac 50 mg 02261774 Sandoz Diclofenac Rapide 50 mg 02261944 Sandoz Diclofenac SR 100 mg 02239355 Teva-Diclofenac K Pro Doc Sandoz Sandoz 100 500 100 100 250 100 100 100 100 100 500 100 100 100 500 100 500 100 250 100 100 100 02243433 Apo-Diclo Rapide 50 mg 02091194 Apo-Diclo SR 100mg Apotex Apotex 02352397 02351684 00870978 02224127 00808547 Sanis Sanis Pro Doc Pro Doc Novopharm Sandoz 100 40.48 0.4048 Teva Can 00514012 Voltaren 50 mg 00881635 Voltaren Rapide 50 mg 00590827 Voltaren S.R. 100 mg Novartis Novartis Novartis 100 500 100 100 100 20.24 101.20 72.81 68.46 143.33 0.2024 0.2024 0.7281 0.6846 1.4333 Pfizer 250 Diclofenac EC Diclofenac K Diclofenac-50 Diclofenac-SR 100 mg Novo-Difenac 50 mg DICLOFENAC SODIC/MISOPROSTOL X Tab. 01917056 Arthrotec 20.24 101.20 20.24 40.48 101.20 20.24 20.24 20.24 40.48 20.24 101.20 40.48 20.24 20.24 101.20 20.24 101.20 40.48 101.20 20.24 20.24 20.24 0.2024 0.2024 0.2024 0.4048 0.4048 0.2024 0.2024 0.2024 0.4048 0.2024 0.2024 0.4048 0.2024 0.2024 0.2024 0.2024 0.2024 0.4048 0.4048 0.2024 0.2024 0.2024 50 mg -200 mcg Tab. 149.75 0.5990 75 mg - 200 mcg 02229837 Arthrotec 75 Page COST OF PKG. SIZE 148 Pfizer 250 203.81 0.8152 2013-04 CODE BRAND NAME MANUFACTURER DICLOFENAC SODIUM X Ent.Tab.or L.A.Tab Apotex Apotex 02352400 02224119 00808539 02158582 02347857 02302616 02231504 Sanis Pro Doc Novopharm Novopharm NT Pharma Phmscience Phmscience 02261952 Sandoz Diclofenac 02261901 Sandoz Diclofenac SR 75 mg 00782459 Voltaren S.R. 75 mg COST OF PKG. SIZE UNIT PRICE 25 mg / 75 mg L.A. PPB 00839175 Apo-Diclo 25 mg 02162814 Apo-Diclo S.R. 75 mg Diclofenac SR Diclofenac-SR 75 mg Novo-Difenac 25 mg Novo-Difenac SR 75 mg NTP-Diclofenac SR pms-Diclofenac 25 mg pms-Diclofenac- SR 75 mg SIZE Sandoz Sandoz 100 100 500 100 100 100 100 100 100 100 500 100 100 7.82 23.46 117.21 23.46 23.46 7.82 23.46 23.46 7.82 23.46 117.21 7.82 23.46 0.0782 0.2346 0.2344 0.2346 0.2346 0.0782 0.2346 0.2346 0.0782 0.2346 0.2344 0.0782 0.2346 Novartis 100 100.56 1.0056 Supp. 50 mg PPB 02231506 pms-Diclofenac 02261928 Sandoz Diclofenac 00632724 Voltaren Phmscience Sandoz Novartis 30 30 30 Supp. 13.02 13.02 32.79 0.4340 0.4340 1.0930 100 mg PPB 02231508 pms-Diclofenac 02261936 Sandoz Diclofenac 00632732 Voltaren Phmscience Sandoz Novartis 30 30 30 DIFLUNISAL X Tab. 17.53 17.53 44.14 0.5843 0.5843 1.4713 250 mg 02048493 Novo-Diflunisal Novopharm 60 02039494 Apo-Diflunisal Apotex 100 02232317 Apo-Etodolac AA Pharma 100 02232318 Apo-Etodolac AA Pharma 100 Tab. 16.94 0.2823 500 mg ETODOLAC X Caps. 53.63 0.5363 200 mg Caps. 76.00 0.6213 300 mg 2013-04 76.00 0.6213 Page 149 CODE BRAND NAME MANUFACTURER SIZE FLURBIPROFEN X Tab. UNIT PRICE 50 mg PPB 01912046 Apo-Flurbiprofen 02100509 Novo-Flurprofen Apotex Novopharm 100 100 01912038 Apo-Flurbiprofen 02100517 Novo-Flurprofen Apotex Novopharm 100 100 Euro-Pharm 120 ml Tab. 22.21 22.21 0.2221 0.2221 100 mg PPB IBUPROFEN Oral Susp. 02354799 Europrofen 30.39 30.39 0.3039 0.3039 100 mg/5 mL Tab. 6.33 0.0528 200 mg 02272849 Jamp-Ibuprofene Jamp 100 00506052 Apo-Ibuprofen Apotex 00636533 Ibuprofen-400 Pro Doc 02317338 Ibuprofene 00629340 Novo-Profen 00836133 pms-Ibuprofen Jamp Novopharm Phmscience 100 1000 100 1000 1000 1000 100 500 Tab. 5.44 0.0544 400 mg PPB IBUPROFEN X Tab. Pro Doc 00629359 Novo-Profen Novopharm 0.0372 0.0372 0.0372 0.0372 0.0372 0.0372 0.0372 0.0372 100 500 100 500 4.65 23.25 4.65 23.25 W W 0.0465 0.0465 25 mg PPB 00611158 Apo-Indomethacin 25 mg Apotex 00337420 Novo-Methacin 25 mg Novopharm 00646261 Pro-Indo-25 Pro Doc 150 3.72 37.20 3.72 37.20 37.20 37.20 3.72 18.60 600 mg PPB 00658804 Ibuprofen-600 INDOMETHACIN X Caps. Page COST OF PKG. SIZE 100 1000 100 1000 100 8.71 87.10 8.71 87.10 8.71 0.0871 0.0871 0.0871 0.0871 0.0871 2013-04 CODE BRAND NAME MANUFACTURER SIZE Caps. COST OF PKG. SIZE UNIT PRICE 50 mg PPB 00611166 Apo-Indomethacin Apotex 00337439 Novo-Methacin Novopharm 00646288 Pro-Indo-50 Pro Doc 100 500 100 500 100 02231799 Sandoz Indomethacine Sandoz 30 Supp. 15.11 75.55 15.11 75.55 15.11 0.1511 0.1511 0.1511 0.1511 0.1511 50 mg Supp. 24.60 0.8200 100 mg PPB 01934139 ratio-Indomethacin 02231800 Sandoz Indomethacine Ratiopharm Sandoz 30 30 AA Pharma 100 KETOPROFEN X Caps. 00790427 Ketoprofen 50 mg 0.8910 0.8910 50 mg Ent. Tab. 00842664 Ketoprofen-E 100 mg 26.73 26.73 33.73 0.1721 100 mg AA Pharma 100 500 L.A. Tab. 68.23 341.15 0.3187 0.3187 200 mg 02172577 Ketoprofen SR 200 mg AA Pharma 100 02015951 pms-Ketoprofen Phmscience 30 Supp. 138.90 0.6374 100 mg 2013-04 29.79 0.9930 Page 151 CODE BRAND NAME MANUFACTURER SIZE MELOXICAM X Tab. UNIT PRICE 7.5 mg PPB 02248973 Apo-Meloxicam Apotex 02390884 Auro-Meloxicam 02250012 Co Meloxicam Aurobindo Cobalt 02324326 02353148 02242785 02255987 02258315 Pro Doc Sanis Bo. Ing. Mylan Novopharm Meloxicam Meloxicam Mobicox Mylan-Meloxicam Novo-Meloxicam 02248607 phl-Meloxicam Pharmel 02248267 pms-Meloxicam Phmscience 02247889 ratio-Meloxicam Ratiopharm 100 500 30 30 100 100 100 100 100 30 100 30 500 30 500 100 500 Tab. 20.03 100.14 6.01 6.01 20.03 20.03 20.03 80.11 20.03 6.01 20.03 6.01 100.14 6.01 100.14 20.03 100.14 0.2003 0.2003 0.2003 0.2003 0.2003 0.2003 0.2003 0.8011 0.2003 0.2003 0.2003 0.2003 0.2003 0.2003 0.2003 0.2003 0.2003 15 mg PPB 02248974 Apo-Meloxicam 02390892 Auro-Meloxicam 02250020 Co Meloxicam Apotex Aurobindo Cobalt 02324334 02353156 02242786 02255995 02248608 Pro Doc Sanis Bo. Ing. Mylan Pharmel Meloxicam Meloxicam Mobicox Mylan-Meloxicam phl-Meloxicam 02248268 pms-Meloxicam Phmscience 02248031 ratio-Meloxicam Ratiopharm 02258323 Teva-Meloxicam Teva Can 100 30 30 100 100 100 100 100 30 500 30 500 100 500 30 100 NABUMETONE X Tab. 02238639 02244563 02343282 02240867 02083531 Apo-Nabumetone Mylan-Nabumetone Nabumetone Novo-Nabumetone Relafen 23.10 6.93 6.93 23.11 23.10 23.10 92.43 23.10 6.93 115.54 6.93 115.54 23.10 115.54 6.93 23.11 0.2310 0.2310 0.2310 0.2311 0.2310 0.2310 0.9243 0.2310 0.2310 0.2311 0.2310 0.2311 0.2310 0.2311 0.2310 0.2311 500 mg PPB Apotex Mylan Sanis Novopharm GSK 100 100 100 100 100 Tab. 36.91 36.91 36.91 36.91 69.19 0.3691 0.3691 0.3691 0.3691 0.6919 750 mg PPB 02240868 Novo-Nabumetone 02083558 Relafen Page COST OF PKG. SIZE 152 Novopharm GSK 100 100 56.31 93.97 0.5631 0.9397 2013-04 CODE BRAND NAME MANUFACTURER SIZE NAPROXEN X Ent. Tab. or Tab. COST OF PKG. SIZE UNIT PRICE 250 mg PPB 00522651 Apo-Naproxen 250 mg Apotex 02246699 Apo-Naproxen EC 02162792 Naprosyn E 250 mg 02350750 Naproxen Apotex Roche Sanis 02350785 00590762 02243312 02346583 Sanis Pro Doc Novopharm NT Pharma Naproxen EC Naproxen-250 Novo-Naprox EC NTP-Naproxen 02346613 NTP-Naproxen EC 02240786 Riva-Naproxen NT Pharma Riva 00565350 Teva-Naproxen Teva Can 100 1000 100 100 100 500 100 100 100 100 500 100 100 250 100 500 Ent. Tab. or Tab. 10.68 106.80 10.68 41.74 10.68 53.40 10.68 10.68 10.68 10.68 53.40 10.68 10.68 26.70 10.68 53.40 0.1068 0.1068 0.1068 0.4174 0.1068 0.1068 0.1068 0.1068 0.1068 0.1068 0.1068 0.1068 0.1068 0.1068 0.1068 0.1068 500 mg PPB 00592277 Apo-Naproxen Apotex 02246701 02241024 02162423 02350777 Apotex Mylan Roche Sanis Apo-Naproxen EC Mylan-Naproxen EC Naprosyn E Naproxen 02350807 Naproxen EC 00618721 Naproxen-500 Sanis Pro Doc 00589861 Novo-Naprox Novopharm 02243314 Novo-Naprox EC 02346605 NTP-Naproxen Novopharm NT Pharma 02346648 02294710 02310953 02240788 NT Pharma Phmscience Pro Doc Riva NTP-Naproxen EC pms-Naproxen EC Pro-Naproxen EC-500 Riva-Naproxen 100 500 100 100 100 100 500 100 100 500 100 500 100 100 500 100 100 100 100 500 Oral Susp. 02162431 Naprosyn 21.10 105.50 21.10 21.10 98.82 21.10 105.50 21.10 21.10 105.50 21.10 105.50 21.10 21.10 105.50 21.10 21.10 21.10 21.10 105.50 0.2110 0.2110 0.2110 0.2110 0.9882 0.2110 0.2110 0.2110 0.2110 0.2110 0.2110 0.2110 0.2110 0.2110 0.2110 0.2110 0.2110 0.2110 0.2110 0.2110 25 mg/mL Roche 474 ml Supp. 29.66 0.0626 500 mg 02017237 pms-Naproxen Phmscience 30 Tab. 14.33 0.4777 125 mg 00522678 Apo-Naproxen 2013-04 Apotex 100 7.81 0.0781 Page 153 CODE BRAND NAME MANUFACTURER SIZE Tab. or Ent. Tab. UNIT PRICE 375 mg PPB 00600806 Apo-Naproxen 375 mg Apotex 00627097 Teva-Naproxen Teva Can 02243313 Teva-Naproxen-EC Teva Can 100 500 100 100 100 100 500 100 100 500 100 500 100 100 100 100 500 100 500 100 02246700 02243432 02162415 02350769 Apotex Mylan Roche Sanis 00642886 Apo-Piroxicam 00695718 Novo-Pirocam Apotex Novopharm 100 100 00642894 Apo-Piroxicam 00695696 Novo-Pirocam Apotex Novopharm 100 100 Apo-Naproxen EC 375 mg Mylan-Naproxen EC 375 Naprosyn E 375 mg Naproxen 02350793 Naproxen EC 00655686 Naproxen-375 Sanis Pro Doc 02346591 NTP-Naproxen 375 mg NT Pharma 02346621 02294702 02310945 02240787 NT Pharma Phmscience Pro Doc Riva NTP-Naproxen EC 375 mg pms-Naproxen EC Pro-Naproxen EC-375 Riva-Naproxen 375 mg PIROXICAM X Caps. 14.58 72.90 14.58 14.58 54.79 14.58 72.90 14.58 14.58 72.90 14.58 72.90 14.58 14.58 14.58 14.58 72.90 14.58 72.90 14.58 0.1458 0.1458 0.1458 0.1458 0.5479 0.1458 0.1458 0.1458 0.1458 0.1458 0.1458 0.1458 0.1458 0.1458 0.1458 0.1458 0.1458 0.1458 0.1458 0.1458 10 mg PPB Caps. 22.13 22.13 0.2213 0.2213 20 mg PPB Supp. 37.11 37.11 0.3711 0.3711 20 mg 02154463 pms-Piroxicam Phmscience 30 00778354 Apo-Sulin 00745588 Novo-Sundac Apotex Novopharm 100 100 00778362 Apo-Sulin 00745596 Novo-Sundac Apotex Novopharm 100 100 SULINDAC X Tab. 49.38 1.6460 150 mg PPB Tab. Page COST OF PKG. SIZE 38.24 38.24 0.3824 0.3824 200 mg PPB 154 48.40 39.20 0.3992 0.3920 2013-04 CODE BRAND NAME MANUFACTURER SIZE TENOXICAM X Tab. 02230661 Tenoxicam UNIT PRICE 20 mg AA Pharma 100 Apotex Novopharm 100 100 TIAPROFENIC ACID X Tab. 02136112 Apo-Tiaprofenique 02179679 Novo-Tiaprofenic COST OF PKG. SIZE 115.52 0.9443 200 mg PPB Tab. 34.37 34.37 0.3437 0.3437 300 mg PPB 02136120 Apo-Tiaprofenique Apotex 02179687 Novo-Tiaprofenic Novopharm 100 500 100 32.57 162.85 32.57 0.3257 0.3257 0.3257 28:08.08 OPIATE AGONISTS BASE AND CODEINE SULFATE Z L.A. Tab. 02230302 Codeine Contin 50 mg Purdue 60 Purdue 60 L.A. Tab. 02163748 Codeine Contin 37.20 0.6200 150 mg Purdue 60 Purdue 60 L.A. Tab. 02163799 Codeine Contin 0.3100 100 mg L.A. Tab. 02163780 Codeine Contin 18.60 56.28 0.9380 200 mg CODEINE PHOSPHATE Z Inj. Sol. 74.46 1.2410 30 mg/mL 00544884 Codeine Sandoz 1 ml 02009757 Codeine Trianon 00593451 ratio-Codeine Ratiopharm 100 500 100 500 Tab. 1.41 1.1400 30 mg PPB 2013-04 7.73 38.66 7.73 38.66 0.0773 0.0773 0.0773 0.0773 Page 155 CODE BRAND NAME MANUFACTURER SIZE FENTANYL Z Patch 02386844 02395657 02396696 02341379 02330105 02311925 02327112 UNIT PRICE 12 mcg/h PPB Co Fentanyl Fentanyl Patch Mylan-Fentanyl Matrix Patch pms-Fentanyl MTX Ran-Fentanyl Matrix Patch ratio-Fentanyl Sandoz Fentanyl Patch Cobalt Pro Doc Mylan Phmscience Ranbaxy Ratiopharm Sandoz 5 5 5 5 5 5 5 Patch 11.16 11.16 11.16 11.16 11.16 11.16 11.16 2.2320 2.2320 2.2320 2.2320 2.2320 2.2320 2.2320 25 mcg/h PPB 02386852 02395665 02396718 02314630 02341387 02330113 02249391 Co Fentanyl Fentanyl Patch Mylan-Fentanyl Matrix Patch Novo-Fentanyl 25 pms-Fentanyl MTX Ran-Fentanyl Matrix Patch Ran-Fentanyl Transdermal System 02282941 ratio-Fentanyl 02327120 Sandoz Fentanyl Patch Cobalt Pro Doc Mylan Novopharm Phmscience Ranbaxy Ranbaxy 5 5 5 5 5 5 5 18.29 18.29 18.29 18.29 18.29 18.29 18.29 3.6580 3.6580 3.6580 3.6580 3.6580 3.6580 3.6580 Ratiopharm Sandoz 5 5 18.29 18.29 3.6580 3.6580 Patch 37 mcg/h 02327139 Sandoz Fentanyl Patch Sandoz 5 02386879 02395673 02396726 02314649 02341395 02330121 02249413 Cobalt Pro Doc Mylan Novopharm Phmscience Ranbaxy Ranbaxy 5 5 5 5 5 5 5 34.42 34.42 34.42 34.42 34.42 34.42 34.42 6.8840 6.8840 6.8840 6.8840 6.8840 6.8840 6.8840 Ratiopharm Sandoz 5 5 34.42 34.42 6.8840 6.8840 Patch 32.99 6.5980 50 mcg/h PPB Co Fentanyl Fentanyl Patch Mylan-Fentanyl Matrix Patch Novo-Fentanyl 50 pms-Fentanyl MTX Ran-Fentanyl Matrix Patch Ran-Fentanyl Transdermal System 02282968 ratio-Fentanyl 02327147 Sandoz Fentanyl Patch Patch 75 mcg/h PPB 02386887 02395681 02396734 02314657 02341409 02330148 02249421 Co Fentanyl Fentanyl Patch Mylan-Fentanyl Matrix Patch Novo-Fentanyl 75 pms-Fentanyl MTX Ran-Fentanyl Matrix Patch Ran-Fentanyl Transdermal System 02282976 ratio-Fentanyl 02327155 Sandoz Fentanyl Patch Page COST OF PKG. SIZE 156 Cobalt Pro Doc Mylan Novopharm Phmscience Ranbaxy Ranbaxy 5 5 5 5 5 5 5 48.41 48.41 48.41 48.41 48.41 48.41 48.41 9.6820 9.6820 9.6820 9.6820 9.6820 9.6820 9.6820 Ratiopharm Sandoz 5 5 48.41 48.41 9.6820 9.6820 2013-04 CODE BRAND NAME MANUFACTURER COST OF PKG. SIZE SIZE Patch UNIT PRICE 100 mcg/h PPB 02386895 02395703 02396742 02314665 02341417 02330156 02249448 Co Fentanyl Fentanyl Patch Mylan-Fentanyl Matrix Patch Novo-Fentanyl 100 pms-Fentanyl MTX Ran-Fentanyl Matrix Patch Ran-Fentanyl Transdermal System 02282984 ratio-Fentanyl 02327163 Sandoz Fentanyl Patch Cobalt Pro Doc Mylan Novopharm Phmscience Ranbaxy Ranbaxy 5 5 5 5 5 5 5 60.26 60.26 60.26 60.26 60.26 60.26 60.26 12.0520 12.0520 12.0520 12.0520 12.0520 12.0520 12.0520 Ratiopharm Sandoz 5 5 60.26 60.26 12.0520 12.0520 HYDROMORPHONE HYDROCHLORIDE Z Inj. Pd. 02085895 Dilaudid 250 mg Purdue 1 67.58 Purdue Sandoz 1 ml 1 ml 00622133 Dilaudid-HP Purdue 02145928 Hydromorphone HP 10 Sandoz 1 ml 5 ml 1 ml 5 ml 50 ml Inj. Sol. 00627100 Dilaudid 02145901 Hydromorphone 2 mg/mL PPB Inj. Sol. 10 mg/mL PPB Inj. Sol. 02146118 Dilaudid-HP-Plus 02145936 Hydromorphone HP 20 Purdue Sandoz 50 ml 50 ml Purdue Sandoz Sandoz 50 ml 50 ml 1 ml Purdue 60 2013-04 486.67 486.67 9.73 W 39.66 0.6610 4.5 mg Purdue 60 Purdue 60 L.A. Caps. (12 h) 02125331 Hydromorph Contin W 3 mg L.A. Caps. (12 h) 02359502 Hydromorph Contin 183.40 183.40 50 mg/mL PPB L.A. Caps. (12 h) 02125323 Hydromorph Contin 2.34 11.69 2.34 11.69 116.90 20 mg/mL PPB Inj. Sol. 02145863 Dilaudid-XP 02146126 Hydromorphone HP 50 99003163 Hydromorphone HP 50 0.95 0.95 48.84 0.8140 6 mg 59.46 0.9910 Page 157 CODE BRAND NAME MANUFACTURER SIZE L.A. Caps. (12 h) UNIT PRICE 9 mg 02359510 Hydromorph Contin Purdue 60 Purdue 60 L.A. Caps. (12 h) 80.04 1.3340 12 mg 02125366 Hydromorph Contin L.A. Caps. (12 h) 103.02 1.7170 18 mg 02243562 Hydromorph Contin Purdue 60 Purdue 60 L.A. Caps. (12 h) 148.62 2.4770 24 mg 02125382 Hydromorph Contin L.A. Caps. (12 h) 190.20 3.1700 30 mg 02125390 Hydromorph Contin Purdue 60 01916394 pms-Hydromorphone Phmscience 10 Supp. 227.88 3.7980 3 mg Syr. 23.56 2.3560 1 mg/mL PPB 00786535 Dilaudid 01916386 pms-Hydromorphone Purdue Phmscience 450 ml 500 ml 02364115 00705438 00885444 02319403 Apotex Purdue Phmscience Teva Can 100 100 100 100 Tab. 29.34 32.60 0.0652 0.0652 1 mg PPB Apo-Hydromorphone Dilaudid pms-Hydromorphone Teva Hydromorphone Tab. 9.59 9.59 9.59 9.59 0.0959 0.0959 0.0959 0.0959 2 mg PPB 02364123 00125083 00885436 02319411 Apo-Hydromorphone Dilaudid pms-Hydromorphone Teva Hydromorphone Apotex Purdue Phmscience Teva Can 100 100 100 100 Tab. 14.16 14.16 14.16 14.16 0.1416 0.1416 0.1416 0.1416 4 mg PPB 02364131 00125121 00885401 02319438 Page COST OF PKG. SIZE 158 Apo-Hydromorphone Dilaudid pms-Hydromorphone Teva Hydromorphone Apotex Purdue Phmscience Teva Can 100 100 100 100 22.40 22.40 22.40 22.40 0.2240 0.2240 0.2240 0.2240 2013-04 CODE BRAND NAME MANUFACTURER SIZE Tab. COST OF PKG. SIZE UNIT PRICE 8 mg PPB 02364158 00786543 00885428 02319446 Apo-Hydromorphone Dilaudid pms-Hydromorphone Teva Hydromorphone Apotex Purdue Phmscience Teva Can 100 100 100 100 MEPERIDINE HYDROCHLORIDE Z Inj. Sol. 00725765 Meperidine Sandoz 1 ml Sandoz 1 ml Sandoz 1 ml 0.96 0.9100 75 mg/mL Inj. Sol. 00725749 Meperidine 0.3528 0.3528 0.3528 0.3528 50 mg/mL Inj. Sol. 00725757 Meperidine 35.28 35.28 35.28 35.28 1.01 0.9600 100 mg/mL Tab. 1.07 1.0100 50 mg 02138018 Demerol SanofiAven 100 METHADONE HYDROCHLORIDE Z Oral Sol. 02247694 Metadol 0.1309 1 mg/mL Paladin 250 ml Paladin 100 ml Oral Sol. 02241377 Metadol 13.09 25.18 0.1007 10 mg/mL Tab. 36.42 0.3642 1 mg 02247698 Metadol Paladin 100 02247699 Metadol Paladin 100 Tab. 16.73 0.1673 5 mg Tab. 55.75 0.5575 10 mg 02247700 Metadol Paladin 100 02247701 Metadol Paladin 100 Tab. 89.21 0.8921 25 mg 2013-04 167.26 1.6726 Page 159 CODE BRAND NAME MANUFACTURER SIZE MORPHINE HYDROCHLORIDE OR SULFATE Z Inj. Sol. 02242484 Morphine (sulfate de) Sandoz 1 ml Sandoz Sandoz 1 ml 1 ml Sandoz Sandoz 1 ml 1 ml 30 ml Sandoz 1 ml 4 ml Sandoz 1 ml 5 ml 10 ml 50 ml Ethypharm 20 50 Ethypharm 20 50 Ethypharm 20 50 Ethypharm 20 50 Page 160 4.64 11.59 0.2320 0.2318 7.00 17.50 0.3500 0.3500 60 mg L.A. Caps. 02019965 M-Eslon 0.2755 0.2756 30 mg L.A. Caps. 02019957 M-Eslon 5.51 13.78 15 mg L.A. Caps. 02019949 M-Eslon 3.22 16.08 32.15 160.71 10 mg L.A. Caps. 02177749 M-Eslon 2.89 11.56 50 mg/mL L.A. Caps. 02019930 M-Eslon 0.90 0.90 27.00 25 mg/mL Inj. Sol. 00617288 Morphine H.P. 50 0.99 0.99 15 mg/mL Inj. Sol. 00676411 Morphine H.P. 25 0.94 10 mg/mL Inj. Sol. 02383004 Morphine 00392561 Morphine (sulfate de) UNIT PRICE 2 mg/mL Inj. Sol. 02382997 Morphine 00392588 Morphine (sulfate de) COST OF PKG. SIZE 12.34 30.84 0.6170 0.6168 100 mg Ethypharm 20 50 18.80 47.01 0.9400 0.9402 2013-04 CODE BRAND NAME MANUFACTURER SIZE L.A. Caps. Ethypharm 20 50 Abbott 100 L.A. Caps. (24 h) L.A. Caps. (24 h) Abbott 100 Abbott 100 L.A. Caps. (24 h) 36.38 0.3638 61.32 0.6132 50 mg 02184443 Kadian L.A. Caps. (24 h) 128.75 1.2875 100 mg 02184451 Kadian Abbott 50 Morphine SR MS Contin Novo-Morphine SR Sandoz Morphine SR Sanis Purdue Novopharm Sandoz 50 60 50 100 M.O.S.-S.R. Morphine SR MS Contin Novo-Morphine SR Valeant Sanis Purdue Novopharm 50 100 60 50 100 100 L.A. Tab. 112.27 2.2454 15 mg PPB L.A. Tab. 11.59 39.42 11.59 23.17 0.2318 0.6570 0.2318 0.2317 30 mg PPB 02244791 Sandoz Morphine SR Sandoz L.A. Tab. 17.90 35.00 59.46 17.50 35.00 35.00 0.3580 0.3500 0.9910 0.3500 0.3500 0.3500 60 mg PPB M.O.S.-S.R. Morphine SR MS Contin Novo-Morphine SR 02245286 pms-Morphine Sulfate SR 02244792 Sandoz Morphine SR Valeant Sanis Purdue Novopharm Phmscience Sandoz 50 100 60 50 100 50 100 Sanis Purdue Novopharm 50 60 50 L.A. Tab. 02350920 Morphine SR 02014319 MS Contin 02302799 Novo-Morphine SR 2013-04 1.7480 1.7480 20 mg 02184435 Kadian 00776203 02350912 02014300 02302780 34.96 87.40 10 mg 02242163 Kadian 00776181 02350890 02014297 02302772 UNIT PRICE 200 mg 02177757 M-Eslon 02350815 02015439 02302764 02244790 COST OF PKG. SIZE 31.56 61.67 104.94 30.84 61.67 30.84 61.67 0.6312 0.6167 1.7490 0.6167 0.6167 0.6167 0.6167 100 mg PPB 47.01 160.02 47.01 0.9402 2.6670 0.9402 Page 161 CODE BRAND NAME MANUFACTURER COST OF PKG. SIZE SIZE L.A. Tab. 02350947 Morphine SR 02014327 MS Contin 02302802 Novo-Morphine SR 200 mg PPB Sanis Purdue Novopharm 50 60 50 Oral Sol. 00690791 ratio-Morphine 00621935 Statex 87.40 297.54 87.40 1.7480 4.9590 1.7480 20 mg/mL PPB Ratiopharm Paladin 50 ml 25 ml 100 ml Supp. 24.90 12.45 38.57 0.4980 0.4980 0.3857 10 mg 00632201 Statex Paladin 10 00596965 Statex Paladin 10 Supp. 16.37 1.6370 20 mg Supp. 19.37 1.9370 30 mg 00639389 Statex Paladin 00614491 Doloral 1 Atlas 00607762 ratio-Morphine Ratiopharm 00591467 Statex Paladin 10 Syr. 21.51 2.1510 1 mg/mL PPB 250 ml 500 ml 200 ml 450 ml 250 ml 500 ml Syr. 3.78 7.56 3.02 6.80 5.00 10.00 0.0151 0.0151 0.0151 0.0151 0.0200 0.0200 5 mg/mL PPB 00614505 Doloral 5 Atlas 00607770 ratio-Morphine Ratiopharm 00591475 Statex Paladin 00690783 ratio-Morphine Ratiopharm 250 ml 500 ml 200 ml 450 ml 250 ml 500 ml Syr. 9.63 19.26 7.70 17.33 9.63 19.26 0.0385 0.0385 0.0385 0.0385 0.0385 0.0385 10 mg/mL 200 ml Syr. 36.76 0.1838 50 mg/mL 00705799 Statex Page UNIT PRICE 162 Paladin 50 ml 47.32 0.9464 2013-04 CODE BRAND NAME MANUFACTURER SIZE Tab. COST OF PKG. SIZE UNIT PRICE 5 mg PPB 02009773 M.O.S. - Sulfate-5 02014203 MS-IR 00594652 Statex Valeant Purdue Paladin 100 60 100 Tab. 11.00 7.02 11.00 0.1100 0.1170 0.1100 10 mg PPB 02009765 M.O.S. - Sulfate-10 02014211 MS-IR 00594644 Statex Valeant Purdue Paladin 100 60 100 Tab. 17.00 10.92 17.00 0.1700 0.1820 0.1700 20 mg 02014238 MS-IR Purdue 60 02009749 M.O.S. - Sulfate-25 00594636 Statex Valeant Paladin 100 100 02014254 MS-IR Purdue 60 Tab. 19.92 0.3320 25 mg PPB Tab. 22.50 22.50 0.2250 0.2250 30 mg Tab. 25.62 0.4270 50 mg PPB 02009706 M.O.S. - Sulfate-50 00675962 Statex Valeant Paladin 100 100 Sandoz 12 OXYCODONE HYDROCHLORIDE Z Supp. 00392480 Supeudol 34.50 34.50 0.3450 0.3450 10 mg Supp. 27.12 2.0875 20 mg 00392472 Supeudol Sandoz 12 02325950 Oxycodone 02319977 pms-Oxycodone 00789739 Supeudol Pro Doc Phmscience Sandoz 100 100 100 02240131 02325969 02319985 00443948 Purdue Pro Doc Phmscience Sandoz 60 100 100 100 Tab. 34.44 2.6408 5 mg PPB Tab. 12.87 12.87 12.87 0.1287 0.1287 0.1287 10 mg PPB 2013-04 Oxy IR Oxycodone pms-Oxycodone Supeudol 22.92 19.86 19.86 19.86 0.3820 0.1986 0.1986 0.1986 Page 163 CODE BRAND NAME MANUFACTURER SIZE Tab. COST OF PKG. SIZE UNIT PRICE 20 mg PPB 02240132 02325977 02319993 02262983 Oxy IR Oxycodone pms-Oxycodone Supeudol 20 Purdue Pro Doc Phmscience Sandoz 60 50 50 50 39.96 17.24 17.24 17.24 0.6660 0.3448 0.3448 0.3448 28:08.12 OPIATE PARTIAL AGONISTS BUTORPHANOL TARTRATE Y Nas. spray 02242504 Apo-Butorphanol 10 mg/mL Apotex 2.5 ml PENTAZOCINE HYDROCHLORIDE Z Tab. 02137984 Talwin 56.53 13.3680 50 mg SanofiAven 100 37.74 0.3774 28:08.92 MISCELLANEOUS ANALGESICS AND ANTIPYRETICS ACETAMINOPHEN Chew. Tab. 02017458 Acetaminophene 02245010 Jamp-Acetaminophen 02263815 Pediaphen 80 mg PPB Riva Jamp Euro-Pharm 24 24 24 Chew. Tab. or Tab. 02017431 02021420 02246087 02263823 0.1000 0.1000 0.1000 160 mg PPB Acetaminophene Cephanol Jamp-Acetaminophen Pediaphen Riva Riva Jamp Euro-Pharm 20 20 20 20 01905848 Acetaminophene 02263807 Pediaphen 00792713 pms-Acetaminophene Trianon Euro-Pharm Phmscience 100 ml 100 ml 100 ml 01958836 01901389 02263831 00792691 Trianon Jamp Euro-Pharm Phmscience 100 ml 100 ml 100 ml 500 ml Liq. 2.95 2.95 2.95 2.95 0.1475 0.1475 0.1475 0.1475 80 mg/5 mL PPB Liq. Page 2.40 2.40 2.40 3.10 3.10 3.10 0.0310 0.0310 0.0310 160 mg/5 mL PPB 164 Acetaminophene Jamp-Acetaminophen Pediaphen pms-Acetaminophene 3.65 3.65 3.65 18.25 0.0365 0.0365 0.0365 0.0365 2013-04 CODE BRAND NAME MANUFACTURER COST OF PKG. SIZE SIZE Ped. Oral Sol. UNIT PRICE 80 mg/mL PPB 01905864 Acetaminophene Trianon 01935275 Jamp-Acetaminophen 02263793 Pediaphen Jamp Euro-Pharm 02027801 Pediatrix Rougier 01919385 Abenol 02230434 Acet 120 Pendopharm Pendopharm 15 ml 24 ml 24 ml 15 ml 24 ml 24 ml Supp. 2.50 2.87 2.87 2.50 2.87 2.87 120 mg 12 12 Supp. 6.63 6.44 0.5525 0.5367 160 mg 02230435 Acet 160 Pendopharm 12 01919393 Abenol 02230436 Acet 325 Pendopharm Pendopharm 12 12 01919407 Abenol 02230437 Acet 650 Pendopharm Pendopharm 12 12 Supp. 7.51 0.6258 325 mg Supp. 8.19 7.95 0.6825 0.6625 650 mg Tab. 9.41 9.13 0.7842 0.7608 325 mg PPB 00718858 Acetaminophen Pharmel 02022214 00382752 02241200 01938088 00389218 Riva Pro Doc Odan Jamp Novopharm Acetaminophene Acetaminophene 325 Acetaminophen-Odan Jamp-Acetaminophen Novo-Gesic 100 1000 1000 1000 1000 1000 100 1000 Tab. 1.14 11.40 11.40 11.40 11.40 11.40 1.14 11.40 0.0114 0.0114 0.0114 0.0114 0.0114 0.0114 0.0114 0.0114 500 mg PPB 00718866 Acetaminophen Pharmel 02022222 00386626 02241201 01939122 02355299 02343371 00482323 Riva Pro Doc Odan Jamp Jamp Jamp Novopharm 2013-04 Acetaminophene Acetaminophene 500 Acetaminophen-Odan Jamp-Acetaminophen Jamp-Acetaminophen Jamp-Acetaminophene E.F. Novo-Gesic Forte 500 1000 1000 1000 1000 1000 1000 1000 100 1000 7.45 14.90 14.90 14.90 14.90 14.90 14.90 14.90 1.49 14.90 0.0149 0.0149 0.0149 0.0149 0.0149 0.0149 0.0149 0.0149 0.0149 0.0149 Page 165 CODE BRAND NAME MANUFACTURER ACETAMINOPHEN/ CODEINE PHOSPHATE Z Elix. 00816027 pms-Acetaminophene avec Codeine 02163942 Tylenol a la codeine Phmscience Janss. Inc Tab. SIZE COST OF PKG. SIZE UNIT PRICE 160 mg -8 mg/5 mL PPB 100 ml 500 ml 500 ml 5.86 29.32 39.96 0.0480 0.0480 0.0799 300 mg - 30 mg PPB 01999648 02254271 02232658 00608882 00789828 Acet codeine 30 phl-Acet-Codeine 30 Procet-30 ratio-Emtec Triatec-30 Phmscience Pharmel Pro Doc Ratiopharm Trianon 01999656 Acet codeine 60 02254263 phl-Acet-Codeine 60 00621463 ratio-Lenoltec No 4 Phmscience Pharmel Ratiopharm 100 100 100 Apotex 50 Tab. 500 500 500 500 100 500 65.00 65.00 65.00 65.00 13.00 65.00 0.1300 0.1300 0.1300 0.1300 0.1300 0.1300 300 mg - 60 mg PPB 13.84 13.84 13.84 0.1384 0.1384 0.1384 28:10 OPIATE ANTAGONISTS NALTREXONE HYDROCHLORIDE X Tab. 02213826 Revia 50 mg 275.24 5.3790 28:12.04 BARBITURATES PHENOBARBITAL Y Elix. 25 mg/5 mL 00645575 Phenobarb elixir Pendopharm 100 ml 00178799 Phenobarb Pendopharm 500 Tab. 0.1167 15 mg Tab. 43.71 0.0874 30 mg 00178802 Phenobarb Pendopharm 500 00178810 Phenobarb Pendopharm 500 Tab. 52.00 0.1040 60 mg Tab. 70.52 0.1410 100 mg 00178829 Phenobarb Page 11.67 166 Pendopharm 500 96.50 0.1930 2013-04 CODE BRAND NAME MANUFACTURER SIZE PRIMIDONE X Tab. COST OF PKG. SIZE UNIT PRICE 125 mg 00399310 Primidone AA Pharma 100 00396761 Primidone AA Pharma 100 Tab. 5.53 0.0553 250 mg 8.70 0.0870 28:12.08 BENZODIAZEPINES CLOBAZAM V Tab. 02244638 02248454 02221799 02238334 02244474 10 mg PPB Apo-Clobazam Clobazam-10 Frisium Novo-Clobazam pms-Clobazam Apotex Pro Doc Lundb Inc Novopharm Phmscience 30 30 30 30 30 CLONAZEPAM V Tab. 3.30 3.30 10.25 3.30 3.30 0.1100 0.1100 0.3417 0.1100 0.1100 0.25 mg 02179660 pms-Clonazepam Phmscience 100 02177889 Apo-Clonazepam Apotex 02344629 Clonazepam-R 02270641 Co Clonazepam MeliaPharm Cobalt 02230950 Mylan-Clonazepam Mylan 02239024 Novo-Clonazepam Novopharm 02236948 phl-Clonazepam-R Pharmel 02207818 pms-Clonazepam-R Phmscience 02311593 Pro-Clonazepam 02103656 ratio-Clonazepam Pro Doc Ratiopharm 02242077 Riva-Clonazepam Riva 00382825 Rivotril 02233960 Sandoz Clonazepam Roche Sandoz 02345676 Zym-Clonazepam Zymcan 100 500 100 100 500 100 500 100 500 100 500 100 500 500 100 500 100 500 100 100 500 100 Tab. 6.90 0.0690 0.5 mg PPB 2013-04 4.95 24.77 4.95 4.95 24.77 4.95 24.77 4.95 24.77 4.95 24.77 4.95 24.77 24.77 4.95 24.77 4.95 24.77 19.82 4.95 24.77 4.95 0.0495 0.0495 0.0495 0.0495 0.0495 0.0495 0.0495 0.0495 0.0495 0.0495 0.0495 0.0495 0.0495 0.0495 0.0495 0.0495 0.0495 0.0495 0.1982 0.0495 0.0495 0.0495 Page 167 CODE BRAND NAME MANUFACTURER SIZE Tab. COST OF PKG. SIZE UNIT PRICE 1 mg PPB 02344602 Clonazepam 02270668 Co Clonazepam 02145235 phl-Clonazépam MeliaPharm Cobalt Pharmel 02048728 pms-Clonazepam Phmscience 02311607 Pro-Clonazepam Pro Doc 02233982 Sandoz Clonazepam 02303329 Zym-Clonazepam Sandoz Zymcan 02177897 Apo-Clonazepam Apotex 02344610 Clonazepam 02270676 Co Clonazepam MeliaPharm Cobalt 02230951 Mylan-Clonazepam Mylan 02239025 Novo-Clonazepam Novopharm 02145243 phl-Clonazépam Pharmel 02048736 pms-Clonazepam Phmscience 02311615 Pro-Clonazepam Pro Doc 02103737 ratio-Clonazepam Ratiopharm 02242078 Riva-Clonazepam Riva 00382841 Rivotril 02233985 Sandoz Clonazepam Roche Sandoz 02303337 Zym-Clonazepam Zymcan 100 100 100 500 100 500 100 500 100 100 Tab. 18.60 18.60 18.60 93.00 18.60 93.00 18.60 93.00 18.60 18.60 0.1860 0.1860 0.1860 0.1860 0.1860 0.1860 0.1860 0.1860 0.1860 0.1860 2 mg PPB 100 500 100 100 500 100 500 100 500 100 500 100 500 100 500 100 500 100 500 100 100 500 100 8.55 42.72 8.55 8.55 42.72 8.55 42.72 8.55 42.72 8.55 42.72 8.55 42.72 8.55 42.72 8.55 42.72 8.55 42.72 34.17 8.55 42.72 8.55 0.0855 0.0854 0.0855 0.0855 0.0854 0.0855 0.0854 0.0855 0.0854 0.0855 0.0854 0.0855 0.0854 0.0855 0.0854 0.0855 0.0854 0.0855 0.0854 0.3417 0.0855 0.0854 0.0855 28:12.12 HYDANTOINS PHENYTOIN X Oral Susp. 00023442 Dilantin-30 30 mg/5 mL Pfizer 250 ml Pfizer Taro 250 ml 237 ml Oral Susp. 00023450 Dilantin-125 02250896 Taro-Phenytoin 0.0406 125 mg/5 mL PPB Tab. 12.00 7.37 0.0480 0.0288 50 mg 00023698 Dilantin Page 10.14 168 Pfizer 100 7.37 0.0737 2013-04 CODE BRAND NAME MANUFACTURER SIZE PHENYTOIN SODIUM X Caps. COST OF PKG. SIZE UNIT PRICE 30 mg 00022772 Dilantin Pfizer 100 00022780 Dilantin Pfizer 100 1000 Caps. 5.38 0.0538 100 mg 7.47 67.14 0.0747 0.0671 28:12.20 SUCCINIMIDES ETHOSUXIMIDE X Caps. 250 mg 00022799 Zarontin Erfa 100 00023485 Zarontin Erfa 500 ml Syr. 29.62 0.2962 250 mg/5 mL METHSUXIMIDE X Caps. 00022802 Celontin 29.60 0.0592 300 mg Erfa 100 32.76 0.3276 28:12.92 MISCELLANEOUS ANTICONVULSANTS CARBAMAZEPINE X Chew. Tab. 02231542 pms-Carbamazepine Chewtabs 02261855 Sandoz Carbamazepine Chewtabs 02244403 Taro-Carbamazepine Chewable 00369810 Tegretol Chewtabs 100 mg PPB Phmscience 100 3.80 0.0380 Sandoz 100 3.80 0.0380 Taro 100 3.80 0.0380 Novartis 100 13.50 0.1350 Phmscience 100 7.49 0.0749 Sandoz 100 7.49 0.0749 Taro 100 7.49 0.0749 Novartis 100 26.65 0.2665 Chew. Tab. 02231540 pms-Carbamazepine Chewtabs 02261863 Sandoz Carbamazepine Chewtabs 02244404 Taro-Carbamazepine Chewable 00665088 Tegretol Chewtabs 2013-04 200 mg PPB Page 169 CODE BRAND NAME MANUFACTURER SIZE L.A. Tab. UNIT PRICE 200 mg PPB 02241882 Mylan-Carbamazepine CR Mylan 02231543 pms-Carbamazepine CR Phmscience 02261839 Sandoz Carbamazepine CR Sandoz 00773611 Tegretol CR Novartis 100 500 100 500 100 100 L.A. Tab. 9.30 46.48 9.30 46.48 9.30 33.08 0.0930 0.0930 0.0930 0.0930 0.0930 0.3308 400 mg PPB 02241883 Mylan-Carbamazepine CR 02231544 pms-Carbamazepine CR Mylan Phmscience 02261847 Sandoz Carbamazepine CR Sandoz 00755583 Tegretol CR Novartis 100 100 500 100 100 18.59 18.59 92.94 18.59 66.16 0.1859 0.1859 0.1859 0.1859 0.6616 100 mg/5 mL PPB Oral Susp. 02367394 Taro-Carbamazepine 02194333 Tegretol Taro Novartis 450 ml 450 ml 00402699 Apo-Carbamazepine Apotex 00010405 Tegretol Novartis 00782718 Teva-Carbamazepine Teva Can 100 500 100 500 100 500 Tab. 24.32 28.70 0.0383 0.0638 200 mg PPB DIVALPROEX SODIUM X Ent. Tab. 02239698 02240341 00596418 02239701 Apo-Divalproex Divalproex-125 Epival 125 Novo-Divalproex Apotex Pro Doc Abbott Novopharm 0.0795 0.0795 0.3218 0.3126 0.0795 0.0795 100 100 100 100 7.24 7.24 24.14 7.24 0.0724 0.0724 0.2414 0.0724 250 mg PPB 02239699 Apo-Divalproex Apotex 02240342 Divalproex-250 Pro Doc 00596426 Epival 250 Abbott 02239702 Novo-Divalproex Novopharm 170 7.95 39.75 32.18 156.30 7.95 39.75 125 mg PPB Ent. Tab. Page COST OF PKG. SIZE 100 500 100 500 100 500 100 500 13.02 65.07 13.02 65.07 43.37 216.87 13.02 65.07 0.1302 0.1301 0.1302 0.1301 0.4337 0.4337 0.1302 0.1301 2013-04 CODE BRAND NAME MANUFACTURER SIZE Ent. Tab. UNIT PRICE 500 mg PPB 02239700 Apo-Divalproex 02240343 Divalproex-500 00596434 Epival 500 Apotex Pro Doc Abbott 02239703 Novo-Divalproex Novopharm 100 100 100 500 100 500 GABAPENTIN X Caps. 26.04 26.04 86.81 434.01 26.04 130.20 0.2604 0.2604 0.8681 0.8680 0.2604 0.2604 100 mg PPB 02244304 Apo-Gabapentin Apotex 02321203 Auro-Gabapentin Aurobindo 02256142 Co Gabapentin Cobalt 02353245 Gabapentin Sanis 02246314 Gabapentin Sivem 02304775 Gabapentin 02361469 Jamp-Gabapentin 02391473 Mar-Gabapentin Sorres Jamp Marcan 02248259 Mylan-Gabapentin Mylan 02084260 Neurontin 02243446 pms-Gabapentin Pfizer Phmscience 02310449 Pro-Gabapentin Pro Doc 02319055 Ran-Gabapentin Ranbaxy 02260883 ratio-Gabapentin Ratiopharm 02251167 Riva-Gabapentin Riva 02244513 Teva-Gabapentin Teva Can 2013-04 COST OF PKG. SIZE 100 500 100 500 100 500 100 500 100 500 100 100 100 500 100 500 100 100 500 100 500 100 500 100 500 100 500 100 500 10.60 52.99 10.60 52.99 10.60 52.99 10.60 52.99 10.60 52.99 10.60 10.60 10.60 52.99 10.60 52.99 41.51 10.60 52.99 10.60 52.99 10.60 52.99 10.60 52.99 10.60 52.99 10.60 52.99 0.1060 0.1060 0.1060 0.1060 0.1060 0.1060 0.1060 0.1060 0.1060 0.1060 0.1060 0.1060 0.1060 0.1060 0.1060 0.1060 0.4151 0.1060 0.1060 0.1060 0.1060 0.1060 0.1060 0.1060 0.1060 0.1060 0.1060 0.1060 0.1060 Page 171 CODE BRAND NAME MANUFACTURER SIZE Caps. Page COST OF PKG. SIZE UNIT PRICE 300 mg PPB 02244305 Apo-Gabapentin Apotex 02321211 Auro-Gabapentin Aurobindo 02256150 Co Gabapentin Cobalt 02353253 Gabapentin Sanis 02246315 Gabapentin Sivem 02304783 Gabapentin 02361485 Jamp-Gabapentin Sorres Jamp 02391481 Mar-Gabapentin Marcan 02248260 Mylan-Gabapentin Mylan 02084279 Neurontin 02243447 pms-Gabapentin Pfizer Phmscience 02310457 Pro-Gabapentin Pro Doc 02319063 Ran-Gabapentin Ranbaxy 02251175 Riva-Gabapentin Riva 02244514 Teva-Gabapentin Teva Can 172 100 500 100 500 100 500 100 500 100 500 100 100 500 100 500 100 500 100 100 500 100 500 100 500 100 500 100 500 25.78 128.89 25.78 128.89 25.78 128.89 25.78 128.89 25.78 128.89 25.78 25.78 128.89 25.78 128.89 25.78 128.89 101.00 25.78 128.89 25.78 128.89 25.78 128.89 25.78 128.89 25.78 128.89 0.2578 0.2578 0.2578 0.2578 0.2578 0.2578 0.2578 0.2578 0.2578 0.2578 0.2578 0.2578 0.2578 0.2578 0.2578 0.2578 0.2578 1.0100 0.2578 0.2578 0.2578 0.2578 0.2578 0.2578 0.2578 0.2578 0.2578 0.2578 2013-04 CODE BRAND NAME MANUFACTURER SIZE Caps. COST OF PKG. SIZE UNIT PRICE 400 mg PPB 02244306 Apo-Gabapentin Apotex 02321238 Auro-Gabapentin Aurobindo 02256169 Co Gabapentin Cobalt 02353261 Gabapentin Sanis 02246316 Gabapentin Sivem 02304791 Gabapentin 02361493 Jamp-Gabapentin Sorres Jamp 02391503 Mar-Gabapentin Marcan 02248261 Mylan-Gabapentin Mylan 02084287 Neurontin 02243448 pms-Gabapentin Pfizer Phmscience 02310465 Pro-Gabapentin Pro Doc 02319071 Ran-Gabapentin Ranbaxy 02260905 ratio-Gabapentin Ratiopharm 02251183 Riva-Gabapentin Riva 02244515 Teva-Gabapentin Teva Can 100 500 100 500 100 500 100 500 100 500 100 100 500 100 500 100 500 100 100 500 100 500 100 500 100 500 100 500 100 500 Tab. 30.72 153.60 30.72 153.60 30.72 153.60 30.72 153.60 30.72 153.60 30.72 30.72 153.60 30.72 153.60 30.72 153.60 120.35 30.72 153.60 30.72 153.60 30.72 153.60 30.72 153.60 30.72 153.60 30.72 153.60 0.3072 0.3072 0.3072 0.3072 0.3072 0.3072 0.3072 0.3072 0.3072 0.3072 0.3072 0.3072 0.3072 0.3072 0.3072 0.3072 0.3072 1.2035 0.3072 0.3072 0.3072 0.3072 0.3072 0.3072 0.3072 0.3072 0.3072 0.3072 0.3072 0.3072 600 mg PPB 02293358 02392526 02388200 02397471 02239717 02258005 02255898 02310473 02260913 02259796 Apo-Gabapentin Gabapentin Gabapentin Mylan-Gabapentin Neurontin phl-Gabapentin pms-Gabapentin Pro-Gabapentin ratio-Gabapentin Riva-Gabapentin 02248457 Teva-Gabapentin 2013-04 Apotex Accord Sivem Mylan Pfizer Pharmel Phmscience Pro Doc Ratiopharm Riva Teva Can 100 100 100 100 100 100 100 100 100 100 500 100 95.80 95.80 95.80 95.80 181.65 95.80 95.80 95.80 95.80 95.80 479.00 95.80 0.9580 0.9580 0.9580 0.9580 1.8165 0.9580 0.9580 0.9580 0.9580 0.9580 0.9580 0.9580 Page 173 CODE BRAND NAME MANUFACTURER SIZE Tab. UNIT PRICE 800 mg PPB 02293366 02392534 02388219 02397498 02239718 02258013 02255901 02310481 02260921 02259818 Apo-Gabapentin Gabapentin Gabapentin Mylan-Gabapentin Neurontin phl-Gabapentin pms-Gabapentin Pro-Gabapentin ratio-Gabapentin Riva-Gabapentin 02247346 Teva-Gabapentin Apotex Accord Sivem Mylan Pfizer Pharmel Phmscience Pro Doc Ratiopharm Riva Teva Can 100 100 100 100 100 100 100 100 100 100 500 100 GSK 30 LAMOTRIGINE X Chew. Tab. 02243803 Lamictal 127.73 127.73 127.73 127.73 242.19 127.73 127.73 127.73 127.73 127.73 638.65 127.73 1.2773 1.2773 1.2773 1.2773 2.4219 1.2773 1.2773 1.2773 1.2773 1.2773 1.2773 1.2773 2 mg Chew. Tab. 4.61 0.1537 5 mg 02240115 Lamictal GSK 02245208 Apo-Lamotrigine 02381354 Auro-Lamotrigine Apotex Aurobindo 02142082 02343010 02302969 02265494 02248232 02246897 02243352 GSK Sanis Pro Doc Mylan Novopharm Phmscience Ratiopharm 28 Tab. 4.32 0.1543 25 mg PPB Lamictal Lamotrigine Lamotrigine-25 Mylan-Lamotrigine Novo-Lamotrigine pms-Lamotrigine ratio-Lamotrigine 100 100 1000 100 100 100 100 100 100 100 Tab. 9.36 9.36 93.60 35.78 9.36 9.36 9.36 9.36 9.36 9.36 0.0936 0.0936 0.0936 0.3578 0.0936 0.0936 0.0936 0.0936 0.0936 0.0936 100 mg PPB 02245209 Apo-Lamotrigine 02381362 Auro-Lamotrigine Apotex Aurobindo 02142104 02343029 02302985 02265508 GSK Sanis Pro Doc Mylan Lamictal Lamotrigine Lamotrigine-100 Mylan-Lamotrigine 02248233 Novo-Lamotrigine 02246898 pms-Lamotrigine 02243353 ratio-Lamotrigine Page COST OF PKG. SIZE 174 Novopharm Phmscience Ratiopharm 100 100 1000 100 100 100 100 500 100 100 100 37.35 37.35 373.50 143.16 37.35 37.35 37.35 186.75 37.35 37.35 37.35 0.3735 0.3735 0.3735 1.4316 0.3735 0.3735 0.3735 0.3735 0.3735 0.3735 0.3735 2013-04 CODE BRAND NAME MANUFACTURER SIZE Tab. COST OF PKG. SIZE UNIT PRICE 150 mg PPB 02245210 Apo-Lamotrigine 02381370 Auro-Lamotrigine Apotex Aurobindo 02142112 02343037 02302993 02265516 02248234 02246899 02246963 GSK Sanis Pro Doc Mylan Novopharm Phmscience Ratiopharm Lamictal Lamotrigine Lamotrigine-150 Mylan-Lamotrigine Novo-Lamotrigine pms-Lamotrigine ratio-Lamotrigine 100 60 100 60 100 100 100 100 100 60 LEVETIRACETAM X Tab. 0.5505 0.5505 0.5505 2.0972 0.5505 0.5505 0.5505 0.5505 0.5505 0.5505 250 mg PPB 02285924 Apo-Levetiracetam 02375249 Auro-Levetiracetam Apotex Aurobindo 02274183 02247027 02353342 02297353 02296101 Cobalt U.C.B. Sanis Pharmel Phmscience Co Levetiracetam Keppra Levetiracetam phl-Levetiracetam pms-Levetiracetam 55.05 33.03 55.05 125.83 55.05 55.05 55.05 55.05 55.05 33.03 100 100 500 100 120 100 100 100 Tab. 82.10 82.10 410.50 82.10 195.07 82.10 82.10 82.10 0.8210 0.8210 0.8210 0.8210 1.6256 0.8210 0.8210 0.8210 500 mg PPB 02285932 Apo-Levetiracetam 02375257 Auro-Levetiracetam Apotex Aurobindo 02274191 Co Levetiracetam Cobalt 02247028 Keppra 02353350 Levetiracetam 02297361 phl-Levetiracetam U.C.B. Sanis Pharmel 02296128 pms-Levetiracetam Phmscience 02311380 Pro-Levetiracetam-500 Pro Doc 100 100 500 100 500 120 100 100 500 100 500 100 Tab. 100.27 100.27 501.35 100.27 501.35 238.06 100.27 100.27 501.35 100.27 501.35 100.27 1.0027 1.0027 1.0027 1.0027 1.0027 1.9838 1.0027 1.0027 1.0027 1.0027 1.0027 1.0027 750 mg PPB 02285940 Apo-Levetiracetam 02375265 Auro-Levetiracetam Apotex Aurobindo 02274205 02247029 02353369 02297388 02296136 02311399 Cobalt U.C.B. Sanis Pharmel Phmscience Pro Doc 2013-04 Co Levetiracetam Keppra Levetiracetam phl-Levetiracetam pms-Levetiracetam Pro-Levetiracetam-750 100 100 500 100 120 100 100 100 100 142.70 142.70 713.50 142.70 332.55 142.70 142.70 142.70 142.70 1.4270 1.4270 1.4270 1.4270 2.7713 1.4270 1.4270 1.4270 1.4270 Page 175 CODE BRAND NAME MANUFACTURER SIZE PREGABALIN X Caps. UNIT PRICE 25 mg PPB + 02394235 Apo-Pregabalin Apotex * 02268418 Lyrica + 02359596 pms-Pregabalin Pfizer Phmscience + 02396483 Pregabalin Pro Doc + 02392801 Ran-Pregabalin Ranbaxy + 02377039 Riva-Pregabalin Riva + 02390817 Sandoz Pregabalin + 02361159 Teva Pregabalin Sandoz Teva Can 100 500 60 100 500 100 500 100 500 100 500 100 60 Caps. 41.81 209.03 46.45 41.81 209.03 41.81 209.03 41.81 209.03 41.81 209.03 41.81 25.09 0.4181 0.4181 0.7742 0.4181 0.4181 0.4181 0.4181 0.4181 0.4181 0.4181 0.4181 0.4181 0.4181 50 mg PPB + 02394243 Apo-Pregabalin Apotex * 02268426 Lyrica + 02359618 pms-Pregabalin Pfizer Phmscience + 02396505 Pregabalin Pro Doc + 02392828 Ran-Pregabalin Ranbaxy + 02377047 Riva-Pregabalin Riva + 02390825 Sandoz Pregabalin + 02361175 Teva Pregabalin Sands Teva Can 100 500 60 100 500 100 500 100 500 100 500 100 60 Caps. 65.58 327.90 72.87 65.58 327.90 65.58 327.90 65.58 327.90 65.58 327.90 65.58 39.35 0.6558 0.6558 1.2145 0.6558 0.6558 0.6558 0.6558 0.6558 0.6558 0.6558 0.6558 0.6558 0.6558 75 mg PPB + 02394251 Apo-Pregabalin Apotex * 02268434 Lyrica + 02359626 pms-Pregabalin Pfizer Phmscience + 02396513 Pregabalin Pro Doc + 02392836 Ran-Pregabalin Ranbaxy + 02377055 Riva-Pregabalin Riva + 02390833 Sandoz Pregabalin + 02361183 Teva Pregabalin Sandoz Teva Can Page COST OF PKG. SIZE 176 100 500 60 100 500 100 500 100 500 100 500 100 60 100 84.86 424.30 94.29 84.86 424.30 84.86 424.30 84.86 424.30 84.86 424.30 84.86 50.92 84.86 0.8486 0.8486 1.5715 0.8486 0.8486 0.8486 0.8486 0.8486 0.8486 0.8486 0.8486 0.8486 0.8486 0.8486 2013-04 CODE BRAND NAME MANUFACTURER SIZE Caps. UNIT PRICE 150 mg PPB + 02394278 Apo-Pregabalin Apotex * 02268450 Lyrica + 02359634 pms-Pregabalin Pfizer Phmscience + 02396521 Pregabalin Pro Doc + 02392844 Ran-Pregabalin Ranbaxy + 02377063 Riva-Pregabalin Riva + 02390841 Sandoz Pregabalin + 02361205 Teva Pregabalin Sandoz Teva Can 100 500 60 100 500 100 500 100 500 100 500 100 60 100 Caps. + * + + + COST OF PKG. SIZE 116.98 548.90 129.98 116.98 548.90 116.98 548.90 116.98 548.90 116.98 548.90 116.98 70.19 109.78 1.1698 1.0978 2.1663 1.1698 1.0978 1.1698 1.0978 1.1698 1.0978 1.1698 1.0978 1.1698 1.1698 1.0978 300 mg PPB 02394294 02268485 02359642 02396548 02392860 Apo-Pregabalin Lyrica pms-Pregabalin Pregabalin Ran-Pregabalin + 02377071 Riva-Pregabalin + 02390868 Sandoz Pregabalin + 02361248 Teva Pregabalin Apotex Pfizer Phmscience Pro Doc Ranbaxy Riva Sandoz Teva Can 100 60 100 100 100 500 100 100 60 Janss. Inc 60 TOPIRAMATE X Sprinkle caps. 02239907 Topamax 2013-04 1.1698 2.1663 1.1698 1.1698 1.1698 1.1698 1.1698 1.1698 1.1698 15 mg Sprinkle caps. 02239908 Topamax 116.98 129.98 116.98 116.98 116.98 584.90 116.98 116.98 70.19 65.11 1.0852 25 mg Janss. Inc 60 68.34 1.1390 Page 177 CODE BRAND NAME MANUFACTURER SIZE Tab. UNIT PRICE 25 mg PPB 02279614 02345803 02287765 02315645 02263351 02248860 02271184 Apo-Topiramate Auro-Topiramate Co Topiramate Mint-Topiramate Mylan-Topiramate Novo-Topiramate phl-Topiramate Apotex Aurobindo Cobalt Mint Mylan Novopharm Pharmel 02262991 pms-Topiramate Phmscience 02313650 02260050 02230893 02395738 02345412 02356856 02389460 02325136 Pro Doc Sandoz Janss. Inc Accord MeliaPharm Sanis Sivem Zymcan Pro-Topiramate Sandoz Topiramate Topamax Topiramate Topiramate Topiramate Topiramate Zym-Topiramate 100 60 100 100 100 100 100 500 100 500 100 100 100 100 100 100 100 100 Tab. 31.28 18.77 31.28 31.28 31.28 31.28 31.28 156.40 31.28 156.40 31.28 31.28 113.93 31.28 31.28 31.28 31.28 31.28 0.3128 0.3128 0.3128 0.3128 0.3128 0.3128 0.3128 0.3128 0.3128 0.3128 0.3128 0.3128 1.1393 0.3128 0.3128 0.3128 0.3128 0.3128 50 mg 02312085 pms-Topiramate Phmscience 100 02279630 02345838 02287773 02315653 02263378 02248861 02271192 02263009 02313669 02260069 02230894 02395746 02345439 02356864 02389487 02325144 Apotex Aurobindo Cobalt Mint Mylan Novopharm Pharmel Phmscience Pro Doc Sandoz Janss. Inc Accord MeliaPharm Sanis Sivem Zymcan 100 60 100 100 100 60 100 100 100 100 60 100 100 100 100 100 Tab. Page COST OF PKG. SIZE 75.95 0.7595 100 mg PPB 178 Apo-Topiramate Auro-Topiramate Co Topiramate Mint-Topiramate Mylan-Topiramate Novo-Topiramate phl-Topiramate pms-Topiramate Pro-Topiramate Sandoz Topiramate Topamax Topiramate Topiramate Topiramate Topiramate Zym-Topiramate 59.28 35.57 59.28 59.28 59.28 35.57 59.28 59.28 59.28 59.28 129.54 59.28 59.28 59.28 59.28 59.28 0.5928 0.5928 0.5928 0.5928 0.5928 0.5928 0.5928 0.5928 0.5928 0.5928 2.1590 0.5928 0.5928 0.5928 0.5928 0.5928 2013-04 CODE BRAND NAME MANUFACTURER SIZE Tab. COST OF PKG. SIZE UNIT PRICE 200 mg PPB 02279649 02345846 02287781 02315661 02263386 02248862 02271206 02263017 02313677 02267837 02230896 02395754 02345447 02356872 02325152 Apo-Topiramate Auro-Topiramate Co Topiramate Mint-Topiramate Mylan-Topiramate Novo-Topiramate phl-Topiramate pms-Topiramate Pro-Topiramate Sandoz Topiramate Topamax Topiramate Topiramate Topiramate Zym-Topiramate Apotex Aurobindo Cobalt Mint Mylan Novopharm Pharmel Phmscience Pro Doc Sandoz Janss. Inc Accord MeliaPharm Sanis Zymcan 100 60 100 100 100 60 100 100 100 100 60 100 100 100 100 Apotex Abbott Phmscience Ratiopharm 450 ml 480 ml 450 ml 480 ml VALPROATE SODIUM X Syr. 02238370 00443832 02236807 02140063 Apo-Valproic Depakene pms-Valproic acid ratio-Valproic Apotex Abbott Mylan 02100630 Novo-Valproic 02230768 pms-Valproic acid Novopharm Phmscience 02140047 ratio-Valproic Ratiopharm 02239714 Sandoz Valproic 02238546 Valproic-250 Sandoz Pro Doc 100 100 100 500 100 100 500 100 500 100 100 Ent. Caps. 0.0398 0.0949 0.0398 0.0398 13.66 45.55 13.66 68.30 13.66 13.66 68.30 13.66 68.30 13.66 13.66 0.1366 0.4555 0.1366 0.1366 0.1366 0.1366 0.1366 0.1366 0.1366 0.1366 0.1366 500 mg PPB Novopharm Phmscience 100 100 500 VIGABATRIN X Oral Pd. 2013-04 17.92 45.55 17.92 19.11 250 mg PPB 02238048 Apo-Valproic 00443840 Depakene 02184648 Mylan-Valproic 02068036 Sabril 0.8853 0.8853 0.8853 0.8853 0.8853 0.8853 0.8853 0.8853 0.8853 0.8853 3.4180 0.8853 0.8853 0.8853 0.8853 250 mg/5 mL PPB VALPROIC ACID X Caps. 02218321 Novo-Valproic 02229628 pms-Valproic Acid E.C. 88.53 53.12 88.53 88.53 88.53 53.12 88.53 88.53 88.53 88.53 205.08 88.53 88.53 88.53 88.53 41.25 41.25 206.25 0.4125 0.4125 0.4125 500 mg/sac. Lundb Inc 50 45.25 0.9050 Page 179 CODE BRAND NAME MANUFACTURER SIZE Tab. COST OF PKG. SIZE UNIT PRICE 500 mg 02065819 Sabril Lundb Inc 100 00370991 Amitriptyline-10 Pro Doc 00335053 Elavil AA Pharma 02247302 pms-Amitriptyline Biomed 100 1000 100 1000 500 90.50 0.9050 28:16.04 ANTIDEPRESSANTS AMITRIPTYLINE HYDROCHLORIDE X Tab. 10 mg PPB Tab. 0.0435 0.0435 0.0664 0.0664 0.0435 25 mg PPB 00371009 Amitriptyline-25 Pro Doc 00335061 Elavil AA Pharma 02247303 pms-Amitriptyline Biomed 100 1000 100 1000 500 Tab. 8.29 82.90 12.11 121.10 41.45 0.0829 0.0829 0.1211 0.1211 0.0829 50 mg PPB 00456349 Amitriptyline-50 Pro Doc 00335088 Elavil AA Pharma 02247304 pms-Amitriptyline Biomed 100 1000 100 1000 100 BUPROPION HYDROCHLORIDE X L.A. Tab. 02331616 02391562 02325373 02285657 Bupropion SR Bupropion SR pms-Bupropion SR ratio-Bupropion SR 02275074 Sandoz Bupropion SR 02325357 02391570 02313421 02285665 Pro Doc Sanis Phmscience Ratiopharm Sandoz 0.1540 0.1540 0.2347 0.2347 0.1540 60 60 60 30 60 30 60 9.29 9.29 9.29 4.64 9.29 4.64 9.29 0.1548 0.1548 0.1548 0.1548 0.1548 0.1548 0.1548 150 mg PPB Bupropion SR Bupropion SR pms-Bupropion SR ratio-Bupropion SR Pro Doc Sanis Phmscience Ratiopharm 02275082 Sandoz Bupropion SR Sandoz 02237825 Wellbutrin SR Valeant 180 15.40 154.00 23.47 234.70 15.40 100 mg PPB L.A. Tab. Page 4.35 43.50 6.64 66.40 21.75 60 60 100 30 60 30 60 60 13.78 13.78 22.97 6.89 13.79 6.89 13.79 51.02 0.2297 0.2297 0.2297 0.2297 0.2298 0.2297 0.2298 0.8503 2013-04 CODE BRAND NAME MANUFACTURER SIZE L.A. Tab. (24 h) Valeant 90 Valeant 90 L.A. Tab. (24 h) 47.45 0.5272 300 mg 02275104 Wellbutrin XL CITALOPRAM HYDROMIDE X Tab. 2013-04 UNIT PRICE 150 mg 02275090 Wellbutrin XL 02301822 02387948 02325047 02370085 02371871 02370077 02312336 02273543 02270609 02303256 COST OF PKG. SIZE Citalopram Citalopram Citalopram-10 Jamp-Citalopram Mar-Citalopram Mint-Citalopram Novo-Citalopram phl-Citalopram pms-Citalopram Riva-Citalopram 94.91 1.0546 10 mg PPB MeliaPharm Sivem Pro Doc Jamp Marcan Mint Novopharm Pharmel Phmscience Riva 100 100 100 100 100 100 100 100 100 100 24.93 24.93 24.93 24.93 24.93 24.93 24.93 24.93 24.93 24.93 0.2493 0.2493 0.2493 0.2493 0.2493 0.2493 0.2493 0.2493 0.2493 0.2493 Page 181 CODE BRAND NAME MANUFACTURER SIZE Tab. UNIT PRICE 20 mg PPB * 02246056 Apo-Citalopram Apotex * 02275562 Auro-Citalopram Aurobindo 02239607 Celexa * 02301830 Citalopram 02284847 Citalopram Lundbeck MeliaPharm Mylan * 02353660 Citalopram Sanis * 02387956 Citalopram Sivem * 02306239 Citalopram Odan Odan * 02257513 Citalopram-20 Pro Doc * 02248050 Co Citalopram Cobalt * 02313405 Jamp-Citalopram Jamp * 02371898 Mar-Citalopram Marcan * 02304686 Mint-Citalopram Mint * 02246594 Mylan-Citalopram Mylan * 02293218 Novo-Citalopram Novopharm * 02248944 phl-Citalopram Pharmel * 02248010 pms-Citalopram Phmscience * 02285622 Ran-Citalo Ranbaxy * 02252112 ratio-Citalopram Ratiopharm * 02303264 Riva-Citalopram Riva * 02248170 Sandoz Citalopram Sandoz * 02355272 Septa-Citalopram Septa 30 500 30 500 30 100 100 100 500 100 500 30 500 30 500 30 500 30 250 30 500 100 500 30 500 30 500 30 100 30 500 30 500 100 500 30 500 30 500 30 500 100 500 Tab. 9.99 166.45 9.99 166.45 39.95 133.17 33.29 33.30 166.45 33.29 166.45 9.99 166.45 9.99 166.45 9.99 166.45 9.99 83.23 9.99 166.45 33.29 166.45 9.99 166.45 9.99 166.45 9.99 33.29 9.99 166.45 9.99 166.45 33.29 166.45 9.99 166.45 9.99 166.45 9.99 166.45 33.29 166.45 0.3329 0.3329 0.3329 0.3329 1.3317 1.3317 0.3329 W W 0.3329 0.3329 0.3329 0.3329 0.3329 0.3329 0.3329 0.3329 0.3329 0.3329 0.3329 0.3329 0.3329 0.3329 0.3329 0.3329 0.3329 0.3329 0.3329 0.3329 0.3329 0.3329 0.3329 0.3329 0.3329 0.3329 0.3329 0.3329 0.3329 0.3329 0.3329 0.3329 0.3329 0.3329 30 mg 02296152 CTP 30 Page COST OF PKG. SIZE 182 Sunovion 30 18.84 0.6280 2013-04 CODE BRAND NAME MANUFACTURER SIZE Tab. COST OF PKG. SIZE UNIT PRICE 40 mg PPB 02246057 Apo-Citalopram Apotex 02275570 Auro-Citalopram Aurobindo 02239608 02301849 02284855 02353679 Lundbeck MeliaPharm Mylan Sanis Celexa Citalopram Citalopram Citalopram 02387964 Citalopram Sivem 02306247 Citalopram Odan Odan 02257521 Citalopram-40 Pro Doc 02248051 Co Citalopram Cobalt 02313413 Jamp-Citalopram Jamp 02371901 Mar-Citalopram 02304694 Mint-Citalopram Marcan Mint 02246595 Mylan-Citalopram Mylan 02293226 Novo-Citalopram Novopharm 02248945 phl-Citalopram Pharmel 02248011 pms-Citalopram Phmscience 02285630 Ran-Citalo Ranbaxy 02252120 ratio-Citalopram Ratiopharm 02303272 Riva-Citalopram Riva 02248171 Sandoz Citalopram Sandoz 02355280 Septa-Citalopram Septa 30 100 30 500 30 100 100 30 100 30 100 30 100 30 100 30 100 30 100 100 30 100 30 100 30 100 30 100 30 100 30 100 30 100 30 100 30 100 30 100 CLOMIPRAMINE HYDROCHLORIDE X Tab. 00330566 Anafranil 02040786 Apo-Clomipramine 02244816 Co Clomipramine 2013-04 9.99 33.30 9.99 166.50 39.95 33.30 33.30 9.99 33.30 9.99 33.30 9.99 33.30 9.99 33.30 9.99 33.30 9.99 33.30 33.30 9.99 33.30 9.99 33.30 9.99 33.30 9.99 33.30 9.99 33.30 9.99 33.30 9.99 33.30 9.99 33.30 9.99 33.30 9.99 33.30 0.3330 0.3330 0.3330 0.3330 1.3317 0.3330 W 0.3330 0.3330 0.3330 0.3330 0.3330 0.3330 0.3330 0.3330 0.3330 0.3330 0.3330 0.3330 0.3330 0.3330 0.3330 0.3330 0.3330 0.3330 0.3330 0.3330 0.3330 0.3330 0.3330 0.3330 0.3330 0.3330 0.3330 0.3330 0.3330 0.3330 0.3330 0.3330 0.3330 10 mg PPB Sunovion Apotex Cobalt 100 100 100 25.81 12.90 12.90 0.2581 0.1290 0.1290 Page 183 CODE BRAND NAME MANUFACTURER SIZE Tab. UNIT PRICE 25 mg PPB 00324019 Anafranil 02040778 Apo-Clomipramine Sunovion Apotex 02244817 Co Clomipramine Cobalt 100 100 500 100 Tab. 35.16 17.58 87.90 17.58 0.3516 0.1758 0.1758 0.1758 50 mg PPB 00402591 Anafranil 02040751 Apo-Clomipramine 02244818 Co Clomipramine Sepracor Apotex Cobalt 100 100 100 DESIPRAMINE HYDROCHLORIDE X Tab. 64.74 32.37 32.37 0.6474 0.3237 0.3237 10 mg 02216248 Apo-Desipramine AA Pharma 100 02216256 Apo-Desipramine AA Pharma 100 Tab. 38.04 0.1919 25 mg Tab. 38.04 0.1763 100 mg 02216280 Apo-Desipramine AA Pharma 100 Apotex Erfa 100 100 DOXEPIN HYDROCHLORIDE X Caps. 02049996 Apo-Doxepin 00024325 Sinequan 89.15 0.8915 10 mg PPB Caps. 18.89 23.60 0.1416 0.2360 25 mg PPB 02050005 Apo-Doxepin 01913425 Novo-Doxepin 00024333 Sinequan Apotex Novopharm Erfa 100 100 100 18.60 14.30 28.95 0.1564 0.1430 0.2895 50 mg PPB Caps. 02050013 Apo-Doxepin 01913433 Novo-Doxepin 00024341 Sinequan Apotex Novopharm Erfa 100 100 100 Caps. 34.50 22.28 53.72 0.2901 0.2228 0.5372 75 mg PPB 02050021 Apo-Doxepin 01913441 Novo-Doxepin 00400750 Sinequan Page COST OF PKG. SIZE 184 Apotex Novopharm Erfa 100 100 100 39.16 39.16 77.12 0.3916 0.3916 0.7712 2013-04 CODE BRAND NAME MANUFACTURER SIZE Caps. COST OF PKG. SIZE UNIT PRICE 100 mg PPB 02050048 Apo-Doxepin 01913468 Novo-Doxepin 00326925 Sinequan Apotex Novopharm Erfa 100 100 100 Caps. 51.60 51.60 101.60 0.5160 0.5160 1.0160 150 mg 01913476 Novo-Doxepin Novopharm 100 Apotex Aurobindo Cobalt Accord MeliaPharm Sanis Sivem Marcan Mint Mylan Pharmel Phmscience Pro Doc Lilly Ratiopharm Riva Sandoz Teva Can Zymcan 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 FLUOXETINE HYDROCHLORIDE X Caps. 02216353 02385627 02242177 02393441 02344149 02286068 02374447 02392909 02380560 02237813 02223481 02177579 02314991 02018985 02241371 02305461 02243486 02216582 02302659 2013-04 Apo-Fluoxetine Auro-Fluoxetine Co Fluoxetine Fluoxetine Fluoxetine Fluoxetine Fluoxetine Mar-Fluoxetine Mint-Fluoxetine Mylan-Fluoxetine phl-Fluoxetine pms-Fluoxetine Pro-Fluoxetine Prozac ratio-Fluoxetine Riva-Fluoxetine Sandoz Fluoxetine Teva-Fluoxetine Zym-Fluoxetine 78.20 0.7393 10 mg PPB 86.50 86.50 86.50 86.50 86.50 86.50 86.50 86.50 86.50 86.50 86.50 86.50 86.50 165.96 86.50 86.50 86.50 86.50 86.50 0.8650 0.8650 0.8650 0.8650 0.8650 0.8650 0.8650 0.8650 0.8650 0.8650 0.8650 0.8650 0.8650 1.6596 0.8650 0.8650 0.8650 0.8650 0.8650 Page 185 CODE BRAND NAME MANUFACTURER SIZE Caps. UNIT PRICE 20 mg PPB 02216361 Apo-Fluoxetine Apotex 02385635 Auro-Fluoxetine Aurobindo 02242178 Co Fluoxetine Cobalt 02344157 Fluoxetine 02286076 Fluoxetine MeliaPharm Sanis 02374455 Fluoxetine Sivem 02383241 Fluoxetine BP 02386402 Jamp-Fluoxetine 02392917 Mar-Fluoxetine Accord Jamp Marcan 02380579 Mint-Fluoxetine Mint 02237814 Mylan-Fluoxetine Mylan 02223503 phl-Fluoxetine Pharmel 02177587 pms-Fluoxetine Phmscience 02315009 Pro-Fluoxetine Pro Doc 00636622 Prozac 02241374 ratio-Fluoxetine Lilly Ratiopharm 02305488 Riva-Fluoxetine Riva 02243487 Sandoz Fluoxetine Sandoz 02216590 Teva-Fluoxetine Teva Can 02302667 Zym-Fluoxetine Zymcan 100 500 100 500 100 500 100 100 500 100 500 100 100 100 500 100 500 100 500 100 500 100 500 100 500 100 100 500 100 500 100 500 100 500 100 Oral Sol. 02231328 Apo-Fluoxetine Page COST OF PKG. SIZE 186 45.98 229.90 45.98 229.90 45.98 229.90 45.98 45.98 229.90 45.98 229.90 45.98 45.98 45.98 229.90 45.98 229.90 45.98 229.90 45.98 229.90 45.98 229.90 45.98 229.90 169.65 45.98 229.90 45.98 229.90 45.98 229.90 45.98 229.90 45.98 0.4598 0.4598 0.4598 0.4598 0.4598 0.4598 0.4598 0.4598 0.4598 0.4598 0.4598 0.4598 0.4598 0.4598 0.4598 0.4598 0.4598 0.4598 0.4598 0.4598 0.4598 0.4598 0.4598 0.4598 0.4598 1.6965 0.4598 0.4598 0.4598 0.4598 0.4598 0.4598 0.4598 0.4598 0.4598 20 mg/5 mL Apotex 120 ml 70.31 0.4658 2013-04 CODE BRAND NAME MANUFACTURER SIZE FLUVOXAMINE MALEATE X Tab. UNIT PRICE 50 mg PPB 02231329 Apo-Fluvoxamine Apotex 02255529 02236753 01919342 02239953 02262622 02240682 02218453 02303345 Cobalt Pro Doc Abbott Novopharm Pharmel Phmscience Ratiopharm Riva Co Fluvoxamine Fluvoxamine-50 Luvox Novo-Fluvoxamine phl-Fluvoxamine pms-Fluvoxamine ratio-Fluvoxamine Riva-Fluvox COST OF PKG. SIZE 02247054 Sandoz Fluvoxamine Sandoz 02231330 Apo-Fluvoxamine Apotex 02255537 02236754 01919369 02239954 02262630 02240683 02218461 02303361 Cobalt Pro Doc Abbott Novopharm Pharmel Phmscience Ratiopharm Riva 100 250 100 100 30 100 100 100 100 100 250 100 Tab. 21.05 52.63 21.05 21.05 25.90 21.05 21.05 21.05 21.05 21.05 52.63 21.05 0.2105 0.2105 0.2105 0.2105 0.8633 0.2105 0.2105 0.2105 0.2105 0.2105 0.2105 0.2105 100 mg PPB Co Fluvoxamine Fluvoxamine-100 Luvox Novo-Fluvoxamine phl-Fluvoxamine pms-Fluvoxamine ratio-Fluvoxamine Riva-Fluvox 02247055 Sandoz Fluvoxamine Sandoz 100 250 100 100 30 100 100 100 100 100 250 100 IMIPRAMINE HYDROCHLORIDE X Tab. 37.84 94.59 37.84 37.84 46.58 37.84 37.84 37.84 37.84 37.84 94.59 37.84 0.3784 0.3784 0.3784 0.3784 1.5527 0.3784 0.3784 0.3784 0.3784 0.3784 0.3784 0.3784 10 mg 00360201 Imipramine AA Pharma 100 1000 00312797 Imipramine AA Pharma 100 1000 Tab. 13.70 137.00 0.1074 0.0896 25 mg Tab. 24.71 247.10 0.1778 0.1480 50 mg 00326852 Imipramine AA Pharma 100 1000 Tab. 48.22 482.22 0.3959 0.3959 75 mg 00644579 Apo-Imipramine 2013-04 AA Pharma 100 63.08 0.3883 Page 187 CODE BRAND NAME MANUFACTURER SIZE L-TRYPTOPHANE X Caps. or Tab. 02248540 02248538 02240333 02240334 00718149 02029456 Apo-Tryptophan (Caps.) Apo-Tryptophan (Tab.) ratio-Tryptophan ratio-Tryptophan Tryptan (Caps) Tryptan (Co.) UNIT PRICE 500 mg PPB Apotex Apotex Ratiopharm Ratiopharm Valeant Valeant 100 100 100 100 100 100 02248539 Apo-Tryptophan (Tab.) 02237250 ratio-Tryptophan Apotex Ratiopharm 00654531 Tryptan (Co.) Valeant 100 100 250 100 02239326 Tryptan (Co.) Valeant 100 Tab. 36.64 36.64 36.64 36.64 67.86 67.86 0.3664 0.3664 0.3664 0.3664 0.6786 0.6786 1 g PPB Tab. 73.29 73.29 183.22 135.72 0.7329 0.7329 0.7329 1.3572 250 mg Tab. 33.93 0.3393 750 mg 02239327 Tryptan (Co.) Valeant 100 MAPROTILIN HYDROCHLORIDE X Tab. 101.79 1.0179 25 mg 02158612 Novo-Maprotiline Novopharm 100 02158620 Novo-Maprotiline Novopharm 100 Tab. 54.93 0.5493 50 mg Tab. 104.01 1.0401 75 mg 02158639 Novo-Maprotiline Novopharm 100 Apotex Aurobindo Jamp MeliaPharm Mylan Novopharm Phmscience Pro Doc Merck Sandoz Zymcan 30 30 100 100 100 30 100 100 30 50 100 MIRTAZAPINE X Tab. Oral Disint. or Tab. 02286610 02299801 02368560 02281732 02256096 02279894 02273942 02312778 02248542 02250594 02325179 Page COST OF PKG. SIZE 188 Apo-Mirtazapine Auro-Mirtazapine OD Jamp-Mirtazapine Mirtazapine Mylan-Mirtazapine Novo-Mirtazapine OD pms-Mirtazapine Pro-Mirtazapine Remeron RD Sandoz Mirtazapine Zym-Mirtazapine 142.04 1.4204 15 mg PPB 2.93 2.93 9.76 27.30 27.30 2.93 27.30 27.30 12.22 4.88 27.30 0.0976 0.0976 W 0.2730 0.2730 0.0976 0.2730 0.2730 0.4073 0.0976 0.2730 2013-04 CODE BRAND NAME MANUFACTURER SIZE Tab. Oral Disint. or Tab. 02286629 02299828 + 02368579 02252279 Apo-Mirtazapine Auro-Mirtazapine OD Jamp-Mirtazapine Mirtazapine + 02370689 Mirtazapine Apotex Aurobindo Jamp MeliaPharm Sanis Mylan 02259354 Novo-Mirtazapine Novopharm 02279908 Novo-Mirtazapine OD 02248762 pms-Mirtazapine Novopharm Phmscience 02312786 Pro-Mirtazapine Pro Doc 02243910 Remeron 02248543 Remeron RD 02265265 Riva-Mirtazapine Merck Merck Riva 02250608 Sandoz Mirtazapine 02325187 Zym-Mirtazapine Sandoz Zymcan 100 30 100 30 100 100 30 100 30 100 30 30 100 30 100 30 30 30 100 100 100 Tab. Oral Disint. or Tab. Apo-Mirtazapine Auro-Mirtazapine OD Mylan-Mirtazapine Novo-Mirtazapine OD Remeron RD 31.00 5.85 31.00 5.85 31.00 31.00 5.85 31.00 5.85 31.00 5.85 5.85 31.00 5.85 31.00 38.86 24.43 5.85 31.00 31.00 31.00 0.3100 0.1950 0.3100 0.1950 0.3100 0.3100 0.1950 0.3100 0.1950 0.3100 0.1950 0.1950 0.3100 0.1950 0.3100 1.2953 0.8143 0.1950 0.3100 0.3100 0.3100 45 mg PPB Apotex Aurobindo Mylan Novopharm Merck 30 30 100 30 30 Apotex Novopharm 100 100 MOCLOBÉMID X Tab. 02232148 Apo-Moclobemide 02239746 Novo-Moclobemide UNIT PRICE 30 mg PPB 02256118 Mylan-Mirtazapine 02286637 02299836 02256126 02279916 02248544 COST OF PKG. SIZE 8.78 8.78 81.90 8.78 36.66 0.2927 0.2927 0.8190 0.2927 1.2220 100 mg PPB Tab. 25.20 25.20 0.2520 0.2520 150 mg PPB 02232150 Apo-Moclobemide 00899356 Manerix 02239747 Novo-Moclobemide Apotex Meda Val Novopharm 100 60 100 Tab. 15.15 13.25 15.15 0.1515 0.2208 0.1515 300 mg PPB 02240456 Apo-Moclobemide 02166747 Manerix 02239748 Novo-Moclobemide 2013-04 Apotex Meda Val Novopharm 100 60 100 29.74 26.01 29.74 0.2974 0.4335 0.2974 Page 189 CODE BRAND NAME MANUFACTURER SIZE NORTRIPTYLINE HYDROCHLORIDE X Caps. 02223511 00015229 02229763 02231781 02177692 Apo-Nortriptyline Aventyl Nortriptyline-10 Novo-Nortriptyline pms-Nortriptyline UNIT PRICE 10 mg PPB Apotex Pendopharm Pro Doc Novopharm Phmscience 100 100 100 100 100 02223538 Apo-Nortriptyline Apotex 00015237 02229764 02231782 02177706 Pendopharm Pro Doc Novopharm Phmscience 100 500 100 100 100 100 Caps. 5.00 20.00 5.00 5.00 5.00 0.0500 0.1019 0.0500 0.0500 0.0500 25 mg PPB Aventyl Nortriptyline Novo-Nortriptyline pms-Nortriptyline PAROXÉTINE HYDROCHLORIDE X Tab. Page COST OF PKG. SIZE 0.1011 0.1011 0.2058 0.1011 0.1011 0.1011 10 mg PPB 02240907 02383276 02262746 02368862 Apo-Paroxetine Auro-Paroxetine Co Paroxetine Jamp-Paroxetine Apotex Aurobindo Cobalt Jamp 02248012 02248450 02282844 02388227 Mylan-Paroxetine Paroxetine Paroxetine Paroxetine Mylan MeliaPharm Sanis Sivem 02302012 02248913 02027887 02247750 Paroxetine Paroxetine-10 Paxil pms-Paroxetine Sorres Pro Doc GSK Phmscience 02247810 ratio-Paroxetine 02248559 Riva-Paroxetine Ratiopharm Riva 02269422 Sandoz Paroxetine 02248556 Teva-Paroxetine Sandoz Teva Can 190 10.11 50.54 40.43 10.11 10.11 10.11 100 100 100 30 100 100 100 100 30 100 100 100 30 30 100 30 30 250 100 30 100 82.10 82.10 82.10 24.63 82.10 82.10 82.10 82.10 24.63 82.10 82.10 82.10 47.25 24.63 82.10 24.63 24.63 205.25 82.10 24.63 82.10 0.8210 0.8210 0.8210 0.8210 0.8210 0.8210 0.8210 0.8210 0.8210 0.8210 0.8210 0.8210 1.5750 0.8210 0.8210 0.8210 0.8210 0.8210 0.8210 0.8210 0.8210 2013-04 CODE BRAND NAME MANUFACTURER SIZE Tab. COST OF PKG. SIZE UNIT PRICE 20 mg PPB 02240908 Apo-Paroxetine Apotex 02383284 Auro-Paroxetine Aurobindo 02262754 Co Paroxetine Cobalt 02368870 Jamp-Paroxetine Jamp 02248013 Mylan-Paroxetine Mylan 02248451 Paroxetine MeliaPharm 02282852 Paroxetine Sanis 02388235 Paroxetine Sivem 02302020 Paroxetine 02248914 Paroxetine-20 Sorres Pro Doc 01940481 Paxil 02247751 pms-Paroxetine GSK Phmscience 02247811 ratio-Paroxetine Ratiopharm 02248560 Riva-Paroxetine Riva 02269430 Sandoz Paroxetine 02248557 Teva-Paroxetine Sandoz Teva Can 02240909 02383292 02262762 02368889 Apo-Paroxetine Auro-Paroxetine Co Paroxetine Jamp-Paroxetine Apotex Aurobindo Cobalt Jamp 02248014 02248452 02282860 02388243 Mylan-Paroxetine Paroxetine Paroxetine Paroxetine Mylan MeliaPharm Sanis Sivem 02302039 02248915 01940473 02247752 Paroxetine Paroxetine-30 Paxil pms-Paroxetine Sorres Pro Doc GSK Phmscience 02247812 ratio-Paroxetine 02248561 Riva-Paroxetine Ratiopharm Riva 02269449 Sandoz Paroxetine 02248558 Teva-Paroxetine Sandoz Teva Can 30 500 100 500 30 500 30 100 100 500 30 500 100 500 30 500 100 30 500 100 30 500 100 500 100 500 100 30 500 Tab. 13.54 225.70 45.13 225.70 13.54 225.70 13.54 45.14 45.13 225.70 13.54 225.70 45.13 225.70 13.54 225.70 45.13 13.54 225.70 168.07 13.54 225.70 45.13 225.70 45.13 225.70 45.13 13.54 225.70 0.4513 0.4514 0.4513 0.4514 0.4513 0.4514 0.4513 0.4514 0.4513 0.4514 0.4513 0.4514 0.4513 0.4514 0.4513 0.4514 0.4513 0.4513 0.4514 1.6807 0.4513 0.4514 0.4513 0.4514 0.4513 0.4514 0.4513 0.4513 0.4514 30 mg PPB 2013-04 100 100 100 30 100 100 100 100 30 100 100 100 30 30 100 30 30 250 100 30 100 47.96 47.96 47.96 14.39 47.96 47.96 47.96 47.96 14.39 47.96 47.96 47.96 53.59 14.39 47.96 14.39 14.39 119.90 47.96 14.39 47.96 0.4796 0.4796 0.4796 0.4796 0.4796 0.4796 0.4796 0.4796 0.4796 0.4796 0.4796 0.4796 1.7863 0.4796 0.4796 0.4796 0.4796 0.4796 0.4796 0.4796 0.4796 Page 191 CODE BRAND NAME MANUFACTURER SIZE Tab. UNIT PRICE 40 mg 02293749 pms-Paroxetine Phmscience 100 Erfa 100 100 100 100 100 100 100 100 100 100 100 250 100 100 100 100 100 100 PHENELZINE SULFATE X Tab. 00476552 Nardil 1.6530 34.58 0.3458 25 mg PPB 02238280 02390906 02287390 02357143 02242519 02240485 02245824 02244838 02374552 02248496 Apo-Sertraline Auro-Sertraline Co Sertraline Jamp-Sertraline Mylan-Sertraline Novo-Sertraline phl-Sertraline pms-Sertraline Ran-Sertraline Riva-Sertraline Apotex Aurobindo Cobalt Jamp Mylan Novopharm Pharmel Phmscience Ranbaxy Riva 02245159 02303779 02353520 02386070 02241302 02132702 Sandoz Sertraline Sertraline Sertraline Sertraline Sertraline-25 Zoloft Sandoz MeliaPharm Sanis Sivem Pro Doc Pfizer 192 165.30 15 mg SERTRALINE HYDROCHLORIDE X Caps. Page COST OF PKG. SIZE 20.38 20.38 20.38 20.38 20.38 20.38 20.38 20.38 20.38 20.38 60.00 20.38 20.38 20.38 20.38 20.38 83.18 0.2038 0.2038 0.2038 0.2038 0.2038 0.2038 0.2038 0.2038 0.2038 0.2038 0.2400 0.2038 0.2038 0.2038 0.2038 0.2038 0.8318 2013-04 CODE BRAND NAME MANUFACTURER SIZE Caps. COST OF PKG. SIZE UNIT PRICE 50 mg PPB 02238281 Apo-Sertraline Apotex 02390914 Auro-Sertraline Aurobindo 02287404 Co Sertraline Cobalt 02357151 Jamp-Sertraline Jamp 02242520 Mylan-Sertraline Mylan 02240484 Novo-Sertraline Novopharm 02245825 phl-Sertraline Pharmel 02244839 pms-Sertraline Phmscience 02374560 Ran-Sertraline 02248497 Riva-Sertraline Ranbaxy Riva 02245160 Sandoz Sertraline Sandoz 02303809 Sertraline 02353539 Sertraline MeliaPharm Sanis 02386089 Sertraline 02241303 Sertraline-50 Sivem Pro Doc 01962817 Zoloft Pfizer 2013-04 100 250 100 250 100 250 100 250 100 500 100 250 100 250 100 250 100 100 250 100 250 100 100 250 100 100 250 100 250 40.00 100.00 40.00 100.00 40.00 100.00 40.00 100.00 40.00 200.00 40.00 100.00 40.00 100.00 40.00 100.00 40.00 40.00 100.00 40.00 100.00 40.00 40.00 100.00 40.00 40.00 100.00 166.34 415.86 0.4000 0.4000 0.4000 0.4000 0.4000 0.4000 0.4000 0.4000 0.4000 0.4000 0.4000 0.4000 0.4000 0.4000 0.4000 0.4000 0.4000 0.4000 0.4000 0.4000 0.4000 0.4000 0.4000 0.4000 0.4000 0.4000 0.4000 1.6634 1.6634 Page 193 CODE BRAND NAME MANUFACTURER SIZE Caps. UNIT PRICE 100 mg PPB 02238282 Apo-Sertraline Apotex 02390922 Auro-Sertraline Aurobindo 02287412 Co Sertraline Cobalt 02357178 Jamp-Sertraline Jamp 02242521 Mylan-Sertraline 02245826 phl-Sertraline Mylan Pharmel 02244840 pms-Sertraline Phmscience 02374579 Ran-Sertraline 02248498 Riva-Sertraline Ranbaxy Riva 02245161 Sandoz Sertraline 02303817 Sertraline 02353547 Sertraline Sandoz MeliaPharm Sanis 02386097 Sertraline 02241304 Sertraline-100 Sivem Pro Doc 02240481 Teva-Sertraline 01962779 Zoloft Teva Can Pfizer 100 250 100 250 100 250 100 250 100 100 250 100 250 100 100 250 100 100 100 250 100 100 250 100 100 GSK 100 TRANYLCYPROMINE SULFATE X Tab. 01919598 Parnate 0.4458 0.4458 0.4458 0.4458 0.4458 0.4458 0.4458 0.4458 0.4458 0.4458 0.4458 0.4458 0.4458 0.4458 0.4458 0.4458 0.4458 0.4458 0.4458 0.4458 0.4458 0.4458 0.4458 0.4458 1.7466 36.05 0.3605 50 mg PPB 02147637 Apo-Trazodone Apotex 02231683 Mylan-Trazodone Mylan 02345943 NTP-Trazodone NT Pharma 02236941 phl-Trazodone Pharmel 01937227 pms-Trazodone Phmscience 02144263 Teva-Trazodone Teva Can 02348772 Trazodone Sanis 02164353 Trazodone-50 Pro Doc 02325101 Zym-Trazodone Zymcan 194 44.58 111.45 44.58 111.45 44.58 111.45 44.58 111.45 44.58 44.58 111.45 44.58 111.45 44.58 44.58 111.45 44.58 44.58 44.58 111.45 44.58 44.58 111.45 44.58 174.66 10 mg TRAZODONE HYDROCHLORIDE X Tab. Page COST OF PKG. SIZE 100 250 100 250 100 500 100 500 100 500 100 500 100 500 100 250 100 5.54 13.84 5.54 13.84 5.54 27.68 5.54 27.68 5.54 27.68 5.54 27.68 5.54 27.68 5.54 13.84 5.54 0.0554 0.0554 0.0554 0.0554 0.0554 0.0554 0.0554 0.0554 0.0554 0.0554 0.0554 0.0554 0.0554 0.0554 0.0554 0.0554 0.0554 2013-04 CODE BRAND NAME MANUFACTURER SIZE Tab. COST OF PKG. SIZE UNIT PRICE 75 mg 02237339 pms-Trazodone Phmscience 100 02147645 Apo-Trazodone Apotex 02231684 Mylan-Trazodone 02345951 NTP-Trazodone 02236942 phl-Trazodone Mylan NT Pharma Pharmel 01937235 pms-Trazodone Phmscience 02144271 Teva-Trazodone Teva Can 02348780 Trazodone 02164361 Trazodone-100 Sanis Pro Doc 02325128 Zym-Trazodone Zymcan 100 500 100 100 100 500 100 500 100 500 100 100 500 100 Tab. 33.66 0.3366 100 mg PPB Tab. 9.89 49.45 9.89 9.89 9.89 49.45 9.89 49.45 9.89 49.45 9.89 9.89 49.45 9.89 0.0989 0.0989 0.0989 0.0989 0.0989 0.0989 0.0989 0.0989 0.0989 0.0989 0.0989 0.0989 0.0989 0.0989 150 mg PPB 02147653 02345978 02144298 02348799 02164388 Apo-Trazodone D NTP-Trazodone Teva-Trazodone Trazodone Trazodone-150 D Apotex NT Pharma Teva Can Sanis Pro Doc 100 100 100 100 100 TRIMIPRAMINE X Caps. 02070987 Apo-Trimip 14.53 14.53 14.53 14.53 14.53 0.1453 0.1453 0.1453 0.1453 0.1453 75 mg AA Pharma 100 Tab. 73.14 0.5381 12.5 mg 00740799 Apo-Trimip 2013-04 AA Pharma 100 21.56 0.0850 Page 195 CODE BRAND NAME MANUFACTURER SIZE VENLAFAXINE CHLORHYDRATE X L.A. Caps. 02331683 Apo-Venlafaxine XR Apotex 02304317 Co Venlafaxine XR Cobalt 02237279 Effexor XR Pfizer 02310279 Mylan-Venlafaxine XR Mylan 02278545 pms-Venlafaxine XR Phmscience 02380072 Ran-Venlafaxine XR 02273969 ratio-Venlafaxine XR Ranbaxy Ratiopharm 02307774 Riva-Venlafaxine XR Riva 02310317 Sandoz Venlafaxine XR 02275023 Teva-Venlafaxine XR 02339242 Venlafaxine XR Sandoz Teva Can Pro Doc 02354713 Venlafaxine XR 02385929 Venlafaxine XR Sanis Sivem 100 500 100 500 15 90 100 500 100 500 30 100 500 100 500 100 100 100 500 100 100 22.06 110.30 22.06 110.30 12.59 75.51 22.06 110.30 22.06 110.30 6.62 22.06 110.30 22.06 110.30 22.06 22.06 22.06 110.30 22.06 22.06 0.2206 0.2206 0.2206 0.2206 0.8393 0.8390 0.2206 0.2206 0.2206 0.2206 0.2206 0.2206 0.2206 0.2206 0.2206 0.2206 0.2206 0.2206 0.2206 0.2206 0.2206 75 mg PPB 02331691 Apo-Venlafaxine XR Apotex 02304325 Co Venlafaxine XR Cobalt 02237280 Effexor XR Pfizer 02310287 Mylan-Venlafaxine XR Mylan 02275031 Novo-Venlafaxine XR Novopharm 02278553 pms-Venlafaxine XR Phmscience 02380080 Ran-Venlafaxine XR Ranbaxy 02273977 ratio-Venlafaxine XR Ratiopharm 02307782 Riva-Venlafaxine XR Riva 02310325 Sandoz Venlafaxine XR Sandoz 02339250 Venlafaxine XR Pro Doc 02354721 Venlafaxine XR Sanis 02385937 Venlafaxine XR Sivem 196 UNIT PRICE 37.5 mg PPB L.A. Caps. Page COST OF PKG. SIZE 100 500 100 500 15 90 100 500 100 500 100 500 100 500 100 500 100 500 100 500 100 500 100 500 100 500 44.12 220.59 44.12 220.59 25.18 151.01 44.12 220.59 44.12 220.59 44.12 220.59 44.12 220.59 44.12 220.59 44.12 220.59 44.12 220.59 44.12 220.59 44.12 220.59 44.12 220.59 0.4412 0.4412 0.4412 0.4412 1.6787 1.6779 0.4412 0.4412 0.4412 0.4412 0.4412 0.4412 0.4412 0.4412 0.4412 0.4412 0.4412 0.4412 0.4412 0.4412 0.4412 0.4412 0.4412 0.4412 0.4412 0.4412 2013-04 CODE BRAND NAME MANUFACTURER SIZE L.A. Caps. COST OF PKG. SIZE UNIT PRICE 150 mg PPB 02331705 Apo-Venlafaxine XR Apotex 02304333 Co Venlafaxine XR Cobalt 02237282 Effexor XR Pfizer 02310295 Mylan-Venlafaxine XR Mylan 02278561 pms-Venlafaxine XR Phmscience 02380099 Ran-Venlafaxine XR Ranbaxy 02273985 ratio-Venlafaxine XR Ratiopharm 02307790 Riva-Venlafaxine XR Riva 02310333 Sandoz Venlafaxine XR Sandoz 02275058 Teva-Venlafaxine XR Teva Can 02339269 Venlafaxine XR Pro Doc 02354748 Venlafaxine XR Sanis 02385945 Venlafaxine XR Sivem 100 500 100 500 15 90 100 500 100 500 100 500 100 500 100 500 100 500 100 500 100 500 100 500 100 500 46.58 232.90 46.58 232.90 26.62 159.72 46.58 232.90 46.58 232.90 46.58 232.90 46.58 232.90 46.58 232.90 46.58 232.90 46.58 232.90 46.58 232.90 46.58 232.90 46.58 232.90 0.4658 0.4658 0.4658 0.4658 1.7747 1.7747 0.4658 0.4658 0.4658 0.4658 0.4658 0.4658 0.4658 0.4658 0.4658 0.4658 0.4658 0.4658 0.4658 0.4658 0.4658 0.4658 0.4658 0.4658 0.4658 0.4658 28:16.08 ANTIPSYCHOTIC AGENTS ARIPIPRAZOLE X Tab. 2 mg 02322374 Abilify B.M.S. 30 02322382 Abilify B.M.S. 30 Tab. 87.42 2.9140 5 mg Tab. 98.40 3.2800 10 mg 02322390 Abilify B.M.S. 30 02322404 Abilify B.M.S. 30 Tab. 113.40 3.7800 15 mg Tab. 113.40 3.7800 20 mg 02322412 Abilify B.M.S. 30 02322455 Abilify B.M.S. 30 Tab. 113.40 3.7800 30 mg 2013-04 113.40 3.7800 Page 197 CODE BRAND NAME MANUFACTURER SIZE CHLORPROMAZINE HYDROCHLORIDE X Tab. 00232823 Novo-Chlorpromazine Novopharm 100 500 00232807 Novo-Chlorpromazine Novopharm 100 500 13.65 68.25 0.1365 0.1365 50 mg Tab. 15.65 78.25 0.1565 0.1565 100 mg 00232831 Novo-Chlorpromazine Novopharm 100 500 Apotex Novartis 100 100 65.94 94.20 0.6594 0.9420 Mylan 100 65.94 0.6594 CLOZAPIN X Tab. 02248034 Apo-Clozapine 00894737 Clozaril8 02247243 Gen-Clozapine 32.00 160.00 0.3200 0.3200 25 mg PPB Tab. 50 mg 02305003 Gen-Clozapine Mylan 100 02248035 Apo-Clozapine 00894745 Clozaril8 02247244 Gen-Clozapine Apotex Novartis 100 100 264.46 377.80 2.6446 3.7780 Mylan 100 264.46 2.6446 Tab. 131.88 1.3188 100 mg PPB Tab. 200 mg 02305011 Gen-Clozapine Mylan 100 FLUPENTIXOL DECANOATE X I.M. Inj. Sol. 02156032 Fluanxol Depot 2% 02156040 Fluanxol Depot 10% 528.92 5.2892 20 mg/mL Lundbeck 1 ml Lundbeck 1 ml I.M. Inj. Sol. Page UNIT PRICE 25 mg Tab. 8 COST OF PKG. SIZE 7.18 100 mg/mL 35.93 Clozaril will be reimbursed at its guaranteed selling price for those persons insured with the RAMQ whose last reimbursement for clozapin, by the RAMQ, in the last 365 days preceding 21 April 2008, was for Clozaril. 198 2013-04 CODE BRAND NAME MANUFACTURER SIZE FLUPENTIXOL DIHYDROCHLORIDE X Tab. COST OF PKG. SIZE UNIT PRICE 0.5 mg 02156008 Fluanxol Lundbeck 100 02156016 Fluanxol Lundbeck 100 Oméga 5 ml Tab. 24.83 0.2483 3 mg FLUPHENAZINE DECANOATE X I.M. Inj. Sol. 02239636 Fluphenazine Omega 0.5362 25 mg/mL I.M. Inj. Sol. 02242570 Fluphenazine Omega 00755575 Modecate Concentre 53.62 23.16 100 mg/mL PPB Oméga B.M.S. 1 ml 1 ml FLUPHENAZINE HYDROCHLORIDE X Tab. 29.78 29.78 1 mg 00405345 Apo-Fluphenazine AA Pharma 100 00410632 Apo-Fluphenazine AA Pharma 100 Tab. 17.39 0.1739 2 mg Tab. 22.52 0.2113 5 mg PPB 00405361 Apo-Fluphenazine 00726354 pms-Fluphenazine AA Pharma Phmscience 100 100 500 HALOPERIDOL X I.M. Inj. Sol. 17.20 17.20 86.00 0.1720 0.1720 0.1720 5 mg/mL 00808652 Haloperidol Sandoz 1 ml 00396796 Apo-Haloperidol Apotex 00363685 Novo-Peridol Novopharm 100 1000 100 00396818 Apo-Haloperidol Apotex 00363677 Novo-Peridol Novopharm Tab. 3.96 0.5 mg PPB Tab. 3.60 36.00 3.60 0.0360 0.0360 0.0360 1 mg PPB 2013-04 100 1000 100 6.14 61.40 6.14 0.0614 0.0614 0.0614 Page 199 CODE BRAND NAME MANUFACTURER SIZE Tab. UNIT PRICE 2 mg PPB 00396826 Apo-Haloperidol Apotex 00363669 Novo-Peridol Novopharm 100 1000 100 Tab. 10.50 105.00 10.50 0.1050 0.1050 0.1050 5 mg PPB 00396834 Apo-Haloperidol Apotex 00363650 Novo-Peridol Novopharm 100 1000 100 500 Tab. 14.87 148.70 14.87 74.35 0.1487 0.1487 0.1487 0.1487 10 mg PPB 00463698 Apo-Haloperidol 00713449 Novo-Peridol Apotex Novopharm 100 100 Tab. 13.30 13.30 0.1330 0.1330 20 mg 00768820 Novo-Peridol Novopharm 100 Sandoz Oméga 5 ml 5 ml HALOPERIDOL (DECANOATE) X I.M. Inj. Sol. 02130297 Haloperidol LA 02239639 Haloperidol-LA Omega 0.6304 28.03 28.03 100 mg/mL PPB 02130300 Haloperidol LA Sandoz 02239640 Haloperidol-LA Omega Oméga 1 ml 5 ml 1 ml 5 ml LOXAPINE SUCCINATE X Tab. 02242868 Xylac 63.04 50 mg/mL PPB I.M. Inj. Sol. 11.08 55.40 11.08 55.40 2.5 mg Pendopharm 100 Tab. 8.06 0.0806 5 mg 02230837 Xylac Pendopharm 100 02230838 Xylac Pendopharm 100 Tab. 15.00 0.1500 10 mg Tab. 24.98 0.2498 25 mg 02230839 Xylac Page COST OF PKG. SIZE 200 Pendopharm 100 38.72 0.3872 2013-04 CODE BRAND NAME MANUFACTURER SIZE Tab. COST OF PKG. SIZE UNIT PRICE 50 mg 02230840 Xylac Pendopharm 100 SanofiAven 1 ml METHOTRIMEPRAZINE X Inj. Sol. 01927698 Nozinan 51.62 0.5162 25 mg/mL Tab. 3.25 2 mg 02238403 Apo-Methoprazine AA Pharma 100 OLANZAPINE X Tab. 0.0523 2.5 mg PPB 02281791 Apo-Olanzapine Apotex 02325659 02337878 02348101 02311968 02372819 02385864 02303116 02337126 Cobalt Mylan MeliaPharm Pro Doc Sanis Sivem Phmscience Riva Co Olanzapine Mylan-Olanzapine Olanzapine Olanzapine Olanzapine Olanzapine pms-Olanzapine Riva-Olanzapine 6.85 02310341 Sandoz Olanzapine 02276712 Teva-Olanzapine 02229250 Zyprexa Sandoz Teva Can Lilly 02281813 02325675 02337894 02348136 02311984 02372835 02385880 02303167 02337142 Apotex Cobalt Mylan MeliaPharm Pro Doc Sanis Sivem Phmscience Riva 100 500 100 100 100 100 100 100 100 100 500 100 100 28 100 Tab. 44.93 224.65 44.93 44.93 44.93 44.93 44.93 44.93 44.93 44.93 224.65 44.93 44.93 49.03 175.10 0.4493 0.4493 0.4493 0.4493 0.4493 0.4493 0.4493 0.4493 0.4493 0.4493 0.4493 0.4493 0.4493 1.7511 1.7510 7.5 mg PPB Apo-Olanzapine Co Olanzapine Mylan-Olanzapine Olanzapine Olanzapine Olanzapine Olanzapine pms-Olanzapine Riva-Olanzapine 02310376 Sandoz Olanzapine 02276739 Teva-Olanzapine 02229277 Zyprexa 2013-04 Sandoz Teva Can Lilly 100 100 100 100 100 100 100 100 100 500 100 100 28 100 134.79 134.79 134.79 134.79 134.79 134.79 134.79 134.79 134.79 1347.90 134.79 134.79 147.09 525.31 1.3479 1.3479 1.3479 1.3479 1.3479 1.3479 1.3479 1.3479 1.3479 2.6958 1.3479 1.3479 5.2532 5.2531 Page 201 CODE BRAND NAME MANUFACTURER SIZE Tab. Oral Disint. or Tab. Page Apotex 02360616 Apo-Olanzapine ODT 02325667 Co Olanzapine Apotex Cobalt 02327562 02389088 02337886 02382709 02321343 02348128 02311976 02372827 02385872 02348160 02338645 02352974 02343665 02303159 02303191 02337134 Co Olanzapine ODT Mar-Olanzapine ODT Mylan-Olanzapine Mylan-Olanzapine ODT Novo-Olanzapine OD Olanzapine Olanzapine Olanzapine Olanzapine Olanzapine ODT Olanzapine ODT Olanzapine ODT Olanzapine ODT pms-Olanzapine pms-Olanzapine ODT Riva-Olanzapine Cobalt Marcan Mylan Mylan Novopharm MeliaPharm Pro Doc Sanis Sivem MeliaPharm Pro Doc Sanis Sivem Phmscience Phmscience Riva 02339811 02310368 02327775 02276720 02229269 Riva-Olanzapine ODT Sandoz Olanzapine Sandoz Olanzapine ODT Teva-Olanzapine Zyprexa Riva Sandoz Sandoz Teva Can Lilly 202 UNIT PRICE 5 mg PPB 02281805 Apo-Olanzapine 02243086 Zyprexa Zydis COST OF PKG. SIZE Lilly 100 500 30 100 500 30 30 100 30 30 100 100 100 100 30 30 30 30 100 30 100 500 30 100 30 100 28 100 28 89.37 449.30 26.81 89.37 449.30 26.81 26.81 89.37 26.81 26.81 89.37 89.37 89.37 89.37 26.81 26.81 26.81 26.81 89.37 26.81 89.37 449.30 26.81 89.37 26.81 89.37 98.06 350.20 100.09 0.8937 0.8986 0.8937 0.8937 0.8986 0.8937 0.8937 0.8937 0.8937 0.8937 0.8937 0.8937 0.8937 0.8937 0.8937 0.8937 0.8937 0.8937 0.8937 0.8937 0.8937 0.8986 0.8937 0.8937 0.8937 0.8937 3.5021 3.5020 3.5746 2013-04 CODE BRAND NAME MANUFACTURER SIZE Tab. Oral Disint. or Tab. UNIT PRICE 10 mg PPB 02281821 Apo-Olanzapine Apotex 02360624 Apo-Olanzapine ODT 02325683 Co Olanzapine Apotex Cobalt 02327570 02389096 02337908 02382717 02321351 02348144 02311992 02372843 02385899 02348179 02338653 02352982 02343673 02303175 02303205 02337150 Co Olanzapine ODT Mar-Olanzapine ODT Mylan-Olanzapine Mylan-Olanzapine ODT Novo-Olanzapine OD Olanzapine Olanzapine Olanzapine Olanzapine Olanzapine ODT Olanzapine ODT Olanzapine ODT Olanzapine ODT pms-Olanzapine pms-Olanzapine ODT Riva-Olanzapine Cobalt Marcan Mylan Mylan Novopharm MeliaPharm Pro Doc Sanis Sivem MeliaPharm Pro Doc Sanis Sivem Phmscience Phmscience Riva 02339838 02310384 02327783 02276747 Riva-Olanzapine ODT Sandoz Olanzapine Sandoz Olanzapine ODT Teva-Olanzapine Riva Sandoz Sandoz Teva Can 02229285 Zyprexa Lilly 02243087 Zyprexa Zydis Lilly 2013-04 COST OF PKG. SIZE 100 500 30 100 500 30 30 100 30 30 100 100 100 100 30 30 30 30 100 30 100 500 30 100 30 100 500 28 100 28 178.57 898.60 53.57 178.57 898.60 53.57 53.57 178.57 53.57 53.57 178.57 178.57 178.57 178.57 53.57 53.57 53.57 53.57 178.57 53.57 178.57 898.60 53.57 178.57 53.57 178.57 898.60 196.12 700.42 200.00 1.7857 1.7972 1.7857 1.7857 1.7972 1.7857 1.7857 1.7857 1.7857 1.7857 1.7857 1.7857 1.7857 1.7857 1.7857 1.7857 1.7857 1.7857 1.7857 1.7857 1.7857 1.7972 1.7857 1.7857 1.7857 1.7857 1.7972 7.0043 7.0042 7.1429 Page 203 CODE BRAND NAME MANUFACTURER SIZE Tab. Oral Disint. or Tab. Apo-Olanzapine Apo-Olanzapine ODT Co Olanzapine Co Olanzapine ODT Mar-Olanzapine ODT Mylan-Olanzapine Mylan-Olanzapine ODT Novo-Olanzapine OD Olanzapine Olanzapine Olanzapine Olanzapine Olanzapine ODT Olanzapine ODT Olanzapine ODT Olanzapine ODT pms-Olanzapine pms-Olanzapine ODT Riva-Olanzapine Apotex Apotex Cobalt Cobalt Marcan Mylan Mylan Novopharm MeliaPharm Pro Doc Sanis Sivem MeliaPharm Pro Doc Sanis Sivem Phmscience Phmscience Riva 02339846 02310392 02327791 02276755 02238850 Riva-Olanzapine ODT Sandoz Olanzapine Sandoz Olanzapine ODT Teva-Olanzapine Zyprexa Riva Sandoz Sandoz Teva Can Lilly Lilly 100 30 100 30 30 100 30 30 100 100 100 100 30 30 30 30 100 30 100 500 30 100 30 100 28 100 28 Apo-Olanzapine Apo-Olanzapine ODT Co Olanzapine Co Olanzapine ODT Mar-Olanzapine ODT Mylan-Olanzapine Mylan-Olanzapine ODT Novo-Olanzapine OD Olanzapine ODT Sandoz Olanzapine ODT Teva-Olanzapine Zyprexa 02243089 Zyprexa Zydis Apotex Apotex Cobalt Cobalt Marcan Mylan Mylan Novopharm Sivem Sandoz Teva Can Lilly Lilly 100 30 100 30 30 100 30 30 30 30 100 28 100 28 PERICYAZINE X Caps. 2.6777 2.6777 2.6777 2.6777 2.6777 2.6777 2.6777 2.6777 2.6777 2.6777 2.6777 2.6777 2.6777 2.6777 2.6777 2.6777 2.6777 2.6777 2.6777 5.3553 2.6777 2.6777 2.6777 2.6777 10.5061 10.5062 10.7111 742.26 222.68 742.26 222.68 222.68 742.26 222.68 222.68 222.68 222.68 742.26 392.23 1400.82 395.84 7.4226 7.4226 7.4226 7.4226 7.4226 7.4226 7.4226 7.4226 7.4226 7.4226 7.4226 14.0082 14.0082 14.1371 5 mg 01926780 Neuleptil Erfa 100 01926772 Neuleptil Erfa 100 Caps. Page 267.77 80.33 267.77 80.33 80.33 267.77 80.33 80.33 267.77 267.77 267.77 267.77 80.33 80.33 80.33 80.33 267.77 80.33 267.77 2677.65 80.33 267.77 80.33 267.77 294.17 1050.62 299.91 20 mg PPB Tab. Oral Disint. or Tab. 02333015 02360640 02325713 02327597 02389126 02337924 02382733 02321386 02343703 02327805 02359707 02238851 UNIT PRICE 15 mg PPB 02281848 02360632 02325691 02327589 02389118 02337916 02382725 02321378 02348152 02312018 02372851 02385902 02348187 02338661 02352990 02343681 02303183 02303213 02337169 02243088 Zyprexa Zydis COST OF PKG. SIZE 17.63 0.1763 10 mg 204 27.14 0.2714 2013-04 CODE BRAND NAME MANUFACTURER SIZE Caps. COST OF PKG. SIZE UNIT PRICE 20 mg 01926764 Neuleptil Erfa 100 Erfa 100 ml Oral Sol. 01926756 Neuleptil 0.4284 10 mg/mL PERPHENAZINE X Tab. 00335134 Perphenazine 42.84 29.85 0.2985 2 mg AA Pharma 100 Tab. 6.26 0.0626 4 mg 00335126 Perphenazine AA Pharma 100 00335118 Perphenazine AA Pharma 100 Tab. 7.58 0.0758 8 mg Tab. 8.32 0.0832 16 mg 00335096 Perphenazine AA Pharma 100 Pendopharm 100 PIMOZIDE X Tab. 00313815 Orap 12.74 0.1274 2 mg Tab. 22.79 0.2279 4 mg PPB 02245433 Apo-Pimozide 00313823 Orap Apotex Pendopharm 100 100 SanofiAven 1 ml PIPOTIAZINE PALMITATE X I.M. Inj. Sol. 01926667 Piportil L4 25 2013-04 13.39 50 mg/mL SanofiAven SanofiAven 2 ml 1 ml Phmscience Sandoz 10 10 PROCHLORPERAZINE X Supp. 00753688 pms-Prochlorperazine 00789720 Sandoz Prochlorperazine 0.4136 0.4136 25 mg/mL I.M. Inj. Sol. 01926675 Piportil L4 100 00894672 Piportil L4 50 41.36 41.36 43.15 22.70 10 mg PPB 8.30 8.30 0.8300 0.8300 Page 205 CODE BRAND NAME MANUFACTURER SIZE PROCHLORPERAZINE MALEATE X Tab. UNIT PRICE 5 mg 00753661 pms-Prochlorperazine Phmscience 100 00753637 pms-Prochlorperazine Phmscience 100 Sandoz 2 ml Tab. 10.55 W 10 mg PROCHLORPERAZINE MESYLATE X Inj. Sol. 00789747 Prochlorperazine 02300184 Seroquel XR AZC 60 AZC 60 AZC 60 AZC 60 206 0.9800 115.80 1.9300 157.20 2.6200 300 mg L.A. Tab. 02300214 Seroquel XR 58.80 200 mg L.A. Tab. 02300206 Seroquel XR 2.09 150 mg L.A. Tab. 02300192 Seroquel XR W 50 mg L.A. Tab. 02321513 Seroquel XR 12.90 5 mg/mL QUETIAPINE (FUMARATE) X L.A. Tab. Page COST OF PKG. SIZE 231.60 3.8600 400 mg AZC 60 314.40 5.2400 2013-04 CODE BRAND NAME MANUFACTURER SIZE Tab. COST OF PKG. SIZE UNIT PRICE 25 mg PPB 02313901 Apo-Quetiapine Apotex 02390205 Auro-Quetiapine Aurobindo 02316080 Co Quetiapine Cobalt 02330415 Jamp-Quetiapine Jamp 02307804 Mylan-Quetiapine 02284235 Novo-Quetiapine Mylan Novopharm 02296551 pms-Quetiapine Phmscience 02317346 Pro-Quetiapine Pro Doc 02387794 Quetiapine 02353164 Quetiapine Accord Sanis 02317893 Quetiapine Sivem + 02397099 Ran-Quetiapine Ranbaxy 02316692 Riva-Quetiapine Riva 02313995 Sandoz Quetiapine Sandoz 02236951 Seroquel AZC 2013-04 100 500 30 500 100 500 100 500 100 30 500 100 500 100 500 60 100 500 100 500 100 500 100 500 60 500 100 12.35 61.75 3.71 61.75 12.35 61.75 12.35 61.75 12.35 3.71 61.75 12.35 61.75 12.35 61.75 7.41 12.35 61.75 12.35 61.75 12.35 61.75 12.35 61.75 7.41 61.75 51.35 0.1235 0.1235 0.1235 0.1235 0.1235 0.1235 0.1235 0.1235 0.1235 0.1235 0.1235 0.1235 0.1235 0.1235 0.1235 0.1235 0.1235 0.1235 0.1235 0.1235 0.1235 0.1235 0.1235 0.1235 0.1235 0.1235 0.5135 Page 207 CODE BRAND NAME MANUFACTURER SIZE Tab. UNIT PRICE 100 mg PPB 02313928 Apo-Quetiapine Apotex 02390213 Auro-Quetiapine Aurobindo 02316099 Co Quetiapine Cobalt 02330423 Jamp-Quetiapine Jamp 02307812 Mylan-Quetiapine 02284243 Novo-Quetiapine Mylan Novopharm 02296578 pms-Quetiapine Phmscience 02317354 Pro-Quetiapine Pro Doc 02387808 Quetiapine 02353172 Quetiapine Accord Sanis 02317907 Quetiapine Sivem + 02397102 Ran-Quetiapine Ranbaxy 02316706 Riva-Quetiapine Riva 02314002 Sandoz Quetiapine Sandoz 02236952 Seroquel AZC 100 500 30 500 100 500 100 500 100 30 500 100 500 100 500 60 100 500 100 500 100 500 100 500 100 500 100 Tab. 32.95 164.75 9.89 164.75 32.95 164.75 32.95 164.75 32.95 9.89 164.75 32.95 164.75 32.95 164.75 19.77 32.95 164.75 32.95 164.75 32.95 164.75 32.95 164.75 32.95 164.75 137.00 0.3295 0.3295 0.3295 0.3295 0.3295 0.3295 0.3295 0.3295 0.3295 0.3295 0.3295 0.3295 0.3295 0.3295 0.3295 0.3295 0.3295 0.3295 0.3295 0.3295 0.3295 0.3295 0.3295 0.3295 0.3295 0.3295 1.3700 150 mg PPB 02284251 Novo-Quetiapine 02387816 Quetiapine Page COST OF PKG. SIZE 208 Novopharm Accord 100 60 96.56 57.94 0.9656 0.9656 2013-04 CODE BRAND NAME MANUFACTURER SIZE Tab. COST OF PKG. SIZE UNIT PRICE 200 mg PPB 02313936 Apo-Quetiapine Apotex 02390248 Auro-Quetiapine Aurobindo 02316110 Co Quetiapine Cobalt 02330458 Jamp-Quetiapine 02307839 Mylan-Quetiapine 02284278 Novo-Quetiapine Jamp Mylan Novopharm 02296594 pms-Quetiapine Phmscience 02317362 Pro-Quetiapine Pro Doc 02387824 Quetiapine 02353199 Quetiapine Accord Sanis 02317923 Quetiapine Sivem Ranbaxy + 02397110 Ran-Quetiapine 02316722 Riva-Quetiapine Riva 02314010 Sandoz Quetiapine 02236953 Seroquel Sandoz AZC 02313944 Apo-Quetiapine Apotex 02390256 Auro-Quetiapine Aurobindo 02316129 Co Quetiapine Cobalt 02330466 Jamp-Quetiapine 02307847 Mylan-Quetiapine 02284286 Novo-Quetiapine Jamp Mylan Novopharm 02296608 pms-Quetiapine Phmscience 02317370 Pro-Quetiapine Pro Doc 02387832 Quetiapine 02353202 Quetiapine Accord Sanis 02317931 Quetiapine Sivem Ranbaxy 100 500 30 500 100 500 100 100 30 100 100 500 100 500 60 100 500 100 100 500 100 500 100 100 66.17 330.84 19.85 330.84 66.17 330.84 66.17 66.17 19.85 66.17 66.17 330.84 66.17 330.84 39.70 66.17 330.84 66.17 66.17 330.84 66.17 330.84 66.17 275.20 0.6617 0.6617 0.6617 0.6617 0.6617 0.6617 0.6617 0.6617 0.6617 0.6617 0.6617 0.6617 0.6617 0.6617 0.6617 0.6617 0.6617 0.6617 0.6617 0.6617 0.6617 0.6617 0.6617 2.7520 300 mg PPB Tab. + 02397129 Ran-Quetiapine 02316730 Riva-Quetiapine Riva 02314029 Sandoz Quetiapine 02244107 Seroquel Sandoz AZC 2013-04 100 500 30 500 100 500 100 100 30 100 100 500 100 500 60 100 500 100 100 500 100 500 100 100 96.57 482.80 28.97 482.80 96.57 482.80 96.57 96.57 28.97 96.56 96.57 482.80 96.57 482.80 57.94 96.57 482.80 96.57 96.57 482.80 96.57 482.80 96.57 401.45 0.9657 0.9656 0.9657 0.9656 0.9657 0.9656 0.9657 0.9657 0.9657 0.9656 0.9657 0.9656 0.9657 0.9656 0.9657 0.9657 0.9656 0.9657 0.9657 0.9656 0.9657 0.9656 0.9657 4.0145 Page 209 CODE BRAND NAME MANUFACTURER SIZE RISPERIDONE X Tab. Apotex 02282585 02359529 02371766 02359790 Cobalt Jamp Marcan Mint 02282240 Mylan-Risperidone Mylan 02282690 Novo-Risperidone Novopharm 02258439 phl-Risperidone Pharmel 02252007 pms-Risperidone Phmscience 02312700 Pro-Risperidone 02328305 Ran-Risperidone Pro Doc Ranbaxy 02240551 02303485 02356880 02283565 02303655 Janss. Inc MeliaPharm Sanis Riva Sandoz Risperdal Risperidone Risperidone Riva-Risperidone Sandoz Risperidone 100 500 100 100 100 60 100 60 100 60 100 100 500 100 500 100 100 500 100 100 100 100 100 Tab. Oral Disint. or Tab. Page Apotex 02282593 02359537 02371774 02359804 Cobalt Jamp Marcan Mint 02282259 Mylan-Risperidone Mylan 02264188 Novo-Risperidone Novopharm 02258447 phl-Risperidone Pharmel 02252015 pms-Risperidone Phmscience 02312719 Pro-Risperidone Pro Doc 02328313 Ran-Risperidone Ranbaxy 02240552 02247704 02303493 02356899 02283573 02303663 Janss. Inc Janss. Inc MeliaPharm Sanis Riva Sandoz 210 Risperdal Risperdal M-Tab Risperidone Risperidone Riva-Risperidone Sandoz Risperidone 13.15 65.70 13.15 13.15 13.15 7.89 13.14 7.89 13.14 7.89 13.14 13.15 65.70 13.15 65.70 13.15 13.15 65.70 20.75 13.15 13.15 13.15 13.15 0.1315 0.1314 0.1315 0.1315 0.1315 0.1315 0.1314 0.1315 0.1314 0.1315 0.1314 0.1315 0.1314 0.1315 0.1314 0.1315 0.1315 0.1314 0.2075 0.1315 0.1315 0.1315 0.1315 0.5 mg PPB 02282127 Apo-Risperidone Co Risperidone Jamp-Risperidone Mar-Risperidone Mint-Risperidon UNIT PRICE 0.25 mg PPB 02282119 Apo-Risperidone Co Risperidone Jamp-Risperidone Mar-Risperidone Mint-Risperidon COST OF PKG. SIZE 100 500 100 100 100 60 100 60 100 60 100 100 500 100 500 100 500 100 500 100 28 100 100 100 100 22.02 110.08 22.02 22.02 22.02 13.21 22.02 13.21 22.02 13.21 22.02 22.02 110.08 22.02 110.08 22.02 110.08 22.02 110.08 34.75 19.97 22.02 22.02 22.02 22.02 0.2202 0.2202 0.2202 0.2202 0.2202 0.2202 0.2202 0.2202 0.2202 0.2202 0.2202 0.2202 0.2202 0.2202 0.2202 0.2202 0.2202 0.2202 0.2202 0.3475 0.7132 0.2202 0.2202 0.2202 0.2202 2013-04 CODE BRAND NAME MANUFACTURER SIZE Tab. Oral Disint. or Tab. UNIT PRICE 1 mg PPB 02282135 Apo-Risperidone Apotex 02282607 Co Risperidone Cobalt 02359545 Jamp-Risperidone 02371782 Mar-Risperidone 02359812 Mint-Risperidon Jamp Marcan Mint 02282267 Mylan-Risperidone Mylan 02264196 Novo-Risperidone Novopharm 02258455 phl-Risperidone Pharmel 02252023 pms-Risperidone Phmscience 02312727 Pro-Risperidone Pro Doc 02328321 Ran-Risperidone Ranbaxy 02025280 Risperdal Janss. Inc 02247705 Risperdal M-Tab 02303507 Risperidone 02356902 Risperidone Janss. Inc MeliaPharm Sanis 02283581 Riva-Risperidone Riva 02279800 Sandoz Risperidone Sandoz 2013-04 COST OF PKG. SIZE 100 500 60 500 100 100 60 100 60 500 60 100 60 500 60 500 60 500 100 500 60 500 28 100 60 500 100 500 60 500 30.41 152.05 18.25 152.05 30.41 30.41 18.25 30.41 18.25 152.05 18.25 30.41 18.25 152.05 18.25 152.05 18.25 152.05 30.41 152.05 28.80 240.00 27.64 30.41 18.25 152.05 30.41 152.05 18.25 152.05 0.3041 0.3041 0.3041 0.3041 0.3041 0.3041 0.3041 0.3041 0.3041 0.3041 0.3041 0.3041 0.3041 0.3041 0.3041 0.3041 0.3041 0.3041 0.3041 0.3041 0.4800 0.4800 0.9871 0.3041 0.3041 0.3041 0.3041 0.3041 0.3041 0.3041 Page 211 CODE BRAND NAME MANUFACTURER SIZE Tab. Oral Disint. or Tab. Page UNIT PRICE 2 mg PPB 02282143 Apo-Risperidone Apotex 02282615 Co Risperidone Cobalt 02359553 Jamp-Risperidone 02371790 Mar-Risperidone 02359820 Mint-Risperidon Jamp Marcan Mint 02282275 Mylan-Risperidone Mylan 02264218 Novo-Risperidone Novopharm 02258463 phl-Risperidone Pharmel 02252031 pms-Risperidone Phmscience 02312735 Pro-Risperidone Pro Doc 02328348 Ran-Risperidone Ranbaxy 02025299 Risperdal Janss. Inc 02247706 Risperdal M-Tab 02303515 Risperidone 02356910 Risperidone Janss. Inc MeliaPharm Sanis 02283603 Riva-Risperidone Riva 02279819 Sandoz Risperidone Sandoz 212 COST OF PKG. SIZE 100 500 60 500 100 100 60 100 60 500 60 500 60 500 60 500 60 500 100 500 60 500 28 100 60 500 100 500 60 500 60.72 303.55 36.43 303.55 60.72 60.72 36.43 60.71 36.43 303.55 36.43 303.55 36.43 303.55 36.43 303.55 36.43 303.55 60.72 303.55 57.50 479.15 55.14 60.72 36.43 303.55 60.72 303.55 36.43 303.55 0.6072 0.6071 0.6072 0.6071 0.6072 0.6072 0.6072 0.6071 0.6072 0.6071 0.6072 0.6071 0.6072 0.6071 0.6072 0.6071 0.6072 0.6071 0.6072 0.6071 0.9583 0.9583 1.9693 0.6072 0.6072 0.6071 0.6072 0.6071 0.6072 0.6071 2013-04 CODE BRAND NAME MANUFACTURER SIZE Tab. Oral Disint. or Tab. Apotex 02282623 Co Risperidone Cobalt 02359561 Jamp-Risperidone Jamp 02371804 Mar-Risperidone 02359839 Mint-Risperidon Marcan Mint 02282283 Mylan-Risperidone Mylan 02264226 Novo-Risperidone Novopharm 02258471 phl-Risperidone Pharmel 02252058 pms-Risperidone Phmscience 02312743 Pro-Risperidone Pro Doc 02328364 Ran-Risperidone 02025302 Risperdal Ranbaxy Janss. Inc 02268086 Risperdal M-Tab 02303523 Risperidone 02356929 Risperidone Janss. Inc MeliaPharm Sanis 02283611 Riva-Risperidone Riva 02279827 Sandoz Risperidone Sandoz 100 250 60 250 60 250 100 60 100 60 100 60 500 60 500 60 500 60 100 100 60 250 28 100 60 250 100 250 60 250 Tab. Oral Disint. or Tab. Apo-Risperidone Co Risperidone Jamp-Risperidone Mar-Risperidone Mint-Risperidon Mylan 02264234 02258498 02252066 02312751 02328372 02025310 02268094 02303531 02356937 02283638 02279835 Novopharm Pharmel Phmscience Pro Doc Ranbaxy Janss. Inc Janss. Inc MeliaPharm Sanis Riva Sandoz 2013-04 91.08 227.69 54.65 227.69 54.65 227.69 91.08 54.65 91.08 54.65 91.08 54.65 455.38 54.65 455.38 54.65 455.38 54.65 91.08 91.08 86.25 359.38 82.78 91.08 54.65 227.69 91.08 227.69 54.65 227.69 0.9108 0.9108 0.9108 0.9108 0.9108 0.9108 0.9108 0.9108 0.9108 0.9108 0.9108 0.9108 0.9108 0.9108 0.9108 0.9108 0.9108 0.9108 0.9108 0.9108 1.4375 1.4375 2.9564 0.9108 0.9108 0.9108 0.9108 0.9108 0.9108 0.9108 4 mg PPB Apotex Cobalt Jamp Marcan Mint 02282291 Mylan-Risperidone Novo-Risperidone phl-Risperidone pms-Risperidone Pro-Risperidone Ran-Risperidone Risperdal Risperdal M-Tab Risperidone Risperidone Riva-Risperidone Sandoz Risperidone UNIT PRICE 3 mg PPB 02282151 Apo-Risperidone 02282178 02282631 02359588 02371812 02359847 COST OF PKG. SIZE 100 60 100 100 60 100 60 100 60 100 100 100 100 60 28 100 60 60 60 121.43 72.86 121.43 121.43 72.86 121.43 72.86 121.43 72.86 121.43 121.43 121.43 121.43 115.00 110.35 121.43 72.86 72.86 72.86 1.2143 1.2143 1.2143 1.2143 1.2143 1.2143 1.2143 1.2143 1.2143 1.2143 1.2143 1.2143 1.2143 1.9167 3.9411 1.2143 1.2143 1.2143 1.2143 Page 213 CODE BRAND NAME MANUFACTURER SIZE RISPERIDONE TARTRATE X Oral Sol. 02280396 Apo-Risperidone 02279266 pms-Risperidone 02236950 Risperdal Apotex Phmscience Janss. Inc 30 ml 30 ml 30 ml 14.41 14.41 16.56 0.4803 0.4803 0.5520 10 mg Erfa 100 THIOTHIXENE X Caps. 31.81 0.3181 2 mg 00024430 Navane Erfa 100 00024449 Navane Erfa 100 Caps. 18.65 0.1865 5 mg Caps. 32.06 0.3206 10 mg 00024457 Navane Erfa 100 AA Pharma 100 TRIFLUOPERAZINE HYDROCHLORIDE X Tab. 00345539 Apo-Trifluoperazine 41.28 0.4128 1 mg Tab. 13.40 0.1051 2 mg 00312754 Trifluoperazine AA Pharma 100 00312746 Trifluoperazine AA Pharma 100 1000 00326836 Trifluoperazine AA Pharma 100 Tab. 17.58 0.1378 5 mg Tab. 23.28 232.80 0.1828 0.1522 10 mg Tab. 27.90 0.2190 20 mg 00595942 Apo-Trifluoperazine Page UNIT PRICE 1 mg/mL PPB THIOPROPERAZINE MESYLATE X Tab. 01927639 Majeptil COST OF PKG. SIZE 214 AA Pharma 100 55.80 0.3728 2013-04 CODE BRAND NAME MANUFACTURER SIZE ZIPRASIDONE X Caps. COST OF PKG. SIZE UNIT PRICE 20 mg 02298597 Zeldox Pfizer 60 02298600 Zeldox Pfizer 60 Caps. 101.63 1.6938 40 mg Caps. 116.42 1.9403 60 mg 02298619 Zeldox Pfizer 60 Caps. 116.42 1.9403 80 mg 02298627 Zeldox Pfizer 60 ZUCLOPENTHIXOL ACETATE X I.M. Inj. Sol. 02230405 Clopixol-acuphase 1 ml 14.91 200 mg/mL Lundbeck 1 ml Lundbeck 100 ZUCLOPENTHIXOL DIHYDROCHLORIDE X Tab. 02230402 Clopixol 1.9403 50 mg/mL Lundbeck ZUCLOPENTHIXOL DECANOATE X I.M. Inj. Sol. 02230406 Clopixol depot 116.42 14.91 10 mg Tab. 38.35 0.3835 25 mg 02230403 Clopixol Lundbeck 100 Paladin 100 95.88 0.9588 28:20.04 AMPHETAMINES DEXAMPHETAMINE SULFATE Y L.A. Caps. 01924559 Dexedrine 10 mg L.A. Caps. 01924567 Dexedrine 2013-04 81.71 0.6391 15 mg Paladin 100 100.05 0.7826 Page 215 CODE BRAND NAME MANUFACTURER SIZE Tab. COST OF PKG. SIZE UNIT PRICE 5 mg 01924516 Dexedrine Paladin 100 56.89 0.4462 28:20.92 CNS STIMULANTS, MISCELLANEOUS METHYLPHENIDATE HYDROCHLORIDE Y L.A. Tab. 20 mg PPB 02266687 Apo-Methylphenidate SR Apotex 00632775 Ritalin SR Novartis 02320312 Sandoz Methylphenidate SR Sandoz 100 100 100 02273950 Apo-Methylphenidate 02326221 Methylphenidate 02246991 phl-Methylphenidate Apotex Pro Doc Pharmel 02234749 pms-Methylphenidate Phmscience 100 100 100 500 100 Tab. 0.2820 0.5306 0.2820 5 mg PPB Tab. 9.47 9.47 9.47 47.35 9.47 0.0947 0.0947 0.0947 0.0947 0.0947 10 mg PPB 02249324 Apo-Methylphenidate Apotex 02326248 Methylphenidate Pro Doc 02126494 phl-Methylphenidate Pharmel 00584991 pms-Methylphenidate Phmscience 100 500 100 500 100 500 100 500 Tab. Page 28.20 53.06 28.20 8.16 40.80 8.16 40.80 8.16 40.80 8.16 40.80 0.0816 0.0816 0.0816 0.0816 0.0816 0.0816 0.0816 0.0816 20 mg PPB 02249332 Apo-Methylphenidate 02326256 Methylphenidate 02126486 phl-Methylphenidate Apotex Pro Doc Pharmel 00585009 pms-Methylphenidate 00005614 Ritalin Phmscience Novartis 216 100 100 100 500 100 100 24.35 24.35 24.35 121.77 24.35 50.35 0.2435 0.2435 0.2435 0.2435 0.2435 0.5035 2013-04 CODE BRAND NAME MANUFACTURER SIZE COST OF PKG. SIZE UNIT PRICE 28:24.08 BENZODIAZEPINES ALPRAZOLAM V Tab. 0.25 mg PPB 02349191 Alprazolam Sanis 100 1000 100 1000 100 1000 100 1000 100 1000 100 1000 100 1000 01908189 Alprazolam-0.25 Pro Doc 00865397 Apo-Alpraz Apotex 02137534 Mylan-Alprazolam Mylan 02346990 NTP-Alprazolam NT Pharma 01913484 Teva-Alprazolam Teva Can 00548359 Xanax Pfizer 02349205 Alprazolam Sanis 01908170 Alprazolam-0.5 Pro Doc 00865400 Apo-Alpraz Apotex 02137542 Mylan-Alprazolam Mylan 02347008 NTP-Alprazolam NT Pharma 01913492 Teva-Alprazolam Teva Can 00548367 Xanax Pfizer 02248706 02243611 02229813 00723770 Pro Doc Apotex Mylan Pfizer 100 100 100 100 Apotex Mylan Pfizer 100 100 100 Apotex 100 Tab. 6.33 63.30 6.33 63.30 6.33 63.30 6.33 63.30 6.33 63.30 6.33 63.30 18.97 178.50 0.0633 0.0633 0.0633 0.0633 0.0633 0.0633 0.0633 0.0633 0.0633 0.0633 0.0633 0.0633 0.1897 0.1785 0.5 mg PPB 100 1000 100 1000 100 1000 100 1000 100 1000 100 1000 100 1000 Tab. 7.57 75.68 7.57 75.68 7.57 75.68 7.57 75.68 7.57 75.68 7.57 75.68 22.67 213.80 0.0757 0.0757 0.0757 0.0757 0.0757 0.0757 0.0757 0.0757 0.0757 0.0757 0.0757 0.0757 0.2267 0.2138 1 mg PPB Alprazolam-1 Apo-Alpraz Mylan-Alprazolam Xanax Tab. 20.92 20.92 20.92 40.81 0.2092 0.2092 0.2092 0.4081 2 mg PPB 02243612 Apo-Alpraz TS 02229814 Mylan-Alprazolam 00813958 Xanax TS BROMAZEPAM V Tab. 02177153 Apo-Bromazepam 2013-04 37.18 37.18 72.55 0.3718 0.3718 0.7255 1.5 mg 5.15 0.0515 Page 217 CODE BRAND NAME MANUFACTURER SIZE Tab. UNIT PRICE 3 mg PPB 02177161 Apo-Bromazepam Apotex 02220520 Bromazepam-3 Pro Doc 00518123 Lectopam 3 02230584 Novo-Bromazepam Roche Novopharm 100 500 100 500 100 100 500 Tab. 3.75 18.74 3.75 18.74 15.29 3.75 18.74 0.0375 0.0375 0.0375 0.0375 0.1529 0.0375 0.0375 6 mg PPB 02177188 Apo-Bromazepam Apotex 02220539 Bromazepam-6 Pro Doc 00518131 Lectopam 6 02230585 Novo-Bromazepam Roche Novopharm 100 500 100 500 100 100 500 CHLORDIAZEPOXIDE HYDROCHLORIDE V Caps. 00522724 Apo-Chlordiazepoxide AA Pharma 5.48 27.38 5.48 27.38 22.34 5.48 27.38 0.0548 0.0548 0.0548 0.0548 0.2234 0.0548 0.0548 5 mg 100 Caps. 6.79 0.0679 10 mg 00522988 Apo-Chlordiazepoxide AA Pharma 100 00522996 Apo-Chlordiazepoxide AA Pharma 100 Phmscience 500 ml Caps. 10.70 0.1070 25 mg DIAZEPAM V Oral Sol. 00891797 pms-Diazepam 02238162 Diastat 16.59 0.1659 1 mg/mL Rectal Gel 48.89 0.0766 5 mg/mL Valeant 1 ml 2 ml 3 ml Tab. Page COST OF PKG. SIZE 71.09 71.09 71.09 2 mg PPB 00405329 Apo-Diazepam Apotex 02247490 pms-Diazepam Biomed 218 100 1000 100 5.08 50.80 5.08 0.0508 0.0508 0.0508 2013-04 CODE BRAND NAME MANUFACTURER SIZE Tab. COST OF PKG. SIZE UNIT PRICE 5 mg PPB 00362158 Apo-Diazepam Apotex 00313580 Diazepam-5 Pro Doc 02247491 pms-Diazepam 00013285 Valium Biomed Roche 00405337 Apo-Diazepam Apotex 00434388 Diazepam-10 Pro Doc 02247492 pms-Diazepam Biomed 100 1000 100 1000 500 100 Tab. 6.50 65.00 6.50 65.00 32.50 15.63 0.0650 0.0650 0.0650 0.0650 0.0650 0.1563 10 mg PPB 100 1000 100 1000 500 FLURAZEPAM HYDROCHLORIDE V Caps. 00521698 Apo-Flurazepam 02248126 Bio-Flurazepam 00578479 Flurazepam-15 8.67 86.70 8.67 86.70 43.35 0.0867 0.0867 0.0867 0.0867 0.0867 15 mg PPB Apotex Biomed Pro Doc 100 120 100 Caps. 11.66 8.10 8.10 0.0843 0.0675 0.0699 30 mg PPB 00521701 Apo-Flurazepam 02248127 Bio-Flurazepam 00578487 Flurazepam-30 Apotex Biomed Pro Doc 100 120 100 LORAZEPAM V Tab. 0.0968 0.0775 0.0803 0.5 mg PPB 00655740 Apo-Lorazepam Apotex 02041413 Ativan 02351072 Lorazepam Pfizer Sanis 00711101 Novo-Lorazem Novopharm 02347733 NTP-Lorazepam NT Pharma 02298201 phl-Lorazepam Pharmel 00728187 pms-Lorazepam Phmscience 00655643 Pro-Lorazepam Pro Doc 2013-04 13.64 9.30 9.30 100 500 500 100 1000 100 1000 100 1000 100 1000 100 1000 100 500 3.59 17.95 17.95 3.59 35.90 3.59 35.90 3.59 35.90 3.59 35.90 3.59 35.90 3.59 17.95 0.0359 0.0359 0.0359 0.0359 0.0359 0.0359 0.0359 0.0359 0.0359 0.0359 0.0359 0.0359 0.0359 0.0359 0.0359 Page 219 CODE BRAND NAME MANUFACTURER SIZE Tab. UNIT PRICE 1 mg PPB 00655759 Apo-Lorazepam Apotex 02041421 Ativan 02351080 Lorazepam Pfizer Sanis 00637742 Novo-Lorazem Novopharm 02347741 NTP-Lorazepam NT Pharma 02298228 phl-Lorazepam Pharmel 00728195 pms-Lorazepam Phmscience 00655651 Pro-Lorazepam Pro Doc 00655767 Apo-Lorazepam Apotex 02041448 Ativan 02351099 Lorazepam Pfizer Sanis 00637750 Novo-Lorazem Novopharm 02347768 NTP-Lorazepam NT Pharma 02298236 phl-Lorazepam Pharmel 00728209 pms-Lorazepam Phmscience 00655678 Pro-Lorazepam Pro Doc 100 1000 1000 100 1000 100 1000 100 1000 100 1000 100 1000 100 1000 Tab. 4.47 44.70 44.70 4.47 44.70 4.47 44.70 4.47 44.70 4.47 44.70 4.47 44.70 4.47 44.70 0.0447 0.0447 0.0447 0.0447 0.0447 0.0447 0.0447 0.0447 0.0447 0.0447 0.0447 0.0447 0.0447 0.0447 0.0447 2 mg PPB 100 1000 1000 100 1000 100 1000 100 1000 100 1000 100 1000 100 1000 MIDAZOLAM V Inj. Sol. Page COST OF PKG. SIZE 0.0699 0.0699 0.0699 0.0699 0.0699 0.0699 0.0699 0.0699 0.0699 0.0699 0.0699 0.0699 0.0699 0.0699 0.0699 1 mg/mL PPB 02242904 Midazolam PPC 02240285 Midazolam Sandoz 02382873 Midazolam SDZ Sandoz 220 6.99 69.90 69.90 6.99 69.90 6.99 69.90 6.99 69.90 6.99 69.90 6.99 69.90 6.99 69.90 2 ml 5 ml 10 ml 2 ml 5 ml 10 ml 2 ml 5 ml 10 ml 1.56 3.90 5.80 1.56 3.90 5.80 1.56 3.90 5.80 2013-04 CODE BRAND NAME MANUFACTURER SIZE Inj. Sol. COST OF PKG. SIZE UNIT PRICE 5 mg/mL PPB 02242905 Midazolam PPC 02240286 Midazolam Sandoz 02382903 Midazolam SDZ Sandoz 1 ml 2 ml 10 ml 1 ml 2 ml 10 ml 1 ml 2 ml 10 ml NITRAZEPAM V Tab. 4.10 8.20 25.30 4.10 8.20 25.30 4.10 8.20 25.30 5 mg PPB 02245230 Apo-Nitrazepam 02229654 Nitrazadon 02234003 Sandoz Nitrazepam Apotex Valeant Sandoz 100 100 100 500 02245231 Apo-Nitrazepam 02229655 Nitrazadon 02234007 Sandoz Nitrazepam Apotex Valeant Sandoz 100 100 100 500 00402680 Apo-Oxazepam Apotex 00497754 Oxazepam-10 Pro Doc 00568392 Riva-Oxazepam Riva 100 1000 100 1000 100 1000 00402745 Apo-Oxazepam Apotex 00497762 Oxazepam-15 Pro Doc 00568406 Riva-Oxazepam Riva Tab. 3.57 3.57 3.57 17.85 0.0357 0.0357 0.0357 0.0357 10 mg PPB OXAZEPAM V Tab. 5.34 5.34 5.34 26.70 0.0534 0.0534 0.0534 0.0534 10 mg PPB Tab. 3.50 35.00 3.50 35.00 3.50 35.00 0.0350 0.0350 0.0350 0.0350 0.0350 0.0350 15 mg PPB 2013-04 100 1000 100 1000 100 1000 5.50 55.00 5.50 55.00 5.50 55.00 0.0550 0.0550 0.0550 0.0550 0.0550 0.0550 Page 221 CODE BRAND NAME MANUFACTURER SIZE Tab. COST OF PKG. SIZE UNIT PRICE 30 mg PPB 00402737 Apo-Oxazepam Apotex 00497770 Oxazepam-30 Pro Doc 00568414 Riva-Oxazepam Riva 100 1000 100 1000 100 1000 TEMAZEPAM V Caps. 0.0750 0.0750 0.0750 0.0750 0.0750 0.0750 15 mg PPB 02225964 Apo-Temazepam Apotex 02244814 02230095 00604453 02229760 Cobalt Novopharm Sepracor Pro Doc Co Temazepam Novo-Temazepam Restoril Temazepam-15 7.50 75.00 7.50 75.00 7.50 75.00 100 500 100 100 100 100 500 Caps. 4.38 21.88 4.38 4.38 17.50 4.38 21.88 0.0438 0.0438 0.0438 0.0438 0.1750 0.0438 0.0438 30 mg PPB 02225972 Apo-Temazepam Apotex 02244815 02230102 00604461 02229761 Cobalt Novopharm Sepracor Pro Doc Co Temazepam Novo-Temazepam Restoril Temazepam-30 100 500 100 100 100 100 500 5.27 26.32 5.27 5.27 21.05 5.27 26.32 0.0527 0.0526 0.0527 0.0527 0.2105 0.0527 0.0526 28:24.92 MISCELLANEOUS ANXIOLYTICS, SEDATIVES, HYPNOTICS BUSPIRON HYDROCHLORIDE X Tab. 02211076 02223163 02231492 02230942 02237858 02242149 Apo-Buspirone Buspirone-10 Novo-Buspirone pms-Buspirone ratio-Buspirone Riva-Buspirone 10 mg PPB Apotex Pro Doc Novopharm Phmscience Ratiopharm Riva CHLORAL HYDRATE X Syr. 02247621 Chloral Hydrate-Odan 00792659 pms-Chloral Hydrate Page 222 100 100 100 100 100 100 500 35.21 35.21 35.21 35.21 35.21 35.21 176.05 0.3521 0.3521 0.3521 0.3521 0.3521 0.3521 0.3521 500 mg/5 mL PPB Odan Phmscience 500 ml 500 ml 21.67 21.67 0.0433 0.0433 2013-04 CODE BRAND NAME MANUFACTURER SIZE HYDROXYZINE HYDROCHLORIDE X Caps. 00646059 Apo-Hydroxyzine 00738824 Novo-Hydroxyzin 02241192 Riva-Hydroxyzin COST OF PKG. SIZE UNIT PRICE 10 mg PPB Apotex Novopharm Riva 100 100 100 500 Caps. 11.16 3.32 3.32 16.60 0.0339 0.0332 0.0332 0.0332 25 mg PPB 00646024 Apo-Hydroxyzine 00738832 Novo-Hydroxyzin 02241193 Riva-Hydroxyzin Apotex Novopharm Riva 100 100 100 500 00646016 Apo-Hydroxyzine 00738840 Novo-Hydroxyzin 02241194 Riva-Hydroxyzin Apotex Novopharm Riva 100 100 100 Sandoz 1 ml Caps. 14.25 5.38 5.38 26.90 0.0548 0.0538 0.0538 0.0538 50 mg PPB I.M. Inj. Sol. 20.68 7.50 7.50 0.0764 0.0750 0.0750 50 mg/mL 00742813 Hydroxyzine Syr. 4.75 3.9900 10 mg/5 mL PPB 00024694 Atarax 00741817 pms-Hydroxyzine Erfa Phmscience 473 ml 500 ml Phmscience 100 PROMETHAZINE HYDROCHLORIDE Tab. 00575186 Histantil 22.17 20.13 0.0469 0.0281 50 mg 16.64 0.1664 28:28 ANTIMANIC AGENTS LITHIUM CARBONATE X Caps. 02242837 00461733 02013231 02237441 Apo-Lithium Carbonate Carbolith Lithane Pal-Lithium 150 mg Apotex Valeant Erfa Paladin 02237006 phl-Lithium Carbonate Pharmel 02216132 pms-Lithium carbonate Phmscience 2013-04 100 100 100 100 1000 100 1000 100 1000 4.22 11.41 8.81 6.33 63.30 4.22 42.20 4.22 42.20 0.0422 0.1141 0.0881 0.0633 0.0633 0.0422 0.0422 0.0422 0.0422 Page 223 CODE BRAND NAME MANUFACTURER SIZE Caps. COST OF PKG. SIZE UNIT PRICE 300 mg 02242838 Apo-Lithium Carbonate Apotex 00236683 Carbolith Valeant 00406775 Lithane 02237442 Pal-Lithium Erfa Paladin 02237007 phl-Lithium Carbonate Pharmel 02216140 pms-Lithium carbonate Phmscience 02011239 02237443 02237008 02216159 Valeant Paladin Pharmel Phmscience 100 1000 100 1000 1000 100 1000 100 1000 100 1000 Caps. 4.43 44.30 8.86 88.61 94.76 6.64 66.40 4.43 44.30 4.43 44.30 0.0443 0.0443 0.0886 0.0886 0.0948 0.0664 0.0664 0.0443 0.0443 0.0443 0.0443 600 mg Carbolith Pal-Lithium phl-Lithium Carbonate pms-Lithium carbonate 100 100 100 100 LITHIUM CITRATE X Syr. 02074834 pms-Lithium Citrate 17.00 13.60 9.18 9.18 0.1700 0.1360 0.0918 0.0918 300 mg/5 mL Phmscience 500 ml 34.37 0.0687 28:32.28 SELECTIVE SEROTONIN AGONISTS ALMOTRIPTAN MALATE X Tab. 02248128 Axert 6.25 mg McNeil Co 6 Tab. 13.0133 12.5 mg 02248129 Axert McNeil Co 6 Pfizer 6 ELETRIPTAN (HYDROBROMIDE) X Tab. 02256290 Relpax 78.26 13.0133 20 mg Tab. 79.18 13.1967 40 mg 02256304 Relpax Pfizer 6 GSK Apotex Novopharm 2 6 8 NARATRIPTAN HYDROCHLORIDE X Tab. 02237820 Amerge 02365499 Apo-Naratriptan 02314290 Novo-Naratriptan Page 78.26 224 79.18 13.1967 1 mg PPB 26.53 46.77 62.36 13.2650 7.1633 7.1638 2013-04 CODE BRAND NAME MANUFACTURER SIZE Tab. COST OF PKG. SIZE UNIT PRICE 2.5 mg PPB 02237821 Amerge GSK 02365502 Apo-Naratriptan 02314304 Novo-Naratriptan 02322323 Sandoz Naratriptan Apotex Novopharm Sandoz 2 6 6 8 8 24 RIZATRIPTAN BENZOATE X Tab. Oral Disint. or Tab. Apotex Apotex Cobalt 02380455 Jamp-Rizatriptan 02379651 Mar-Rizatriptan Jamp Marcan 02240518 02379198 02393360 02351870 Merck Mylan Phmscience Sandoz 6 6 6 12 6 6 30 12 6 6 6 Tab. Oral Disint. or Tab. Apotex Apotex Cobalt 02374749 Co Rizatriptan ODT Cobalt 02380463 Jamp-Rizatriptan Jamp 02379678 Mar-Rizatriptan Marcan 02240521 02240519 02379201 02393379 02351889 Merck Merck Mylan Phmscience Sandoz 6 6 6 12 6 12 6 30 6 12 12 12 6 6 6 GSK 2 GSK 1 SUMATRIPTAN (HEMISULFATE) X Nas. spray 02230420 Imitrex 2013-04 5.1500 5.1500 5.1500 5.3267 5.1500 5.1500 5.3267 14.2975 5.1500 5.1500 5.1500 30.90 30.90 30.90 61.80 30.90 61.80 30.90 154.50 30.90 61.80 171.57 171.57 30.90 30.90 30.90 5.1500 5.1500 5.1500 5.1500 5.1500 5.1500 5.1500 5.1500 5.1500 5.1500 14.2975 14.2975 5.1500 5.1500 5.1500 20 mg SUMATRIPTAN SUCCINATE X Kit 02212188 Imitrex Stat Dose 30.90 30.90 30.90 63.92 30.90 30.90 159.80 171.57 30.90 30.90 30.90 10 mg PPB 02393476 Apo-Rizatriptan 02393492 Apo-Rizatriptan RPD 02381702 Co Rizatriptan Maxalt Maxalt RPD Mylan-Rizatriptan ODT pms-Rizatriptan RDT Sandoz Rizatriptan ODT 13.9750 13.9767 6.1438 6.1438 6.1438 6.1438 5 mg PPB 02393468 Apo-Rizatriptan 02393484 Apo-Rizatriptan RPD 02374730 Co Rizatriptan ODT Maxalt RPD Mylan-Rizatriptan ODT pms-Rizatriptan RDT Sandoz Rizatriptan ODT 27.95 83.86 36.86 49.15 49.15 147.45 27.31 13.6550 6 mg/0.5 mL 81.32 Page 225 CODE BRAND NAME MANUFACTURER S.C. Inj. Sol. SIZE UNIT PRICE 6 mg/0.5 mL PPB 99000598 Imitrex Stat Dose 02361698 Sumatriptan SUN Injection GSK Taro 2 2 02268388 02257890 02212153 02268914 02286823 02270722 Apotex Cobalt GSK Mylan Novopharm Pharmel 6 6 6 6 6 6 30 6 30 6 6 6 6 6 Tab. 73.24 43.96 36.6200 50 mg PPB Apo-Sumatriptan Co Sumatriptan Imitrex DF Mylan-Sumatriptan Novo-Sumatriptan DF phl-Sumatriptan 02256436 pms-Sumatriptan Phmscience 02271117 02263025 02324652 02286521 02385570 Riva Sandoz Pro Doc Sanis Sivem Riva-Sumatriptan Sandoz Sumatriptan Sumatriptan Sumatriptan Sumatriptan DF Tab. 42.81 42.81 83.86 42.81 42.81 42.81 214.06 42.81 214.06 42.81 42.81 42.81 42.81 42.81 7.1350 7.1350 13.9767 7.1350 7.1350 7.1350 7.1353 7.1350 7.1353 7.1350 7.1350 7.1350 7.1350 7.1350 100 mg PPB 02268396 02257904 02212161 02268922 02239367 02286831 Apo-Sumatriptan Co Sumatriptan Imitrex DF Mylan-Sumatriptan Novo-Sumatriptan Novo-Sumatriptan DF 02270730 phl-Sumatriptan Pharmel 02256444 pms-Sumatriptan Phmscience 02271125 02263033 02324660 02286548 02385589 Riva Sandoz Pro Doc Sanis Sivem 6 6 6 6 6 6 50 6 30 6 30 6 6 6 6 6 AZC 6 Riva-Sumatriptan Sandoz Sumatriptan Sumatriptan Sumatriptan Sumatriptan DF Apotex Cobalt GSK Mylan Novopharm Novopharm ZOLMITRIPTAN X Nas. spray 02248993 Zomig Page COST OF PKG. SIZE 226 47.16 47.16 92.38 47.16 47.16 47.16 392.98 47.16 235.79 47.16 235.79 47.16 47.16 47.16 47.16 47.16 7.8600 7.8600 15.3967 7.8600 7.8600 7.8600 7.8596 7.8600 7.8596 7.8600 7.8596 7.8600 7.8600 7.8600 7.8600 7.8600 5 mg 83.10 13.8500 2013-04 CODE BRAND NAME MANUFACTURER SIZE Tab. Oral Disint. or Tab. UNIT PRICE 2.5 mg PPB 02380951 Apo-Zolmitriptan Apotex 02381575 02369036 02387158 02324229 Apotex Mylan Mylan Phmscience Apo-Zolmitriptan Rapid Mylan-Zolmitriptan Mylan-Zolmitriptan ODT pms-Zolmitriptan COST OF PKG. SIZE 02324768 pms-Zolmitriptan ODT 02362988 Sandoz Zolmitriptan Phmscience Sandoz 02362996 Sandoz Zolmitriptan ODT Sandoz 02313960 Teva Zolmitriptan 02342545 Teva Zolmitriptan OD 02379929 Zolmitriptan Teva Can Teva Can Pro Doc 02379988 Zolmitriptan ODT 02238660 Zomig Pro Doc AZC 02243045 Zomig Rapimelt AZC 3 6 6 6 6 6 30 6 3 6 2 6 6 6 6 30 6 3 6 2 6 14.00 28.00 27.99 32.00 28.00 27.99 140.00 27.99 14.00 28.00 9.33 28.00 27.99 27.99 27.99 140.00 27.99 41.55 83.10 27.70 83.10 4.6650 4.6667 4.6650 5.3333 4.6667 4.6650 4.6667 4.6650 4.6650 4.6667 4.6650 4.6667 4.6650 4.6650 4.6650 4.6667 4.6650 13.8500 13.8500 13.8500 13.8500 28:32.92 ANTIMIGRAINE AGENTS, MISCELLANEOUS PIZOTIFEN MALATE X Tab. 0.5 mg 00329320 Sandomigran Paladin 100 Tab. 37.84 0.3784 1 mg 00511552 Sandomigran DS Paladin 100 Mylan Phmscience 100 100 62.83 0.6283 28:36.04 ADAMANTANES AMANTADINE HYDROCHLORIDE X Caps. 02139200 Mylan-Amantadine 01990403 pms-Amantadine 100 mg PPB Syr. 51.79 51.79 0.5179 0.5179 50 mg/5 mL 02022826 pms-Amantadine 2013-04 Phmscience 500 ml 40.50 0.0810 Page 227 CODE BRAND NAME MANUFACTURER SIZE COST OF PKG. SIZE UNIT PRICE 28:36.08 ANTICHOLINERGIC AGENTS BENZTROPINE MESYLATE X Tab. 1 mg 00706531 pms-Benztropine Phmscience 1000 00426857 Benztropine Phmscience 00587265 pms-Benztropine Phmscience 100 1000 100 1000 Tab. 0.0224 2 mg BIPERIDENE HYDROCHLORIDE X Tab. 00124982 Akineton 00587362 pms-Procyclidine 4.50 45.00 4.50 45.00 0.0450 0.0450 0.0450 0.0450 2 mg Abbott 100 PROCYCLIDINE HYDROCHLORIDE X Elix. 19.05 0.1905 2.5 mg/5 mL Phmscience 500 ml Tab. 125.81 0.2516 2.5 mg 00649392 pms-Procyclidine Phmscience 100 1000 00587354 pms-Procyclidine Phmscience 100 1000 Tab. 5.55 55.50 0.0555 0.0555 5 mg TRIHEXYPHENIDYL HYDROCHLORIDE X Tab. 2.60 25.99 0.0260 0.0260 2 mg 00545058 Trihexyphenidyl AA Pharma 100 00545074 Apo-Trihex AA Pharma 100 Tab. Page 45.00 3.69 0.0311 5 mg 228 6.68 0.0560 2013-04 CODE BRAND NAME MANUFACTURER SIZE COST OF PKG. SIZE UNIT PRICE 28:36.12 CATECHOL-O-METHYLTRANSFERASE INHIBITORS ENTACAPONE X Tab. 02321459 02243763 02390337 02380005 02375559 Apo-Entacapone Comtan Mylan-Entacapone Sandoz Entacapone Teva Entacapone 200 mg PPB Apotex Novartis Mylan Sandoz Teva Can 100 100 100 100 100 40.10 151.92 40.10 40.10 40.10 0.4010 1.5192 0.4010 0.4010 0.4010 28:36.16 DOPAMINE PRECURSORS LEVODOPA/ CARBIDOPA X L.A. Tab. 02272873 Levocarb CR 02028786 Sinemet CR 100 mg -25 mg PPB AA Pharma Merck L.A. Tab. 02245211 Levocarb CR 00870935 Sinemet CR 100 100 51.26 68.65 0.4119 0.6865 200 mg -50 mg PPB AA Pharma Merck Tab. 100 100 100.00 125.11 0.7507 1.2511 100 mg -10 mg PPB 02195933 Apo-Levocarb 02244494 Novo-Levocarbidopa 00355658 Sinemet 100/10 Apotex Novopharm Merck Tab. 100 100 100 18.77 18.77 44.49 0.1877 0.1877 0.4449 100 mg -25 mg PPB 02195941 Apo-Levocarb Apotex 02244495 Novo-Levocarbidopa Novopharm 02311178 Pro-Levocarb-100/25 Pro Doc 00513997 Sinemet 100/25 Merck 100 500 100 500 100 500 100 02230454 Apo-Bromocriptine AA Pharma 100 02087324 Apo-Bromocriptine AA Pharma 100 28.03 140.15 28.03 140.15 28.03 140.15 66.42 0.2803 0.2803 0.2803 0.2803 0.2803 0.2803 0.6642 28:36.20 DOPAMINE RECEPTOR AGONISTS BROMOCRIPTIN MESYLATE X Caps. 5 mg Tab. 146.44 0.8016 2.5 mg 2013-04 97.82 0.4501 Page 229 CODE BRAND NAME MANUFACTURER SIZE PRAMIPEXOLE DIHYDROCHLORIDE X Tab. UNIT PRICE 0.25 mg PPB 02292378 02297302 02237145 02376350 02290111 02325802 02367602 02309122 02315262 02269309 Apo-Pramipexole Co Pramipexole Mirapex Mylan-Pramipexole pms-Pramipexole Pramipexole Pramipexole Pramipexole Sandoz Pramipexole Teva-Pramipexole Apotex Cobalt Bo. Ing. Mylan Phmscience Pro Doc Sanis Sivem Sandoz Teva Can 100 100 90 90 100 100 90 100 100 90 02292386 02297310 02241594 02376369 02290138 02325810 02367610 02309130 02315270 02269317 Apo-Pramipexole Co Pramipexole Mirapex Mylan-Pramipexole pms-Pramipexole Pramipexole Pramipexole Pramipexole Sandoz Pramipexole Teva-Pramipexole Apotex Cobalt Bo. Ing. Mylan Phmscience Pro Doc Sanis Sivem Sandoz Teva Can 100 100 90 90 100 100 90 100 100 90 Tab. 26.29 26.29 94.62 23.66 26.29 26.29 23.66 26.29 26.29 23.66 0.2629 0.2629 1.0513 0.2629 0.2629 0.2629 0.2629 0.2629 0.2629 0.2629 0.5 mg PPB Tab. 109.09 109.09 195.05 98.18 109.09 109.09 98.18 109.09 109.09 98.18 1.0909 1.0909 2.1672 1.0909 1.0909 1.0909 1.0909 1.0909 1.0909 1.0909 1 mg PPB 02292394 02297329 02237146 02376377 02290146 02325829 02367629 02309149 02315289 02269325 Apo-Pramipexole Co Pramipexole Mirapex Mylan-Pramipexole pms-Pramipexole Pramipexole Pramipexole Pramipexole Sandoz Pramipexole Teva-Pramipexole Apotex Cobalt Bo. Ing. Mylan Phmscience Pro Doc Sanis Sivem Sandoz Teva Can 100 100 90 90 100 100 90 100 100 90 Tab. 52.57 52.57 189.25 47.31 52.57 52.57 47.31 52.57 52.57 47.31 0.5257 0.5257 2.1028 0.5257 0.5257 0.5257 0.5257 0.5257 0.5257 0.5257 1.5 mg PPB 02292408 02297337 02237147 02376385 02290154 02325837 02367645 02309157 02315297 02269333 Page COST OF PKG. SIZE 230 Apo-Pramipexole Co Pramipexole Mirapex Mylan-Pramipexole pms-Pramipexole Pramipexole Pramipexole Pramipexole Sandoz Pramipexole Teva-Pramipexole Apotex Cobalt Bo. Ing. Mylan Phmscience Pro Doc Sanis Sivem Sandoz Teva Can 100 100 90 90 100 100 90 100 100 90 52.57 52.57 189.25 47.31 52.57 52.57 47.31 52.57 52.57 47.31 0.5257 0.5257 2.1028 0.5257 0.5257 0.5257 0.5257 0.5257 0.5257 0.5257 2013-04 CODE BRAND NAME MANUFACTURER SIZE ROPINIROLE HYDROCHLORIDE X Tab. COST OF PKG. SIZE UNIT PRICE 0.25 mg PPB 02337746 02316846 02352338 02326590 02314037 02232565 02353040 Apo-Ropinirole Co Ropinirole Jamp-Ropinirole pms-Ropinirole Ran-Ropinirole Requip Ropinirole Apotex Cobalt Jamp Phmscience Ranbaxy GSK Sanis 100 100 100 100 100 100 100 02337762 02316854 02352346 02326612 02314053 02232567 02353059 Apo-Ropinirole Co Ropinirole Jamp-Ropinirole pms-Ropinirole Ran-Ropinirole Requip Ropinirole Apotex Cobalt Jamp Phmscience Ranbaxy GSK Sanis 100 100 100 100 100 100 100 02337770 02316862 02352354 02326620 02314061 02232568 02353067 Apo-Ropinirole Co Ropinirole Jamp-Ropinirole pms-Ropinirole Ran-Ropinirole Requip Ropinirole Apotex Cobalt Jamp Phmscience Ranbaxy GSK Sanis 100 100 100 100 100 100 100 Tab. 7.10 7.10 7.10 7.10 7.10 26.43 7.10 0.0710 0.0710 0.0710 0.0710 0.0710 0.2643 0.0710 1 mg PPB Tab. 28.38 28.38 28.38 28.38 28.38 105.70 28.38 0.2838 0.2838 0.2838 0.2838 0.2838 1.0570 0.2838 2 mg PPB Tab. 31.22 31.22 31.22 31.22 31.22 116.27 31.22 0.3122 0.3122 0.3122 0.3122 0.3122 1.1627 0.3122 5 mg PPB 02337800 02316870 02352362 02326639 02314088 02232569 02353075 Apo-Ropinirole Co Ropinirole Jamp-Ropinirole pms-Ropinirole Ran-Ropinirole Requip Ropinirole Apotex Cobalt Jamp Phmscience Ranbaxy GSK Sanis 100 100 100 100 100 100 100 85.96 85.96 85.96 85.96 85.96 320.12 85.96 0.8596 0.8596 0.8596 0.8596 0.8596 3.2012 0.8596 28:36.32 MONOAMINE OXYDASE B INHIBITORS SELEGILINE HYDROCHLORIDE X Tab. 02230641 02231036 02068087 02238319 2013-04 Apo-Selegiline Mylan-Selegiline Novo-Selegiline Selegiline 5 mg PPB Apotex Mylan Novopharm Pharmel 100 60 60 300 50.22 30.13 30.13 225.97 0.5022 0.5022 0.5022 0.7532 Page 231 CODE BRAND NAME MANUFACTURER SIZE COST OF PKG. SIZE UNIT PRICE 28:36.92 ANTIPARKINSONIAN AGENTS, MISCELLANEOUS ETHOPROPAZINE HYDROCHLORIDE X Tab. 01927744 Parsitan 50 mg Erfa 100 LEVODOPA/ BENSERAZIDE HYDROCHLORIDE X Caps. 00522597 Prolopa 50/12.5 19.53 0.1953 50 mg -12.5 mg Roche 100 Caps. 27.87 0.2787 100 mg -25 mg 00386464 Prolopa 100/25 Roche LÉVODOPA/ CARBIDOPA/ ENTACAPONE X Tab. 02305933 Stalevo Novartis 02337827 Stalevo Novartis Tab. 100 45.88 0.4588 50 mg - 12.5 mg - 200 mg 100 160.05 1.6005 75 mg - 18,75 mg - 200 mg Tab. 100 160.05 1.6005 100 mg - 25 mg - 200 mg 02305941 Stalevo Novartis 02337835 Stalevo Novartis Tab. 100 160.05 1.6005 125 mg - 31,25 mg - 200 mg Tab. 100 160.05 1.6005 150 mg - 37.5 mg - 200 mg 02305968 Stalevo Novartis 100 160.05 1.6005 28:92 MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS TETRABENAZINE X Tab. 02199270 Nitoman Page 232 25 mg Valeant 112 699.92 6.2493 2013-04 36:00 DIAGNOSTIC AGENTS 36:26 36:88 36:88.12 36:88.40 36:88.92 diabetes mellitus urine and feces contents ketones sugar urine and feces contents, miscellaneous CODE BRAND NAME MANUFACTURER SIZE COST OF PKG. SIZE 50 100 50 100 51 102 100 50 100 50 100 50 100 100 50 50 100 50 100 100 50 100 100 50 100 25 50 100 100 50 100 100 50 100 50 50 100 50 50 100 50 100 40.80 71.25 40.80 71.25 41.62 72.68 71.25 34.44 67.50 30.37 59.15 40.81 69.89 69.89 33.75 37.00 69.00 37.00 69.00 68.90 32.50 63.00 45.56 34.95 69.90 17.50 33.50 63.00 69.43 36.45 72.90 68.90 39.75 68.90 22.78 39.75 68.90 27.00 22.78 39.57 39.75 69.43 UNIT PRICE 36:26 DIABETES MELLITUS QUANTITATIVE GLUCOSE BLOOD TEST Strip 99002884 Accu-Chek Advantage Roche Diag 99100214 Accu-Chek Aviva Roche Diag 99004364 Accu-Chek Compact Roche Diag 99100791 00908193 99100827 99100834 Roche Diag Roche Diag SanofiAven Bionime Accu-Chek Mobile Accutrend Glucose BGStar Bionime Rightest GS100 99100096 Contour Bayer 99100849 Contour NEXT 00920371 Encore 99004704 Freestyle Bayer Bayer Ab Diabete 99100478 FreeStyle Lite Ab Diabete 99100928 FreeStyle Precision 99100332 iTest Abbott Auto.Cont. 99100930 Medi+Sure 99100497 Nova-Max Medisure NovaBiomed 99100479 On-Call Plus Acon 99100787 OneTouch Verio 99100516 Oracle Lifescan TremHarr 00801135 Precision Plus 99004119 Precision Xtra Ab Diabete Ab Diabete 99100412 Sidekick 99004577 Sof-Tact Nipro Diag Ab Diabete 99100714 TRUEtest 99100413 TrueTrack Nipro Diag Nipro Diag 99004240 Ultra Lifescan 99002604 Ascensia Autodisc Bayer 99100388 Breeze 2 Bayer Strip Disc (10) 2013-04 5 10 5 10 40.56 69.89 40.56 69.89 Page 235 CODE BRAND NAME MANUFACTURER SIZE QUANTITATIVE KETONE BLOOD TEST Strip 99100929 FreeStyle Precision (Cetone) 99100850 Nova Max Plus (Ketone) 99004879 Precision Xtra (Cetone) COST OF PKG. SIZE UNIT PRICE PPB Abbott 10 15.06 NovaBiomed Ab Diabete 10 10 14.99 15.06 Bayer 50 6.06 Bayer 100 16.62 00035130 Diastix Bayer 50 5.44 00035122 Clinitest Bayer 100 9.60 50 100 6.53 13.03 36:88.12 KETONES QUALITATIVE ACETONE TEST Strip 00035092 Ketostix SEMI-QUANTITATIVE ACETONE TEST Tab. 00035106 Acetest 36:88.40 SUGAR SEMI-QUANTITATIVE GLUCOSE TEST Strip Tab. 36:88.92 URINE AND FECES CONTENTS, MISCELLANEOUS SEMI-QUANTITATIVE ACETONE AND GLUCOSE TEST Strip 00647705 Chemstrip uG/K 00035149 Keto-Diastix Page 236 Roche Diag Bayer 2013-04 40:00 ELECTROLYTIC, CALORIC AND WATER BALANCE 40:08 40:12 40:18 40:18.18 40:20 40:28 40:28.08 40:28.16 40:28.20 40:28.24 40:28.92 40:36 40:40 alkalinizing agents replacement preparations ion‑removing agents potassium‑removing agents caloric agents diuretics loop diuretics potassium‑sparing diuretics thiazide diuretics thiazide‑like diuretics diuretics, miscellaneous irrigating solutions uricosuric agents CODE BRAND NAME MANUFACTURER SIZE COST OF PKG. SIZE UNIT PRICE 40:08 ALKALINIZING AGENTS CITRIC ACID/ SODIUM CITRATE Oral Sol. 334 mg -500 mg/5 mL 00721344 pms-Dicitrate Phmscience 500 ml SODIUM BICARBONATE Tab. 22.33 0.0140 500 mg PPB 80030520 Jamp-Sodium Bicarbonate Jamp 80022194 Sandoz Sodium Bicarbonate Sandoz 500 500 34.20 35.90 0.0684 0.0702 40:12 REPLACEMENT PREPARATIONS CALCIUM CARBONATE Tab. 500 mg PPB 00682039 Apo-Cal 80017732 Cal-500 80003773 Calcium 500 Apotex Pro Doc Trianon 80019737 02237352 02246040 80001408 Vida Nutra Euro-Pharm Jamp Novopharm Calcium 500 Euro-Cal Jamp-Calcium Novo-Calcium 00618098 Nu-Cal Odan 80001122 Pharma-Cal 500 mg Pendopharm 80004046 phl-Calcium Pharmel CALCIUM CARBONATE/VITAMIN D Caps. or Tab. Biomed 80015972 Calcite 500 + D 800 Riva 80015847 80021724 80024378 80028413 80019533 Jamp Jamp Mayaka Jamp Mantra Ph. 80024948 Nu-Cal D 800 Odan 80017422 U-Cal D800 80021091 Vida_Cal D Fort Triton Vida Nutra 2013-04 32.20 10.80 2.16 10.80 10.80 10.80 10.80 2.16 10.80 2.16 10.80 10.80 21.60 10.80 21.60 0.0223 0.0216 0.0216 0.0216 0.0216 0.0216 0.0216 0.0216 0.0216 0.0216 0.0216 0.0216 0.0216 0.0216 0.0216 500 mg - 715 UI et 800 UI PPB 80025939 Bio Cal-D Cal-Os D D-Cal LiquiCal-D Liqui-Jamp Plus M Cal 500 500 100 500 500 500 500 100 500 100 500 500 1000 500 1000 30 500 60 500 500 500 100 120 60 500 60 500 100 90 500 3.60 60.00 7.20 60.00 60.00 60.00 12.00 14.40 7.20 60.00 7.20 60.00 12.00 10.80 60.00 0.1200 0.1200 0.1200 0.1200 0.1200 0.1200 0.1200 0.1200 0.1200 0.1200 0.1200 0.1200 0.1200 0.1200 0.1200 Page 239 CODE BRAND NAME MANUFACTURER Tab. COST OF PKG. SIZE UNIT PRICE 500 mg - 125 UI and 200 UI PPB 80004143 80017196 80004966 80004968 Page SIZE Biocal-D Cal-500-D Calcite D 500 Calcium D 500 Biomed Pro Doc Riva Trianon 80021290 Calcium Vitamin D 125 Vida Nutra 02237351 Euro-Cal-D 02246041 Jamp-Calcium+Vitamin D 125 U.I. 00720798 Neo-Cal-D 500 02244477 Nu-Cal D Euro-Pharm Jamp 80007304 O-Calcium 500 mg with Vitamin D 80001199 Pharma-Cal D 200 UI 80005934 phl-Calcium 500 + D 200 IU Novopharm 80004281 pms-Calcium 500 + D 125 UI Phmscience 240 Néolab Odan Pendopharm Pharmel 500 500 100 100 500 90 500 500 100 500 500 100 500 100 500 500 500 1000 500 34.00 34.00 6.80 6.80 34.00 6.12 34.00 34.00 6.80 34.00 34.00 6.80 34.00 6.80 34.00 34.00 34.00 68.00 34.00 0.0680 0.0680 0.0680 0.0680 0.0680 0.0680 0.0680 0.0680 0.0680 0.0680 0.0680 0.0680 0.0680 0.0680 0.0680 0.0680 0.0680 0.0680 0.0680 2013-04 CODE BRAND NAME MANUFACTURER Tab. or Chew. Tab.orCaps. Biomed 80000159 Calcia 400 80017099 Calcia Duo Medexus Medexus 80004963 Calcite 500 + D 400 Riva 80004969 Calcium 500 + D 400 Trianon 80017190 80009628 80002901 02245511 Pro Doc Odan Euro-Pharm Euro-Pharm 80004545 Carbocal D 400 (Co.) Euro-Pharm 80012435 Jamp-Calcium + Vitamin D 500 UI 99100832 Jamp-Calcium+Vitamin D 400 U.I. 80002623 Jamp-Calcium+Vitamin D 400 UI Chewable 80025360 J-Cal-D 400 Jamp 80000408 LiquiCal D 400 80021961 Liqui-Jamp Mayaka Jamp 80009412 M Cal (chew tab.) 80013329 M Cal (tab.) Mantra Ph. Mantra Ph. 02246984 Neo-Cal-D Forte 80002703 Nu-Cal D 400 80020974 Opus Cal-D 400 Néolab Odan Opus 80001248 Pharma-Cal D 400 UI Phmscience 80003414 phl-Calcium 500 + D 400 IU Pharmel 80008566 Pro-Cal-D 400 Pro Doc Jamp Jamp Jamp 80021369 Px-Calcium 500 mg + D 400 Phoenix UI 80019198 ratio-Calcium Vit D Ratiopharm 80019239 Sandoz Calcium 500 mg + D 400 UI 80021089 Vida_Cal D Regulier 2013-04 COST OF PKG. SIZE UNIT PRICE 500 mg - 400 UI et 500 UI PPB 80012594 Biocal-D Forte Cal-D 400 Calodan D-400 Carbocal D 400 (Co. croq) Carbocal D 400 (Co.) SIZE Sandoz Vida Nutra 60 500 60 60 500 60 500 100 500 500 60 60 60 500 60 500 500 7.20 60.00 7.20 7.20 60.00 7.20 60.00 12.00 60.00 60.00 7.20 7.20 7.20 60.00 7.20 60.00 60.00 0.1200 0.1200 0.1200 0.1200 0.1200 0.1200 0.1200 0.1200 0.1200 0.1200 0.1200 0.1200 0.1200 0.1200 0.1200 0.1200 0.1200 60 500 60 300 60 500 100 100 120 60 60 500 500 500 60 500 60 500 100 500 60 500 60 500 60 500 500 7.20 60.00 7.20 36.00 7.20 60.00 12.00 12.00 14.40 7.20 7.20 60.00 60.00 60.00 7.20 60.00 7.20 60.00 12.00 60.00 7.20 60.00 7.20 60.00 7.20 60.00 60.00 0.1200 0.1200 0.1200 0.1200 0.1200 0.1200 0.1200 0.1200 0.1200 0.1200 0.1200 0.1200 0.1200 0.1200 0.1200 0.1200 0.1200 0.1200 0.1200 0.1200 0.1200 0.1200 0.1200 0.1200 0.1200 0.1200 0.1200 90 500 10.80 60.00 0.1200 0.1200 Page 241 CODE BRAND NAME MANUFACTURER Tab. or Chew. Tab.orCaps. COST OF PKG. SIZE UNIT PRICE 500 mg - 1 000 UI PPB 80027407 Bio Cal-D Biomed 80025501 Calcite 500 + D 1000 Riva 80018540 Cal-Os D 1000 80027625 Carbocal D 1000 Jamp Euro-Pharm 80027787 Jamp-Calcium+Vitamine D 1000 UI (Co. Croq.) 80025051 LiquiCal-D 80028899 Liqui-Jamp Fort 80019536 M Cal Jamp 80024405 Nu-Cal D 1000 Odan Mayaka Jamp Mantra Ph. CALCIUM CITRATE/VITAMIN D Chew. Tab. 30 500 60 500 500 30 500 60 3.60 60.00 7.20 60.00 60.00 3.60 60.00 7.20 0.1200 0.1200 0.1200 0.1200 0.1200 0.1200 0.1200 0.1200 100 120 60 500 60 500 12.00 14.40 7.20 60.00 7.20 60.00 0.1200 0.1200 0.1200 0.1200 0.1200 0.1200 500 mg -400 UI PPB 80004774 Biocal-D CR 80000281 Ci-Cal D 400 80003262 Jamp Calci-Os Biomed Euro-Pharm Jamp 80013612 Ci-Cal D 200 80015811 Jamp-Calcium Citrate & Vitamin D 200 IU Euro-Pharm Jamp Tab. 60 60 60 7.44 7.44 7.44 0.1240 0.1240 0.1240 250 mg - 200 U.I. PPB ELECTROLYTE (REPLACEMENT)/ DEXTROSE Oral Pd. 01931563 Gastrolyte 80027403 Jamp Rehydralyte 21.60 7.20 0.0600 0.0600 10 10 7.01 7.01 0.7010 0.7010 500 mg/5 mL (Mg-25 mg/5 mL) PPB 80009357 Jamp-Magnesium Jamp 80004109 Magnesium-Odan Odan 00026697 Rougier Magnesium Rougier 99100788 Rougier Magnesium sugar free Teva Can 242 360 120 4.9 g/sac. to 5.1 g/sac. PPB SanofiAven Jamp MAGNESIUM GLUCOHEPTONATE Oral Sol. Page SIZE 500 ml 2000 ml 500 ml 2000 ml 500 ml 2000 ml 500 ml 2000 ml 9.98 39.95 9.98 39.95 9.98 39.95 9.98 39.95 0.0200 0.0200 0.0200 0.0200 0.0200 0.0200 0.0200 0.0200 2013-04 CODE BRAND NAME MANUFACTURER MAGNESIUM GLUCONATE Tab. 80009539 Jamp-Magnesium 00555126 Maglucate Jamp Phmscience 100 100 Biomed 02242261 Euro-K 20 Euro-Pharm 80013007 Jamp-K 20 00713376 K-Dur 80025624 MK 20 Jamp Merck Mantra Ph. 80004415 Odan K-20 80028233 Opus K-20 02243975 Riva-K 20 SR Odan Opus Riva LA Caps or LA Tab Apotex 02246734 Euro-K 600 80013005 Jamp-K 8 02042304 Micro-K Euro-Pharm Jamp Paladin 80008214 Odan K-8 Odan 02244068 Riva-K 8 SR Riva Oral Sol. 100 500 100 500 500 100 100 500 100 500 100 500 19.95 99.75 19.95 99.75 99.75 20.48 19.95 99.75 19.95 99.75 19.95 99.75 100 1000 500 1000 100 500 100 1000 100 500 0.1995 0.1995 0.1995 0.1995 0.1995 0.2048 0.1995 0.1995 0.1995 0.1995 0.1995 0.1995 8.99 74.90 22.50 45.00 9.30 39.60 7.59 75.90 4.50 22.50 0.0899 0.0749 0.0450 0.0450 0.0811 0.0792 0.0460 0.0459 0.0450 0.0450 6.65 mmol/5 mL (en K+) PPB Jamp GSK Phmscience 500 ml 500 ml 500 ml POTASSIUM CITRATE Eff. Tab. 5.10 7.53 5.10 0.0102 0.0151 0.0102 25 mmol (en K+) WellSpring L.A. Tab. 2013-04 0.1088 0.1088 8 mmol (en K+) PPB 00602884 Apo-K 80023817 Jamp-K-Citrate 02243768 K-Citra 80026332 MK 10 10.88 10.88 20 mmol (en K+) PPB 80026265 Bio K-20 Potassium 02085992 K-Lyte UNIT PRICE 500 mg (Mg - 28 mg to 30 mg) PPB POTASSIUM CHLORIDE L.A. Tab. 80024835 Jamp-Potassium Chloride 01918303 K-10 02238604 pms-Potassium Chloride COST OF PKG. SIZE SIZE 30 16.65 0.5550 10 mmol (en K+) PPB Jamp Seaford Mantra Ph. 100 100 100 15.45 15.45 15.45 0.1545 0.1545 0.1545 Page 243 CODE BRAND NAME MANUFACTURER SIZE SODIUM ACID PHOSPHATE Eff. Tab. 80027202 Phosphate-Novartis UNIT PRICE 1.936 g Novartis 20 SODIUM CHLORIDE I.V. Inj. Sol. 00060240 Chlorure de Sodium 5% COST OF PKG. SIZE 9.16 0.4580 50 mg/mL Baxter 250 ml I.V. Inj. Sol. 5.25 234 mg/mL 11 99100498 30 ml 40:18.18 POTASSIUM-REMOVING AGENTS CALCIUM POLYSTYRENE SULPHONATE Oral Pd. 02017741 Resonium Calcium POLYSTYRENE SODIUM SULFONATE X Oral Pd. 02026961 Kayexalate 00755338 pms-Sodium Polystyrene Sulfonate Oral Susp. 00769541 Solystat Rect. Susp. 00769533 Solystat Exchange capacity: 1.6 mmol de k/g SanofiAven 300 g 92.50 Exchange capacity: 1 mmol de k/g PPB SanofiAven Phmscience 454 g 454 g 66.30 66.30 Exchange capacity: 1 mmol de k/4mL Pendopharm 500 ml 52.19 0.1044 Exchange capacity: 1 mmol de k/4mL Pendopharm 120 ml 17.15 W 0.1222 40:20 CALORIC AGENTS LEVOCARNITINE X I.V. Inj. Sol. 02144344 Carnitor 1 g/5 mL Sigma-Tau 5 ml Sigma-Tau 118 ml Oral Sol. 02144336 Carnitor UE 100 mg/mL UE 11 Where no price is indicated, pharmacists may purchase the product of their choice. The product thus obtained is considered insured and the price payable by the Régie is the pharmacist's cost price. Page 244 2013-04 CODE BRAND NAME MANUFACTURER SIZE Tab. COST OF PKG. SIZE UNIT PRICE 330 mg 02144328 Carnitor Sigma-Tau 90 Valeo 100 UE 40:28.08 LOOP DIURETICS ETHACRYNIC ACID X Tab. 02258528 Edecrin 25 mg FUROSEMIDE X Inj. Sol. 0.3096 10 mg/mL 00527033 Furosemide Sandoz 02382539 Furosemide SDZ Sandoz 2 ml 4 ml 2 ml 4 ml Oral Sol. 02224720 Lasix 30.96 1.73 3.46 1.73 3.46 10 mg/mL SanofiAven 120 ml Tab. 28.79 0.2399 20 mg PPB 00396788 Apo-Furosemide Apotex 02247371 Bio-Furosemide 02351420 Furosemide (Sanis) Biomed Sanis 00496723 Furosemide-20 02224690 Lasix 00337730 Novo-Semide Pro Doc SanofiAven Novopharm 02348292 NTP-Furosemide NT Pharma 02247493 pms-Furosemide Biomed 100 1000 500 100 1000 1000 30 100 1000 100 1000 500 Tab. 3.73 37.25 18.63 3.73 37.25 37.25 2.30 3.73 37.25 3.73 37.25 18.63 0.0373 0.0373 0.0373 0.0373 0.0373 0.0373 0.0767 0.0373 0.0373 0.0373 0.0373 0.0373 40 mg PPB 00362166 Apo-Furosemide Apotex 02247372 Bio-Furosemide 02351439 Furosemide (Sanis) Biomed Sanis 00397792 Furosemide -40 02224704 Lasix 00337749 Novo-Semide Pro Doc SanofiAven Novopharm 02348306 NTP-Furosemide NT Pharma 02247494 pms-Furosemide Biomed 2013-04 100 1000 500 100 1000 1000 30 100 1000 100 1000 500 5.58 55.80 27.90 5.58 55.80 55.80 3.42 5.58 55.80 5.58 55.80 27.90 0.0558 0.0558 0.0558 0.0558 0.0558 0.0558 0.1140 0.0558 0.0558 0.0558 0.0558 0.0558 Page 245 CODE BRAND NAME MANUFACTURER SIZE Tab. COST OF PKG. SIZE UNIT PRICE 80 mg PPB 00707570 Apo-Furosemide Apotex 02351447 Furosemide (Sanis) 00667080 Furosemide-80 Sanis Pro Doc 00765953 Novo-Semide 02348314 NTP-Furosemide Novopharm NT Pharma 100 500 100 100 500 100 100 Tab. 12.20 61.00 12.20 12.20 61.00 12.20 12.20 0.1220 0.1220 0.1220 0.1220 0.1220 0.1220 0.1220 500 mg 02224755 Lasix Special SanofiAven 20 AA Pharma 100 52.47 2.6235 40:28.16 POTASSIUM-SPARING DIURETICS AMILORIDE HYDROCHLORIDE X Tab. 02249510 Midamor 5 mg 27.17 0.2717 40:28.20 THIAZIDE DIURETICS HYDROCHLOROTHIAZIDE X Tab. 02327856 Apo-Hydro 02274086 pms-Hydrochlorothiazide 12.5 mg PPB Apotex Phmscience 500 500 Tab. 0.0322 0.0322 25 mg PPB 00326844 Apo-Hydro Apotex 02247170 Bio-Hydrochlorothiazide Biomed 02360594 Hydrochlorothiazide Sanis 00341975 Hydrochlorothiazide-25 02247386 pms-Hydrochlorothiazide Pro Doc Biomed 00021474 Teva-Hydrochlorothiazide Teva Can 00312800 Apo-Hydro Apotex 02247171 Bio-Hydrochlorothiazide 02360608 Hydrochlorothiazide Biomed Sanis 00021482 Novo-Hydrazide Novopharm 02247387 pms-Hydrochlorothiazide Biomed 100 1000 500 1000 100 1000 1000 500 1000 100 1000 Tab. Page 16.12 16.12 1.57 15.65 7.83 15.65 1.57 15.65 15.65 7.83 15.65 1.57 15.65 0.0157 0.0157 0.0157 0.0157 0.0157 0.0157 0.0157 0.0157 0.0157 0.0157 0.0157 50 mg PPB 246 100 1000 100 100 1000 100 1000 100 2.17 21.68 2.17 2.17 21.68 2.17 21.68 2.17 0.0217 0.0217 0.0217 0.0217 0.0217 0.0217 0.0217 0.0217 2013-04 CODE BRAND NAME MANUFACTURER SIZE COST OF PKG. SIZE UNIT PRICE 40:28.24 THIAZIDE-LIKE DIURETICS CHLORTHALIDONE X Tab. 00360279 Chlorthalidone 50 mg AA Pharma 100 02245246 Apo-Indapamide 02373904 Jamp-Indapamide Apotex Jamp 02179709 Lozide 02240067 Mylan-Indapamide Servier Mylan 02239619 pms-Indapamide Phmscience 02312530 Pro-Indapamide Pro Doc 02247245 Riva-Indapamide Riva 100 30 100 30 30 100 30 100 30 100 30 500 02223678 Apo-Indapamide 02373912 Jamp-Indapamide Apotex Jamp 00564966 Lozide 02153483 Mylan-Indapamide Servier Mylan 02231184 Novo-Indapamide Novopharm 02240350 phl-Indapamide Pharmel 02239620 pms-Indapamide Phmscience 02312549 Pro-Indapamide Pro Doc 02242125 Riva-Indapamide Riva 02188910 Tria-Indapamide Trianon 100 30 100 30 30 500 30 100 30 100 30 100 30 100 30 100 30 SanofiAven 100 INDAPAMIDE X Tab. 12.42 0.0813 1.25 mg PPB Tab. 7.45 2.24 7.45 8.94 2.24 7.45 2.24 7.45 2.24 7.45 2.24 37.25 0.0745 0.0747 0.0745 0.2980 0.0747 0.0745 0.0747 0.0745 0.0747 0.0745 0.0747 0.0745 2.5 mg PPB METOLAZONE X Tab. 00888400 Zaroxolyn 2013-04 11.82 3.55 11.82 14.18 3.55 59.09 3.55 11.82 3.55 11.82 3.55 11.82 3.55 11.82 3.55 11.82 3.55 0.1182 0.1183 0.1182 0.4727 0.1183 0.1182 0.1183 0.1182 0.1183 0.1182 0.1183 0.1182 0.1183 0.1182 0.1183 0.1182 0.1183 2.5 mg 16.14 0.1614 Page 247 CODE BRAND NAME MANUFACTURER SIZE COST OF PKG. SIZE UNIT PRICE 40:28.92 DIURETICS, MISCELLANEOUS AMILORIDE HYDROCHLORIDE HYDROCHLOROTHIAZIDE X Tab. 00870943 Ami-Hydro 00784400 Apo-Amilzide Pro Doc Apotex 01937219 Novamilor Novopharm SPIRONOLACTONE/ HYDROCHLOROTHIAZIDE X Tab. 00180408 Aldactazide 00613231 Novo-Spirozine Pfizer Novopharm Tab. 5 mg -50 mg PPB 100 100 1000 100 1000 8.38 8.38 83.78 8.38 83.78 0.0838 0.0838 0.0838 0.0838 0.0838 25 mg -25 mg PPB 100 100 9.28 8.58 0.0928 0.0557 50 mg -50 mg PPB 00594377 Aldactazide 50 00657182 Novo-Spirozine-50 Pfizer Novopharm TRIAMTERENE/ HYDROCHLOROTHIAZIDE X Tab. 00441775 Apo-Triazide Apotex 00532657 Novo-Triamzide Novopharm 00519367 Pro-Triazide 02240846 Riva-Zide Pro Doc Riva 100 100 24.19 22.36 0.2419 0.1452 50 mg -25 mg PPB 100 1000 100 1000 1000 500 1000 6.08 60.80 6.08 60.80 60.80 30.40 60.80 0.0608 0.0608 0.0608 0.0608 0.0608 0.0608 0.0608 40:36 IRRIGATING SOLUTIONS DIMETHYLSULFOXIDE X Irr. Sol. 02243231 Dimethylsulfoxide pour Irrigation 00493392 Rimso-50 500 mg/g PPB Sandoz 50 ml 51.95 Bioniche 50 ml 56.90 POLYMYXIN B SULFATE/ NEOMYCIN SULFATE X Urol. Sol. 00666157 Neosporine Page 248 GSK 0.6796 200 000 U-57 mg/mL 20 ml 31.87 2013-04 CODE BRAND NAME MANUFACTURER SIZE COST OF PKG. SIZE UNIT PRICE 40:40 URICOSURIC AGENTS PROBENECID X Tab. 00294926 Benuryl 500 mg Valeant 100 AA Pharma 100 SULFINPYRAZONE X Tab. 00441767 Apo-Sulfinpyrazone 2013-04 18.84 W 200 mg 29.97 0.2997 Page 249 48:00 ANTITUSSIVES, EXPECTORANTS AND MUCOLYTIC AGENTS 48:10 48:10.24 48:10.32 48:24 anti‑inflammatory agents leukotriene modifiers mast‑cell stabilizers mucolytic agents CODE BRAND NAME MANUFACTURER SIZE COST OF PKG. SIZE UNIT PRICE 48:10.24 LEUKOTRIENE MODIFIERS MONTELUKAST SODIUM X Chew. Tab. + 02377608 Apo-Montelukast 02379821 02379317 02382458 02380749 Montelukast Montelukast Montelukast Mylan-Montelukast 4 mg PPB Apotex Pro Doc Sanis Sivem Mylan 02354977 pms-Montelukast Phmscience 02330385 Sandoz Montelukast 02243602 Singulair 02355507 Teva Montelukast Sandoz Merck Teva Can 30 30 30 30 30 100 30 100 100 30 30 Chew. Tab. 0.3647 0.3647 0.3647 0.3647 0.3647 0.3646 0.3647 0.3646 0.3647 1.4000 0.3647 5 mg PPB + 02377616 Apo-Montelukast 02379848 02379325 02382466 02380757 10.94 10.94 10.94 10.94 10.94 36.46 10.94 36.46 36.47 42.00 10.94 Montelukast Montelukast Montelukast Mylan-Montelukast Apotex Pro Doc Sanis Sivem Mylan 02354985 pms-Montelukast Phmscience 02330393 Sandoz Montelukast 02238216 Singulair 02355515 Teva Montelukast Sandoz Merck Teva Can Gran. 30 30 30 30 30 100 30 100 100 30 30 19.32 19.32 19.32 19.32 19.32 64.40 19.32 64.40 64.40 46.36 19.32 0.6440 0.6440 0.6440 0.6440 0.6440 0.6440 0.6440 0.6440 0.6440 1.5453 0.6440 4 mg/packet PPB 02358611 Sandoz Montelukast 02247997 Singulair 2013-04 Sandoz Merck 30 30 17.50 42.00 0.5833 1.4000 Page 253 CODE BRAND NAME MANUFACTURER SIZE Tab. COST OF PKG. SIZE UNIT PRICE 10 mg PPB 02374609 Apo-Montelukast Apotex + 02389517 Ran-Montelukast Ranbaxy + 02398826 Riva-Montelukast FC Riva Sandoz Merck Teva Can 30 100 30 100 30 100 30 30 30 100 30 100 30 100 30 100 30 100 30 30 02391422 Jamp-Montelukast Jamp 02379856 Montelukast Pro Doc 02379333 Montelukast 02382474 Montelukast 02379236 Montélukast sodique Sanis Sivem Accord 02368226 Mylan-Montelukast Mylan 02373947 pms-Montelukast FC Phmscience AZC 60 02328593 Sandoz Montelukast 02238217 Singulair 02355523 Teva Montelukast ZAFIRLUKAST X Tab. 02236606 Accolate 28.38 94.59 28.38 94.59 28.38 94.59 28.38 28.38 28.38 94.59 28.38 94.59 28.38 94.59 28.38 94.59 28.38 94.59 68.23 28.38 0.9459 0.9459 0.9459 0.9459 0.9459 0.9459 0.9459 0.9459 0.9459 0.9459 0.9459 0.9459 0.9459 0.9459 0.9459 0.9459 0.9459 0.9459 2.2743 0.9459 20 mg 44.95 0.7492 48:10.32 MAST-CELL STABILIZERS CROMOGLICATE (SODIUM) Nas. spray 01950541 Rhinaris CS Anti-allergique 2% Pendopharm 13 ml 26 ml Sol. Inh. 02046113 pms-Sodium cromoglycate 9.57 13.86 1 % (2 mL) Phmscience 50 24.23 0.4846 48:24 MUCOLYTIC AGENTS ACETYLCYSTEINE Sol. Page 200 mg/mL PPB 02243098 Acetylcysteine Sandoz 02091526 Mucomyst WellSpring 254 10 ml 30 ml 10 ml 30 ml 6.03 14.78 7.20 17.65 0.4320 0.3530 2013-04 52:00 E. N. T. AGENTS 52:02 52:04 52:04.04 52:04.20 52:08 52:08.08 52:16 52:24 52:40 52:40.04 52:40.08 52:40.12 52:40.20 52:40.28 52:40.92 52:92 antiallergic agents anti‑infectives antibiotics antivirals anti‑inflammatory agents corticosteroids local anesthetics mydriatics antiglaucoma agents alfa‑adrenergic agonists beta‑adrenergic blocking agents carbonic anhydrase inhibators miotics prostaglandin analogs antiglaucoma agents, miscellaneous miscellaneous EENT drugs CODE BRAND NAME MANUFACTURER SIZE COST OF PKG. SIZE UNIT PRICE 52:02 ANTIALLERGIC AGENTS CROMOGLICATE (SODIUM) Oph. Sol. 2 % PPB 02009277 Cromolyn Pendopharm 02230621 Opticrom Allergan 5 ml 10 ml 10 ml LODOXAMIDE TROMETHAMIDE X Oph. Sol. 00893560 Alomide 5.70 9.50 9.98 0.9840 0.1 % Alcon 10 ml Sandoz 3.5 g 10.73 1.0530 52:04.04 ANTIBIOTICS CHLORAMPHENICOL X Oph. Oint. 01980564 Pentamycetin 1% Oph. Sol. Sandoz 10 ml Sandoz 10 ml Oph. Sol. 5.28 0.5 % 02164051 Pentamycetin CIPROFLOXACIN HYDROCHLORIDE X Oph. Oint. 02200864 Ciloxan 6.30 0.4620 0.3 % Alcon 3.5 g Apotex Alcon Phmscience Sandoz 5 ml 5 ml 5 ml 5 ml Oph. Sol. 10.15 0.3 % PPB Apo-Ciproflox Ciloxan pms-Ciprofloxacin Sandoz Ciprofloxacin ERYTHROMYCIN X Oph. Oint. 02326663 Erythromycin 01912755 pms-Erythromycine 02224887 Soframycine 7.05 10.15 3.81 3.81 0.7940 1.4480 0.5 % PPB Sterigen Phmscience 3.5 g 3.5 g Erfa 8 ml FRAMYCETIN SULFATE X Oph. Sol. 2013-04 1.5657 0.25 % 01980556 Pentamycetin 02263130 01945270 02253933 02387131 7.56 3.83 3.83 0.5 % 8.00 Page 257 CODE BRAND NAME MANUFACTURER SIZE FUSIDIC (ACID) X Oph. Sol. 02243862 Fucithalmic Leo 5g 8.99 0.3 % Sandoz 3.5 g Oph. Sol. 5.25 1.1886 0.3 % PPB 00512192 Garamycin 02229440 Sandoz Gentamicine Merck Sandoz 5 ml 5 ml Merck Sandoz 7.5 ml 7.5 ml Ot. Sol. 2.03 2.03 0.3 % PPB 00512184 Garamycin 02229441 Sandoz Gentamicine OFLOXACINE X Oph. Sol. 02248398 02143291 02252570 02247189 UNIT PRICE 1% GENTAMICIN SULFATE X Oph. Oint. 02230888 Sandoz Gentamicine COST OF PKG. SIZE Apo-Ofloxacin Ocuflox pms-Ofloxacin Sandoz Ofloxacin 7.74 7.74 0.3 % PPB Apotex Allergan Phmscience Sandoz 5 ml 5 ml 5 ml 5 ml 3.54 12.23 3.54 3.54 1.4420 POLYMYXIN B SULFATE/ NEOMYCIN SULFATE/ GRAMICIDIN X Oph./Ot. Sol. 10 000 U -2.5 mg -0.025 mg/mL PPB 00694371 Neosporine 00807435 Optimyxin Plus GSK Sandoz 10 ml 10 ml SULFACETAMIDE (SODIUM) X Oph. Sol. 00028053 Sulamyd sodium 10 % Sandoz 15 ml Alcon 3.5 g TOBRAMYCIN X Oph. Oint. 00614254 Tobrex Page 258 7.40 0.3673 0.3 % Oph. Sol. 02239577 pms-Tobramycin 02241755 Sandoz Tobramycine 00513962 Tobrex 0.3% 7.35 7.25 8.65 0.3 % PPB Phmscience Sandoz Alcon 5 ml 5 ml 5 ml 2.92 2.92 8.72 1.7260 2013-04 CODE BRAND NAME MANUFACTURER COST OF PKG. SIZE SIZE UNIT PRICE 52:04.20 ANTIVIRALS TRIFLURIDINE X Oph. Sol. 02248529 Sandoz Trifluridine 00687456 Viroptic 1 % PPB Sandoz Theramed 22.79 22.79 7.5 ml 7.5 ml 52:08.08 CORTICOSTEROIDS BECLOMETHASONE DIPROPIONATE X Aéro ou Vap Nasal 02238796 Apo-Beclomethasone AQ 02172712 Mylan-Beclo AQ 02228300 Rivanase AQ 0.05 mg/dose PPB Apotex Mylan Riva 200 dose(s) 200 dose(s) 200 dose(s) AZC 200 dose(s) BUDESONIDE X Nas. Inh. Pd. 02035324 Rhinocort Turbuhaler 100 mcg/dose Nas. spray 02241003 Mylan-Budesonide AQ 02231923 Rhinocort Aqua Mylan AZC 120 dose(s) 120 dose(s) Mylan 165 dose(s) Alcon 3.5 g Alcon 5 ml 2013-04 8.74 8.06 1.5820 0.1 % Sandoz 5 ml Nu-Pharm 25 ml FLUNISOLIDE X Nas. spray 02239288 Apo-Flunisolide 15.81 0.1 % DEXAMETHASONE SODIUM PHOSPHATE X Oph./Ot. Sol. 00739839 Sandoz Dexamethasone 0.0530 0.1 % Oph. Sol. 00042560 Maxidex 10.12 10.59 100 mcg/dose DEXAMETHASONE X Oph. Oint. 00042579 Maxidex 23.56 64 mcg/dose PPB Nas. spray 02230648 Mylan-Budesonide AQ 12.26 12.26 9.80 7.03 1.2440 0.025 % 14.85 0.3992 Page 259 CODE BRAND NAME MANUFACTURER COST OF PKG. SIZE SIZE FLUOROMETHOLONE X Oph. Susp. 0.1 % PPB 00247855 FML Allergan 02238568 pms-Fluorometholone 00432814 Sandoz Fluorometholone Phmscience Sandoz 5 ml 10 ml 5 ml 5 ml 15.29 30.58 8.09 8.09 Oph. Susp. 00707511 FML Forte Allergan 5 ml 10 ml Alcon 5 ml 13.13 26.26 0.1 % FLUTICASONE FUROATE X Nas. spray 02298589 Avamys 9.10 1.7880 27.5 mcg/dose GSK 120 dose(s) Apotex GSK Ratiopharm 120 dose(s) 120 dose(s) 120 dose(s) FLUTICASONE PROPIONATE X Nas. spray 02294745 Apo-Fluticasone 02213672 Flonase 02296071 ratio-Fluticasone 2.1000 1.5660 0.25 % FLUOROMETHOLONE ACETATE X Oph. Susp. 00756784 Flarex UNIT PRICE 20.73 50 mcg/dose PPB 21.97 23.71 21.97 0.1068 0.1068 HYDROCORTISONE ACETATE X Oph. Oint. 01980661 Cortamed 2.5 % Sandoz 3.5 g 21.70 MOMETASONE FUROATE MONOHYDRATE X Nas. spray 02238465 Nasonex Merck 50 mcg/dose 140 dose(s) PREDNISOLONE ACETATE X Oph. Susp. 00299405 Pred Mild 01916181 Sandoz Prednisolone Page 260 4.8743 26.98 0.12 % PPB Allergan Sandoz 10 ml 10 ml 17.96 13.45 1.3180 1.0460 2013-04 CODE BRAND NAME MANUFACTURER SIZE Oph. Susp. UNIT PRICE 1 % PPB 00700401 ratio-Prednisolone Ratiopharm 01916203 Sandoz Prednisolone Sandoz 5 ml 10 ml 5 ml 10 ml TRIAMCINOLONE ACETONIDE X Nas. spray 02213834 Nasacort AQ COST OF PKG. SIZE 8.50 17.00 8.50 17.00 55 mcg/dose SanofiAven 120 dose(s) 23.14 52:16 LOCAL ANESTHETICS LIDOCAINE HYDROCHLORIDE Oral Top. Jel. 2 % PPB 01968823 Lidodan Visqueuse Odan 00811874 pms-Lidocaine Viscous Phmscience 50 ml 100 ml 50 ml 100 ml 4.50 5.25 4.50 5.25 0.0900 0.0525 0.0900 0.0525 52:24 MYDRIATICS ATROPINE SULFATE X Oph. Sol. 00035017 Isopto Atropine 1% Alcon 5 ml Alcon 15 ml Alcon 15 ml CYCLOPENTOLATE HYDROCHLORIDE X Oph. Sol. 00252506 Cyclogyl 1% HOMATROPINE HYDROBROMIDE Oph. Sol. 00000779 Isopto Homatropine 2013-04 9.58 5% Alcon 15 ml Alcon 5 ml PHENYLEPHRINE HYDROCHLORIDE Oph. Sol. 00465763 Mydfrin 2.5% 12.66 2% Oph. Sol. 00000787 Isopto Homatropine 3.14 11.41 2.5 % 5.08 Page 261 CODE BRAND NAME MANUFACTURER SIZE TROPICAMIDE X Oph. Sol. 00000981 Mydriacyl UNIT PRICE 0.5 % Alcon 15 ml Alcon 15 ml Oph. Sol. 00001007 Mydriacyl COST OF PKG. SIZE 13.13 1% 16.90 52:40.04 ALFA-ADRENERGIC AGONISTS BRIMONIDINE TARTRATE X Oph. Sol. 02248151 Alphagan P * 02301334 Apo-Brimonidine P 0.15 % PPB Allergan Apotex 5 ml 10 ml 5 ml 10 ml Oph. Sol. 11.55 23.10 8.66 17.33 1.3860 1.3860 0.2 % PPB 02236876 Alphagan Allergan 02260077 Apo-Brimonidine Apotex 02246284 pms-Brimonidine Phmscience 02243026 ratio-Brimonidine Ratiopharm 02305429 Sandoz Brimonidine Sandoz 5 ml 10 ml 5 ml 10 ml 5 ml 10 ml 5 ml 10 ml 5 ml 10 ml 16.50 33.00 5.78 11.55 5.78 11.55 5.78 11.55 5.78 11.55 52:40.08 BETA-ADRENERGIC BLOCKING AGENTS BETOXALOL HYDROCHLORIDE X Oph. Susp. 01908448 Betoptic S 0.25 % Alcon 5 ml 10 ml LEVOBUNOLOL HYDROCHLORIDE X Oph. Sol. 02031159 ratio-Levobunolol 02241715 Sandoz Levobunolol Page 262 11.50 23.00 2.2880 0.25 % PPB Ratiopharm Sandoz 10 ml 5 ml 10 ml 15 ml 9.33 4.67 9.33 14.00 2013-04 CODE BRAND NAME MANUFACTURER SIZE Oph. Sol. Phmscience 02031167 ratio-Levobunolol Ratiopharm 02241716 Sandoz Levobunolol Sandoz 5 ml 10 ml 5 ml 10 ml 15 ml 5 ml 10 ml 15 ml TIMOLOL MALEATE X Oph. Sol. 5.76 11.52 5.76 11.52 17.28 5.76 11.52 17.28 0.25 % PPB 00755826 Apo-Timop Apotex 02083353 pms-Timolol 02166712 Sandoz Timolol Phmscience Sandoz 5 ml 10 ml 10 ml 5 ml 10 ml 15 ml Oph. Sol. 4.84 9.68 9.68 4.84 9.68 14.52 0.5 % PPB 00755834 Apo-Timop Apotex 02083345 pms-Timolol Phmscience 02166720 Sandoz Timolol Sandoz 00451207 Timoptic Merck 5 ml 10 ml 5 ml 10 ml 5 ml 10 ml 15 ml 10 ml Alcon Merck 5 ml 5 ml Apotex Alcon Merck 5 ml 5 ml 5 ml AA Pharma 100 500 Oph. Sol. Gel 6.08 12.15 6.08 12.15 6.08 12.15 18.22 33.39 0.25 % PPB Oph. Sol. Gel 02290812 Apo-Timop Gel 02242276 Timolol Maleate-EX 02171899 Timoptic-XE UNIT PRICE 0.5 % PPB 02237991 pms-Levobunolol 02242275 Timolol Maleate-EX 02171880 Timoptic-XE COST OF PKG. SIZE 9.78 18.00 0.5 % PPB 10.76 10.76 21.54 52:40.12 CARBONIC ANHYDRASE INHIBATORS ACETAZOLAMIDE X Tab. 00545015 Acetazolamide 250 mg 2013-04 250 mg 12.37 61.85 0.1237 0.1237 Page 263 CODE BRAND NAME MANUFACTURER SIZE BRINZOLAMIDE X Oph. Susp. 02238873 Azopt Alcon 5 ml Sandoz Merck 5 ml 5 ml 16.42 3.2240 2 % PPB METHAZOLAMIDE X Tab. 02245882 Methazolamide UNIT PRICE 1% DORZOLAMIDE (HYDROCHLORIDE) X Oph. Sol. 02316307 Sandoz Dorzolamide 02216205 Trusopt COST OF PKG. SIZE 8.44 17.94 50 mg AA Pharma 100 48.17 0.4817 52:40.20 MIOTICS CARBACHOL X Oph. Sol. 00000655 Isopto Carbachol 1.5 % Alcon 15 ml Oph. Sol. 00000663 Isopto Carbachol Alcon 15 ml Alcon 5g Alcon 15 ml Alcon 15 ml 13.07 3.21 2% Oph. Sol. 00000884 Isopto Carpine 0.8320 1% Oph. Sol. 00000868 Isopto Carpine 12.72 4% Oph. Sol. 00000841 Isopto Carpine 0.6913 3% PILOCARPINE HYDROCHLORIDE X Oph. gel 00575240 Pilopine HS 10.57 3.70 4% Alcon 15 ml Allergan 3 ml 5 ml 4.19 52:40.28 PROSTAGLANDIN ANALOGS BIMATOPROST X Oph. Sol. 02324997 Lumigan RC Page 264 0.01 % 32.43 54.05 2013-04 CODE BRAND NAME MANUFACTURER SIZE LATANOPROST X Oph. Sol. 02296527 02254786 02367335 02231493 Apo-Latanoprost Co Latanoprost Sandoz Latanoprost Xalatan UNIT PRICE 0.005 % PPB Apotex Cobalt Sandoz Pfizer 2.5 ml 2.5 ml 2.5 ml 2.5 ml TRAVOPROST X Oph. Sol. 02318008 Travatan Z COST OF PKG. SIZE 9.46 9.46 9.46 27.38 0.004 % Alcon 2.5 ml 5 ml 27.70 55.40 52:40.92 ANTIGLAUCOMA AGENTS, MISCELLANEOUS BRIMONIDINE TARTRATE/ TIMOLOL MALEATE X Oph. Sol. 02248347 Combigan Allergan 0.2 % - 0.5 % 10 ml DORZOLAMIDE HYDROCHLORIDE/ TIMOLOL MALEATE X Oph. Sol. 02299615 Apo-Dorzo-Timop 02240113 Cosopt 02344351 Sandoz Dorzolamide/ Timolol 02320525 Teva Dorzotimol 2 % -0.5 % PPB Apotex Merck Sandoz 10 ml 10 ml 10 ml 25.57 54.84 25.57 Teva Can 10 ml 25.57 Oph. Sol. 02258692 Cosopt sans preservateur 40.12 2 % - 0.5 % (0.2mL) Merck 60 Alcon 5 ml 28.41 0.4735 52:92 MISCELLANEOUS EENT DRUGS APRACLONIDINE (HYDROCHLORIDE) X Oph. Sol. 02076306 Iopidine 0.5 % BRINZOLAMIDE/TIMOLOL MALEATE X Oph. Susp. 02331624 Azarga 2013-04 4.3680 1 % -0.5 % Alcon 5 ml Bo. Ing. Phmscience 30 ml 30 ml IPRATROPIUM BROMIDE X Nas. spray 02163705 Atrovent 02239627 pms-Ipratropium 22.26 21.33 0.03 % PPB 29.43 10.43 Page 265 CODE BRAND NAME MANUFACTURER SIZE SODIUM CHLORIDE Oph. Sol. 02245735 Sandoz Sodium Chloride Page 266 COST OF PKG. SIZE UNIT PRICE 5% Sandoz 15 ml 8.45 2013-04 56:00 GASTRO-INTESTINAL DRUGS 56:08 56:14 56:16 56:22 56:22.08 56:22.92 56:28 56:28.12 56:28.28 56:28.32 56:28.36 56:32 56:36 56:92 antidiarrhea agents cholelitholytic agents digestants antiemetics antihistamines miscellaneous antiemetics antiulcer agents and acid suppressants histamine H2‑antagonists prostaglandins protectants proton‑pump inhibitors prokinetic agents anti‑inflammatory agents GI drugs, miscellaneous CODE BRAND NAME MANUFACTURER SIZE COST OF PKG. SIZE UNIT PRICE 56:08 ANTIDIARRHEA AGENTS DIPHENOXYLATE HYDROCHLORHYDE/ ATROPINE SULFATE Z Tab. 00036323 Lomotil Pfizer 2.5 mg -0.025 mg 250 LOPERAMIDE HYDROCHLORIDE Oral Sol. 02016095 pms-Loperamide 110.33 0.4413 0.2 mg/mL Phmscience 230 ml Tab. 21.30 0.0926 2 mg PPB 02212005 Apo-Loperamide Apotex 02256452 Jamp-Loperamide 02225182 Loperamide-2 Jamp Pro Doc 02132591 Novo-Loperamide 02298198 phl-Loperamide Novopharm Pharmel 02228351 pms-Loperamide Phmscience 02238211 Riva-Loperamide Riva 02257564 Sandoz Loperamide Sandoz 100 500 120 100 500 500 100 500 100 500 100 500 100 500 9.52 47.58 11.42 9.52 47.58 47.58 9.52 47.58 9.52 47.58 9.52 47.58 9.52 47.58 0.0952 0.0952 0.0952 0.0952 0.0952 0.0952 0.0952 0.0952 0.0952 0.0952 0.0952 0.0952 0.0952 0.0952 56:14 CHOLELITHOLYTIC AGENTS URSODIOL X Tab. 250 mg PPB 02273497 pms-Ursodiol C Phmscience 02238984 Urso Aptalis 100 500 100 02273500 pms-Ursodiol C 02245894 Urso DS Phmscience Aptalis 100 100 Tab. 86.35 431.75 131.42 0.7886 0.7885 1.3142 500 mg PPB 163.80 249.27 1.4957 2.4927 56:16 DIGESTANTS LACTASE Chew. Tab. 80017689 Biolactose Regular 02239139 Jamp-Lactase Enzyme Regular 02017512 Lactomax 2013-04 3 000 U PPB Biomed Jamp 100 100 9.75 9.75 0.0975 0.0975 Sterimax 100 9.75 0.0975 Page 269 CODE BRAND NAME MANUFACTURER SIZE Chew. Tab. 80017706 Biolactose Extra Strenght 02239140 Jamp-Lactase Enzyme Extra strenght 02224909 Lactomax Extra Strong Biomed Jamp 80 80 9.75 9.75 0.1219 0.1219 Sterimax 80 9.75 0.1219 Merck Ent. Caps. 02181215 Cotazym ECS 4 Janss. Inc Abbott Merck Abbott Page 270 37.96 0.3796 100 21.73 0.2173 100 17.03 0.1703 100 17.03 0.1703 100 500 33.68 168.40 0.3368 0.3368 100 94.93 0.9493 100 27.23 0.2723 12 000 U -39 000 U -39 000 U Aptalis Ent. Caps. 00789429 Pancrease MT 16 100 10 000 U - 33 200 U - 37 500 U Ent. Caps. 02045834 Ultrase MT 12 W 10 000 U -30 000 U -30 000 U Janss. Inc Ent. Caps. 02200104 Creon 10 18.33 8 000 U -30 000 U -30 000 U Ent. Caps. 00789437 Pancrease MT 10 100 6 000 U - 30 000 U - 19 000 U Abbott Ent. Caps. 00502790 Cotazym ECS 8 0.1866 0.1866 5 000 U - 16 600 U - 18 750 U Ent. Caps. 80025653 Creon 6 18.66 186.60 4 500 U - 20 000 U - 25 000 U Aptalis Ent. Caps. 02239007 Creon 5 100 1000 4 000 U -12 000 U -12 000 U Ent. Caps. 02203324 Ultrase 8 000 U -30 000 U -30 000 U 4 000 U - 11 000 U - 11 000 U Merck Ent. Caps. 00789445 Pancrease MT 4 UNIT PRICE 4 500 U PPB PANCRELIPASE (LIPASE-AMYLASE-PROTEASE) Caps. 00263818 Cotazym COST OF PKG. SIZE 100 42.51 0.4251 16 000 U -48 000 U -48 000 U Janss. Inc 100 151.88 1.5188 2013-04 CODE BRAND NAME MANUFACTURER Ent. Caps. 00821373 Cotazym ECS 20 Merck 100 250 88.30 220.75 0.8830 0.8830 100 73.66 0.7366 20 000 U -66 400 U -75 000 U Abbott Ent. Caps. 01985205 Creon 25 UNIT PRICE 20 000 U -65 000 U -65 000 U Aptalis Ent. Caps. 02239008 Creon 20 COST OF PKG. SIZE 20 000 U -55 000 U -55 000 U Ent. Caps. 02045869 Ultrase MT 20 SIZE 100 79.23 0.7923 25 000 U -74 000 U -62 500 U Abbott Tab. 100 85.07 0.8507 8 000 U -30 000 U -30 000 U 02230019 Viokase 8 Aptalis 02241933 Viokase 16 Aptalis Tab. 100 17.03 0.1703 16 000 U -60 000 U -60 000 U 100 34.06 0.3406 56:22.08 ANTIHISTAMINES DIMENHYDRINATE I.M. Inj. Sol. 02061732 Dimenhydrinate 00392537 Dimenhydrinate 50 mg/mL PPB Bioniche Sandoz 1 ml 1 ml 5 ml I.V. Inj. Sol. 00392731 Dimenhydrinate 10 mg/mL Sandoz 5 ml PROCHLORPERAZINE X Supp. 00753688 pms-Prochlorperazine 00789720 Sandoz Prochlorperazine 1.10 1.08 4.30 1.76 0.2980 10 mg PPB Phmscience Sandoz 10 10 PROCHLORPERAZINE MALEATE X Tab. 8.30 8.30 0.8300 0.8300 5 mg 00753661 pms-Prochlorperazine Phmscience 100 00753637 pms-Prochlorperazine Phmscience 100 Tab. 10.55 W 10 mg 2013-04 12.90 W Page 271 CODE BRAND NAME MANUFACTURER SIZE PROCHLORPERAZINE MESYLATE X Inj. Sol. 00789747 Prochlorperazine COST OF PKG. SIZE UNIT PRICE 5 mg/mL Sandoz 2 ml 2.09 56:22.92 MISCELLANEOUS ANTIEMETICS DOXYLAMINE SUCCINATE/ PYRIDOXINE HYDROCHLORIDE X L.A. Tab. 00609129 Diclectin Duchesnay 10 mg -10 mg 300 NABILONE Z Caps. 374.13 1.2471 0.5 mg PPB 02256193 Cesamet 02393581 Co Nabilone Valeant Cobalt 02380900 pms-Nabilone 02358085 Ran-Nabilone 02384884 Teva Nabilone Phmscience Ranbaxy Teva Can 00548375 Cesamet 02393603 Co Nabilone Valeant Cobalt 02380919 pms-Nabilone 02358093 Ran-Nabilone 02384892 Teva Nabilone Phmscience Ranbaxy Teva Can 50 50 100 100 50 50 Caps. 155.13 38.79 77.58 77.58 38.79 38.79 3.1026 0.7758 0.7758 0.7758 0.7758 0.7758 1 mg PPB 50 50 100 100 50 50 310.25 77.57 155.14 155.14 77.57 77.57 6.2050 1.5514 1.5514 1.5514 1.5514 1.5514 56:28.12 HISTAMINE H2-ANTAGONISTS CIMETIDINE X Tab. 300 mg PPB 00487872 Apo-Cimetidine Apotex 02227444 Mylan-Cimetidine Mylan 100 1000 100 Tab. 0.0860 0.0860 0.0860 400 mg PPB 00600059 Apo-Cimetidine Apotex 02227452 Mylan-Cimetidine Mylan 100 500 100 Tab. Page 8.60 86.00 8.60 13.50 67.50 13.50 0.1350 0.1350 0.1350 600 mg PPB 00600067 Apo-Cimetidine Apotex 02227460 Mylan-Cimetidine Mylan 272 100 500 100 500 17.03 85.12 17.03 85.12 0.1703 0.1702 0.1703 0.1702 2013-04 CODE BRAND NAME MANUFACTURER SIZE Tab. COST OF PKG. SIZE UNIT PRICE 800 mg PPB 00749494 Apo-Cimetidine 02227479 Mylan-Cimetidine Apotex Mylan 100 100 01953842 Apo-Famotidine 02351102 Famotidine 02196018 Mylan-Famotidine Apotex Sanis Mylan 02022133 Novo-Famotidine Novopharm 02347636 NTP-Famotidine 00710121 Pepcid NT Pharma Merck 100 100 100 500 100 500 100 28 FAMOTIDINE Tab. 0.2530 0.2530 20 mg PPB FAMOTIDINE X Tab. 26.58 26.58 26.58 132.90 26.58 132.90 26.58 28.83 0.2658 0.2658 0.2658 0.2658 0.2658 0.2658 0.2658 1.0296 40 mg PPB 01953834 Apo-Famotidine Apotex 02351110 Famotidine 02196026 Mylan-Famotidine Sanis Mylan 02022141 Novo-Famotidine Novopharm 02347644 NTP-Famotidine 00710113 Pepcid NT Pharma Merck 100 500 100 100 500 100 500 100 28 Apotex Pendopharm Novopharm Phmscience 100 100 100 100 NIZATIDINE X Caps. 02220156 00778338 02240457 02177714 25.30 25.30 48.34 241.70 48.34 48.34 241.70 48.34 241.70 48.34 52.60 0.4834 0.4834 0.4834 0.4834 0.4834 0.4834 0.4834 0.4834 1.8786 150 mg PPB Apo-Nizatidine Axid Novo-Nizatidine pms-Nizatidine Caps. 20.98 83.92 20.98 20.98 0.2098 0.4273 0.2098 0.2098 300 mg PPB 02220164 00778346 02240458 02177722 Apo-Nizatidine Axid Novo-Nizatidine pms-Nizatidine Apotex Pendopharm Novopharm Phmscience RANITIDINE HYDROCHLORIDE X Oral Sol. 02280833 Apo-Ranitidine 02242940 Novo-Ranidine 2013-04 100 100 100 100 38.02 152.06 38.02 38.02 0.3802 0.7742 0.3802 0.3802 150 mg/10 mL PPB Apotex Novopharm 300 ml 300 ml 27.96 27.96 0.0932 0.0932 Page 273 CODE BRAND NAME MANUFACTURER SIZE Tab. Page COST OF PKG. SIZE UNIT PRICE 150 mg PPB 00733059 Apo-Ranitidine Apotex 02248570 Co Ranitidine Cobalt 02207761 Mylan-Ranitidine Mylan 02367378 Myl-Ranitidine Mylan 00828564 Novo-Ranidine Novopharm 02245782 phl-Ranitidine 02242453 pms-Ranitidine Pharmel Phmscience 02353016 Ranitidine Sanis 02385953 Ranitidine Sivem 02303353 Ranitidine 00740748 Ranitidine-150 Sorres Pro Doc 02336480 Ran-Ranitidine Ranbaxy 00828823 ratio-Ranitidine Ratiopharm 02247814 Riva-Ranitidine Riva 02243229 Sandoz Ranitidine Sandoz 02212331 Zantac GSK 274 60 500 60 500 60 500 100 500 60 500 500 60 500 100 500 60 500 100 60 500 100 250 60 500 60 250 60 500 100 500 10.80 90.00 10.80 90.00 10.80 90.00 18.00 90.00 10.80 90.00 90.00 10.80 90.00 18.00 90.00 10.80 90.00 18.00 10.80 90.00 18.00 45.00 10.80 90.00 10.80 45.00 10.80 90.00 18.00 90.00 0.1800 0.1800 0.1800 0.1800 0.1800 0.1800 0.1800 0.1800 0.1800 0.1800 0.1800 0.1800 0.1800 0.1800 0.1800 0.1800 0.1800 0.1800 0.1800 0.1800 0.1800 0.1800 0.1800 0.1800 0.1800 0.1800 0.1800 0.1800 0.1800 0.1800 2013-04 CODE BRAND NAME MANUFACTURER SIZE Tab. COST OF PKG. SIZE UNIT PRICE 300 mg PPB 00733067 Apo-Ranitidine Apotex 02248571 Co Ranitidine Cobalt 02207788 Mylan-Ranitidine Mylan 02367386 Myl-Ranitidine 00828556 Novo-Ranidine Mylan Novopharm 02245783 phl-Ranitidine 02242454 pms-Ranitidine Pharmel Phmscience 02286114 Ranitidine 02353024 Ranitidine 02385961 Ranitidine Mylan Sanis Sivem 02303388 Ranitidine 00740756 Ranitidine-300 Sorres Pro Doc 02336502 Ran-Ranitidine Ranbaxy 00828688 ratio-Ranitidine 02247815 Riva-Ranitidine Ratiopharm Riva 02243230 Sandoz Ranitidine Sandoz 02212358 Zantac GSK 30 500 30 100 30 500 100 30 500 250 30 250 500 100 30 100 100 30 100 100 250 30 30 100 30 100 60 02244022 Misoprostol AA Pharma 100 02244023 Misoprostol AA Pharma 100 10.80 180.00 10.80 36.00 10.80 180.00 36.00 10.80 180.00 90.00 10.80 90.00 180.00 36.00 10.80 36.00 36.00 10.80 36.00 36.00 90.00 10.80 10.80 36.00 10.80 36.00 21.60 0.3600 0.3600 0.3600 0.3600 0.3600 0.3600 0.3600 0.3600 0.3600 0.3600 0.3600 0.3600 W 0.3600 0.3600 0.3600 0.3600 0.3600 0.3600 0.3600 0.3600 0.3600 0.3600 0.3600 0.3600 0.3600 0.3600 56:28.28 PROSTAGLANDINS MISOPROSTOL X Tab. 100 mcg Tab. 25.84 0.2584 200 mcg 43.03 0.4303 56:28.32 PROTECTANTS SUCRALFATE X Oral Susp. 02103567 Sulcrate Plus 2013-04 1 g/5 mL Aptalis 500 ml 49.42 0.0988 Page 275 CODE BRAND NAME MANUFACTURER SIZE Tab. COST OF PKG. SIZE UNIT PRICE 1 g PPB 02125250 Apo-Sucralfate Apotex 02045702 Novo-Sucralate Novopharm 02130939 Sucralfate-1 02100622 Sulcrate Pro Doc Aptalis 100 500 100 500 100 100 Takeda 90 13.09 65.44 13.09 65.44 13.09 54.41 0.1309 0.1309 0.1309 0.1309 0.1309 0.5441 56:28.36 PROTON-PUMP INHIBITORS DEXLANSOPRAZOLE X L.A. Caps. 02354950 Dexilant 30 mg L.A. Caps. Takeda 90 ESOMEPRAZOLE (MAGNESIUM TRIHYDRATED) X L.A. Tab. 02339099 Apo-Esomeprazole Apotex 02244521 Nexium AZC 1.1000 47.66 158.87 56.07 1.5887 1.5887 1.8690 40 mg PPB 02339102 Apo-Esomeprazole Apotex 02244522 Nexium AZC 30 500 30 100 LANSOPRAZOLE X LA Tab or LA Caps Apo-Lansoprazole Lansoprazole Lansoprazole Mylan-Lansoprazole Novo-Lansoprazole 47.66 794.35 56.07 186.90 1.5887 1.5887 1.8690 1.8690 15 mg PPB Apotex Sanis Sivem Mylan Novopharm 02165503 Prevacid Abbott 02249464 Prevacid FasTab 02385643 Sandoz Lansoprazole Abbott Sandoz 276 99.00 20 mg PPB 30 100 30 L.A. Tab. Page 1.1000 60 mg 02354969 Dexilant 02293811 02357682 02385767 02353830 02280515 99.00 100 100 100 100 30 100 30 100 30 100 50.00 50.00 50.00 50.00 15.00 50.00 60.00 200.00 60.00 50.00 0.5000 0.5000 0.5000 0.5000 0.5000 0.5000 2.0000 2.0000 2.0000 0.5000 2013-04 CODE BRAND NAME MANUFACTURER SIZE LA Tab or LA Caps UNIT PRICE 30 mg PPB 02293838 Apo-Lansoprazole Apotex 02366282 Lansoprazole Pro Doc 02357690 Lansoprazole Sanis 02385775 Lansoprazole Sivem 02353849 Mylan-Lansoprazole Mylan 02280523 Novo-Lansoprazole Novopharm 02165511 Prevacid Abbott 02249472 Prevacid FasTab 02385651 Sandoz Lansoprazole Abbott Sandoz 100 500 100 500 100 500 100 500 30 100 30 500 30 100 30 100 OMEPRAZOLE (BASE OR MAGNESIUM) X Caps. or Tab. 50.00 250.00 50.00 250.00 50.00 250.00 50.00 250.00 15.00 50.00 15.00 250.00 60.00 200.00 60.00 50.00 0.5000 0.5000 0.5000 0.5000 0.5000 0.5000 0.5000 0.5000 0.5000 0.5000 0.5000 0.5000 2.0000 2.0000 2.0000 0.5000 20 mg PPB 02245058 Apo-Omeprazole (caps.) Apotex 00846503 Losec (caps.) 02190915 Losec (tab.) AZC AZC 02329433 Mylan-Omeprazole (caps.) Mylan 02295415 Novo-Omeprazole Teva Can 02348691 Omeprazole Sanis 02339927 Omeprazole (caps.) Pro Doc 02385384 Omeprazole (caps.) Sivem 02320851 pms-Omeprazole (caps.) Phmscience 02310260 pms-Omeprazole DR (tab.) Phmscience 02374870 Ran-Omeprazole Ranbaxy 02260867 ratio-Omeprazole (tab.) Ratiopharm 02296446 Sandoz Omeprazole (Caps.) Sandoz 2013-04 COST OF PKG. SIZE 100 500 30 30 100 30 500 100 500 30 500 100 500 100 500 100 500 30 500 100 100 30 500 55.00 275.00 33.00 68.61 228.70 16.50 275.00 55.00 275.00 16.50 275.00 55.00 275.00 55.00 275.00 55.00 275.00 16.50 275.00 55.00 55.00 16.50 275.00 0.5500 0.5500 1.1000 2.2870 2.2870 0.5500 0.5500 0.5500 0.5500 0.5500 0.5500 0.5500 0.5500 0.5500 0.5500 0.5500 0.5500 0.5500 0.5500 0.5500 0.5500 0.5500 0.5500 Page 277 CODE BRAND NAME MANUFACTURER SIZE PANTOPRAZOLE (MAGNESIUM OR SODIUM) X Ent. Tab. 02292920 Apo-Pantoprazole Apotex 02300486 Co Pantoprazole 02299585 Mylan-Pantoprazole Cobalt Mylan 02285487 Novo-Pantoprazole 02229453 Pantoloc 02309866 Pantoprazole Novopharm Nycomed MeliaPharm 02318695 Pantoprazole Pro Doc 02370808 Pantoprazole 02385759 Pantoprazole Sanis Sivem 02310201 Pantoprazole 02307871 pms-Pantoprazole Sorres Phmscience 02305046 Ran-Pantoprazole 02316463 Riva-Pantoprazole Ranbaxy Riva 02301083 Sandoz Pantoprazole Sandoz 02267233 Tecta Nycomed Page 100 500 100 100 500 100 100 100 500 100 500 100 100 500 100 100 500 100 100 500 30 500 30 50.53 252.70 50.53 50.53 252.70 50.53 204.16 50.53 252.70 50.53 252.70 50.53 50.53 252.70 50.53 50.53 252.70 50.53 50.53 252.70 15.16 252.70 22.50 0.5053 0.5054 0.5053 0.5053 0.5054 0.5053 2.0416 0.5053 0.5054 0.5053 0.5054 0.5053 0.5053 0.5054 0.5053 0.5053 0.5054 0.5053 0.5053 0.5054 0.5053 0.5054 0.7500 10 mg PPB 02345579 Apo-Rabeprazole 02243796 Pariet 02310805 pms-Rabeprazole EC Apotex Janss. Inc Phmscience 02315181 Pro-Rabeprazole 02385449 Rabeprazole 02320614 Rabeprazole EC Pro Doc Sivem MeliaPharm 02356511 02320592 02298074 02330083 Sanis Sorres Ranbaxy Riva 02314177 Sandoz Rabeprazole Sandoz 02296632 Teva-Rabeprazole Sodium Teva Can 278 UNIT PRICE 40 mg PPB RABEPRAZOLE SODIUM X Ent. Tab. Rabeprazole EC Rabeprazole EC Ran-Rabeprazole Riva-Rabeprazole EC COST OF PKG. SIZE 100 100 30 500 100 100 30 500 100 100 100 100 500 30 100 100 16.72 65.00 5.02 83.60 16.72 16.72 5.02 83.60 16.72 16.72 16.72 16.72 83.60 5.02 16.72 16.72 0.1672 0.6500 0.1672 0.1672 0.1672 0.1672 0.1672 0.1672 0.1672 0.1672 0.1672 0.1672 0.1672 0.1672 0.1672 0.1672 2013-04 CODE BRAND NAME MANUFACTURER SIZE Ent. Tab. COST OF PKG. SIZE UNIT PRICE 20 mg PPB 02345587 Apo-Rabeprazole 02243797 Pariet 02310813 pms-Rabeprazole EC Apotex Janss. Inc Phmscience 02315203 Pro-Rabeprazole 02385457 Rabeprazole Pro Doc Sivem 02320622 Rabeprazole EC MeliaPharm 02356538 02320606 02298082 02330091 Sanis Sorres Ranbaxy Riva Rabeprazole EC Rabeprazole EC Ran-Rabeprazole Riva-Rabeprazole EC 02314185 Sandoz Rabeprazole Sandoz 02296640 Teva-Rabeprazole EC Teva Can 100 100 30 500 100 30 100 30 500 100 100 100 100 500 30 100 30 100 33.43 130.00 10.03 167.20 33.44 10.03 33.44 10.03 167.20 33.43 33.43 33.44 33.43 167.20 10.03 33.44 10.03 33.44 0.3343 1.3000 0.3343 0.3344 0.3344 0.3343 0.3344 0.3343 0.3344 0.3343 0.3343 0.3344 0.3343 0.3344 0.3343 0.3344 0.3343 0.3344 56:32 PROKINETIC AGENTS DOMPERIDONE MALEATE X Tab. 02103613 02238341 02236857 02369206 02278669 02157195 02236466 02268078 01912070 Apo-Domperidone Domperidone Domperidone-10 Jamp-Domperidone Mylan-Domperidone Novo-Domperidone pms-Domperidone Ran-Domperidone ratio-Domperidone 10 mg PPB Apotex Sivem Pro Doc Jamp Mylan Novopharm Phmscience Ranbaxy Ratiopharm 500 500 500 500 500 500 500 500 500 METOCLOPRAMIDE HYDROCHLORIDE X Inj. Sol. 02185431 Metoclopramide injection 29.69 29.69 29.69 29.70 29.69 29.69 29.69 29.69 29.69 0.0594 0.0594 0.0594 0.0594 0.0594 0.0594 0.0594 0.0594 0.0594 5 mg/mL Sandoz 2 ml 10 ml 30 ml Oral Sol. 2.83 14.15 42.45 1 mg/mL 02230433 pms-Metoclopramide Phmscience 00842826 Apo-Metoclop Apotex 02230431 pms-Metoclopramide Phmscience 500 ml Tab. 22.42 0.0448 5 mg PPB 2013-04 100 500 100 500 5.56 27.80 5.56 27.80 0.0556 0.0556 0.0556 0.0556 Page 279 CODE BRAND NAME MANUFACTURER SIZE Tab. COST OF PKG. SIZE UNIT PRICE 10 mg PPB 00842834 Apo-Metoclop Apotex 02230432 pms-Metoclopramide Phmscience 100 500 100 500 5.83 29.15 5.83 29.15 0.0583 0.0583 0.0583 0.0583 56:36 ANTI-INFLAMMATORY AGENTS 5-AMINOSALICYLIC ACID X Ent. Tab. 01997580 Asacol 02171929 Novo-5-ASA 400 mg Warner Novopharm 180 100 500 Ent. Tab. GSK Ferring 02112787 Salofalk Aptalis 100 240 500 150 500 Ent. Tab. Warner 180 Shire 120 Aptalis 1 Ferring Aptalis 1 1 1.0280 186.77 1.5564 3.68 4 g PPB Supp. 4.46 6.24 1 g PPB 02153564 Pentasa 02242146 Salofalk Ferring Aptalis 30 30 Supp. 48.00 48.00 1.6000 1.6000 500 mg 02112760 Salofalk Page 185.04 2g Rect. Susp. 02153556 Pentasa (100 mL) 02112809 Salofalk (58,2 mL) 0.5731 0.5569 0.5569 0.5155 0.5156 1.2 g Rect. Susp. 02112795 Salofalk (58,2 mL) 57.31 133.65 278.44 77.33 257.79 800 mg L.A. Tab. 02297558 Mezavant 0.5290 0.2651 0.2651 500 mg 01914030 Mesasal 02099683 Pentasa 02267217 Asacol 800 95.22 31.11 155.55 280 Aptalis 30 34.19 1.1397 2013-04 CODE BRAND NAME MANUFACTURER SIZE OLSALAZINE SODIUM X Caps. 02063808 Dipentum COST OF PKG. SIZE UNIT PRICE 250 mg U.C.B. 100 49.93 0.4971 56:92 GI DRUGS, MISCELLANEOUS LANSOPRAZOLE/ AMOXICILLIN/ CLARITHROMYCINE X Kit 02238525 Hp-PAC 2013-04 Abbott 30 mg-2 x 500 mg-500 mg 7 80.88 11.5543 Page 281 60:00 GOLD COMPOUNDS CODE BRAND NAME MANUFACTURER SIZE COST OF PKG. SIZE UNIT PRICE 60:00 GOLD COMPOUNDS AURANOFIN X Caps. 01916823 Ridaura 3 mg Xediton 60 SODIUM AUROTHIOMALATE X I.M. Inj. Sol. 02245456 Aurothiomalate de sodium 01927620 Myochrysine 1 ml 1 ml 2013-04 6.31 9.92 5.9600 25 mg/mL PPB Sandoz SanofiAven 1 ml 1 ml I.M. Inj. Sol. 02245458 Aurothiomalate de sodium 01927604 Myochrysine 1.9923 10 mg/mL PPB Sandoz SanofiAven I.M. Inj. Sol. 02245457 Aurothiomalate de sodium 01927612 Myochrysine 119.54 7.66 12.05 7.2300 50 mg/mL PPB Sandoz SanofiAven 1 ml 1 ml 11.89 18.74 11.2500 Page 285 64:00 HEAVY METALS ANTAGONISTS CODE BRAND NAME MANUFACTURER SIZE COST OF PKG. SIZE UNIT PRICE 64:00 HEAVY METALS ANTAGONISTS DEFEROXAMINE MESYLATE X Inj. Pd. 01981250 Desferal 02247022 Mesylate de desferrioxamine pour injection 02243450 pms-Deferoxamine 2 g PPB Novartis Hospira 1 1 56.13 28.35 Phmscience 1 28.35 Inj. Pd. 01981242 Desferal 02241600 Mesylate de desferrioxamine pour injection 02242055 pms-Deferoxamine 500 mg PPB Novartis Hospira 1 1 13.97 7.06 Phmscience 1 7.06 PENICILLAMINE X Caps. 00016055 Cuprimine 2013-04 250 mg Valeo 100 74.92 0.7492 Page 289 68:00 HORMONES AND SYNTHETIC SUBSTITUTES 68:04 68:08 68:12 68:16 68:16.04 68:16.12 68:18 68:20 68:20.02 68:20.04 68:20.08 68:20.20 68:22 68:22.12 68:24 68:28 68:32 68:36 68:36.04 68:36.08 adrenals androgens contraceptives estrogens and antiestrogens estrogens estrogen agonist‑antagonists gonadotropins antidiabetic agents alpha‑glucosidase inhibitors biguanides insulins sulfonylureas antihypoglycemic agents glycogenolytic agents parathyroid pituitary progestins thyroid and antithyroid agents thyroid agents antithyroid agents CODE BRAND NAME MANUFACTURER COST OF PKG. SIZE SIZE UNIT PRICE 68:04 ADRENALS BECLOMETHASONE DIPROPIONATE X Oral aerosol 02242029 Qvar 50 mcg/dose Med Pharma 200 dose(s) Med Pharma 200 dose(s) Oral aerosol 02242030 Qvar 29.28 100 mcg/dose 58.56 BETAMETHASONE ACETATE/ BETAMETHASONE SODIUM PHOSPHATE X Inj. Susp. 3 mg -3 mg/mL 02237835 Betaject Sandoz 1 ml 5 ml BUDESONIDE X Inh. Pd. 00852074 Pulmicort Turbuhaler 200 dose(s) AZC 200 dose(s) AZC 200 dose(s) AZC 20 AZC 20 AZC 2013-04 17.14 20 34.28 0.8570 1.7140 100 mcg/dose Nycomed 120 dose(s) Nycomed 120 dose(s) Oral aerosol 02285614 Alvesco 0.4285 0.5 mg/mL (2mL) CICLESONIDE X Oral aerosol 02285606 Alvesco 8.57 0.25 mg/mL (2 mL) Sol. Inh. 01978926 Pulmicort nebuamp 111.36 0.125 mg/mL (2 mL) Sol. Inh. 01978918 Pulmicort nebuamp 63.16 400 mcg/dose Sol. Inh. 02229099 Pulmicort nebuamp 30.90 200 mcg/dose Inh. Pd. 00851760 Pulmicort Turbuhaler 7.2900 7.2820 100 mcg/dose AZC Inh. Pd. 00851752 Pulmicort Turbuhaler 9.53 47.65 44.15 200 mcg/dose 72.81 Page 293 CODE BRAND NAME MANUFACTURER COST OF PKG. SIZE SIZE CORTISONE ACETATE X Tab. 00280437 Cortisone Acetate-ICN 25 mg Valeant 100 30.66 DEXAMETHASONE X Elix. 01946897 pms-Dexamethasone 0.3066 0.5 mg/5 mL Phmscience 100 ml Tab. 35.52 0.3085 0.5 mg PPB 02261081 02237044 01964976 02240684 Apo-Dexamethasone phl-Dexamethasone pms-Dexamethasone ratio-Dexamethasone Apotex Pharmel Phmscience Ratiopharm 100 100 100 100 7.82 7.82 7.82 7.82 Tab. 0.0782 0.0782 0.0782 0.0782 0.75 mg 01964968 pms-Dexamethasone Phmscience 100 02279363 pms-Dexamethasone Phmscience 100 46.20 Tab. 0.4620 2 mg 42.36 Tab. 0.4236 4 mg PPB 02250055 00489158 02237046 01964070 02311267 02240687 Apo-Dexamethasone Dexasone phl-Dexamethasone pms-Dexamethasone Pro-Dexamethasone-4 ratio-Dexamethasone Apotex Valeant Pharmel Phmscience Pro Doc Ratiopharm 100 100 100 100 100 50 100 30.46 30.46 30.46 30.46 30.46 15.23 30.46 DEXAMETHASONE SODIUM PHOSPHATE X Inj. Sol. 01977547 Dexamethasone 00664227 Dexamethasone 02204266 Dexamethasone Omega Cytex Sandoz Oméga Inj. Sol. Page UNIT PRICE 4 mg/mL PPB 5 ml 5 ml 5 ml 8.03 8.03 8.03 10 mg/mL PPB 00874582 Dexamethasone 02204274 Dexamethasone Omega Sandoz Oméga 02260301 phl-Dexamethasone 00783900 pms-Dexamethasone Pharmel Phmscience 294 0.3046 0.3046 0.3046 0.3046 0.3046 0.3046 0.3046 1 ml 1 ml 10 ml 10 ml 10 ml 4.23 4.23 12.83 12.83 12.83 2013-04 CODE BRAND NAME MANUFACTURER COST OF PKG. SIZE SIZE FLUDROCORTISONE ACETATE X Tab. 02086026 Florinef 0.1 mg Paladin 100 FLUTICASONE PROPIONATE X Inh. Pd. 02237244 Flovent Diskus GSK 60 dose(s) GSK 60 dose(s) GSK 60 dose(s) GSK 60 dose(s) GSK 120 dose(s) GSK 120 dose(s) 76.11 22.61 125 mcg/dose Oral aerosol 02244293 Flovent HFA 38.05 50 mcg/dose Oral aerosol 02244292 Flovent HFA 22.61 500 mcg/coque Oral aerosol 02244291 Flovent HFA 13.95 250 mcg/coque Inh. Pd. 02237247 Flovent Diskus 0.2396 100 mcg/coque Inh. Pd. 02237246 Flovent Diskus 23.96 50 mcg/coque Inh. Pd. 02237245 Flovent Diskus UNIT PRICE 38.05 250 mcg/dose GSK 120 dose(s) Pfizer 100 76.11 HYDROCORTISONE X Tab. 10 mg 00030910 Cortef Tab. 14.26 0.1426 20 mg 00030929 Cortef Pfizer 100 HYDROCORTISONE SODIUM SUCCINATE X Inj. Pd. 00878626 Hydrocortisone 00030635 Solu-Cortef 2013-04 Novopharm Pfizer 25.76 0.2576 1 g PPB 1 1 8.60 14.02 8.4200 Page 295 CODE BRAND NAME MANUFACTURER SIZE Inj. Pd. 00872520 Hydrocortisone 00030600 Solu-Cortef Novopharm Pfizer 1 1 Novopharm Pfizer 1 1 Novopharm Pfizer 1 1 2.00 3.25 1.9500 250 mg PPB Inj. Pd. 00878618 Hydrocortisone 00030627 Solu-Cortef UNIT PRICE 100 mg PPB Inj. Pd. 00872539 Hydrocortisone 00030619 Solu-Cortef COST OF PKG. SIZE 3.40 5.64 3.3900 500 mg PPB METHYLPREDNISOLONE X Tab. 5.10 8.36 5.0200 4 mg 00030988 Medrol Pfizer 100 00036129 Medrol Pfizer 100 Pfizer 5 ml Tab. 32.93 0.3293 16 mg METHYLPREDNISOLONE ACETATE X Inj. Susp. 01934325 Depo-Medrol 0.9503 20 mg/mL Inj. Susp. 10.76 40 mg/mL PPB 01934333 Depo-Medrol Pfizer 00030759 Depo-Medrol (sans preservatif) 02245407 Methylprednisolone Pfizer 02245400 Methylprednisolone (sans preservatif) 2 ml 5 ml 1 ml 9.11 16.45 4.75 Sandoz 2 ml 5 ml 1 ml 6.46 14.52 3.23 Pfizer Sandoz Sandoz 1 ml 5 ml 1 ml Sandoz Inj. Susp. 00030767 Depo-Medrol 02245408 Methylprednisolone 02245406 Methylprednisolone (sans preservatif) 95.03 2.4600 1.7780 2.5700 80 mg/mL PPB 9.11 34.95 6.45 4.9200 4.9200 METHYLPREDNISOLONE ACETATE/ LIDOCAINE HYDROCHLORIDE X Inj. Susp. 40 mg -10 mg/mL 00260428 Depo-Medrol & Lidocaine Page 296 Pfizer 1 ml 2 ml 5 ml 5.48 9.15 20.85 2013-04 CODE BRAND NAME MANUFACTURER COST OF PKG. SIZE SIZE METHYLPREDNISOLONE SODIUM SUCCINATE X Inj. Pd. 02241229 Methylprednisolone 02367971 Solu-Medrol 1 g PPB Novopharm Pfizer 1 1 Novopharm Pfizer 1 1 31.00 43.88 Inj. Pd. 02231893 Methylprednisolone 02367947 Solu-Medrol 3.60 4.82 Novopharm Pfizer 1 1 8.50 11.43 Novopharm Pfizer 1 1 18.60 28.66 60 dose(s) 32.00 400 mcg/dose Merck 30 dose(s) 60 dose(s) PREDNISOLONE SODIUM PHOSPHATE X Oral Sol. 02230619 Pediapred 02245532 pms-Prednisolone 17.2000 200 mcg/dose Merck Inh. Pd. 02243596 Asmanex Twisthaler 6.8600 500 mg PPB MOMETASON FUROATE X Inh. Pd. 02243595 Asmanex Twisthaler 2.9000 125 mg PPB Inj. Pd. 02231895 Methylprednisolone 02367963 Solu-Medrol 26.3300 40 mg PPB Inj. Pd. 02231894 Methylprednisolone 02367955 Solu-Medrol UNIT PRICE 32.00 64.00 5 mg/5 mL PPB SanofiAven Phmscience 120 ml 120 PREDNISONE X Tab. 12.70 8.05 0.1058 0.0635 1 mg PPB 00598194 Apo-Prednisone 00271373 Winpred Apotex Valeant 100 100 00312770 Apo-Prednisone Apotex 00021695 Novo-Prednisone Novopharm 00156876 Prednisone-5 Pro Doc 100 1000 100 1000 1000 Tab. 10.72 10.35 0.1072 0.1035 5 mg PPB 2013-04 2.20 21.95 2.20 21.95 21.95 0.0220 0.0220 0.0220 0.0220 0.0220 Page 297 CODE BRAND NAME MANUFACTURER SIZE Tab. COST OF PKG. SIZE UNIT PRICE 50 mg PPB 00550957 Apo-Prednisone 00232378 Novo-Prednisone 00607517 Prednisone-50 Apotex Novopharm Pro Doc 100 100 100 TRIAMCINOLONE ACETONIDE X I.M. Inj. Susp. B.M.S. 01977563 Triamcinolone 02229550 Triamcinolone Cytex Sandoz 1 ml 5 ml 1 ml 1 ml 5 ml Inj. Susp. 7.29 25.52 4.77 4.77 19.50 3.9400 3.9400 2.7580 10 mg/mL PPB B.M.S. Sandoz 5 ml 5 ml Valeo 1 ml 5 ml SanofiAven 100 TRIAMCINOLONE HEXACETONIDE X Inj. Susp. 02194155 Aristospan 0.0913 0.0913 0.0913 40 mg/mL PPB 01999869 Kenalog-40 01999761 Kenalog-10 02229540 Triamcinolone 9.13 9.13 9.13 15.71 12.25 1.8860 20 mg/mL 6.17 26.94 68:08 ANDROGENS DANAZOL X Caps. 02018144 Cyclomen 50 mg Caps. 0.7872 100 mg 02018152 Cyclomen SanofiAven 100 02018160 Cyclomen SanofiAven 100 Watson 60 Caps. 116.79 1.1679 200 mg TESTOSTERONE Y Patch 02239653 Androderm 186.61 1.8661 2.5 mg/24 h Patch 118.43 1.9738 5 mg/24 h 02245972 Androderm Page 78.72 298 Watson 30 118.43 3.9477 2013-04 CODE BRAND NAME MANUFACTURER SIZE Top. Jel. COST OF PKG. SIZE UNIT PRICE 1% (2.5 g) 02245345 AndroGel Abbott 30 Abbott Paladin 30 30 Top. Jel. 65.13 2.1710 1 % (5.0 g) PPB 02245346 AndroGel 02280248 Testim 1% TESTOSTERONE CYPIONATE Y Oily Inj. Sol. 00030783 Depo-Testosterone Pfizer 10 ml Valeant 5 ml Merck Phmscience 120 100 120 24.45 200 mg/mL TESTOSTERONE UNDECANOATE Y Caps. 00782327 Andriol 02322498 pms-Testosterone 3.8390 3.4507 100 mg/mL TESTOSTERONE ENANTHATE Y Oily Inj. Sol. 00029246 Delatestryl 115.17 103.52 24.42 40 mg PPB 112.80 56.40 67.68 0.9400 0.5640 0.5640 68:12 CONTRACEPTIVES ETHINYLESTRADIOL DESOGESTREL X Tab. 0.025 mg/0.1 mg-0.025 mg/0.125 mg-0.025 mg/0.15 mg 02272903 Linessa 21 02257238 Linessa 28 Merck Merck 02317192 02317206 02042487 02042479 02042533 Apotex Apotex Merck Merck Janss. Inc Tab. 1 1 12.40 12.40 0.030 mg -0.15 mg PPB Apri 21 Apri 28 Marvelon 21 Marvelon 28 Ortho-Cept (28) 1 1 1 1 1 ETHINYLESTRADIOL/ DROSPIRENONE X Tab. 11.42 11.42 12.95 12.95 12.69 7.7700 7.7700 0.02 mg -3 mg 02321157 Yaz Bayer 1 02261723 Yasmin 21 02261731 Yasmin 28 Bayer Bayer 1 1 Tab. 11.84 0.03 mg - 3 mg 2013-04 11.84 11.84 Page 299 CODE BRAND NAME MANUFACTURER SIZE ETHINYLESTRADIOL/ ETHYNODIOL DIACETATE X Tab. 00469327 Demulen 30 (21) 00471526 Demulen 30 (28) UNIT PRICE 0.03 mg -2 mg Pfizer Pfizer 1 1 Merck 1 3 ETHINYLESTRADIOL/ ETONOGESTREL X Vaginal ring 02253186 Nuvaring COST OF PKG. SIZE 11.91 12.74 2.6mg -11.4mg 14.72 44.16 ETHINYLESTRADIOL/ LEVONORGESTREL - ETHINYLESTRADIOL X Tab. 0.03 mg - 0.15 mg (84 tab.) 0.01 mg (7 tab.) 02346176 Seasonique Paladin 1 ETHINYLESTRADIOL/ NORELGESTROMIN X Patch (3) 02248297 Evra Janss. Inc ETHINYLESTRADIOL/ NORETHINDRONE X Tab. 02187086 02187094 00317047 00340731 Brevicon 0.5/35 (21) Brevicon 0.5/35 (28) Ortho 0.5/35 (21) Ortho 0.5/35 (28) Tab. 0.60 mg - 6 mg 1 14.95 0.035 mg -0.5 mg PPB Pfizer Pfizer Janss. Inc Janss. Inc 1 1 1 1 10.92 10.92 12.69 12.69 0.035 mg -0.5 mg -0.035 mg -0.75 mg -0.035 mg -1 mg 00602957 Ortho 7/7/7 (21) 00602965 Ortho 7/7/7 (28) Tab. Janss. Inc Janss. Inc 1 1 12.69 12.69 0.035 mg -0.5 mg -0.035 mg -1 mg -0.035 mg -0.5 mg 02187108 Synphasic 21 02187116 Synphasic 28 Pfizer Pfizer 02189054 02189062 00372846 00372838 02197502 02199297 Pfizer Pfizer Janss. Inc Janss. Inc Pfizer Pfizer Tab. Page 52.66 1 1 10.35 10.35 0.035 mg -1 mg PPB 300 Brevicon 1/35 (21) Brevicon 1/35 (28) Ortho 1/35 (21) Ortho 1/35 (28) Select 1/35 (21) Select 1/35 (28) 1 1 1 1 1 1 10.92 10.92 12.55 12.55 7.37 7.37 2013-04 CODE BRAND NAME MANUFACTURER SIZE ETHINYLESTRADIOL/ NORETHINDRONE ACETATE X Tab. COST OF PKG. SIZE UNIT PRICE 0.02 mg -1 mg 00315966 Minestrin 1/20 (21) 00343838 Minestrin 1/20 (28) Paladin Paladin 1 1 00297143 Loestrin 1.5/30 (21) 00353027 Loestrin 1.5/30 (28) Paladin Paladin 1 1 Tab. 12.73 12.73 0.03 mg -1.5 mg ETHINYLOESTRADIOL NORGESTIMATE X Tab. 02258560 Tri-Cyclen LO (21) 02258587 Tri-Cyclen LO (28) Tab. 12.73 12.73 0.025 mg/0.180 mg - 0.215 mg -0.250 mg Janss. Inc Janss. Inc 1 1 12.15 12.15 0.035 mg -0.180 mg -0.035 mg -0.215 mg -0.035 mg -0.25 mg 02028700 Tri-Cyclen (21) 02029421 Tri-Cyclen (28) Janss. Inc Janss. Inc Tab. 1 1 12.69 12.69 0.035 mg -0.25 mg 01968440 Cyclen (21) 01992872 Cyclen (28) Janss. Inc Janss. Inc ETHYNYLOESTRADIOL/ LEVONORGESTREL X Tab. 02236974 02236975 02387875 02387883 02298538 02298546 02388138 02388146 Alesse 21 Alesse 28 Alysena 21 Alysena 28 Aviane 21 Aviane 28 Esme 21 Esme 28 Tab. Pfizer Pfizer Apotex Apotex Apotex Apotex Mylan Mylan 1 1 12.69 12.69 0.020 mg -0.10 mg PPB 1 1 1 1 1 1 1 1 12.70 12.70 9.74 9.74 9.74 9.74 9.74 9.74 6.8600 6.8600 6.8600 6.8600 6.8600 6.8600 0.03 mg -0.05 mg -0.04 mg -0.075 mg -0.03 mg -0.125 mg 00707600 Triquilar 21 00707503 Triquilar 28 Bayer Bayer Tab. 1 1 14.52 14.52 11.7000 11.7000 0.03 mg -0.15 mg PPB 02042320 02042339 02295946 02295954 2013-04 Min-Ovral 21 Min-Ovral 28 Portia 21 Portia 28 Pfizer Pfizer Apotex Apotex 1 1 1 1 12.13 12.13 9.74 9.74 7.2800 7.2800 Page 301 CODE BRAND NAME MANUFACTURER SIZE Tab. (91) 02296659 Seasonale Paladin 1 Bayer 1 Cobalt Bayer Paladin 2 2 2 Janss. Inc 1 318.45 0.75 mg PPB NORETHINDRONE X Tab. (28) 00037605 Micronor 54.06 52 mg LEVONORGESTREL Tab. 02364905 Next Choice 02285576 Norlevo 02241674 Plan B UNIT PRICE 0.03 mg -0.15 mg LEVONORGESTREL X Intra-Uter. Dev. 02243005 Mirena COST OF PKG. SIZE 9.74 16.24 16.24 4.8700 8.1200 8.1200 0.35 mg 12.69 68:16.04 ESTROGENS CONJUGATED ESTROGENS (BIOLOGICS) X Vag. Cr. 02043440 Premarin Pfizer 0.625 mg/g 14 g CONJUGATED ESTROGENS (SYNTHETIC) X Tab. 00265470 C.E.S. 0.625 mg Valeant 100 1000 Shire 100 ESTRADIOL-17B X Tab. 02225190 Estrace 7.74 77.40 W W 0.5 mg Tab. 11.31 0.1131 1 mg 02148587 Estrace Shire 100 02148595 Estrace Shire 100 Tab. 21.87 0.2187 2 mg Vag. Tab (App.) 02325462 Vagifem 10 Page 8.79 302 38.59 0.3859 10 mcg N.Nordisk 18 42.07 2013-04 CODE BRAND NAME MANUFACTURER SIZE Vaginal ring COST OF PKG. SIZE UNIT PRICE 2 mg 02168898 Estring Paladin 1 ESTRONE X Vag. Cr. 62.77 1 mg/g 00727369 Estragyn vaginal cream Triton 45 g 15.55 68:16.12 ESTROGEN AGONIST-ANTAGONISTS CLOMIFENE X Tab. 50 mg PPB 02091879 Clomid 00893722 Serophene SanofiAven Serono 50 10 Apotex Cobalt Lilly Novopharm Phmscience 100 30 28 30 30 100 RALOXIFENE HYDROCHLORIDE X Tab. 02279215 02358840 02239028 02312298 02358921 Apo-Raloxifene Co Raloxifene Evista Novo-Raloxifène pms-Raloxifene 242.50 48.50 4.8500 4.8500 60 mg PPB 84.57 25.37 46.15 25.37 25.37 84.57 0.8457 0.8457 1.6482 0.8457 0.8457 0.8457 68:18 GONADOTROPINS DEGARELIX ACETATE X Kit 80 mg 02337029 Firmagon Ferring 1 02337037 Firmagon Ferring 1 Kit 255.00 120 mg NAFARELIN ACETATE X Nas. spray 02188783 Synarel 690.00 2 mg/mL Pfizer 8 ml Bayer 120 283.56 68:20.02 ALPHA-GLUCOSIDASE INHIBITORS ACARBOSE X Tab. 02190885 Glucobay 2013-04 50 mg 29.76 0.2480 Page 303 CODE BRAND NAME MANUFACTURER SIZE Tab. COST OF PKG. SIZE UNIT PRICE 100 mg 02190893 Glucobay Bayer 120 02167786 Apo-Metformin Apotex 02257726 Co Metformin Cobalt 02099233 Glucophage SanofiAven 02380196 Jamp-Metformin Jamp 02380722 Jamp-Metformin Blackberry 02378620 Mar-Metformin Jamp Marcan 02378841 Metformin Marcan 02242794 Metformin 02284782 Metformin MeliaPharm Mylan 02353377 Metformin Sanis 02385341 Metformin FC Sivem 02388766 Mint-Metformin Mint 02148765 Mylan-Metformin Mylan 02045710 Novo-Metformin Novopharm 02246964 phl-Metformin Pharmel 02223562 pms-Metformin Phmscience 02314908 Pro-Metformin Pro Doc 02269031 Ran-Metformin Ranbaxy 02242974 ratio-Metformin Ratiopharm 02239081 Riva-Metformin Riva 02246820 Sandoz Metformin FC Sandoz 02379767 Septa-Metformin Septa 100 500 100 500 100 500 100 500 500 100 500 100 500 100 100 500 100 500 100 500 100 500 100 500 100 500 100 500 100 500 100 500 100 500 100 500 100 500 100 500 100 500 41.15 0.3429 68:20.04 BIGUANIDES METFORMIN HYDROCHLORIDE X Tab. Page 304 500 mg PPB 5.87 29.33 5.87 29.33 23.68 106.53 5.87 29.33 29.33 5.87 29.33 5.87 29.33 5.87 5.87 29.33 5.87 29.33 5.87 29.33 5.87 29.33 5.87 29.33 5.87 29.33 5.87 29.33 5.87 29.33 5.87 29.33 5.87 29.33 5.87 29.33 5.87 29.33 5.87 29.33 5.87 29.33 0.0587 0.0587 0.0587 0.0587 0.2368 0.2131 0.0587 0.0587 0.0587 0.0587 0.0587 0.0587 0.0587 0.0587 W W 0.0587 0.0587 0.0587 0.0587 0.0587 0.0587 0.0587 0.0587 0.0587 0.0587 0.0587 0.0587 0.0587 0.0587 0.0587 0.0587 0.0587 0.0587 0.0587 0.0587 0.0587 0.0587 0.0587 0.0587 0.0587 0.0587 2013-04 CODE BRAND NAME MANUFACTURER COST OF PKG. SIZE SIZE Tab. UNIT PRICE 850 mg PPB 02229785 Apo-Metformin Apotex 02257734 Co Metformin Cobalt 02162849 Glucophage 02380218 Jamp-Metformin SanofiAven Jamp 02380730 Jamp-Metformin Blackberry Jamp 02378639 Mar-Metformin 02378868 Metformin Marcan Marcan 02246965 Metformin MeliaPharm 02284790 Metformin Mylan 02353385 Metformin Sanis 02385368 Metformin FC Sivem 02388774 Mint-Metformin Mint 02229656 Mylan-Metformin Mylan 02230475 Novo-Metformin Novopharm 02242589 pms-Metformin Phmscience 02314894 Pro-Metformin Pro Doc 02269058 Ran-Metformin 02242931 ratio-Metformin Ranbaxy Ratiopharm 02242783 Riva-Metformin Riva 02246821 Sandoz Metformin FC Sandoz 02379775 Septa-Metformin Septa 100 500 100 500 100 100 500 100 500 100 100 500 100 500 100 500 100 500 100 500 100 500 100 500 100 500 100 500 100 500 100 100 500 100 500 100 500 100 500 13.31 66.55 13.31 66.55 30.80 13.31 66.55 13.31 66.55 13.31 13.31 66.55 13.31 66.55 15.36 76.80 13.31 66.55 13.31 66.55 13.31 66.55 13.31 66.55 13.31 66.55 13.31 66.55 13.31 66.55 13.31 13.31 66.55 13.31 66.55 13.31 66.55 13.31 66.55 0.1331 0.1331 0.1331 0.1331 0.3080 0.1331 0.1331 0.1331 0.1331 0.1331 0.1331 0.1331 0.1331 0.1331 W W 0.1331 0.1331 0.1331 0.1331 0.1331 0.1331 0.1331 0.1331 0.1331 0.1331 0.1331 0.1331 0.1331 0.1331 0.1331 0.1331 0.1331 0.1331 0.1331 0.1331 0.1331 0.1331 0.1331 68:20.08 INSULINS ASPART INSULIN S.C. Inj. Sol. 02245397 NovoRapid 100 U/mL N.Nordisk 10 ml S.C. Inj. Sol. 02244353 NovoRapid 02377209 NovoRapid FlexTouch 2013-04 25.37 100 U/mL (3 mL) N.Nordisk N.Nordisk 5 5 50.79 50.79 Page 305 CODE BRAND NAME MANUFACTURER COST OF PKG. SIZE SIZE INSULIN CRISTAL ZINC (BIOSYNTHETIC OF HUMAN SEQUENCE) S.C. Inj. Sol. 00586714 Humulin R 02024233 Novolin ge Toronto 100 U/mL Lilly N.Nordisk 10 ml 10 ml Lilly N.Nordisk 5 5 S.C. Inj. Sol. 01959220 Humulin R 02024284 Novolin ge Toronto Penfill 35.50 36.75 100 U/mL SanofiAven 10 ml SanofiAven SanofiAven 5 5 S.C. Inj. Sol. 02279479 Apidra 02294346 Apidra Solostar 48.45 49.00 100 U/mL Lilly N.Nordisk 10 ml 10 ml Lilly Lilly N.Nordisk 5 5 5 S.C. Inj. Susp. 01959239 Humulin N 99100670 Humulin N KwikPen 02024268 Novolin ge NPH Penfill 24.50 100 U/mL (3 mL) INSULIN ISOPHANE (BIOSYNTHETIC OF HUMAN SEQUENCE) S.C. Inj. Susp. 00587737 Humulin N 02024225 Novolin ge NPH 17.12 18.39 100 U/mL (3 mL) INSULIN GLULISINE S.C. Inj. Sol. 02279460 Apidra UNIT PRICE 17.12 18.39 100 U/mL (3 mL) 35.50 34.89 36.75 INSULINS ZINC CRISTALLINE AND ISOPHANE BIOSYNTHETIC OF HUMAN SEQUENCE S.C. Inj. Susp. 30 U -70 U/mL 00795879 Humulin 30/70 02024217 Novolin ge 30/70 Lilly N.Nordisk S.C. Inj. Susp. 01959212 Humulin 30/70 02025248 Novolin ge 30/70 Penfill Page 306 5 5 35.50 36.75 40 U -60 U/mL (3 mL) N.Nordisk S.C. Inj. Susp. 02024322 Novolin ge 50/50 Penfill 17.12 18.39 30 U -70 U/mL (3 mL) Lilly N.Nordisk S.C. Inj. Susp. 02024314 Novolin ge 40/60 Penfill 10 ml 10 ml 5 36.75 50 U -50 U/mL(3 mL) N.Nordisk 5 36.75 2013-04 CODE BRAND NAME MANUFACTURER COST OF PKG. SIZE SIZE LISPRO INSULIN S.C. Inj. Sol. UNIT PRICE 100 U/mL 02229704 Humalog Lilly 10 ml Lilly Lilly 5 5 S.C. Inj. Sol. 26.17 100 U/mL (3 mL) 02229705 Humalog 99100630 Humalog KwikPen 51.44 51.44 68:20.20 SULFONYLUREAS CHLORPROPAMIDE X Tab. 100 mg 00399302 Apo-Chlorpropamide Apotex 100 00312711 Apo-Chlorpropamide Apotex 100 Tab. 7.45 0.0745 250 mg GLYBURIDE X Tab. 0.0450 2.5 mg PPB 01913654 Apo-Glyburide Apotex 02224550 Diabeta 02350459 Glyburide SanofiAven Sanis 01959352 Glyburide-2.5 Pro Doc 00808733 Mylan-Glybe 02345854 NTP-Glyburide Mylan NT Pharma 01900927 02236543 02248008 01913670 Ratiopharm Pharmel Sandoz Teva Can 2013-04 18.15 ratio-Glyburide Riva-Glyburide Sandoz Glyburide Teva-Glyburide 100 500 30 100 500 100 500 500 100 500 300 500 500 100 500 3.21 16.03 3.51 3.21 16.03 3.21 16.03 16.03 3.21 16.03 9.62 16.03 16.03 3.21 16.03 0.0321 0.0321 0.1170 0.0321 0.0321 0.0321 0.0321 0.0321 0.0321 0.0321 0.0321 0.0321 0.0321 0.0321 0.0321 Page 307 CODE BRAND NAME MANUFACTURER SIZE Tab. COST OF PKG. SIZE UNIT PRICE 5 mg PPB 01913662 Apo-Glyburide Apotex 02224569 Diabeta SanofiAven 02350467 Glyburide Sanis 00808741 Mylan-Glybe 02345862 NTP-Glyburide 02236734 pms-Glyburide Mylan NT Pharma Phmscience 02316544 Pro-Glyburide Pro Doc 01900935 ratio-Glyburide Ratiopharm 02236548 Riva-Glyburide 02248009 Sandoz Glyburide Pharmel Sandoz 01913689 Teva-Glyburide Teva Can 100 500 30 300 100 500 500 500 30 500 30 500 30 300 500 100 500 100 500 TOLBUTAMIDE X Tab. 00312762 Tolbutamide 5.73 28.70 6.25 62.50 5.73 28.70 28.70 28.65 1.72 28.70 1.72 28.70 1.72 17.22 28.70 5.73 28.70 5.73 28.70 0.0573 0.0574 0.2083 0.2083 0.0573 0.0574 0.0574 0.0573 0.0573 0.0574 0.0573 0.0574 0.0573 0.0574 0.0574 0.0573 0.0574 0.0573 0.0574 500 mg AA Pharma 100 1000 10.89 108.90 0.0855 0.0712 68:22.12 GLYCOGENOLYTIC AGENTS GLUCAGON X Inj. Pd. 02333619 GlucaGen 02333627 GlucaGen HypoKit 02243297 Glucagon 1 mg PPB Paladin Paladin Lilly 1 1 1 77.10 77.10 85.67 68:24 PARATHYROID CALCITONIN SALMON (SYNTHETIC) X Inj. Sol. 02007134 Caltine 100 UI Ferring 1 ml SanofiAven 2 ml Inj. Sol. 01926691 Calcimar Solution 200 U/mL Nas. spray 02247585 Apo-Calcitonin 02240775 Miacalcin NS 02261766 Sandoz Calcitonin NS Page 308 7.82 46.04 200 UI/dose PPB Apotex Novartis Sandoz 28 dose(s) 28 dose(s) 28 dose(s) 39.20 54.09 39.20 1.0432 1.0432 2013-04 CODE BRAND NAME MANUFACTURER COST OF PKG. SIZE SIZE UNIT PRICE 68:28 PITUITARY COSYNTROPIN ZINC HYDROXIDE I.M. Inj. Susp. 00253952 Synacthen Depot 1 mg/mL Novartis 1 ml Ferring 1 ml 23.49 DESMOPRESSIN ACETATE X Inj. Sol. 00873993 DDAVP 4 mcg/mL 10.06 Inj. Sol. 15 mcg/mL 02024179 Octostim Ferring 1 ml Ferring 2.5 ml 34.56 Nas. Sol. 0.1 mg/mL 00402516 DDAVP Nas. spray 10 mcg/dose PPB 00836362 DDAVP Ferring 02242465 Desmopressin AA Pharma 25 dose(s) 50 dose(s) 25 dose(s) 50 dose(s) Nas. spray Ferring Tab. or Tab. Oral Disint. Apo-Desmopressin DDAVP DDAVP Melt Desmopressin Novo-Desmopressin pms-Desmopressin 1.1328 1.1328 25 dose(s) 386.00 0.1 mg or 0.06 mg PPB Apotex Ferring Ferring MeliaPharm Novopharm Phmscience Tab. or Tab. Oral Disint. 100 30 30 100 30 100 33.05 39.65 29.73 33.05 9.92 33.05 0.3305 1.3217 0.9910 0.3305 0.3305 0.3305 0.2 mg ou 0.12 mg PPB 02284049 Apo-Desmopressin 00824143 DDAVP Apotex Ferring 02285002 DDAVP Melt 02346796 Desmopressin 02287749 Novo-Desmopressin Ferring MeliaPharm Novopharm 02304376 pms-Desmopressin Phmscience 2013-04 47.20 94.40 35.40 70.80 150 mcg/dose 02237860 Octostim 02284030 00824305 02284995 02346788 02287730 02304368 47.20 100 30 100 30 100 30 100 100 66.09 79.30 264.32 59.47 66.09 19.83 66.09 66.09 0.6609 2.6433 2.6432 1.9823 0.6609 0.6609 0.6609 0.6609 Page 309 CODE BRAND NAME MANUFACTURER SIZE COST OF PKG. SIZE UNIT PRICE 68:32 PROGESTINS DIENOGEST X Tab. 2 mg 02374900 Visanne Bayer 28 55.00 Pfizer 5 ml MEDROXYPROGESTERONE ACETATE X I.M. Inj. Susp. 00030848 Depo-Provera 50 mg/mL I.M. Inj. Susp. 24.65 150 mg/mL PPB 00585092 Depo-Provera 02322250 Medroxyprogesterone acetate injection Pfizer Sandoz 1 ml 1 ml 02244726 Apo-Medroxy Apotex 02253550 Medroxy-2.5 Pro Doc 02221284 Novo-Medrone 00708917 Provera Novopharm Pfizer 100 500 100 500 100 100 500 Tab. 26.98 18.00 16.1900 2.5 mg PPB Tab. 4.16 20.79 4.16 20.79 4.16 13.28 66.37 0.0416 0.0416 0.0416 0.0416 0.0416 0.1328 0.1327 5 mg PPB 02244727 02253577 02221292 00030937 Apo-Medroxy Medroxy-5 Novo-Medrone Provera Apotex Pro Doc Novopharm Pfizer 100 100 100 100 02277298 Apo-Medroxy 02221306 Novo-Medrone 00729973 Provera Apotex Novopharm Pfizer 100 100 100 02267640 Apo-Medroxy Apotex 100 Cytex 10 ml Tab. 8.24 8.24 8.24 26.25 0.0824 0.0824 0.0824 0.2625 10 mg PPB Tab. 16.71 16.71 53.00 0.1671 0.1671 0.5300 100 mg PROGESTERONE X Oily Inj. Sol. 01977652 Progesterone Page 1.9643 310 120.57 0.9519 50 mg/mL 63.00 2013-04 CODE BRAND NAME MANUFACTURER SIZE COST OF PKG. SIZE UNIT PRICE 68:36.04 THYROID AGENTS LEVOTHYROXINE (SODIUM) X Tab. 0.025 mg 02264323 Euthyrox 02172062 Synthroid Serono Abbott 1000 90 1000 02213192 Eltroxin 02264331 Euthyrox 02172070 Synthroid Triton Serono Abbott 500 1000 90 1000 02264358 Euthyrox 02172089 Synthroid Serono Abbott 1000 90 1000 Tab. 56.44 6.97 71.09 0.0564 0.0774 0.0711 0.05 mg Tab. 13.70 24.92 4.21 42.53 0.0274 0.0249 0.0468 0.0425 0.075 mg Tab. 61.00 7.52 76.75 0.0610 0.0836 0.0768 0.088 mg 02264366 Euthyrox 02172097 Synthroid Serono Abbott 1000 90 1000 Tab. 61.00 7.52 76.75 0.0610 0.0836 0.0768 0.1 mg 02213206 Eltroxin 02264374 Euthyrox 02172100 Synthroid Triton Serono Abbott 500 1000 90 1000 02264390 Euthyrox 02171228 Synthroid Serono Abbott 1000 90 1000 02264404 Euthyrox 02172119 Synthroid Serono Abbott 1000 90 1000 Tab. 16.82 30.60 5.58 56.61 0.0336 0.0306 0.0620 0.0566 0.112 mg Tab. 64.41 7.96 81.04 0.0644 0.0884 0.0810 0.125 mg Tab. 65.44 8.09 82.41 0.0654 0.0899 0.0824 0.137 mg 02264412 Euthyrox 02233852 Synthroid 2013-04 Serono Abbott 100 90 1000 11.48 14.14 157.07 0.1148 0.1571 0.1571 Page 311 CODE BRAND NAME MANUFACTURER SIZE Tab. COST OF PKG. SIZE UNIT PRICE 0.15 mg 02213214 Eltroxin 02264420 Euthyrox 02172127 Synthroid Triton Serono Abbott 500 1000 90 1000 02264439 Euthyrox 02172135 Synthroid Serono Abbott 1000 90 1000 02213222 Eltroxin 02264447 Euthyrox 02172143 Synthroid Triton Serono Abbott 500 100 90 1000 Tab. 18.66 33.94 5.99 60.82 0.0373 0.0339 0.0666 0.0608 0.175 mg Tab. 69.90 8.64 88.06 0.0699 0.0960 0.0881 0.2 mg Tab. 19.74 3.59 6.41 64.81 0.0395 0.0359 0.0712 0.0648 0.3 mg 02213230 Eltroxin 02264455 Euthyrox 02172151 Synthroid Triton Serono Abbott 500 100 90 Pfizer 100 LIOTHYRONINE (SODIUM) X Tab. 01919458 Cytomel 29.61 7.85 8.82 0.0592 0.0785 0.0980 5 mcg Tab. 98.18 0.9818 25 mcg 01919466 Cytomel Pfizer 100 106.73 1.0673 68:36.08 ANTITHYROID AGENTS METHIMAZOL X Tab. 00015741 Tapazole 5 mg Paladin 100 PROPYLTHIOURACIL X Tab. 0.2473 50 mg 00010200 Propyl-Thyracil Paladin 100 00010219 Propyl-Thyracil Paladin 100 Tab. Page 24.73 21.40 0.2140 100 mg 312 33.50 0.3350 2013-04 84:00 SKIN AND MUCOUS MEMBRANE AGENTS 84:04 anti‑infectieux 84:04.04 84:04.08 84:04.12 84:04.92 84:06 84:28 84:32 84:50 84:50.06 84:92 antibiotics antifungals scabicides and pediculicides local anti‑infectives, miscellaneous anti‑inflammatory agents keratolytic agents keratoplastic agents demelanisant agent and melanisant pigmenting agents skin and mucous membrane agents, miscellaneous CODE BRAND NAME MANUFACTURER SIZE COST OF PKG. SIZE UNIT PRICE 84:04.04 ANTIBIOTICS BACITRACIN Inj./Top. Pd. 00030708 Bacitracine 50 000 U Pfizer 50 ml Pendopharm Jamp 30 g 450 g Top. Oint. 00584908 Bacitin 02351714 Bacitracin 500 U/g PPB CLINDAMYCIN PHOSPHATE X Top. Sol. Valeo Pfizer 02266938 Taro-Clindamycin Taro 60 ml 30 ml 60 ml 30 ml 60 ml FUSIDIC (ACID) X Top. Cr. Leo 15 g 30 g Ratiopharm 15 g Ratiopharm 15 g 120 ml 2013-04 0.5927 0.5927 3.66 0.2440 3.66 0.2440 61.52 0.75 % Galderma 60 g Valeant GSK 45 g 30 g Top. Cr. 02156091 Noritate 02242919 Rosasol 8.89 17.78 0.75 % Galderma Top. Cr. 02226839 Metrocreme 0.1787 0.1 % METRONIDAZOLE X Lot. 02248206 Metrolotion 9.15 8.93 17.86 6.78 9.15 0.1 % Top. Oint. 00805025 ratio-Gentamicin 0.0993 0.0994 2% GENTAMICIN SULFATE X Top. Cr. 00805386 ratio-Gentamicin 2.98 44.72 1 % PPB 02243659 Clinda-T 00582301 Dalacin T 00586668 Fucidin 9.10 30.76 0.5127 1 % PPB 24.03 15.23 0.5340 0.5077 Page 315 CODE BRAND NAME MANUFACTURER SIZE Top. Jel. 02297809 Metrogel 60 g 01916947 Bactroban GSK CONS 02279983 Taro-Mupirocin Taro 15 g 30 g 15 g 30 g MUPIROCIN Top. Oint. 0.6000 7.52 15.06 5.18 10.36 0.5013 0.5020 0.3013 0.3013 2% GSK CONS POLYMYXIN B SULFATE/ BACITRACIN (ZINC) Top. Oint. Odan 15 g 7.52 0.5013 10 000 U -500 U/g 15 g 30 g SODIUM FUSIDATE X Top. Oint. 00586676 Fucidin 36.00 2 % PPB MUPIROCIN CALCIUM Top. Cr. 00621366 Bioderm UNIT PRICE 1% Galderma 02239757 Bactroban COST OF PKG. SIZE 5.04 6.37 0.3360 0.2123 2% Leo 15 g 30 g Valeant 60 ml 8.89 17.78 0.5927 0.5927 84:04.08 ANTIFUNGALS CICLOPIROX OLAMINE X Lot. 02221810 Loprox 1% Top. Cr. 02221802 Loprox 1% Valeant 45 g Taro 20 g 30 g 50 g 500 g CLOTRIMAZOLE Top. Cr. 00812382 Clotrimaderm Page 316 28.38 21.29 0.4731 10 mg/g 4.20 6.30 9.00 44.20 0.2100 0.2100 0.1800 0.0884 2013-04 CODE BRAND NAME MANUFACTURER SIZE Vag. Cr. (App.) 00812366 Clotrimaderm 00874051 Neo-Zol Taro Néolab 50 g 50 g Taro 25 g Taro 30 g Taro 45 g Taro Ratiopharm 454 g 15 g 30 g 450 g Ratiopharm 30 g Taro 120 g Novartis 2013-04 2.71 0.0903 5.90 30 g 14.83 0.4943 1% Novartis TERCONAZOL X Top.Cr./Ov.(App.) 02130874 Terazol 3 Duo Pak 0.0630 0.0633 0.0630 0.0630 1% Top. vap. 02238703 Lamisil 28.60 0.95 1.89 28.35 25 000 U/g TERBINAFIN HYDROCHLORIDE X Top. Cr. 02031094 Lamisil 6.80 100 000 U/g NYSTATIN X Vag. Cr. (App.) 00716901 Nyaderm 0.3167 100 000 U/g PPB Top. Oint. 02194228 ratio-Nystatin 9.50 2% NYSTATIN Top. Cr. 00716871 Nyaderm 02194236 ratio-Nystatin 8.75 2% MICONAZOLE NITRATE Vag. Cr. (App.) 02231106 Micozole 8.75 8.75 2% KETOCONAZOLE X Top. Cr. 02245662 Ketoderm UNIT PRICE 1 % PPB Vag. Cr. (App.) 00812374 Clotrimaderm COST OF PKG. SIZE 30 ml 14.65 0.8 % -80 mg (9g -3) Janss. Inc 1 19.34 Page 317 CODE BRAND NAME MANUFACTURER SIZE Vag. Cr. (App.) 02247651 Taro-Terconazole 00894729 Terazol 7 COST OF PKG. SIZE UNIT PRICE 0.4 % PPB Taro Janss. Inc 45 g 45 g Pediapharm 50 ml 12.27 19.34 0.2580 84:04.12 SCABICIDES AND PEDICULICIDES DIMETICONE Sol. 02373785 Nyda 50% P/P GAMMA-BENZENE HEXACHLORIDE Lot. 02245872 Hexit 1% Odan 50 ml 500 ml Shamp. 00430617 Hexit 50 ml MedFutures 120 ml 240 ml Medtech 50 ml 200 ml 3.65 11.50 22.42 1% Lot. 4.48 15.87 5% 02231348 Kwellada-P Lotion Medtech 100 ml Top. Cr. 02219905 Nix 02229642 Pronto Shampooing 02125447 R & C Shampoo with conditioner 318 25.06 5% GSK CONS PYRETHRINS/ PIPERONYL BUTOXYDE Shamp. Page 0.0455 50 % PERMETHRIN Cr. Rinse 02231480 Kwellada-P Creme rinse 3.70 22.75 1% Odan ISOPROPYL MYRISTATE Top. Sol. 02279592 Resultz 22.42 30 g 14.04 0.4680 0.33 % -3 % à 4 % PPB Del Medtech 59 ml 50 ml 200 ml 4.45 4.15 14.71 0.0736 2013-04 CODE BRAND NAME MANUFACTURER SIZE COST OF PKG. SIZE UNIT PRICE 84:04.92 LOCAL ANTI-INFECTIVES, MISCELLANEOUS ALUMINUM ACETATE Pd. 00579947 Buro-Sol 2.36 g/sac. GSK 10 SULFADIAZINE (SILVER) X Top. Cr. 00323098 Flamazine 7.17 0.7170 1% S. & N. 20 g 50 g 500 g 4.86 10.96 66.01 0.2430 0.2192 0.1320 84:06 ANTI-INFLAMMATORY AGENTS AMCINONIDE X Lot. 0.1 % PPB 02192276 Cyclocort GSK 02247097 ratio-Amcinonide Ratiopharm 20 ml 60 ml 20 ml 60 ml Top. Cr. GSK 02247098 ratio-Amcinonide Ratiopharm 02246714 Taro-Amcinonide Taro 30 g 60 g 15 g 30 g 60 g 15 g 30 g 60 g Top. Oint. 13.20 24.42 2.93 5.87 11.73 2.93 5.87 11.73 0.4400 0.4070 0.1953 0.1957 0.1955 0.1953 0.1957 0.1955 0.1 % PPB 02192268 Cyclocort GSK 02247096 ratio-Amcinonide Ratiopharm 15 g 60 g 15 g 30 g 60 g BECLOMETHASONE DIPROPIONATE X Top. Cr. 2013-04 0.2028 0.1 % PPB 02192284 Cyclocort 02089602 Propaderm 8.95 20.28 4.54 13.63 7.99 24.42 4.73 9.45 16.42 0.5327 0.4070 0.2853 0.2847 0.2443 0.025 % Paladin 45 g 19.13 0.4251 Page 319 CODE BRAND NAME MANUFACTURER SIZE BETAMETHASONE DIPROPIONATE X Lot. 00417246 Diprosone Merck 00809187 ratio-Topisone Ratiopharm 30 ml 75 ml 30 ml 75 ml 5.94 14.85 5.94 14.85 0.05 % PPB 00323071 Diprosone Merck 00804991 ratio-Topisone Ratiopharm 01925350 Taro-Sone Taro 15 g 50 g 15 g 50 g 50 g Top. Oint. 3.07 10.24 3.07 10.24 10.24 0.2047 0.2048 0.2047 0.2048 0.2048 0.05 % PPB 00344923 Diprosone Merck 00805009 ratio-Topisone Ratiopharm 15 g 50 g 15 g 50 g 450 g BETAMETHASONE DIPROPIONATE/ GLYCOL BASE X Lot. 00862975 Diprolene Merck 01927914 ratio-Topilene Ratiopharm 3.23 10.76 3.23 10.76 96.89 0.2153 0.2152 0.2153 0.2152 0.2153 0.05 % PPB 30 ml 60 ml 30 ml 60 ml Top. Cr. 14.05 16.18 14.05 16.18 0.05 % PPB 00688622 Diprolene Merck 00849650 ratio-Topilene Ratiopharm 15 g 50 g 15 g 50 g Top. Oint. 7.78 25.93 7.78 25.93 0.5187 0.5186 0.5187 0.5186 0.05 % PPB 00629367 Diprolene Merck 00849669 ratio-Topilene Ratiopharm 320 UNIT PRICE 0.05 % PPB Top. Cr. Page COST OF PKG. SIZE 15 g 50 g 15 g 50 g 7.78 25.93 7.78 25.93 0.5187 0.5186 0.5187 0.5186 2013-04 CODE BRAND NAME MANUFACTURER BETAMETHASONE DIPROPIONATE/ SALICYLIC ACID X Lot. 00578428 Diprosalic Lotion Merck 02245688 ratio-Topisalic Ratiopharm SIZE 30 ml 60 ml 30 ml 60 ml 10.57 21.14 10.57 21.14 0.05 % -3 % Merck 15 g 50 g BETAMETHASONE DISODIUM PHOSPHATE X Rect. Sol. 02060884 Betnesol UNIT PRICE 0.05 % -2 % PPB Top. Oint. 00578436 Diprosalic Pommade COST OF PKG. SIZE Paladin 11.74 34.96 0.7827 0.6992 5 mg/ 100 mL 100 ml BETAMETHASONE VALERATE X Lot. 8.79 0.05 % 00653209 ratio-Ectosone Ratiopharm 60 ml 00750050 ratio-Ectosone Ratiopharm 60 ml Lot. 11.40 0.1 % Scalp Lot. 0.1 % PPB 00716634 Betaderm 00653217 ratio-Ectosone Taro Ratiopharm 01940112 Rivasone Riva 00027944 Valisone Valeo 75 ml 30 ml 75 ml 30 ml 75 ml 75 ml Taro Valeo 454 g 450 g Taro Valeo 454 g 450 g Top. Cr. 00716618 Betaderm 02357860 Celestoderm V/2 2013-04 27.50 26.80 0.0606 0.0596 0.1 % PPB Top. Oint. 00716642 Betaderm 02357879 Celestoderm V/2 6.40 2.56 6.40 2.56 6.40 6.40 0.05 % PPB Top. Cr. 00716626 Betaderm 02357844 Celestoderm V 15.00 41.00 40.00 0.0903 0.0889 0.05 % PPB Taro Valeo 454 g 450 g 27.50 26.80 0.0606 0.0596 Page 321 CODE BRAND NAME MANUFACTURER SIZE Top. Oint. Taro Valeo 454 g 450 g AZC 115 ml BUDESONIDE X Rect. Sol. 02052431 Entocort Dermovate Capillaire Mylan-Clobetasol pms-Clobetasol ratio-Clobetasol 02245522 Taro-Clobetasol 0.0903 0.0889 8.24 0.05 % PPB Taro Mylan Phmscience Ratiopharm Taro 60 ml 60 ml 60 ml 20 ml 60 ml 60 ml Top. Cr. 34.11 11.94 11.94 3.98 11.94 11.94 0.05 % PPB 02213265 Dermovate Taro 02024187 Mylan-Clobetasol Mylan 02093162 Novo-Clobetasol 02232191 pms-Clobetasol Novopharm Phmscience 02309521 pms-Clobetasol 01910272 ratio-Clobetasol Phmscience Ratiopharm 02245523 Taro-Clobetasol Taro 15 g 50 g 15 g 50 g 50 g 15 g 50 g 50 g 15 g 50 g 450 g 15 g 50 g 454 g Top. Oint. 10.29 32.56 3.42 11.40 11.40 3.42 11.40 11.40 3.42 11.40 102.57 3.42 11.40 103.48 0.6860 0.6512 0.2280 0.2280 0.2280 0.2280 0.2280 0.2280 0.2280 0.2280 0.2279 0.2280 0.2280 0.2279 0.05 % PPB 02213273 Dermovate Taro 02026767 Mylan-Clobetasol Mylan 02126192 02232193 02309548 01910280 Novopharm Phmscience Phmscience Ratiopharm Novo-Clobetasol pms-Clobetasol pms-Clobetasol ratio-Clobetasol 02245524 Taro-Clobetasol 322 41.00 40.00 0.02 mg/mL CLOBETASOL PROPIONATE X Scalp Lot. Page UNIT PRICE 0.1 % PPB 00716650 Betaderm 02357852 Celestoderm V 02213281 02216213 02232195 01910299 COST OF PKG. SIZE Taro 15 g 50 g 15 g 50 g 50 g 50 g 50 g 15 g 50 g 450 g 15 g 50 g 10.29 32.56 3.42 11.40 11.40 11.40 11.40 3.42 11.40 102.57 3.42 11.40 0.6860 0.6512 0.2280 0.2280 0.2280 0.2280 0.2280 0.2280 0.2280 0.2279 0.2280 0.2280 2013-04 CODE BRAND NAME MANUFACTURER SIZE CLOBETASONE BUTYRATE Top. Cr. 02214415 Spectro Eczemacare medicated cream GSK CONS 30 g Phmscience 15 g 60 g 454 g Phmscience 60 g Valeant 20 g 60 g Valeant 20 g 60 g Valeant 60 g Valeant 60 g GSK 30 g 60 g 2013-04 0.4540 0.3828 13.08 34.59 0.6540 0.5765 26.82 0.4470 34.59 0.5765 11.34 22.69 0.3780 0.3782 0.1 % GSK 30 g GSK 30 g Top. Oint. 00587834 Nerisone 9.08 22.97 0.1 % Top. Cr. 00587826 Nerisone 0.2610 0.25 % DIFLUCORTOLONE VALERATE X Oil. Top. Cr. 00587818 Nerisone 15.66 0.05 % Top. Oint. 02221934 Topicort 0.2613 0.2610 0.2610 0.25 % Top. Jel. 02221926 Topicort 3.92 15.66 118.49 0.05 % Emol. Top. Cr. 02221896 Topicort 0.3817 0.05 % DESOXIMETASONE X Emol. Top. Cr. 02221918 Topicort Doux 11.45 0.05 % Top. Oint. 02229323 pms-Desonide UNIT PRICE 0.05 % DESONIDE X Top. Cr. 02229315 pms-Desonide COST OF PKG. SIZE 11.34 0.3780 0.1 % 11.34 W Page 323 CODE BRAND NAME MANUFACTURER SIZE DIFLUCORTOLONE VALERATE SALICYLIQUE ACID X Oil. Top. Cr. 02028719 Nerisalic GSK 30 g Valeo 60 g Valeo 60 ml 118 ml 02163152 Lidemol Cream Emollient Valeo 00598933 Tiamol Taro 02240269 Topactin Emolliente Triton 30 g 100 g 25 g 100 g 60 g 225 g FLUOCINONIDE X Emol. Top. Cr. 02161923 Lidex Cream Valeo 00716863 Lyderm Taro 00816132 Topactin Triton 60 g 400 g 15 g 60 g 400 g 30 g 450 g 29.15 5.94 19.80 4.95 19.80 11.88 44.55 0.1980 0.1980 0.1980 0.1980 0.1980 0.1980 14.27 95.12 3.57 14.27 95.12 7.33 110.00 0.2378 0.2378 0.2380 0.2378 0.2378 0.2443 0.2444 0.05 % PPB Valeo Taro 60 g 15 g 60 g Top. Oint. 324 24.55 0.05 % PPB Top. Jel. Page 0.4308 0.05 % PPB Top. Cr. 02161966 Lidex Ointment 02236996 Lyderm 25.85 0.01 % Hill 02161974 Lidex Gel 02236997 Lyderm W 0.01 % Topical oil 00873292 Derma-Smoothe/FS 15.91 0.025 % Top. Sol. 02162504 Synalar Solution UNIT PRICE 0.1 % -3 % FLUOCINOLONE ACETONIDE X Top. Oint. 02162512 Synalar Regulier COST OF PKG. SIZE 18.46 4.61 18.46 0.3077 0.3073 0.3077 0.05 % PPB Valeo Taro 60 g 60 g 18.21 18.21 0.3035 0.3035 2013-04 CODE BRAND NAME MANUFACTURER SIZE COST OF PKG. SIZE UNIT PRICE HYDROCORTISONE X Lot. 1% 00192600 Emo-Cort 00578541 Sarna HC GSK GSK 60 ml 150 ml 00595802 Emo-Cort 00856711 Sarna HC GSK GSK 60 ml 75 ml Lot. 8.92 13.47 2.5 % Rect. Sol. 02112736 Cortenema 00230316 Hycort 100 mg PPB Aptalis Valeant 60 ml 60 ml GSK GSK 45 g 30 g Top. Cr. 00192597 Emo-Cort 00804533 Prevex HC 7.42 7.84 0.1649 0.2613 2.5 % GSK 45 g 225 g Top. Oint. 00716693 Cortoderm 6.45 5.14 1% Top. Cr. 00595799 Emo-Cort Cream 2.5% 12.07 13.02 9.94 43.86 0.2209 0.1949 1% Taro 454 g 17.70 0.0390 HYDROCORTISONE ACETATE X Rect. Oint. (App.) 0.5 % to 0.75 % PPB 02128446 Anodan-HC Odan 02209764 Egozinc-HC Phmscience 02387239 JampZinc - HC Jamp 00607789 ratio-Hemcort HC Ratiopharm 02179547 Riva-sol HC Riva 02247691 Sandoz Anuzinc HC Sandoz 15 g 30 g 15 g 30 g 15 g 30 g 15 g 30 g 15 g 30 g 15 g 30 g Rectal foam (app.) 00579335 Cortifoam 2013-04 6.24 12.39 6.24 12.39 6.24 12.39 6.24 12.39 6.24 12.39 6.24 12.39 0.4160 0.4130 0.4160 0.4130 0.4160 0.4130 0.4160 0.4130 0.4160 0.4130 0.4160 0.4130 10 % Paladin 15 g 78.78 Page 325 CODE BRAND NAME MANUFACTURER COST OF PKG. SIZE SIZE Supp. 10 mg PPB 02236399 Anodan-HC Odan 02210517 00607797 02240112 02242798 Phmscience Ratiopharm Riva Sandoz Egozinc-HC ratio-Hemcort HC Riva-sol HC Sandoz Anuzinc HC 12 24 12 12 12 12 24 7.29 14.58 7.29 7.29 7.29 7.29 14.58 Top. Cr. 00716839 Hyderm 00749834 Topiderm HC 2 % Taro 15 g 500 g Triton 30 g 225 g 150 ml 150 ml 00681989 Dermaflex HC Triton 00503134 Uremol-HC GSK 120 g 225 g 50 g 225 g Top. Cr. 0.2700 0.2338 12.75 14.22 0.0556 14.77 27.70 8.24 36.60 0.0989 0.0976 0.1648 0.1627 0.2 % Taro 15 g 60 g 500 g Top. Oint. 2.50 7.27 60.58 0.1667 0.1212 0.1212 0.2 % Taro 15 g 60 g 00871095 Elocom Merck 02266385 Taro-Mometasone Lotion Taro 30 ml 75 ml 30 ml 75 ml MOMETASON FUROATE X Lot. 326 8.10 52.60 1 % -10 % PPB HYDROCORTISONE VALERATE X Top. Cr. 02242985 Hydroval 0.2133 0.0364 1 % -10 % PPB Triton GSK 02242984 Hydroval 3.20 18.20 2% HYDROCORTISONE ACETATE/ UREA X Lot. 00681997 Dermaflex HC 00560022 Uremol-HC 0.6075 0.6075 0.6075 0.6075 0.6075 0.6075 0.6075 1% Top. Cr. Page UNIT PRICE 2.50 7.27 0.1667 0.1212 0.1 % PPB 13.60 32.09 9.37 23.43 0.2720 0.2568 2013-04 CODE BRAND NAME MANUFACTURER SIZE Top. Cr. Merck 02367157 Taro-Mometasone Taro 15 g 50 g 15 g 50 g Top. Oint. Merck 02248130 ratio-Mometasone Ratiopharm 02264749 Taro-Mometasone Taro 15 g 50 g 15 g 50 g 15 g 50 g TRIAMCINOLONE ACETONIDE X Oral Top. Oint. 0.6300 0.5960 0.3780 0.3576 9.12 28.77 3.38 11.26 3.38 11.26 0.6080 0.5754 0.2253 0.2252 0.2253 0.2252 0.1 % Taro 7.5 g Top. Cr. 6.83 0.1 % PPB 02194058 Aristocort R Valeo 00716960 Triaderm Taro 30 g 500 g 500 g Top. Cr. 3.90 26.65 25.32 0.1300 0.0533 0.0320 0.5 % Valeo 15 g 50 g Valeo 30 g Top. Oint. 02194031 Aristocort R 9.45 29.80 7.89 26.31 0.1 % PPB 00851736 Elocom 02194066 Aristocort C UNIT PRICE 0.1 % PPB 00851744 Elocom 01964054 Oracort COST OF PKG. SIZE 17.28 57.60 1.1520 1.1520 0.1 % 3.90 0.1300 84:28 KERATOLYTIC AGENTS BENZOYLE PEROXIDE, ALCOHOL BASE X Top. Jel. 00263699 Panoxyl 10 10 % GSK 60 g GSK 60 g Top. Jel. 00373036 Panoxyl 20 2013-04 W 20 % LACTIC (ACID)/ SALICYLIC (ACID)/ GLACIAL ACETIC (ACID) Liq. 00609501 Viron Lotion 8.58 Odan 11.18 W 10.2 % -10 % -9.8 % 15 ml 6.99 0.3673 Page 327 CODE BRAND NAME MANUFACTURER SIZE SALICYLIC ACID SODIUM THIOSULFATE Top. Jel. 00326577 Adasept Gel COST OF PKG. SIZE UNIT PRICE 2 % -8 % Odan 50 ml 80024301 Dermaflex 80023775 JamUrea 20 00398179 Uremol Triton Jamp GSK 00396125 Urisec Odan 120 g 225 g 100 g 225 g 120 g 225 g 454 g 6.99 0.1082 UREA Top. Cr. 20 % and 22 % PPB 5.75 10.78 6.24 11.77 5.75 11.69 21.75 0.0479 0.0479 0.0624 0.0523 0.0479 0.0488 0.0479 84:32 KERATOPLASTIC AGENTS TAR (MINERAL) Top. Emuls. 00579955 Doak Oil 2% GSK 250 ml GSK 250 ml Top. Emuls. 00579971 Doak-Oil Forte 10 % Top. Jel. 00344508 Targel 9.66 10 % Odan 100 g Odan 100 g TAR (MINERAL)/ SALICYLIC ACID Top. Jel. 00510335 Targel S.A. 7.26 13.90 0.1282 10 % -3 % 15.35 0.1419 84:50.06 PIGMENTING AGENTS METHOXSALEN X Caps. 10 mg 00252654 Oxsoralen Ultra Valeant 100 01907476 Oxsoralen Valeant 30 ml Lot. Page 43.00 0.4300 1% 328 44.07 2013-04 CODE BRAND NAME MANUFACTURER SIZE COST OF PKG. SIZE UNIT PRICE 84:92 SKIN AND MUCOUS MEMBRANE AGENTS, MISCELLANEOUS ACITRETINE X Caps. 10 mg 02070847 Soriatane Tribute 30 02070863 Soriatane Tribute 30 Caps. 54.00 1.6553 25 mg CALCIPOTRIOL X Scalp Lot. 02194341 Dovonex Leo 60 ml Leo 60 g Leo 30 g Galderma 60 g 0.7225 22.01 0.7337 3 mcg/g FLUOROURACIL X Top. Cr. 00330582 Efudex 43.35 50 mcg/g CALCITRIOL X Top. Oint. 02338572 Silkis 45.55 50 mcg/g Top. Oint. 01976133 Dovonex 2.9090 50 mcg/mL Top. Cr. 02150956 Dovonex 94.90 40.80 0.6800 5% Valeant 40 g 32.00 0.8000 Convatec 30 g 6.64 0.2213 HYDROCOLLOIDAL GEL Top. Jel. 00921084 DuoDERM Gel 2013-04 Page 329 CODE BRAND NAME MANUFACTURER SIZE COST OF PKG. SIZE 15 g 25 g 15 g 25 g 8g 15 g 15 g 2.95 3.93 2.58 4.31 2.25 3.15 2.74 0.1967 0.1572 0.1720 0.1724 0.2813 0.2100 0.1827 28 g 84 g 3.70 8.98 0.1321 0.1069 UNIT PRICE HYDROGEL Top. Jel. 99100795 Cutimed Gel BSN Med 99100365 Nu-Gel Systagenix 99100152 Purilon Gel Coloplast 99100192 Tegaderm 3M - Hydrogel wound filler 99100300 Woun'dres 3M Canada Coloplast ISOTRETINOIN X Caps. 00582344 Accutane 10 02257955 Clarus 10 mg PPB Roche Mylan 30 30 Caps. 0.9313 0.9313 40 mg PPB 00582352 Accutane 40 02257963 Clarus Roche Mylan 30 30 PODOFILOX X Top. Sol. 01945149 Condyline 02074788 Wartec 00907936 Intrasite 57.01 57.01 1.9003 1.9003 0.5 % PPB SanofiAven Paladin 3.5 ml 3 ml PROPYLENE GLYCOL/ CARBOXYMETHYLCELLULOSE Top. Jel. 37.00 35.01 20 % -3 % S. & N. 8g 15 g 25 g 00920533 Normlgel Mölnlycke 5g 15 g 00920517 Hypergel Mölnlycke 5g 15 g SODIUM CHLORIDE Gel 2.73 3.70 5.74 0.3413 0.2467 0.2296 0.9 % Gel Page 27.94 27.94 1.50 2.92 20 % 330 2.30 4.49 2013-04 CODE BRAND NAME MANUFACTURER SIZE ZINC OXIDE Band. 01907603 Viscopaste PB7 2013-04 COST OF PKG. SIZE UNIT PRICE 7,5 cm X 6 m S. & N. 1 8.80 Page 331 86:00 SPASMOLYTICS 86:12 86:16 genitourinary smooth muscle relaxants respiratory smooth muscle relaxants CODE BRAND NAME MANUFACTURER SIZE COST OF PKG. SIZE UNIT PRICE 86:12 GENITOURINARY SMOOTH MUSCLE RELAXANTS OXYBUTYNINE CHLORIDE X Syr. 5 mg/5 mL 02223376 pms-Oxybutynin Phmscience 500 ml 02240549 pms-Oxybutynin Phmscience 100 Tab. 22.20 0.0444 2.5 mg Tab. 13.72 0.1372 5 mg PPB 02163543 Apo-Oxybutynin Apotex 02230800 Mylan-Oxybutynine Mylan 02230394 Novo-Oxybutynin Novopharm 02220636 Oxybutynine-5 Pro Doc 02245827 phl-Oxybutynin Pharmel 02240550 pms-Oxybutynin Phmscience 02299364 Riva-Oxybutynin Riva 100 500 100 500 100 500 100 500 100 500 100 500 100 500 9.86 49.30 9.86 49.30 9.86 49.30 9.86 49.30 9.86 49.30 9.86 49.30 9.86 49.30 0.0986 0.0986 0.0986 0.0986 0.0986 0.0986 0.0986 0.0986 0.0986 0.0986 0.0986 0.0986 0.0986 0.0986 86:16 RESPIRATORY SMOOTH MUSCLE RELAXANTS OXTRIPHYLLINE X Elix. 100 mg/5 mL PPB 00476366 Choledyl 00792942 pms-Oxtriphylline Erfa Phmscience 500 ml 500 ml THEOPHYLLINE X Alcohol free Sol. 17.25 11.45 0.0345 0.0207 80 mg/15 mL 01966219 Theolair Med Pharma 500 ml 00627410 Theophylline Atlas 500 ml Elix. 9.81 0.0196 80 mg/15 mL Elix. sugar less 00466409 Pulmophylline 2013-04 1.76 0.0035 80 mg/15 mL Riva 500 ml 4.30 0.0086 Page 335 CODE BRAND NAME MANUFACTURER SIZE L.A. Tab. 00692689 Apo-Theo LA 02230085 Novo-Theophyl SR 100 100 Apotex Novopharm Riva 100 100 100 500 00692700 Apo-Theo LA 02230087 Novo-Theophyl SR Apotex Novopharm 00599905 Theochron Riva 100 100 500 100 500 L.A. Tab. 336 9.07 9.07 9.07 45.35 0.0907 0.0907 0.0907 0.0907 14.00 14.00 70.00 14.00 70.00 0.1400 0.1400 0.1400 0.1400 0.1400 400 mg Purdue 50 Purdue 50 L.A. Tab. Page 0.1300 0.1300 300 mg L.A. Tab. 02014181 Uniphyl 13.00 13.00 200 mg L.A. Tab. 02014165 Uniphyl UNIT PRICE 100 mg Apotex Novopharm 00692697 Apo-Theo LA 02230086 Novo-Theophyl SR 00631701 Theochron COST OF PKG. SIZE 24.90 0.4980 600 mg 30.16 0.6032 2013-04 88:00 VITAMINS 88:08 88:16 88:24 88:28 vitamin b complex vitamin d vitamin k multivitamins CODE BRAND NAME MANUFACTURER SIZE COST OF PKG. SIZE UNIT PRICE 88:08 VITAMIN B COMPLEX CYANOCOBALAMIN Inj. Sol. 02241500 Vitamine B 12 0.1 mg/mL Sandoz 1 ml Cytex Oméga Sandoz 10 ml 10 ml 1 ml 10 ml Sandoz 10 ml Inj. Sol. 01987003 Cyanocobalamine 00626112 Vitamine B 12 00521515 Vitamine B 12 1.2900 1 mg/mL PPB FOLIC ACID Inj. Sol. 00816086 Acide Folique 1.45 3.07 3.07 1.38 3.07 1.3200 5 mg/mL FOLIC ACID X Tab. 16.40 5 mg PPB 00426849 Apo-Folic Apotex 02285673 Euro-Folic 02366061 Jamp-Folic Acid Euro-Pharm Jamp 100 1000 1000 1000 2.59 25.86 19.80 19.80 0.0240 0.0201 0.0198 0.0198 NIACIN Tab. 100 mg 00268585 Niacine-ICN Valeant 500 00557412 Jamp-Niacin 01939130 Niacine 00294950 Niacine-ICN Jamp Odan Valeant 100 100 500 Jamp Odan 1000 100 Tab. 12.00 0.0240 500 mg PPB 4.62 7.95 22.78 0.0462 0.0459 0.0456 PYRIDOXINE HYDROCHLORIDE Tab. 25 mg PPB 80002890 Jamp Vitamin B6 01943200 Vitamine B 6 2013-04 18.79 4.50 0.0188 0.0184 Page 339 CODE BRAND NAME MANUFACTURER SIZE COST OF PKG. SIZE UNIT PRICE THIAMINE HYDROCHLORIDE Inj. Sol. 02193221 Thiamiject 02243525 Thiamine 00816078 Vitamine B 1 100 mg/mL PPB Oméga Cytex Sandoz 10 ml 10 ml 1 ml 10 ml Tab. 11.88 11.88 1.42 11.88 50 mg PPB 02245506 Euro-B1 80009633 Jamp-Vitamin B1 Euro-Pharm Jamp 500 500 Tab. 35.00 35.00 0.0700 0.0700 100 mg 80009588 Jamp-Vitamin B1 Jamp 500 Leo 100 64.68 0.1294 88:16 VITAMIN D ALFACALCIDOL X Caps. 00474517 One-Alpha 0.25 mcg Caps. 0.4245 1 mcg 00474525 One-Alpha Leo 100 Leo 0.5 ml 1 ml I.V. Inj. Sol. 02242502 One-Alpha 02240329 One-Alpha 1.2707 7.99 15.98 2 mcg/mL Leo 10 ml CALCITRIOL X Caps. 00481823 Rocaltrol 127.07 2 mcg/mL Oral Sol. 49.83 4.9830 0.25 mcg Roche 100 Caps. 92.80 0.9280 0.50 mcg 00481815 Rocaltrol Roche 100 Roche 10 ml Oral Sol. 00824291 Rocaltrol Page 42.45 340 147.58 1.4758 1 mcg/mL 29.56 2.9560 2013-04 CODE BRAND NAME MANUFACTURER SIZE COST OF PKG. SIZE UNIT PRICE CHOLECALCIFEROL X Caps. or Tab. 00821772 02253178 02379007 02371499 10 000 UI PPB D-Tabs Euro D 10 000 Jamp-Vitamine D Pharma-D Riva Euro-Pharm Jamp Phmscience 60 60 60 100 ERGOCALCIFEROL X Caps. 02237450 D-Forte 02301911 Osto-D2 Euro-Pharm Triton 100 100 19.86 19.86 0.1986 0.1986 8 288 UI/mL PPB 80020776 D2-Dol 80003615 Erdol Jamp Odan 60 ml 60 ml VITAMIN D Caps. or Tab. 12.80 12.80 400 UI PPB 80001125 Calciferol (tablet) 02242651 Euro D 400 Pendopharm Euro-Pharm 80006629 02240624 80002228 80001145 80005560 Jamp Jamp Odan Pendopharm Riva Jamp-Vitamine D (Caps.) Jamp-Vitamine D (Co.) Odan-D Pharma-D 400 IU Riva-D 80008590 Vitamin D 400 UI 00765384 Vitamine D Biomed Lalco 500 100 500 500 500 500 500 100 500 500 100 Caps. or Tab. 2013-04 0.2100 0.2100 0.2100 0.2100 50 000 U PPB Oral Sol. 80003010 80007769 80008446 80021081 12.60 12.60 12.60 21.00 15.00 3.00 15.00 15.00 15.00 15.00 15.00 3.00 15.00 15.00 3.00 0.0300 0.0300 0.0300 0.0300 0.0300 0.0300 0.0300 0.0300 0.0300 0.0300 0.0300 800 UI PPB Euro D 800 Jamp-Vitamine D Vitamin D 800 UI Vitamin D 800 UI Euro-Pharm Jamp Biomed Vida Nutra 100 500 100 90 500 6.00 30.00 6.00 5.40 30.00 0.0600 0.0600 0.0600 0.0600 0.0600 Page 341 CODE BRAND NAME MANUFACTURER Caps. or Tab. 80007766 80003707 80027592 80008496 UNIT PRICE 1 000 UI PPB D-Gel-1000 Euro-D 1000 Opus D-1000 Pharma-D 1000 IU (Caps.) 80002169 Pharma-D 1000 IU (Co.) 80021090 Vitamin D 1000 IU Jamp Euro-Pharm Opus Phmscience Phmscience Vida Nutra Oral Sol. 80001869 80019649 00762881 80003038 80004595 COST OF PKG. SIZE SIZE 500 500 500 100 500 100 90 500 35.00 35.00 35.00 7.00 35.00 7.00 6.30 35.00 0.0700 0.0700 0.0700 0.0700 0.0700 0.0700 0.0700 0.0700 400 UI/dose PPB Baby Ddrops D3-DOL D-VI-SOL Jamp-Vitamine D PediaVIT D D Drops Jamp M.J. Jamp Euro-Pharm 90 dose(s) 90 dose(s) 50 dose(s) 50 dose(s) 50 9.90 9.90 5.50 5.50 5.50 88:24 VITAMIN K PHYTONADIONE X I.M. Inj. Sol. 00781878 Vitamine K 1 2 mg/mL Sandoz 0.5 ml I.M. Inj. Sol. 00804312 Vitamine K 1 1.93 10 mg/mL Sandoz 1 ml 2.22 88:28 MULTIVITAMINS VITAMINS A, D AND C Oral Sol. 80008471 Jamp-Vitamins A-D-C 02229790 Pediavit 00762903 Tri-Vi-Sol Page 342 1 500 U -400 U -30 mg/mL PPB Jamp Euro-Pharm M.J. 50 ml 50 ml 50 ml 9.36 9.36 9.36 2013-04 92:00 UNCLASSIFIED THERAPEUTIC AGENTS 92:00.02 92:08 92:12 92:16 92:24 92:28 92:44 92:92 other miscellaneous 5‑alfa‑Reductase inhibitors Antidotes Antigout Agents Bone Resorption Inhibitors Cariostatic Agents Immunosuppressive Agents Other Miscellaneous Therapeutic Agents CODE BRAND NAME MANUFACTURER SIZE COST OF PKG. SIZE UNIT PRICE 92:00 UNCLASSIFIED THERAPEUTIC AGENTS ALBUMINE DILUENT Sol. 0.03 % 00541486 Albumine Diluent Oméga 02283735 Diluent albumin AllergiLab ALLERGENIC EXTRACTS, AQUEOUS, GLYCERINATED Inj. Sol. 99003813 Monovalent 99003791 Polyvalent AllergiLab AllergiLab Inj. Sol. 1.8 ml 4.5 ml 20 ml 4.5 ml 9 ml 1.49 2.14 3.87 1.82 2.04 Maintenance Treatment (10 mL) 1 1 82.17 82.17 Complete Treatment Set (10 mL) 99003856 Monovalent AllergiLab 99003805 Polyvalent AllergiLab 3 4 3 4 110.98 110.98 110.98 110.98 ALLERGENIC EXTRACTS, AQUEOUS, GLYCERINATED, STANDARDIZED Inj. Sol. Maintenance Treatment (10 mL) 02247757 99003996 99100062 99003880 99100063 99003899 02247754 99100067 99100068 99100066 99004100 99100064 99003910 99100065 99003929 99003902 2013-04 Monovalent non-Pollen Monovalent standardise Monovalent-Acariens Monovalent-Acariens standardise Monovalent-Chat Monovalent-Chat standardise Monovalent-Pollen Polyvalent - Pollen Polyvalent - Pollens Acariens Polyvalent non-Pollen Polyvalent standardise Polyvalent-Acariens Polyvalent-Acariens standardise Polyvalent-Chat Polyvalent-Chat standardise Polyvalent-PollensAcariens standardise Oméga AllergiLab Oméga AllergiLab 1 1 1 1 107.64 107.78 107.64 107.78 Oméga AllergiLab 1 1 107.64 107.78 Oméga Oméga Oméga 1 1 1 107.64 107.64 107.64 Oméga AllergiLab Oméga AllergiLab 1 1 1 1 107.74 107.78 107.64 107.78 Oméga AllergiLab AllergiLab 1 1 1 107.64 107.78 107.78 Page 345 CODE BRAND NAME MANUFACTURER Inj. Sol. Oméga AllergiLab 99100061 Monovalent-Acariens 99003937 Monovalent-Acariens standardise 99100073 Monovalent-Chat 99003945 Monovalent-Chat standardise 99100075 Monovalent-Pollen 99100079 Polyvalent - Pollen 99100080 Polyvalent - Pollens Acariens 99100078 Polyvalent non-Pollen 99004097 Polyvalent standardise 99003953 Polyvalent-PollensAcariens standardise COST OF PKG. SIZE UNIT PRICE Complete Treatment Set (10 mL) 99100074 Monovalent non-Pollen 99004003 Monovalent standardise 99100076 Polyvalent-Acariens 99003961 Polyvalent-Acariens standardise 99100077 Polyvalent-Chat 99003988 Polyvalent-Chat standardise SIZE Oméga AllergiLab 4 3 4 3 4 151.84 153.65 153.65 153.93 153.65 Oméga AllergiLab 3 3 153.93 153.65 Oméga Oméga Oméga 4 4 4 153.93 153.93 153.93 Oméga AllergiLab 4 3 4 3 3 153.93 153.65 153.65 153.93 153.65 4 3 4 3 4 153.93 153.65 153.65 153.65 153.65 Oméga AllergiLab Oméga AllergiLab AllergiLab ALLERGENIC EXTRACTS,AQUEOUS, GLYCERINATED, NON STANDARDIZED AND STANDARDIZED Inj. Sol. Maintenance Treatment (10 mL) 99003821 Polyvalent-Pollens non stand.-Acariens stand. AllergiLab Inj. Sol. 99003864 Polyvalent-Pollens non stand.-Acariens stand. Page 346 1 100.30 Complete Treatment Set (10 mL) AllergiLab 3 4 140.86 140.86 2013-04 CODE BRAND NAME MANUFACTURER ALLERGENS (ALUM-PRECIPITATED EXTRACTS OF) Inj. Sol. 99003694 Presaisonnier- Arbres et Graminees 99100069 Presaisonnier- Arbres et Graminees 99003716 Presaisonnier- Arbres, Graminees, Herbe a poux 99100070 Presaisonnier- Arbres, Graminees, Herbe a poux 99003708 Presaisonnier- Graminees et Herbe a poux 99100071 Presaisonnier- Graminees et Herbe a poux 99003686 Presaisonnier- Herbe a poux 99100072 Presaisonnier- Herbe a poux 99003651 Presaisonnier-Arbres 99003678 Presaisonnier-Graminees 00889784 Suspal- MonovalentAcariens 00889792 Suspal- Polyvalent-Acariens 00861367 Suspal-Monovalent 00861375 Suspal-Polyvalent 2013-04 UNIT PRICE Maintenance Treatment (5 mL) 1 93.90 AllergiLab 3 113.12 AllergiLab 1 93.90 Oméga 3 114.10 AllergiLab 1 93.90 Oméga 3 114.10 AllergiLab 1 93.90 Oméga 3 114.10 AllergiLab AllergiLab Oméga 1 1 1 93.90 93.90 109.79 Oméga Oméga Oméga 1 1 1 101.18 102.25 101.18 37.7067 38.0333 38.0333 38.0333 Maintenance Treatment (10 mL) Oméga 1 120.55 Oméga Oméga Oméga 1 1 1 127.03 127.02 127.02 Inj. Sol. 99003759 Presaisonnier- Arbres et Graminees 99003775 Presaisonnier- Arbres, Graminees, Herbe a poux 99003767 Presaisonnier- Graminees et Herbe a poux 99003740 Presaisonnier- Herbe a poux 99003724 Presaisonnier-Arbres 99003732 Presaisonnier-Graminees 00889822 Suspal- MonovalentAcariens 99000458 Suspal- Polyvalent-Acariens 00861286 Suspal-Monovalent 00861405 Suspal-Polyvalent COST OF PKG. SIZE AllergiLab Inj. Sol. 00908614 Suspal- MonovalentAcariens 00889814 Suspal- Polyvalent-Acariens 00861332 Suspal-Monovalent 00861359 Suspal-Polyvalent SIZE Complete Treatment Set (5 mL) AllergiLab 3 114.18 AllergiLab 3 114.18 AllergiLab 3 114.18 AllergiLab 3 114.18 AllergiLab AllergiLab Oméga 3 3 3 114.18 114.18 127.02 Oméga Oméga Oméga 3 3 3 127.02 127.02 127.02 Page 347 CODE BRAND NAME MANUFACTURER Inj. Sol. Oméga Oméga 1 1 106.56 106.56 Oméga 1 106.56 Oméga 1 106.56 Oméga Oméga 1 1 106.56 106.56 Inj. Sol. Oméga 3 138.86 Oméga Oméga Oméga 3 3 3 138.86 138.86 138.86 ALLERGENS (AQUEOUS EXTRACTS OF) Inj. Sol. 00861170 Monovalent 99000415 Monovalent-Acariens 00861189 Polyvalent 106.5600 Oméga Oméga Oméga 1 1 1 82.89 87.19 83.96 Maintenance Treatment (10 mL) 00861227 Monovalent 99000431 Monovalent-Acariens 00861251 Polyvalent Oméga Oméga Oméga Inj. Sol. 1 1 1 94.72 91.48 87.19 Complete Treatment Set (5 mL) Monovalent Monovalent-Acariens Polyvalent Polyvalent-Acariens Oméga Oméga Oméga Oméga Inj. Sol. 3 3 3 3 104.41 104.41 101.18 104.40 Complete Treatment Set (10 mL) Monovalent Monovalent-Acariens Polyvalent Polyvalent-Acariens Oméga Oméga Oméga Oméga 3 3 3 3 HYMENOPTERA VENOM Inj. Pd. 00894346 Venin d'abeille (apis mellifera) 348 106.5600 Maintenance Treatment (5 mL) Inj. Sol. Page UNIT PRICE Complete Treatment Set (10 mL) 00889849 Suspal- MonovalentAcariens 00889857 Suspal- Polyvalent-Acariens 00861308 Suspal-Monovalent 00861316 Suspal-Polyvalent 00861138 00889768 00861162 00889776 COST OF PKG. SIZE Complete Treatment Set (8 mL) 00896942 Presaisonnier- Arbres 99100625 Presaisonnier- Arbres et Graminees 99100083 Presaisonnier- Arbres, Graminees, Herbe a poux 99100082 Presaisonnier- Graminees et Herbe a poux 00896934 Presaisonnier- Gramines 00896950 Presaisonnier- Herbes-apoux 00861073 00889733 00861081 00889741 SIZE 121.63 127.02 121.64 127.02 1.1 mg Oméga 1 173.30 2013-04 CODE BRAND NAME MANUFACTURER SIZE Inj. Pd. 99100021 Venin d'abeille (apis mellifera) Oméga 1 Oméga 6 AllergiLab Oméga Allergy 1 1 1 233.68 219.58 220.00 Oméga AllergiLab Allergy 1 1 1 219.59 233.68 220.00 Allergy Oméga Oméga 1 1 1 240.00 245.42 219.59 Allergy AllergiLab Allergy 1 1 1 220.00 184.60 174.00 AllergiLab AllergiLab 1 1 255.01 233.68 Oméga Oméga Oméga 1 1 1 2013-04 219.5800 219.5900 259.41 289.55 259.41 259.4100 3.3 mg AllergiLab Allergy Oméga 1 1 1 Oméga 1 Inj. Pd. 99100026 Vespides combines 19.1950 1.3 mg Inj. Pd. 99100230 Vespides combines 01948873 Vespides combines 00895245 Vespides combines 115.17 1.1 mg Inj. Pd. 99100016 Frelon a tete blanche 99100017 Guepe (Polistes Spp.) 99100018 Guepe de l'est (vespula maculifrons) 205.98 100 mcg HYMENOPTERA VENOM PROTEIN Inj. Pd. 99100226 Frelon a tete blanche 99004607 Frelon a tete blanche 01948997 Frelon a tete blanche (Dolichovespula Maculata) 99004593 Frelon a tete jaune 99100227 Frelon Jaune 01948938 Frelon jaune (Dolichoves pula Arenaria) 01948970 Guepe (Polistes Spp.) 00894362 Guepe (Polistes Spp.) 00894354 Guepe de l'est (vespula maculifrons) 01948954 Guepe jaune (Vespula Spp.) 99100225 Honey Bee Venom 01948903 Venin d'abeille (apis mellifera) 99100229 Wasp Venon 99100228 Yellow Jacket Venom UNIT PRICE 1.3 mg Inj. Pd. 00541435 Venin d'abeille (apis mellifera) COST OF PKG. SIZE 462.02 434.00 431.65 3.9 mg 510.14 Page 349 CODE BRAND NAME MANUFACTURER SIZE Inj. Pd. Oméga Oméga 6 6 150.70 138.86 25.1167 23.1433 Oméga 6 138.86 23.1433 Oméga 6 138.86 23.1433 Inj. Pd. 99004046 01948989 99100278 99100279 99100280 99004054 01948962 99100270 99004062 01948911 120 mcg Frelon a tete blanche Frelon a tete blanche Frelon Jaune Frelon jaune (Dolichoves pula Arenaria) Guepe Guepe (Polistes Spp.) Guepe (Polistes Spp.) Guepe a taches blanches dolichovespula maculata Guepe de l'est (vespula maculifrons) Guepe jaune Guepe jaune (Vespula Spp.) Guepe jaune dolichovespula arenaria Venin d'abeille Venin d'abeille (apis mellifera) AllergiLab Allergy AllergiLab Allergy 6 6 6 6 160.05 140.00 160.05 140.00 26.6750 23.3333 26.6750 AllergiLab Allergy Oméga Oméga 6 6 6 6 171.79 148.00 172.22 160.38 28.6317 28.7033 26.7300 Oméga 6 162.54 27.0900 AllergiLab Allergy Oméga 6 6 6 162.19 140.00 162.54 27.0317 AllergiLab Allergy 6 6 119.51 105.00 19.9183 Oméga 6 Inj. Pd. 00614424 Vespides combines 99004070 Vespides combines 01948881 Vespides combines 99100281 Vespides combines Frelon a tete blanche Frelon a tete jaune Guepe (Polistes Spp.) Guepe de l'est (vespula maculifrons) 99100282 Venin d'abeille (apis mellifera) AllergiLab Allergy Oméga 6 6 6 Oméga Oméga Oméga Oméga 1 1 1 1 350 44.6700 308.37 260.00 310.01 123.71 123.79 130.24 129.19 Oméga 1 102.26 Oméga 1 51.3950 51.6683 550 mcg Inj. Pd. 99100284 Vespides combines 268.02 360 mcg Inj. Pd. 99100266 99100267 99100268 99100269 27.0900 300 mcg Inj. Pd. Page UNIT PRICE 100 mcg 00541451 Guepe (Polistes Spp.) 00541427 Guepe a taches blanches dolichovespula maculata 00541478 Guepe de l'est (vespula maculifrons) 00541443 Guepe jaune dolichovespula arenaria 99004038 01949004 99004011 01948946 COST OF PKG. SIZE 1 650 mcg 233.58 2013-04 CODE BRAND NAME MANUFACTURER SIZE COST OF PKG. SIZE UNIT PRICE 92:00.02 OTHER MISCELLANEOUS ZINC OXIDE/ ICHTHAMMOL Band. 01948466 Ichthopaste 7,5 cm X 6 m S. & N. 1 GSK 30 7.02 92:08 5-ALFA-REDUCTASE INHIBITORS DUTASTERIDE X Caps. 02247813 Avodart 0.5 mg FINASTERIDE X Tab. 02365383 02354462 02355043 02348888 Apo-Finasteride Co Finasteride Finasteride Finasteride 48.12 1.6040 5 mg PPB Apotex Cobalt Accord MeliaPharm 02350270 Finasteride 02357224 Jamp-Finasteride 02389878 Mint-Finasteride Pro Doc Jamp Mint 02356058 Mylan-Finasteride Mylan 02348500 Novo-Finasteride 02310112 pms-Finasteride Teva Can Phmscience 02010909 Proscar 02371820 Ran-Finasteride 02306905 ratio-Finasteride Merck Ranbaxy Ratiopharm 02322579 Sandoz Finasteride Sandoz 30 30 30 30 100 30 30 30 100 30 100 30 30 100 30 30 30 100 30 500 13.90 13.90 13.90 13.90 46.33 13.90 13.90 13.90 46.33 13.90 46.33 13.90 13.90 46.33 53.98 13.90 13.90 46.33 13.90 231.63 0.4633 0.4633 0.4633 0.4633 0.4633 0.4633 0.4633 0.4633 0.4633 0.4633 0.4633 0.4633 0.4633 0.4633 1.7993 0.4633 0.4633 0.4633 0.4633 0.4633 92:12 ANTIDOTES FOLINIC ACID X Tab. 02170493 Leucovorin 2013-04 5 mg Pfizer 24 100 139.75 557.93 5.8229 5.5793 Page 351 CODE BRAND NAME MANUFACTURER SIZE COST OF PKG. SIZE UNIT PRICE 92:16 ANTIGOUT AGENTS ALLOPURINOL X Tab. 100 mg PPB 02396327 Mar-Allopurinol Marcan 00402818 Zyloprim AA Pharma 02396335 Mar-Allopurinol Marcan 00479799 Zyloprim AA Pharma 02396343 Mar-Allopurinol Marcan 00402796 Zyloprim AA Pharma 100 1000 100 1000 Tab. 7.80 78.00 7.80 78.00 0.0780 0.0780 0.0780 0.0780 200 mg PPB 100 500 100 500 Tab. 13.00 65.00 13.00 65.00 0.1300 0.1300 0.1300 0.1300 300 mg PPB 100 500 100 500 COLCHICINE X Tab. 21.25 106.25 21.25 106.25 0.2125 0.2125 0.2125 0.2125 0.6 mg PPB 00287873 Colchicine 00572349 Colchicine Euro-Pharm Odan 02373823 Jamp-Colchicine Jamp 100 100 500 100 500 Tab. 25.65 25.65 129.88 25.65 129.88 0.2565 0.2565 0.2598 0.2565 0.2598 1 mg PPB 00206032 Colchicine 00621374 Colchicine 02373831 Jamp-Colchicine Euro-Pharm Odan Jamp 100 100 100 50.80 50.80 50.80 0.5080 0.5080 0.5080 92:24 BONE RESORPTION INHIBITORS ALENDRONATE MONOSODIUM X Oral Sol. 02248625 Fosamax Page 352 70 mg/75 ml Merck 4 36.68 9.1700 2013-04 CODE BRAND NAME MANUFACTURER SIZE Tab. COST OF PKG. SIZE UNIT PRICE 5 mg PPB 02381478 Alendronate monosodique 02248727 Apo-Alendronate Accord Apotex 02384698 Ran-Alendronate 02288079 Sandoz Alendronate 02248251 Teva-Alendronate Ranbaxy Sandoz Teva Can 28 30 100 28 30 30 100 Tab. 21.33 22.85 76.18 21.33 22.85 22.85 76.18 0.7617 0.7617 0.7618 0.7617 0.7617 0.7617 0.7618 10 mg PPB 02381486 Alendronate monosodique 02248728 Apo-Alendronate Accord Apotex 02388545 02201011 02394863 02270129 02384701 02288087 Aurobindo Merck Mint Mylan Ranbaxy Sandoz Auro-Alendronate Fosamax Mint-Alendronate Mylan-Alendronate Ran-Alendronate Sandoz Alendronate 02247373 Teva-Alendronate Teva Can 28 30 100 100 28 28 100 28 30 90 30 100 Tab. 13.96 14.96 49.87 49.86 52.86 13.96 49.87 13.96 14.96 44.88 14.96 49.87 0.4986 0.4986 0.4987 0.4986 1.8879 0.4986 0.4987 0.4986 0.4986 0.4987 0.4986 0.4987 40 mg PPB 02258102 Co Alendronate 02201038 Fosamax 2013-04 Cobalt Merck 30 28 65.84 106.10 2.1947 3.7893 Page 353 CODE BRAND NAME MANUFACTURER SIZE Tab. UNIT PRICE 70 mg PPB 02352966 Alendronate Sanis 02302004 Alendronate 02299712 Alendronate FC Sorres Sivem 02381494 Alendronate monosodique 02303078 Alendronate-70 02248730 Apo-Alendronate Accord Pro Doc Apotex 02388553 Auro-Alendronate 02258110 Co Alendronate Aurobindo Cobalt 02245329 02385031 02394871 02286335 02261715 Merck Jamp Mint Mylan Novopharm Fosamax Jamp-Alendronate Mint-Alendronate Mylan-Alendronate Novo-Alendronate 02284006 pms-Alendronate FC Phmscience 02384728 Ran-Alendronate 02270889 Riva-Alendronate Ranbaxy Riva 02288109 Sandoz Alendronate Sandoz ALENDRONATE/CHOLECALCIFEROL X Tab. 02314940 Fosavance 4 100 30 4 30 4 4 4 100 4 4 100 4 4 4 4 4 50 4 30 4 4 100 4 30 01984845 Bonefos 02245828 Clasteon 4 Bayer Sunovion 120 120 354 18.17 4.5425 222.72 145.00 1.8560 1.2083 60 mg/mL (5 mL) Bayer 1 ETIDRONATE DISODIUM X Tab. 02248686 Co Etidronate 02245330 Mylan-Etidronate 2.5150 2.5143 2.5143 2.5150 2.5143 2.5150 2.5150 2.5150 2.5143 2.5150 2.5150 2.5143 9.6550 2.5150 2.5150 2.5150 2.5150 2.5143 2.5150 2.5143 2.5150 2.5150 2.5143 2.5150 2.5143 400 mg PPB I.V. Perf. Sol. 01984837 Bonefos 10.06 251.43 75.43 10.06 75.43 10.06 10.06 10.06 251.43 10.06 10.06 251.43 38.62 10.06 10.06 10.06 10.06 125.72 10.06 75.43 10.06 10.06 251.43 10.06 75.43 70 mg - 140 mcg (5 600 UI) Merck DISODIC CLODRONATE X Caps. Page COST OF PKG. SIZE 61.95 200 mg PPB Cobalt Mylan 100 60 35.69 21.41 0.3569 0.3569 2013-04 CODE BRAND NAME MANUFACTURER SIZE COST OF PKG. SIZE UNIT PRICE ETIDRONATE DISODIUM/ CALCIUM CARBONATE X Tab. 400 mg - Ca+500 mg (14 tab. - 76 tab.) PPB 02263866 02176017 02353210 02247323 02324199 Co Etidrocal Didrocal Etidrocal Mylan-Eti-Cal Carepac Novo-EtidronateCal Cobalt Warner Sanis Mylan Novopharm 90 90 90 90 90 PAMIDRONATE DISODIUM X I.V. Perf. Sol. 02244551 Pamidronate Disodique pour injection 02246598 Pamidronate Disodium Injection 02249677 Pamidronate Disodium Omega 02264978 Sandoz Pamidronate Hospira 1 176.70 PPC 1 176.70 Oméga 1 176.70 Sandoz 1 176.70 Novartis Hospira 1 1 166.55 86.78 PPC 1 82.19 Oméga 1 82.19 Sandoz 1 82.19 Novartis Hospira 1 1 499.63 260.33 PPC 1 246.56 Oméga 1 246.56 Sandoz Valeo 1 1 246.56 260.33 30 mg PPB Sol./Pd. I.V. inf. 02059789 Aredia 02244552 Pamidronate Disodique pour injection 02246599 Pamidronate Disodium Injection 02249685 Pamidronate Disodium Omega 02264986 Sandoz Pamidronate 02382032 Val-Pamidronate Disodium 0.2221 0.4500 0.2221 0.2221 0.2221 60 mg PPB Sol./Pd. I.V. inf. 02059762 Aredia 02244550 Pamidronate Disodique pour injection 02246597 Pamidronate Disodium Injection 02249669 Pamidronate Disodium Omega 02264951 Sandoz Pamidronate 19.99 40.50 19.99 19.99 19.99 90 mg PPB RISEDRONATE SODIUM X Tab. 5 mg PPB 02242518 Actonel 02298376 Novo-Risedronate Warner Novopharm 28 30 02239146 Actonel 02298384 Novo-Risedronate Warner Novopharm 30 30 Tab. 51.00 31.58 1.8214 1.0527 30 mg PPB 2013-04 354.00 204.48 11.8000 6.8160 Page 355 CODE BRAND NAME MANUFACTURER SIZE Tab. COST OF PKG. SIZE UNIT PRICE 35 mg PPB 02246896 Actonel 02353687 Apo-Risedronate Warner Apotex 02368552 Jamp-Risedronate 02357984 Mylan-Risedronate Jamp Mylan 02298392 Novo-Risedronate Novopharm 02302209 pms-Risedronate Phmscience 02319861 02347474 02370255 02352141 Ratiopharm Pro Doc Sanis Sivem ratio-Risedronate Risedronate Risedronate Risedronate 02341077 Riva-Risedronate Riva 02327295 Sandoz Risedronate Sandoz RISEDRONATE SODIUM/ CALCIUM CARBONATE X Tab. 02279657 Actonel Plus Calcium 4 4 30 4 4 30 4 30 4 30 4 4 4 4 30 4 30 4 30 39.05 9.95 74.68 9.95 9.95 74.68 9.95 74.68 9.95 74.68 9.95 9.95 9.95 9.95 74.68 9.95 74.68 9.95 74.68 9.7625 2.4875 2.4893 2.4875 2.4875 2.4893 2.4875 2.4893 2.4875 2.4893 2.4875 2.4875 2.4875 2.4875 2.4893 2.4875 2.4893 2.4875 2.4893 35 mg - Ca+500 mg (4 tab. - 24 tab.) Warner 28 36.22 1.2936 92:28 CARIOSTATIC AGENTS SODIUM FLUORIDE Chew. Tab. 00575569 Fluor-A-Day 2.2 mg (F-1 mg) Phmscience Oral Sol. 120 6.09 0.0508 5.56 mg/mL (F-2.5 mg/mL) PPB 00610100 Fluor-A-Day 02245747 Pediafluor Phmscience Euro-Pharm 60 ml 60 ml 3.98 3.98 92:44 IMMUNOSUPPRESSIVE AGENTS AZATHIOPRINE X Tab. 02242907 02343002 02243371 00004596 02231491 02236819 Page 356 Apo-Azathioprine Azathioprine Azathioprine-50 Imuran Mylan-Azathioprine Teva-Azathioprine 50 mg PPB Apotex Sanis Pro Doc Triton Mylan Teva Can 100 100 100 100 100 100 500 24.05 24.05 24.05 94.53 24.05 24.05 120.23 0.2405 0.2405 0.2405 0.9453 0.2405 0.2405 0.2405 2013-04 CODE BRAND NAME MANUFACTURER SIZE CYCLOSPORINE X Caps. COST OF PKG. SIZE UNIT PRICE 10 mg 02237671 Neoral Novartis 60 02150689 Neoral 02247073 Sandoz Cyclosporine Novartis Sandoz 30 30 Caps. 37.43 0.6238 25 mg Caps. 43.50 29.85 1.4500 0.9950 50 mg 02150662 Neoral 02247074 Sandoz Cyclosporine Novartis Sandoz 30 30 02150670 Neoral 02242821 Sandoz Cyclosporine Novartis Sandoz 30 30 Caps. 84.81 58.20 2.8270 1.9400 100 mg Oral Sol. 5.6560 3.8813 100 mg/mL 02244324 Apo-Cyclosporine 02150697 Neoral Apotex Novartis 50 ml 50 ml MYCOPHENOLATE MOFETIL X Caps. 02352559 02192748 02386399 02383780 02371154 02364883 02320630 169.68 116.44 Apo-Mycophenolate Cellcept Jamp-Mycophenolate Mofetilmycophenolate Mylan-Mycophenolate Novo-Mycophenolate Sandoz Mycophenolate Mofetil 188.54 251.38 3.7708 5.0276 250 mg PPB Apotex Roche Jamp Accord Mylan Teva Can Sandoz 100 100 100 100 50 100 100 Oral Susp. 51.55 206.20 51.55 51.55 25.78 51.55 51.55 0.5155 2.0620 0.5155 0.5155 0.5155 0.5155 0.5155 200 mg/mL 02242145 Cellcept Roche 175 ml Tab. 288.68 500 mg PPB 02352567 02237484 02379996 02380382 02378574 02370549 02348675 + 02389754 Apo-Mycophenolate Cellcept Co Mycophenolate Jamp-Mycophenolate Mofetilmycophenolate Mylan-Mycophenolate Novo-Mycophenolate Ran-Mycophenolate 02313855 Sandoz Mycophenolate Mofetil 2013-04 Apotex Roche Cobalt Jamp Accord Mylan Teva Can Ranbaxy Sandoz 100 50 50 50 50 50 50 50 100 50 103.10 206.20 51.55 51.55 51.55 51.55 51.55 51.55 103.10 51.55 1.0310 4.1240 1.0310 1.0310 1.0310 1.0310 1.0310 1.0310 1.0310 1.0310 Page 357 CODE BRAND NAME MANUFACTURER SIZE MYCOPHÉNOLATE SODIUM X Ent. Tab. 02264560 Myfortic Novartis 120 Novartis 120 1.9977 479.44 3.9953 1 mg/mL Pfizer 60 ml Tab. 451.16 7.5193 1 mg 02247111 Rapamune Pfizer 100 Astellas 100 TACROLIMUS X Caps. 02243144 Prograf 751.96 7.5196 0.5 mg Caps. 197.00 1.9700 1 mg 02175991 Prograf Astellas 100 249.95 02175983 Prograf Astellas 100 1249.85 Caps. 2.4995 5 mg L.A. Caps. 02296462 Advagraf 02296470 Advagraf Astellas 50 Astellas 50 358 1.9700 124.97 2.4994 3 mg Astellas 50 Astellas 50 L.A. Caps. 02296489 Advagraf 98.50 1 mg L.A. Caps. 02331667 Advagraf 12.4985 0.5 mg L.A. Caps. Page 239.72 360 mg SIROLIMUS X Oral Sol. 02243237 Rapamune UNIT PRICE 180 mg Ent. Tab. 02264579 Myfortic COST OF PKG. SIZE 374.91 7.4982 5 mg 624.92 12.4984 2013-04 CODE BRAND NAME MANUFACTURER SIZE COST OF PKG. SIZE UNIT PRICE 92:92 OTHER MISCELLANEOUS THERAPEUTIC AGENTS BÉTAINE ANHYDROUS X Oral Pd. 02238526 Cystadane 1 g/1.7 mL RDT 180 g BUPROPION HYDROCHLORIDE X L. A tab 02238441 Zyban4 150 mg Valeant 100 Bayer 3 ml CYPROTERONE ACETATE X I.M. Inj. Pd. 00704423 Androcur Depot 726.69 84.86 0.8486 100 mg/mL Tab. 78.85 50 mg PPB 00704431 Androcur 02245898 Cyproterone 02390760 Med-Cyproterone Bayer AA Pharma GMP 02395797 Riva-Cyproterone Riva 60 100 60 100 60 LACTOSE Tab. 00501190 Placebo Odan 100 1000 Tercica 1 Tercica 1 4 2013-04 1102.00 1470.00 120 mg/0.5 mL Tercica 1 OCTREOTIDE X I.M. Inj. Susp. 02239323 Sandostatin LAR 0.0633 0.0632 90 mg/0.3 mL S.C. Inj.Sol (syr) 02283417 Somatuline Autogel 7.20 72.00 60 mg/0.3 mL S.C. Inj.Sol (syr) 02283409 Somatuline Autogel 1.4085 1.4085 1.4085 1.4085 1.4085 100 mg LANREOTIDE (AS ACETATE) X S.C. Inj.Sol (syr) 02283395 Somatuline Autogel 84.51 140.85 84.51 140.85 84.51 1840.00 10 mg Novartis 1 1211.00 The duration of reimbursements for anti-smoking treatments with this drug is limited to 12 consecutive weeks per 12-month period. Page 359 CODE BRAND NAME MANUFACTURER SIZE I.M. Inj. Susp. 02239324 Sandostatin LAR Novartis 1 Novartis 1 1615.40 30 mg Inj. Sol. 02248639 Octreotide Acetate Omega 00839191 Sandostatin Oméga Novartis 1 ml 1 ml Oméga Novartis 1 ml 1 ml Oméga Novartis 5 ml 5 ml Oméga Novartis 1 ml 1 ml Ferring 30 15.50 44.83 75 mcg Tab. 32.70 1.0900 150 mcg 02223775 Norprolac Ferring 30 Janss. Inc 100 SODIUM PENTOSAN POLYSULFATE X Caps. 02029448 Elmiron Page 31.71 91.75 500 mcg /mL PPB QUINAGOLIDE HYDROCHLORIDE X Tab. 02223767 Norprolac 3.30 9.54 200 mcg/mL PPB Inj. Sol. 02248641 Octreotide Acetate Omega 00839213 Sandostatin 1.75 5.05 100 mcg/mL PPB Inj. Sol. 02248642 Octreotide Acetate Omega 02049392 Sandostatin 2022.00 50 mcg/mL PPB Inj. Sol. 02248640 Octreotide Acetate Omega 00839205 Sandostatin UNIT PRICE 20 mg I.M. Inj. Susp. 02239325 Sandostatin LAR COST OF PKG. SIZE 360 48.90 1.6300 100 mg 131.40 1.3140 2013-04 EXCEPTIONAL MEDICATIONS CODE BRAND NAME MANUFACTURER SIZE COST OF PKG. SIZE UNIT PRICE EXCEPTIONAL MEDICATIONS ABATACEPT X I.V. Perf. Pd. 02282097 Orencia 250 mg B.M.S. 1 ABIRATERONE X Tab. 02371065 Zytiga 250 mg Janss. Inc ABSORPTIVE DRESSING - GELLING FIBRE Dressing 99003481 3M Tegaderm High Integrity Alginate Dressing (10x10-100 cm²) 99100285 3M Tegaderm High Integrity Alginate Dressing (10x20-200 cm²) 00920223 Algosteril (10 cm x 10 cm 100 cm²) 00921092 Algosteril (10 cm x 20 cm 200 cm²) 99001772 Aquacel hydrofiber (10 cm x 10 cm - 100 cm²) 99100153 Biatain Alginate Ag (10 cm x 10 cm - 100 cm²) 00898643 Kaltostat (10 cm x 20 cm 200 cm²) 99100656 Maxorb Extra (10,2 cm x 10,2 cm - 104 cm²) 99003007 Melgisorb (10 cm x 10 cm 100 cm²) 99003023 Melgisorb (10 cm x 20 cm 200 cm²) 99100004 Nu-Derm Alginate (10 cm x 10 cm - 100 cm²) 99100005 Nu-Derm Alginate (10 cm x 20 cm - 200 cm²) 99100821 Restore Calcium Alginate Dressing (10 cm x 10 cm 100 cm²) 99100822 Restore Calcium Alginate Dressing (10 cm x 20 cm 200 cm²) 99100467 Versiva XC Non-Adhesive (11 cm x 11 cm - 121 cm²) 2013-04 459.61 120 3400.00 28.3333 100 cm² to 200 cm² (active surface) 3M Canada 10 38.97 3M Canada 1 7.53 Erfa 16 68.00 4.2500 Erfa 16 105.50 6.5938 Convatec 10 61.44 6.1440 Coloplast 10 34.20 3.4200 Convatec 10 85.60 8.5600 Medline 100 134.75 1.3475 Mölnlycke 50 182.33 3.6466 Mölnlycke 50 342.47 6.8494 Systagenix 50 205.44 4.1088 Systagenix 25 188.92 7.5568 Hollister 10 37.00 3.7000 Hollister 5 37.00 7.4000 Convatec 10 51.79 5.1790 3.8970 Page 363 CODE BRAND NAME MANUFACTURER Dressing 99003279 Algisite M (15 cm x 20 cm 300 cm²) 99100932 Aquacel foam (15 cm x 15 cm - 225 cm²) 99100931 Aquacel foam (15 cm x 20 cm - 300 cm²) 99100934 Aquacel foam (20 cm x 20 cm - 400 cm²) 99001764 Aquacel hydrofiber (15 cm x 15 cm - 225 cm²) 99100891 Biatain Alginate (15 cm x 15 cm - 225 cm²) 99100657 Maxorb Extra (10,2 cm x 20,3 cm - 207 cm²) 99100468 Versiva XC Non-Adhesive (15 cm x 15 cm - 225 cm²) 99100472 Versiva XC Non-Adhesive (20 cm x 20 cm - 400 cm²) Page 364 UNIT PRICE S. & N. 10 100.28 10.0280 Convatec 5 46.91 9.3820 Convatec 5 62.55 12.5100 Convatec 5 83.40 16.6800 Convatec 5 65.35 13.0700 Coloplast 10 87.75 8.7750 Medline 50 235.00 4.7000 Convatec 5 52.49 10.4980 Convatec 5 96.72 19.3440 Less than 100 cm² (active surface) Erfa 10 17.04 1.7040 Convatec 10 16.50 1.6500 Convatec 10 24.97 2.4970 Coloplast 30 52.50 1.7500 Convatec 10 19.02 1.9020 Convatec 10 55.57 5.5570 Medline 100 160.50 1.6050 Mölnlycke 50 89.23 1.7846 Systagenix 50 94.33 1.8866 Hollister 10 17.30 1.7300 Convatec 10 33.95 3.3950 Dressing 99100888 Aquacel Burn hydrofiber (23 cm x 30 cm - 690 cm²) COST OF PKG. SIZE 201 cm² to 500 cm² (active surface) Dressing 00920266 Algosteril (5 cm x 5 cm 25 cm²) 99100937 Aquacel foam (5 cm x 5 cm - 25 cm²) 99001780 Aquacel hydrofiber (5 cm x 5 cm - 25 cm²) 99100156 Biatain Alginate (5 cm x 5 cm - 25 cm²) 00898627 Kaltotstat (5 cm x 5 cm 25 cm²) 00898635 Kaltotstat (7.5 cm x 12 cm 90 cm²) 99100658 Maxorb Extra (5,1 cm x 5,1 cm - 26 cm²) 99003066 Melgisorb (5 cm x 5 cm 25 cm²) 99100006 Nu-Derm Alginate (5 cm x 5 cm - 25 cm²) 99100823 Restore Calcium Alginate Dressing (5,1 cm x 5,1 cm 26 cm²) 99100466 Versiva XC Non-Adhesive (7.5 cm x 7.5 cm - 56 cm²) SIZE More than 500 cm² (active surface) Convatec 5 220.00 44.0000 2013-04 CODE BRAND NAME MANUFACTURER SIZE Strip COST OF PKG. SIZE UNIT PRICE 30 cm to 90 cm 99003260 Algisite M 30 cm 00921157 Algosteril (30 cm) 99001705 Aquacel hydrofiber (2 cm x 45 cm) 99100155 Biatain Alginate (44 cm ou 1" X 17 1/2") 99100100 Curasorb 30 cm 99100101 Curasorb 60 cm 99100102 Curasorb 90 cm 00898899 Kaltostat 40 cm 99100659 Maxorb Extra Post-op Rope (30,5 cm) 99003015 Melgisorb 30 cm 99100003 Nu-Derm Alginate 30 cm 2013-04 S. & N. Erfa Convatec 5 10 5 24.81 49.97 41.60 4.9620 4.9970 8.3200 Coloplast 6 41.22 6.8700 Tyco Tyco Tyco Convatec Medline 1 1 1 5 20 4.17 5.97 10.50 35.49 80.35 7.0980 4.0175 Mölnlycke Systagenix 50 25 215.18 133.11 4.3036 5.3244 Page 365 CODE BRAND NAME MANUFACTURER SIZE COST OF PKG. SIZE UNIT PRICE ABSORPTIVE DRESSING - HYDROPHILIC FOAM ALONE OR IN ASSOCIATION Dressing 100 cm² to 200 cm² (active surface) 99100193 3M Tegaderm Foam Dressing (nonadhesive) (10cm x 10cm-100cm²) 99100052 Allevyn Compression (10 cm x 10 cm - 100 cm²) 99100537 Allevyn Gentle (10 cm x 10 cm - 100 cm²) 99100475 Allevyn Gentle (10 cm x 20 cm - 200 cm²) 00907863 Allevyn Non-Adhesive (10 cm x 10 cm - 100 cm²) 00920738 Allevyn Non-Adhesive (10 cm x 20 cm - 200 cm²) 99100135 Biatain (10 cm x 10 cm 100 cm²) 99100601 Biatain (10 cm x 20 cm 200 cm²) 99100298 Biatain Soft-Hold (10 cm x 10 cm - 100 cm²) 99100600 Biatain Soft-Hold (10 cm x 20 cm - 200 cm²) 99002787 Combiderm Non-Adhesive (13 cm x 13 cm - 169 cm²) 99004801 Copa (10 cm x 10 cm 100 cm²) 99100794 Cutimed Cavity (10 cm x 10 cm - 100 cm²) 99100744 Cutimed Siltec (10 cm x 10 cm - 100 cm²) 99100745 Cutimed Siltec (10 cm x 20 cm - 200 cm²) 99003244 Mepilex (10 cm x 10 cm 100 cm²) 99003252 Mepilex (10 cm x 20 cm 179 cm²) 99100664 Optifoam Basic (10,2 cm x 12,7 cm - 130 cm²) 99100666 Optifoam Non-Adhesive (10,2 cm x 10,2 cm 104 cm²) 99100708 Restore Advanced Foam Dressing (10 cm x 10 cm 100 cm²) 99100889 Tegaderm 3M-Foam Dressing (non adhesive) 10 x 20-200 cm² 99100000 Tielle Max (11 cm x 11 cm 121 cm²) Page 366 3M Canada 1 4.41 S. & N. 1 5.01 S. & N. 10 49.50 4.9500 S. & N. 10 100.05 10.0050 S. & N. 1 5.02 S. & N. 1 10.01 Coloplast 10 39.50 3.9500 Coloplast 5 39.50 7.9000 Coloplast 5 19.75 3.9500 Coloplast 5 39.50 7.9000 Convatec 10 54.88 5.4880 Tyco 50 94.88 1.8976 BSN Med 10 37.44 3.7440 BSN Med 10 37.44 3.7440 BSN Med 10 79.00 7.9000 Mölnlycke 5 24.70 4.9400 Mölnlycke 5 46.70 9.3400 Medline 100 146.10 1.4610 Medline 100 230.56 2.3056 Hollister 10 35.32 3.5320 3M Canada 5 39.50 7.9000 Systagenix 10 62.44 6.2440 2013-04 CODE BRAND NAME MANUFACTURER Dressing 99100196 3M Tegaderm Foam Dressing (nonadhesive) (20cm x 20cm-400cm²) 99100536 Allevyn Gentle (15 cm x 15 cm - 225 cm²) 99100535 Allevyn Gentle (20 cm x 20 cm - 400 cm²) 99002949 Allevyn Non-Adhesive (15 cm x 15 cm - 225 cm²) 00907855 Allevyn Non-Adhesive (20 cm x 20 cm - 400 cm²) 99100571 Biatain (15 cm x 15 cm 225 cm²) 99100603 Biatain (20 cm x 20 cm 400 cm²) 99100572 Biatain Soft-Hold (15 cm x 15 cm - 225 cm²) 99005034 Combiderm Non-Adhesive (15 cm x 25 cm - 375 cm²) 99004836 Curafoam (15 cm x 20 cm 300 cm²) 99100793 Cutimed Cavity (15 cm x 15 cm - 225 cm²) 99100746 Cutimed Siltec (15 cm x 15 cm - 225 cm²) 99100747 Cutimed Siltec (20 cm x 20 cm - 400 cm²) 99100602 Mepilex (15 cm x 15 cm 225 cm²) 99003538 Mepilex (20 cm x 20 cm 400 cm²) 99100667 Optifoam Non-Adhesive (15,2 cm x 15,2 cm 231 cm²) 99100709 Restore Advanced Foam Dressing (15 cm x 15 cm 225 cm²) 99100539 Tielle Max (15 cm x 15 cm 225 cm²) 99100356 Tielle Max (15 cm x 20 cm 300 cm²) 2013-04 SIZE COST OF PKG. SIZE UNIT PRICE 201 cm² to 500 cm² (active surface) 3M Canada 30 492.37 16.4123 S. & N. 10 95.60 9.5600 S. & N. 10 170.00 17.0000 S. & N. 1 9.69 S. & N. 1 17.22 Coloplast 5 44.50 8.9000 Coloplast 5 79.00 15.8000 Coloplast 5 44.50 8.9000 Convatec 1 11.16 Tyco 25 285.51 11.4204 BSN Med 5 41.51 8.3020 BSN Med 10 83.04 8.3040 BSN Med 5 71.10 14.2200 Mölnlycke 5 47.00 9.4000 Mölnlycke 5 92.60 18.5200 Medline 100 443.45 4.4345 Hollister 10 74.48 7.4480 Systagenix 10 94.97 9.4970 Systagenix 5 58.21 11.6420 Page 367 CODE BRAND NAME MANUFACTURER Dressing 99100241 Allevyn Compression (5 cm x 6 cm - 30 cm²) 99100570 Allevyn Gentle (5 cm x 5 cm - 25 cm²) 00920711 Allevyn Non-Adhesive (5 cm x 5 cm - 25 cm²) 99100599 Biatain (5 cm x 7 cm 35 cm²) 99004534 Combiderm Non-Adhesive (7.5 cm x 7.5 cm - 56 cm²) 99004852 Copa (5 cm x 5 cm - 25 cm²) 99100743 Cutimed Siltec (5 cm x 6 cm - 30 cm²) 99100665 Optifoam Basic (7,6 cm x 7,6 cm - 58 cm²) 1 1.95 S. & N. 1 1.75 S. & N. 1 1.78 Coloplast 10 13.83 1.3830 Convatec 10 33.54 3.3540 Tyco BSN Med 25 10 36.25 17.07 1.4500 1.7070 Medline 200 102.05 0.5103 More than 500 cm² (active surface) 3M Canada 1 25.78 Mölnlycke 2 86.00 Page 368 43.0000 Sacrum or triangular S. & N. 1 9.39 S. & N. 1 17.05 Convatec 1 8.62 Convatec 1 14.39 Mölnlycke 5 47.90 9.5800 Mölnlycke 5 69.80 13.9600 Systagenix 10 63.33 6.3330 Thin dr. 99100034 Allevyn Thin (10 cm x 10 cm - 100 cm²) 99100749 Cutimed Siltec L (10 cm x 10 cm - 100 cm²) 99100133 Mepilex Lite (10 cm x 10 cm - 100 cm²) 99100704 Restore Advanced Lite Foam Dressing (10 cm x 12,5 cm-125cm²) UNIT PRICE S. & N. Dressing 99004259 Allevyn Sacrum (17 cm x 17 cm - 123 cm²) 99002957 Allevyn Sacrum (23 cm x 23 cm - 237 cm²) 99005018 Combiderm ACD (Triangular 15 cm x 18 cm - 96 cm²) 99100105 Combiderm ACD (Triangular 20 cm x 22.5 cm - 216 cm²) 99100447 Mepilex Border Sacrum (18 cm x 18 cm - 120 cm²) 99100448 Mepilex Border Sacrum (23 cm x 23 cm - 238 cm²) 99100001 Tielle Plus (Sacrum 15 cm x 15 cm - 70 cm²) COST OF PKG. SIZE Less than 100 cm² (active surface) Dressing 99100195 3M Tegaderm Foam Dressing (nonadhesive) (10cm x 60cm-600cm²) 99100604 Mepilex (20 cm x 50 cm 1 000 cm²) SIZE 100 cm² to 200 cm² (active surface) S. & N. 1 4.11 BSN Med 10 34.20 Mölnlycke 1 3.54 Hollister 10 31.79 3.4200 3.1790 2013-04 CODE BRAND NAME MANUFACTURER Thin dr. 99100035 Allevyn Thin (15 cm x 20 cm - 300 cm²) 99100750 Cutimed Siltec L (15 cm x 15 cm - 225 cm²) 99100134 Mepilex Lite (15 cm x 15 cm - 225 cm²) 99100707 Restore Advanced Foam Dressing (15 cm x 15 cm 225 cm²) 99100705 Restore Advanced Lite Foam Dressing (15 cm x 20 cm-300 cm²) 1 10.15 BSN Med 10 57.31 Mölnlycke 1 6.37 Hollister 10 67.03 6.7030 Hollister 10 89.37 8.9370 1 1.32 BSN Med 10 12.99 Mölnlycke 1 2.11 Hollister 10 22.32 1.2990 2.2320 More than 500 cm² (active surface) ABSORPTIVE DRESSING - SODIUM CHLORIDE Dressing Mölnlycke Dressing 2 77.38 38.6900 100 cm² to 200 cm² (active surface) 30 27.29 0.9097 201 cm² to 500 cm² (active surface) Tyco Dressing 00899429 Mesalt (5 cm x 5 cm 25 cm²) 00899518 Mesalt (7.5 cm X 7.5 cm 56 cm²) 5.7310 Less than 100 cm² (active surface) S. & N. 99100605 Mepilex Lite (20 cm x 50 cm Mölnlycke - 1 000 cm²) 99004712 Curasalt (15 cm x 17 cm 255 cm²) UNIT PRICE S. & N. Thin dr. 00899496 Mesalt (10 cm x 10 cm 100 cm²) COST OF PKG. SIZE 201 cm² to 500 cm² (active surface) Thin dr. 99100036 Allevyn Thin (5 cm x 6 cm 30 cm²) 99100748 Cutimed Siltec L (5 cm x 6 cm - 30 cm²) 99100132 Mepilex Lite (6.8 cm x 8.5 cm - 58 cm²) 99100706 Restore Advanced Lite Foam Dressing (6 cm x 6 cm - 36cm²) SIZE 96 202.04 2.1046 Less than 100 cm² (active surface) Mölnlycke 30 21.25 0.7083 Mölnlycke 30 22.99 0.7663 Strip 1m 00920525 Mesalt (1 m) 2013-04 Mölnlycke 10 44.70 4.4700 Page 369 CODE BRAND NAME MANUFACTURER SIZE ACAMPROSATE X L.A. Tab. 02293269 Campral Mylan 84 AbbVie Abbott 2 2 Gilead 30 Genzyme 1 Novartis 28 714.2400 714.2400 696.73 23.2243 840.31 150 mg Tab. 32.31 1.1539 300 mg 02302071 Rasilez Novartis 28 Novartis 28 ALISKIRENE/HYDROCHLOROTHIAZIDE X Tab. 02332728 Rasilez HCT 32.31 1.1539 150 mg- 12.5 mg Tab. 31.08 1.1100 150 mg - 25 mg 02332736 Rasilez HCT Novartis 28 02332744 Rasilez HCT Novartis 28 Tab. 31.08 1.1100 300 mg- 12.5 mg Tab. 31.08 1.1100 300 mg - 25 mg 02332752 Rasilez HCT Page 1428.48 1428.48 50 mg ALISKIREN X Tab. 02302063 Rasilez 0.8000 10 mg ALGLUCOSIDASE ALFA X I.V. Perf. Pd. 02284863 Myozyme 67.20 40 mg PPB ADEFOVIR DIPIVOXIL X Tab. 02247823 Hepsera UNIT PRICE 333 mg ADALIMUMAB X S.C. Inj.Sol (syr) 02258595 Humira 99100385 Humira (pen) COST OF PKG. SIZE 370 Novartis 28 31.08 1.1100 2013-04 CODE BRAND NAME MANUFACTURER SIZE AMBRISENTAN X Tab. COST OF PKG. SIZE UNIT PRICE 5 mg 02307065 Volibris GSK 30 02307073 Volibris GSK 30 Tab. 3600.00 120.0000 10 mg AMLODIPINE (BESYLATE)/ ATORVASTATIN CALCIUM X Tab. 02273233 Caduet Pfizer 3600.00 120.0000 5 mg -10 mg 90 Tab. 67.96 0.7551 5 mg - 20 mg 02273241 Caduet Pfizer 90 02273268 Caduet Pfizer 90 Tab. 77.32 0.8591 5 mg - 40 mg Tab. 80.83 0.8981 5 mg - 80 mg 02273276 Caduet Pfizer 90 02273284 Caduet Pfizer 90 Tab. 80.83 0.8981 10 mg -10 mg Tab. 82.75 0.9194 10 mg - 20 mg 02273292 Caduet Pfizer 90 02273306 Caduet Pfizer 90 Tab. 92.11 1.0234 10 mg - 40 mg Tab. 95.62 1.0624 10 mg - 80 mg 02273314 Caduet Pfizer 90 Shire 100 AMPHETAMINE (MIXED SALTS) Y L.A. Caps. 02248808 Adderall XR 2013-04 1.0624 5 mg L.A. Caps. 02248809 Adderall XR 95.62 205.78 2.0578 10 mg Shire 100 233.86 2.3386 Page 371 CODE BRAND NAME MANUFACTURER SIZE L.A. Caps. 02248810 Adderall XR Shire 100 Shire 100 290.01 Shire 100 Shire 100 2.9001 318.09 Phmscience 60 54.00 S. & N. 5g 10 g 17 g 8.49 16.99 28.86 S. & N. 10 g 20 g 40 g 13.72 27.44 54.88 3.1809 30 mg ANETHOLE TRITHIONE Tab. 02240344 Sialor 2.6194 25 mg L.A. Caps. 02248813 Adderall XR 261.94 20 mg L.A. Caps. 02248812 Adderall XR UNIT PRICE 15 mg L.A. Caps. 02248811 Adderall XR COST OF PKG. SIZE 346.18 3.4618 25 mg 0.9000 ANTIMICROBIAL DRESSING - IODINE Paste 99100098 Iodosorb Top. Oint. 99100099 Iodosorb Page 372 2013-04 CODE BRAND NAME MANUFACTURER ANTIMICROBIAL DRESSING - SILVER Dressing 99100348 3M - Tegaderm Ag Mesh (10 cm x 12.7 cm - 127cm²) 99100349 3M Tegaderm Ag Mesh (10 cm x 20 cm - 200 cm²) 99100852 3M Tegaderm- Alginate Ag silver dressing 10,2 x 12,7-129 cm² 99100559 Allevyn Ag Gentle (10 cm x 10 cm - 100 cm²) 99100456 Allevyn Ag Non-Adhesive (10 cm x 10 cm - 100 cm²) 99100324 Biatain Ag Non-Adhesive (10 cm x 10 cm - 100 cm²) 99100325 Biatain Ag Non-Adhesive (10 cm x 20 cm - 200 cm²) 99100541 Biatain Alginate Ag (10 cm x 10 cm - 100 cm²) 99100545 Melgisorb Ag (10 cm x 10 cm - 100 cm²) 99100366 Mepilex Ag (10 cm x 10 cm 100 cm²) 99100367 Mepilex Ag (10 cm x 20 cm 179 cm²) 99100663 Optifoam Ag Non-Adhesive (10 cm x 10 cm - 100 cm²) 99100579 Restore Dressing alginate calcium Silver 10.2x12-122 cm² 99100562 Restore Foam Dressing Silver sulphate 10 cm x 10 cm 100 cm² 99100288 Silvercel (10 cm x 20 cm 200 cm²) 99100289 Silvercel (11 cm x 11 cm 121 cm²) 2013-04 SIZE COST OF PKG. SIZE UNIT PRICE 100 cm² to 200 cm² (active surface) 3M Canada 1 5.24 3M Canada 1 7.94 3M Canada 10 59.70 5.9700 S. & N. 10 74.10 7.4100 S. & N. 10 74.10 7.4100 Coloplast 5 33.25 6.6500 Coloplast 5 66.50 13.3000 Coloplast 10 52.50 5.2500 Mölnlycke 10 59.74 5.9740 Mölnlycke 5 34.33 6.8660 Mölnlycke 5 64.67 12.9340 Medline 100 453.00 4.5300 Hollister 10 89.33 8.9330 Hollister 10 83.27 8.3270 Systagenix 5 80.44 16.0880 Systagenix 10 96.00 9.6000 Page 373 CODE BRAND NAME MANUFACTURER Dressing 99100350 3M Tegaderm Ag Mesh (20 cm x 20 cm - 400 cm²) 99100560 Allevyn Ag Gentle (15 cm x 15 cm - 225 cm²) 99100561 Allevyn Ag Gentle (20 cm x 20 cm - 400 cm²) 99100457 Allevyn Ag Non-Adhesif (20 cm x 20 cm - 400 cm²) 99100455 Allevyn Ag Non-Adhesive (15 cm x 15 cm - 225 cm²) 99100326 Aquacel AG (14.5 cm x 14.5 cm - 210 cm²) 99100595 Biatain Ag Non-Adhesive (15 cm x 15 cm - 225 cm²) 99100329 Biatain Ag Non-Adhesive (20 cm x 20 cm - 400 cm²) 99100543 Melgisorb Ag (15 cm x 15 cm - 225 cm²) 99100368 Mepilex Ag (15 cm x 15 cm 225 cm²) 99100369 Mepilex Ag (20 cm x 20 cm 400 cm²) 99100825 Restore Foam Dressing Silver (15 cm x 20 cm 300 cm²) Page 374 COST OF PKG. SIZE UNIT PRICE 201 cm² to 500 cm² (active surface) 3M Canada 1 15.52 S. & N. 10 157.50 15.7500 S. & N. 10 280.40 28.0400 S. & N. 10 283.96 28.3960 S. & N. 10 159.50 15.9500 Convatec 5 93.02 18.6040 Coloplast 5 74.81 14.9620 Coloplast 5 124.80 24.9600 Mölnlycke 10 102.29 10.2290 Mölnlycke 5 77.06 15.4120 Mölnlycke 5 124.83 24.9660 Hollister 10 194.40 19.4400 Dressing 99100347 3M Tegaderm Ag Mesh (5 cm x 5 cm - 25 cm²) 99100851 3M Tegaderm- Alginate Ag silver dressing 5.1 x 5,1-26cm² 99100557 Allevyn Ag Gentle (5 cm x 5 cm - 25 cm²) 99100450 Allevyn Ag Non-Adhesive (5 cm x 5 cm - 25 cm²) 99100338 Aquacel AG (9.5 cm x 9.5 cm - 90 cm²) 99100594 Biatain Ag Non-Adhesive (5 cm x 7 cm - 35 cm²) 99100544 Melgisorb Ag (5 cm x 5 cm 25 cm²) 99100824 Restore Calcium Alginate Dressing, Silver (5cm x 5cm-25 cm²) 99100287 Silvercel (5 cm x 5 cm 25 cm²) SIZE Less than 100 cm² (active surface) 3M Canada 1 2.55 3M Canada 10 27.50 2.7500 S. & N. 10 43.02 4.3020 S. & N. 10 43.02 4.3020 Convatec 10 102.78 10.2780 Coloplast 5 11.64 2.3280 Mölnlycke 10 27.75 2.7750 Hollister 10 27.50 2.7500 Systagenix 10 31.70 3.1700 2013-04 CODE BRAND NAME MANUFACTURER Dressing SIZE COST OF PKG. SIZE UNIT PRICE More than 500 cm² (active surface) 99100235 Acticoat (20 cm x 40 cm 600 cm2) 99100236 Acticoat (40 cm x 40 cm 1 600 cm²) 99100593 Acticoat Flex 3 (40 cm x 40 cm - 1 600 cm²) 99100328 Aquacel AG (19.5 cm x 29.5 cm - 575 cm²) 99100596 Mepilex Ag (20 cm x 50 cm 1 000 cm²) S. & N. 1 66.28 S. & N. 1 130.27 S. & N. 6 781.62 130.2700 Convatec 5 224.00 44.8000 Mölnlycke 2 106.20 53.1000 S. & N. 10 151.40 15.1400 S. & N. 10 244.30 24.4300 Coloplast 5 100.00 20.0000 Dressing Sacrum 99100451 Allevyn Ag Adhesive Sacrum (17 cm x 17 cm 123 cm²) 99100452 Allevyn Ag Adhesive Sacrum (23 cm x 23 cm 237 cm²) 99100247 Biatain Ag Adhesive (sacrum 23 cm x 23 cm 200 cm²) Dressing Sacrum or triangular 99100800 Mepilex Border Sacrum Ag (23 cm x 23 cm - 239 cm²) 99100801 Mepilex Border Sacrum Ag (18 cm x 18 cm - 121 cm²) Mölnlycke 1 22.87 Mölnlycke 1 13.09 APREPITANT X Caps. 80 mg 02298791 Emend Merck 2 02298805 Emend Merck 6 Caps. 60.36 30.1800 125 mg Caps. 181.08 30.1800 125mg (1 caps.) and 80mg (2 caps.) 02298813 Emend Tri-Pack Merck 3 Apotex Pro Doc Teva Can Phmscience Sandoz Lilly 30 30 30 30 30 28 ATOMOXETINE HYDROCHLORIDE X Caps. 02318024 02396904 02314541 02381028 02386410 02262800 2013-04 Apo-Atomoxetine Atomoxetine Novo-Atomoxetine pms-Atomoxetine Sandoz Atomoxetine Strattera 90.54 10 mg PPB 42.12 42.12 42.12 42.12 42.12 72.80 1.4040 1.4040 1.4040 1.4040 1.4040 2.6000 Page 375 CODE BRAND NAME MANUFACTURER SIZE Caps. UNIT PRICE 18 mg PPB 02318032 02396912 02378930 02314568 02381036 02386429 02262819 Apo-Atomoxetine Atomoxetine Mylan-Atomoxe Novo-Atomoxetine pms-Atomoxetine Sandoz Atomoxetine Strattera Apotex Pro Doc Mylan Teva Can Phmscience Sandoz Lilly 30 30 100 30 30 30 28 Caps. 48.28 48.28 160.93 48.28 48.28 48.28 83.44 1.6093 1.6093 1.6093 1.6093 1.6093 1.6093 2.9800 25 mg PPB 02318040 Apo-Atomoxetine Apotex 02396920 Atomoxetine Pro Doc 02378949 Mylan-Atomoxe 02314576 Novo-Atomoxetine 02381044 pms-Atomoxetine Mylan Teva Can Phmscience 02386437 Sandoz Atomoxetine 02262827 Strattera Sandoz Lilly 30 100 30 100 100 30 30 100 30 28 Caps. 53.30 177.67 53.30 177.67 177.67 53.30 53.30 177.67 53.30 92.12 1.7767 1.7767 1.7767 1.7767 1.7767 1.7767 1.7767 1.7767 1.7767 3.2900 40 mg PPB 02318059 Apo-Atomoxetine Apotex 02396939 Atomoxetine Pro Doc 02378957 Mylan-Atomoxe 02314584 Novo-Atomoxetine 02381052 pms-Atomoxetine Mylan Teva Can Phmscience 02386445 Sandoz Atomoxetine 02262835 Strattera Sandoz Lilly 02318067 Apo-Atomoxetine Apotex 02396947 Atomoxetine Pro Doc 02378965 Mylan-Atomoxe 02314592 Novo-Atomoxetine 02381060 pms-Atomoxetine Mylan Teva Can Phmscience 02386453 Sandoz Atomoxetine 02262843 Strattera Sandoz Lilly 30 100 30 100 100 30 30 100 30 28 Caps. 60.75 202.50 60.75 202.50 202.50 60.75 60.75 202.50 60.75 105.00 2.0250 2.0250 2.0250 2.0250 2.0250 2.0250 2.0250 2.0250 2.0250 3.7500 60 mg PPB 30 100 30 100 100 30 30 100 30 28 AXITINIB X Tab. 02389630 Inlyta Page COST OF PKG. SIZE 376 67.39 224.63 67.39 224.63 224.63 67.39 67.39 224.63 67.39 116.48 2.2463 2.2463 2.2463 2.2463 2.2463 2.2463 2.2463 2.2463 2.2463 4.1600 1 mg Pfizer 60 1116.00 18.6000 2013-04 CODE BRAND NAME MANUFACTURER SIZE Tab. COST OF PKG. SIZE UNIT PRICE 5 mg 02389649 Inlyta Pfizer 60 Bayer 50 g 02374757 Co Betahistine 02280191 Novo-Betahistine 02243878 Serc Cobalt Novopharm Abbott 100 100 100 02374765 Co Betahistine 02280205 Novo-Betahistine 02247998 Serc Cobalt Novopharm Abbott 100 100 100 02273411 Bisacodyl-Odan Odan 02246039 Jamp-Bisacodyl Jamp 100 1000 100 00582883 pms-Bisacodyl Phmscience 100 AZELAIC ACID X Top. Jel. 02270811 Finacea 5580.00 93.0000 15 % BETAHISTINE DIHYDROCHLORIDE X Tab. 30.00 0.6000 16 mg PPB Tab. 24.19 24.19 45.99 0.2419 0.2419 0.4599 24 mg PPB BISACODYL Ent. Tab. 36.29 36.29 68.97 0.3629 0.3629 0.6897 5 mg PPB Supp. 4.05 40.50 4.05 0.0405 0.0405 0.0405 10 mg BOCEPREVIR X Caps. 02370816 Victrelis 50.14 0.5014 200 mg Merck 168 1890.00 11.2500 BOCEPREVIR/RIBAVIRIN/INTERFERON ALFA-2B (PEGYLATED) X Kit 200 mg - 200 mg - 80 mcg/0.5 mL 02371448 Victrelis Triple Merck 02371456 Victrelis Triple Merck Kit 1 2652.55 200 mg - 200 mg - 100 mcg/0.5 mL Kit 1 2652.55 200 mg - 200 mg - 120 mcg/0.5 mL 02371464 Victrelis Triple 2013-04 Merck 1 2726.00 Page 377 CODE BRAND NAME MANUFACTURER Kit SIZE COST OF PKG. SIZE UNIT PRICE 200 mg - 200 mg - 150 mcg/0.5 mL 02371472 Victrelis Triple (84) 99100893 Victrelis Triple (98) Merck Merck 1 1 2726.00 2726.00 BORDERED ABSORPTIVE DRESSING - GELLING FIBRE Dressing 100 cm² to 200 cm² (active surface) 99100944 Aquacel foam (17.5 cm x Convatec 17.5 cm - 182 cm²) 99100469 Versiva XC Adhesive (14cm Convatec x 14cm - 100 cm²) 99100470 Versiva XC Adhesive Convatec (19 cm x 19 cm - 196 cm²) Dressing 99100942 Aquacel foam (21 cm x 21 cm - 289 cm²) 99100943 Aquacel foam (25 cm x 30 cm - 456 cm²) 99100471 Versiva XC Adhesive (22 cm x 22 cm - 289 cm²) 112.08 11.2080 10 70.51 7.0510 5 69.15 13.8300 201 cm² to 500 cm² (active surface) Convatec 5 77.02 15.4040 Convatec 5 121.52 24.3040 Convatec 5 93.49 18.6980 Dressing 99100464 Versiva XC Adhesive (10 cm x 10 cm - 49 cm²) 10 Less than 100 cm² (active surface) Convatec 10 Dressing 99100945 Aquacel foam (16.9 cm x Convatec 20 cm - 115 cm²) 99100465 Versiva XC - Sacrum (21 cm Convatec x 25 cm - 218 cm²) Page 378 41.68 4.1680 Sacrum 5 43.00 8.6000 5 90.62 18.1240 2013-04 CODE BRAND NAME MANUFACTURER SIZE COST OF PKG. SIZE UNIT PRICE BORDERED ABSORPTIVE DRESSING - HYDROPHILIC FOAM ALONE OR IN ASSOCIATION Dressing 100 cm² to 200 cm² (active surface) 99100199 3M Tegaderm Foam Adhesive Dressing (14.3cm x 14.3cm-100 cm²) 99100854 3M Tegaderm- Foam adhesive dressing 19cm x 22,2 cm-188cm² 99001667 Allevyn Adhesive (12.5 cm x 12.5 cm - 100 cm²) 99004585 Allevyn Adhesive (12.5 cm x 22.5 cm - 200 cm²) 99100476 Allevyn Gentle Border (12.5 cm x 12.5 cm 100 cm²) 99100032 Allevyn Plus Adhesif (12.5 cm x 22.5 cm 200 cm²) 99100031 Allevyn Plus Adhesive (12.5 cm x 12.5 xcm 100 cm²) 99100139 Biatain Adhesive (18 cm x 18 cm - 196 cm²) 99100654 Biatain Silicone (15 cm x 15 cm - 104 cm²) 99100742 Biatain Silicone (17,5 cm x 17,5 cm - 156 cm²) 99005026 Combiderm ACD (15 cm x 25 cm - 200 cm²) 99100752 Cutimed Siltec B (15 cm x 15 cm - 100 cm²) 99100753 Cutimed Siltec B (17,5 cm x 17,5 cm - 144 cm²) 99004321 Mepilex Border (15 cm x 15 cm - 121 cm²) 99004348 Mepilex Border (15 cm x 20 cm - 168 cm²) 99100661 Optifoam (15,2 cm x 15,2 cm - 131 cm²) 99100796 Restore Advanced Foam Dressing Adhesive 15 x 15 100 cm² 99100797 Restore Advanced Foam Dressing Adhesive 15 x 20 -125 cm² 99004623 Tielle (15 cm x 15 cm 121 cm²) 99001799 Tielle (15 cm x 20 cm 176 cm²) 99001675 Tielle (18 cm x 18 cm 196 cm²) 99100012 Tielle Plus (15 cm x 15 cm 121 cm²) 99004895 Tielle Plus (15 cm x 20 cm 176 cm²) 2013-04 3M Canada 1 6.87 3M Canada 5 55.00 11.0000 S. & N. 10 58.65 5.8650 S. & N. 10 110.18 11.0180 S. & N. 10 59.00 5.9000 S. & N. 1 12.41 S. & N. 1 6.39 Coloplast 5 52.92 10.5840 Coloplast 5 32.75 6.5500 Coloplast 5 48.95 9.7900 Convatec 1 12.00 BSN Med 10 58.00 5.8000 BSN Med 5 43.61 8.7220 Mölnlycke 1 7.96 Mölnlycke 1 11.77 Medline 100 440.30 4.4030 Hollister 10 62.00 6.2000 Hollister 10 77.50 7.7500 Systagenix 10 88.48 8.8480 Systagenix 5 63.31 12.6620 Systagenix 5 56.13 11.2260 Systagenix 10 88.48 8.8480 Systagenix 5 64.35 12.8700 Page 379 CODE BRAND NAME MANUFACTURER Dressing 99001659 Allevyn Adhesive (17,5 cm x 17,5 cm - 225 cm2) 99001896 Allevyn Adhesive (22.5 cm x 22.5 cm - 400 cm²) 99100477 Allevyn Gentle Border (17.5 cm x 17.5 cm 225 cm²) 99100033 Allevyn Plus Adhesive (17.5 cm x 17.5 cm 225 cm²) 99004526 Combiderm ACD (20 cm x 20 cm - 225 cm²) 99100754 Cutimed Siltec B (22,5 cm x 22,5 cm - 272 cm²) Page 380 SIZE COST OF PKG. SIZE UNIT PRICE 201 cm² to 500 cm² (active surface) S. & N. 1 11.72 S. & N. 1 22.41 S. & N. 10 118.00 S. & N. 1 12.60 Convatec 5 51.54 10.3080 BSN Med 5 66.86 13.3720 11.8000 2013-04 CODE BRAND NAME MANUFACTURER Dressing 99100198 3M Tegaderm Foam Adhesive Dressing (10 cm x 11 cm - 46 cm²) 99100197 3M Tegaderm Foam Adhesive Dressing (8.8 cm x 8.8 cm-25 cm²) 99100853 3M Tegaderm- Foam adhesive dressing 14,3 x 15,6 - 86 cm² 99001713 Allevyn Adhesive (7.5 cm x 7.5 cm - 25 cm²) 99100474 Allevyn Gentle Border (10 cm x 10 cm - 56 cm²) 99100612 Biatain Adhesif (10 cm x 10 cm - 28,3 cm²) 99100613 Biatain Adhesif (7,5 cm x 7,5 cm - 12,6 cm²) 99100137 Biatain Adhesive (12.5 cm x 12.5 cm - 64 cm²) 99100820 Biatain Silicone (10 cm x 10 cm - 36 cm²) 99100653 Biatain Silicone (12,5 cm x 12,5 cm - 64 cm²) 99004968 Combiderm ACD (10 cm x 10 cm - 49 cm²) 99001853 Combiderm ACD (13 cm x 13 cm - 81 cm²) 99100751 Cutimed Siltec B (12,5 cm x 12,5 cm - 64 cm²) 99004313 Mepilex Border (10 cm x 10 cm - 42 cm²) 99100445 Mepilex Border (10 cm x 20 cm - 96 cm²) 99100355 Mepilex Border (12.5 cm x 12.5 cm - 72 cm²) 99100606 Mepilex Border (7,5 cm x 7,5 cm - 25 cm²) 99100660 Optifoam (10,2 cm x 10,2 cm - 40 cm²) 99001683 Tielle (11 cm x 11 cm 49 cm²) 99100538 Tielle (7 cm x 9 cm - 15 cm²) 99004887 Tielle Plus (11 cm x 11 cm 49 cm²) 2013-04 COST OF PKG. SIZE UNIT PRICE Less than 100 cm² (active surface) 3M Canada 1 4.41 3M Canada 1 2.68 3M Canada 5 25.00 5.0000 S. & N. 10 24.14 2.4140 S. & N. 10 49.00 4.9000 Coloplast 10 27.10 2.7100 Coloplast 10 12.10 1.2100 Coloplast 10 44.80 4.4800 Coloplast 10 32.00 Coloplast 10 52.00 Convatec 1 3.20 Convatec 10 45.83 4.5830 BSN Med 10 52.00 5.2000 Mölnlycke 1 4.55 Mölnlycke 5 44.17 8.8340 Mölnlycke 5 29.45 5.8900 Mölnlycke 5 11.90 2.3800 Medline 100 243.10 2.4310 Systagenix 10 54.78 5.4780 Systagenix Systagenix 10 10 16.78 55.07 1.6780 5.5070 Thin dr. 99100887 Allevyn Gentle Border Lite (15 cm x 15 cm - 146 cm²) 99100297 Mepilex Border Lite (15 cm x 15 cm - 121 cm²) SIZE 5.2000 100 cm² to 200 cm² (active surface) S. & N. 10 59.95 5.9950 Mölnlycke 5 24.88 4.9760 Page 381 CODE BRAND NAME MANUFACTURER Thin dr. 99100886 Allevyn Gentle Border Lite (10 cm x 10 cm - 52 cm²) 99100885 Allevyn Gentle Border Lite (5.5 cm x 12 cm - 27 cm²) 99100884 Allevyn Gentle Border Lite (7,5 cm x 7.5 cm - 23 cm²) 99100890 Biatain Silicone Lite (12.5 cm x 12.5 cm 64 cm²) 99100296 Mepilex Border Lite (10 cm x 10 cm - 42 cm²) 99100293 Mepilex Border Lite (4 cm x 5 cm - 6 cm²) 99100294 Mepilex Border Lite (5 cm x 12.5 cm - 21 cm²) 99100295 Mepilex Border Lite (7.5 cm x 7.5 cm - 20 cm²) SIZE COST OF PKG. SIZE UNIT PRICE Less than 100 cm² (active surface) S. & N. 10 36.83 3.6830 S. & N. 10 25.69 2.5690 S. & N. 10 20.15 2.0150 Coloplast 10 27.80 2.7800 Mölnlycke 5 14.94 2.9880 Mölnlycke 10 13.89 1.3890 Mölnlycke 5 10.68 2.1360 Mölnlycke 5 8.90 1.7800 BORDERED ABSORPTIVE DRESSING - POLYESTER AND RAYON FIBRE Dressing 100 cm² to 200 cm² (active surface) 00920509 Alldress (15 cm x 15 cm 100 cm²) 00920495 Alldress (15 cm x 20 cm 150 cm²) Mölnlycke 10 28.80 2.8800 Mölnlycke 10 36.70 3.6700 Dressing 00920487 Alldress (10 cm x 10 cm 25 cm²) Less than 100 cm² (active surface) Mölnlycke BORDERED ANTIMICROBIAL DRESSING - SILVER Dressing 99100453 Allevyn Ag Adhesive (12.5 cm x 12.5 cm 100 cm²) 99100564 Allevyn Ag Gentle Border (12.5 cm x 12.5 cm 100 cm²) 99100597 Biatain Ag Adhesive (18 cm x 18 cm - 169 cm²) 99100799 Mepilex Border Ag (10 cm x 25 cm - 99 cm²) 99100712 Mepilex Border Ag (15 cm x 15 cm - 121 cm²) 99100713 Mepilex Border Ag (15 cm x 20 cm - 168 cm²) Page 382 10 23.80 2.3800 100 cm² to 200 cm² (active surface) S. & N. 10 118.19 11.8190 S. & N. 10 118.19 11.8190 Coloplast 5 92.95 18.5900 Mölnlycke 1 15.67 Mölnlycke 1 13.87 Mölnlycke 1 19.86 2013-04 CODE BRAND NAME MANUFACTURER Dressing 99100454 Allevyn Ag Adhesive (17.5 cm x 17.5 cm 225 cm²) 99100565 Allevyn Ag Gentle Border (17.5 cm x 17.5 cm 225 cm²) COST OF PKG. SIZE UNIT PRICE 201 cm² to 500 cm² (active surface) S. & N. 10 276.70 27.6700 S. & N. 10 276.70 27.6700 Dressing 99100449 Allevyn Ag Adhesive (7.5 cm x 7.5 cm - 25 cm²) 99100563 Allevyn Ag Gentle Border (7.5 cm x 7.5 cm - 25 cm²) 99100245 Biatain Ag Adhesive (12.5 cm x 12.5 cm 64 cm²) 99100598 Biatain Ag Adhesive (7,5 cm x 7,5 cm - 12,6 cm²) 99100926 Biatain Silicone Ag (10 cm x 10 cm - 30 cm²) 99100927 Biatain Silicone Ag (12,5 cm x 12,5 cm - 64 cm²) 99100710 Mepilex Border Ag (10 cm x 10 cm - 42 cm²) 99100798 Mepilex Border Ag (10 cm x 20 cm - 96 cm²) 99100711 Mepilex Border Ag (7,5 cm x 7,5 cm - 25 cm²) 99100662 Optifoam Ag Adhesive (10 cm x 10 cm - 40 cm²) SIZE Less than 100 cm² (active surface) S. & N. 10 53.00 5.3000 S. & N. 10 53.00 5.3000 Coloplast 5 35.20 7.0400 Coloplast 5 13.20 2.6400 Coloplast 5 24.75 4.9500 Coloplast 5 50.55 10.1100 Mölnlycke 1 6.94 Mölnlycke 1 13.88 Mölnlycke 1 4.67 Medline 100 433.00 4.3300 BORDERED MOISTURE-RETENTIVE DRESSING - HYDROCOLLOIDAL OR POLYURETHANE Dressing 100 cm² to 200 cm² (active surface) 00800961 3M Tegaderm Hydrocolloid Dressing (17 cm x 20 cm 187 cm²) 00907707 DuoDERM CGF Border (14 cm x 14 cm - 100 cm²) 3M Canada 1 6.50 Convatec 1 4.39 Dressing 00907715 DuoDERM CGF Border (20 cm x 20 cm - 225 cm²) 201 cm² to 500 cm² (active surface) Convatec Dressing 00801038 3M Tegaderm Hydrocolloid Dressing (10 cm x 12 cm 50 cm²) 00801003 3M Tegaderm Hydrocolloid Dressing (13 cm x 15 cm 94 cm²) 00907804 DuoDERM CGF Border (10 cm x 10 cm - 36 cm²) 2013-04 1 11.35 Less than 100 cm² (active surface) 3M Canada 1 2.99 3M Canada 1 4.00 Convatec 1 2.31 Page 383 CODE BRAND NAME MANUFACTURER SIZE Dressing UNIT PRICE Sacrum 99100855 Tegaderm 3M-Pansement hydrocolloide 16,1cm x 17,1cm-172cm² 3M Canada Thin dr. 6 54.81 9.1350 100 cm² to 200 cm² (active surface) 99100292 3M Tegaderm Hydrocolloid Thin Dressing (17cm x 20cm-187cm²) 3M Canada Thin dr. 1 5.61 Less than 100 cm² (active surface) 99100291 3M Tegaderm Hydrocolloid Thin Dressing (13 cm x 15 cm-94cm²) 99100857 3M Tegaderm- Hydrocolloid thin dressing 10cm x 12cm-63cm² 3M Canada 1 3.38 3M Canada 10 19.56 BOSENTAN X Tab. 1.9560 62.5 mg PPB 02386194 02383497 02383012 02386275 02244981 Co Bosentan Mylan-Bosentan pms-Bosentan Sandoz Bosentan Tracleer Cobalt Mylan Phmscience Sandoz Actelion 60 56 60 60 56 02386208 02383500 02383020 02386283 02244982 Co Bosentan Mylan-Bosentan pms-Bosentan Sandoz Bosentan Tracleer Cobalt Mylan Phmscience Sandoz Actelion 60 56 60 60 56 Allergan 1 Tab. 1347.75 1257.90 1347.75 1347.75 3594.00 22.4625 22.4625 22.4625 22.4625 64.1786 125 mg PPB BOTULINUM TOXIN TYPE A X I.M. Inj. Pd. 99100741 Botox 01981501 Botox 384 22.4625 22.4625 22.4625 22.4625 64.1786 178.50 100 UI Allergan 1 Allergan 1 I.M. Inj. Pd. 99100646 Botox 1347.75 1257.90 1347.75 1347.75 3594.00 50 UI I.M. Inj. Pd. Page COST OF PKG. SIZE 357.00 200 UI 714.00 2013-04 CODE BRAND NAME MANUFACTURER SIZE BOTULINUM TOXIN TYPE A FREE FROM COMPLEXING PROTEINS X I.M. Inj. Pd. 02324032 Xeomin Merz 1 RB Pharma 7 RB Pharma 7 * Cobalt Paladin 8 8 60 g Leo 60 g 120 g Jamp Jamp Oral Sol. 80025038 SoluCAL D Fort 350 ml 1500 ml 2013-04 7.5900 13.2150 84.22 1.4037 84.22 168.43 1.4037 1.4036 15.60 66.06 0.0446 0.0440 500 mg - 400 UI/25 mL 350 ml 16.33 0.0467 500 mg - 1000 U.I./25ml Jamp 350 ml CAPECITABINE X Tab. 02238453 Xeloda 60.72 105.72 100 mg/5 mL CALCIUM GLUCONATE/CALCIUM LACTATE/VITAMIN D Oral Sol. 99100830 SoluCAL D (all flavours) 4.7300 50 mcg/g -0.5 mg/g CALCIUM GLUCONATE/CALCIUM LACTATE Oral Sol. 99100833 SoluCAL (all flavours) 33.11 50 mcg/g -0.5 mg/g Leo Top. Oint. 02244126 Dovobet 2.6700 0.5 mg PPB CALCIPOTRIOL/ BETAMETHASONE DIPROPIONATE X Top. Jel. 02319012 Dovobet Gel 18.69 8 mg - 2 mg CABERGOLINE X Tab. 02301407 Co Cabergoline 02242471 Dostinex 330.00 2 mg - 0.5 mg S-Ling. Tab. 02295709 Suboxone UNIT PRICE 100 UI BUPRENORPHINE/NALOXONE Z S-Ling. Tab. 02295695 Suboxone COST OF PKG. SIZE 16.33 0.0467 150 mg Roche 60 109.80 1.8300 Page 385 CODE BRAND NAME MANUFACTURER SIZE Tab. UNIT PRICE 500 mg 02238454 Xeloda Roche 120 Allergan 30 CARBOXYMETHYLCELLULOSE SODIUM Oph. Sol. 02049260 Refresh plus 00870153 Celluvisc Allergan 30 Allergan 15 ml 1 Merck 1 Serono 1 Serono 1 222.00 222.00 90.00 340.00 250 mcg Serono 1 Amgen 30 CINACALCET HYDROCHLORIDE X Tab. 02257130 Sensipar 6.25 3 mg CHORIOGONADOTROPIN ALFA X S.C. Inj.Sol (syr) 02262088 Ovidrel 0.3193 0.25 mg S.C. Inj. Pd. 02247767 Cetrotide 9.58 70 mg CETRORELIX X S.C. Inj. Pd. 02247766 Cetrotide 0.2950 50 mg Merck I.V. Inj. Pd. 02244266 Cancidas 8.85 0.5 % CASPOFUNGIN ACETATE X I.V. Inj. Pd. 02244265 Cancidas 6.1000 1 % (0.4 mL) CARBOXYMETHYLCELLULOSE SODIUM/ PURITE Oph. Sol. 02231008 Refresh tears 732.00 0.5 % (0.4 mL) Oph. Sol. 72.00 30 mg Tab. 323.52 10.7840 60 mg 02257149 Sensipar Page COST OF PKG. SIZE 386 Amgen 30 589.81 19.6603 2013-04 CODE BRAND NAME MANUFACTURER SIZE Tab. COST OF PKG. SIZE UNIT PRICE 90 mg 02257157 Sensipar Amgen 30 CIPROFLOXACIN HYDROCHLORIDE X I.V. Perf. Sol. 02267462 Ciprofloxacine Perfusion Intravenous 100 ml 200 ml Paladin 40 g 1 02252767 Apo-Clopidrogel Apotex 02394820 Clopidogrel Pro Doc 02385813 Clopidogrel Sivem 02303027 Co Clopidogrel Cobalt 02351536 Mylan-Clopidogrel Mylan 02238682 Plavix SanofiAven 02348004 Pms-Clopidrogel Phmscience 02379813 Ran-Clopidogrel Ranbaxy 02388529 Riva-Clopidogrel Riva 02359316 Sandoz Clopidogrel Sandoz 02293161 Teva Clopidogrel Teva Can 30 500 30 500 30 500 30 500 100 500 28 500 30 500 100 500 30 500 100 500 30 500 CLOPIDOGREL BISULFATE X Tab. 20.98 75 mg PPB CODEINE PHOSPHATE Z Syr. 2013-04 26.26 2% Ferring 00050024 Codeine 10.27 20.50 20 mg/g Vag. cr. (single-dose) 02306514 Clindesse 28.6143 2 mg/mL Novopharm CLINDAMYCIN PHOSPHATE X Vag. Cr. 02060604 Dalacin C 858.43 19.73 328.80 19.73 328.80 19.73 328.80 19.73 328.80 65.76 328.80 74.23 1325.60 19.73 328.80 65.76 328.80 19.73 328.80 65.76 328.80 19.73 328.80 0.6576 0.6576 0.6576 0.6576 0.6576 0.6576 0.6576 0.6576 0.6576 0.6576 2.6511 2.6512 0.6576 0.6576 0.6576 0.6576 0.6576 0.6576 0.6576 0.6576 0.6576 0.6576 25 mg/5 mL Atlas 500 ml 2000 ml 19.43 62.71 0.0389 0.0314 Page 387 CODE BRAND NAME MANUFACTURER SIZE COLESEVELAM (CHLORHYDRATE DE) X Tab. 02373955 Lodalis UNIT PRICE 625 mg Valeant 180 COLLAGENASE X Top. Oint. 02063670 Santyl COST OF PKG. SIZE 198.00 1.1000 250 U/g Health-ULC 30 g Jamp 500 87.50 2.9167 CYANOCOBALAMIN L. A tab 80021427 Jamp-Vitamin B12 L.A. 1200 mcg Oral Sol. 80026092 Jamp-Vitamine B12 Jamp 350 ml 12.50 0.0357 110 mg Bo. Ing. 60 Caps. 96.00 1.6000 150 mg 02358808 Pradaxa Bo. Ing. 60 DARBEPOETINE ALFA X Syringe 02246354 Aranesp 02246355 Aranesp Amgen 4 Amgen 4 Amgen 4 Amgen 4 388 26.8000 214.40 53.6000 321.60 80.4000 40 mcg/0.4 mL Syringe 99004925 Aranesp 107.20 30 mcg/0.3 mL Syringe 99004917 Aranesp 1.6000 20 mcg/0.5 mL Syringe 02246357 Aranesp 96.00 10 mcg/0.4 mL Syringe Page 0.1050 200 mcg/mL DABIGATRAN ETEXILATE X Caps. 02312441 Pradaxa 52.50 428.80 107.2000 50 mcg/0.5 mL Amgen 4 536.00 134.0000 2013-04 CODE BRAND NAME MANUFACTURER SIZE Syringe 02246358 Aranesp Amgen 4 Amgen 4 Amgen 4 Amgen 4 Amgen 4 Amgen 1 Amgen 1 Amgen 1 1393.60 348.4000 1608.00 402.0000 536.00 Janss. Inc 60 828.00 500 mcg/1.0 mL DARUNAVIR X Tab. 02324024 Prezista 268.0000 300 mcg/0.6 mL Syringe 99100211 Aranesp 1072.00 200 mcg/0.4 mL Syringe 99100210 Aranesp 214.4000 150 mcg/0.3 mL Syringe 99100209 Aranesp 857.60 130 mcg/0.65 mL Syringe 02246360 Aranesp 160.8000 100 mcg/0.5 mL Syringe 99100364 Aranesp 643.20 80 mcg/0.4 mL Syringe 99004909 Aranesp UNIT PRICE 60 mcg/0.3 mL Syringe 99004933 Aranesp COST OF PKG. SIZE 1380.00 600 mg DASATINIB X Tab. 877.62 14.6270 20 mg 02293129 Sprycel B.M.S. 60 02293137 Sprycel B.M.S. 60 Tab. 2195.08 36.5847 50 mg Tab. 4390.13 73.1688 70 mg 02293145 Sprycel 2013-04 B.M.S. 60 4841.45 80.6908 Page 389 CODE BRAND NAME MANUFACTURER SIZE Tab. UNIT PRICE 100 mg 02320193 Sprycel B.M.S. 30 Amgen 1 DENOSUMAB X Inj. Sol. 02368153 Xgeva 02343541 Prolia Amgen 1 538.45 330.00 0.7 mg Allergan 1 DICLOFENAC SODIUM X Oph. Sol. 01940414 Voltaren Ophta 146.3377 60 mg/mL DEXAMETHASONE X Implant intravitreal 02363445 Ozurdex 4390.13 120 mg/1.7 mL S.C. Inj.Sol (syr) 1295.00 0.1 % Alcon 2.5 ml 5 ml 10 ml DIPHENHYDRAMINE HYDROCHLORIDE Caps. or Tab. 6.30 12.60 25.21 25 mg PPB 02257548 Jamp-Diphenhydramine Jamp 02239029 Nadryl 25 00757683 pms-Diphenhydramine Riva Phmscience 02298503 Jamp-Diphenhydramine Jamp 00792705 pms-Diphenhydramine Phmscience Elix. 250 500 100 100 500 13.35 26.70 5.34 5.34 26.70 0.0534 0.0534 0.0534 0.0534 0.0534 12.5 mg/5 mL PPB 120 ml 250 ml 100 ml 500 ml Tab. Page COST OF PKG. SIZE 2.81 5.85 2.34 11.70 0.0234 0.0234 0.0234 0.0234 50 mg PPB 02257556 Jamp-Diphenhydramine Jamp 00757691 pms-Diphenhydramine Phmscience 390 100 500 100 500 7.04 35.20 7.04 35.20 0.0704 0.0704 0.0704 0.0704 2013-04 CODE BRAND NAME MANUFACTURER DIPYRIDAMOLE/ ACETYLSALICYLIC ACID X Caps. 02242119 Aggrenox Bo. Ing. SIZE UNIT PRICE 200 mg L.A. - 25 mg 60 DOCUSATE CALCIUM Caps. 49.38 0.8230 240 mg PPB 00806226 Calax Odan 00830275 Docusate Calcium Trianon 02283255 Jamp-Docusate Calcium 00842044 Novo-Docusate Calcium Jamp Novopharm 00664553 pms-Docusate-Calcium Phmscience 100 500 100 1000 250 100 500 300 DOCUSATE SODIUM Caps. 8.16 40.80 8.16 81.60 20.40 8.16 40.80 24.48 0.0816 0.0816 0.0816 0.0816 0.0816 0.0816 0.0816 0.0816 100 mg PPB 02245079 Apo-Docusate Sodium 00830267 Docusate de Sodium Apotex Trianon 00716731 Docusate Sodique Taro 02326086 02247385 02303825 02245946 02020084 Pro Doc Euro-Pharm Euro-Pharm Jamp Novopharm Docusate sodium Euro-Docusate Euro-Docusate C Jamp-Docusate Sodium Novo-Docusate COST OF PKG. SIZE 1000 100 1000 100 1000 1000 1000 1000 1000 100 1000 100 1000 100 1000 1000 100 1000 02298163 phl-Docusate Sodium Pharmel 00703494 pms-Docusate Sodium Phmscience 00870196 ratio-Docusate Sodium 00514888 Selax Ratiopharm Odan 02335077 Jamp-Docusate Sodium 02029529 Soflax Jamp Phmscience 100 1000 02335085 Jamp-Docusate Sodium 02006596 Selax Jamp Odan 100 100 Caps. 25.00 3.28 25.00 3.28 25.00 25.00 25.00 25.00 25.00 3.28 25.00 3.28 25.00 3.28 25.00 25.00 3.28 25.00 0.0250 0.0328 0.0250 0.0328 0.0250 0.0250 0.0250 0.0250 0.0250 0.0328 0.0250 0.0328 0.0250 0.0328 0.0250 0.0250 0.0328 0.0250 200 mg PPB Caps. 8.39 83.87 0.0839 0.0839 250 mg PPB 2013-04 9.50 9.50 0.0950 0.0950 Page 391 CODE BRAND NAME MANUFACTURER Syr. COST OF PKG. SIZE SIZE 20 mg/5 mL PPB 02238283 Docusate de Sodium Atlas 02024624 02283239 00703508 00870226 00695033 Trianon Jamp Phmscience Ratiopharm Odan Docusate de Sodium Jamp-Docusate Sodium pms-Docusate Sodium ratio-Docusate Sodium Selax 225 ml 500 ml 250 ml 250 ml 500 ml 500 ml 250 ml 500 ml Syr. 4.95 5.95 5.50 5.50 5.95 5.95 5.50 5.95 0.0220 0.0119 0.0220 0.0220 0.0119 0.0119 0.0220 0.0119 50 mg/mL PPB 02283220 Jamp-Docusate Sodium 00848417 pms-Docusate Jamp Phmscience 500 ml 500 ml Syr. or Oral Sol. 02332485 Jamp-Docusate Sodium 00880140 pms-Docusate Sodium 02006723 Soflax 02231379 Anzemet Jamp Phmscience Phmscience 500 ml 500 ml 25 ml SanofiAven 15 Pfizer 02269457 Aricept RDT Pfizer 28 30 28 Tab. or Tab. Oral Disint. 0.1732 0.1732 0.1732 419.42 27.9613 132.23 141.67 133.50 4.7225 4.7223 4.7679 10 mg 02232044 Aricept Pfizer 02269465 Aricept RDT Pfizer 28 30 28 Roche 30 Lilly 28 DORNASE ALFA X Sol. Inh. 132.23 141.67 133.50 4.7225 4.7223 4.7679 1 mg/mL (2.5 mL) DULOXETINE X L.A. Caps. 392 86.60 86.60 4.33 5 mg 02232043 Aricept 02301482 Cymbalta 0.8584 0.8584 100 mg DONEPEZIL HYDROCHLORIDE X Tab. or Tab. Oral Disint. 02046733 Pulmozyme 429.19 429.19 10 mg/mL DOLASETRON MESYLATE X Tab. Page UNIT PRICE 1130.66 37.6887 30 mg 51.17 1.8275 2013-04 CODE BRAND NAME MANUFACTURER SIZE L.A. Caps. 02301490 Cymbalta UNIT PRICE 60 mg Lilly 28 GSK 14 28 ELTROMBOPAG X Tab. 02361825 Revolade COST OF PKG. SIZE 102.33 3.6546 25 mg Tab. 735.00 1470.00 52.5000 52.5000 50 mg 02361833 Revolade GSK 14 28 Roche 60 B.M.S. 30 ENFUVIRTIDE X S.C. Inj. Pd. 02247725 Fuzeon 105.0000 105.0000 108 mg ENTECAVIR X Tab. 02282224 Baraclude 1470.00 2940.00 2385.60 39.7600 0.5 mg EPLERENONE X Tab. 660.00 22.0000 25 mg 02323052 Inspra Pfizer 30 02323060 Inspra Pfizer 30 Tab. 76.69 2.5563 50 mg EPOETIN ALFA X Syringe 02231583 Eprex Janss. Inc 6 Janss. Inc 6 2013-04 14.2500 171.00 28.5000 3 000 UI/0.3 mL Janss. Inc 6 Janss. Inc 6 Syringe 02231586 Eprex 85.50 2 000 UI/0.5 mL Syringe 02231585 Eprex 2.5563 1 000 UI/0.5 mL Syringe 02231584 Eprex 76.69 256.50 42.7500 4 000 UI/0.4 mL 342.00 57.0000 Page 393 CODE BRAND NAME MANUFACTURER SIZE Syringe 02243400 Eprex Janss. Inc 6 Janss. Inc 6 Janss. Inc 6 Janss. Inc 6 Janss. Inc 1 Janss. Inc 1 Janss. Inc 1 GSK 1 GSK 1 133.9500 278.52 417.77 417.77 18.13 1.5 mg ERLOTINIB (HYDROCHLORIDE) X Tab. 36.26 100 mg 02269015 Tarceva Roche 30 02269023 Tarceva Roche 30 Tab. Page 803.70 0.5 mg Inj. Pd. 02230848 Flolan 114.0000 40 000 UI/mL (1 mL) EPOPROSTENOL SODIUM X Inj. Pd. 02230845 Flolan 684.00 30 000 UI/0.75 mL Syringe 02240722 Eprex 85.5000 20 000 UI/0.5 mL Syringe 02288680 Eprex 513.00 10 000 UI/1.0 mL Syringe 02243239 Eprex 71.2500 8 000 UI/0.8 mL Syringe 02231587 Eprex 427.50 6 000 UI/0.6 mL Syringe 02243403 Eprex UNIT PRICE 5 000 UI/0.5 mL Syringe 02243401 Eprex COST OF PKG. SIZE 1600.00 53.3333 150 mg 394 2400.00 80.0000 2013-04 CODE BRAND NAME MANUFACTURER ESTRADIOL-17B X Patch 02247499 00756849 02245676 02243722 Climara-25 Estraderm 25 Estradot Oesclim 25 SIZE COST OF PKG. SIZE UNIT PRICE 0.025 mg/24 h (4) and (8) PPB Bayer Novartis Novartis Triton 4 8 8 8 Novartis 8 Patch 19.67 19.28 20.04 19.28 4.9175 W 2.5050 2.4100 0.0375 mg/24 h 02243999 Estradot Patch 20.04 2.5050 0.05 mg/24 h (4) and (8) PPB 02231509 02244000 02243724 02246967 Climara -50 Estradot Oesclim 50 Sandoz Estradiol Derm 50 Bayer Novartis Triton Sandoz Patch 4 8 8 8 21.01 21.44 19.85 16.80 5.2525 2.6800 2.4813 1.7812 0.075 mg/24 h (4) et (8) PPB 02247500 Climara-75 02244001 Estradot 02246968 Sandoz Estradiol Derm 75 Bayer Novartis Sandoz Patch 4 8 8 22.40 23.00 17.90 5.6000 2.8750 1.9125 0.1 mg/24 h (4) et (8) PPB 02231510 00756792 02244002 02246969 Climara -100 Estraderm 100 Estradot Sandoz Estradiol Derm 100 Bayer Novartis Novartis Sandoz 4 8 8 8 Top. Jel. 02238704 Estrogel 23.69 23.26 23.88 18.70 5.9225 2.9075 2.9850 2.0112 0.06 % Merck ESTRADIOL-17B/ NORETHINDRONE ACETATE X Patch 02241835 Estalis 140/50 Novartis 02241837 Estalis 250/50 Novartis Patch 80 g 24.35 0.2692 0.05 mg -0.14 mg/24 h 8 23.95 2.9938 0.05 mg -0.25 mg/24 h ESTRADIOL-17B/LEVONORGESTREL X Patch 02250616 Climara Pro 2013-04 8 23.95 2.9938 0.045 mg - 0.015 mg/24 h Bayer 4 22.98 5.7450 Page 395 CODE BRAND NAME MANUFACTURER SIZE ÉTANERCEPT X S.C. Inj. Pd. 02242903 Enbrel Amgen 4 Amgen Amgen 4 4 182.1375 1437.13 1437.13 359.2825 359.2825 100 mg Janss. Inc 120 Tab. 671.40 5.5950 200 mg 02375931 Intelence Janss. Inc 60 Novartis 30 EVEROLIMUS X Tab. 02339528 Afinitor 02247521 Ezetrol Merck-Sch 30 100 Takeda 30 Pfizer 30 396 52.20 174.01 1.7400 1.7401 47.70 1.5900 45.00 1.5000 8 mg Pfizer FILGRASTIM X Inj. Sol. 01968017 Neupogen 186.0000 4 mg L.A. Tab. 02380048 Toviaz 5580.00 80 mg FESOTERODINE FUMARATE X L.A. Tab. 02380021 Toviaz 10.9000 10 mg FEBUXOSTAT X Tab. 02357380 Uloric 654.00 10 mg EZETIMIBE X Tab. Page 728.55 50 mg/mL ETRAVIRINE X Tab. 02306778 Intelence UNIT PRICE 25 mg S.C. Inj.Sol (syr) 02274728 Enbrel 99100373 Enbrel SureClick COST OF PKG. SIZE 30 45.00 1.5000 300 mcg/mL (1.0 mL) Amgen 10 1731.89 173.1890 2013-04 CODE BRAND NAME MANUFACTURER Inj. Sol. 99001454 Neupogen SIZE Amgen 10 35 ml 15 20 100 33.65 0.9614 574.98 766.63 3833.15 38.3320 38.3315 38.3315 75 UI Serono 1 Serono 1 Inj. Pd. 02248156 Gonal-f 277.1020 10 mg SanofiAven FOLLITROPIN ALFA X Inj. Pd. 02248154 Gonal-f 2771.02 50 mg/5 mL Pfizer FLUDARABINE PHOPHATE X Tab. 02246226 Fludara UNIT PRICE 300 mcg/mL (1.6mL) FLUCONAZOLE X Oral Susp. 02024152 Diflucan COST OF PKG. SIZE 70.88 450 UI Inj. Pd. 425.25 1050 UI 02248157 Gonal-f Serono 1 02270404 Gonal-f Serono 1 Sty 992.25 300 UI Sty 283.50 450 UI 02270390 Gonal-f Serono 1 02270382 Gonal-f Serono 1 Sty 425.25 900 UI FOLLITROPIN BETA X Cartridge 02243948 Puregon 300 UI Merck 1 Merck 1 Cartridge 99100718 Puregon 2013-04 850.50 291.00 600 UI 582.00 Page 397 CODE BRAND NAME MANUFACTURER COST OF PKG. SIZE SIZE Cartridge 99100637 Puregon 900 UI Merck 1 Merck 5 873.00 Inj. Sol. 02242439 Puregon 50 UI/0.5 mL Inj. Sol. 02242441 Puregon Merck 5 120 dose(s) AZC 120 dose(s) 62.50 81.25 8 mg PPB 02339439 Mylan-Galantamine ER Mylan 02266717 Reminyl ER 02377950 Teva Galantamine ER Janss. Inc Teva Can 30 100 30 30 37.40 124.65 137.70 37.40 1.2467 1.2465 4.5900 1.2467 16 mg PPB 02339447 Mylan-Galantamine ER Mylan 02266725 Reminyl ER 02377969 Teva Galantamine ER Janss. Inc Teva Can 30 100 30 30 L.A. Caps. 37.40 124.65 137.70 37.40 1.2467 1.2465 4.5900 1.2467 24 mg PPB 02339455 Mylan-Galantamine ER Mylan 02266733 Reminyl ER 02377977 Teva Galantamine ER Janss. Inc Teva Can 30 100 30 30 GANIRELIX X S.C. Inj.Sol (syr) 398 97.0000 6 mcg -200 mcg/dose L.A. Caps. Page 48.5000 6 mcg -100 mcg/dose GALANTAMINE HYDROBROMIDE X L.A. Caps. 02245641 Orgalutran 485.00 AZC Inh. Pd. 02245386 Symbicort 200 Turbuhaler 242.50 100 UI/0.5 mL FORMOTEROL FUMARATE DIHYDRATE/ BUDESONIDE X Inh. Pd. 02245385 Symbicort 100 Turbuhaler UNIT PRICE 37.40 124.65 137.70 37.40 1.2467 1.2465 4.5900 1.2467 250 mcg/0.5 ml Merck 1 94.71 2013-04 CODE BRAND NAME MANUFACTURER COST OF PKG. SIZE SIZE GEFITINIB X Tab. UNIT PRICE 250 mg 02248676 Iressa AZC 30 2199.00 GLARGINE INSULIN S.C. Inj. Sol. 02245689 Lantus 73.3000 100 U/mL SanofiAven 10 ml SanofiAven SanofiAven 5 5 S.C. Inj. Sol. 58.07 100 U/mL (3 mL) 02251930 Lantus 02294338 Lantus SoloStar GLATIRAMER ACETATE X S.C. Inj.Sol (syr) 02245619 Copaxone 88.12 88.12 20 mg/mL Teva Innov 30 Servier AA Pharma 60 100 02356422 Diamicron MR Servier 60 02245247 Apo-Gliclazide Apotex 00765996 Diamicron 02287072 Gliclazide 02248453 Gliclazide-80 Servier Sanis Pro Doc 02229519 Mylan-Gliclazide Mylan 02238103 Novo-Gliclazide Novopharm 60 100 60 100 60 100 60 100 100 500 GLICLAZIDE X L.A. Tab. 1296.00 43.2000 30 mg PPB 02242987 Diamicron MR 02297795 Gliclazide MR L.A. Tab. 8.43 14.05 0.1405 0.1405 60 mg Tab. 15.17 0.2528 80 mg PPB GLIMEPIRIDE X Tab. 02245272 02295377 02273756 02273101 02269589 2013-04 Amaryl Apo-Glimepiride Novo-Glimepiride ratio-Glimepiride Sandoz Glimepiride 5.59 9.31 22.35 9.32 5.59 9.31 5.59 9.31 9.32 46.55 0.0932 0.0931 0.3725 0.0932 0.0932 0.0931 0.0932 0.0931 0.0932 0.0931 1 mg PPB SanofiAven Apotex Novopharm Ratiopharm Sandoz 30 100 30 30 30 23.21 38.57 11.57 11.57 11.57 0.7737 0.3857 0.3857 0.3857 0.3857 Page 399 CODE BRAND NAME MANUFACTURER SIZE Tab. COST OF PKG. SIZE UNIT PRICE 2 mg PPB 02245273 02295385 02273764 02273128 02269597 Amaryl Apo-Glimepiride Novo-Glimepiride ratio-Glimepiride Sandoz Glimepiride SanofiAven Apotex Novopharm Ratiopharm Sandoz 30 100 30 30 30 02245274 02295393 02273772 02273136 02269619 Amaryl Apo-Glimepiride Novo-Glimepiride ratio-Glimepiride Sandoz Glimepiride SanofiAven Apotex Novopharm Ratiopharm Sandoz 30 100 30 30 30 Tab. 23.21 38.57 11.57 11.57 11.57 0.7737 0.3857 0.3857 0.3857 0.3857 4 mg PPB 0.7737 0.3857 0.3857 0.3857 0.3857 23.21 38.57 11.57 11.57 11.57 GLYCERIN 5 Supp. 99100357 12 GOLIMUMAB X S.C. Inj.Sol (App.) 02324784 Simponi 50 mg/0.5 mL Janss. Inc 1 S.C. Inj.Sol (syr) 02324776 Simponi 50 mg/0.5 mL Janss. Inc 1 Ferring 1 PPC Merck 1 1 Ferring Ferring 5 5 GONADORELIN X Inj. Pd. 02046210 Lutrepulse 5 Page 115.00 10 000 U PPB GONADOTROPINS X Inj. Pd. 02283093 Menopur 02247790 Repronex 1447.00 0.8 mg GONADOTROPIN (CHORIONIC) X Inj. Pd. 02247459 Chorionic Gonadotropin 02182904 Pregnyl 1447.00 72.00 72.00 75 UI 275.00 275.00 55.0000 55.0000 Where no price is indicated, pharmacists may purchase the product of their choice. The product thus obtained is considered insured and the price payable by the Régie is the pharmacist's cost price. 400 2013-04 CODE BRAND NAME MANUFACTURER SIZE GRANISETRON HYDROCHLORIDE X Tab. 02308894 Granisetron 02185881 Kytril AA Pharma Roche 10 2 10 Paladin 3 Paladin 90 Alcon Sandoz 15 ml 15 ml 3.78 1.2600 Alcon Sandoz 15 ml 15 ml 342.00 3.8000 0.5 % PPB Oph. Sol. 00000817 Isopto Tears 00874965 Sandoz Eyelube 10.8000 18.0000 18.0000 300 IR HYDROXYPROPYLMETHYLCELLULOSE Oph. Sol. 00000809 Isopto Tears 00889806 Sandoz Eyelube 135.00 36.00 180.00 100 IR S-Ling. Tab. 02381893 Oralair UNIT PRICE 1 mg PPB GRASS POLLEN ALLERGEN EXTRACT X S-Ling. Tab. 02381885 Oralair COST OF PKG. SIZE 4.16 4.16 1 % PPB HYDROXYPROPYLMETHYLCELLULOSE/ DEXTRAN 70 Oph. Sol. 00390291 Tears Naturale Alcon 00743445 Tears Naturale II Alcon 4.70 4.70 0.3 % -0.1 % 15 ml 30 ml 15 ml 30 ml IMATINIB MESYLATE X Tab. 5.28 8.91 5.10 9.26 0.2793 0.2737 100 mg 02253275 Gleevec Novartis 120 02253283 Gleevec Novartis 30 Med Pharma 24 Tab. 3182.21 26.5184 400 mg IMIQUIMOD X Top. Cr. 02239505 Aldara 2013-04 3182.21 106.0737 250 mg/sac. 287.52 11.9800 Page 401 CODE BRAND NAME MANUFACTURER SIZE INFLIXIMAB X I.V. Perf. Pd. 02244016 Remicade Janss. Inc 1 N.Nordisk 5 N.Nordisk 5 Lilly Lilly INTERFACE DRESSING - POLYAMIDE OR SILICONE Dressing 99100353 3M Tegaderm NonAdherent Contact Layer 7.5 cm x 20 cm-150cm² 99100239 Mepitel (10 cm x 18 cm 180 cm²) Page 402 5 5 51.44 51.44 100 cm² to 200 cm² (active surface) 5.23 Mölnlycke 1 7.40 201 cm² to 500 cm² (active surface) 3M Canada 1 15.84 Less than 100 cm² (active surface) 3M Canada 1 3.39 Mölnlycke 1 3.48 Mölnlycke 1 4.52 Dressing 99100240 Mepitel (20 cm x 30 cm 600 cm²) 25 % - 75 % (3mL) 1 Dressing 99100352 3M Tegaderm NonAdherent Contact Layer 7.5 cm x 10 cm-75 cm² 99100237 Mepitel (5 cm X 7.5 cm 38 cm²) 99100238 Mepitel (7.5 cm x 10 cm 75 cm²) 98.69 3M Canada Dressing 99100354 3M Tegaderm NonAdherent Contact Layer 20 cm x 25 cm-500 cm² 52.20 100 U/mL (3 mL) INSULIN LISPRO/ INSULIN LISPRO PROTAMINE S.C. Inj. Susp. 02240294 Humalog Mix 25 99100631 Humalog Mix 25 KwikPen 940.00 30 % - 70 % (3 mL) INSULIN DETEMIR S.C. Inj. Sol. 02271842 Levemir UNIT PRICE 100 mg INSULIN ASPART/ INSULIN ASPART PROTAMINE S.C. Inj. Susp. 02265435 NovoMix30 COST OF PKG. SIZE More than 500 cm² (active surface) Mölnlycke 1 21.36 2013-04 CODE BRAND NAME MANUFACTURER SIZE INTERFERON ALFA-2B (PEGYLATED) X S.C. Inj. Pd. 02242966 Unitron-Peg Merck 2 Merck 2 Merck 2 Merck 2 Biogen Biogen 4 4 Serono 4 4 791.70 W 1409.85 1409.85 352.4625 352.4625 1434.74 358.6850 1746.62 436.6550 22 mcg (6 MUI) Serono 3 Serono 3 S.C. Inj.Sol (syr) 02237320 Rebif W 44 mcg/0.5 mL (1,5 mL) Serono S.C. Inj.Sol (syr) 02237319 Rebif 791.70 22 mcg/0.5 mL (1,5 mL) S.C. Inj. Sol. 02318261 Rebif W 30 mcg (6 MUI) S.C. Inj. Sol. 02318253 Rebif 791.70 150 mcg/0.5 mL INTERFERON BETA-1A X I.M. Inj. Sol. 99100763 Avonex Pen 02269201 Avonex PS W 120 mcg/0.5 mL S.C. Inj. Pd. 02242969 Unitron-Peg 791.70 80 mcg/0.5 mL S.C. Inj. Pd. 02242968 Unitron-Peg UNIT PRICE 50 mcg/0.5 mL S.C. Inj. Pd. 02242967 Unitron-Peg COST OF PKG. SIZE 358.69 119.5633 44 mcg (12 MUI) INTERFERON BETA-1B X Inj. Pd. 436.66 145.5533 0.3 mg PPB 02169649 Betaseron Bayer 02337819 Extavia Novartis 15 45 15 Kit 1490.39 4471.17 1490.39 99.3593 99.3593 99.3593 0.3 mg 99100555 Betaseron - Initiation pack 2013-04 Bayer 1 1192.31 Page 403 CODE BRAND NAME MANUFACTURER SIZE KETOROLAC TROMETHAMINE X Oph. Sol. Allergan 02245821 Apo-Ketorolac Apotex 02247461 ratio-Ketorolac Ratiopharm 5 ml 10 ml 5 ml 10 ml 5 ml 10 ml LACOSAMIDE X Tab. 16.80 33.60 8.00 16.00 8.00 16.00 3.3140 3.3140 50 mg U.C.B. 60 139.20 Tab. 2.3200 100 mg 02357623 Vimpat U.C.B. 60 02357631 Vimpat U.C.B. 60 199.20 Tab. 3.3200 150 mg 259.20 Tab. 4.3200 200 mg 02357658 Vimpat U.C.B. 60 LACTULOSE Syr. or Oral Sol. 02242814 Apo-Lactulose Apotex 02247383 Euro-Lac Euro-Pharm 02295881 Jamp-Lactulose Jamp 00703486 pms-Lactulose Phmscience 00854409 ratio-Lactulose Ratiopharm 02331551 Teva Lactulose Teva Can 02287145 Fosrenol 500 ml 1000 ml 500 ml 1000 ml 500 ml 1000 ml 500 ml 1000 ml 500 ml 1000 ml 500 ml 1000 ml 404 5.3200 7.25 14.50 7.25 14.50 7.25 14.50 7.25 14.50 7.25 14.50 7.25 14.50 0.0145 0.0145 0.0145 0.0145 0.0145 0.0145 0.0145 0.0145 0.0145 0.0145 0.0145 0.0145 250 mg Shire 90 Shire 90 Chew. Tab. 02287153 Fosrenol 319.20 667 mg/mL PPB LANTHANUM HYDRATE X Chew. Tab. Page UNIT PRICE 0.5 % PPB 01968300 Acular 02357615 Vimpat COST OF PKG. SIZE 96.38 1.0709 500 mg 192.74 2.1416 2013-04 CODE BRAND NAME MANUFACTURER SIZE Chew. Tab. UNIT PRICE 750 mg 02287161 Fosrenol Shire 90 Shire 90 Chew. Tab. 290.06 3.2229 1000 mg 02287188 Fosrenol LAPATINIB X Tab. 384.56 4.2729 250 mg 02326442 Tykerb GSK 70 LATANOPROST/ TIMOLOL MALEATE X Oph. Sol. 02246619 Xalacom Apo-Leflunomide Arava Leflunomide Mylan-Leflunomide Novo-Leflunomide 1645.00 23.5000 0.005 % - 0.5 % Pfizer 2.5 ml LEFLUNOMIDE X Tab. 02256495 02241888 02351668 02319225 02261251 COST OF PKG. SIZE 30.99 10 mg PPB Apotex SanofiAven Sanis Mylan Novopharm 02309327 phl-Leflunomide 02288265 pms-Leflunomide 02283964 Sandoz Leflunomide Pharmel Phmscience Sandoz 02256509 02241889 02351676 02319233 02261278 Apotex SanofiAven Sanis Mylan Novopharm 30 30 30 30 30 100 30 30 30 Tab. 79.30 299.70 79.30 79.30 79.30 264.33 79.30 79.30 79.30 2.6433 9.9900 2.6433 2.6433 2.6433 2.6433 2.6433 2.6433 2.6433 20 mg PPB Apo-Leflunomide Arava Leflunomide Mylan-Leflunomide Novo-Leflunomide 02309335 phl-Leflunomide 02288273 pms-Leflunomide 02283972 Sandoz Leflunomide Pharmel Phmscience Sandoz 30 30 30 30 30 100 30 30 30 LENALIDOMIDE X Caps. 79.30 304.24 79.30 79.30 79.30 264.33 79.30 79.30 79.30 2.6433 10.1413 2.6433 2.6433 2.6433 2.6433 2.6433 2.6433 2.6433 5 mg 02304899 Revlimid Celgene 28 9520.00 02304902 Revlimid Celgene 28 10108.00 Caps. 340.0000 10 mg 2013-04 361.0000 Page 405 CODE BRAND NAME MANUFACTURER SIZE Caps. UNIT PRICE 15 mg 02317699 Revlimid Celgene 21 02317710 Revlimid Celgene 21 Caps. 8022.00 382.0000 25 mg LEVOFLOXACIN X I.V. Perf. Sol. 02236839 Levaquin 02370921 Trajenta Janss. Inc 50 ml 100 ml 150 ml 424.0000 22.57 45.14 45.14 5 mg Bo. Ing. 30 90 LINEZOLID X I.V. Perf. Sol. 02243685 Zyvoxam 8904.00 5 mg/mL LINAGLIPTINE X Tab. 67.50 202.50 2.2500 2.2500 2 mg/mL Pfizer 300 ml Tab. 99.91 600 mg 02243684 Zyvoxam Pfizer 20 Shire 100 LISDEXAMFETAMINE (DIMESYLATE) X Caps. 02347156 Vyvanse 1468.78 73.4390 20 mg Caps. 224.00 2.2400 30 mg 02322951 Vyvanse Shire 100 02347164 Vyvanse Shire 100 Caps. 251.00 2.5100 40 mg Caps. 278.00 2.7800 50 mg 02322978 Vyvanse Shire 100 02347172 Vyvanse Shire 100 Caps. Page COST OF PKG. SIZE 305.00 3.0500 60 mg 406 331.00 3.3100 2013-04 CODE BRAND NAME MANUFACTURER COST OF PKG. SIZE SIZE MAGNESIUM HYDROXIDE Oral Susp. 00468401 Lait de Magnesie UNIT PRICE 400 mg/5 mL Atlas MAGNESIUM HYDROXIDE/ ALUMINUM HYDROXIDE 5 Oral Susp. 99002574 500 ml 2.49 0.0050 300 mg - 300 mg/5 mL 500 ml Oral Susp. 300 mg -600 mg/5 mL 99002442 350 ml 99002868 50 Tab. 100 mg -184 mg Tab. 200 mg -200 mg 99100716 36 99002450 40 Tab. 300 mg -600 mg MARAVIROC X Tab. 150 mg 02299844 Celsentri ViiV 60 02299852 Celsentri ViiV 60 Tab. 990.00 16.5000 300 mg MEGESTROL ACETATE X Tab. 02195917 Megestrol 5 2013-04 990.00 16.5000 40 mg AA Pharma 100 100.73 1.0073 Where no price is indicated, pharmacists may purchase the product of their choice. The product thus obtained is considered insured and the price payable by the Régie is the pharmacist's cost price. Page 407 CODE BRAND NAME MANUFACTURER SIZE MEMANTINE HYDROCHLORIDE X Tab. Apotex Cobalt 02260638 Ebixa 02349116 Memantine Lundbeck MeliaPharm 02321130 pms-Memantine Phmscience 02320908 ratio-Memantine 02348950 Riva-Memantine Ratiopharm Riva 02344807 Sandoz Memantine Sandoz 100 30 100 30 30 100 30 100 100 30 100 30 100 METHYL AMINOLEVULINATE X Top. Cr. Galderma 2g Purdue 100 Purdue 100 Purdue 100 Purdue 100 Purdue 100 Purdue 50 Page 408 0.9657 124.68 1.2468 171.18 1.7118 218.15 2.1815 50 mg L.A. Caps. 02277204 Biphentin 96.57 40 mg L.A. Caps. 02277190 Biphentin 0.6745 30 mg L.A. Caps. 02277182 Biphentin 67.45 20 mg L.A. Caps. 02277174 Biphentin 300.00 15 mg L.A. Caps. 02277158 Biphentin 1.2617 1.2617 1.2617 2.3367 1.2617 1.2617 1.2617 1.2617 1.2617 1.2617 1.2617 1.2617 1.2617 10 mg L.A. Caps. 02277131 Biphentin 126.17 37.85 126.17 70.10 37.85 126.17 37.85 126.17 126.17 37.85 126.17 37.85 126.17 168 mg/g METHYLPHENIDATE HYDROCHLORIDE Y L.A. Caps. 02277166 Biphentin UNIT PRICE 10 mg PPB 02366487 Apo-Memantine 02324067 Co Memantine 02323273 Metvix COST OF PKG. SIZE 132.20 2.6440 60 mg Purdue 50 156.20 3.1240 2013-04 CODE BRAND NAME MANUFACTURER SIZE L.A. Caps. 02277212 Biphentin Purdue 50 Janss. Inc Teva Can 100 100 Janss. Inc Teva Can 100 100 Janss. Inc Teva Can 100 100 Janss. Inc Teva Can 100 100 Med Pharma 70 g 1 2013-04 266.38 133.39 2.6638 1.3339 329.12 164.80 3.2912 1.6480 18.62 98.00 100 mg Astellas 1 MICRONIZED PROGESTERONE X Caps. 02166704 Prometrium 2.3501 1.1768 50 mg Astellas I.V. Perf. Pd. 02311054 Mycamine 235.01 117.68 0.75 % MICAFUNGIN SODIUM X I.V. Perf. Pd. 02294222 Mycamine 2.0364 1.0197 54 mg METRONIDAZOLE X Vag. Jel. 02125226 Nidagel 203.64 101.97 36 mg L.A. Tab. (12 h) 02247734 Concerta 02315092 Novo-Methylphenidate ERC 4.0572 27 mg L.A. Tab. (12 h) 02247733 Concerta 02315084 Novo-Methylphenidate ERC 202.86 18 mg L.A. Tab. (12 h) 02250241 Concerta 02315076 Novo-Methylphenidate ERC UNIT PRICE 80 mg L.A. Tab. (12 h) 02247732 Concerta 02315068 Novo-Methylphenidate ERC COST OF PKG. SIZE 196.00 100 mg Merck 28 100 29.65 106.00 1.0589 1.0600 Page 409 CODE BRAND NAME MANUFACTURER SIZE MINERAL OIL Liq. 00704172 Huile Minerale COST OF PKG. SIZE UNIT PRICE 100 % Atlas 250 ml 500 ml 2.15 3.11 McNeil Co 130 ml 4.24 0.0086 0.0062 Liq. (Rect.) 00107875 Fleet Huileux MODAFINIL X Tab. 02239665 Alertec 02285398 Modafinil 100 mg PPB Shire AA Pharma 30 100 39.52 92.93 1.3173 0.7905 MOISTURE-RETENTIVE DRESSING - HYDROCOLLOIDAL OR POLYURETHANE Dressing 100 cm² to 200 cm² (active surface) 00801011 3M Tegaderm Hydrocolloid Dressing (10 cm x 10 cm 100 cm²) 99100609 Comfeel Plus Ulcer (10 cm x 10 cm - 100 cm²) 99000040 Cutinova hydro (10 cm x 10 cm - 100 cm²) 00899666 DuoDERM CGF (10 cm x 10 cm - 100 cm²) 99004984 DuoDERM Signal (14 cm x 14 cm - 188 cm²) 99100010 Nu-Derm Hydrocolloid Border (10 cm x 10 cm 100 cm²) 99100007 Nu-Derm Hydrocolloid Standard (10 cm x 10 cm 100 cm²) 99004720 Ultec (10.2 cm x 10.2 cm 104 cm²) Page 410 3M Canada 1 3.55 Coloplast 10 28.00 2.8000 S. & N. 5 19.90 3.9800 Convatec 21.70 86.82 8.15 4.3400 4.3410 Convatec 5 20 1 Systagenix 160 576.40 3.6025 Systagenix 50 202.51 4.0502 Tyco 5 18.00 3.6000 2013-04 CODE BRAND NAME MANUFACTURER Dressing 00800996 3M Tegaderm Hydrocolloid Dressing (15 cm x 15 cm 225 cm²) 99100610 Comfeel Plus Ulcer (15 cm x 15 cm - 225 cm²) 99100611 Comfeel Plus Ulcer (20 cm x 20 cm - 400 cm²) 99000059 Cutinova hydro (15 cm x 20 cm - 300 cm²) 00899674 DuoDERM CGF (15 cm x 15 cm - 225 cm²) 00801046 DuoDERM CGF (15 cm x 20 cm - 300 cm²) 00899682 DuoDERM CGF (20 cm x 20 cm - 400 cm²) 99004992 DuoDERM Signal (20 cm x 20 cm - 388 cm²) 99100011 Nu-Derm Hydrocolloid Border (15 cm x 15 cm 225 cm²) 99100008 Nu-Derm Hydrocolloid Standard (20 cm x 20 cm 400 cm²) 99004747 Ultec (15.2 cm x 20.3 cm 309 cm²) 99004755 Ultec (20.3 cm x 20.3 cm 412 cm²) 2013-04 UNIT PRICE 3M Canada 1 8.50 Coloplast 5 31.50 6.3000 Coloplast 5 56.00 11.2000 S. & N. 3 35.55 11.8500 Convatec 1 9.50 Convatec 1 12.65 Convatec 1 16.87 Convatec 1 16.36 Systagenix 20 172.67 8.6335 Systagenix 20 254.73 12.7365 Tyco 30 229.90 7.6633 Tyco 30 273.20 9.1067 Less than 100 cm² (active surface) Coloplast 30 20.16 S. & N. 1 2.33 Convatec 1 4.09 Systagenix Dressing 00800988 DuoDERM CGF (20 cm x 30 cm - 600 cm2) COST OF PKG. SIZE 201 cm² to 500 cm² (active surface) Dressing 99100608 Comfeel Plus Ulcer (4 cm x 6 cm - 24 cm²) 99000032 Cutinova hydro (5 cm x 6 cm - 30 cm²) 99004976 DuoDERM Signal (10 cm x 10 cm - 94 cm²) 99100022 Nu-Derm Hydrocolloid Border (5 cm x 5 cm 25 cm²) SIZE 100 167.34 0.6720 1.6734 More than 500 cm² (active surface) Convatec 1 17.92 Page 411 CODE BRAND NAME MANUFACTURER Dressing 99100148 Comfeel Plus Triangle (18 cm x 20 cm - 180 cm²) 00907758 DuoDERM CGF Border (Triangular 15 cm x 18 cm 99 cm²) 00907782 DuoDERM CGF Border (Triangular 20 cm x 23 cm 270 cm²) 99100108 DuoDERM Signal (Sacrum 20 cm x 23 cm - 258 cm²) 99100107 DuoDERM Signal (Triangular 15 cm x 18 cm 216 cm²) 99100106 DuoDERM Signal (Triangular 20 cm x 23 cm 322 cm²) 99100110 Nu-Derm Hydrocolloid Border (Sacrum 18 cm x 18 cm - 135 cm²) Coloplast 5 46.75 Convatec 1 5.43 Convatec 1 11.17 Convatec 1 14.13 Convatec 1 10.65 Convatec 1 16.33 Systagenix 1 14.39 Page 412 UNIT PRICE 9.3500 100 cm² to 200 cm² (active surface) 3M Canada 1 3.10 Coloplast 10 28.10 2.8100 Coloplast 10 36.60 3.6600 Convatec 1 3.00 Convatec 1 3.82 Convatec 1 3.24 Medline 10 21.28 2.1280 Systagenix 100 296.30 2.9630 Thin dr. 99100144 Comfeel Plus Clear (15 cm x 15 cm - 225 cm²) 99100145 Comfeel Plus Clear (20 cm x 20 cm - 400 cm²) 00908134 DuoDERM CGF Extra Thin (15 cm x 15 cm - 225 cm²) COST OF PKG. SIZE Sacrum or triangular Thin dr. 99100290 3M Tegaderm Hydrocolloid Thin Dressing (10cm x 10cm-100 cm²) 99100143 Comfeel Plus Clear (10 cm x 10 cm - 100 cm²) 99100147 Comfeel Plus Clear (9 cm x 14 cm - 126 cm²) 99000261 DuoDERM CGF Extra Thin (10 cm x 10 cm - 100 cm²) 00920029 DuoDERM CGF Extra Thin (10 cm x 15 cm - 118 cm²) 00920088 DuoDERM CGF Extra Thin (5 cm x 20 cm - 100 cm²) 99100655 Exuderm OdorShield (10 cm x 10 cm - 100 cm²) 99100009 Nu-Derm Hydrocolloid Thin (10 cm x 10 cm - 100 cm²) SIZE 201 cm² to 500 cm² (active surface) Coloplast 5 27.30 5.4600 Coloplast 5 38.22 7.6440 Convatec 1 5.77 2013-04 CODE BRAND NAME MANUFACTURER Thin dr. COST OF PKG. SIZE SIZE Less than 100 cm² (active surface) 99100146 Comfeel Plus Clear (5 cm x 7 cm - 35 cm²) 00920010 DuoDERM CGF Extra Thin (7.5 cm x 7.5 cm - 56 cm²) 00920231 DuoDERM CGF Extra-Thin (5 cm x 10 cm - 50 cm²) Coloplast 10 15.80 Convatec 1 2.60 Convatec 1 1.96 Thin dr. 1 8.43 5 36.79 MOMETASONE FUROATE/ FORMOTEROL FUMARATE DIHYDRATE X Oral aerosol 02361744 Zenhale Merck 02361752 Zenhale Merck 120 dose(s) Merck 120 dose(s) 96.00 400 mg/250 mL Bayer MULTIVITAMINS 5 Caps. or Tab. 12 420.24 35.0200 Vit A 5000 UI - Vit D 400 UI et autres 99002493 100 Chew. Tab. Vit A 5000 UI - Vit D 400 UI et autres 99002507 100 NAPROXEN/ESOMEPRAZOLE X Tab. 02361701 Vimovo 78.00 200 mcg - 5 mcg MOXIFLOXACIN HYDROCHLORIDE X I.V. Perf. Sol. 02246414 Avelox I.V. 60.00 100 mcg - 5 mcg Oral aerosol 02361760 Zenhale 7.3580 50 mcg - 5 mcg 120 dose(s) Oral aerosol 2013-04 1.5800 Sacrum 00920037 DuoDERM CGF Extra-Thin Convatec (Sacrum 15 cm x 18 cm 216 cm²) 99100652 Exuderm OdorShield Sacral Medline (15,2 cm x 16,3 cm 271 cm²) 5 UNIT PRICE 375 mg - 20 mg AZC 60 55.20 0.9200 Where no price is indicated, pharmacists may purchase the product of their choice. The product thus obtained is considered insured and the price payable by the Régie is the pharmacist's cost price. Page 413 CODE BRAND NAME MANUFACTURER COST OF PKG. SIZE SIZE Tab. UNIT PRICE 500 mg - 20 mg 02361728 Vimovo AZC 60 Biogen 1 Novartis 112 NATALIZUMAB X I.V. Inj. Sol. 02286386 Tysabri 0.9200 300mg/15ml NILOTINIB X Caps. 02368250 Tasigna 55.20 2451.32 150 mg Caps. 3054.72 27.2743 200 mg 02315874 Tasigna Novartis 112 NUTRITIONAL FORMULAS - FAT EMULSION (INFANTS AND CHILDREN) Liq. 99100401 Microlipid Nestlé-Nut 48 3947.17 35.2426 89 mL suppl. 141.12 2.9400 NUTRITIONAL FORMULAS - CASEIN HYDROLYSATE (INFANTS AND CHILDREN) Liq. 237 mL suppl. 99100206 Alimentum Abbott 1 00898562 Nutramigen 99100531 Nutramigen A+ M.J. M.J. 1 1 Liq. 945 mL suppl. Ped. Oral Pd. 00881104 Nutramigen 99100532 Nutramigen A+ 00881112 Pregestimil 99100533 Pregestimil A+ M.J. 1 M.J. M.J. M.J. 1 1 1 414 14.56 454 g suppl. NUTRITIONAL FORMULAS - FRACTIONATED COCONUT OIL Liq. 99100217 Medium chain triglycerides 5.31 5.31 400 g suppl. Ped. Oral Pd. Page 1.41 Nestlé-Nut 16.53 17.72 17.72 suppl. 946 ml 34.49 2013-04 CODE BRAND NAME MANUFACTURER NUTRITIONAL FORMULAS - MONOMERIC Oral Pd. 99000229 Vivonex Pediatrique SIZE COST OF PKG. SIZE UNIT PRICE 48.7 g/sachet suppl. Nestlé-Nut 6 Nestlé-Nut 6 Oral Pd. 39.42 6.5700 79.5 g/ sac. suppl. 00921017 Vivonex Plus Oral Pd. 39.39 6.5650 80 g/sac. suppl. 00861464 Tolerex Nestlé-Nut Oral Pd. 6 23.40 3.9000 80.4 g/sac. suppl. 00895229 Vivonex T.E.N. Nestlé-Nut 10 65.60 6.5600 NUTRITIONAL FORMULAS - MONOMERIC WITH IRON (INFANTS OR CHILDREN) Liq. 237 mL suppl. 99100463 EO28 Splash Nutricia 27 Ped. Oral Pd. 6.6207 400 g suppl. 99003368 99100892 99004402 99100790 Neocate Neocate avec DHA et ARA Neocate Junior Neocate junior with fibers prebiotics 99100715 Nutramigen AA Nutricia Nutricia Nutricia Nutricia 4 4 4 4 180.84 174.00 191.23 184.00 M.J. 1 51.66 NUTRITIONAL FORMULAS - POLYMERIC LOW RESIDUE - SPECIFIC USE Oral Pd. 99100792 Modulen IBD Nestlé-Nut 1 NUTRITIONAL FORMULAS - POLYMERIC LOW-RESIDUE Liq. 99100244 99100395 99004615 99100462 178.76 Novasource Renal Nutren 2.0 Promote TwoCal HN Nestlé-Nut Nestlé-Nut Abbott Abbott W 43.5000 47.8075 46.0000 400 g suppl. 27.10 1 L suppl. 1 1 1 1 Liq. 8.38 10.35 5.61 9.84 1.5 L suppl. 99000164 99002000 99003570 99004216 2013-04 Isosource HN Nutren 1.5 Osmolite 1.0 cal Osmolite 1.2 cal Nestlé-Nut Nestlé-Nut Abbott Abbott 1 1 1 1 7.50 11.58 8.01 8.08 Page 415 CODE BRAND NAME MANUFACTURER Liq. SIZE UNIT PRICE 235 mL à 250 mL suppl. 00898694 00898708 99000512 99002639 99003546 00907766 99003406 00895350 99004224 99000474 99001543 00896969 99003554 99002647 99004690 Boost 1.0 Boost 1.5 Isosource HN Nepro Novasource Renal Nutren 1.5 Nutren Junior Osmolite 1.0 cal Osmolite 1.2 cal Pediasure Promote Pulmocare Resource 2.0 Suplena TwoCal HN Nestlé-Nut Nestlé-Nut Nestlé-Nut Abbott Nestlé-Nut Nestlé-Nut Nestlé-Nut Abbott Abbott Abbott Abbott Abbott Nestlé-Nut Abbott Abbott 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 NUTRITIONAL FORMULAS - POLYMERIC WITH RESIDUE Liq. 1.15 1.45 1.12 2.09 1.92 1.77 1.54 1.25 1.25 1.56 1.36 3.22 1.92 2.00 2.32 1 L suppl. 99003635 99004267 99003597 99100393 99100703 Compleat modifie Glucerna 1.0 Cal Jevity 1.2 cal Jevity 1.5 Cal Nepro Glucostable Nestlé-Nut Abbott Abbott Abbott Abbott 1 1 1 1 1 99004127 99000202 99004496 99100645 99003600 99100402 99100042 Isosource 1.5 Cal Isosource HN Avec Fibres Isosource VHN Jevity 1 cal Jevity 1.2 cal Jevity 1.5 Cal Resource pour diabetiques Nestlé-Nut Nestlé-Nut Nestlé-Nut Abbott Abbott Abbott Nestlé-Nut 1 1 1 1 1 1 1 99000504 99004658 00920347 99004135 00801194 99000180 99000482 99003392 99100417 99100702 99003414 Compleat modifie Compleat Pediatrique Glucerna 1.0 Cal Isosource 1.5 Cal Isosource HN Avec Fibres Isosource VHN Jevity 1 cal Jevity 1.2 cal Jevity 1.5 Cal Nepro Glucostable Nutren Junior Fibres avec Prebio Pediasure avec fibres Pediasure Plus avec fibres Resource Essentiels Jeunesse 1.5 Resource pour diabetiques Nestlé-Nut Nestlé-Nut Abbott Nestlé-Nut Nestlé-Nut Nestlé-Nut Abbott Abbott Abbott Abbott Nestlé-Nut 1 1 1 1 1 1 1 1 1 1 1 1.90 2.42 1.57 1.75 1.72 1.98 1.65 1.89 2.38 1.90 1.54 Abbott Abbott Nestlé-Nut 1 1 1 1.56 2.35 2.17 Nestlé-Nut 1 1.63 Liq. 7.45 6.67 8.06 10.07 8.01 1.5 L suppl. Liq. 10.53 10.29 12.20 10.63 12.09 15.10 9.79 235 mL à 250 mL suppl. 99001381 99005050 99100216 99002019 Page COST OF PKG. SIZE 416 2013-04 CODE BRAND NAME MANUFACTURER SIZE Oral Pd. COST OF PKG. SIZE UNIT PRICE 85 g/sac. suppl. 99003236 Scandishake Aromatisee Aptalis 4 NUTRITIONAL FORMULAS - POLYMERIZED GLUCOSE Oral Pd. 00860891 Polycose Abbott 11.81 2.9525 350 g suppl. 1 8.69 NUTRITIONAL FORMULAS - POST-DISCHARGE PRETERM FORMULA (INFANTS) Ped. Oral Pd. 363 g suppl. 99100122 Enfamil Enfacare A+ 99100123 Similac Advance Neosure M.J. Abbott 1 1 NUTRITIONAL FORMULAS - PROTEINS Oral Pd. 99003783 Beneprotein 227 g suppl. Nestlé-Nut 6 NUTRITIONAL FORMULAS - SEMI-ELEMENIAL Liq. 99002922 Peptamen 1.5 99100826 Peptamen AF 99003562 Perative 14.45 14.41 Nestlé-Nut Nestlé-Nut Abbott 91.86 15.3100 1 L suppl. 1 1 1 Liq. 38.36 38.08 11.22 1.5 L suppl. 99100094 Peptamen avec Prebio 1 Nestlé-Nut 99004283 00908444 99003031 99100309 99004631 99000296 99100789 99003511 Abbott Nestlé-Nut Nestlé-Nut Nestlé-Nut Nestlé-Nut Nestlé-Nut Nestlé-Nut Abbott Liq. 1 39.90 235 mL à 250 mL suppl. Optimental Peptamen Peptamen 1.5 Peptamen AF Peptamen avec Prebio 1 Peptamen Junior Peptamen Junior 1.5 Perative 1 1 1 1 1 1 1 1 Oral Pd. 00889962 Vital H.N. 79 g/sac. suppl. Abbott 24 NUTRITIONAL FORMULAS - SKIM MILK/ COCONUT OIL Oral Pd. 00881201 Portagen 2013-04 6.25 6.65 9.59 9.77 6.65 6.65 9.98 2.64 M.J. 183.60 7.6500 454 g suppl. 1 20.22 Page 417 CODE BRAND NAME MANUFACTURER SIZE COST OF PKG. SIZE UNIT PRICE ODOUR-CONTROL DRESSING - ACTIVATED CHARCOAL Dressing 100 cm² to 200 cm² (active surface) 99001802 Actisorb Silver (10.5 cm x 10.5 cm - 110 cm²) 99001810 Actisorb Silver (10.5 cm x 19 cm - 200 cm²) Systagenix 50 95.12 1.9024 Systagenix 50 212.90 4.2580 Dressing 99100103 Actisorb Silver (6.5 cm x 9.5 cm - 62 cm²) Less than 100 cm² (active surface) Systagenix 1 ONDANSETRON X Oral Sol. 02291967 Ondansetron 02229639 Zofran 4 mg/5 mL PPB AA Pharma GSK 50 ml 50 ml Tab. Oral Disint. or Tab. Page 73.07 96.61 1.1594 1.9322 4 mg PPB 02288184 Apo-Ondansetron Apotex 02296349 Co Ondansetron 02313685 Jamp-Ondansetron Cobalt Jamp 02371731 Mar-Ondansetron Marcan 02305259 Mint-Ondansetron Mint 02297868 Mylan-Ondansetron Mylan 02264056 Novo-Ondansetron 02346095 Ondansetron Novopharm MeliaPharm 02306212 Ondansetron Odan Odan 02278618 phl-Ondansetron Pharmel 02258188 pms-Ondansetron Phmscience 02312247 Ran-Ondansetron Ranbaxy 02278529 ratio-Ondansetron Ratiopharm 02370298 Riva-Ondansetron 02274310 Sandoz Ondansetron Riva Sandoz 02376091 Septa-Ondansetron Septa 02213567 Zofran GSK 02239372 Zofran ODT 02344440 Zym-Ondansetron GSK Zymcan 418 2.70 10 30 10 10 100 10 30 10 30 10 100 10 10 100 10 100 10 100 10 100 10 100 10 100 10 10 100 10 100 10 100 10 10 100 33.50 100.49 33.50 33.50 334.95 33.50 100.49 33.50 100.49 33.50 334.95 33.50 33.50 334.95 33.50 334.95 33.50 334.95 33.50 334.95 33.50 334.95 33.50 334.95 33.50 33.50 334.95 33.50 334.95 126.60 1265.96 123.71 33.50 334.95 3.3500 3.3495 3.3500 3.3500 3.3495 3.3500 3.3495 3.3500 3.3495 3.3500 3.3495 3.3500 3.3500 3.3495 3.3500 3.3495 3.3500 3.3495 3.3500 3.3495 3.3500 3.3495 3.3500 3.3495 3.3500 3.3500 3.3495 3.3500 3.3495 12.6600 12.6596 12.3710 3.3500 3.3495 2013-04 CODE BRAND NAME MANUFACTURER SIZE Tab. Oral Disint. or Tab. COST OF PKG. SIZE UNIT PRICE 8 mg PPB 02288192 Apo-Ondansetron Apotex 02296357 Co Ondansetron 02313693 Jamp-Ondansetron Cobalt Jamp 02371758 Mar-Ondansetron Marcan 02305267 Mint-Ondansetron Mint 02297876 Mylan-Ondansetron Mylan 02346168 Ondansetron MeliaPharm 02325160 Ondansetron 02306220 Ondansetron Odan Pro Doc Odan 02278626 phl-Ondansetron Pharmel 02258196 pms-Ondansetron Phmscience 02312255 Ran-Ondansetron Ranbaxy 02278537 ratio-Ondansetron Ratiopharm 02370301 Riva-Ondansetron 02274329 Sandoz Ondansetron Riva Sandoz 02376105 Septa-Ondansetron Septa 02264064 Teva-Ondansetron Teva Can 02213575 Zofran GSK 02239373 Zofran ODT 02344459 Zym-Ondansetron GSK Zymcan 10 30 10 10 30 10 30 10 30 10 100 10 100 10 10 100 10 100 10 100 10 100 10 100 10 10 100 10 100 10 100 10 100 10 10 100 OSELTAMIVIR PHOSPHATE X Caps. 51.11 153.33 51.11 51.11 153.33 51.11 153.33 51.11 153.33 51.11 511.10 51.11 511.10 51.11 51.11 511.10 51.11 511.10 51.11 511.10 51.11 511.10 51.11 511.10 51.11 51.11 511.10 51.11 511.10 51.11 511.10 193.22 1932.26 188.77 51.11 511.10 5.1110 5.1110 5.1110 5.1110 5.1110 5.1110 5.1110 5.1110 5.1110 5.1110 5.1110 5.1110 5.1110 5.1110 5.1110 5.1110 5.1110 5.1110 5.1110 5.1110 5.1110 5.1110 5.1110 5.1110 5.1110 5.1110 5.1110 5.1110 5.1110 5.1110 5.1110 19.3220 19.3226 18.8770 5.1110 5.1110 30 mg 02304848 Tamiflu Roche 10 02304856 Tamiflu Roche 10 Caps. 19.50 1.9500 45 mg Caps. 30.00 3.0000 75 mg 02241472 Tamiflu 2013-04 Roche 10 39.00 3.9000 Page 419 CODE BRAND NAME MANUFACTURER SIZE OXCARBAZEPINE X Oral Susp. UNIT PRICE 60 mg/mL 02244673 Trileptal Novartis 250 ml 02284294 Apo-Oxcarbazepine 02242067 Trileptal Apotex Novartis 100 50 Tab. 77.45 0.3098 150 mg PPB Tab. 62.09 38.72 0.4647 0.7744 300 mg PPB 02284308 Apo-Oxcarbazepine 02242068 Trileptal Apotex Novartis 100 50 Tab. 85.20 42.60 0.8520 0.8520 600 mg PPB 02284316 Apo-Oxcarbazepine 02242069 Trileptal Apotex Novartis 100 50 Watson 8 OXYBUTYNIN X Patch 02254735 Oxytrol 02243960 Ditropan XL Janss. Inc 100 Janss. Inc Purdue 100 100 420 6.4775 183.30 1.8330 183.30 133.79 1.8330 1.3379 15 mg Purdue 100 Apotex Cobalt Purdue 100 100 60 OXYCODONE Z L.A. Tab. 02366746 Apo-Oxycodone CR 02394170 Co Oxycodone CR 02258129 OxyContin 51.82 10 mg PPB L.A. Tab. 02273586 Uromax 1.7040 1.7040 5 mg L.A. Tab. 02243961 Ditropan XL 02273578 Uromax 170.40 85.20 36 mg OXYBUTYNINE CHLORIDE X L.A. Tab. Page COST OF PKG. SIZE 144.08 1.4408 5 mg PPB 34.02 34.02 37.80 0.3402 0.3402 W 2013-04 CODE BRAND NAME MANUFACTURER SIZE L.A. Tab. 02366754 02394189 02202441 02372525 02309882 Apo-Oxycodone CR Co Oxycodone CR OxyContin OxyNEO pms-Oxycodone CR Apotex Cobalt Purdue Purdue Phmscience 100 100 60 60 100 Apotex Purdue Purdue 100 60 60 L.A. Tab. Apo-Oxycodone CR Co Oxycodone CR OxyContin OxyNEO pms-Oxycodone CR 57.24 63.60 63.60 0.5724 W 1.0600 Apotex Cobalt Purdue Purdue Phmscience 100 100 60 60 100 71.12 71.12 79.14 79.02 71.12 0.7112 0.7112 W 1.3170 0.7112 30 mg PPB 02394774 Apo-Oxycodone CR 02323206 OxyContin 02372541 OxyNEO Apotex Purdue Purdue 100 60 60 93.96 104.40 104.40 0.9396 W 1.7400 40 mg PPB L.A. Tab. Apo-Oxycodone CR Co Oxycodone CR OxyContin OxyNEO pms-Oxycodone CR Apotex Cobalt Purdue Purdue Phmscience 100 100 60 60 100 L.A. Tab. 123.26 123.26 137.40 136.95 123.26 1.2326 1.2326 W 2.2825 1.2326 60 mg PPB 02394782 Apo-Oxycodone CR 02323214 OxyContin 02372576 OxyNEO Apotex Purdue Purdue 100 60 60 L.A. Tab. 170.10 189.00 189.00 1.7010 W 3.1500 80 mg PPB Apo-Oxycodone CR Co Oxycodone CR OxyContin OxyNEO pms-Oxycodone CR Apotex Cobalt Purdue Purdue Phmscience 100 100 60 60 100 PALIPERIDONE PALMITATE X I.M. Inj. Susp. 02354217 Invega Sustenna 2013-04 0.4741 0.4741 W 0.8780 0.4741 20 mg PPB L.A. Tab. 02366789 02394219 02202484 02372584 02309912 47.41 47.41 52.68 52.68 47.41 15 mg PPB 02394766 Apo-Oxycodone CR 02323192 OxyContin 02372533 OxyNEO 02306530 02394200 02202476 02372568 02309904 UNIT PRICE 10 mg PPB L.A. Tab. 02366762 02394197 02202468 02372797 02309890 COST OF PKG. SIZE 227.66 227.66 253.80 252.96 227.66 2.2766 2.2766 W 4.2160 2.2766 50 mg/0.5 mL Janss. Inc 1 304.10 Page 421 CODE BRAND NAME MANUFACTURER SIZE I.M. Inj. Susp. 02354225 Invega Sustenna Janss. Inc 1 Janss. Inc 1 Janss. Inc 1 Allergan 3.5 g 7g Alcon 3.5 g GSK 120 Pfizer 1 Roche 1 AA Pharma 02221977 Trental SanofiAven 100 500 60 Pfizer 100 422 4440.00 37.0000 1013.91 395.84 400 mg PPB 02230090 Apo-Pentoxifylline SR PILOCARPINE HYDROCHLORIDE X Tab. Page 1.2486 180 mcg/0.5 mL PENTOXIFYLLINE X L.A. Tab. 02216345 Salagen 5.05 0.3 mg PEGINTERFERON ALFA-2A X S.C. Inj.Sol (syr) 02248077 Pegasys 1.8629 1.3157 200 mg PEGAPTANIB (SODIUM) X Syringe 02267225 Macugen 6.98 9.85 94 % -3 % PAZOPANIB HYDROCHLORIDE X Tab. 02352303 Votrient 608.22 57.3 % - 42.5 % Oph. Oint. 02082519 Tears Naturale 456.18 150 mg/1.5 mL PARAFFIN/MINERAL OIL Oph. Oint. 00210889 Lacrilube 456.18 100 mg/1.0 mL I.M. Inj. Susp. 02354241 Invega Sustenna UNIT PRICE 75 mg/0.75 mL I.M. Inj. Susp. 02354233 Invega Sustenna COST OF PKG. SIZE 58.46 292.30 40.48 0.4049 0.4048 0.6747 5 mg 105.32 1.0532 2013-04 CODE BRAND NAME MANUFACTURER SIZE PIMECROLIMUS X Top. Cr. 02247238 Elidel 02345366 02374013 02303124 02312050 02375850 02301423 Valeant 30 g 60 g Actos Apo-Pioglitazone Auro-Pioglitazone Co Pioglitazone Jamp-Pioglitazone Mint-Pioglitazone Mylan-Pioglitazone Novo-Pioglitazone phl-Pioglitazone Pioglitazone Takeda Apotex Aurobindo Cobalt Jamp Mint Mylan Novopharm Pharmel Accord Pioglitazone Pioglitazone HCl pms-Pioglitazone Pro-Pioglitazone Ran-Pioglitazone ratio-Pioglitazone MeliaPharm Sivem Phmscience Pro Doc Ranbaxy Ratiopharm 90 100 100 100 90 100 90 100 100 30 90 100 100 100 100 100 100 500 100 100 02297906 Sandoz Pioglitazone 02320754 Zym-Pioglitazone UNIT PRICE 1% PIOGLITAZONE HYDROCHLORIDE X Tab. 02242572 02302942 02384906 02302861 + 02397307 02326477 02298279 02274914 02307669 02391600 COST OF PKG. SIZE 62.94 125.89 2.0980 2.0982 15 mg PPB Sandoz Zymcan Tab. 191.26 81.33 81.33 81.33 73.20 81.33 73.20 81.33 81.33 24.40 73.20 81.33 81.33 81.33 81.33 81.33 81.33 406.67 81.33 81.33 2.1251 0.8133 0.8133 0.8133 0.8133 0.8133 0.8133 0.8133 0.8133 0.8133 0.8133 0.8133 0.8133 0.8133 0.8133 0.8133 0.8133 0.8133 0.8133 0.8133 30 mg PPB 02242573 02302950 02384914 02302888 02365529 02326485 02298287 02274922 Actos Apo-Pioglitazone Auro-Pioglitazone Co Pioglitazone Jamp-Pioglitazone Mint-Pioglitazone Mylan-Pioglitazone Novo-Pioglitazone Takeda Apotex Aurobindo Cobalt Jamp Mint Mylan Novopharm 02307677 phl-Pioglitazone 02339587 Pioglitazone Pharmel Accord 02345374 02374021 02303132 02312069 02375869 02301431 MeliaPharm Sivem Phmscience Pro Doc Ranbaxy Ratiopharm Pioglitazone Pioglitazone HCl pms-Pioglitazone Pro-Pioglitazone Ran-Pioglitazone ratio-Pioglitazone 02297914 Sandoz Pioglitazone 02320762 Zym-Pioglitazone 2013-04 Sandoz Zymcan 90 100 100 100 90 100 90 100 500 100 30 500 100 100 100 100 100 100 500 100 100 267.95 113.93 113.93 113.93 102.54 113.93 102.54 113.93 760.30 113.93 34.18 760.30 113.93 113.93 113.93 113.93 113.93 113.93 760.30 113.93 113.93 2.9772 1.1393 1.1393 1.1393 1.1393 1.1393 1.1393 1.1393 1.5206 1.1393 1.1393 1.5206 1.1393 1.1393 1.1393 1.1393 1.1393 1.1393 1.5206 1.1393 1.1393 Page 423 CODE BRAND NAME MANUFACTURER SIZE Tab. COST OF PKG. SIZE UNIT PRICE 45 mg PPB 02242574 02302977 02384922 02302896 02365537 02326493 02298295 02274930 Actos Apo-Pioglitazone Auro-Pioglitazone Co Pioglitazone Jamp-Pioglitazone Mint-Pioglitazone Mylan-Pioglitazone Novo-Pioglitazone Takeda Apotex Aurobindo Cobalt Jamp Mint Mylan Novopharm 02307723 phl-Pioglitazone 02339595 Pioglitazone Pharmel Accord 02345382 02374048 02303140 02312077 02375877 02301458 MeliaPharm Sivem Phmscience Pro Doc Ranbaxy Ratiopharm Pioglitazone Pioglitazone HCl pms-Pioglitazone Pro-Pioglitazone Ran-Pioglitazone ratio-Pioglitazone 02297922 Sandoz Pioglitazone 02320770 Zym-Pioglitazone Sandoz Zymcan 90 100 100 100 90 100 90 100 500 100 30 500 100 100 100 100 100 100 500 100 100 POLYETHYLENE GLYCOL Oral Pd. 402.90 171.32 171.32 171.32 154.19 171.32 154.19 171.32 1143.25 171.32 51.40 1143.25 171.32 171.32 171.32 171.32 171.32 171.32 1143.25 171.32 171.32 4.4767 1.7132 1.7132 1.7132 1.7132 1.7132 1.7132 1.7132 2.2865 1.7132 1.7132 2.2865 1.7132 1.7132 1.7132 1.7132 1.7132 1.7132 2.2865 1.7132 1.7132 1 g/g PPB 02374137 Emolax 02317680 Lax-A-Day 02358034 Peg 3350 Jamp Pendopharm Medisca MedFutures 510 g 510 g 255 g 510 g 238 g 12.70 19.99 6.35 14.74 5.93 02328232 PegaLAX (14 packs of 17 grams) 02346672 Relaxa Red Leaf 510 g 12.70 0.0249 POLYETHYLENE GLYCOL/ SODIUM SULFATE/ SODIUM BICARBONATE/ SODIUM CHLORIDE/ POTASSIUM CHLORIDE Oral Pd. 0.851 g - 0.082 g - 0.024 g - 0.021 g - 0.011 g / g 99100717 PegLyte (280 g) 00777838 PegLyte (pack of 70 g) Pendopharm Pendopharm 1 4 Allergan 30 POLYVINYL ALCOHOL Oph. Sol. 02138670 Refresh Page 424 3.1600 1.4 % (0.4 mL) POLYVINYL ALCOHOL/ POVIDONE Oph. Sol. 00579408 Tears Plus 16.45 12.64 9.95 0.3187 1.4 % -0.6 % Allergan 15 ml 30 ml 6.66 11.19 0.3623 2013-04 CODE BRAND NAME MANUFACTURER SIZE POSACONAZOLE X Oral Susp. 02293404 Posanol Merck 1 Lilly 30 79.70 Serono 18 144.00 2.6567 8% Vag. Tab. (eff.) 02334992 Endometrin 988.00 10 mg PROGESTERONE X Vag. gel (App.) 02241013 Crinone UNIT PRICE 40 mg/mL PRASUGREL X Tab. 02349124 Effient COST OF PKG. SIZE 100 mg Ferring 21 84.00 4.0000 PSYLLIUM MUCILLOID 5 Oral Pd. 99002876 504 g QUANTITATIVE PROTHROMBIN-TIME BLOOD TEST Strip 99100333 CoaguChek XS Roche Diag RANIBIZUMAB X Inj. Sol. 02296810 Lucentis 6 24 48 37.20 148.80 297.60 10 mg/mL (0,23ml) Novartis 1 RASAGILINE MESYLATE X Tab. 1575.00 0.5 mg 02284642 Azilect Teva Innov 30 02284650 Azilect Teva Innov 30 Tab. 210.00 7.0000 1 mg 5 2013-04 210.00 7.0000 Where no price is indicated, pharmacists may purchase the product of their choice. The product thus obtained is considered insured and the price payable by the Régie is the pharmacist's cost price. Page 425 CODE BRAND NAME MANUFACTURER SIZE REPAGLINIDE X Tab. 02355663 02321475 02239924 02354926 02357453 Apo-Repaglinide Co Repaglinide GlucoNorm pms-Repaglinide Sandoz Repaglinide UNIT PRICE 0.5 mg PPB Apotex Cobalt N.Nordisk Phmscience Sandoz 100 100 100 100 100 Tab. 9.96 9.96 27.62 9.96 9.96 0.0996 0.0996 0.2762 0.0996 0.0996 1 mg PPB 02355671 02321483 02239925 02354934 02357461 Apo-Repaglinide Co Repaglinide GlucoNorm pms-Repaglinide Sandoz Repaglinide Apotex Cobalt N.Nordisk Phmscience Sandoz 100 100 100 100 100 02355698 02321491 02239926 02354942 02357488 Apo-Repaglinide Co Repaglinide GlucoNorm pms-Repaglinide Sandoz Repaglinide Apotex Cobalt N.Nordisk Phmscience Sandoz 100 100 100 100 100 Tab. 10.36 10.36 28.74 10.36 10.36 0.1036 0.1036 0.2874 0.1036 0.1036 2 mg PPB RIBAVIRIN/ PEGINTERFERON ALFA-2A X Kit 10.75 10.75 29.83 10.75 10.75 0.1075 0.1075 0.2983 0.1075 0.1075 200mg -180 mcg/0.5ml 02253429 Pegasys RBV (28) 99100171 Pegasys RBV (35) 99100173 Pegasys RBV (42) Roche Roche Roche 99100174 Pegasys RBV (42) Roche Kit 1 1 1 395.84 395.84 395.84 200 mg -180 mcg/1ml RIBAVIRINE/ INTERFERON ALFA-2B (PEGYLATED) X Kit 02246026 Pegetron Merck 02246027 Pegetron 02254581 Pegetron Redipen Merck Merck Kit 1 395.84 200 mg-50 mcg/0.5 mL 1 752.20 200 mg-80 mcg/0.5 mL Kit 1 1 752.20 752.20 200 mg-100 mcg/0.5 mL 02246028 Pegetron 02254603 Pegetron Redipen Page COST OF PKG. SIZE 426 Merck Merck 1 1 752.20 752.20 2013-04 CODE BRAND NAME MANUFACTURER Kit SIZE COST OF PKG. SIZE UNIT PRICE 200 mg-120 mcg/0.5 mL 02246029 Pegetron 02254638 Pegetron Redipen Merck Merck 02246030 Pegetron 02254646 Pegetron Redipen Merck Merck Kit 1 1 831.18 831.18 200 mg-150 mcg/0.5 mL 1 1 RILUZOLE X Tab. 02352583 Apo-Riluzole 02390299 Mylan-Riluzole 02242763 Rilutek 50 mg PPB Apotex Mylan SanofiAven 60 60 60 RISPERIDONE X I.M. Inj. Pd. 02298465 Risperdal Consta Janss. Inc 1 Janss. Inc 1 Janss. Inc 1 156.09 234.16 50 mg Janss. Inc 1 RITUXIMAB X I.V. Perf. Sol. 02241927 Rituxan 75.41 37.5 mg I.M. Inj. Pd. 02255758 Risperdal Consta 3.4362 3.4362 9.7640 25 mg I.M. Inj. Pd. 02255723 Risperdal Consta 206.17 206.17 585.84 12.5 mg I.M. Inj. Pd. 02255707 Risperdal Consta 831.18 831.18 312.20 10 mg/mL Roche 10 ml 50 ml RIVAROXABAN X Tab. 453.10 2265.50 10 mg 02316986 Xarelto Bayer 50 02378604 Xarelto Bayer 28 Tab. 142.00 2.8400 15 mg 2013-04 79.52 2.8400 Page 427 CODE BRAND NAME MANUFACTURER SIZE Tab. UNIT PRICE 20 mg 02378612 Xarelto Bayer 28 Apotex Novartis Mylan Novopharm 100 56 100 56 100 60 100 60 100 56 100 RIVASTIGMINE X Caps. 02336715 02242115 02333280 02305984 Apo-Rivastigmine Exelon Mylan-Rivastigmine Novo-Rivastigmine 79.52 2.8400 1.5 mg PPB 02306034 pms-Rivastigmine Phmscience 02311283 ratio-Rivastigmine Ratiopharm 02324563 Sandoz Rivastigmine Sandoz Caps. 65.15 136.50 65.15 36.48 65.15 39.09 65.15 39.09 65.15 36.48 65.15 0.6515 2.4375 0.6515 0.6514 0.6515 0.6514 0.6515 0.6514 0.6515 0.6514 0.6515 3 mg PPB 02336723 02242116 02332817 02305992 Apo-Rivastigmine Exelon Mylan-Rivastigmine Novo-Rivastigmine Apotex Novartis Mylan Novopharm 02306042 pms-Rivastigmine Phmscience 02311291 ratio-Rivastigmine Ratiopharm 02324571 Sandoz Rivastigmine Sandoz 02336731 02242117 02332825 02306018 Apotex Novartis Mylan Novopharm 100 56 100 56 100 60 100 60 100 56 100 Caps. Page COST OF PKG. SIZE 65.15 136.50 65.15 36.48 65.15 39.09 65.15 39.09 65.15 36.48 65.15 0.6515 2.4375 0.6515 0.6514 0.6515 0.6514 0.6515 0.6514 0.6515 0.6514 0.6515 4.5 mg PPB Apo-Rivastigmine Exelon Mylan-Rivastigmine Novo-Rivastigmine 02306050 pms-Rivastigmine Phmscience 02311305 ratio-Rivastigmine Ratiopharm 02324598 Sandoz Rivastigmine Sandoz 428 100 56 100 56 100 60 100 60 100 56 100 65.15 136.50 65.15 36.48 65.15 39.09 65.15 39.09 65.15 36.48 65.15 0.6515 2.4375 0.6515 0.6514 0.6515 0.6514 0.6515 0.6514 0.6515 0.6514 0.6515 2013-04 CODE BRAND NAME MANUFACTURER COST OF PKG. SIZE SIZE Caps. UNIT PRICE 6 mg PPB 02336758 02242118 02332833 02306026 Apo-Rivastigmine Exelon Mylan-Rivastigmine Novo-Rivastigmine Apotex Novartis Mylan Novopharm 02306069 pms-Rivastigmine 02311313 ratio-Rivastigmine Phmscience Ratiopharm 02324601 Sandoz Rivastigmine Sandoz 100 56 100 56 100 60 60 100 56 100 65.15 136.50 65.15 36.48 65.15 39.09 39.09 65.15 36.48 65.15 Oral Sol. 02245240 Exelon 0.6515 2.4375 0.6515 0.6514 0.6515 0.6514 0.6514 0.6515 0.6514 0.6515 2 mg/mL Novartis 120 ml Patch 153.02 1.2752 4.6 mg/24H 02302845 Exelon Patch 5 Novartis 30 02302853 Exelon Patch 10 Novartis 30 GSK 60 Patch 131.63 4.3877 9.5 mg/24H ROSIGLITAZONE MALEATE X Tab. 02241112 Avandia 131.63 4.3877 2 mg Tab. 76.76 1.2793 4 mg 02241113 Avandia GSK 100 02241114 Avandia GSK 60 Tab. 200.73 2.0073 8 mg ROSIGLITAZONE MALEATE/ METFORMIN HYDROCHLORIDE X Tab. 172.24 2.8707 1 mg - 500 mg 02247085 Avandamet GSK 100 02247086 Avandamet GSK 100 Tab. 62.16 0.6216 2 mg - 500 mg Tab. 112.40 1.1240 2 mg - 1000 mg 02248440 Avandamet 2013-04 GSK 100 122.76 1.2276 Page 429 CODE BRAND NAME MANUFACTURER COST OF PKG. SIZE SIZE Tab. 4 mg - 500 mg 02247087 Avandamet GSK 100 02248441 Avandamet GSK 100 Tab. 153.33 1.5333 4 mg - 1000 mg 167.31 RUFINAMIDE X Tab. 02369613 Banzel 1.6731 100 mg Eisai 30 21.54 Tab. 0.7180 200 mg 02369621 Banzel Eisai 30 02369648 Banzel Eisai 120 43.09 Tab. 1.4363 400 mg 375.58 RUXOLITINIB PHOSPHATE X Tab. 3.1298 5 mg 02388006 Jakavi Novartis 60 02388014 Jakavi Novartis 60 4931.51 Tab. 82.1918 15 mg 4931.51 Tab. 82.1918 20 mg 02388022 Jakavi Novartis SALBUTAMOL SULFATE X Inh. Pd. 02243115 Ventolin Diskus 02240835 Advair 100 Diskus GSK Inh. Pd. 02240836 Advair 250 Diskus 430 4931.51 82.1918 60 dose(s) 13.17 50 mcg-100 mcg/coque 60 dose(s) 75.79 50 mcg-250 mcg/coque GSK 60 dose(s) GSK 60 dose(s) Inh. Pd. 02240837 Advair 500 Diskus 60 200 mcg/coque GSK SALMETEROL XINAFOATE/ FLUTICASONE PROPIONATE X Inh. Pd. Page UNIT PRICE 90.69 50 mcg-500 mcg/coque 128.74 2013-04 CODE BRAND NAME MANUFACTURER Oral aerosol 02245126 Advair 125 GSK 120 dose(s) GSK 120 dose(s) 90.69 25 mcg -250 mcg/dose SAPROPTERIN DIHYDROCHLORIDE X Tab. 02350580 Kuvan UNIT PRICE 25 mcg -125 mcg/dose Oral aerosol 02245127 Advair 250 COST OF PKG. SIZE SIZE 128.74 100 mg Biomarin 120 SAXAGLIPTIN X Tab. 3960.00 33.0000 2.5 mg 02375842 Onglyza B.M.S. 30 02333554 Onglyza B.M.S. 30 100 Tab. 69.00 2.3000 5 mg SENNOSIDES A & B Liq. 80024394 Jamp-Sennaquil 00367729 Senokot 69.00 230.00 2.3000 2.3000 8.5 mg/5 mL PPB Jamp Purdue 250 ml 250 ml 500 ml Tab. 7.96 7.96 16.91 0.0318 0.0318 0.0338 8.6 mg PPB 80019511 Bio-Sennosides 02247389 Euro-Senna 80009595 Jamp-Senna Biomed Euro-Pharm Jamp 80009182 Jamp-Sennosides Coated 02298090 phl-Sennosides Jamp Opus Pharmel 00896411 pms-Sennosides Phmscience 01949292 Riva-Senna Riva 02068109 Sennatab 02089653 Sennosides Phmscience Sandoz + 80038814 Opus Senna 2013-04 500 1000 100 500 500 1000 100 1000 100 1000 100 1000 1000 500 23.20 46.40 4.64 23.20 23.20 46.40 4.64 46.40 4.64 46.40 4.64 46.40 46.40 23.20 0.0464 0.0464 0.0464 0.0464 0.0464 0.0464 0.0464 0.0464 0.0464 0.0464 0.0464 0.0464 0.0464 0.0464 Page 431 CODE BRAND NAME MANUFACTURER SIZE Tab. COST OF PKG. SIZE UNIT PRICE 12 mg PPB 80009183 Jamp-Sennosides Coated 02298104 phl-Sennosides Jamp Pharmel 00896403 pms-Sennosides Phmscience 02089645 Sennosides Sandoz 500 100 1000 100 1000 500 SanofiAven 180 SEVELAMER CARBONATE X Tab. 02354586 Renvela SanofiAven 180 1.4991 277.36 1.5409 20 mg PPB Ratiopharm Pfizer 100 90 SITAGLIPTIN X Tab. 02303922 Januvia 269.83 800 mg SILDENAFIL CITRATE X Tab. 02319500 ratio-Sildenafil R 02279401 Revatio 0.0555 0.0693 0.0555 0.0693 0.0555 0.0555 800 mg SEVELAMER HYDROCHLORIDE X Tab. 02244310 Renagel 27.75 6.93 55.50 6.93 55.50 27.75 625.20 962.75 6.2520 10.6972 100 mg Merck 30 100 SITAGLIPTIN/METFORMIN X Tab. 78.53 261.78 2.6177 2.6178 50 mg -500 mg 02333856 Janumet Merck 60 02333864 Janumet Merck 60 Tab. 82.20 1.3700 50 mg -850 mg Tab. 82.20 1.3700 50 mg -1000 mg 02333872 Janumet Merck 60 82.20 1.3700 SODIUM CITRATE/ SODIUM LAURYLSULFOACETATE/ SORBITOL Rect. Sol. 90 mg/mL - 9 mg/mL - 625 mg/mL 02063905 Microlax Page 432 McNeil Co 12 10.98 0.9150 2013-04 CODE BRAND NAME MANUFACTURER SODIUM PHOSPHATE MONOBASIC/ SODIUM PHOSPHATE DIBASIC Ped. Rect. Sol. 00108065 Fleet Pediatrique SIZE McNeil Co 65 ml McNeil Co 130 ml 2.86 16 g -6 g/100 mL SOLIFENACIN SUCCINATE X Tab. 02277263 Vesicare UNIT PRICE 160 mg -60 mg/mL Rect. Sol. 00009911 Fleet COST OF PKG. SIZE 3.07 5 mg Astellas 30 90 Tab. 45.00 135.00 1.5000 1.5000 10 mg 02277271 Vesicare Astellas 30 90 Lilly Serono 1 1 Roche 1 SOMATOTROPHIN X Cartridge 02243077 Humatrope 02350122 Saizen Lilly Serono 1 1 Serono 1 Lilly 1 Serono 1 2013-04 1120.08 3.33 mg Inj. Pd. 00745626 Humatrope 02237971 Saizen 870.00 24 mg Inj. Pd. 02215136 Saizen 522.00 522.00 20 mg Cartridge 02243079 Humatrope 389.44 12 mg PPB Cartridge 02350149 Saizen 261.00 261.00 10 mg Cartridge 02243078 Humatrope 02350130 Saizen 1.5000 1.5000 6 mg PPB Cartridge 02249002 Nutropin AQ Pen 45.00 135.00 135.45 5 mg PPB Lilly Serono 1 1 206.94 206.94 Page 433 CODE BRAND NAME MANUFACTURER SIZE Inj. Pd. 02272083 Saizen Serono 1 Roche 1 Roche Roche 1 1 Sandoz 1 5 Sandoz 1 5 139.5000 279.00 1395.00 279.0000 12.5 mg Pfizer 28 Caps. 1768.27 63.1525 25 mg 02280809 Sutent Pfizer 28 02280817 Sutent Pfizer 28 Caps. 3536.52 126.3043 50 mg TACROLIMUS X Top. Oint. 02244149 Protopic 02244148 Protopic 434 7073.05 252.6089 0.03 % Astellas 30 g 60 g Top. Oint. Page 139.50 697.50 10 mg/1.5 mL SUNITINIB (MALATE) X Caps. 02280795 Sutent 389.44 389.44 5 mg/1.5 mL Cartridge 02325071 Omnitrope 389.44 5 mg/mL (2 mL) SOMATROPIN X Cartridge 02325063 Omnitrope 348.03 10 mg Inj. Sol. 02229722 Nutropin AQ 02376393 Nutropin AQ NuSpin UNIT PRICE 8.8 mg Inj. Pd. 02216191 Nutropin COST OF PKG. SIZE 64.50 129.00 2.1500 2.1500 0.1 % Astellas 30 g 60 g 69.00 138.00 2.3000 2.3000 2013-04 CODE BRAND NAME MANUFACTURER SIZE TADALAFIL X Tab. 02338327 Adcirca Lilly 56 680.81 12.1573 375 mg Vertex 168 Merck 5 TEMOZOLOMIDE X Caps. 02241093 Temodal UNIT PRICE 20 mg TELAPREVIR X Tab. 02371553 Incivek COST OF PKG. SIZE 11656.00 69.3810 5 mg Caps. 37.49 7.4980 20 mg PPB 02395274 Co Temozolomide Cobalt 02241094 Temodal Merck 5 20 5 Caps. 89.98 359.90 149.96 17.9960 17.9950 29.9920 100 mg PPB 02395282 Co Temozolomide Cobalt 02241095 Temodal Merck 5 20 5 Caps. 449.89 1799.54 749.81 89.9780 89.9770 149.9620 140 mg PPB 02395290 Co Temozolomide Cobalt 02312794 Temodal Merck 5 20 5 20 Caps. 629.84 2519.38 1049.74 4198.96 125.9680 125.9690 209.9480 209.9480 250 mg PPB 02395312 Co Temozolomide Cobalt 02241096 Temodal Merck TERIPARATIDE X S.C. Inj. Sol. 02254689 Forteo 5 20 5 2013-04 224.9380 224.9375 374.8960 250 mcg/mL (2.4 mL or 3 mL) Lilly 1 THALIDOMIDE X Caps. 02355191 Thalomid 1124.69 4498.75 1874.48 809.73 50 mg Celgene 28 825.16 29.4700 Page 435 CODE BRAND NAME MANUFACTURER SIZE Caps. UNIT PRICE 100 mg 02355205 Thalomid Celgene 28 02355221 Thalomid Celgene 28 Caps. 1650.32 58.9400 200 mg TICAGRELOR X Tab. 02368544 Brilinta 02285401 Tygacil AZC 60 Pfizer 10 Bo. Ing. 120 Apotex Mylan Paladin 100 150 150 Novartis 224 Novartis 56 Roche 1 436 990.00 8.2500 36.86 55.29 112.76 0.3686 0.3686 0.7517 2880.36 2880.36 51.4350 80 mg/4 mL I.V. Perf. Sol. 02350106 Actemra 80.2500 300 mg/5 mL TOCILIZUMAB X I.V. Perf. Sol. 02350092 Actemra 802.50 28 mg Sol. Inh. 02239630 Tobi 1.4800 4 mg PPB TOBRAMYCIN SULFATE X Inh. Pd. 02365154 Tobi Podhaler 88.80 250 mg TIZANIDINE HYDROCHLORIDE X Tab. 02259893 Apo-Tizanidine 02272059 Mylan-Tizanidine 02239170 Zanaflex 117.8800 50 mg TIPRANAVIR X Caps. 02273322 Aptivus 3300.64 90 mg TIGECYCLINE X I.V. Perf. Pd. Page COST OF PKG. SIZE 179.20 200 mg/10 mL Roche 1 448.00 2013-04 CODE BRAND NAME MANUFACTURER SIZE I.V. Perf. Sol. 02350114 Actemra COST OF PKG. SIZE UNIT PRICE 400 mg/20 ml Roche 1 TOCOPHERYL ACETATE (DL-ALPHA) 5 Caps. 896.00 100 UI 99002396 100 99002418 100 Caps. 200 UI Caps. 400 UI 99002426 100 Chew. Tab. 200 UI 99100202 90 Oral Sol. 50 UI/mL 99002469 25 ml Oral Sol. 77 UI/mL 99002477 150 ml TOLTERODINE L-TARTRATE X L.A. Caps. 02244612 Detrol LA 2 mg Pfizer 30 90 L.A. Caps. 56.76 170.28 1.8920 1.8920 4 mg 02244613 Detrol LA Pfizer 30 90 02239064 Detrol Pfizer 60 Tab. 56.76 170.28 1.8920 1.8920 1 mg Tab. 56.76 0.9460 2 mg 02239065 Detrol 5 2013-04 Pfizer 60 500 56.76 473.01 0.9460 0.9460 Where no price is indicated, pharmacists may purchase the product of their choice. The product thus obtained is considered insured and the price payable by the Régie is the pharmacist's cost price. Page 437 CODE BRAND NAME MANUFACTURER SIZE TRANDOLAPRIL/ VERAPAMIL HYDROCHLORIDE X Tab. COST OF PKG. SIZE UNIT PRICE 2 mg -240 mg 02240946 Tarka Abbott 100 02238097 Tarka Abbott 100 Alcon 2.5 ml 5 ml Tab. 172.30 1.7230 4 mg -240 mg TRAVOPROST/ TIMOLOL (MALEATE OF) X Oph. Sol. 02278251 DuoTrav U.T.C. 20 ml U.T.C. 20 ml 2250.00 5 mg/mL U.T.C. 20 ml U.T.C. 20 ml Inj. Sol. 02246555 Remodulin 900.00 2.5 mg/mL Inj. Sol. 02246554 Remodulin 31.11 62.22 1 mg/mL Inj. Sol. 02246553 Remodulin 1.9121 0.004 % - 0.5 % TREPROSTINIL SODIUM X Inj. Sol. 02246552 Remodulin 191.21 4500.00 10 mg/mL 9000.00 TRETINOIN X Top. Cr. 00897329 Retin-A 00657204 Stieva-A 0.01 % PPB Janss. Inc GSK 30 g 45 g Janss. Inc GSK 30 g 45 g Top. Cr. 00897310 Retin-A 00578576 Stieva-A Page 438 0.3560 0.2918 0.025 % PPB Top. Cr. 00443794 Retin-A 00518182 Stieva-A 10.68 13.13 10.68 13.13 0.3560 0.2918 0.05 % PPB Janss. Inc GSK 30 g 45 g 10.36 13.13 0.3453 0.2918 2013-04 CODE BRAND NAME MANUFACTURER SIZE Top. Cr. 00870021 Retin-A 00662348 Stieva-A Forte Janss. Inc GSK 30 g 45 g Janss. Inc Valeant 30 g 25 g Janss. Inc GSK Valeant 30 g 45 g 25 g GSK Valeant 45 g 25 g 60 Ferring 5 Janss. Inc 1 0.3453 0.2918 0.2964 13.13 7.41 W 0.2964 45.57 0.7595 265.00 53.0000 45 mg/0.5 mL VALGANCICLOVIR HYDROCHLORIDE X Oral Susp. 02306085 Valcyte 10.36 13.13 7.41 75 UI USTEKINUMAB X Syringe 02320673 Stelara W 0.2964 20 mg Sunovion UROFOLLITROPIN X Inj. Pd. 02268140 Bravelle 10.36 7.41 0.05 % PPB TROSPIUM CHLORIDE X Tab. 02275066 Trosec W 0.2918 0.025 % PPB Top. Jel. 00641863 Stieva-A 01926489 Vitamin A Acid Gel 10.68 13.13 0.01 % PPB Top. Jel. 00443816 Retin-A 00587966 Stieva-A 01926470 Vitamin A Acid Gel UNIT PRICE 0.1 % PPB Top. Jel. 00870013 Retin-A 01926462 Vitamin A Acid Gel Doux COST OF PKG. SIZE 4311.72 50 mg/mL Roche 100 ml Tab. 253.98 2.5398 450 mg 02245777 Valcyte Roche 60 Roche 56 VEMURAFENIB X Tab. 02380242 Zelboraf 2013-04 1371.49 22.8582 240 mg 2606.35 46.5420 Page 439 CODE BRAND NAME MANUFACTURER SIZE VERTEPORFIN X I.V. Inj. Pd. 02242367 Visudyne UNIT PRICE 15 mg Novartis 1 VORICONAZOLE X I.V. Perf. Pd. 1791.30 10 mg/mL 02256487 Vfend Pfizer 1 02256460 Vfend Pfizer 30 Tab. 145.55 145.5500 50 mg Tab. 370.53 12.3510 200 mg 02256479 Vfend Pfizer 30 GSK 5 ZANAMIVIR X Inh. Pd. (App.) 02240863 Relenza 02248296 Zometa 440 49.3830 36.54 4 mg/5 mL Novartis 5 ml Novartis 1 I.V. Perf. Sol. 02269198 Aclasta 1481.49 5 mg/coque (4) ZOLEDRONIC ACID X I.V. Perf. Sol. Page COST OF PKG. SIZE 538.45 5 mg/ 100 mL 668.60 2013-04 SUPPLIES CODE BRAND NAME MANUFACTURER SIZE COST OF PKG. SIZE UNIT PRICE SUPPLIES 6 AEROSOL HOLDING CHAMBER 99002116 1 AEROSOL HOLDING CHAMBER AND MASK 99002124 1 DISPOSABLE NEEDLE FOR INSULIN AUTO-INJECTOR 99002108 1 DISPOSABLE NEEDLE WITH SAFETY DEVICE FOR INSULIN AUTO-INJECTOR 9 99100517 1 DISPOSABLE SYRINGE (WITHOUT NEEDLE) 1.0 cc 99002337 1 2.0 cc 99002531 1 99002175 1 3 cc 5 cc 99002183 1 99002191 1 10 cc 20 cc 99100668 6 9 2013-04 1 Where no price is indicated, pharmacists may purchase the product of their choice. The product thus obtained is considered insured and the price payable by the Régie is the pharmacist's cost price. This type of supply is reimbursable for persons carrying a blood-borne infection. Page 443 CODE BRAND NAME MANUFACTURER SIZE COST OF PKG. SIZE UNIT PRICE 30 cc 99100669 1 DISPOSABLE SYRINGE WITH NEEDLE FOR INSULIN 0.25 cc 99002132 1 0.3 cc 99002140 1 0.5 cc 99002159 1 99002167 1 1.0 cc DISPOSABLE SYRINGE WITH NEEDLE(S) 1.0 cc 99002345 1 99002558 1 2.0 cc 3 cc 99002205 1 99002213 1 5 cc 10 cc 99002221 1 MASK FOR AEROSOL HOLDING CHAMBER 99003643 Page 444 1 2013-04 PRODUCTS FOR EXTEMPORANEOUS PREPARATIONS CODE BRAND NAME MANUFACTURER SIZE COST OF PKG. SIZE UNIT PRICE PRODUCTS FOR EXTEMPORANEOUS PREPARATIONS 6 AMPHOTERICIN B X Inj. Pd. 99100416 50 mg 20 ml COLLOIDAL SULFUR 00901725 50 g CYCLOSPORINE X Inj. Sol. 99100387 1 ERYTHROMYCIN X Pd. (external use) 99100163 2g HYDROCORTISONE 00900761 5g HYDROCORTISONE ACETATE X 00906689 10 g LIQUOR CARBONIS DETERGENS 00903256 500 ml METHADONE HYDROCHLORIDE Z 00907561 Methadone 6 2013-04 25 g 100 g Where no price is indicated, pharmacists may purchase the product of their choice. The product thus obtained is considered insured and the price payable by the Régie is the pharmacist's cost price. Page 447 CODE BRAND NAME MANUFACTURER SIZE COST OF PKG. SIZE UNIT PRICE MITOMYCINE X Inj. Pd. 99004518 1 PRECIPITATED SULFUR 00901733 500 g SALICYLIC ACID 00901164 50 g SUBLIMED SULFUR 00896217 125 g TAR (MINERAL) 00897361 25 g TAR (WOOD) 00908169 100 ml VANCOMYCIN HYDROCHLORIDE X Pd. 99100176 Page 448 1g 2013-04 VEHICLES, SOLVENTS OR ADJUVANTS CODE BRAND NAME MANUFACTURER SIZE COST OF PKG. SIZE UNIT PRICE VEHICLES, SOLVENTS OR ADJUVANTS 6 ANHYDROUS SODIUM CITRATE 99002779 100 g ARTIFICIEL Oph. Sol. 00921270 15 ml BASES/ EMULSIONS 02009609 Aquaphor 99002825 Cliniderm 00896624 Cold Cream 00902918 Dermabase (creme) 99000385 Glaxal Base (creme) 00837776 Schering Base (creme) 00403342 Surfa Base (creme) 396 g 85 g 454 g 450 g 460 g 50 g 100 g 450 g 450 g 500 g CARBOXYMETHYLCELLULOSE SODIUM 00897175 100 g CASSETTE OR BAG FOR ADMINISTRATION DEVICE 99002248 1 CHLOROFORM 99002752 100 ml CITRIC ACID Pd. 99001500 6 2013-04 50 g Where no price is indicated, pharmacists may purchase the product of their choice. The product thus obtained is considered insured and the price payable by the Régie is the pharmacist's cost price. Page 451 CODE BRAND NAME MANUFACTURER SIZE DEXTROSE Inj. Sol. 99002256 UNIT PRICE 5% 500 ml 1000 ml DEXTROSE (MINI-BAGS) Inj. Sol. 00921289 COST OF PKG. SIZE 5% 25 ml 50 ml 100 ml 250 ml DISPOSABLE NEEDLE FOR SYRINGUES 99005077 100 DISTILLED WATER 00906719 4550 ml ELASTOMERIC INFUSOR (CONTINUOUS) 99002280 1 ELASTOMERIC INFUSOR (INTERMITENT) 99002272 1 EMPTY BAG FOR IV SOLUTIONS Bag 99002299 1 ETHANOL Liq. 99002388 95 % 750 ml GELATIN (EMPTY CAPSULE) Caps. 99001519 Page 452 1 2013-04 CODE BRAND NAME MANUFACTURER COST OF PKG. SIZE SIZE UNIT PRICE GLYCERIN 5 00903159 100 ml GLYCINE/ SODIUM CHLORIDE 94 mg -73.3 mg 02230857 Flolan (diluant pour) GSK 50 ml 10.36 HYDRATED LANOLIN 00902659 450 g LACTOSE 00900834 MAGNESIUM HYDROXIDE / ALUMINUM HYDROXIDE Oral Susp. 99003376 500 g 400 mg -400 mg/5 mL 350 ml MAGNESIUM HYDROXIDE/ ALUMINIUM HYDROXIDE/ SIMETHICONE Oral Susp. 400 mg - 400 mg - 40 mg/5 mL 99100243 350 ml METHYLCELLULOSE 00902365 100 g 99001527 500 g Pd. 1 500 cps MINERAL OIL 00906654 5 2013-04 500 ml Where no price is indicated, pharmacists may purchase the product of their choice. The product thus obtained is considered insured and the price payable by the Régie is the pharmacist's cost price. Page 453 CODE BRAND NAME MANUFACTURER SIZE COST OF PKG. SIZE UNIT PRICE PROPYLENE GLYCOL 00903353 500 ml SIMPLE SYRUP 00905038 500 ml SODIUM BENZOATE Pd. 99001535 100 g SODIUM BICARBONATE Pd. 99100058 100 g SODIUM CHLORIDE Flush. sol. 0.9 % PPB 99100499 BD Saline SP NaCl 0.9 % B-D 99100894 Chlorure de Sodium MedXL 3 ml 5 ml 10 ml 10 ml Inj. Sol. 99002310 0.9 % 500 ml 1000 ml SODIUM CHLORIDE (SMALL VOLUMES) Inj. Sol. 99002329 0.90 0.95 1.00 0.95 0.9 % 5 ml 10 ml 20 ml 50 ml SODIUM CHLORIDE INHALATION THERAPY 0.9 % 00801267 Page 454 3 ml 2013-04 CODE BRAND NAME MANUFACTURER SIZE SODIUM CHLORURE MINI-SAC Inj. Sol. 00921300 COST OF PKG. SIZE UNIT PRICE 0.9 % 25 ml 50 ml 100 ml 250 ml SOFT WHITE PARAFFIN 00902691 450 g SOFT YELLOW PARAFFIN 00902683 454 g SORBITOL 99000555 100 g STERILE SYRINGE CAP 99100673 25 STERILE WATER FOR INJECTION 99100407 250 ml 500 ml 1000 ml 2000 ml STERILE WATER FOR INJECTION (SMALL VOLUMES) 99002264 5 ml 10 ml 20 ml 50 ml STERILE WATER INHALATION THERAPY 00920282 2013-04 3 ml 5 ml Page 455 CODE BRAND NAME MANUFACTURER SIZE COST OF PKG. SIZE UNIT PRICE SWEET ALMOND OIL 00907448 100 ml SWEETENERS (VARIOUS FLAVOURS) 99002353 500 ml SYRINGE FOR ADMINISTRATION DEVICE 99002302 1 TRAGACANTH Pd. 99002361 100 g VEHICLES FOR ORAL SUSPENSIONS Oral Susp. 99003171 99003198 99003201 99003228 Ora-Plus Ora-Sweet Ora-Sweet SF Vehicule H.S.C. 473 ml 473 ml 473 ml 250 ml WATER FOR INJECTION (INHALATION THERAPY) 00905178 00905186 2 ml 10 ml 30 ml 50 ml 5 ml WATER FOR INJECTION/ BENZYL ALCOHOL 0.9% 00906077 30 ml WATER FOR INJECTION/ BENZYL ALCOHOL 1.5 % 00402257 Page 456 30 ml 50 ml 2013-04 CODE BRAND NAME MANUFACTURER SIZE COST OF PKG. SIZE UNIT PRICE WATER FOR INJECTION/ PARABENS 00905445 30 ml XANTHAN GUM 99002760 2013-04 100 g Page 457
Similar documents
List of Medications
Products for Which the Wholesaler’s Mark-Up Is Limited to a Maximum Amount
More informationNew List, in force from 15 July 2016
List of Drugs for Which the Lowest Price Method Does Not Apply
More information